Citrus Sinensis ID: 004633
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 741 | 2.2.26 [Sep-21-2011] | |||||||
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.354 | 0.432 | 0.496 | 3e-66 | |
| O22040 | 666 | Mitogen-activated protein | no | no | 0.411 | 0.457 | 0.424 | 1e-63 | |
| Q9FZ36 | 651 | Mitogen-activated protein | no | no | 0.407 | 0.463 | 0.415 | 5e-63 | |
| Q54R82 | 942 | Mitogen-activated protein | no | no | 0.357 | 0.281 | 0.435 | 6e-63 | |
| Q99759 | 626 | Mitogen-activated protein | yes | no | 0.336 | 0.397 | 0.448 | 6e-61 | |
| Q61084 | 626 | Mitogen-activated protein | yes | no | 0.336 | 0.397 | 0.448 | 1e-60 | |
| O22042 | 651 | Mitogen-activated protein | no | no | 0.344 | 0.391 | 0.459 | 9e-60 | |
| Q9SZ67 | 1895 | Probable WRKY transcripti | no | no | 0.336 | 0.131 | 0.464 | 2e-59 | |
| Q9Y2U5 | 619 | Mitogen-activated protein | no | no | 0.349 | 0.418 | 0.441 | 2e-58 | |
| Q10407 | 1116 | MAP kinase kinase kinase | yes | no | 0.346 | 0.230 | 0.437 | 2e-57 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 253 bits (647), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 136/274 (49%), Positives = 185/274 (67%), Gaps = 11/274 (4%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
P + WQKG+L+GRG+FGSVY G + + G A+KEV ++ ++ ECI+QLE E
Sbjct: 324 PDGGAIITSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGE 382
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRH 465
IK+L L+H+NIV+Y G+ +LYI+LE V GS+ + Y R RD S+V +TR
Sbjct: 383 IKLLSQLQHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRD---SVVSLYTRQ 439
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 525
IL+GL YLH IHRDIK AN+LVDA+G VKLADFG+AK ++ + S KG+P WMAP
Sbjct: 440 ILDGLKYLHDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWMAP 498
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 584
EVI +KD + + A DIWSLGCTV+EM TG+ P+S+ E QA+F++ T P +P+
Sbjct: 499 EVIN---RKDSDGYGSPA-DIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPD 554
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
LS + + F+L+C NP ERP+A ELL HPF+R
Sbjct: 555 TLSLDARLFILKCLKVNPEERPTAAELLNHPFVR 588
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 244 bits (624), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 144/339 (42%), Positives = 201/339 (59%), Gaps = 34/339 (10%)
Query: 311 ESNNHLNAHPLPLPPGALSPPKSSVTSAVMP-HIMEKPSASPKK----------SQWQKG 359
+ +N N P P G L+ +TS + I KPS SP W+KG
Sbjct: 19 DDDNQENQPPFP---GVLA---DKITSCIRKSKIFIKPSFSPPPPANTVDMAPPISWRKG 72
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGHLKHE 416
+LIGRG FG+VY+G N ++G A+K+V I + K+ I++LE+E+K+L +L H
Sbjct: 73 QLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKNLSHP 132
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
NIV+Y G+ DD L I LE+V GSI+ + E ES+VR +TR +L GL YLH+
Sbjct: 133 NIVRYLGTVREDDTLNILLEFVPGGSISSLL-EKFGPFPESVVRTYTRQLLLGLEYLHNH 191
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+HRDIKGAN+LVD G +KLADFG +K L ++ S+KG+P WMAPEVI
Sbjct: 192 AIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVILQTGH 251
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKV--LNRTPPIPEMLSSEG 590
+ + DIWS+GCTVIEM+TGK PWS +++ A+F + PPIP+ LSS+
Sbjct: 252 -------SFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTLSSDA 304
Query: 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 629
KDFLL+C P RP+A ELL+HPF+ + ++ S +
Sbjct: 305 KDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDL 343
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 5e-63, Method: Compositional matrix adjust.
Identities = 138/332 (41%), Positives = 197/332 (59%), Gaps = 30/332 (9%)
Query: 319 HPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS---------QWQKGKLIGRGTFGS 369
HP P P S +TS + ++ S SP + +W+KG+LIGRG FG+
Sbjct: 26 HPPPFP----SLLADKITSCIRKSMVFAKSQSPPNNSTVQIKPPIRWRKGQLIGRGAFGT 81
Query: 370 VYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426
VY+G N ++G A+K+V I + K+ I++LE+E+K+L +L H NIV+Y G+
Sbjct: 82 VYMGMNLDSGELLAVKQVLITSNCASKEKTQAHIQELEEEVKLLKNLSHPNIVRYLGTVR 141
Query: 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486
D+ L I LE+V GSI+ + E ES+VR +T +L GL YLH+ +HRDIKGA
Sbjct: 142 EDETLNILLEFVPGGSISSLL-EKFGAFPESVVRTYTNQLLLGLEYLHNHAIMHRDIKGA 200
Query: 487 NLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 543
N+LVD G +KLADFG +K L +S S+KG+P WMAPEVI + +
Sbjct: 201 NILVDNQGCIKLADFGASKQVAELATISGAKSMKGTPYWMAPEVILQTGH-------SFS 253
Query: 544 VDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKV--LNRTPPIPEMLSSEGKDFLLRCFLR 600
DIWS+GCTVIEM+TGK PWS +++ A+F + PPIP+ +SS+ DFLL+C +
Sbjct: 254 ADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPIPDNISSDANDFLLKCLQQ 313
Query: 601 NPVERPSAVELLEHPFIRNANYQNLSVPMRVF 632
P RP+A ELL+HPF+ ++ S + F
Sbjct: 314 EPNLRPTASELLKHPFVTGKQKESASKDLTSF 345
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 6e-63, Method: Compositional matrix adjust.
Identities = 122/280 (43%), Positives = 186/280 (66%), Gaps = 15/280 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGH 412
+WQKG+++GRG +GSVY+G N++TG A+K+++I I DPK I +EI+V+
Sbjct: 169 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 228
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L+H+NIV+Y G+ + L ++LEY+ GSI+ + + +E++++ +T+ IL GL++
Sbjct: 229 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSF 287
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAV 531
LH+ + IHRDIKGAN+L+D G+VKL+DFG +K +G+ + S++G+P WMAPEVIK
Sbjct: 288 LHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIK-- 345
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVL--NRTPPIPEMLSS 588
+ G+ + + DIWSLGC ++EM T +PPWS E M+ + N P IP +S
Sbjct: 346 --QTGHGR---SSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQ 400
Query: 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628
E DFL CF R+P ERP A +LL+HPFI N + N+ +P
Sbjct: 401 EAFDFLNLCFKRDPKERPDANQLLKHPFIMNLD-DNIQLP 439
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 122/272 (44%), Positives = 176/272 (64%), Gaps = 23/272 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W++GKL+G+G FG VY+ + +TG A K+V PD P++++ + LE EI++L +L+H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421
Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
E IVQYYG + + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 526
HS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+PE
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMR---SVTGTPYWMSPE 537
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 584
VI +G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ + P +P
Sbjct: 538 VISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 590
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
+S G+DFL R F+ +RPSA ELL H F
Sbjct: 591 HISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 235 bits (599), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 122/272 (44%), Positives = 176/272 (64%), Gaps = 23/272 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W++GKL+G+G FG VY+ + +TG A K+V PD P++++ + LE EI++L +L+H
Sbjct: 362 WRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALECEIQLLKNLQH 421
Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
E IVQYYG + + L I++EY+ GS+ ++ + +TES+ R +TR IL G++YL
Sbjct: 422 ERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYL 480
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 526
HS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+PE
Sbjct: 481 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMSPE 537
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 584
VI +G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ + P +P
Sbjct: 538 VISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPS 590
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
+S G+DFL R F+ +RPSA ELL H F
Sbjct: 591 HISEHGRDFLRRIFV-EARQRPSAEELLTHHF 621
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 9e-60, Method: Compositional matrix adjust.
Identities = 125/272 (45%), Positives = 170/272 (62%), Gaps = 17/272 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---KSAECIKQLEQEIKVLG 411
+W+KG+LIG G FG VY+G N ++G AIK+V I P K+ I++LE+E+++L
Sbjct: 67 RWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELEEEVQLLK 126
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+L H NIV+Y G+ D L I +E+V GSI+ + E E ++ +T+ +L GL
Sbjct: 127 NLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLL-EKFGSFPEPVIIMYTKQLLLGLE 185
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVI 528
YLH+ +HRDIKGAN+LVD G ++LADFG +K + L+ S+KG+P WMAPEVI
Sbjct: 186 YLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYWMAPEVI 245
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEM 585
+ + DIWS+GCTVIEM TGKPPWSE A + RT PPIPE
Sbjct: 246 LQTGH-------SFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPED 298
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
LS E KDFL++C + P R SA ELL+HPF+
Sbjct: 299 LSPEAKDFLMKCLHKEPSLRLSATELLQHPFV 330
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9SZ67|WRK19_ARATH Probable WRKY transcription factor 19 OS=Arabidopsis thaliana GN=WRKY19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (589), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 123/265 (46%), Positives = 172/265 (64%), Gaps = 16/265 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
WQKG+L+GRG+ GSVY G + + G A KEV ++ ++ E I+Q+E I +L L+H
Sbjct: 1626 WQKGQLLGRGSLGSVYEGISAD-GDFFAFKEVSLLDQGSQAHEWIQQVEGGIALLSQLQH 1684
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+NIV+Y G+ + +LYI+LE V GS+ + + + + +S+V +TR IL+GL YLH
Sbjct: 1685 QNIVRYRGTTKDESNLYIFLELVTQGSLRKLYQRN--QLGDSVVSLYTRQILDGLKYLHD 1742
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP--NWMAPEVIKAVMQ 533
IHR+IK AN+LVDA+G VKLADFG+AK +SL +P NWMAPEVI
Sbjct: 1743 KGFIHRNIKCANVLVDANGTVKLADFGLAK-------VMSLWRTPYWNWMAPEVILNPKD 1795
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKD 592
DG DIWSLGCTV+EMLTG+ P+S+ E A++ + + P IP++LS + +D
Sbjct: 1796 YDG---YGTPADIWSLGCTVLEMLTGQIPYSDLEIGTALYNIGTGKLPKIPDILSLDARD 1852
Query: 593 FLLRCFLRNPVERPSAVELLEHPFI 617
F+L C NP ERP+A ELL HPF+
Sbjct: 1853 FILTCLKVNPEERPTAAELLNHPFV 1877
|
Transcription factor. Interacts specifically with the W box (5'-(T)TGAC[CT]-3'), a frequently occurring elicitor-responsive cis-acting element. May act also as a disease resistance protein with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 228 bits (580), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 125/283 (44%), Positives = 179/283 (63%), Gaps = 24/283 (8%)
Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
PS SP+ + W+ GKL+G+G FG VY+ + +TG A+K+V PD P++++ + LE
Sbjct: 346 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 405
Query: 406 EIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
EI++L +L HE IVQYYG + + L I++EY+ GSI ++ + +TE++ R +T
Sbjct: 406 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 464
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSL 516
R IL G+ YLHS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+
Sbjct: 465 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMK---SV 521
Query: 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 576
G+P WM+PEVI +G + A DIWS+ CTV+EMLT KPPW+EFE A+FK+
Sbjct: 522 TGTPYWMSPEVISG----EGYGRKA---DIWSVACTVVEMLTEKPPWAEFEAMAAIFKIA 574
Query: 577 NR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
+ P +P +S +DFL R F+ + RPSA ELL H F+
Sbjct: 575 TQPTNPKLPPHVSDYTRDFLKRIFVEAKL-RPSADELLRHMFV 616
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 224 bits (570), Expect = 2e-57, Method: Compositional matrix adjust.
Identities = 122/279 (43%), Positives = 162/279 (58%), Gaps = 22/279 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD------DPKSAECIKQLEQEIK 408
+W KG+LIG GT+G V++ N TG A+K+V+I P D + + + EI
Sbjct: 824 KWMKGELIGNGTYGKVFLAMNINTGELIAVKQVEI-PQTINGRHDQLRKDIVDSINAEIS 882
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
++ L H NIVQY G E + + I+LEYV GSI R +R + E +VR +R +L
Sbjct: 883 MIADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIGRCLRNYG-PFEEQLVRFVSRQVLY 941
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSPNWMAP 525
GL+YLHS IHRD+K NLL+D GV K++DFG++KH + LS++GS WMAP
Sbjct: 942 GLSYLHSKGIIHRDLKADNLLIDFDGVCKISDFGISKHSDNVYDNDANLSMQGSIFWMAP 1001
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV--LNRTPPIP 583
EVI Q + VD+WSLGC V+EML G+ PWS E QAMFK+ + PPIP
Sbjct: 1002 EVIHNDHQ-----GYSAKVDVWSLGCVVLEMLAGRRPWSTDEAIQAMFKLGTEKKAPPIP 1056
Query: 584 EMLSS----EGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
L S E FL CF N RP+A ELL HPF++
Sbjct: 1057 SELVSQVSPEAIQFLNACFTVNADVRPTAEELLNHPFMK 1095
|
May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 741 | ||||||
| 255538424 | 692 | conserved hypothetical protein [Ricinus | 0.792 | 0.848 | 0.576 | 1e-168 | |
| 225470467 | 707 | PREDICTED: uncharacterized protein LOC10 | 0.865 | 0.906 | 0.498 | 1e-162 | |
| 449470172 | 709 | PREDICTED: uncharacterized protein LOC10 | 0.840 | 0.878 | 0.517 | 1e-155 | |
| 225458499 | 782 | PREDICTED: uncharacterized protein LOC10 | 0.601 | 0.570 | 0.623 | 1e-154 | |
| 449448516 | 760 | PREDICTED: uncharacterized protein LOC10 | 0.878 | 0.856 | 0.443 | 1e-144 | |
| 255562635 | 709 | conserved hypothetical protein [Ricinus | 0.595 | 0.622 | 0.598 | 1e-143 | |
| 449521088 | 604 | PREDICTED: uncharacterized protein LOC10 | 0.666 | 0.817 | 0.531 | 1e-141 | |
| 356565641 | 637 | PREDICTED: uncharacterized protein LOC10 | 0.564 | 0.656 | 0.586 | 1e-140 | |
| 357465415 | 700 | Mitogen-activated protein kinase kinase | 0.731 | 0.774 | 0.471 | 1e-137 | |
| 356514005 | 634 | PREDICTED: mitogen-activated protein kin | 0.435 | 0.509 | 0.686 | 1e-135 |
| >gi|255538424|ref|XP_002510277.1| conserved hypothetical protein [Ricinus communis] gi|223550978|gb|EEF52464.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1542), Expect = e-168, Method: Compositional matrix adjust.
Identities = 360/625 (57%), Positives = 425/625 (68%), Gaps = 38/625 (6%)
Query: 21 NNRKLTRVRKLRHVPDDELGLLMT-DRACSPSASPDSARMSPSPGTSDHWSSSAVPKPLP 79
N ++LTR RK+RH +LGL + DR SP ASPDSAR SP S SS A+P+PLP
Sbjct: 21 NTKRLTRQRKIRHETQQDLGLQFSQDRLNSPPASPDSARKPRSPPCSSSSSSPALPQPLP 80
Query: 80 LPDLASLFRKPES----SGHGF-ESPEGRPHR--GRKSTNQ----TAKGSAGFLSHFHKG 128
LP+ + R+ E GH SPE RP R S +Q +A GS+ F F
Sbjct: 81 LPE-SHFTRRLEPFGFIPGHAVPASPEERPIYLLRRNSADQVDINSATGSSNFQWRFSPQ 139
Query: 129 DSQVLNIESVKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNP----KSISTRR 184
D N+++ + LR ++ RS P SS VSP+RSN + N K T
Sbjct: 140 DP---NVDTANHGLRLNIAPRSAP----SSPLVSPRRSNAGEFSTTFNAADSTKCSKTCC 192
Query: 185 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
+G +DLNIEC NY P+SAPTS FSSP VSPQ S T + SF A
Sbjct: 193 KGQLNDLNIECVNYKLSWIDSPRSAPTSGFSSPNVSPQRSYTIDFLPSFVA--------- 243
Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 304
EVPDLGR G TS S K D S + P +QS N + P K F L +K
Sbjct: 244 REVPDLGRHAGHTSRKSLVKTG-NGLDRSAI-YPSQQSPTPNKKPPHKFSFQLHNKMFVG 301
Query: 305 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 362
SKE E+N+ +AHPLPLPPGA SP +S + S A++ H +EKP+ S +K+QW KGKLI
Sbjct: 302 KSKEWPETNSQFSAHPLPLPPGAASP-QSFIPSPPAILHHTIEKPNVSLRKTQWLKGKLI 360
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
GRGT+GSVY+GTNRETGA CA+KEVDIIP D KS ECIKQLEQEI++L HL+H NIVQYY
Sbjct: 361 GRGTYGSVYVGTNRETGALCAMKEVDIIPGDSKSVECIKQLEQEIRLLQHLEHPNIVQYY 420
Query: 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 482
E+VDDH YIYLEYV+PGSI++YVREHC +TESIVRNFTRHIL+GLAYLHS TIHRD
Sbjct: 421 SCEIVDDHFYIYLEYVYPGSISKYVREHCGAMTESIVRNFTRHILSGLAYLHSKKTIHRD 480
Query: 483 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 542
IKGANLLV++SG+VKLADFGMAKHL+GLSYELSLKGSP+WMAPEVI+AVMQ + NP LAL
Sbjct: 481 IKGANLLVNSSGIVKLADFGMAKHLSGLSYELSLKGSPHWMAPEVIQAVMQNNANPDLAL 540
Query: 543 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNP 602
AVDIWSLGCT+IEM TGKPPW E EGPQAMFK LN+TPPIPE +S E KDFL C RNP
Sbjct: 541 AVDIWSLGCTIIEMFTGKPPWGELEGPQAMFKALNKTPPIPEAMSPEAKDFLCCCLRRNP 600
Query: 603 VERPSAVELLEHPFIRNANYQNLSV 627
ERPSA LLEHPF+RN++ NLS
Sbjct: 601 AERPSASMLLEHPFLRNSSELNLST 625
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225470467|ref|XP_002263088.1| PREDICTED: uncharacterized protein LOC100245919 [Vitis vinifera] gi|296084711|emb|CBI25853.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1490), Expect = e-162, Method: Compositional matrix adjust.
Identities = 344/690 (49%), Positives = 428/690 (62%), Gaps = 49/690 (7%)
Query: 25 LTRVRKLRHVPDDELGLLMTDRACS-PSASPDSARMSPSPGTSDHWSSSAVPKPLPLPDL 83
LTR RKLRHV + + L+ R+ + P S S S SS VP PLP P+L
Sbjct: 25 LTRARKLRHVRGNHIDALVRSRSSAEPKDLLPLPSSSSSFDHSSERLSSVVPHPLPRPEL 84
Query: 84 ASLFRKPESSGHGF--ESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIESVKND 141
A LFR+ S + P P G S GF KG+S V D
Sbjct: 85 ALLFRRNGGSNSNLNCDRPLPSPKEGL---------SRGFEDR-DKGNSFV-------GD 127
Query: 142 LRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPL------HNPKSISTRRRGFSHDLNIEC 195
V V ST T S + R +++ L S+ R F
Sbjct: 128 GNGEVAVSSTATG--SKVGYNEARKSMEQFDTLSSRYLPQGQNSVKNNRVNF-------- 177
Query: 196 ANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF-SSFWAPKEIQDWSTAEVPDLGRFV 254
+ D+ +SAPTS SSPAVSPQ + GN+F S +P+ Q WS E+P
Sbjct: 178 -----KLDVPTRSAPTSSLSSPAVSPQRTSPGNLFLSQNVSPQVFQGWSAPEMPVFDMVT 232
Query: 255 GCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNN 314
G T +SP ++ ++S D+SPL SP +S N RSP PL K + S E+N+
Sbjct: 233 GFTPQMSP-EQTMFSTDNSPLHSPTVKSPHVNPRSPSGPASPLHPKISLETSTARRENNS 291
Query: 315 HLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT 374
H N H LPLPPG ++PP++S ++ P ++ K + P +QWQKGKLIGRGTFGSVY+ T
Sbjct: 292 HANVHRLPLPPGVVAPPQAS---SIHP-VIAKTESFPMTTQWQKGKLIGRGTFGSVYVAT 347
Query: 375 NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434
NRETGA CA+KEV+++PDDPKSAE IKQLEQEIK+L LKH NIVQY+GSE V+D LYIY
Sbjct: 348 NRETGALCAMKEVELLPDDPKSAESIKQLEQEIKILSQLKHPNIVQYFGSETVEDRLYIY 407
Query: 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 494
LEYVHPGSIN+YVREHC ITES+VRNFTRHIL+GLAYLHST TIHRDIKGANLLVDASG
Sbjct: 408 LEYVHPGSINKYVREHCGAITESVVRNFTRHILSGLAYLHSTKTIHRDIKGANLLVDASG 467
Query: 495 VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 554
VVKLADFGM+KHLTG + +LSLKGSP WMAPE+++AVMQKD + LA AVDIWSLGCT+I
Sbjct: 468 VVKLADFGMSKHLTGAAADLSLKGSPYWMAPELMQAVMQKDHSSDLAFAVDIWSLGCTII 527
Query: 555 EMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
EML GKPPWSE+EG AMFKV+ +PPIP+ LSSEGKDFL CF RNP ERP A++LLEH
Sbjct: 528 EMLNGKPPWSEYEGAAAMFKVMRESPPIPKTLSSEGKDFLRCCFRRNPAERPPAIKLLEH 587
Query: 615 PFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEV 674
F++N+ ++ + + FS + L DK++ E++ + + +P SP R + K S
Sbjct: 588 RFLKNSTQLDVPLLTQAFSGMKLPDKANKSREKSNDRVDPVPISP--RKKTSKGKKASGT 645
Query: 675 CPQCHAGTFNCATASRHSSCSTFGVHISLS 704
Q H T + AS HS ST SLS
Sbjct: 646 GQQSHRETSDLTVASHHSPRSTLEALPSLS 675
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470172|ref|XP_004152792.1| PREDICTED: uncharacterized protein LOC101219854 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 554 bits (1427), Expect = e-155, Method: Compositional matrix adjust.
Identities = 347/670 (51%), Positives = 425/670 (63%), Gaps = 47/670 (7%)
Query: 20 FNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSP----GTSDHWSSSAVP 75
F R+LTR RKLRH+ D ++G P + PDS +S P G S+ WSSS P
Sbjct: 38 FIQRRLTRQRKLRHLTDQDVGFEH------PRSLPDSPDISAKPKSPLGGSERWSSSPSP 91
Query: 76 KPLPLPDLASLFRKPESSGHGFESPEGRPHRG--RKSTNQTAKGSAGFLSHFHKGDSQVL 133
+PLPLP+L + R PE + + G P RK ++ + H + + L
Sbjct: 92 QPLPLPELFPV-RSPEFGSNYGQGRVGSPVETSVRKCSDHATTNVSRSFGHNQRRVATDL 150
Query: 134 NIESVKNDLRPSVPVRSTPTSLSS-SHAVSPQRSNL---QNPTPLHNPKSISTRRRGFSH 189
+E V + R ++P SLS+ S ++P + L + TP + + RG
Sbjct: 151 TLEVVDGNSRTGATAFTSPQSLSANSGKLNPNKEFLFGCSDQTP-------NNKGRGSPT 203
Query: 190 DLNIECANYSSRADIIPK-----SAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
+ E NY ++ PK SAPTS+ SP VSP+ S GN F + E Q+ +
Sbjct: 204 HPSAERGNY----NLTPKKSSSKSAPTSILPSPVVSPRKSYNGNHFVPGLSHHEHQESPS 259
Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQ 304
SP P + S+ PL SP +SS SN RS + FPL K
Sbjct: 260 N-----------NSPKVPPLKTALSSQPFPLHSPTARSSISNSRSHNDMTFPLHTKLQKD 308
Query: 305 NSKELLESNNHLNAHPLPLPPGALSPPKSSVTS--AVMPHIMEKPSASPKKSQWQKGKLI 362
NS + ES+ H+NAHPLPLPP ++ ++S S + + H++EKP S K QWQKGKLI
Sbjct: 309 NSIDRSESHAHVNAHPLPLPPPLVASSQASAQSLPSNVHHVIEKPFISSMKGQWQKGKLI 368
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
GRGTFGSVY+ TNRETGA CA+KEVD+IPDDPKSAECIKQLEQEI+VL HLKH NIVQYY
Sbjct: 369 GRGTFGSVYLATNRETGALCAMKEVDLIPDDPKSAECIKQLEQEIEVLSHLKHPNIVQYY 428
Query: 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 482
GSE++ D YIYLEYV+PGSIN+YVRE C ITESIVRNFTRHIL+GLAYLHST TIHRD
Sbjct: 429 GSEIIGDCFYIYLEYVYPGSINKYVRERCGAITESIVRNFTRHILSGLAYLHSTKTIHRD 488
Query: 483 IKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 542
IKGANLLVD+SGVVKLADFGMAKHLTG Y+LSLKGSP WMAPEVIKA M KD NP LAL
Sbjct: 489 IKGANLLVDSSGVVKLADFGMAKHLTG-QYDLSLKGSPYWMAPEVIKAAMLKDANPDLAL 547
Query: 543 AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNP 602
AVDIWSLGCT+IEML GKPPW EFEG Q MFKVLN+TPPIPE LS EGKDFL CF RNP
Sbjct: 548 AVDIWSLGCTIIEMLNGKPPWCEFEGHQVMFKVLNKTPPIPEKLSPEGKDFLQCCFQRNP 607
Query: 603 VERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETR 662
+RP+A+ LL+HPF+R+++ N S+P FS +NL +K + K + +S T
Sbjct: 608 ADRPTAMVLLDHPFLRSSSDSNASIPTSAFSTMNLLEKLLSPKDPLNPKGDQAQNSSGTL 667
Query: 663 VRNRKLPCNS 672
N L C S
Sbjct: 668 TSNDYLSCRS 677
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225458499|ref|XP_002282240.1| PREDICTED: uncharacterized protein LOC100257467 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1418), Expect = e-154, Method: Compositional matrix adjust.
Identities = 290/465 (62%), Positives = 342/465 (73%), Gaps = 19/465 (4%)
Query: 185 RGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWAPKEIQDWST 244
RGFS DLN E Y+ R +I +SAPTS FSSPA+SPQ G S +A IQD+ +
Sbjct: 228 RGFSQDLNDEACPYNLRVNIPARSAPTSGFSSPALSPQRFSPGERLPSSYA--AIQDFQS 285
Query: 245 AEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNL----RSPRKVYFPLRHK 300
P R GC+S +SP K ++ D+SPL SP QS + +SP + F L K
Sbjct: 286 ---PGFDRLPGCSSQMSPLK-TPHTPDYSPLHSPTVQSPCISPCLSPKSPTGIAFSLYPK 341
Query: 301 SLPQNSKELLESNNHLNAHPLPLPPGALSP-----PKSSVT---SAVMPHIMEKPSASPK 352
LP + E N H+ HPLPLPP AL P P ++T SA+ H EKP+
Sbjct: 342 LLPGSHVTWPEKNGHVTVHPLPLPPIALMPSELPLPPKALTPSESAISHHTAEKPNVPSM 401
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
KSQWQKGKLIGRGTFGSVY+ TNRETGA CA+KEVDIIPDDPKS+ECIKQLEQEIKVL H
Sbjct: 402 KSQWQKGKLIGRGTFGSVYVATNRETGALCAMKEVDIIPDDPKSSECIKQLEQEIKVLHH 461
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
LKH NIVQYYGSE+VDDH YIYLEYVHPGSIN+YV +H +TE++VRNFTRHIL+GLAY
Sbjct: 462 LKHPNIVQYYGSEIVDDHFYIYLEYVHPGSINKYV-DHFGAMTENVVRNFTRHILSGLAY 520
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
LHST TIHRDIKGANLLVD+ GVVKLADFG+AK LTG + +LSLKGSP+WMAPEV++AV+
Sbjct: 521 LHSTKTIHRDIKGANLLVDSFGVVKLADFGLAKFLTGQACDLSLKGSPHWMAPEVMQAVL 580
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592
+KD NP LA AVDIWSLGCT+IEML G+PPWSEF P AMFKVL+ +PP+PE LSSEGKD
Sbjct: 581 RKDANPDLAFAVDIWSLGCTIIEMLNGRPPWSEFAAPAAMFKVLHESPPLPETLSSEGKD 640
Query: 593 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINL 637
FL CF RNP ERPSA LL+H F+R++ QN+S + FS + L
Sbjct: 641 FLQHCFRRNPAERPSAAMLLDHSFVRSSQDQNVSGFSQAFSGMQL 685
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448516|ref|XP_004142012.1| PREDICTED: uncharacterized protein LOC101219486 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1335), Expect = e-144, Method: Compositional matrix adjust.
Identities = 323/728 (44%), Positives = 423/728 (58%), Gaps = 77/728 (10%)
Query: 5 GKAGNFFKNRVQSSSFNNRKLTRVRKLRHVPDDELGLLMTDRACSPSASPDSARMSPSPG 64
G A N ++ V F + +R RKLR++ E + + A +P+ +S SP
Sbjct: 36 GSAENNYRGIVWR--FGASRYSRHRKLRNLSGREH--VDSSLAKWSDTAPEPVSLSRSPS 91
Query: 65 TSDHWSSSAVPKPLPLPDLASLFRKPE------SSGHGFESPEGRPHRGRKSTNQTAKGS 118
TSDH AVP LPLP+++ LF+ E S+G + P P KGS
Sbjct: 92 TSDH---PAVP--LPLPEVSPLFQPRERISTSNSAGGEGDCPLPSP-----------KGS 135
Query: 119 AGFLSHFHKGDSQVLNI------ESVKNDLRPSVPVRSTPTSLSSSHA----VSPQRSNL 168
G GD + ++ + + + P+ ++S S+ H + + S
Sbjct: 136 RG-----RAGDERDVDRDRNAPPQKIGGGISPNASIKSVSDSVGERHKKEGQIEARLSGR 190
Query: 169 QNPTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGN 228
N P++ R GF D+ +SAPTS ++SP SPQ + +GN
Sbjct: 191 ANQDARRYPEN---SRNGF-------------WIDVPSRSAPTSPYTSPTPSPQRNISGN 234
Query: 229 VFS-SFWAPKEIQDWSTAEVPD-------LGRFVGCTS--PVSPFKRNV---------YS 269
+ + + +P Q WS E+P+ +G V P S R V S
Sbjct: 235 ISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHVWSAPELPSSAMMRGVPPAFFDCSTLS 294
Query: 270 ADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALS 329
+ SP+ SP +S + RSP PL K + E + H++ HPLPLPPG
Sbjct: 295 TESSPMHSPRGKSPHLDPRSPTGPTSPLHAKISHETHAMRREGSGHVSVHPLPLPPGVPM 354
Query: 330 PPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI 389
P SS ++ + + S S K+QWQKGKLIGRGTFGSVY+ +NR+ GA CA+KEV++
Sbjct: 355 PSASSPSTPISQANTKSESIS-MKNQWQKGKLIGRGTFGSVYVASNRQNGALCAMKEVEL 413
Query: 390 IPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE 449
DDPKSAE IKQLEQEIK+L LKH NIVQYYGS+++DD LYIYLEYVHPGSIN+YVRE
Sbjct: 414 FHDDPKSAESIKQLEQEIKLLSQLKHPNIVQYYGSDIIDDRLYIYLEYVHPGSINKYVRE 473
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
HC +TES+VRNFTRHIL+GLAYLHST TIHRDIKGANLLVD+ GVVKLADFGMAKHLTG
Sbjct: 474 HCGAMTESVVRNFTRHILSGLAYLHSTKTIHRDIKGANLLVDSCGVVKLADFGMAKHLTG 533
Query: 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 569
+LSLKGSP WMAPE++ +VMQKD P LALAVDIWSLGCT+IEM TGKPPWSE+EG
Sbjct: 534 QVADLSLKGSPYWMAPELLLSVMQKDNTPDLALAVDIWSLGCTIIEMFTGKPPWSEYEGA 593
Query: 570 QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 629
AMFKV+ TPP+PE LS E +DFL CF RNP ERP+A LLEHPF++N Y + S
Sbjct: 594 AAMFKVMKDTPPMPESLSYEARDFLKCCFQRNPAERPTAAMLLEHPFMKNLQYTDASSCS 653
Query: 630 RVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCPQCHAGTFNCATAS 689
+V + +L DK + ++ + K++ P + KL ++ + P H T + S
Sbjct: 654 QVVAGASLMDKCYSPSKQYSSKSDQSSMLPSPQNSKGKLAADNVIGPLSHHETSDLTVMS 713
Query: 690 RHSSCSTF 697
R+S ST
Sbjct: 714 RYSPRSTL 721
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562635|ref|XP_002522323.1| conserved hypothetical protein [Ricinus communis] gi|223538401|gb|EEF40007.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 515 bits (1327), Expect = e-143, Method: Compositional matrix adjust.
Identities = 273/456 (59%), Positives = 324/456 (71%), Gaps = 15/456 (3%)
Query: 190 DLNIE-CANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFSSFWA--PKEIQDWSTAE 246
D +++ CA+YS R + +SAPTS FSSP Q T F ++ K Q WS E
Sbjct: 216 DFSVDHCADYS-RINAPIRSAPTSPFSSP----QKLTTAADFLPYYQMIAKGNQVWSAPE 270
Query: 247 VPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNS 306
+ L + P + F +S D SPL SPP +S + N +SP L + + S
Sbjct: 271 MATLD--IPGLPPPAFFDYTAFSTDTSPLHSPPSRSPRRNPKSPTGGPASLNARLSIETS 328
Query: 307 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGT 366
+E N +L HPLPLPPGA S S+ +P ++ K + P KSQWQKGKLIGRGT
Sbjct: 329 REC---NANLEVHPLPLPPGASS--SRPSISSSVPQVISKAESIPLKSQWQKGKLIGRGT 383
Query: 367 FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426
FGSVY+ +NRETGA CA+KEVD+ PDDPKSAE IKQLEQEIKVL HLKH NIVQYYGSE+
Sbjct: 384 FGSVYVASNRETGALCAMKEVDMFPDDPKSAESIKQLEQEIKVLSHLKHPNIVQYYGSEI 443
Query: 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486
V DH YIYLEYVHPGSIN+YVREHC ITE++VR+F+RHIL+GLAYLHS TIHRDIKGA
Sbjct: 444 VGDHFYIYLEYVHPGSINKYVREHCGAITENVVRSFSRHILSGLAYLHSMKTIHRDIKGA 503
Query: 487 NLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 546
NLLVDASGVVKLADFGM+KHLTG + ELSLKGSP WMAPE+++AVMQKD + LALAVDI
Sbjct: 504 NLLVDASGVVKLADFGMSKHLTGQAAELSLKGSPYWMAPELMQAVMQKDTSSDLALAVDI 563
Query: 547 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP 606
WSLGCT+IEM TGKPPWS++EG AMFKVL PPIPE LS EGKDFL CF RNP +RP
Sbjct: 564 WSLGCTIIEMFTGKPPWSDYEGAAAMFKVLRDIPPIPETLSPEGKDFLHCCFQRNPADRP 623
Query: 607 SAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSH 642
SA LLEH ++RN+ + R + I L D +H
Sbjct: 624 SASMLLEHRWLRNSQQLDFPSSTRSINGIKLMDLTH 659
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521088|ref|XP_004167563.1| PREDICTED: uncharacterized protein LOC101228290 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1312), Expect = e-141, Method: Compositional matrix adjust.
Identities = 273/514 (53%), Positives = 342/514 (66%), Gaps = 20/514 (3%)
Query: 203 DIIPKSAPTSVFSSPAVSPQSSKTGNVFS-SFWAPKEIQDWSTAEVPD-------LGRFV 254
D+ +SAPTS ++SP SPQ + +GN+ + + +P Q WS E+P+ +G V
Sbjct: 53 DVPSRSAPTSPYTSPTPSPQRNISGNISNFHYMSPVGNQGWSAPELPNFPCVAAPVGNHV 112
Query: 255 GCTS--PVSPFKRNV---------YSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLP 303
P S R V S + SP+ SP +S + RSP PL K
Sbjct: 113 WSAPELPSSAMMRGVPPAFFDCSTLSTESSPMHSPRGKSPHLDPRSPTGPTSPLHAKISH 172
Query: 304 QNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIG 363
+ E + H++ HPLPLPPG P SS ++ + + S S K+QWQKGKLIG
Sbjct: 173 ETHAMRREGSGHVSVHPLPLPPGVPMPSASSPSTPISQANTKSESIS-MKNQWQKGKLIG 231
Query: 364 RGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG 423
RGTFGSVY+ +NR+ GA CA+KEV++ DDPKSAE IKQLEQEIK+L LKH NIVQYYG
Sbjct: 232 RGTFGSVYVASNRQNGALCAMKEVELFHDDPKSAESIKQLEQEIKLLSQLKHPNIVQYYG 291
Query: 424 SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 483
S+++DD LYIYLEYVHPGSIN+YVREHC +TES+VRNFTRHIL+GLAYLHST TIHRDI
Sbjct: 292 SDIIDDRLYIYLEYVHPGSINKYVREHCGAMTESVVRNFTRHILSGLAYLHSTKTIHRDI 351
Query: 484 KGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALA 543
KGANLLVD+ GVVKLADFGMAKHLTG +LSLKGSP WMAPE++ +VMQKD P LALA
Sbjct: 352 KGANLLVDSCGVVKLADFGMAKHLTGQVADLSLKGSPYWMAPELLLSVMQKDNTPDLALA 411
Query: 544 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPV 603
VDIWSLGCT+IEM TGKPPWSE+EG AMFKV+ TPP+PE LS E +DFL CF RNP
Sbjct: 412 VDIWSLGCTIIEMFTGKPPWSEYEGAAAMFKVMKDTPPMPESLSYEARDFLKCCFQRNPA 471
Query: 604 ERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRV 663
ERP+A LLEHPF++N Y + S +V + +L DK + ++ + K++ P +
Sbjct: 472 ERPTAAMLLEHPFMKNLQYTDASSCSQVVAGASLMDKCYSPSKQYSSKSDQSSMLPSPQN 531
Query: 664 RNRKLPCNSEVCPQCHAGTFNCATASRHSSCSTF 697
KL ++ + P H T + SR+S ST
Sbjct: 532 SKGKLAADNVIGPLSHHETSDLTVMSRYSPRSTL 565
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565641|ref|XP_003551047.1| PREDICTED: uncharacterized protein LOC100790701 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1301), Expect = e-140, Method: Compositional matrix adjust.
Identities = 261/445 (58%), Positives = 317/445 (71%), Gaps = 27/445 (6%)
Query: 212 SVFSSPAVSPQSSKTGNVFSSFWA-PKEIQDWSTAEVP--DLGRFVGCTSPVSPFKRNVY 268
S+ SP++SPQ ++ G+ ++A PK Q WST E+P D G P + F +
Sbjct: 161 SISGSPSMSPQKTRNGDFVPYYYACPKGNQFWSTPEMPTCDAGLL-----PPAFFDLSAL 215
Query: 269 SADHSPLP----SPPRQSSQSNLRS---PRKVYFPLRHKSLPQNSKELLESNNH--LNAH 319
S + S P SP R+S Q + R+ P P+ +P E NN + H
Sbjct: 216 STETSLSPNSHQSPQRKSPQKHTRTFSGPPSPIHPMLSLEIPTVRHE----NNAPPVAVH 271
Query: 320 PLPLPP--GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRE 377
PLPLPP G SPP +A H M K + P KSQW+KGKLIGRGTFGSVY+ TNRE
Sbjct: 272 PLPLPPRAGLTSPP----AAATFSHAMVKSESLPMKSQWKKGKLIGRGTFGSVYVATNRE 327
Query: 378 TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437
TGA CA+KEV++ PDDPKSAECIKQLEQEIKVL +LKH NIVQYYGSE+V+D YIYLEY
Sbjct: 328 TGALCAMKEVELFPDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYIYLEY 387
Query: 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 497
VHPGSIN+YVR+HC ITES++RNFTRHIL+GLAYLHS TIHRDIKGANLLVD++GVVK
Sbjct: 388 VHPGSINKYVRDHCGAITESVIRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSAGVVK 447
Query: 498 LADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
LADFGMAKHLTG LSL+GSP WMAPE+++AV+QKD +P LA A+DIWSLGCT+IEM
Sbjct: 448 LADFGMAKHLTGFEANLSLRGSPYWMAPELLQAVIQKDNSPDLAFAIDIWSLGCTIIEMF 507
Query: 558 TGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
TGKPPWSE+EG A+FKV+ TPPIPE LSSEGKDFL CF RNP ERP+A LLEH F+
Sbjct: 508 TGKPPWSEYEGAAALFKVMKETPPIPETLSSEGKDFLRCCFKRNPAERPTAAVLLEHRFL 567
Query: 618 RNANYQNLSVPMRVFSRINLGDKSH 642
+N+ + P ++++ + DK H
Sbjct: 568 KNSQQPDAISPTQLYNGTSFMDKPH 592
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357465415|ref|XP_003602992.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] gi|355492040|gb|AES73243.1| Mitogen-activated protein kinase kinase kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 495 bits (1274), Expect = e-137, Method: Compositional matrix adjust.
Identities = 293/622 (47%), Positives = 377/622 (60%), Gaps = 80/622 (12%)
Query: 20 FNNRKLTRVRKLRHVPDDELG--LLMTDRACSPSASPDSARMSPSPGTSDHWSSSAVPKP 77
R+LTR ++L + D ++G TD A S S SP +SDHWS+SAVP+P
Sbjct: 23 IQQRRLTRQKRLCYPNDQDVGESFHSTDVAVSFSLP-----TSPYRTSSDHWSTSAVPQP 77
Query: 78 LPLPDLASLFRKPESSGHGFESPEGRPHRGRKSTNQTAKGSAGFLSHFHKGDSQVLNIES 137
LPLP+ R+P+ H P R T ++ + S+ HF + +
Sbjct: 78 LPLPESPLTTRRPDH--HAAALPFSRK-SADHDTVRSLRSSSNLGRHFFNTVTG-----N 129
Query: 138 VKNDLRPSVPVRSTPTSLSSSHAVSPQRSNLQNPTPLHNPKSISTRRRGFSHDLNIECAN 197
K+DLR ++P P R L + S R SHD + E +
Sbjct: 130 AKSDLRVNIP---------------PTRG-------LVSSNSSCKDTRKHSHDNDCEGIS 167
Query: 198 YSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVFS-SFWAPKEIQDW------STAEVPDL 250
+S+ KSAP S+FSSP SP+ + ++ S P++ D TA PDL
Sbjct: 168 -NSKLQFAAKSAPNSIFSSPVTSPRRLSSVDLLDPSIILPQDFNDMFRVLPAKTAHSPDL 226
Query: 251 G--RFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKE 308
R G SP + + + SQ + + +V+
Sbjct: 227 SPRRSFGNHSPANHHRHTIQGG------------SQQHSKFCTRVW-------------- 260
Query: 309 LLESNNHLNAHPLPLPPGALSPPKSS---VTSAVMPHIMEKPSASPKKSQWQKGKLIGRG 365
NNHL+AHPLPLPP A P+ S +S M H E + K WQKGKLIGRG
Sbjct: 261 --PENNHLDAHPLPLPPRASPQPQQSPAHQSSVTMNHSTENIHS--MKGHWQKGKLIGRG 316
Query: 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425
+FGSVY TN ETGASCA+KEVD++PDDPKS +CIKQL+QEI++LG L H NIV+YYGSE
Sbjct: 317 SFGSVYHATNLETGASCALKEVDLVPDDPKSTDCIKQLDQEIRILGQLHHPNIVEYYGSE 376
Query: 426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 485
VV D L IY+EYVHPGS+ +++++HC +TES+VRNFTRHIL+GLAYLHST TIHRDIKG
Sbjct: 377 VVGDRLCIYMEYVHPGSLQKFMQDHCGVMTESVVRNFTRHILSGLAYLHSTKTIHRDIKG 436
Query: 486 ANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545
ANLLVDASG+VKLADFG++K LT SYELSLKGSP WMAPE++ A M+ + NP +A+AVD
Sbjct: 437 ANLLVDASGIVKLADFGVSKILTEKSYELSLKGSPYWMAPELMMAAMKNETNPTVAMAVD 496
Query: 546 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVER 605
IWSLGCT+IEMLTGKPPWSEF G QAMFKVL+R+P IP+ LS EG+DFL +CF RNP +R
Sbjct: 497 IWSLGCTIIEMLTGKPPWSEFPGHQAMFKVLHRSPDIPKTLSPEGQDFLEQCFQRNPADR 556
Query: 606 PSAVELLEHPFIRNANYQNLSV 627
PSA LL HPF++N + Q++ V
Sbjct: 557 PSAAVLLTHPFVQNLHEQDVIV 578
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514005|ref|XP_003525698.1| PREDICTED: mitogen-activated protein kinase kinase kinase 3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 489 bits (1260), Expect = e-135, Method: Compositional matrix adjust.
Identities = 226/329 (68%), Positives = 266/329 (80%), Gaps = 6/329 (1%)
Query: 316 LNAHPLPLPPGA--LSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIG 373
+ HPLPLPPGA SPP +A H + K + P KSQW+KGKLIGRGTFGSVY+
Sbjct: 265 VGVHPLPLPPGAALTSPP----AAATFSHAVAKSESFPMKSQWKKGKLIGRGTFGSVYVA 320
Query: 374 TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
TNRETGA CA+KEV++ PDDPKSAECIKQLEQEIKVL +LKH NIVQYYGSE+V+D YI
Sbjct: 321 TNRETGALCAMKEVELFPDDPKSAECIKQLEQEIKVLSNLKHSNIVQYYGSEIVEDRFYI 380
Query: 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493
YLEYVHPGSIN+YVREHC ITES++RNFTRHIL+GLAYLHS TIHRDIKGANLLVD++
Sbjct: 381 YLEYVHPGSINKYVREHCGAITESVIRNFTRHILSGLAYLHSKKTIHRDIKGANLLVDSA 440
Query: 494 GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
GVVKLADFGMAKHLTG LSL+GSP WMAPE+++AV+QKD +P LA A+DIWSLGCT+
Sbjct: 441 GVVKLADFGMAKHLTGFEANLSLRGSPYWMAPELLQAVIQKDNSPDLAFAIDIWSLGCTI 500
Query: 554 IEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
IEM TGKPPWSE+EG A+FKV+ TPPIPE LSSEGKDFL CF RNP ERP+A LLE
Sbjct: 501 IEMFTGKPPWSEYEGAAALFKVMKETPPIPETLSSEGKDFLRCCFKRNPAERPTAAVLLE 560
Query: 614 HPFIRNANYQNLSVPMRVFSRINLGDKSH 642
H F++N+ ++ ++++ + DK H
Sbjct: 561 HRFLKNSQLLDVLSSTQLYNETSFMDKPH 589
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 741 | ||||||
| TAIR|locus:2174969 | 716 | MAPKKK5 "mitogen-activated pro | 0.434 | 0.449 | 0.655 | 3e-129 | |
| TAIR|locus:2026674 | 883 | YDA "YODA" [Arabidopsis thalia | 0.377 | 0.317 | 0.575 | 7e-92 | |
| TAIR|locus:2024832 | 609 | MAP3KA "mitogen-activated prot | 0.361 | 0.440 | 0.571 | 7.2e-86 | |
| TAIR|locus:2133559 | 608 | MEKK1 "MAPK/ERK kinase kinase | 0.345 | 0.421 | 0.505 | 2e-63 | |
| TAIR|locus:2133529 | 560 | MEKK3 "MAPK/ERK kinase kinase | 0.348 | 0.460 | 0.464 | 6.9e-63 | |
| ZFIN|ZDB-GENE-120215-96 | 623 | si:dkey-32h20.5 "si:dkey-32h20 | 0.368 | 0.438 | 0.423 | 2e-61 | |
| DICTYBASE|DDB_G0283265 | 1267 | mkkA "octicosapeptide/Phox/Bem | 0.357 | 0.209 | 0.432 | 6.2e-60 | |
| UNIPROTKB|F1MH06 | 626 | MAP3K3 "Uncharacterized protei | 0.352 | 0.416 | 0.440 | 2e-59 | |
| TAIR|locus:2035989 | 666 | NP1 "NPK1-related protein kina | 0.391 | 0.435 | 0.448 | 9.3e-59 | |
| UNIPROTKB|E2RN16 | 620 | MAP3K2 "Uncharacterized protei | 0.353 | 0.422 | 0.442 | 1.1e-58 |
| TAIR|locus:2174969 MAPKKK5 "mitogen-activated protein kinase kinase kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1130 (402.8 bits), Expect = 3.0e-129, Sum P(2) = 3.0e-129
Identities = 215/328 (65%), Positives = 259/328 (78%)
Query: 333 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
SS S P K + P SQW+KGKLIGRGTFGSVY+ +N ETGA CA+KEV++ PD
Sbjct: 323 SSAASVPSPQAPLKLDSFPMNSQWKKGKLIGRGTFGSVYVASNSETGALCAMKEVELFPD 382
Query: 393 DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 452
DPKSAECIKQLEQEIK+L +L+H NIVQY+GSE V+D +IYLEYVHPGSIN+Y+R+HC
Sbjct: 383 DPKSAECIKQLEQEIKLLSNLQHPNIVQYFGSETVEDRFFIYLEYVHPGSINKYIRDHCG 442
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512
+TES+VRNFTRHIL+GLAYLH+ T+HRDIKGANLLVDASGVVKLADFGMAKHLTG
Sbjct: 443 TMTESVVRNFTRHILSGLAYLHNKKTVHRDIKGANLLVDASGVVKLADFGMAKHLTGQRA 502
Query: 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM 572
+LSLKGSP WMAPE+++AVMQKD NP LA AVDIWSLGCT+IEM TGKPPWSEFEG AM
Sbjct: 503 DLSLKGSPYWMAPELMQAVMQKDSNPDLAFAVDIWSLGCTIIEMFTGKPPWSEFEGAAAM 562
Query: 573 FKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA----NYQNLSVP 628
FKV+ +PPIPE +S EGKDFL CF RNP ERP+A LLEH F++N+ + N V
Sbjct: 563 FKVMRDSPPIPESMSPEGKDFLRLCFQRNPAERPTASMLLEHRFLKNSLQPTSPSNSDVS 622
Query: 629 MRVFSRINLGDKSHDQVERATRKTESLP 656
++F+ +N+ + S + E+ K + +P
Sbjct: 623 -QLFNGMNITEPSSRR-EKPNFKLDQVP 648
|
|
| TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 7.0e-92, Sum P(2) = 7.0e-92
Identities = 167/290 (57%), Positives = 211/290 (72%)
Query: 333 SSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
S+ TS +P + A+ S+W+KG+L+G G+FG VY+G N E+G CA+KEV +
Sbjct: 376 SAATSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCS 435
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 451
DDPKS E +QL QEI VL L+H+NIVQYYGSE VDD LYIYLEYV GSI + ++E+
Sbjct: 436 DDPKSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYG 495
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511
+ E+ +RN+T+ IL+GLAYLH+ NT+HRDIKGAN+LVD G VK+ADFGMAKH+T S
Sbjct: 496 Q-FGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVADFGMAKHITAQS 554
Query: 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA 571
LS KGSP WMAPEVIK +G+ LAVDIWSLGCTV+EM T KPPWS++EG A
Sbjct: 555 GPLSFKGSPYWMAPEVIK---NSNGSN---LAVDIWSLGCTVLEMATTKPPWSQYEGVPA 608
Query: 572 MFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
MFK+ N P IP+ LS EGKDF+ +C RNP RP+A +LL+H F+RN
Sbjct: 609 MFKIGNSKELPDIPDHLSEEGKDFVRKCLQRNPANRPTAAQLLDHAFVRN 658
|
|
| TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 817 (292.7 bits), Expect = 7.2e-86, Sum P(2) = 7.2e-86
Identities = 159/278 (57%), Positives = 201/278 (72%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S W+KGK +G GTFG VY+G N E G CAIKEV +I DD S EC+KQL QEI +L L
Sbjct: 212 STWKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKECLKQLNQEINLLNQL 271
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H NIVQYYGSE+ ++ L +YLEYV GSI++ ++++ TE +++N+TR IL GLAYL
Sbjct: 272 CHPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDY-GSFTEPVIQNYTRQILAGLAYL 330
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
H NT+HRDIKGAN+LVD +G +KLADFGMAKH+T S LS KGSP WMAPEV VM
Sbjct: 331 HGRNTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTMLSFKGSPYWMAPEV---VMS 387
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGK 591
++G AVDIWSLGCT++EM T KPPWS+FEG A+FK+ N TP IP+ LS++ K
Sbjct: 388 QNGYTH---AVDIWSLGCTILEMATSKPPWSQFEGVAAIFKIGNSKDTPEIPDHLSNDAK 444
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFIRNAN-YQNLSVP 628
+F+ C RNP RP+A +LLEHPF+RN + S+P
Sbjct: 445 NFIRLCLQRNPTVRPTASQLLEHPFLRNTTRVASTSLP 482
|
|
| TAIR|locus:2133559 MEKK1 "MAPK/ERK kinase kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 628 (226.1 bits), Expect = 2.0e-63, Sum P(2) = 2.0e-63
Identities = 135/267 (50%), Positives = 181/267 (67%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ WQKG+L+GRG+FGSVY G + + G A+KEV ++ ++ ECI+QLE EIK+L L
Sbjct: 331 TSWQKGQLLGRGSFGSVYEGISGD-GDFFAVKEVSLLDQGSQAQECIQQLEGEIKLLSQL 389
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAY 472
+H+NIV+Y G+ +LYI+LE V GS+ + Y R RD S+V +TR IL+GL Y
Sbjct: 390 QHQNIVRYRGTAKDGSNLYIFLELVTQGSLLKLYQRYQLRD---SVVSLYTRQILDGLKY 446
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
LH IHRDIK AN+LVDA+G VKLADFG+AK ++ + S KG+P WMAPEVI
Sbjct: 447 LHDKGFIHRDIKCANILVDANGAVKLADFGLAK-VSKFNDIKSCKGTPFWMAPEVINR-K 504
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK 591
DG A DIWSLGCTV+EM TG+ P+S+ E QA+F++ T P +P+ LS + +
Sbjct: 505 DSDGYGSPA---DIWSLGCTVLEMCTGQIPYSDLEPVQALFRIGRGTLPEVPDTLSLDAR 561
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFIR 618
F+L+C NP ERP+A ELL HPF+R
Sbjct: 562 LFILKCLKVNPEERPTAAELLNHPFVR 588
|
|
| TAIR|locus:2133529 MEKK3 "MAPK/ERK kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 576 (207.8 bits), Expect = 6.9e-63, Sum P(3) = 6.9e-63
Identities = 124/267 (46%), Positives = 172/267 (64%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ W KG+L+GRG++ SVY + E G A+KEV ++ ++ ECI+QLE EI +L L
Sbjct: 301 TSWLKGQLLGRGSYASVYEAIS-EDGDFFAVKEVSLLDKGIQAQECIQQLEGEIALLSQL 359
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+H+NIV+Y G+ LYI+LE V GS+ + + ++ ++V +TR IL GL YL
Sbjct: 360 QHQNIVRYRGTAKDVSKLYIFLELVTQGSVQKLYERY--QLSYTVVSLYTRQILAGLNYL 417
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
H +HRDIK AN+LVDA+G VKLADFG+A+ + + +S KG+ WMAPEVI
Sbjct: 418 HDKGFVHRDIKCANMLVDANGTVKLADFGLAE-ASKFNDIMSCKGTLFWMAPEVINR-KD 475
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKD 592
DGN A DIWSLGCTV+EM TG+ P+S+ + QA FK+ T P +P+ LS + +
Sbjct: 476 SDGNGSPA---DIWSLGCTVLEMCTGQIPYSDLKPIQAAFKIGRGTLPDVPDTLSLDARH 532
Query: 593 FLLRCFLRNPVERPSAVELLEHPFIRN 619
F+L C NP ERP+A ELL HPF+ N
Sbjct: 533 FILTCLKVNPEERPTAAELLHHPFVIN 559
|
|
| ZFIN|ZDB-GENE-120215-96 si:dkey-32h20.5 "si:dkey-32h20.5" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 573 (206.8 bits), Expect = 2.0e-61, Sum P(3) = 2.0e-61
Identities = 125/295 (42%), Positives = 186/295 (63%)
Query: 333 SSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
S+ T +VM + PS SP+ + W+ GKL+G+G FG V++ + +TG A+K+V P
Sbjct: 340 SNPTLSVMD--ISPPSRSPRAPTNWRLGKLLGQGAFGRVFLCYDADTGRELAVKQVQFDP 397
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH---LYIYLEYVHPGSINRYVR 448
D P++++ + LE EI++L +L HE IVQYYG + D H L I++EY+ GSI ++
Sbjct: 398 DSPETSKEVSALECEIQLLKNLFHERIVQYYGC-LRDTHEKTLSIFMEYMPGGSIKDQLK 456
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
+ +TE++ R +TR IL G+ YLHS +HRDIKGAN+L D++G VKL DFG ++ L
Sbjct: 457 SYGA-LTENVTRKYTRQILEGVCYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASRRLQ 515
Query: 509 GLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
+ S+ G+P WM+PEVI +G + A DIWS+GCTV+EMLT +PPW+
Sbjct: 516 TICLSGTGIKSVTGTPYWMSPEVISG----EGYGRKA---DIWSIGCTVVEMLTQRPPWA 568
Query: 565 EFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
EFE A+FK+ + P +P +S +DFL R F+ +RP+A +LL H F+
Sbjct: 569 EFEAMAAIFKIATQPTNPTLPPHVSDHCRDFLKRIFVETK-QRPAAEDLLRHTFV 622
|
|
| DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 6.2e-60, Sum P(2) = 6.2e-60
Identities = 121/280 (43%), Positives = 186/280 (66%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLEQEIKVLGH 412
+WQKG+++GRG +GSVY+G N++TG A+K+++I+ DPK I +EI+V+
Sbjct: 494 KWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNMILSFSKEIEVMRS 553
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L+H+NIV+Y G+ + L ++LEY+ GSI+ + + +E++++ +T+ IL GL++
Sbjct: 554 LRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGA-FSENVIKVYTKQILQGLSF 612
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAV 531
LH+ + IHRDIKGAN+L+D G+VKL+DFG +K +G+ + S++G+P WMAPEVIK
Sbjct: 613 LHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGIVSQFKSMQGTPYWMAPEVIK-- 670
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVL--NRTPPIPEMLSS 588
+ G+ + + DIWSLGC ++EM T +PPWS E M+ + N P IP +S
Sbjct: 671 --QTGHGRSS---DIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQ 725
Query: 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628
E DFL CF R+P ERP A +LL+HPFI N + N+ +P
Sbjct: 726 EAFDFLNLCFKRDPKERPDANQLLKHPFIMNLD-DNIQLP 764
|
|
| UNIPROTKB|F1MH06 MAP3K3 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 2.0e-59, Sum P(2) = 2.0e-59
Identities = 123/279 (44%), Positives = 178/279 (63%)
Query: 347 PSASPKKS-QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
P+ SP W++GKL+G+G FG VY+ + +TG A K+V PD P++++ + LE
Sbjct: 352 PTKSPSAPINWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSPETSKEVSALEC 411
Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
EI++L +L+HE IVQYYG + + L I++EY+ GS+ ++ + +TES+ R +T
Sbjct: 412 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYT 470
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGS 519
R IL G++YLHS +HRDIKGAN+L D++G VKL DFG +K L + S+ G+
Sbjct: 471 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGT 530
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR- 578
P WM+PEVI +G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ +
Sbjct: 531 PYWMSPEVISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP 583
Query: 579 -TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
P +P +S G+DFL R F+ +RPSA ELL H F
Sbjct: 584 TNPQLPSHISEHGRDFLRRIFVEAR-QRPSAEELLTHHF 621
|
|
| TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 603 (217.3 bits), Expect = 9.3e-59, P = 9.3e-59
Identities = 140/312 (44%), Positives = 196/312 (62%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLGH 412
W+KG+LIGRG FG+VY+G N ++G A+K+V I + K+ I++LE+E+K+L +
Sbjct: 69 WRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQELEEEVKLLKN 128
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L H NIV+Y G+ DD L I LE+V GSI+ + E ES+VR +TR +L GL Y
Sbjct: 129 LSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLL-EKFGPFPESVVRTYTRQLLLGLEY 187
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 529
LH+ +HRDIKGAN+LVD G +KLADFG +K + L+ S+KG+P WMAPEVI
Sbjct: 188 LHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTPYWMAPEVI- 246
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAMFKV--LNRTPPIPEML 586
+Q G+ + + DIWS+GCTVIEM+TGK PWS+ ++ A+F + PPIP+ L
Sbjct: 247 --LQT-GH---SFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPDTL 300
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVE 646
SS+ KDFLL+C P RP+A ELL+HPF+ + ++ S + NL Q+
Sbjct: 301 SSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDLGSVLN-NLSTPLPLQIN 359
Query: 647 RATRKTESLPDS 658
T+S PDS
Sbjct: 360 N----TKSTPDS 367
|
|
| UNIPROTKB|E2RN16 MAP3K2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 1.1e-58, Sum P(2) = 1.1e-58
Identities = 124/280 (44%), Positives = 178/280 (63%)
Query: 347 PSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
PS SP+ + W+ GKL+G+G FG VY+ + +TG A+K+V PD P++++ + LE
Sbjct: 347 PSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSPETSKEVNALEC 406
Query: 406 EIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
EI++L +L HE IVQYYG + + L I++EY+ GSI ++ + +TE++ R +T
Sbjct: 407 EIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGA-LTENVTRKYT 465
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGS 519
R IL G+ YLHS +HRDIKGAN+L D++G VKL DFG +K L + S+ G+
Sbjct: 466 RQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMKSVTGT 525
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR- 578
P WM+PEVI +G + A DIWS+GCTV+EMLT KPPW+EFE A+FK+ +
Sbjct: 526 PYWMSPEVISG----EGYGRKA---DIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 578
Query: 579 -TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
P +P +S +DFL R F+ + RPSA ELL H F+
Sbjct: 579 TNPKLPPHVSDYTRDFLKRIFIEAKL-RPSADELLRHMFV 617
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 741 | |||
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-128 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-118 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-96 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-93 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-90 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-87 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-85 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-82 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-81 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-78 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-76 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-76 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-74 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-70 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-69 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-67 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-66 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-66 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-66 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-64 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-62 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-61 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-61 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-59 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-58 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-52 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-51 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-51 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-50 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-50 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-50 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-49 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-48 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-47 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-46 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-46 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-45 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-45 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-45 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-45 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-44 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-44 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-44 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-44 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-43 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-43 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-43 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-43 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-42 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-41 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-41 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-41 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-41 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-41 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-40 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-40 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-40 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-40 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-40 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-40 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-39 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-39 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-39 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-39 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-39 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-38 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-38 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-38 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-38 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-38 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-37 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-37 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-37 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-36 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-36 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-36 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-36 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-36 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-36 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-35 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-35 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-34 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-34 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-33 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-33 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-33 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-33 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-33 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-32 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-32 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-32 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-32 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-31 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-31 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-31 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-31 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-31 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-30 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-30 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-30 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-30 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-30 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-29 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-29 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-29 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-29 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-28 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-28 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-28 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-28 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-27 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-27 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-27 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-27 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-27 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-27 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-27 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-27 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-27 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-27 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-26 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-26 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-26 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-26 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-26 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-25 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-25 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-25 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-25 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-24 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-24 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-24 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-23 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-23 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-23 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-23 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-22 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-22 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-22 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-21 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-21 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-21 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-21 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-21 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-20 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-20 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-20 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-20 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-19 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-19 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-19 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-19 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-18 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-17 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-12 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-11 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-09 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 382 bits (982), Expect = e-128
Identities = 146/264 (55%), Positives = 185/264 (70%), Gaps = 9/264 (3%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+KG+L+G G+FGSVY G N + G A+KEV + D E +KQLEQEI +L L+H
Sbjct: 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIVQY G+E +D+LYI+LE V GS+ + ++++ E ++R +TR IL GL YLH
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD 120
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
NT+HRDIKGAN+LVD +GVVKLADFGMAK + S+ S KGSP WMAPEVI Q+
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVI---AQQG 177
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDF 593
G LA DIWSLGCTV+EM TGKPPWS+ EG A+FK+ PPIP+ LS E KDF
Sbjct: 178 GY---GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 594 LLRCFLRNPVERPSAVELLEHPFI 617
+L+C R+P RP+A ELLEHPF+
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 356 bits (916), Expect = e-118
Identities = 135/271 (49%), Positives = 182/271 (67%), Gaps = 19/271 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+W +G+L+GRG+FGSVY+ +++TG A+K V++ D + E LE+EI++L L+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE---ALEREIRILSSLQ 57
Query: 415 HENIVQYYGSEV--VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
H NIV+YYGSE + L I+LEYV GS+ + + + E ++R +TR IL GLAY
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIK 529
LHS +HRDIKGAN+LVD+ GVVKLADFG AK L + S++G+P WMAPEVI+
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRT--PPIPEML 586
++ G A DIWSLGCTVIEM TGKPPWSE P A++K+ + P IPE L
Sbjct: 177 G--EEYG-----RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL 229
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
S E KDFL +C R+P +RP+A ELL+HPF+
Sbjct: 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 298 bits (766), Expect = 2e-96
Identities = 126/265 (47%), Positives = 168/265 (63%), Gaps = 13/265 (4%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+Q G LIGRG FG VY G N ETG AIK++ + + A +K + QEI +L +LK
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLE-KIKEEA--LKSIMQEIDLLKNLK 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H NIV+Y GS D LYI LEY GS+ + +++ ES+V + +L GLAYLH
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVYVYQVLQGLAYLH 116
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQ 533
IHRDIK AN+L GVVKLADFG+A L +S + S+ G+P WMAPEVI +
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI----E 172
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKD 592
G + A DIWSLGCTVIE+LTG PP+ + A+F+ V + PP+PE +S E KD
Sbjct: 173 MSG---ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD 229
Query: 593 FLLRCFLRNPVERPSAVELLEHPFI 617
FL++CF ++P RP+A +LL+HP+I
Sbjct: 230 FLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 289 bits (743), Expect = 6e-93
Identities = 95/266 (35%), Positives = 147/266 (55%), Gaps = 16/266 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ + +G G+FG VY+ +++TG AIK + +++ +EIK+L LKH
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD----RERILREIKILKKLKH 56
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ Y +D LY+ +EY G + +++ R ++E R + R IL+ L YLHS
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-LSEDEARFYLRQILSALEYLHS 115
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRD+K N+L+D G VKLADFG+A+ L + G+P +MAPEV+
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL------ 169
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTPPIPE---MLSSEGK 591
AVDIWSLG + E+LTGKPP+ + +FK + PP P +S E K
Sbjct: 170 -GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFI 617
D + + +++P +R +A E L+HPF
Sbjct: 229 DLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 281 bits (722), Expect = 9e-90
Identities = 130/272 (47%), Positives = 169/272 (62%), Gaps = 17/272 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+WQ+G IG GTFG VY N +TG A+KE+ I +DPK+ IK++ E+KVL LK
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT---IKEIADEMKVLELLK 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H N+V+YYG EV + +YI++EY G++ + EH R + E ++R +T +L GLAYLH
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGLSYELSLKGSPNWMAPEVIK 529
S +HRDIK AN+ +D +GV+KL DFG A L T SL G+P +MAPEVI
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV-LNRTPPIPE--M 585
A DIWSLGC V+EM TGK PWSE + Q MF V PPIP+
Sbjct: 177 ----GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
LS EGKDFL RC +P +RP+A ELL+HPF+
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 4e-87
Identities = 121/271 (44%), Positives = 176/271 (64%), Gaps = 20/271 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W++GKL+G+G FG VY+ + +TG A+K+V PD P++ + + LE EI++L +L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
E IVQYYG D+ L I++EY+ GS+ ++ + +TE++ R +TR IL G+ YLHS
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS 122
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPEVI 528
+HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+PEVI
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMK---SVTGTPYWMSPEVI 179
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEML 586
+G + A D+WS+GCTV+EMLT KPPW+EFE A+FK+ P +P +
Sbjct: 180 SG----EGYGRKA---DVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV 232
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
S + ++FL R F+ N +RPSA ELL H F+
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 271 bits (695), Expect = 1e-85
Identities = 127/276 (46%), Positives = 166/276 (60%), Gaps = 20/276 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-----DDPKSAECIKQLEQEIKVL 410
W KG+LIG+GT+G VY+ N TG A+K+V++ D + + +K L EI+ L
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
L H NIVQY G E +++L I+LEYV GSI +R + R E +VR FT +L GL
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGL 121
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH---LTGLSYELSLKGSPNWMAPEV 527
AYLHS +HRD+K NLLVDA G+ K++DFG++K + +S++GS WMAPEV
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPE- 584
I + Q + VDIWSLGC V+EM G+ PWS+ E AMFK+ N PPIP
Sbjct: 182 IHSYSQ-----GYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPD 236
Query: 585 ---MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
LS DFL CF NP RP+A ELL+HPFI
Sbjct: 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 1e-82
Identities = 109/264 (41%), Positives = 157/264 (59%), Gaps = 15/264 (5%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ + IG+G FG VY ++ TG AIK + + +S E +++ EI++L KH
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-----ESKEKKEKIINEIQILKKCKH 56
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+YYGS + D L+I +E+ GS+ ++ + +TES + + +L GL YLHS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
IHRDIK AN+L+ + G VKL DFG++ L+ ++ G+P WMAPEVI K
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN---GKP 173
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKD 592
+ K DIWSLG T IE+ GKPP+SE +A+FK+ PP PE S E KD
Sbjct: 174 YDYK----ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229
Query: 593 FLLRCFLRNPVERPSAVELLEHPF 616
FL +C +NP +RP+A +LL+HPF
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 4e-81
Identities = 95/270 (35%), Positives = 143/270 (52%), Gaps = 18/270 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ + +G G+FG+VY ++ TG A+K + KS + +EI++L L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK--RSEKSKKDQTAR-REIRILRRLSH 57
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ + DHLY+ +EY G + Y+ ++E + IL GL YLHS
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-LSEDEAKKIALQILRGLEYLHS 116
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L+D +GVVK+ADFG+AK L S L + G+P +MAPEV+
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLL----- 171
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-------MLS 587
G VD+WSLG + E+LTGKPP+S + + P E S
Sbjct: 172 -GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
E KD + +C ++P +RP+A E+L+HP+
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 8e-78
Identities = 105/261 (40%), Positives = 153/261 (58%), Gaps = 18/261 (6%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
+G G++GSVY ++ETG AIK V + D ++++ +EI +L IV+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVK 62
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
YYGS + L+I +EY GS++ ++ + +TE + L GL YLHS IH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIH 122
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
RDIK N+L++ G KLADFG++ LT ++ ++ G+P WMAPEVI + N K
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVI---QEIGYNNK 179
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKDFLLR 596
DIWSLG T IEM GKPP+S+ +A+F + N+ PP PE S E DF+ +
Sbjct: 180 ----ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235
Query: 597 CFLRNPVERPSAVELLEHPFI 617
C +++P ERPSA++LL+HPFI
Sbjct: 236 CLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (631), Expect = 2e-76
Identities = 103/274 (37%), Positives = 146/274 (53%), Gaps = 24/274 (8%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ + IG+G+FG VY ++ T AIK +D+ ++ + I+ ++QEI+ L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL----EEAEDEIEDIQQEIQFLSQC 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ I +YYGS + L+I +EY GS ++ + E+ + R +L GL YL
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYL 114
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAPEVI 528
H IHRDIK AN+L+ G VKLADFG++ LT K G+P WMAPEVI
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT----STMSKRNTFVGTPFWMAPEVI 170
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE--ML 586
K Q + K DIWSLG T IE+ G+PP S+ + +F + PP E
Sbjct: 171 K---QSGYDEK----ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKF 223
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
S KDF+ C ++P ERPSA ELL+H FI+ A
Sbjct: 224 SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 6e-76
Identities = 126/275 (45%), Positives = 168/275 (61%), Gaps = 20/275 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI----IPDDPKSAECIKQLEQEIKVL 410
+W KG LIG G+FGSVY+G N +G A+K+V++ + + L +EI +L
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
L+HENIVQY GS + DHL I+LEYV GS+ + + E++VRNF R IL GL
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGL 119
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-------SLKGSPNWM 523
YLH+ IHRDIKGAN+LVD G +K++DFG++K L S SL+GS WM
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI 582
APEV+K K DIWSLGC V+EMLTGK P+ + QA+FK+ N +P I
Sbjct: 180 APEVVKQTSY---TRK----ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
P +SSE DFL + F + +RP+A ELL+HPF+
Sbjct: 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 3e-74
Identities = 114/269 (42%), Positives = 155/269 (57%), Gaps = 20/269 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+K IG G G VY T+R TG AIK++ + + + + EI ++ KH
Sbjct: 24 LEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCKH 74
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV YY S +V D L++ +EY+ GS+ + ++ + E + R +L GL YLHS
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQK 534
N IHRDIK N+L+ G VKLADFG A LT S S+ G+P WMAPEVIK +K
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK---RK 191
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--PEMLSSEGK 591
D PK VDIWSLG IEM G+PP+ +A+F + PP+ PE S E K
Sbjct: 192 DYGPK----VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFIRNA 620
DFL +C +++P +RPSA ELL+HPF++ A
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 230 bits (587), Expect = 4e-70
Identities = 121/274 (44%), Positives = 173/274 (63%), Gaps = 27/274 (9%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W++GKL+G+G FG VY+ + +TG A K+V P+ P++++ + LE EI++L +L+H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 416 ENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
E IVQYYG + D L I++EY+ GS+ ++ + +TES+ R +TR IL G++
Sbjct: 64 ERIVQYYG--CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMS 120
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMA 524
YLHS +HRDIKGAN+L D++G VKL DFG +K L TG+ S+ G+P WM+
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR---SVTGTPYWMS 177
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPI 582
PEVI +G + A D+WSLGCTV+EMLT KPPW+E+E A+FK+ + P +
Sbjct: 178 PEVISG----EGYGRKA---DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQL 230
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
P +S +DF L C RPSA ELL HPF
Sbjct: 231 PSHISEHARDF-LGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 227 bits (579), Expect = 6e-69
Identities = 112/264 (42%), Positives = 159/264 (60%), Gaps = 17/264 (6%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
++G+GT+G VY + T AIKE+ + + ++ L +EI + +LKH NIVQ
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE-----RDSRYVQPLHEEIALHSYLKHRNIVQ 69
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT--ESIVRNFTRHILNGLAYLHSTNT 478
Y GS+ + I++E V GS++ +R + E + +T+ IL GL YLH
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 479 IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDG 536
+HRDIKG N+LV+ SGVVK++DFG +K L G++ + G+ +MAPEVI + G
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYG 189
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKV--LNRTPPIPEMLSSEGKDF 593
P DIWSLGCT++EM TGKPP+ E PQA MFKV P IPE LS+E K+F
Sbjct: 190 AP-----ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244
Query: 594 LLRCFLRNPVERPSAVELLEHPFI 617
+LRCF +P +R SA +LL+ PF+
Sbjct: 245 ILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 5e-67
Identities = 118/272 (43%), Positives = 174/272 (63%), Gaps = 17/272 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ W+ GKL+G+G FG VY+ + +TG A+K+V P+ P++++ + LE EI++L +L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 414 KHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
HE IVQYYG + ++ L I++E++ GSI ++ + +TE++ R +TR IL G++
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVS 120
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE----LSLKGSPNWMAPEV 527
YLHS +HRDIKGAN+L D+ G VKL DFG +K L + S+ G+P WM+PEV
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEM 585
I +G + A DIWS+GCTV+EMLT KPPW+EFE A+FK+ + P +P
Sbjct: 181 ISG----EGYGRKA---DIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
+S +DFL R F+ + RPSA ELL H F+
Sbjct: 234 VSDHCRDFLKRIFVEAKL-RPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 220 bits (561), Expect = 2e-66
Identities = 105/275 (38%), Positives = 166/275 (60%), Gaps = 22/275 (8%)
Query: 355 QWQKGKLIGRGTFGSVYIG-TNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQEIKVLGH 412
+W KG+++G+G +G+VY G TN G A+K+V++ + +AE ++L++E+ +L
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
LKH NIVQY G+ + D+ + I++E+V GSI+ + + E + +T+ IL+G+AY
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAY 117
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-------SLKGSPNWMAP 525
LH+ +HRDIKG N+++ +G++KL DFG A+ L + S+ G+P WMAP
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPI 582
EVI + G + + DIWS+GCTV EM TGKPP + + AMF + P +
Sbjct: 178 EVIN----ESGYGRKS---DIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRL 230
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
P+ S+ DF+ C R+ ERPSA++LL H F+
Sbjct: 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 4e-66
Identities = 102/262 (38%), Positives = 148/262 (56%), Gaps = 17/262 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG GT+G VY + TG AIK + + P D + ++QEI +L +H NIV Y
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD-----FEIIQQEISMLKECRHPNIVAY 65
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
+GS + D L+I +EY GS+ + ++E + R L GLAYLH T IHR
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR 125
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIKGAN+L+ G VKLADFG++ LT ++ S G+P WMAPEV AV +K G
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-AVERKGGYDGK 184
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK------DFL 594
DIW+LG T IE+ +PP + +A+F +++++ P L + K DF+
Sbjct: 185 C---DIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFPPPKLKDKEKWSPVFHDFI 240
Query: 595 LRCFLRNPVERPSAVELLEHPF 616
+C ++P +RP+A +LL+HPF
Sbjct: 241 KKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 218 bits (556), Expect = 9e-66
Identities = 115/273 (42%), Positives = 174/273 (63%), Gaps = 23/273 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ GKL+GRG FG VY+ + +TG A+K+V PD ++++ + LE EI++L +L+H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ IVQYYG + + L I++EY+ GSI ++ + +TE++ R +TR IL G++YL
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYL 122
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLKGSPNWMAPE 526
HS +HRDIKGAN+L D++G VKL DFG +K + TG+ S+ G+P WM+PE
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK---SVTGTPYWMSPE 179
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 584
VI +G + A D+WS+ CTV+EMLT KPPW+E+E A+FK+ + P +P+
Sbjct: 180 VISG----EGYGRKA---DVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
+S +DFL + F+ RP+A LL HPF+
Sbjct: 233 GVSDACRDFLKQIFVEEKR-RPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 2e-64
Identities = 87/256 (33%), Positives = 134/256 (52%), Gaps = 43/256 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G G FG+VY+ +++TG AIK + S+ +++L +EI++L L H NIV+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKK----EDSSSLLEELLREIEILKKLNHPNIVKL 56
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YG ++HLY+ +EY GS+ ++E+ ++E + IL GL YLHS IHR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 482 DIKGANLLVDA-SGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPK 539
D+K N+L+D+ +G VKLADFG++K LT L ++ G+P +MAPEV+ G
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL------GKGY 170
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 599
+ DIWSLG + E+ E KD + +
Sbjct: 171 YSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQ 199
Query: 600 RNPVERPSAVELLEHP 615
++P +RPSA E+LEH
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 5e-63
Identities = 96/276 (34%), Positives = 157/276 (56%), Gaps = 20/276 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLGHL 413
+W KG+ +G G F S Y + +TG A+K+V + + E + + L +EI+++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H +I++ G+ D H +++E++ GS++ + ++ E+++ N+T +L GL+YL
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYL 119
Query: 474 HSTNTIHRDIKGANLLVDASG-VVKLADFG----MAKHLTGLS-YELSLKGSPNWMAPEV 527
H IHRD+KGANLL+D++G +++ADFG +A TG ++ L G+ +MAPEV
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKV--LNRTPPI 582
++ G + D+WS+GC +IEM T KPPW+ + +FK+ P I
Sbjct: 180 LR------GEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
PE LS +D LRC P +RP + ELL+HP R
Sbjct: 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 1e-62
Identities = 88/270 (32%), Positives = 144/270 (53%), Gaps = 29/270 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K IG+G+FG VY+ + G +KE+D+ K + E+K+L L H NI+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK---EREDALNEVKILKKLNHPNII 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHST 476
+YY S L I +EY G +++ +++ ++ E + ++ + L YLHS
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQK 534
+HRDIK N+ + ++G+VKL DFG++K L+ + +L ++ G+P +++PE+ +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-TVDLAKTVVGTPYYLSPELCQ----- 176
Query: 535 DGNP---KLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNRT-PPIPEMLS 587
P K DIWSLGC + E+ T K P FEG + K+L PPIP S
Sbjct: 177 -NKPYNYK----SDIWSLGCVLYELCTLKHP---FEGENLLELALKILKGQYPPIPSQYS 228
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
SE ++ + ++P ERPS ++L+ PFI
Sbjct: 229 SELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 1e-61
Identities = 100/276 (36%), Positives = 146/276 (52%), Gaps = 22/276 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-K 414
++ ++IG GT+G VY +++TG AIK +DII D+ +++++E +L
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE------EEEIKEEYNILRKYSN 61
Query: 415 HENIVQYYG------SEVVDDHLYIYLEYVHPGSINRYV---REHCRDITESIVRNFTRH 465
H NI +YG DD L++ +E GS+ V R+ + + E + R
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMA 524
L GLAYLH IHRDIKG N+L+ + VKL DFG++ L + G+P WMA
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMA 181
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI-- 582
PEVI A ++ + D+WSLG T IE+ GKPP + +A+FK+ PP
Sbjct: 182 PEVI-ACDEQP-DASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239
Query: 583 -PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
PE S + DF+ C ++N +RP ELLEHPFI
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 8e-61
Identities = 95/275 (34%), Positives = 151/275 (54%), Gaps = 19/275 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S ++ K++G+G+ G VY ++ TG A+K++ + D E KQL +E+K L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDE---EFRKQLLRELKTLRSC 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ +V+ YG+ + + I LEY+ GS+ +++ I E ++ R IL GL YL
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYL 115
Query: 474 HST-NTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAV 531
H+ + IHRDIK +NLL+++ G VK+ADFG++K L L + G+ +M+PE I+
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG- 174
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ--AMFKVLNRTPPI---PEML 586
+ DIWSLG T++E GK P+ P + + + PP E
Sbjct: 175 -ESYSYAA-----DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF 228
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
S E +DF+ C ++P +RPSA ELL+HPFI+ A+
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 2e-59
Identities = 101/289 (34%), Positives = 152/289 (52%), Gaps = 18/289 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S +Q+ +LIGRG +G+VY G + TG A+K +++ D ++ +++E+ +L L
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD----IQREVALLSQL 56
Query: 414 KH---ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
+ NI +YYGS + L+I +EY GS+ ++ I E + R +L L
Sbjct: 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVAL 114
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIK 529
Y+H IHRDIK AN+LV +G VKL DFG+A L S + G+P WMAPEVI
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPE-MLS 587
D DIWSLG T+ EM TG PP+S+ + +AM + PP + + S
Sbjct: 175 EGKYYD------TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS 228
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 636
++F+ C P ER SA ELL+ +I+ + +S+ + SR
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSILKELISRYQ 277
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 2e-58
Identities = 103/269 (38%), Positives = 149/269 (55%), Gaps = 11/269 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ +G G FG VY ++ETG A K + I +S E ++ EI +L KH
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI-----ESEEELEDFMVEIDILSECKH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV Y + ++ L+I +E+ G+++ + E R +TE +R R +L L +LHS
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L+ G VKLADFG+ AK+ + L + G+P WMAPEV+ K
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 591
D NP A DIWSLG T+IE+ +PP E + + K+L PP P SS
Sbjct: 182 D-NPYDYKA-DIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFIRNA 620
DFL C +++P +RP+A ELL+HPF+ +
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 7e-54
Identities = 77/267 (28%), Positives = 124/267 (46%), Gaps = 20/267 (7%)
Query: 357 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ GK +G G FG VY GT T A+K + + + E +E ++
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE----FLEEASIMKK 57
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L H NIV+ G + LYI EY+ G + ++R+H +T + I G+ Y
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIK 529
L S N +HRD+ N LV + VVK++DFG+++ + Y G WMAPE +K
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-PPIPEMLS 587
+ K D+WS G + E+ T G+ P+ + + + + P PE
Sbjct: 178 -------DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCP 230
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLEH 614
E + +L+C+ +P +RP+ EL+E
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-52
Identities = 79/269 (29%), Positives = 131/269 (48%), Gaps = 27/269 (10%)
Query: 357 QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
GK +G G FG VY G + A+K + + S + I++ +E +++
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK----EDASEQQIEEFLREARIMRK 57
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L H N+V+ G ++ LYI +EY+ G + Y+R++ ++ S + +F I G+ Y
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WMAPEVI 528
L S N IHRD+ N LV + VVK++DFG+++ L + K WMAPE +
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY--DDDYYRKRGGKLPIRWMAPESL 175
Query: 529 KAVMQKDG--NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 584
K+G K D+WS G + E+ T G+ P+ + + + N P P
Sbjct: 176 -----KEGKFTSK----SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPP 226
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLE 613
E D +L+C+ +P +RP+ EL+E
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 7e-52
Identities = 80/267 (29%), Positives = 131/267 (49%), Gaps = 24/267 (8%)
Query: 358 KGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
GK +G G FG VY GT A+K + + S + I++ +E +++ L
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK----EDASEQQIEEFLREARIMRKL 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAY 472
H NIV+ G ++ L I +EY+ G + Y+R++ ++++ S + +F I G+ Y
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SP-NWMAPEVIKA 530
L S N IHRD+ N LV + VVK++DFG+++ L Y G P WMAPE +
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL-- 176
Query: 531 VMQKDG--NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML 586
K+G K D+WS G + E+ T G+ P+ + + + P P
Sbjct: 177 ---KEGKFTSK----SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC 229
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLE 613
E +L+C+ +P +RP+ EL+E
Sbjct: 230 PPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 90/270 (33%), Positives = 134/270 (49%), Gaps = 25/270 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G VY AIK +D+ K + +L +E++ + H N+V+Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDL----EKCQTSVDELRKEVQAMSQCNHPNVVKY 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTNTI 479
Y S VV D L++ + Y+ GS+ ++ + E+I+ + +L GL YLHS I
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLK---GSPNWMAPEVIKAVMQK 534
HRDIK N+L+ G VK+ADFG++ L G K G+P WMAPEV++ Q
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME---QV 181
Query: 535 DG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM------LS 587
G + K DIWS G T IE+ TG P+S++ + + L PP E S
Sbjct: 182 HGYDFK----ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
+ + C ++P +RP+A ELL+H F
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 110/274 (40%), Positives = 152/274 (55%), Gaps = 19/274 (6%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
PKK ++ + + IG+G G+VY + TG AIK++++ PK I EI V+
Sbjct: 17 PKK-KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELII----NEILVM 70
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
KH NIV Y S +V D L++ +EY+ GS+ V E C D E + R L L
Sbjct: 71 RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQAL 128
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIK 529
+LHS IHRDIK N+L+ G VKL DFG +T S ++ G+P WMAPEV
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-- 186
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--PEML 586
V +K PK VDIWSLG IEM+ G+PP+ +A++ + N TP + PE L
Sbjct: 187 -VTRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
S+ +DFL RC + +R SA ELL+HPF++ A
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 1e-50
Identities = 101/270 (37%), Positives = 143/270 (52%), Gaps = 11/270 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ +G G FG VY N+ETGA A K ++ KS E ++ EI++L H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNH 68
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
IV+ G+ D L+I +E+ G+++ + E R +TE ++ R +L L YLHS
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L+ G +KLADFG+ AK++ L S G+P WMAPEV+ K
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 591
D DIWSLG T+IEM +PP E + + K+ PP P S E +
Sbjct: 189 DT--PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
DFL ++P RPSA +LLEHPF+ +
Sbjct: 247 DFLKTALDKHPETRPSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 96/277 (34%), Positives = 147/277 (53%), Gaps = 28/277 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQEIKVLGHLKHE 416
IG G+ G V I T++ TG A+K++D+ KQ L E+ ++ +H
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLR----------KQQRRELLFNEVVIMRDYQHP 76
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
NIV+ Y S +V D L++ +E++ G++ V H R + E + +L L++LH+
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLAVLKALSFLHAQ 134
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKD 535
IHRDIK ++L+ + G VKL+DFG ++ + SL G+P WMAPEVI +
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL---- 190
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKD 592
VDIWSLG VIEM+ G+PP+ QAM ++ + PP +S +
Sbjct: 191 ---PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRS 247
Query: 593 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 629
FL R +R+P +R +A ELL HPF+ A + VP+
Sbjct: 248 FLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 8e-50
Identities = 91/269 (33%), Positives = 143/269 (53%), Gaps = 20/269 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G G G V +R TG A+K I + A KQ+ +E+ +L IV +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVK---TIRLEINEAI-QKQILRELDILHKCNSPYIVGF 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIH 480
YG+ + + I +EY+ GS+++ ++E I E I+ +L GL YLH IH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH 124
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K +N+LV++ G +KL DFG++ L S + G+ ++MAPE I+
Sbjct: 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVN-SLAKTFVGTSSYMAPERIQG-------NDY 176
Query: 541 ALAVDIWSLGCTVIEMLTGK-PPWSEFEGPQAMF----KVLNRTPP-IP-EMLSSEGKDF 593
++ DIWSLG ++IE+ TG+ P E + P +F ++N PP +P S + +DF
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236
Query: 594 LLRCFLRNPVERPSAVELLEHPFIRNANY 622
+ C +++P ERPS ELLEHPFI+
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 4e-49
Identities = 88/301 (29%), Positives = 151/301 (50%), Gaps = 60/301 (19%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHL 413
+K + +G GT+G VY +++TG A+K++ + ++ P + ++ EI +L L
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST--ALR----EISLLKEL 55
Query: 414 KHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
KH NIV+ +V+ + LY+ EY + +Y+ + ++ +++++ +L GLA
Sbjct: 56 KHPNIVKLL--DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA 112
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM------AP 525
Y HS +HRD+K N+L++ GV+KLADFG+A+ ++ + L+ + + AP
Sbjct: 113 YCHSHRILHRDLKPQNILINRDGVLKLADFGLAR-----AFGIPLRTYTHEVVTLWYRAP 167
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL------ 576
E++ G+ + AVDIWS+GC EM+TGKP + SE + +F++L
Sbjct: 168 EILL------GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE 221
Query: 577 ------------NRTPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
P P L EG D L + NP +R SA E L+HP+
Sbjct: 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
Query: 617 I 617
Sbjct: 282 F 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-48
Identities = 87/276 (31%), Positives = 125/276 (45%), Gaps = 34/276 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+ IG+G+FG+V + G KE+D K E +QL E+ +L LKH NIV
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--EK-QQLVSEVNILRELKHPNIV 62
Query: 420 QYYGSEVVDDH--LYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAYL 473
+YY + + LYI +EY G I + +E I E + +L L
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLALYEC 121
Query: 474 H-----STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEV 527
H +HRD+K AN+ +DA+ VKL DFG+AK L S+ + G+P +M+PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ 181
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN------RTPP 581
+ + K DIWSLGC + E+ PP F L +
Sbjct: 182 L---NHMSYDEK----SDIWSLGCLIYELCALSPP---FTA--RNQLQLASKIKEGKFRR 229
Query: 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
IP SSE + + +P +RPS ELL+ P I
Sbjct: 230 IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 8e-48
Identities = 72/271 (26%), Positives = 118/271 (43%), Gaps = 27/271 (9%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K +G G FG VY G A+K + + + K +E +V+ L H
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE----RKDFLKEARVMKKLGHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--------ITESIVRNFTRHILN 468
N+V+ G ++ LY+ LEY+ G + Y+R+ ++ + +F I
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAP 525
G+ YL S +HRD+ N LV VVK++DFG+++ + Y G WMAP
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-PPIP 583
E +K + D+WS G + E+ T G P+ + + + P P
Sbjct: 177 ESLK-------DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP 229
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
E E + +L C+ +P +RP+ EL+E
Sbjct: 230 EYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 5e-47
Identities = 101/258 (39%), Positives = 141/258 (54%), Gaps = 15/258 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG+G+FG VY G + T AIK +D+ ++ + I+ ++QEI VL I +Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYITRY 67
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YGS + L+I +EY+ GS ++ + E+ + R IL GL YLHS IHR
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHR 125
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK AN+L+ G VKLADFG+A LT + + G+P WMAPEVIK
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK-------QSAY 178
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCFL 599
DIWSLG T IE+ G+PP S+ + +F + +PP E S K+F+ C
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238
Query: 600 RNPVERPSAVELLEHPFI 617
++P RP+A ELL+H FI
Sbjct: 239 KDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 166 bits (421), Expect = 2e-46
Identities = 106/262 (40%), Positives = 144/262 (54%), Gaps = 16/262 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG+G+FG V+ G + T AIK +D+ ++ + I+ ++QEI VL + +Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YGS + D L+I +EY+ GS + D E+ + R IL GL YLHS IHR
Sbjct: 68 YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD--ETQIATILREILKGLDYLHSEKKIHR 125
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK AN+L+ G VKLADFG+A LT + + G+P WMAPEVIK Q + K
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDSK- 181
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLRCFL 599
DIWSLG T IE+ G+PP SE + +F + PP E S K+F+ C
Sbjct: 182 ---ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238
Query: 600 RNPVERPSAVELLEHPFI-RNA 620
+ P RP+A ELL+H FI R A
Sbjct: 239 KEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 9e-46
Identities = 96/266 (36%), Positives = 138/266 (51%), Gaps = 11/266 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ +G G FG VY N+ETG A K +D KS E ++ EI +L H
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT-----KSEEELEDYMVEIDILASCDH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ + +++L+I +E+ G+++ + E R +TE +R + L L YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGM-AKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L G +KLADFG+ AK+ + S G+P WMAPEV+ K
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 591
D D+WSLG T+IEM +PP E + + K+ PP P SSE K
Sbjct: 182 D--RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFI 617
DFL +C +N R + +LL+HPF+
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 2e-45
Identities = 110/286 (38%), Positives = 156/286 (54%), Gaps = 22/286 (7%)
Query: 343 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
IMEK S K ++ + + IG+G G+V+ + TG AIK++++ PK
Sbjct: 4 IMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKEL 62
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
I EI V+ LK+ NIV + S +V D L++ +EY+ GS+ V E C D E+
Sbjct: 63 II----NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMD--EAQ 116
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK 517
+ R L L +LH+ IHRDIK N+L+ G VKL DFG +T S ++
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-L 576
G+P WMAPEV V +K PK VDIWSLG IEM+ G+PP+ +A++ +
Sbjct: 177 GTPYWMAPEV---VTRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229
Query: 577 NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
N TP + PE LS +DFL RC + +R SA ELL+HPF++ A
Sbjct: 230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 100/258 (38%), Positives = 142/258 (55%), Gaps = 15/258 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG+G+FG V+ G + T AIK +D+ ++ + I+ ++QEI VL + +Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDL----EEAEDEIEDIQQEITVLSQCDSPYVTKY 67
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YGS + L+I +EY+ GS +R D E + + IL GL YLHS IHR
Sbjct: 68 YGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLKEILKGLDYLHSEKKIHR 125
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK AN+L+ G VKLADFG+A LT + + G+P WMAPEVI+ Q + K
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDSK- 181
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPEMLSSEGKDFLLRCFL 599
DIWSLG T IE+ G+PP S+ + +F + PP + S K+F+ C
Sbjct: 182 ---ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238
Query: 600 RNPVERPSAVELLEHPFI 617
++P RP+A ELL+H FI
Sbjct: 239 KDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 5e-45
Identities = 110/298 (36%), Positives = 159/298 (53%), Gaps = 18/298 (6%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
S K ++ + + IG+G G+VY + TG AIK++++ PK I EI
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNL-QQQPKKELII----NEI 67
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
V+ K+ NIV Y S +V D L++ +EY+ GS+ V E C D E + R L
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECL 125
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPE 526
L +LHS IHRDIK N+L+ G VKL DFG +T S ++ G+P WMAPE
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--P 583
V V +K PK VDIWSLG IEM+ G+PP+ +A++ + N TP + P
Sbjct: 186 V---VTRKAYGPK----VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKS 641
E LS+ +DFL RC + R SA ELL+HPF++ A + P+ + ++ + + S
Sbjct: 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEAIKNSS 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-45
Identities = 92/261 (35%), Positives = 135/261 (51%), Gaps = 16/261 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+FG+VY + T AIK++ +S E + + +E++ L L+H N ++Y
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
G + + ++ +EY GS + + H + + E + L GLAYLHS IHR
Sbjct: 81 KGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 539
DIK N+L+ G VKLADFG A + +S S G+P WMAPEVI A+ Q DG
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSA---SLVSPANSFVGTPYWMAPEVILAMDEGQYDGK-- 194
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRC 597
VD+WSLG T IE+ KPP A++ + P S ++F+ C
Sbjct: 195 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSC 250
Query: 598 FLRNPVERPSAVELLEHPFIR 618
+ P +RPS+ ELL+H F+
Sbjct: 251 LQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-44
Identities = 85/266 (31%), Positives = 134/266 (50%), Gaps = 28/266 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVLGHLKHEN 417
+G+G+FG V + ++TG A+K + K ++ + E +L + H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK------KKKIIKRKEVEHTLTERNILSRINHPF 54
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
IV+ + + ++ LY+ LEY G + ++ + +E R + I+ L YLHS
Sbjct: 55 IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLG 113
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
I+RD+K N+L+DA G +KL DFG+AK L + S + G+P ++APEV+ K
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL---GKGY 170
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEGKDF 593
AVD WSLG + EMLTGKPP F + ++ K+L PE LS E +D
Sbjct: 171 GK----AVDWWSLGVLLYEMLTGKPP---FYAEDRKEIYEKILKDPLRFPEFLSPEARDL 223
Query: 594 LLRCFLRNPVER---PSAVELLEHPF 616
+ ++P +R A E+ HPF
Sbjct: 224 ISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 1e-44
Identities = 87/287 (30%), Positives = 136/287 (47%), Gaps = 33/287 (11%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ + +G G+FG VY+ +R+ A+K + + ++ +EI++L L H
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEV--ERFLREIQILASLNH 56
Query: 416 E-NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAY 472
NIV+ Y + LY+ +EYV GS+ +++ ++ES IL+ L Y
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 473 LHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYEL-------SLKGSPNWMA 524
LHS IHRDIK N+L+D G VVKL DFG+AK L + G+P +MA
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-------- 576
PEV+ + + DIWSLG T+ E+LTG PP+ + A + L
Sbjct: 177 PEVLLGLSLAYASSS----SDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 577 -----NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
+P PE++S D L + ++P R S+ L H +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 2e-44
Identities = 96/275 (34%), Positives = 146/275 (53%), Gaps = 21/275 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK- 414
W+ + IG+GT+G V+ N++ G+ A+K +D I D +++E E +L L
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD------IDEEIEAEYNILKALSD 73
Query: 415 HENIVQYYG-----SEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHI 466
H N+V++YG D L++ LE + GS+ V+ + + E I+
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAP 525
L GL +LH TIHRD+KG N+L+ G VKL DFG++ LT + G+P WMAP
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--- 582
EVI Q D D+WSLG T IE+ G PP ++ +A+FK+ PP
Sbjct: 194 EVIACEQQLDST--YDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ 251
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
PE+ S+E DF+ +C ++ +RP+ +LL+H FI
Sbjct: 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-44
Identities = 106/277 (38%), Positives = 150/277 (54%), Gaps = 18/277 (6%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
S K ++ + + IG+G G+VY + TG AI+++++ PK I EI
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELII----NEI 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
V+ K+ NIV Y S +V D L++ +EY+ GS+ V E C D E + R L
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECL 126
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPE 526
L +LHS IHRDIK N+L+ G VKL DFG +T + S + G+P WMAPE
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTPPI--P 583
V V +K PK VDIWSLG IEM+ G+PP+ +A++ + N TP + P
Sbjct: 187 V---VTRKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
E LS+ +DFL RC + +R SA ELL+H F++ A
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 2e-43
Identities = 95/276 (34%), Positives = 142/276 (51%), Gaps = 21/276 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-K 414
W+ + IG+GT+G VY TN++ G+ A+K +D I D +++E E +L L
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD------VDEEIEAEYNILQSLPN 77
Query: 415 HENIVQYYGSEVVDDH-----LYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHI 466
H N+V++YG D L++ LE + GS+ V+ + E+++
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAP 525
L GL +LH+ IHRD+KG N+L+ G VKL DFG++ LT + G+P WMAP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--- 582
EVI Q D + D+WSLG T IE+ G PP + + +FK+ PP
Sbjct: 198 EVIACEQQYDYS--YDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
PE F+ +C +++ RPS LLEHPFI+
Sbjct: 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 86/297 (28%), Positives = 132/297 (44%), Gaps = 58/297 (19%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
++G G +G V N+ TG AIK+ DD + + E+KVL L+HENIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR---EVKVLRQLRHENIVN 64
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ LY+ EYV ++ + + VR++ +L +AY HS N IH
Sbjct: 65 LKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN--------WM-APEVIKAV 531
RDIK N+LV SGV+KL DFG A+ L + + W APE++
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRA-------RPASPLTDYVATRWYRAPELLV-- 174
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFE---------GP--QAMFKVLN 577
G+ VD+W++GC + E+L G+P + S+ + GP + ++ +
Sbjct: 175 ----GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230
Query: 578 --------RTPPIPEMLSSEGK----------DFLLRCFLRNPVERPSAVELLEHPF 616
P + S E + DFL C +P ER + ELL+HP+
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 3e-43
Identities = 99/262 (37%), Positives = 147/262 (56%), Gaps = 18/262 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG GT+G VY N TG AIK + + P E ++QEI ++ KH NIV Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
+GS + D L+I +E+ GS+ + ++ES + +R L GL YLHS +HR
Sbjct: 72 FGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIKGAN+L+ +G VKLADFG++ +T ++ S G+P WMAPEV AV +K G +L
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV-AAVERKGGYNQL 189
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK------DFL 594
DIW++G T IE+ +PP + +A+F ++ ++ P L + K F+
Sbjct: 190 C---DIWAVGITAIELAELQPPMFDLHPMRALF-LMTKSNFQPPKLKDKMKWSNSFHHFV 245
Query: 595 LRCFLRNPVERPSAVELLEHPF 616
+NP +RP+A +LL+HPF
Sbjct: 246 KMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 4e-43
Identities = 100/273 (36%), Positives = 149/273 (54%), Gaps = 27/273 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENI 418
+++G GT+G VY G + +TG AIK +D+ D+ + +++ EI +L + H NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE------EIKLEINMLKKYSHHRNI 75
Query: 419 VQYYGSEVV------DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 471
YYG+ + DD L++ +E+ GS+ V+ + E + R IL GLA
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKA 530
+LH+ IHRDIKG N+L+ + VKL DFG++ L + + G+P WMAPEVI
Sbjct: 136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 531 VMQKDGNPKLALAV--DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS 588
D NP DIWSLG T IEM G PP + +A+F ++ R PP P++ S
Sbjct: 196 ----DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPP-PKLKSK 249
Query: 589 EGK----DFLLRCFLRNPVERPSAVELLEHPFI 617
+ DF+ C ++N + RPS +LL+HPFI
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 157 bits (397), Expect = 1e-42
Identities = 105/290 (36%), Positives = 149/290 (51%), Gaps = 28/290 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+FG+VY TN T A+K++ ++ E + + +E+K L LKH N ++Y
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSY--SGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
G + + ++ +EY GS + + H + + E + T L GLAYLHS N IHR
Sbjct: 87 KGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 539
DIK N+L+ G VKLADFG A + + S G+P WMAPEVI A+ Q DG
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDGK-- 200
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD----FLL 595
VD+WSLG T IE+ KPP A++ + P + S+E D F+
Sbjct: 201 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LQSNEWTDSFRGFVD 254
Query: 596 RCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 645
C + P ERP++ ELL H F+R P RV I+L ++ D V
Sbjct: 255 YCLQKIPQERPASAELLRHDFVRRDR------PARVL--IDLIQRTKDAV 296
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 84/297 (28%), Positives = 131/297 (44%), Gaps = 57/297 (19%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG GT+G VY N++TG A+K+ I ++ K I + EIK+L L+H NIV+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRL 63
Query: 422 YGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
E+V +Y+ EY+ + + TES ++ + + +L GL YLHS
Sbjct: 64 K--EIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----WM-APEVIKAVM 532
+HRDIKG+N+L++ GV+KLADFG+A+ T S + W PE++
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTK---RNSADYTNRVITLWYRPPELLL--- 174
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPP------------------------WSEFEG 568
G + VD+WS+GC + E+ GKP W
Sbjct: 175 ---GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 569 PQAMFKVLNRTPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
F+ L P ++ D L + +P +R SA + L+H +
Sbjct: 232 LP-WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-41
Identities = 93/271 (34%), Positives = 145/271 (53%), Gaps = 23/271 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENI 418
+L+G GT+G VY G + +TG AIK +D+ D+ + +++QEI +L + H NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE------EIKQEINMLKKYSHHRNI 65
Query: 419 VQYYGSEV------VDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLA 471
YYG+ + +DD L++ +E+ GS+ ++ + E + R IL GL+
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKA 530
+LH IHRDIKG N+L+ + VKL DFG++ L + + G+P WMAPEVI
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 531 VMQKDGNPKLA--LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP--IPEML 586
D NP D+WSLG T IEM G PP + +A+F + P +
Sbjct: 186 ----DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 241
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
S + + F+ C ++N +RP+ +L++HPFI
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 91/272 (33%), Positives = 141/272 (51%), Gaps = 18/272 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+ G V I + +G A+K +D+ + + + L E+ ++ +H+N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHQNVVEM 83
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
Y S +V + L++ +E++ G++ V + + E + +L L YLHS IHR
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK ++L+ G VKL+DFG ++ + SL G+P WMAPEVI
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-------Y 194
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE---MLSSEGKDFLLRC 597
VDIWSLG VIEM+ G+PP+ QAM ++ + PP + +S +DFL R
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 598 FLRNPVERPSAVELLEHPFIRNANYQNLSVPM 629
R P ER +A ELL+HPF+ VP+
Sbjct: 255 LTREPQERATAQELLDHPFLLQTGLPECLVPL 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 63/303 (20%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K IG G +G V ++ TG AIK++ + DD A K++ +EIK+L HL+HENI+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDA---KRILREIKLLRHLRHENII 62
Query: 420 Q-----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
S + +YI E + +++ ++ + +T+ ++ F IL GL YLH
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLH 120
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------A 524
S N IHRD+K +N+LV+++ +K+ DFG+A+ + E ++ A
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE------KGFLTEYVVTRWYRA 174
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWS 564
PE++ + + A+DIWS+GC E+LT KP P
Sbjct: 175 PELLLSSSRYT------KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228
Query: 565 E----FEGPQAMFKVLNRTP----PIPEML---SSEGKDFLLRCFLRNPVERPSAVELLE 613
E +A + + P+ ++ S E D L + + +P +R +A E L
Sbjct: 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288
Query: 614 HPF 616
HP+
Sbjct: 289 HPY 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 98/261 (37%), Positives = 143/261 (54%), Gaps = 16/261 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G GT+G VY N TG A+K + + P D S ++QEI ++ KH NIV Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-----IQQEIFMVKECKHCNIVAY 71
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
+GS + + L+I +EY GS+ + ++E + R L GLAYLHS +HR
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIKGAN+L+ +G VKLADFG+A +T ++ S G+P WMAPEV AV + G +L
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AAVEKNGGYNQL 189
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLNRTPPIPEML--SSEGKDFLL 595
DIW++G T IE+ +PP + +A+F K + P + + SS +F+
Sbjct: 190 C---DIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246
Query: 596 RCFLRNPVERPSAVELLEHPF 616
+NP +RP+A LL H F
Sbjct: 247 ISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 79/258 (30%), Positives = 133/258 (51%), Gaps = 15/258 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQ 420
IG+G+FG V+ + A+K++D+ + + E I E +VL L I++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID----EARVLAKLDSSYIIR 63
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTI 479
YY S + L I +EY G +++ ++ R + E V F IL GLA+LHS +
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
HRDIK NL +DA VK+ D G+AK L ++ ++ G+P +++PE+ + K N
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE---DKPYNE 180
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597
K D+W+LG + E TGK P+ + +G + + PP+ +M S + + +C
Sbjct: 181 K----SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236
Query: 598 FLRNPVERPSAVELLEHP 615
++ +RP +LL +P
Sbjct: 237 LTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 89/284 (31%), Positives = 142/284 (50%), Gaps = 47/284 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G G GSV + TG A+K + P+ + KQ+ +E+++ K IV+Y
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNP----DLQKQILRELEINKSCKSPYIVKY 64
Query: 422 YGSEVVDDH---LYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS 475
YG+ +D+ + I +EY GS++ V++ I E ++ +L GL+YLHS
Sbjct: 65 YGA-FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFG--------MAKHLTGLSYELSLKGSPNWMAPEV 527
IHRDIK +N+L+ G VKL DFG +A TG S+ +MAPE
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF---------YMAPER 174
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFEGPQAMFKVLNR--TPPIPE 584
I+ G P ++ D+WSLG T++E+ + P+ E E P ++L+ P PE
Sbjct: 175 IQ------GKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227
Query: 585 MLSSEG---------KDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ G KDF+ +C ++P RP+ ++LEHP+I+
Sbjct: 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 94/272 (34%), Positives = 149/272 (54%), Gaps = 18/272 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+ G V I T + TG A+K++D+ + + + L E+ ++ HEN+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQRRELLFNEVVIMRDYHHENVVDM 84
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
Y S +V D L++ +E++ G++ V H R + E + +L L+YLH+ IHR
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK ++L+ + G +KL+DFG ++ + SL G+P WMAPEVI +
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL-------PY 195
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IPEM--LSSEGKDFLLRC 597
VDIWSLG VIEM+ G+PP+ QAM ++ + PP + + +SS + FL
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255
Query: 598 FLRNPVERPSAVELLEHPFIRNANYQNLSVPM 629
+R P +R +A ELL+HPF++ A + VP+
Sbjct: 256 LVREPSQRATAQELLQHPFLKLAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 83/277 (29%), Positives = 137/277 (49%), Gaps = 28/277 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQEIKVLGHLKHENIVQ 420
I +G +G V++ + TG AIK +I + + Q+ E +L + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIK---VIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
Y S +LY+ +EY+ G + + E+ + E + R + I+ L YLHS IH
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 481 RDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLK--------GSPNWMAPEVIKAV 531
RD+K N+L+D++G +KL DFG++K L L+ G+P+++APEVI
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG- 175
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPE--MLSS 588
+ + VD WSLGC + E L G PP+ E P+ +F +LN PE +S
Sbjct: 176 --QGHSK----TVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNILNGKIEWPEDVEVSD 228
Query: 589 EGKDFLLRCFLRNPVERP---SAVELLEHPFIRNANY 622
E D + + + +P +R S E+ HPF + ++
Sbjct: 229 EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-40
Identities = 87/289 (30%), Positives = 135/289 (46%), Gaps = 46/289 (15%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENIVQ 420
IG G G V+ +RETG + A+K+V + + I Q +EIK L +H +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVAL----RRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ +EY+ P ++ +R+ R + E+ V+++ R +L G+AY+H+ +H
Sbjct: 64 LLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNW-MAPEVIKAVMQKDGNP 538
RD+K ANLL+ A GV+K+ADFG+A+ S + + W APE++ G
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY------GAR 176
Query: 539 KLALAVDIWSLGCTVIEMLTGKP--------------------P----WSEFEG-PQAMF 573
K VD+W++GC E+L G P P W P
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236
Query: 574 KVLNRTPPIP--EML---SSEGKDFLLRCFLR-NPVERPSAVELLEHPF 616
+ PIP E+ S E D LL+ L +P +R SA E L HP+
Sbjct: 237 ITFPESKPIPLEEIFPDASPEALD-LLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 8e-40
Identities = 91/303 (30%), Positives = 143/303 (47%), Gaps = 71/303 (23%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA-----ECIKQLEQEIKVLGHLK 414
K +G GTFGSVY+ N+ETG AIK++ K EC+ +E+K L L
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMN--LREVKSLRKLN 55
Query: 415 -HENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGL 470
H NIV+ EV +D LY EY+ G++ + +++ + +ES++R+ IL GL
Sbjct: 56 EHPNIVKLK--EVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL------TGLSYELSLKGSPNWM- 523
A++H HRD+K NLLV VVK+ADFG+A+ + T Y S W
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT--DYV-----STRWYR 165
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP---------------------- 561
APE++ + + VDIW+LGC + E+ T +P
Sbjct: 166 APEILLR------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPT 219
Query: 562 --PWSE-FEGPQAM-FKVLNRTP-PIPEML---SSEGKDFLLRCFLRNPVERPSAVELLE 613
W E ++ + F+ P + +++ S E D + +P +RP+A + L+
Sbjct: 220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279
Query: 614 HPF 616
HP+
Sbjct: 280 HPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 8e-40
Identities = 89/297 (29%), Positives = 133/297 (44%), Gaps = 62/297 (20%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV--------- 409
GK+IG G+F +V + +ET AIK +D +QL +E KV
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDK-----------RQLIKEKKVKYVKIEKEV 54
Query: 410 LGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHIL 467
L L H I++ Y + +++LY LEY G + +Y+R++ D E R + IL
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD--EKCTRFYAAEIL 112
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---------- 517
L YLHS IHRD+K N+L+D +K+ DFG AK L S S K
Sbjct: 113 LALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 518 -----------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF 566
G+ +++PE++ +K + D+W+LGC + +MLTGKPP F
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLN---EKPAGK----SSDLWALGCIIYQMLTGKPP---F 222
Query: 567 EGP---QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP----SAVELLEHPF 616
G K+L P + KD + + + +P +R EL HPF
Sbjct: 223 RGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 82/274 (29%), Positives = 134/274 (48%), Gaps = 27/274 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHE-- 416
K I +G FGSVY+ R TG AIK ++ D + + ++ E ++ ++ E
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIK---VLKKSDMIAKNQVTNVKAERAIM-MIQGESP 57
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ + Y S D+LY+ +EY++ G ++ + E + + ++ G+ LH
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
IHRDIK NLL+D +G +KL DFG+++ GL + G+P+++APE I +
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSR--NGLENK-KFVGTPDYLAPETI---LGVGD 170
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-----VLNRTPPIPEMLSSEGK 591
+ D WSLGC + E L G PP+ E P A+F +N + E S E
Sbjct: 171 DK----MSDWWSLGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEFCSPEAV 225
Query: 592 DFLLRCFLRNPVERPSA---VELLEHPFIRNANY 622
D + R +P +R A E+ HPF ++ N+
Sbjct: 226 DLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 27/275 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQEIKVLGHLKHEN 417
+G G FG V + + + A+K V K + + E ++L H
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV------KKRHIVETGQQEHIFSEKEILEECNHPF 54
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
IV+ Y + ++Y+ +EY G + +R+ E R + ++ YLH+
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRG 113
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
I+RD+K NLL+D++G VKL DFG AK L + G+P ++APE+I K +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL---NKGYD 170
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFK-VLNRTPPI--PEMLSSEGKDF 593
+VD WSLG + E+LTG+PP+ E E P ++ +L + P + KD
Sbjct: 171 ----FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDL 226
Query: 594 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQ 623
+ + RNP ER ++ +H + +++
Sbjct: 227 IKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 84/275 (30%), Positives = 141/275 (51%), Gaps = 25/275 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
K +G G+FG V + ++ +G A+K I K + +KQ+E E ++L ++H
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALK----ILSKAKIVK-LKQVEHVLNEKRILQSIRHP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V YGS D +LY+ +EYV G + ++R+ E + R + ++ L YLHS
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+ ++RD+K NLL+D+ G +K+ DFG AK + G +Y L G+P ++APE+I G
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--GTPEYLAPEII----LSKG 174
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLL 595
K AVD W+LG + EML G PP+ + + P ++ K+L P S + KD +
Sbjct: 175 YGK---AVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGKVRFPSFFSPDAKDLIR 230
Query: 596 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
+ +R ++ HP+ ++ L
Sbjct: 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 83/296 (28%), Positives = 140/296 (47%), Gaps = 47/296 (15%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+QK IG GT+G VY ++ TG AIK++ + + K +EIK+L L H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIP---KTALREIKLLKELNH 57
Query: 416 ENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
NI++ +V LY+ E++ + + +++ R + ES+++++ +L GLA+
Sbjct: 58 PNIIKLL--DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFC 114
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVM 532
HS +HRD+K NLL++ GV+KLADFG+A+ + W APE++
Sbjct: 115 HSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP--------- 580
VDIWS+GC E+L+ +P + SE + +F+ L TP
Sbjct: 175 GYSTP------VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG-TPDPEVWPKFT 227
Query: 581 ----------------PIPEM---LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
P+P++ S + D L + +P +R +A + L HP+
Sbjct: 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 91/276 (32%), Positives = 151/276 (54%), Gaps = 17/276 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G +GSVY +R TG + A+KE+ + D+ K + I +L+ +L IV +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD----ILHKAVSPYIVDF 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHST-NT 478
YG+ ++ +Y+ +EY+ GS+++ I E ++R T ++ GL +L N
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
IHRD+K N+LV+ +G VKL DFG++ +L S + G ++MAPE IK + NP
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA-SLAKTNIGCQSYMAPERIK-SGGPNQNP 182
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPP-IPEMLSSEGKDF 593
+ D+WSLG +++EM G+ P+ E +F L+ PP +P S + +DF
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPP-ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDF 241
Query: 594 LLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 629
+ +C + P RP+ +LLEHP++ Y+N V M
Sbjct: 242 VAKCLNKIPNRRPTYAQLLEHPWLV--KYKNADVDM 275
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 93/272 (34%), Positives = 147/272 (54%), Gaps = 18/272 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+ G V I T + +G A+K++D+ + + + L E+ ++ +HEN+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
Y S +V D L++ +E++ G++ V H R + E + +L L+ LH+ IHR
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIV-THTR-MNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
DIK ++L+ G VKL+DFG ++ + SL G+P WMAPE+I +
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-------PY 193
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML---SSEGKDFLLRC 597
VDIWSLG VIEM+ G+PP+ +AM + + PP + L S K FL R
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253
Query: 598 FLRNPVERPSAVELLEHPFIRNANYQNLSVPM 629
+R+P +R +A ELL+HPF+ A + VP+
Sbjct: 254 LVRDPAQRATAAELLKHPFLAKAGPPSCIVPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 3e-38
Identities = 89/312 (28%), Positives = 143/312 (45%), Gaps = 70/312 (22%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC------IKQLEQEIK 408
+++KGK +G GT+ VY ++ETG AIK+ I + K A+ ++ EIK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKK--IKLGERKEAKDGINFTALR----EIK 54
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+L LKH NI+ ++ + E++ + + +++ +T + ++++ L
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPEV 527
GL YLHS +HRD+K NLL+ + GV+KLADFG+A+ S+ GSPN M +V
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----SF-----GSPNRKMTHQV 163
Query: 528 I----KAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF 573
+ +A P+L VD+WS+GC E+L P S+ + +F
Sbjct: 164 VTRWYRA-------PELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF 216
Query: 574 KVL--------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSA 608
+ L PP P S + D L R NP +R +A
Sbjct: 217 EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA 276
Query: 609 VELLEHPFIRNA 620
+ LEHP+ N
Sbjct: 277 RQALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 84/267 (31%), Positives = 136/267 (50%), Gaps = 27/267 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAE-CIKQLEQEIKVLGHLKHEN 417
K IG+G F VY G A+K+V I D K+ + C+K EI +L L H N
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK----EIDLLKQLDHPN 63
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINR---YVREHCRDITESIVRNFTRHILNGLAYLH 474
+++Y S + ++ L I LE G ++R + ++ R I E + + + + L ++H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQ 533
S +HRDIK AN+ + A+GVVKL D G+ + + + SL G+P +M+PE I
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----H 179
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKVLNRT-----PPIP-EML 586
++G DIWSLGC + EM + P F G + ++ + + PP+P +
Sbjct: 180 ENG---YNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEKCDYPPLPADHY 233
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLE 613
S E +D + RC +P +RP +L+
Sbjct: 234 SEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 82/264 (31%), Positives = 133/264 (50%), Gaps = 23/264 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLGHLKHENI 418
K +G+G++GSVY A+KEVD+ + + + EI++L + H NI
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASVNHPNI 61
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHS 475
+ Y + + + L I +EY G +++ + + + I E + +L GL LH
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRD+K AN+L+ A+ +VK+ D G++K L + + G+P++MAPEV K
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWK------ 174
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLN-RTPPIPEMLSSEGK 591
G P + DIWSLGC + EM T PP FE +KV + PPIP + S + +
Sbjct: 175 GRP-YSYKSDIWSLGCLLYEMATFAPP---FEARSMQDLRYKVQRGKYPPIPPIYSQDLQ 230
Query: 592 DFLLRCFLRNPVERPSAVELLEHP 615
+F+ P RP+ ++L P
Sbjct: 231 NFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 91/314 (28%), Positives = 133/314 (42%), Gaps = 73/314 (23%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
GKL G GTFG VY +TG A+K+ I+ + K I L +EIK+L LKH N+
Sbjct: 14 GKL-GEGTFGEVYKARQIKTGRVVALKK--ILMHNEKDGFPITAL-REIKILKKLKHPNV 69
Query: 419 VQY------YGSEVVDDHLYIYLEYVHP-------GSI-NRYVREHCRDITESIVRNFTR 464
V + +Y+ V P G + N V+ +TES ++ +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLLENPSVK-----LTESQIKCYML 122
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN--- 521
+L G+ YLH + +HRDIK AN+L+D G++K+ADFG+A+ G G
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 522 --------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 561
W PE++ G + AVDIW +GC EM T +P
Sbjct: 183 YTNLVVTRWYRPPELLL------GERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236
Query: 562 ---------P-------WSEFEGPQAMFKVLNRTPPIPEM---LSSEGKDFLLRCFLRNP 602
P W G + + N + E L EG D L + +P
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDP 296
Query: 603 VERPSAVELLEHPF 616
+R +A + LEHP+
Sbjct: 297 YKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 95/262 (36%), Positives = 138/262 (52%), Gaps = 20/262 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+FG+VY + T AIK++ +S E + + +E+K L +KH N ++Y
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSY--SGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
G + + ++ +EY GS + + H + + E + T L GLAYLHS N IHR
Sbjct: 91 KGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 539
DIK N+L+ G VKLADFG A + + S G+P WMAPEVI A+ Q DG
Sbjct: 150 DIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQYDGK-- 204
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD----FLL 595
VD+WSLG T IE+ KPP A++ + P + S+E D F+
Sbjct: 205 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDYFRNFVD 258
Query: 596 RCFLRNPVERPSAVELLEHPFI 617
C + P +RP++ ELL+H F+
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 81/272 (29%), Positives = 140/272 (51%), Gaps = 19/272 (6%)
Query: 360 KLIGRGTFGSVYI----GTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K++G+G+FG V + GTN K+V + DD EC +E+ + L +H
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD---VEC-TMVERRVLALA-WEH 55
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ + + +HL+ +EY++ G + +++ E+ R + I+ GL +LH
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHK 114
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
I+RD+K N+L+D G +K+ADFGM K ++ G + G+P+++APE++K
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ--- 171
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 594
K +VD WS G + EML G+ P+ + + +LN P P +S E KD L
Sbjct: 172 ----KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCL 227
Query: 595 LRCFLRNPVER-PSAVELLEHPFIRNANYQNL 625
+ F R+P +R ++ +HPF R +++ L
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFFRGIDWERL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 112/356 (31%), Positives = 177/356 (49%), Gaps = 41/356 (11%)
Query: 273 SPLPSPPRQSSQSNLRS-PRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPP 331
P P +++ +S PR+ P LPQ L A PLPLPP + S
Sbjct: 6 PPPGVPLPSTARHTTKSRPRRR--PDLTLPLPQRDPSL--------AVPLPLPPPSSSSS 55
Query: 332 KSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
SS +SA PSA+ S+ ++ IG G G+VY +R TG A+K +
Sbjct: 56 SSSSSSA----SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 451
+D +Q+ +EI++L + H N+V+ + + + + LE++ GS+ E
Sbjct: 112 ED----TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-----EGT 162
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GL 510
E + + R IL+G+AYLH + +HRDIK +NLL++++ VK+ADFG+++ L +
Sbjct: 163 HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222
Query: 511 SYELSLKGSPNWMAPEVIKAVMQK---DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
S G+ +M+PE I + DG A DIWSLG +++E G+ P+
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDG-----YAGDIWSLGVSILEFYLGRFPFG--V 275
Query: 568 GPQAMFKVL------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
G Q + L ++ P P S E + F+ C R P +R SA++LL+HPFI
Sbjct: 276 GRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 91/277 (32%), Positives = 140/277 (50%), Gaps = 18/277 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G+FG+VY + AIK++ +S E + + +E++ L L+H N +QY
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSY--SGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
G + + ++ +EY GS + + H + + E + T L GLAYLHS N IHR
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV--MQKDGNPK 539
D+K N+L+ G+VKL DFG A + + G+P WMAPEVI A+ Q DG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQYDGK-- 194
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE--MLSSEGKDFLLRC 597
VD+WSLG T IE+ KPP A++ + P + S ++F+ C
Sbjct: 195 ----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 598 FLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSR 634
+ P +RP++ LL+H F+ + +V M + R
Sbjct: 251 LQKIPQDRPTSEVLLKHRFVLRE--RPPTVIMDLIQR 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 84/268 (31%), Positives = 140/268 (52%), Gaps = 17/268 (6%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++ K K IG G+FG + ++E G IKE++I PK E + +E+ VL ++K
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMK 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAY 472
H NIVQY S + +LYI ++Y G + + + R + E + ++ I L +
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKH 116
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKA 530
+H +HRDIK N+ + G +KL DFG+A+ L + EL+ G+P +++PE+ +
Sbjct: 117 VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELARTCIGTPYYLSPEICE- 174
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSE 589
+ N K DIW+LGC + EM T K + + K++ + PP+ S +
Sbjct: 175 --NRPYNNK----SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYD 228
Query: 590 GKDFLLRCFLRNPVERPSAVELLEHPFI 617
++ + + F RNP +RPS +LE FI
Sbjct: 229 LRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 77/262 (29%), Positives = 139/262 (53%), Gaps = 15/262 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG + E + KEV++ K + EI +L L+H NI+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQHPNII 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
YY + D+ L I +EY + G++ ++ VR+ + E +V + I++ ++Y+H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
+HRDIK N+ + +G++KL DFG++K L + S ++ G+P +M+PE+ + V
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV------ 176
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLL 595
K DIW+LGC + E+LT K + + K++ N T P+ + SSE +
Sbjct: 177 -KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVH 234
Query: 596 RCFLRNPVERPSAVELLEHPFI 617
++P +RP+A E+L+ P +
Sbjct: 235 SLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 77/266 (28%), Positives = 123/266 (46%), Gaps = 25/266 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKE---VDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
IG+G FG V I R+T A+K + ++ + E ++L L H +
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFL 62
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + S ++++Y+ ++ + G + RY +E V+ + I+ L YLHS
Sbjct: 63 VNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
IHRDIK N+L+D G V + DF +A +T + S G+P +MAPEV+ Q
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--QGYS-- 177
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW-----SEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593
+AVD WSLG T E L GK P+ + + +A + P S+E D
Sbjct: 178 ---VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--TADVLYPATWSTEAIDA 232
Query: 594 LLRCFLRNPVERPSAV--ELLEHPFI 617
+ + R+P +R +L HP+
Sbjct: 233 INKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 81/278 (29%), Positives = 135/278 (48%), Gaps = 27/278 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K++G+G+FG V + + T A+K + I+ DD EC E+ + L KH
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDD--DVECT-MTEKRVLALAG-KHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ Q + D L+ +EYV+ G + +++ E R + I+ GL +LH
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQ 533
I+RD+K N+L+D+ G +K+ADFGM K G+ ++ G+P+++APE++
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKE--GILGGVTTSTFCGTPDYIAPEILSYQ-- 171
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKD 592
AVD W+LG + EML G+ P+ E + +F+ +L P LS E K
Sbjct: 172 -----PYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKS 225
Query: 593 FLLRCFLRNPVERPSAV-----ELLEHPFIRNANYQNL 625
L +NP +R + ++ HPF R ++ L
Sbjct: 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKL 263
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 94/290 (32%), Positives = 138/290 (47%), Gaps = 46/290 (15%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
L+G G++G V ++ETG AIK + K +EI++L L+HEN+V
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 421 YYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
EV LY+ E+V ++ + ++ + ES VR + IL G+ + HS N
Sbjct: 65 LI--EVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGN 537
IHRDIK N+LV SGVVKL DFG A+ L + + W APE++ G+
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV------GD 175
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-----------NRTPP-- 581
K AVDIW++GC V EMLTG+P + S+ + + K L + P
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235
Query: 582 ---IPEM------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
+PE+ LS D +C +P +RPS+ +LL H F
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 76/266 (28%), Positives = 141/266 (53%), Gaps = 13/266 (4%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++K +++GRG FG V++ + IK+ IP + + + + E +VL L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQ---IPVEQMTKDERLAAQNECQVLKLLS 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYL 473
H NI++YY + + D L I +EY G++ Y+++ C + E + +F IL L ++
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 474 HSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
H+ +HRD+K N+L+D VVK+ DFG++K L+ S ++ G+P +++PE+ +
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-- 175
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK 591
K N K DIW+LGC + E+ + K + P + K+++ T PI + S + +
Sbjct: 176 -KPYNQK----SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR 230
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFI 617
+L +P +RP +++ P
Sbjct: 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 12/210 (5%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ K +G GTFG V++ +R + A+K + I + + + + E +VL +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAI--PEVIRLKQEQHVHNEKRVLKEV 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H I++ + +E LY+ +EYV G + Y+R + S + I+ L YL
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYL 117
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
HS ++RD+K N+L+D G +KL DFG AK L ++ +L G+P ++APEVI Q
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLAPEVI----Q 171
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+ K AVD W+LG + EML G PP+
Sbjct: 172 SKGHNK---AVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 100/340 (29%), Positives = 160/340 (47%), Gaps = 49/340 (14%)
Query: 344 MEKPSASP-KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-- 400
KP S K S ++ G+ +G G+FG V I ++ TG AIK + K E +
Sbjct: 7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL-------KKREILKM 59
Query: 401 KQLE---QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITES 457
KQ++ QE +L L H IV S ++ +Y LE+V G + ++R+ R
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR-FPND 118
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 517
+ + + ++ YLHS + I+RD+K NLL+D G VK+ DFG AK + ++ +L
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--TLC 176
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVL 576
G+P ++APEVI Q G+ K AVD W++G + E + G PP+ + + P ++ K+L
Sbjct: 177 GTPEYLAPEVI----QSKGHGK---AVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKIL 228
Query: 577 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV-----ELLEHPFIRNANYQNL------ 625
P +D + + +R + ++ HP+ AN+ L
Sbjct: 229 AGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP 288
Query: 626 -SVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVR 664
+P+RV S GD T E PDSP R+
Sbjct: 289 APIPVRVKSP---GD---------TSNFEKYPDSPVDRLP 316
|
Length = 329 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 92/290 (31%), Positives = 131/290 (45%), Gaps = 48/290 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLKHENIVQ 420
IG G++G V+ NRETG AIK+ DDP IK++ +EI++L LKH N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPV----IKKIALREIRMLKQLKHPNLVN 64
Query: 421 YYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
EV L++ EY +N + + R + E +++ L + + H N
Sbjct: 65 LI--EVFRRKRKLHLVFEYCDHTVLNELEK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVMQKDGN 537
IHRD+K N+L+ G +KL DFG A+ LTG + + + W APE++ Q G
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY-GP 180
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPW------------------------SEFEGPQAMF 573
P VD+W++GC E+LTG+P W F Q
Sbjct: 181 P-----VDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235
Query: 574 KVLNRTPPIPEML-------SSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
+ P E L SS FL C +P ER S ELLEHP+
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 7e-34
Identities = 83/279 (29%), Positives = 136/279 (48%), Gaps = 34/279 (12%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQEIKVLGHLKHEN 417
+G+G +G V++ ++TG A+K + KS ++ + E +L K E
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK------KSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+V+ + D++LY+ +EYV PG R + + ++E R + + + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYV-PGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
IHRD+K N L+DASG +KL DFG++K ++Y S+ GSP++MAPEV++
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRG------- 172
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-------KVLNR---TPPIPEMLS 587
VD WSLGC + E L G PP+S P + + L R P LS
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFN-LS 230
Query: 588 SEGKDFLLRCFLRNPVERPSAVE-LLEHPFIRNANYQNL 625
E D + + + +P R ++E + HPF + ++ L
Sbjct: 231 DEAWDLITKL-INDPSRRFGSLEDIKNHPFFKEVDWNEL 268
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 84/307 (27%), Positives = 136/307 (44%), Gaps = 67/307 (21%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGH 412
+++ IG G +G+VY + TG A+K+V + + P S +EI +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS------TLREIALLKQ 54
Query: 413 LK---HENIVQYYG-SEVVDDH----LYIYLEYVHPGSINRYVREHC--RDITESIVRNF 462
L+ H NIV+ L + E+V + Y+ C + +++
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDL 112
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN- 521
R +L G+ +LHS +HRD+K N+LV + G VK+ADFG+A+ S+E++L +
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMAL--TSVV 167
Query: 522 ---WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFK 574
W APEV+ +Q A VD+WS+GC E+ +P + SE + +F
Sbjct: 168 VTLWYRAPEVL---LQS----SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220
Query: 575 VLNRTP-------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAV 609
V+ +PE+ EG D L + NP +R SA
Sbjct: 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEI-CEEGLDLLKKMLTFNPHKRISAF 279
Query: 610 ELLEHPF 616
E L+HP+
Sbjct: 280 EALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 90/279 (32%), Positives = 136/279 (48%), Gaps = 44/279 (15%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQEIKVLGHLKHE-- 416
IG GT G VY ++TG A+K++ ++ E K++ ++ V+ H+
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQM------RRTGNKEENKRILMDLDVV-LKSHDCP 74
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------ITESIVRNFTRHIL 467
IV+ YG + D ++I +E + C D I E I+ T I+
Sbjct: 75 YIVKCYGYFITDSDVFICME----------LMSTCLDKLLKRIQGPIPEDILGKMTVAIV 124
Query: 468 NGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
L YL IHRD+K +N+L+DASG VKL DFG++ L + G +MAPE
Sbjct: 125 KALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNRTPPI 582
I D NPK + D+WSLG +++E+ TG+ P+ +EFE + K+L PP
Sbjct: 185 RIDP---PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEPPS 238
Query: 583 P---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
E S + F+ C ++ +RP ELL+HPFIR
Sbjct: 239 LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 83/263 (31%), Positives = 135/263 (51%), Gaps = 16/263 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K IG G+FG +Y+ + C IKE+D+ K E K +E+ +L +KH NIV
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKHPNIV 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
++ S + L+I +EY G + R R+ +E + ++ I GL ++H
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122
Query: 479 IHRDIKGANLLVDASGVV-KLADFGMAKHLTGLSYELSLK--GSPNWMAPEVIKAVMQKD 535
+HRDIK N+ + +G+V KL DFG+A+ L S EL+ G+P +++PE+ + +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-SMELAYTCVGTPYYLSPEICQ---NRP 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL 594
N K DIWSLGC + E+ T K P+ Q + K+ PI S + + +
Sbjct: 179 YNNK----TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI 234
Query: 595 LRCFLRNPVERPSAVELLEHPFI 617
+ F +P +RPS +L+ PF+
Sbjct: 235 SQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 90/318 (28%), Positives = 146/318 (45%), Gaps = 68/318 (21%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-------LEQE 406
++ K+IGRG FG V++ +++TG A+K + + ++ IK+ E++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAERD 53
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGS--INRYVREHCRDITESIVRNFTR 464
I IV+ Y S ++HLY+ +EY+ PG +N +R+ E R +
Sbjct: 54 ILA--DADSPWIVKLYYSFQDEEHLYLVMEYM-PGGDLMNLLIRKDV--FPEETARFYIA 108
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLK--- 517
++ L +H IHRDIK N+L+DA G +KLADFG+ K + Y
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 518 -----------------------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 554
G+P+++APEV++ L D WSLG +
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-------PYGLECDWWSLGVILY 221
Query: 555 EMLTGKPPWSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSA 608
EML G PP+ + Q + K++N R PP P +S E D + R L +P +R +
Sbjct: 222 EMLYGFPPFYS-DTLQETYNKIINWKESLRFPPDPP-VSPEAIDLICR-LLCDPEDRLGS 278
Query: 609 VE-LLEHPFIRNANYQNL 625
E + HPF + +++NL
Sbjct: 279 FEEIKSHPFFKGIDWENL 296
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 84/303 (27%), Positives = 149/303 (49%), Gaps = 63/303 (20%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGH 412
+QK + IG GT+G VY ++ TG A+K++ + +D P +A I+ EI +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IR----EISLLKE 54
Query: 413 LKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNG 469
L H NIV+ +VV ++ LY+ E++ + +Y+ + +++++ +L G
Sbjct: 55 LNHPNIVRLL--DVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WM- 523
+AY HS +HRD+K NLL+D G +KLADFG+A+ ++ + ++ + W
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHEVVTLWYR 166
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL---- 576
APE++ G+ + + VDIWS+GC EM+ +P + SE + +F+ L
Sbjct: 167 APEILL------GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPD 220
Query: 577 -----------------------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+ + +P L +G D L + + +P +R SA L+
Sbjct: 221 EDVWPGVTSLPDYKPTFPKWARQDLSKVVPN-LDEDGLDLLSKMLVYDPAKRISAKAALQ 279
Query: 614 HPF 616
HP+
Sbjct: 280 HPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 88/276 (31%), Positives = 141/276 (51%), Gaps = 18/276 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQ 420
+GRG +G V + TG A+K I S E K+L ++ + V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKR---IRATVNSQE-QKRLLMDLDISMRSVDCPYTVT 64
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHST- 476
+YG+ + ++I +E V S++++ V + I E I+ I+ L YLHS
Sbjct: 65 FYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+ IHRD+K +N+L++ +G VKL DFG++ +L + G +MAPE I +
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP----EL 179
Query: 537 NPK-LALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPP-IP-EMLSSEGKD 592
N K + D+WSLG T+IE+ TG+ P+ ++ P Q + +V+ P +P E S E +D
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQD 239
Query: 593 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628
F+ +C +N ERP+ ELL+HPF +N V
Sbjct: 240 FVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 85/298 (28%), Positives = 143/298 (47%), Gaps = 53/298 (17%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+QK + IG GT+G VY N+ TG A+K++ + D ++ +EI +L L H
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 58
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLH 474
NIV+ ++ LY+ E++H + +++ I +++++ +L GLA+ H
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------WMAPEVI 528
S +HRD+K NLL++ G +KLADFG+A+ ++ + ++ + + APE++
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK---PPWSEFEGPQAMFKVLNRTP----- 580
G + AVDIWSLGC EM+T + P SE + +F+ L TP
Sbjct: 173 L------GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG-TPDEVVW 225
Query: 581 ----PIPE------------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
+P+ L +G+D L + +P +R SA L HPF
Sbjct: 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 84/282 (29%), Positives = 140/282 (49%), Gaps = 26/282 (9%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
Q +++G G G+VY + T A+K +IP D + E KQ+ E+++L
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVK---VIPLD-ITVELQKQIMSELEILYKCD 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
I+ +YG+ V++ + I E++ GS++ Y R I E ++ ++ GL YL
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLW 112
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
S +HRD+K +N+LV+ G VKL DFG++ L S + G+ +MAPE I
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISG---- 167
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-------VLNRTPPI-PEML 586
+ + D+WSLG + +E+ G+ P+ + + Q +++ PP+ P
Sbjct: 168 ---EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224
Query: 587 SSEG-KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 627
SE F+ +C + P ERP+ L++HPFI N N V
Sbjct: 225 FSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 43/290 (14%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIV 419
IGRG FG+V ++ +G A+K + D+ K K+L ++ V+ IV
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQ---KRLLMDLDVVMRSSDCPYIV 66
Query: 420 QYYGS-----------EVVD---DHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTR 464
++YG+ E++D D Y +YV E + I E I+
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFY------------KYVYEVLKSVIPEEILGKIAV 114
Query: 465 HILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ L YL IHRD+K +N+L+D +G +KL DFG++ L + G +M
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 174
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI 582
APE I + D+WSLG T+ E+ TGK P+ ++ + +V+ PPI
Sbjct: 175 APERI----DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPI 230
Query: 583 -----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 627
S +F+ C +++ +RP ELLEHPFI++ +N+ V
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDV 280
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 87/301 (28%), Positives = 142/301 (47%), Gaps = 70/301 (23%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENI 418
IG GT+G VY G N++TG A+K++ + ++ P +A +EI +L L+H NI
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI------REISLLKELQHPNI 61
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHST 476
V + + LY+ E++ + +Y+ + + +V+++ IL G+ + HS
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAK-----------HLTGLSYELSLKGSPNWMAP 525
+HRD+K NLL+D GV+KLADFG+A+ + L Y AP
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR----------AP 170
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP-- 580
EV+ G+P+ + VDIWS+G EM T KP + SE + +F++L TP
Sbjct: 171 EVLL------GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG-TPTE 223
Query: 581 -------PIPEM------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHP 615
+P+ L +G D L + + +P +R SA + L HP
Sbjct: 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283
Query: 616 F 616
+
Sbjct: 284 Y 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 93/309 (30%), Positives = 140/309 (45%), Gaps = 81/309 (26%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
I GT+G VY +++TG A+K++ + + K I L +EI +L L+H NIV
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSL-REINILLKLQHPNIVTV 69
Query: 422 YGSEVV----DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFT--------RHILN 468
EVV D +Y+ +EYV EH + + E++ + F +L+
Sbjct: 70 --KEVVVGSNLDKIYMVMEYV----------EHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA-------KHLTGLSYELSLKGSPN 521
G+A+LH +HRD+K +NLL++ G++K+ DFG+A K T L L
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL------- 170
Query: 522 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------------- 561
W APE++ G + + A+D+WS+GC E+LT KP
Sbjct: 171 WYRAPELLL------GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG 224
Query: 562 -P----WSEF-EGPQAMFKVLNRTPP------IPE-MLSSEGKDFLLRCFLRNPVERPSA 608
P W F E P A K + P P LS G D L R +P +R SA
Sbjct: 225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284
Query: 609 VELLEHPFI 617
+ L+HP+
Sbjct: 285 EDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 97/300 (32%), Positives = 144/300 (48%), Gaps = 55/300 (18%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
+++K + IG GT+G+V+ NRET A+K V + DD P SA +EI +L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLK 54
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGL 470
LKH+NIV+ Y D L + EY + +Y + C DI IV++F +L GL
Sbjct: 55 ELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYF-DSCNGDIDPEIVKSFMFQLLKGL 112
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIK 529
A+ HS N +HRD+K NLL++ +G +KLADFG+A+ S + W P+V+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 172
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP------QAMFKVLNR----- 578
G + ++D+WS GC E+ P F G + +F++L
Sbjct: 173 ------GAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEES 224
Query: 579 ------------TPPIPEM---------LSSEGKDFLLRCFLR-NPVERPSAVELLEHPF 616
P P L+S G+D LL+ L NPV+R SA E L+HP+
Sbjct: 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRD-LLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 2e-31
Identities = 82/275 (29%), Positives = 143/275 (52%), Gaps = 25/275 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K++G+G+FG V + + G A+K +V +I DD EC E +VL L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD---VECTMV---EKRVLA-LAW 53
Query: 416 EN--IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAY 472
EN + Y + +HL+ +E+++ G + ++++ R D+ + + I+ GL +
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF--YAAEIVCGLQF 111
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAV 531
LHS I+RD+K N+++D G +K+ADFGM K ++ G + + G+P+++APE+++ +
Sbjct: 112 LHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591
K +VD WS G + EML G+ P+ + + + TP P ++ E K
Sbjct: 172 -------KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESK 224
Query: 592 DFLLRCFLRNPVERPSAV-ELLEHPFIRNANYQNL 625
D L + F R+P R V + HPF + N+ L
Sbjct: 225 DILEKLFERDPTRRLGVVGNIRGHPFFKTINWTAL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 81/274 (29%), Positives = 146/274 (53%), Gaps = 23/274 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K++G+G+FG V++ + T AIK +V ++ DD EC +E+ + L +H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD---VEC-TMVEKRVLSLA-WEH 55
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLH 474
+ Y + ++L+ +EY++ G + +++ H D+ + + I+ GL +LH
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFLH 113
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
S ++RD+K N+L+D G +K+ADFGM K ++ G + + G+P+++APE++ + Q
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL--LGQ 171
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593
K +VD WS G + EML G+ P+ + + + P P L+ E KD
Sbjct: 172 KYNT-----SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDI 226
Query: 594 LLRCFLRNPVERPSAV--ELLEHPFIRNANYQNL 625
L++ F+R P ER V ++ +HPF R ++ L
Sbjct: 227 LVKLFVREP-ERRLGVKGDIRQHPFFREIDWSAL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 5e-31
Identities = 76/256 (29%), Positives = 131/256 (51%), Gaps = 14/256 (5%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G G+FG + + + A+KE+ + PKS+ ++ +E +L +KH NIV
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+ S D HLYI +EY G + + ++ + + E + + + G+ ++H
Sbjct: 62 AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGN 537
+HRDIK N+ + +G VKL DFG A+ LT +Y + G+P ++ PE+ + + + +
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKS 181
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLR 596
DIWSLGC + E+ T K P+ + KV + P+P S E + + +
Sbjct: 182 -------DIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234
Query: 597 CFLRNPVERPSAVELL 612
F RNP RPSA +L
Sbjct: 235 MFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 79/271 (29%), Positives = 139/271 (51%), Gaps = 28/271 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G G GSV + TG A K V I KS KQ+ +E++++ + IV +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHI---GAKS-SVRKQILRELQIMHECRSPYIVSF 68
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI-H 480
YG+ + ++++ + +E++ GS++R ++ I I+ ++ GL YL++ + I H
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RDIK +N+LV++ G +KL DFG++ L S + G+ +M+PE I+ K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELIN-SIADTFVGTSTYMSPERIQG-------GKY 179
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFE-------GPQAMFKVLNR-----TPPIP-EMLS 587
+ D+WSLG ++IE+ GK P++ P + +L + P +P
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLE-HPFI 617
+ +DF+ C L++P ERP+ +L PFI
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 88/260 (33%), Positives = 131/260 (50%), Gaps = 27/260 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K IGRG F VY T G A+K+V I + D A+CIK EI +L L H N
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPN 63
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYLH 474
+++YY S + D+ L I LE G ++R ++ + R I E V + + + L ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQ 533
S +HRDIK AN+ + A+GVVKL D G+ + + + SL G+P +M+PE I
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI----H 179
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------PPIP-EML 586
++G DIWSLGC + EM + P F G + L + PP+P +
Sbjct: 180 ENG---YNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCDYPPLPSDHY 233
Query: 587 SSEGKDFLLRCFLRNPVERP 606
S E + + C +P +RP
Sbjct: 234 SEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 91/287 (31%), Positives = 135/287 (47%), Gaps = 47/287 (16%)
Query: 357 QKGKLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE----QEIK 408
+K +++G G FG V Y N TG A+K + EC +Q +EI
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--------KRECGQQNTSGWKKEIN 58
Query: 409 VLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+L L HENIV+Y G SE L + +EYV GS+ Y+ +H ++ + ++ F + I
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQI 116
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TG-LSYELSLKG-SPN-W 522
G+AYLHS + IHRD+ N+L+D +VK+ DFG+AK + G Y + G SP W
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEFE---GP-QAMFK 574
A E +K K + A D+WS G T+ E+LT + P +FE GP Q
Sbjct: 177 YAVECLKEN-------KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 575 VLNRTP--------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
V+ P P+ E + C+ RP+ L+
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 82/278 (29%), Positives = 136/278 (48%), Gaps = 28/278 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
KL+G+GTFG V + + TG A+K EV I D+ + E +VL + +H
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE------VAHTLTESRVLQNTRH 54
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ S D L +EY + G + ++ R +E R + I++ L YLHS
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALGYLHS 113
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
+ ++RD+K NL++D G +K+ DFG+ K G+S ++K G+P ++APEV++
Sbjct: 114 CDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE--- 168
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592
+ AVD W LG + EM+ G+ P+ + + +L P LS E K
Sbjct: 169 ----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKS 224
Query: 593 FLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
L ++P +R A E++EH F + N+Q++
Sbjct: 225 LLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV 262
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 82/319 (25%), Positives = 133/319 (41%), Gaps = 76/319 (23%)
Query: 361 LIGRGTFG--SVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
LIG+ V++ ++ T A+K++++ D S E +K L+QEI L+H NI
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINL---DSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 477
+ Y S +VD LY+ + GS ++ H + + E + + +LN L Y+HS
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL----------KGSP------- 520
IHR +K +++L+ G V L+GL Y +S+ P
Sbjct: 122 FIHRSVKASHILLSGDGKV---------VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 521 NWMAPEVIKAVMQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 579
W++PEV++ +Q G N K DI+S+G T E+ G P+ + Q + + + T
Sbjct: 173 PWLSPEVLQQNLQ--GYNEK----SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT 226
Query: 580 PP-------IPEMLSSEGKD---------------------------FLLRCFLRNPVER 605
P P S + F+ C R+P R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 606 PSAVELLEHPF---IRNAN 621
PSA +LL H F + N
Sbjct: 287 PSASQLLNHSFFKQCKRRN 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 82/274 (29%), Positives = 129/274 (47%), Gaps = 22/274 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV---DIIP-DDPKSAECIKQLEQEIKVLGHLKHEN 417
+GRG FG V + ++TG AIK + DII D+ +S C K++ + +H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRI---FETANSERHPF 63
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+V + +DH+ +EY G + ++ H +E + ++ GL YLH
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKDG 536
++RD+K NLL+D G VK+ADFG+ K G S G+P ++APEV+
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT------- 174
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLR 596
AVD W LG + EML G+ P+ + + ++N P LS E + R
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR 234
Query: 597 CFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
RNP R A ++ + PF R+ N+ +L
Sbjct: 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 76/273 (27%), Positives = 125/273 (45%), Gaps = 30/273 (10%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FG V++G + E + V + + S + K E+E ++L + +HENIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFEREAELLTNFQHENIV 71
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-------------ITESIVRNFTRHI 466
++YG D + EY+ G +N+++R H D +T S + I
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----NW 522
+G+ YL S + +HRD+ N LV VVK+ DFGM++ + Y + G W
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY-YRVGGHTMLPIRW 190
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPP 581
M PE ++M + K D+WS G + E+ T GK PW + + +
Sbjct: 191 MPPE---SIMYR----KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243
Query: 582 I-PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
P SE D +L C+ R+P +R + ++ E
Sbjct: 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 76/267 (28%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+ G IG+G FG V +G R G A+K + DD +A+ E V+ L+H
Sbjct: 9 KLGATIGKGEFGDVMLGDYR--GQKVAVKC---LKDDSTAAQ---AFLAEASVMTTLRHP 60
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHS 475
N+VQ G + + LYI EY+ GS+ Y+R R IT + F + G+ YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVM 532
N +HRD+ N+LV V K++DFG+AK W APE ++
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALR--- 172
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG- 590
K + D+WS G + E+ + G+ P+ P V+ M + EG
Sbjct: 173 ----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLK--DVVPHVEKGYRMEAPEGC 224
Query: 591 ----KDFLLRCFLRNPVERPSAVELLE 613
+ C+ +P +RP+ +L E
Sbjct: 225 PPEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 82/265 (30%), Positives = 132/265 (49%), Gaps = 25/265 (9%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDPKSAECIKQLEQEIKVLG 411
+ +Q K IGRG F VY T A+K+V I D +C+K EI +L
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK----EIDLLK 57
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN---RYVREHCRDITESIVRNFTRHILN 468
L H N+++Y S + D+ L I LE G ++ +Y ++ R I E V + + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEV 527
+ ++HS +HRDIK AN+ + A+GVVKL D G+ + + + SL G+P +M+PE
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPI 582
I ++G DIWSLGC + EM + P+ + +F + + PP+
Sbjct: 178 I----HENG---YNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPL 228
Query: 583 P-EMLSSEGKDFLLRCFLRNPVERP 606
P E S + ++ + C +P +RP
Sbjct: 229 PTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 89/284 (31%), Positives = 144/284 (50%), Gaps = 30/284 (10%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEVD--IIPDDPKSAECIKQLEQEIKVLGHLK 414
+++G G +G V++ + G A+K + I K+AE + E +VL ++
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT---ERQVLEAVR 62
Query: 415 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGLA 471
+V + + D L++ L+YV+ G + + Y REH TES VR + I+ L
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLALD 119
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIK 529
+LH I+RDIK N+L+D+ G V L DFG++K E S G+ +MAPEVI+
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-----VLNRTPPIPE 584
G+ AVD WSLG E+LTG P++ +G Q +L PP P+
Sbjct: 180 G-----GSGGHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPK 233
Query: 585 MLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 625
+S+E +DF+ + ++P +R A E+ HPF + ++ +L
Sbjct: 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL 277
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 85/281 (30%), Positives = 132/281 (46%), Gaps = 39/281 (13%)
Query: 360 KLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K +G G FG V + TG A+K ++ ++ ++ E+EI++L L H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD----FEREIEILRTLDH 65
Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
ENIV+Y G + L + +EY+ GS+ Y++ H I + F+ I G+ YL
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---GLSYELSLKGSP-NWMAPEVIK 529
S IHRD+ N+LV++ +VK++DFG+AK L Y SP W APE ++
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP---PWSEF-------EGPQAMFKVLN- 577
K + A D+WS G T+ E+ T G P P +EF +G + ++L
Sbjct: 186 -------TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 578 -----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
R P P E D + C+ P +RPS +L+
Sbjct: 239 LKEGERLPR-PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 83/294 (28%), Positives = 140/294 (47%), Gaps = 43/294 (14%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ + +G GT+ +VY G NR TG A+KE+ + ++ + I+ EI ++ LK
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR----EISLMKELK 56
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAY 472
HENIV+ + ++ L + EY+ + +Y+ + + V++FT +L G+A+
Sbjct: 57 HENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAV 531
H +HRD+K NLL++ G +KLADFG+A+ S + W AP+V+
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL-- 173
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPP-------- 581
G+ + ++DIWS+GC + EM+TG+P + + K+ TP
Sbjct: 174 ----GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229
Query: 582 -IPEM------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
+PE G D L R NP R SA + L+HP+
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 83/303 (27%), Positives = 135/303 (44%), Gaps = 65/303 (21%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-- 419
IG G +G V + +G AIK++ D P A K+ +E+K+L H KH+NI+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNIIAI 69
Query: 420 -QYYGSEVVD-DHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHST 476
D +Y+ ++ + ++ + H +TE +R F +L GL Y+HS
Sbjct: 70 RDILRPPGADFKDVYVVMDLME-SDLHHII--HSDQPLTEEHIRYFLYQLLRGLKYIHSA 126
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------APE 526
N IHRD+K +NLLV+ +++ DFGMA+ L+ E +M APE
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-----YFMTEYVATRWYRAPE 181
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEML---------------------TGKPPWSE 565
++ ++ P+ A+D+WS+GC EML G P E
Sbjct: 182 LLLSL------PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS-EE 234
Query: 566 F------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ + + L R P+P ++ S E D L + +P ER + + L+H
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 615 PFI 617
PF+
Sbjct: 295 PFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 75/263 (28%), Positives = 135/263 (51%), Gaps = 16/263 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G++G V + +R G IK++++ S K EQE ++L LKH NIV
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNL---RNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 420 QYYGS-EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN 477
Y S E D LYI + + G + ++E + + E+ V + I L YLH +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 535
+HRD+K N+ + + ++K+ D G+A+ L ++ +L G+P +M+PE+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLIGTPYYMSPELFS------ 175
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL 594
N D+W+LGC V EM T K ++ + +++++ + PP+P+ S E + +
Sbjct: 176 -NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI 234
Query: 595 LRCFLRNPVERPSAVELLEHPFI 617
+ P +RPS +L P+I
Sbjct: 235 ATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 87/279 (31%), Positives = 140/279 (50%), Gaps = 30/279 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
KL+G+GTFG V + + TG A+K EV I D+ + E +VL + +H
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE------VAHTVTESRVLQNTRH 54
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH 474
+ + D L +EY + G + ++ RE R TE R + I++ L YLH
Sbjct: 55 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 112
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 531
S + ++RDIK NL++D G +K+ DFG+ K G+S ++K G+P ++APEV++
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLE-- 168
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591
+ AVD W LG + EM+ G+ P+ + + +L P LS E K
Sbjct: 169 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 223
Query: 592 DFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 625
L ++P +R PS A E++EH F + N+Q++
Sbjct: 224 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 262
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 25/278 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K++G+G+FG V + + T AIK + I+ DD +C E+ I L KH
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDD--DVDC-TMTEKRILALAA-KHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ + D L+ +EYV+ G + + + R E R + + L +LH
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDL-MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+DA G KLADFGM K + + G+P+++APE+++ +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL---- 171
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 594
+ +VD W+LG + EM+ G+PP+ E + +F+ +L+ P LS E L
Sbjct: 172 ---EYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSIL 227
Query: 595 LRCFLRNPVERPSAV-------ELLEHPFIRNANYQNL 625
+NP +R V + +HPF + ++ L
Sbjct: 228 KAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 77/266 (28%), Positives = 122/266 (45%), Gaps = 25/266 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K +G G+FG V G +G V + D K ++ + +E ++ L HEN++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD-KLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNT 478
+ YG V+ L + E GS+ +R+ S + ++ I NG+ YL S
Sbjct: 60 RLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSY--ELSLKGSPNWMAPEVIKAVMQK 534
IHRD+ N+L+ + VK+ DFG+ + L Y E LK W APE ++
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR--- 175
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV------LNRTPPIPEMLS 587
+ A D+W G T+ EM T G+ PW+ G Q + K+ L R PE
Sbjct: 176 ----TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER----PEACP 227
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLE 613
+ + +L+C+ NP +RP+ L E
Sbjct: 228 QDIYNVMLQCWAHNPADRPTFAALRE 253
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 82/277 (29%), Positives = 139/277 (50%), Gaps = 24/277 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
+++G+G+FG V + +E+G A+K + D+I D EC E+ I L H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVEC-TMTEKRILSLAR-NHPF 57
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Q Y D L+ +E+V+ G + ++++ R E+ R + I + L +LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKG 116
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+D G KLADFGM K G + + G+P+++APE+++ ++
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS-TFCGTPDYIAPEILQEML--- 172
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 594
+VD W++G + EML G P+ E E +F+ +LN P LS + D L
Sbjct: 173 ----YGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDIL 227
Query: 595 LRCFLRNPVERPSAVEL------LEHPFIRNANYQNL 625
+NP R ++ L L HPF + +++ L
Sbjct: 228 KAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKL 264
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 94/319 (29%), Positives = 148/319 (46%), Gaps = 50/319 (15%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP---DDPKSAECIKQ-- 402
S S + QKG +G GT+G V + TG AIK+V II D K + +
Sbjct: 3 SFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCG 62
Query: 403 ----LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
+E+K++ +KHENI+ V D + + ++ + + + V R +TES
Sbjct: 63 IHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR-LTESQ 120
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 518
V+ ILNGL LH +HRD+ AN+ +++ G+ K+ADFG+A+ Y +L
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 519 SPNW-----MAPEVI----KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEF 566
M +V+ +A G K AVD+WS+GC E+LTGKP + +E
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240
Query: 567 EGPQAMFKVLNRTP---PIPEMLS---------SEGKDF-------------LLRCFLR- 600
+ +F++L TP P+ + KD LL+ L+
Sbjct: 241 DQLGRIFELLG-TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299
Query: 601 NPVERPSAVELLEHPFIRN 619
NP+ER SA E L+H + ++
Sbjct: 300 NPLERISAKEALKHEYFKS 318
|
Length = 335 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 92/305 (30%), Positives = 146/305 (47%), Gaps = 56/305 (18%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 414
+K +G G G V +R +G A K + +I P Q+ +E+KVL
Sbjct: 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP------AIRNQIIRELKVLHECN 57
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
IV +YG+ D + I +E++ GS+++ +++ R I E+I+ + +L GL YL
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLR 116
Query: 475 STNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+ I HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ---- 171
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGK----------------PPWSEFEG--------- 568
G + DIWSLG +++EM G+ P SE E
Sbjct: 172 --GT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228
Query: 569 -------PQAMFKVL----NRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEHP 615
P A+F++L N PP S E +DF+ +C +NP ER EL +HP
Sbjct: 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288
Query: 616 FIRNA 620
FI+ A
Sbjct: 289 FIKRA 293
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 80/285 (28%), Positives = 151/285 (52%), Gaps = 28/285 (9%)
Query: 360 KLIGRGTFGSVYIG---TNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
K++G G +G V++ + ++G A +K+ I+ + A+ + E +VL H+
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----QKAKTTEHTRTERQVLEHI 61
Query: 414 KHEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
+ +V + + D L++ L+Y++ G + ++ + R E V+ ++ I+ L +
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEH 120
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKA 530
LH I+RDIK N+L+D++G V L DFG++K E S G+ +MAP++++
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS----EFEGPQAMFKVLNRTPPIPEML 586
G+ K AVD WS+G + E+LTG P++ + + ++L PP P+ +
Sbjct: 181 --GDGGHDK---AVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 235
Query: 587 SSEGKDFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNLS 626
S+ KD + R +++P +R PS A E+ +HPF + N+ +L+
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 85/286 (29%), Positives = 134/286 (46%), Gaps = 32/286 (11%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA----ECIKQLEQEIKVLGHLKHE 416
L+GRG FG V + + TG A+K + KS E + E+E +L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMK------KSVLLAQETVSFFEEERDILSISNSP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGS-----INRYVREHCRDITESIVRNFTRHILNGLA 471
I Q + D+LY+ +EY PG +NRY + E + + + ++ +
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEY-QPGGDLLSLLNRYEDQ----FDEDMAQFYLAELVLAIH 116
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIK 529
+H +HRDIK N+L+D +G +KLADFG A LT + G+P+++APEV+
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPE 584
M DG + D WSLG EM+ G+ P+ E + ++N + P P+
Sbjct: 177 T-MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL--SVP 628
+SS+ D L++ L ER L HPF ++ N+ S+P
Sbjct: 236 -VSSDFLD-LIQSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLP 279
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 1e-27
Identities = 79/278 (28%), Positives = 136/278 (48%), Gaps = 28/278 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
KL+G+GTFG V + + +G A+K EV I D+ + E +VL + +H
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE------VAHTLTESRVLKNTRH 54
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ S D L +EYV+ G + ++ R +E R + I++ L YLHS
Sbjct: 55 PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHS 113
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
++RD+K NL++D G +K+ DFG+ K G++ ++K G+P ++APEV++
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLE--- 168
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592
+ AVD W LG + EM+ G+ P+ + + +L P LS++ K
Sbjct: 169 ----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKS 224
Query: 593 FLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
L +++P +R A E++ H F N+Q++
Sbjct: 225 LLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDV 262
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 72/267 (26%), Positives = 115/267 (43%), Gaps = 38/267 (14%)
Query: 362 IGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEI----KVLGHLK 414
+G G FGSV G A+K + E I ++E V+ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--------KQEHIAAGKKEFLREASVMAQLD 54
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H IV+ G + L + +E G + +Y+++ R+I S ++ + G+AYL
Sbjct: 55 HPCIVRLIGV-CKGEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLE 112
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGS--P-NWMAPEVIKA 530
S + +HRD+ N+L+ K++DFGM++ L G Y + P W APE I
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPE 584
K + D+WS G T+ E + G P+ E +G + + + L R PE
Sbjct: 173 G-------KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR----PE 221
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVEL 611
E +L C+ P +RP+ EL
Sbjct: 222 ECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 97/335 (28%), Positives = 159/335 (47%), Gaps = 46/335 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 414
K+IGRG FG V + ++ + A+K + E IK+ + +E ++ H
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLS-------KFEMIKRSDSAFFWEERDIMAHAN 101
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
E IVQ + + D +LY+ +EY+ G + + + DI E R +T ++ L +H
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH 159
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
S IHRD+K N+L+D SG +KLADFG M G+ + G+P++++PEV+K+
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS-- 217
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLS 587
+ G+ D WS+G + EML G P+ K+++ P E+ S
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI-S 275
Query: 588 SEGKDFLLRCFL--------RNPVERPSAVELLEHPFIRNA--NYQNL--SVPMRVFSRI 635
+ KD L+ FL RN V+ E+ HPF +N + N+ +V V
Sbjct: 276 KQAKD-LICAFLTDREVRLGRNGVD-----EIKSHPFFKNDQWTFDNIRETVAPVVPELS 329
Query: 636 NLGDKSH-DQVERATRKTESLPDSPETRVRNRKLP 669
+ D S+ D +E + E+ P P+ N +LP
Sbjct: 330 SDIDTSNFDDIEDDDKNEETFP-LPKAFAGN-QLP 362
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 72/233 (30%), Positives = 112/233 (48%), Gaps = 47/233 (20%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S+++K IG+GTFG V+ +++T A+K+ ++ ++ K I L +EIK+L L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITAL-REIKILQLL 68
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY------VREHCR------------DIT 455
KHEN+V +L I + NRY V E C T
Sbjct: 69 KHENVV----------NL-IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT 117
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 515
S ++ + +LNGL Y+H +HRD+K AN+L+ G++KLADFG+A+ ++ LS
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR-----AFSLS 172
Query: 516 LKGSPNWMAPEVIKAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 561
PN V+ + P+L L +D+W GC + EM T P
Sbjct: 173 KNSKPNRYTNRVVTLWYRP---PELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 80/266 (30%), Positives = 136/266 (51%), Gaps = 23/266 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
+G+G+FG+VY+ +++ A +K + IP + E + Q QE ++L L H IV+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV-QANQEAQLLSKLDHPAIVK 66
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGLAYLHSTN 477
++ S + D I EY ++ + E ++E+ V + +L G+ Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 535
+HRD+K N+ + + ++K+ DFG+++ L G S +L + G+P +M+PE +K +
Sbjct: 127 ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPEALK---HQG 181
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN----RTPPIPEMLSSEGK 591
+ K DIWSLGC + EM FEG + VL TP +PE S +
Sbjct: 182 YDSK----SDIWSLGCILYEMCCLA---HAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN 234
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFI 617
+ ++P RPSA E+L +PFI
Sbjct: 235 SIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 91/314 (28%), Positives = 151/314 (48%), Gaps = 65/314 (20%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S++ + +G G+ G V+ + + A+K+ I+ DP+S +K +EIK++ L
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKK--IVLTDPQS---VKHALREIKIIRRL 59
Query: 414 KHENIVQYY------GSEVVDDH--------LYIYLEYVHPGSINRYVREHCRDITESIV 459
H+NIV+ Y GS++ +D +YI EY+ V E ++E
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDL--ANVLEQGP-LSEEHA 116
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAK----HLTGLSYEL 514
R F +L GL Y+HS N +HRD+K AN+ ++ V+K+ DFG+A+ H + Y L
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY-L 175
Query: 515 SLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS---EFEGPQ 570
S W +P + ++ + K A+D+W+ GC EMLTGKP ++ E E Q
Sbjct: 176 SEGLVTKWYRSPRL---LLSPNNYTK---AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229
Query: 571 AMFK------------VLNRTP------------PIPEML---SSEGKDFLLRCFLRNPV 603
+ + +LN P P+ ++L + E DFL + NP+
Sbjct: 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM 289
Query: 604 ERPSAVELLEHPFI 617
+R +A E L HP++
Sbjct: 290 DRLTAEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 78/262 (29%), Positives = 120/262 (45%), Gaps = 23/262 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
+ IG+G FG VY G + A+K + PD K L QE ++L H N
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLK-----RKFL-QEAEILKQYDHPN 53
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
IV+ G V +YI +E V GS+ ++R+ +T + + G+ YL S N
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQK 534
IHRD+ N LV + V+K++DFGM++ G Y +S LK P W APE +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY---- 169
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGK 591
+ D+WS G + E + G P+ Q ++ + R P P++ E
Sbjct: 170 ---GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA-PQLCPEEIY 225
Query: 592 DFLLRCFLRNPVERPSAVELLE 613
+L+C+ +P RPS E+
Sbjct: 226 RLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 95/316 (30%), Positives = 154/316 (48%), Gaps = 29/316 (9%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHL 413
K++G+G +G V+ T +TG A+K + I+ + +A + E +L +
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTA----HTKAERNILEAV 57
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAY 472
KH IV + LY+ LEY+ G + ++ RE E + I L +
Sbjct: 58 KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEH 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAV 531
LH I+RD+K N+L+DA G VKL DFG+ K + + + G+ +MAPE++
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL--- 172
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591
+ G+ K AVD WSLG + +MLTG PP++ + + K+L +P L+ E +
Sbjct: 173 -MRSGHGK---AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEAR 228
Query: 592 DFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVE 646
D L + RNP R P A E+ HPF R+ N+ +L + +V +S + V
Sbjct: 229 DLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDL-LARKVEPPFKPLLQSEEDVS 287
Query: 647 R-ATRKTESLP-DSPE 660
+ ++ T P DSP+
Sbjct: 288 QFDSKFTRQTPVDSPD 303
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 85/301 (28%), Positives = 144/301 (47%), Gaps = 58/301 (19%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK-QLEQ---EIKVLGHLKH 415
KLI G +G+VY+ ++ET A+K+++ K ++ Q++Q E +L ++
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKIN------KQNLILRNQIQQVFVERDILTFAEN 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-------VRNFTRHILN 468
+V + S HL + +EYV G C + ++I R + +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGD--------CATLLKNIGALPVDMARMYFAETVL 112
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK----HLTGLSYELSLK------- 517
L YLH+ +HRD+K NLL+ + G +KL DFG++K LT YE ++
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 518 -----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQA 571
G+P ++APEVI + Q G P VD W++G + E L G P+ F + P+
Sbjct: 173 DKQVCGTPEYIAPEVI--LRQGYGKP-----VDWWAMGIILYEFLVGCVPF--FGDTPEE 223
Query: 572 MF-KVLNRT---PPIPEMLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQN 624
+F +V++ P E L ++ +D + R +NP+ER A E+ +H F ++
Sbjct: 224 LFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283
Query: 625 L 625
L
Sbjct: 284 L 284
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 99/334 (29%), Positives = 143/334 (42%), Gaps = 105/334 (31%)
Query: 362 IGRGTFGSVY--IGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLKHENI 418
IGRGT+G VY N + G AIK+ D + I Q +EI +L LKHEN+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKK---FKGDKEQYTGISQSACREIALLRELKHENV 64
Query: 419 VQYYGSEVVDDH----LYIYLEYV-HP-GSINRYVREHCRD-ITESIVRNFTRHILNGLA 471
V EV +H +Y+ +Y H I ++ R+ R I S+V++ ILNG+
Sbjct: 65 VSL--VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 472 YLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
YLHS +HRD+K AN+LV GVVK+ D G+A+ + AP
Sbjct: 123 YLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL---------------FNAP-- 165
Query: 528 IKAVMQKDG--------NPKLAL-------AVDIWSLGCTVIEMLTGKPPWSEFEGPQA- 571
+K + D P+L L A+DIW++GC E+LT +P F+G +A
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI---FKGREAK 222
Query: 572 --------------MFKVLNRTPP---------IPEM----------------------- 585
+F+VL TP +PE
Sbjct: 223 IKKSNPFQRDQLERIFEVLG-TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281
Query: 586 ---LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
S+G D L + +P +R +A E LEHP+
Sbjct: 282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 87/306 (28%), Positives = 139/306 (45%), Gaps = 59/306 (19%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++++K IG GT+G VY + +G A+K+V + D+ + I L +EI +L +L
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRM--DNERDGIPISSL-REITLLLNL 63
Query: 414 KHENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+H NIV+ EVV D +++ +EY + + +ES V+ +L G
Sbjct: 64 RHPNIVEL--KEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SPN----WM- 523
L YLH IHRD+K +NLL+ G +K+ADFG+A+ +Y L K +P W
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-----TYGLPAKPMTPKVVTLWYR 175
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL---- 576
APE++ G A+D+W++GC + E+L KP SE E + ++L
Sbjct: 176 APELLL------GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229
Query: 577 ------------------------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
N P LS G L + +P +R +A E L
Sbjct: 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKKRATAEEAL 288
Query: 613 EHPFIR 618
E + +
Sbjct: 289 ESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 83/307 (27%), Positives = 139/307 (45%), Gaps = 62/307 (20%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSA----ECIKQLEQEIK 408
++K + IG GT+G VY ++ TG A+K+ + D+ P +A ++ L + I
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRH 465
++ L E++ + G LY+ EY+ ++ R R + +++F
Sbjct: 63 IVRLLDVEHVEEKNGKPS----LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSPN--- 521
+L G+A+ H +HRD+K NLLVD G++K+AD G+ + + + +K +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IPVKSYTHEIV 173
Query: 522 ---WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKV 575
+ APEV+ G+ + VDIWS+GC EM +P + SE + +FK+
Sbjct: 174 TLWYRAPEVLL------GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKL 227
Query: 576 LNRTP-----------------PI--PEMLSS-------EGKDFLLRCFLRNPVERPSAV 609
L TP P P+ LS EG D L + +P +R SA
Sbjct: 228 LG-TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286
Query: 610 ELLEHPF 616
L HP+
Sbjct: 287 AALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 81/276 (29%), Positives = 138/276 (50%), Gaps = 23/276 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
++G+G+FG V + + T AIK + II DD EC +E+ + L K
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDD--DVECT-MVEKRVLALPG-KPP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ Q + D LY +EYV+ G + ++++ + E + I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSK 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+++DA G +K+ADFGM K ++ G + G+P+++APE+I Q
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII--AYQPY 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDFL 594
G +VD W+ G + EML G+PP+ + E +F+ ++ P+ LS E
Sbjct: 179 GK-----SVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSIC 232
Query: 595 LRCFLRNPVER----PSAV-ELLEHPFIRNANYQNL 625
++P +R P+ ++ EH F R +++ L
Sbjct: 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 85/288 (29%), Positives = 148/288 (51%), Gaps = 35/288 (12%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHL 413
K++G G +G V++ T +TG A+K + ++ + A+ ++ E VL H+
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV----QKAKTVEHTRTERNVLEHV 61
Query: 414 KHEN-IVQYYGSEVVDDHLYIYLEYVHPGSI--NRYVREHCRDITESIVRNFTRHILNGL 470
+ +V + + + L++ L+YV G + + Y R++ +E VR ++ I+ L
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILAL 118
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVI 528
+LH ++RDIK N+L+D+ G V L DFG++K E S G+ +MAPE+I
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-----PQAMFKVLNRTPPIP 583
+ K G+ K AVD WSLG + E+LTG P++ EG + ++L PP P
Sbjct: 179 RG---KGGHGK---AVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPFP 231
Query: 584 EMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLS 626
+ E +D L + ++P +R A E+ EHPF + +++ L+
Sbjct: 232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 19/278 (6%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G FG V + TG A K++D + E + E++I + IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ D L + + ++ G + ++ E+ + I+ GL +LH ++
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K N+L+D G V+++D G+A L G G+P +MAPEV++
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ-------GEVY 171
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEF----EGPQAMFKVLNRTPPIPEMLSSEGKDFLLR 596
+VD ++LGCT+ EM+ G+ P+ + E + + L P+ S E KD
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231
Query: 597 CFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 629
++P +R SA E+ EHP ++ N++ L M
Sbjct: 232 LLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGM 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 84/307 (27%), Positives = 139/307 (45%), Gaps = 60/307 (19%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
Q++K + IG GT+G VY +R T + A+K++ + +D P +A +EI +L
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI------REISLLK 56
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYV------HPGSINRYVREHCRDITESIVRNFTRH 465
++H NIV+ + LY+ EY+ H S + + +++ +
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP------RLIKTYLYQ 110
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWM- 523
IL G+AY HS +HRD+K NLL+D +KLADFG+A+ + + W
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP 580
APE++ G+ + VDIWS+GC EM+ KP + SE + +F++L TP
Sbjct: 171 APEILL------GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG-TP 223
Query: 581 ---------PIPEM------------------LSSEGKDFLLRCFLRNPVERPSAVELLE 613
+P+ L G D L + +P +R +A LE
Sbjct: 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283
Query: 614 HPFIRNA 620
H + ++
Sbjct: 284 HEYFKDL 290
|
Length = 294 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 79/304 (25%), Positives = 139/304 (45%), Gaps = 57/304 (18%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 413
++Q +G G +G V + +TG AIK++ P +SA K+ +E+++L H+
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHM 71
Query: 414 KHENIVQ----YYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRHI 466
HEN++ + + ++D +YL V +N V+ C+ +++ ++ I
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYL--VTHLMGADLNNIVK--CQKLSDDHIQFLVYQI 127
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAP 525
L GL Y+HS IHRD+K +N+ V+ +K+ DFG+A+H E++ + W AP
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAP 184
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSE 565
E++ M + VDIWS+GC + E+LTGK P E
Sbjct: 185 EIMLNWMHYNQ------TVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238
Query: 566 F------EGPQAMFKVLNRTP-----PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
E + + L + P + + D L + + +P +R +A E L H
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298
Query: 615 PFIR 618
P++
Sbjct: 299 PYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 86/314 (27%), Positives = 143/314 (45%), Gaps = 72/314 (22%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ K +G+G +G V N ET + AIK++ + K + L +E+K+L H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRAL-RELKLLRHF 58
Query: 414 K-HENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+ H+NI Y ++V + LY+Y E + +++ +R +T++ ++F IL
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQP-LTDAHFQSFIYQILC 116
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----- 523
GL Y+HS N +HRD+K NLLV+A +K+ DFG+A+ + + + +M
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-----GFSENPGENAGFMTEYVA 171
Query: 524 -----APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKV 575
APE++ + A+D+WS+GC + E+L KP F+G + ++
Sbjct: 172 TRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKP---VFKGKDYVDQLNQI 222
Query: 576 LNR--TPPIPEMLSS----------------EGKDF-------------LLRCFLR-NPV 603
L TP E LS K F LL L +P
Sbjct: 223 LQVLGTPD-EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT 281
Query: 604 ERPSAVELLEHPFI 617
+R S E LEHP++
Sbjct: 282 KRISVEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 88/301 (29%), Positives = 139/301 (46%), Gaps = 62/301 (20%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLK-HENIV 419
+G+G +G V+ +R T A+K++ D + + + EI L L H NIV
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR----EIMFLQELGDHPNIV 70
Query: 420 QYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNF-TRHILNGLAYLHST 476
+ ++ IYL EY+ ++ +R +I E + + + +L L Y+HS
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMET-DLHAVIR---ANILEDVHKRYIMYQLLKALKYIHSG 126
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP--------NWM-APEV 527
N IHRD+K +N+L+++ VKLADFG+A+ L+ L +P W APE+
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP---ENPVLTDYVATRWYRAPEI 183
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWS----------EFEGP------ 569
+ G+ + VD+WS+GC + EML GKP P + E GP
Sbjct: 184 LL------GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 570 --------QAMFKVLNRTP--PIPEML---SSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
M L P P+ E+L S + D L + + NP +R +A E LEHP+
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297
Query: 617 I 617
+
Sbjct: 298 V 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 74/262 (28%), Positives = 122/262 (46%), Gaps = 26/262 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K +G G FG V++G R AIK ++ + A + +E KV+ L H +V
Sbjct: 10 KELGSGQFGVVHLGKWRAQ-IKVAIKAIN------EGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
Q YG LYI E++ G + Y+R+ +++ ++ + + + G+ YL + I
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGN 537
HRD+ N LV ++GVVK++DFGM +++ Y S K W PEV
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF------- 175
Query: 538 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSEGK 591
K + D+WS G + E+ T GK P+ + + + + L R P++ S
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----PKLASMTVY 231
Query: 592 DFLLRCFLRNPVERPSAVELLE 613
+ + C+ P RP+ ELL
Sbjct: 232 EVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 80/263 (30%), Positives = 120/263 (45%), Gaps = 30/263 (11%)
Query: 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K +G G FG V G R A IKE + D+ +E KV+ L HE
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE---------FIEEAKVMMKLSHEK 60
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+VQ YG +YI EY+ G + Y+REH + S + + + G+AYL S
Sbjct: 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVMQKD 535
IHRD+ N LVD G VK++DFG+++++ Y S+ K W PEV+
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS---- 176
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSSE 589
K + D+W+ G + E+ + GK P+ F + + KV L R P + S +
Sbjct: 177 ---KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR----PHLASEK 229
Query: 590 GKDFLLRCFLRNPVERPSAVELL 612
+ C+ ERP+ +LL
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 89/327 (27%), Positives = 146/327 (44%), Gaps = 87/327 (26%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-- 417
K+IGRG FG V + ++TG A+K++ + +E +++ EQ + H++ E
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEK-EQ----VAHVRAERDI 54
Query: 418 --------IVQYYGSEVVDDHLYIYLEYVHPGS--INRYVREHCRDI-TESIVRNFTRHI 466
+V+ Y S +++LY+ +EY+ PG + ++ +D TE R +
Sbjct: 55 LAEADNPWVVKLYYSFQDENYLYLIMEYL-PGGDMMTLLMK---KDTFTEEETRFYIAET 110
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-----HLT------------- 508
+ + +H IHRDIK NLL+DA G +KL+DFG+ H T
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 509 -----------------------GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545
L+Y S G+P+++APEV +Q N D
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAY--STVGTPDYIAPEVF---LQTGYNK----ECD 221
Query: 546 IWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN--RTPPIPE--MLSSEGKDFLLR--CF 598
WSLG + EML G PP+ + PQ + K++N T P+ LS E KD + R C
Sbjct: 222 WWSLGVIMYEMLVGYPPFCS-DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCE 280
Query: 599 LRNPVERPSAVELLEHPFIRNANYQNL 625
+ E+ HPF + +++++
Sbjct: 281 AERRLGNNGVNEIKSHPFFKGVDWEHI 307
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 80/279 (28%), Positives = 133/279 (47%), Gaps = 39/279 (13%)
Query: 360 KLIGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ +G+G FGSV Y TG A+K++ +AE ++ E+EI++L L+H
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-----HSTAEHLRDFEREIEILKSLQH 64
Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+NIV+Y G +L + +EY+ GS+ Y+++H + + + I G+ YL
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKG-SP-NWMAPEVIK 529
S +HRD+ N+LV++ VK+ DFG+ K L Y++ G SP W APE +
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEF--------EGPQAMFKVL- 576
K ++A D+WS G + E+ T P +EF +G ++ ++
Sbjct: 185 -------ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 577 ----NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
N P P +E + C+ +P +RPS EL
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 89/279 (31%), Positives = 137/279 (49%), Gaps = 28/279 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVD--IIPDDPKSAECIKQLEQEIKVLGHLKHEN-I 418
IG+GTFG VY ++T A+K + I + A I E+ I V L I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG--ERNILVRTLLDESPFI 58
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V S D LY+ +Y+ G + ++++ R +E + + ++ L +LH +
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVLALEHLHKYDI 117
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
++RD+K N+L+DA+G + L DFG++K +LT + G+ ++APEV+ + + G
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL---LDEKGY 174
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVLN----RTPPIPEMLSSEGK 591
K VD WSLG V EM G WS F Q M++ + R P +LS EG+
Sbjct: 175 TKH---VDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFP--KNVLSDEGR 226
Query: 592 DFLLRCFLRNPVER----PSAVELLEHPFIRNANYQNLS 626
F+ RNP R AVEL EHPF + ++ LS
Sbjct: 227 QFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLS 265
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 28/264 (10%)
Query: 359 GKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K +G G FG V++G + A I+E + DD +E KV+ L H
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD---------FIEEAKVMMKLSHP 59
Query: 417 NIVQYYGSEVVDDH--LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
N+VQ YG V ++I EY+ G + Y+RE + + + + + YL
Sbjct: 60 NLVQLYG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL--KGSPNWMAPEVIKAVM 532
S IHRD+ N LV VVK++DFG+A+++ Y S K W PEV
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFD--- 174
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSE 589
+ + D+WS G + E+ + GK P+ F + + V R P++ +E
Sbjct: 175 ----YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR-PKLAPTE 229
Query: 590 GKDFLLRCFLRNPVERPSAVELLE 613
+ C+ P +RP+ +LL
Sbjct: 230 VYTIMYSCWHEKPEDRPAFKKLLS 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 81/277 (29%), Positives = 134/277 (48%), Gaps = 28/277 (10%)
Query: 360 KLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHL 413
+ +G G+FG V + T + E AIK + ++ IKQ + E K+L ++
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFE-------KSKIIKQKQVDHVFSERKILNYI 88
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H V YGS + +LY+ LE+V G ++R + R + + I+ YL
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAAQIVLIFEYL 147
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
S N ++RD+K NLL+D G +K+ DFG AK + +Y +L G+P ++APE++ V
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILLNV-- 203
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593
G+ K A D W+LG + E+L G PP+ E K+L P+ L + K
Sbjct: 204 --GHGK---AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258
Query: 594 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
+ + + +R A + EHP+ N ++ +L
Sbjct: 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295
|
Length = 340 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 20/221 (9%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQE 406
K+++ +K K++G G FG+VY G G AIK + + S + K++ E
Sbjct: 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR----EETSPKANKEILDE 59
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
V+ + H ++V+ G + I + + G + YVR H +I + N+ I
Sbjct: 60 AYVMASVDHPHVVRLLGICLSSQVQLI-TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI 118
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWM 523
G++YL +HRD+ N+LV VK+ DFG+AK L E +G WM
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
A E I + D+WS G TV E++T G P+
Sbjct: 179 ALESIL-------HRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 36/219 (16%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG GT+G VY +++TG A+K+V + D+ K I + +EIK+L L H NIV
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAI-REIKILRQLNHRNIVNL 71
Query: 422 YGSEVVDDH------------LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
E+V D Y+ EY+ + + +E +++F + +L G
Sbjct: 72 K--EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDHIKSFMKQLLEG 128
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
L Y H N +HRDIK +N+L++ G +KLADFG+A+ L +VI
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR--------LYNSEESRPYTNKVIT 180
Query: 530 AVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 561
+ P+L L A+D+WS GC + E+ T KP
Sbjct: 181 LWYRP---PELLLGEERYGPAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 81/277 (29%), Positives = 135/277 (48%), Gaps = 26/277 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-----VLGHLK 414
K+IG+G+FG V + ++ G A+K + K A K+ ++ I +L ++K
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQ------KKAILKKKEQKHIMAERNVLLKNVK 54
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYL 473
H +V + S D LY L+YV+ G + ++ RE R E R + I + L YL
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYL 112
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVM 532
HS N I+RD+K N+L+D+ G V L DFG+ K + + G+P ++APEV++
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR--- 169
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592
K + VD W LG + EML G PP+ + + +LN+ + +S +
Sbjct: 170 -KQPYDR---TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARH 225
Query: 593 FLLRCFLRNPVERPSA----VELLEHPFIRNANYQNL 625
L ++ +R A +E+ H F + N+ +L
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-24
Identities = 80/274 (29%), Positives = 130/274 (47%), Gaps = 26/274 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLKHE 416
IG+G+FG V R+T A+K + + A + + E E VL +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTI-------RKAHIVSRSEVTHTLAERTVLAQVNCP 53
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLHS 475
IV S + LY+ L +++ G + ++ RE D++ + R +T +L L LH
Sbjct: 54 FIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
N I+RD+K N+L+D G + L DFG+ K ++ + G+P ++APE++
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH--- 168
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 594
G K AVD W+LG + EMLTG PP+ + + K+L P+ + KD L
Sbjct: 169 -GYTK---AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLL 224
Query: 595 LRCFLRNPVER---PSAVELLEHPFIRNANYQNL 625
+ R+P R A E+ HPF +++ L
Sbjct: 225 IGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKL 258
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 79/309 (25%), Positives = 137/309 (44%), Gaps = 62/309 (20%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
KL+G+G G V++ + TG A+K +D +I + +K++ E ++L L H
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-----VKRVLTEQEILATLDHP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYL 473
+ Y S + +L + ++Y G + R ++ C ++E + R + +L L YL
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKC--LSEEVARFYAAEVLLALEYL 119
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPN--------- 521
H ++RD+K N+L+ SG + L+DF ++K + KGS
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 522 ------------------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
++APEVI DG+ AVD W+LG + EML G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISG----DGH---GSAVDWWTLGILLYEMLYGTTP- 231
Query: 564 SEFEGP---QAMFKVLNRTPPIPEM--LSSEGKDFLLRCFLRNPVER----PSAVELLEH 614
F+G + +L + P +SS +D + + +++P +R A E+ +H
Sbjct: 232 --FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289
Query: 615 PFIRNANYQ 623
PF R N+
Sbjct: 290 PFFRGVNWA 298
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 81/289 (28%), Positives = 138/289 (47%), Gaps = 37/289 (12%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLG 411
+++ K +G G +G+V +R TGA AIK++ P +E K+ +E+++L
Sbjct: 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLK 69
Query: 412 HLKHENIVQ----YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
H+KHEN++ + +D YL G+ + +H + ++E ++ +L
Sbjct: 70 HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK-LSEDRIQFLVYQML 128
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APE 526
GL Y+H+ IHRD+K NL V+ +K+ DFG+A+ E++ W APE
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS---EMTGYVVTRWYRAPE 185
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPP--- 581
VI M VDIWS+GC + EMLTGKP + + + +++ TP
Sbjct: 186 VILNWMH------YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239
Query: 582 IPEMLSSEGKDFL----------LRCFLRNPVERPSAVELLEHPFIRNA 620
+ ++ S + K+++ R L N P AV +LE + +A
Sbjct: 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNA--NPLAVNVLEKMLVLDA 286
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 19/260 (7%)
Query: 359 GKLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
G+ IG G FG VY G + A+K P E + QE ++ H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN-CTSPSVRE---KFLQEAYIMRQFDH 66
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+IV+ G + ++ ++I +E G + Y++ + + + + ++ + LAYL S
Sbjct: 67 PHIVKLIGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQ 533
+HRDI N+LV + VKL DFG++++L SY + KG P WMAPE I
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF--- 182
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK 591
+ A D+W G + E+L G P+ + + ++ N P+P
Sbjct: 183 ----RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238
Query: 592 DFLLRCFLRNPVERPSAVEL 611
+ +C+ +P +RP EL
Sbjct: 239 SLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 82/312 (26%), Positives = 136/312 (43%), Gaps = 69/312 (22%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q IG G +G V T++ TG AIK+ I P + C + L +EIK+L
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--ISPFE-HQTFCQRTL-REIKILRRF 60
Query: 414 KHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
KHENI+ +YI E + + + ++ + ++ ++ F IL
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKT--QHLSNDHIQYFLYQILR 117
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------- 521
GL Y+HS N +HRD+K +NLL++ + +K+ DFG+A+ ++ +
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR--------IADPEHDHTGFLTEY 169
Query: 522 ----WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------- 561
W APE++ + G K A+DIWS+GC + EML+ +P
Sbjct: 170 VATRWYRAPEIM---LNSKGYTK---AIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL 223
Query: 562 -----PWSE----FEGPQAM--FKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVER 605
P E +A K L P +P ++ + D L + NP +R
Sbjct: 224 GVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283
Query: 606 PSAVELLEHPFI 617
+ E L HP++
Sbjct: 284 ITVEEALAHPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 74/268 (27%), Positives = 124/268 (46%), Gaps = 35/268 (13%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FG V++ N + V + D +A K ++E ++L +L+HE+IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------ITESIVRNFTR 464
++YG D L + EY+ G +N+++R H D + S + +
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---- 520
I +G+ YL S + +HRD+ N LV A+ +VK+ DFGM++ + Y + G
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPI 189
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-- 577
WM PE ++M + K D+WS G + E+ T GK PW + + + +
Sbjct: 190 RWMPPE---SIMYR----KFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIECITQG 241
Query: 578 RTPPIPEMLSSEGKDFLLRCFLRNPVER 605
R P + E D +L C+ R P +R
Sbjct: 242 RVLERPRVCPKEVYDIMLGCWQREPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 80/279 (28%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 362 IGRGTFGSV----YIGTNRETGASCAIKEVDIIPDDPKSAEC-IKQLEQEIKVLGHLKHE 416
+G G FG V Y TG A+K + P+S I L++EI++L +L HE
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADLKKEIEILRNLYHE 66
Query: 417 NIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
NIV+Y G +E + + + +E++ GS+ Y+ + I + I G+ YL
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPN-WMAPEVIKA 530
S +HRD+ N+LV++ VK+ DFG+ K + ++K SP W APE +
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL-- 184
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT----GKPPWSEFE---GPQA-------MFKVL 576
+Q K +A D+WS G T+ E+LT P + F GP + +VL
Sbjct: 185 -IQS----KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239
Query: 577 N--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+ P P E + +C+ P +R + L+E
Sbjct: 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 44/271 (16%)
Query: 362 IGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+G G FG V++ + A+K + D+ + K +E ++L +L+HE
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR-----KDFHREAELLTNLQHE 67
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------------ITESIVRNFTR 464
+IV++YG V D L + EY+ G +N+++R H D +T+S + + +
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---- 520
I G+ YL S + +HRD+ N LV + +VK+ DFGM++ + Y + G
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPI 186
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-----FK 574
WM PE ++M + K D+WSLG + E+ T GK PW + + + +
Sbjct: 187 RWMPPE---SIMYR----KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239
Query: 575 VLNRTPPIPEMLSSEGKDFLLRCFLRNPVER 605
VL R P E D +L C+ R P R
Sbjct: 240 VLQR----PRTCPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 80/295 (27%), Positives = 124/295 (42%), Gaps = 53/295 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+ +G G++ +VY G +R G A+K + + ++ I+ E +L LKH NIV
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANIV 66
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ + L EY+H + +Y+ +H + VR F +L GLAY+H + +
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
HRD+K NLL+ G +KLADFG+A+ + S S + W P ++ G
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPP--DVLL---GATD 180
Query: 540 LALAVDIWSLGCTVIEMLTG--------------------------------------KP 561
+ A+DIW GC IEML G KP
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240
Query: 562 PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
W PQ + V R P + +D + + P +R SA + L HP+
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPP-----KAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 51/225 (22%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K IGRG +G V N ET AIK++ D+ A K+ +EIK+L HL HEN++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA---KRTLREIKLLRHLDHENVI 67
Query: 420 Q----------------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
Y E++D L+ + S +HC+ F
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLS-----DDHCQ--------YFL 114
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+L GL Y+HS N +HRD+K +NLL++A+ +K+ DFG+A+ + ++M
Sbjct: 115 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---------TTSEKGDFM 165
Query: 524 APEVIKAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKP 561
V V + P+L L A+D+WS+GC E+L KP
Sbjct: 166 TEYV---VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 22/265 (8%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLK 414
K K+IG G FG V+ G + G KEV + K KQ + E ++G
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGR----KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H NI++ G I EY+ G++++Y+R+H + + + R I G+ YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---SYELSLKGSP-NWMAPEVIKA 530
N +HRD+ N+LV+++ K++DFG+++ L +Y S P W APE I
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI-- 182
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT--PPIPEMLS 587
K A D+WS G + E+++ G+ P+ + + M K +N P P
Sbjct: 183 -----AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM-KAINDGFRLPAPMDCP 236
Query: 588 SEGKDFLLRCFLRNPVERPSAVELL 612
S +L+C+ ++ RP V+++
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 72/275 (26%), Positives = 119/275 (43%), Gaps = 50/275 (18%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL-----------EQEIKVL 410
+G G FG V++ A C +++P+ K +K L ++E ++L
Sbjct: 13 LGEGAFGKVFL-------AECH----NLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH--------------CRDITE 456
L+H++IV++YG L + EY+ G +NR++R H +T
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
+ I +G+ YL S + +HRD+ N LV VVK+ DFGM++ + Y +
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY-YRV 180
Query: 517 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 571
G WM PE +++ + K DIWS G + E+ T GK PW + +A
Sbjct: 181 GGRTMLPIRWMPPE---SILYR----KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233
Query: 572 MFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVER 605
+ + R P E + C+ R P +R
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-23
Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 29/279 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK----EVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
KL+G+GTFG V + + TG A+K EV + D+ + E +VL + +H
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE------VAHTLTENRVLQNSRH 54
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ S D L +EY + G + ++ R +E R + I++ L YLHS
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHS 113
Query: 476 T-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAV 531
N ++RD+K NL++D G +K+ DFG+ K G+ ++K G+P ++APEV++
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLE-- 169
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591
+ AVD W LG + EM+ G+ P+ + + +L P LS E K
Sbjct: 170 -----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAK 224
Query: 592 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
L ++P +R A E+++H F +Q++
Sbjct: 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDV 263
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 42/277 (15%)
Query: 362 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+G+G+FG VY G + E AIK V+ ++ E I+ L E V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFL-NEASVMKEFNCH 69
Query: 417 NIVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRD---------ITESIVRNFTRH 465
++V+ G VV + +E + G + Y+R + T
Sbjct: 70 HVVRLLG--VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGS-P-NW 522
I +G+AYL + +HRD+ N +V VK+ DFGM + + Y KG P W
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-F----KVL 576
MAPE + KDG D+WS G + EM T + P+ + + F L
Sbjct: 188 MAPESL-----KDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240
Query: 577 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+ PE + + + C+ NP RP+ +E++
Sbjct: 241 DL----PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 89/324 (27%), Positives = 154/324 (47%), Gaps = 20/324 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHEN 417
K+IGRG FG V + + TG A+K ++ + K AE C ++ E+++ V G +
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKW-EMLKRAETACFRE-ERDVLVNGDRRWIT 64
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Y + +++LY+ ++Y G + + + + E + R + ++ + +H
Sbjct: 65 NLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRDIK N+L+D +G ++LADFG L G G+P++++PE+++A+ +D
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM--ED 180
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEG 590
G + D WSLG + EML G+ P+ + K++N PP +S E
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240
Query: 591 KDFLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL--SVPMRVFSRINLGDKSH-DQV 645
KD + R C + R + +HPF ++ N+ S V + D S+ D
Sbjct: 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVD 300
Query: 646 ERATRKTESLPDSPETRVRNRKLP 669
+ R TESLP S LP
Sbjct: 301 DDDLRNTESLPPSSHGAFSGNHLP 324
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 21/261 (8%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-LEQEIKVLG 411
+ + + +G G FG V++GT T A+K + K + QE +++
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTL-------KPGTMSPEAFLQEAQIMK 56
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGL 470
L+H+ +VQ Y ++ +YI EY+ GS+ +++ + + + + I G+
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVI 528
AYL S N IHRD+ N+LV + V K+ADFG+A+ + Y K W APE
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA 176
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEML 586
+ + D+WS G + E++T G+ P+ + + +V P P
Sbjct: 177 NY-------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNC 229
Query: 587 SSEGKDFLLRCFLRNPVERPS 607
E D +L+C+ ++P ERP+
Sbjct: 230 PEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 83/300 (27%), Positives = 135/300 (45%), Gaps = 47/300 (15%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K +G G++ +VY G ++ TG A+KE+ + ++ I+ E +L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR----EASLLK 58
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH NIV + L + EY+ + +Y+ + ++ VR F +L GLA
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKA 530
Y H +HRD+K NLL+ G +KLADFG+A+ + S S + W P+V+
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL- 176
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQ--AMFKVLNRTP------ 580
G+ + + ++D+W +GC EM TG+P P S Q +F+VL TP
Sbjct: 177 -----GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLG-TPTEETWP 230
Query: 581 ---------------PIPEML---------SSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
P L G++ L+ P +R SA E ++HP+
Sbjct: 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 4e-23
Identities = 79/263 (30%), Positives = 133/263 (50%), Gaps = 23/263 (8%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
P++S + KL G+G FG V++GT T AIK + P++ QE +V+
Sbjct: 4 PRESLRLEVKL-GQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA------FLQEAQVM 55
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNG 469
L+HE +VQ Y + V ++ +YI EY+ GS+ +++ E + + + + I +G
Sbjct: 56 KKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 114
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEV 527
+AY+ N +HRD++ AN+LV + V K+ADFG+A+ + Y K W APE
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE- 173
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPE 584
A + + + D+WS G + E+ T G+ P+ + + +V R P PE
Sbjct: 174 --AALYG----RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 227
Query: 585 MLSSEGKDFLLRCFLRNPVERPS 607
S D + +C+ + P ERP+
Sbjct: 228 CPESL-HDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 23/255 (9%)
Query: 360 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G G FG V+ G N T A+K + DPK E +++ L+H +
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPK------DFLAEAQIMKKLRHPKL 63
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 477
+Q Y +++ +YI E + GS+ Y++ R + + + + +G+AYL + N
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQKD 535
IHRD+ N+LV + + K+ADFG+A+ + YE K W APE
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY----- 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 592
+ ++ D+WS G + E++T G+ P+ + + +V R P P E D
Sbjct: 179 --NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-PPGCPKELYD 235
Query: 593 FLLRCFLRNPVERPS 607
+L C+ +P +RP+
Sbjct: 236 IMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 6e-23
Identities = 80/279 (28%), Positives = 136/279 (48%), Gaps = 28/279 (10%)
Query: 360 KLIGRGTFGSVYIG---TNRETGASCAIKEVDIIPDDPKSAECIK---QLEQEIKVLGHL 413
K++G+G+FG V++ T + G A+K + K+ ++ + + E +L +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLK------KATLKVRDRVRTKMERDILAEV 55
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAY 472
H IV+ + + + LY+ L+++ G + R +E TE V+ + + L +
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDH 113
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAV 531
LHS I+RD+K N+L+D G +KL DFG++K + S G+ +MAPEV+
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV--- 170
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591
+ G+ + D WS G + EMLTG P+ + + M +L +P+ LS E +
Sbjct: 171 -NRRGH---TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 226
Query: 592 DFLLRCFLRNPVER----PSAVELLE-HPFIRNANYQNL 625
L F RNP R P VE ++ HPF ++ L
Sbjct: 227 SLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL 265
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 93/342 (27%), Positives = 158/342 (46%), Gaps = 44/342 (12%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QE 406
K ++ K+IGRG FG V + ++ T A+K + E IK+ + +E
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-------SKFEMIKRSDSAFFWEE 93
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
++ +VQ + + D +LY+ +EY+ G + + + D+ E R +T +
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEV 151
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMA 524
+ L +HS IHRD+K N+L+D SG +KLADFG M + G+ + G+P++++
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TP 580
PEV+K+ + G+ D WS+G + EML G P+ K++N T
Sbjct: 212 PEVLKS---QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 268
Query: 581 PIPEMLSSEGKDFLLRCFL--------RNPVERPSAVELLEHPFIRN-----ANYQNLSV 627
P +S E K+ L+ FL RN VE E+ H F +N ++
Sbjct: 269 PDDNDISKEAKN-LICAFLTDREVRLGRNGVE-----EIKRHLFFKNDQWAWETLRDTVA 322
Query: 628 PMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLP 669
P+ ++ + D +E + E+ P P+ V N +LP
Sbjct: 323 PVVPDLSSDIDTSNFDDIEEDKGEEETFP-IPKAFVGN-QLP 362
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 9e-23
Identities = 73/260 (28%), Positives = 121/260 (46%), Gaps = 30/260 (11%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG+G FG V +G R G A+K I +D + + E V+ L+H N+VQ
Sbjct: 14 IGKGEFGDVMLGDYR--GNKVAVK---CIKNDATAQAFLA----EASVMTQLRHSNLVQL 64
Query: 422 YGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITE-SIVRNFTRHILNGLAYLHSTNTI 479
G V + LYI EY+ GS+ Y+R R + + F+ + + YL + N +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
HRD+ N+LV V K++DFG+ K + S + + K W APE ++ K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-------EKK 175
Query: 540 LALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG-----KDF 593
+ D+WS G + E+ + G+ P+ + V+ R +M + +G D
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKGYKMDAPDGCPPVVYDV 231
Query: 594 LLRCFLRNPVERPSAVELLE 613
+ +C+ + RPS ++L E
Sbjct: 232 MKQCWHLDAATRPSFLQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 1e-22
Identities = 89/300 (29%), Positives = 134/300 (44%), Gaps = 64/300 (21%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-KQLEQEIKVLGHLKHENI 418
K +G G +GSV ++ TG AIK++ P +E K+ +E+ +L H++HEN+
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 419 V---QYYGSEVVDDHLY-IYLEYVHPGSINRYVREHCRDI-----TESIVRNFTRHILNG 469
+ + S V D YL V P Y++ + I +E V+ +L G
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYL--VMP-----YMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVI 528
L Y+HS IHRD+K NL V+ +K+ DFG+A+H E++ W APEVI
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVI 186
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF-- 566
M + VDIWS+GC + EMLTGK P EF
Sbjct: 187 LNWMHYNQ------TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240
Query: 567 ----EGPQAMFKVLNRTPP------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
+ ++ K L + P P+ S + D L + + +R +A E LEHP+
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKA-SPQAVDLLEKMLELDVDKRLTATEALEHPY 299
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 80/303 (26%), Positives = 130/303 (42%), Gaps = 76/303 (25%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ- 420
+G G FG V ++ TG + AIK+ I + K+ +E+K+L HL+HENI+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKK---IMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74
Query: 421 -----------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
Y+ +E++ L+ L R + + ++ F IL G
Sbjct: 75 SDIFISPLEDIYFVTELLGTDLHRLLT--------------SRPLEKQFIQYFLYQILRG 120
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK----HLTGLSYELSLKGSPNWMAP 525
L Y+HS +HRD+K +N+L++ + +K+ DFG+A+ +TG + + AP
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV------STRYYRAP 174
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSE 565
E++ QK + VDIWS GC EML GKP P +
Sbjct: 175 EIM-LTWQKYD-----VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228
Query: 566 F------EGPQAMFKVLNRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
E + L + P+P + D L + + +P +R SA E L H
Sbjct: 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288
Query: 615 PFI 617
P++
Sbjct: 289 PYL 291
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 83/315 (26%), Positives = 128/315 (40%), Gaps = 88/315 (27%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G FG V+ T+ G A+K++ + + S K++ +E+K+L KH+N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS---CKRVFRELKMLCFFKHDNVLSA 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITE--------SIVRN----------FT 463
L+ + P I+ + E +TE IV F
Sbjct: 65 -------------LDILQPPHIDPF--EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFL 109
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA--------KHLTGLSYELS 515
IL GL YLHS +HRDIK NLLV+++ V+K+ DFG+A KH+T E+
Sbjct: 110 YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT---QEVV 166
Query: 516 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------- 560
+ + APE++ G+ AVDIWS+GC E+L +
Sbjct: 167 ---TQYYRAPEILM------GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
Query: 561 ------PPWSEFEGP-QAMFKVLNRTPPIPEMLSS----------EGKDFLLRCFLRNPV 603
P + + R P P L E L R + +P
Sbjct: 218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277
Query: 604 ERPSAVELLEHPFIR 618
+R SA + L HP++
Sbjct: 278 KRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 70/264 (26%), Positives = 123/264 (46%), Gaps = 20/264 (7%)
Query: 361 LIGRGTFGSVYIGTNRETGAS-CAIKEVDII-PDDPKSA----ECIKQLEQEIKVLG-HL 413
+G G FG VY + G + A+KE+++ P K + I + E+ ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 470
+H NIV+YY + + +D LYI ++ + + + ++E + TE + N ++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 471 AYLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
YLH I HRD+ N+++ V + DFG+AK S S+ G+ + PE++K
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVK 186
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMFKVLNRTPPIPEMLSS 588
N D+W+ GC + +M T +PP +S A V P+PE + S
Sbjct: 187 -------NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239
Query: 589 EGKDFLL-RCFLRNPVERPSAVEL 611
E ++ C + RP +++
Sbjct: 240 EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 73/301 (24%), Positives = 127/301 (42%), Gaps = 54/301 (17%)
Query: 359 GKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDDPK-----------SAECIKQLEQE 406
+ +G G FG V++ S + D P S + +E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH----------CRDITE 456
+K+L L NI + G VD L + +EY+ G +N+++++H + ++
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
S + I +G+ YL S N +HRD+ N LV + +K+ADFGM+++L Y +
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-YRV 188
Query: 517 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSE----- 565
+G WMA E +V+ K D+W+ G T+ E+LT + P+
Sbjct: 189 QGRAPLPIRWMAWE---SVLLG----KFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
Query: 566 -------FEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
F L R P P+ + + +L C+ R+ +RP+ E+ H F++
Sbjct: 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIY----ELMLECWRRDEEDRPTFREI--HLFLQ 295
Query: 619 N 619
Sbjct: 296 R 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 21/261 (8%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ--LEQEIKVL 410
+ ++ + +G G FG V+ G + AIK I+ KS + +KQ ++E++ L
Sbjct: 5 REEFTLERKLGSGYFGEVWEGLWKNR-VRVAIK---IL----KSDDLLKQQDFQKEVQAL 56
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNG 469
L+H++++ + V + +YI E + GS+ ++R + + + + + + G
Sbjct: 57 KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP-NWMAPEVI 528
+AYL N+IHRD+ N+LV V K+ADFG+A+ + Y S K P W APE
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEML 586
+ + D+WS G + EM T G+ P+ + ++ P P
Sbjct: 177 -------SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKC 229
Query: 587 SSEGKDFLLRCFLRNPVERPS 607
E +L C+ P +RPS
Sbjct: 230 PQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-22
Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 29/227 (12%)
Query: 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
SP KS ++ G +IG G+FG VY +T AIK+V DP+ +E+ +
Sbjct: 63 SPNKS-YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDPQYKN------RELLI 112
Query: 410 LGHLKHENIV---QYYGSEVVDDH-----LYIYLEYVHPGSINRYVREHCRD---ITESI 458
+ +L H NI+ YY +E + L + +E++ P ++++Y++ + R+ + +
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFI-PQTVHKYMKHYARNNHALPLFL 171
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLK 517
V+ ++ + LAY+HS HRD+K NLL+D + +KL DFG AK+L +S
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
S + APE++ G +D+WSLGC + EM+ G P +S
Sbjct: 232 CSRFYRAPELML------GATNYTTHIDLWSLGCIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 67/257 (26%), Positives = 121/257 (47%), Gaps = 28/257 (10%)
Query: 360 KLIGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K +G G FG V++G A ++K+ + P+ E ++ L+H
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---------AFLAEANLMKQLQHPR 62
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHST 476
+V+ Y + V + +YI EY+ GS+ +++ +T + + + I G+A++
Sbjct: 63 LVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK 121
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQ 533
N IHRD++ AN+LV + K+ADFG+A+ + Y + +G+ W APE I
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY--- 177
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEG 590
+ D+WS G + E++T G+ P+ P+ + + L R P P+ E
Sbjct: 178 ----GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-QNLERGYRMPRPDNCPEEL 232
Query: 591 KDFLLRCFLRNPVERPS 607
+ + C+ P ERP+
Sbjct: 233 YELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 9e-22
Identities = 81/287 (28%), Positives = 139/287 (48%), Gaps = 39/287 (13%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 414
K+IGRG FG V + ++ + A+K + E IK+ + +E ++
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLL-------SKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+VQ + + D +LY+ +EY+ G + + + D+ E + +T ++ L +H
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH 159
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFG--MAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
S IHRD+K N+L+D G +KLADFG M TG+ + G+P++++PEV+K+
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS-- 217
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PE--MLSS 588
+ G+ D WS+G + EML G P+ K+++ + PE +S
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK 276
Query: 589 EGKDFLLRCFL--------RNPVERPSAVELLEHPFIRNA--NYQNL 625
K+ L+ FL RN VE E+ +HPF +N N+ N+
Sbjct: 277 HAKN-LICAFLTDREVRLGRNGVE-----EIKQHPFFKNDQWNWDNI 317
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 75/257 (29%), Positives = 116/257 (45%), Gaps = 18/257 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+L+G+G FG V+ GT ++ A+K + +P + K IK L E ++L H NI
Sbjct: 1 ELLGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELK----IKFL-SEARILKQYDHPNI 54
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V+ G +YI +E V G ++R+ ++ + F G+AYL S N
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSP-NWMAPEVIKAVMQKDG 536
IHRD+ N LV + V+K++DFGM++ Y S LK P W APE +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY------ 168
Query: 537 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFL 594
+ + D+WS G + E + G P+ QA +V P+ + +
Sbjct: 169 -GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227
Query: 595 LRCFLRNPVERPSAVEL 611
RC+ P RP EL
Sbjct: 228 QRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 72/293 (24%), Positives = 130/293 (44%), Gaps = 47/293 (16%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
+ + GK +G G FG V N ++ A+K + + ++ + ++E
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM- 68
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----------CRDIT 455
+K++G KH+NI+ G + LY+ +EY G++ ++R R
Sbjct: 69 MKMIG--KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 456 ESI----VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511
E++ + +F + G+ +L S IHRD+ N+LV V+K+ADFG+A+ + +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 512 Y-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
Y L +K WMAPE + + D+WS G + E+ T G P+
Sbjct: 187 YYRKTTNGRLPVK----WMAPEALFDRV-------YTHQSDVWSFGVLLWEIFTLGGSPY 235
Query: 564 SEFEGPQAMFKVLN---RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+ +FK+L R P+ + E + C+ P +RP+ +L+E
Sbjct: 236 PGIPVEE-LFKLLKEGYRMEK-PQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 81/310 (26%), Positives = 139/310 (44%), Gaps = 40/310 (12%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K + K + +G GT+ +V+ G ++ T A+KE+ + ++ I+ E+ +L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLK 59
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH NIV + D L + EY+ + +Y+ + ++ V+ F IL GLA
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
Y H +HRD+K NLL++ G +KLADFG+A+ + + S + W P +
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL- 177
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQAMFKVLNRTP--------- 580
G+ + + +D+W +GC EM +G+P P S E + L TP
Sbjct: 178 ----GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233
Query: 581 --------------PIPEM-----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
P P + L +EG + L + +R SA E ++H + R+
Sbjct: 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293
Query: 622 YQNLSVPMRV 631
+ S+P +
Sbjct: 294 TRIHSLPESI 303
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 82/280 (29%), Positives = 134/280 (47%), Gaps = 32/280 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-----EIKVL-GHL 413
K+IG+G+FG V + + G+ A+K + + +K+ EQ E VL +L
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVL-------QKKTILKKKEQNHIMAERNVLLKNL 53
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAY 472
KH +V + S + LY L+YV+ G + ++ RE C E R + + + + Y
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIGY 111
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIK 529
LHS N I+RD+K N+L+D+ G V L DFG+ K G+ E + G+P ++APEV++
Sbjct: 112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLR 169
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 589
VD W LG + EML G PP+ + Q +L++ +P +
Sbjct: 170 -------KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA 222
Query: 590 GKDFLLRCFLRNPVERPSA----VELLEHPFIRNANYQNL 625
D L+ ++ R A +E+ H F N+ +L
Sbjct: 223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 23/276 (8%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHL-KHE 416
++G+G+FG V + + T AIK + +I DD EC E +VL K
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD--DVECTMV---EKRVLALQDKPP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ Q + D LY +EYV+ G + ++++ + E + I GL +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRR 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+++D+ G +K+ADFGM K H+ + G+P+++APE+I Q
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII--AYQPY 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLL 595
G +VD W+ G + EML G+PP+ + + ++ P+ LS E
Sbjct: 179 G-----KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICK 233
Query: 596 RCFLRNPVER-----PSAVELLEHPFIRNANYQNLS 626
++P +R ++ EH F R ++ L
Sbjct: 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 89/337 (26%), Positives = 159/337 (47%), Gaps = 60/337 (17%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K +G G G V+ +++ +G A K +I + K A Q+ +E++VL
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARK---LIHLEIKPA-IRNQIIRELQVLH 58
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
IV +YG+ D + I +E++ GS+++ +++ R I E I+ + ++ GL
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 117
Query: 472 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
YL + I HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 118 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQG 176
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGK-----PPWSEFE------------------ 567
++ DIWS+G +++EM G+ P E E
Sbjct: 177 T-------HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229
Query: 568 -----------------GPQAMFKVL----NRTPP-IPE-MLSSEGKDFLLRCFLRNPVE 604
P A+F++L N PP +P + +E +DF+ +C ++NP E
Sbjct: 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAE 289
Query: 605 RPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKS 641
R +L+ H FI+ + + + + S I L S
Sbjct: 290 RADLKQLMVHAFIKRSEAEEVDFAGWLCSTIGLNQPS 326
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 74/273 (27%), Positives = 125/273 (45%), Gaps = 34/273 (12%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLKH 415
K KL G G +G VY G ++ + A+K + D + +++ +E V+ +KH
Sbjct: 11 KHKL-GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--------VEEFLKEAAVMKEIKH 61
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF-TRHILNGLAYLH 474
N+VQ G + YI E++ G++ Y+RE R ++V + I + + YL
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVM 532
N IHRD+ N LV + +VK+ADFG+++ +TG +Y K W APE +
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL---- 177
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEML 586
K ++ D+W+ G + E+ T G P+ + Q + + R P
Sbjct: 178 ---AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP-- 232
Query: 587 SSEGKDFLLRCFLRNPVERPSAVEL---LEHPF 616
+ + + C+ NP +RPS E+ E F
Sbjct: 233 --KVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 80/274 (29%), Positives = 132/274 (48%), Gaps = 20/274 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK--EVDIIPDDPKSAECIKQLEQEIKVL-GHLKHE 416
K+IG+G+FG V + + G A+K + I+ + + K + E VL ++KH
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ----KHIMAERNVLLKNVKHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V + S + LY L++V+ G + +++ R E R + I + L YLHS
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSI 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKD 535
N ++RD+K N+L+D+ G V L DFG+ K S + G+P ++APEVI+ Q
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK--QPY 173
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLNRTPPIPEMLSSEGK 591
N VD W LG + EML G PP+ + + + K L P S +
Sbjct: 174 DN-----TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625
+ L + R + +E+ EHPF + ++ +L
Sbjct: 229 ELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-21
Identities = 81/280 (28%), Positives = 140/280 (50%), Gaps = 37/280 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 413
++Q +G G +GSV + +TG A+K++ P +S K+ +E+++L H+
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS----RPFQSIIHAKRTYRELRLLKHM 73
Query: 414 KHENIVQ----YYGSEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
KHEN++ + + +++ +YL ++ +N V+ C+ +T+ V+ IL
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILR 131
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEV 527
GL Y+HS + IHRD+K +NL V+ +K+ DFG+A+H E++ + W APE+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEI 188
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEFEGPQAMFKVLNRTPPIPEM 585
+ M + VDIWS+GC + E+LTG+ P ++ + L TP E+
Sbjct: 189 MLNWMHYN------QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AEL 241
Query: 586 L---SSEGKDFLLRCFLRNPV---------ERPSAVELLE 613
L SSE ++ + P P AV+LLE
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 281
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 77/282 (27%), Positives = 134/282 (47%), Gaps = 31/282 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL-KHE 416
++IGRG++ V + ++T A+K V +++ DD E I ++ E V H
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD----EDIDWVQTEKHVFEQASNHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V + + L+ +EYV+ G + +++ R + E R ++ I L YLH
Sbjct: 57 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHER 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH-LTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+D+ G +KL D+GM K L + G+PN++APE+++
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG----- 170
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWS---EFEGPQA-----MFKV-LNRTPPIPEML 586
+VD W+LG + EM+ G+ P+ + P +F+V L + IP L
Sbjct: 171 --EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 228
Query: 587 SSEGKDFLLRCFLRNPVERPSAV------ELLEHPFIRNANY 622
S + L ++P ER ++ HPF RN ++
Sbjct: 229 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 69/253 (27%), Positives = 125/253 (49%), Gaps = 20/253 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K +G G FG V++GT A+K + P+S +E +++ L+H+ +V
Sbjct: 12 KKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPES------FLEEAQIMKKLRHDKLV 64
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNT 478
Q Y + V ++ +YI EY+ GS+ ++++ R + + + + G+AY+ N
Sbjct: 65 QLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDG 536
IHRD++ AN+LV V K+ADFG+A+ + Y K W APE A +
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG-- 178
Query: 537 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFL 594
+ + D+WS G + E++T G+ P+ + + +V P P+ + +
Sbjct: 179 --RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236
Query: 595 LRCFLRNPVERPS 607
L+C+ ++P ERP+
Sbjct: 237 LQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 81/300 (27%), Positives = 131/300 (43%), Gaps = 51/300 (17%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYI----GTNRETGASCAIKEVDIIPDDPKSAECIKQLE-- 404
P+K K KL G G FG V++ G + + +D+ + P +K L
Sbjct: 3 PRKRLTFKEKL-GEGQFGEVHLCEAEGMEKFMDKDFS---LDVSGNQPVLV-AVKMLRED 57
Query: 405 ----------QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---- 450
+EIK++ LK NI++ + D L + EY+ G +N+++ H
Sbjct: 58 ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 451 ------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504
I+ S + I +G+ YL S N +HRD+ N LV + +K+ADFGM+
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 505 KHL-TGLSYELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--G 559
++L +G Y + + WM+ E I K A D+W+ G T+ E+LT
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILL-------GKFTTASDVWAFGVTLWEILTLCK 230
Query: 560 KPPWSEFEGPQAM------FKVLNRTP--PIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
+ P+S+ Q + F+ R P P + +L C+ RN ERPS E+
Sbjct: 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 76/277 (27%), Positives = 131/277 (47%), Gaps = 26/277 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-----VLGHLK 414
K+IG+G+FG V + ++ A+K + K A K+ E+ I +L ++K
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQ------KKAILKKKEEKHIMSERNVLLKNVK 54
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYL 473
H +V + S D LY L+Y++ G + ++ RE C E R + I + L YL
Sbjct: 55 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYL 112
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGLSYELSLKGSPNWMAPEVIKAVM 532
HS N ++RD+K N+L+D+ G + L DFG+ K ++ + G+P ++APEV+
Sbjct: 113 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLH--- 169
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592
VD W LG + EML G PP+ + +LN+ + +++ +
Sbjct: 170 ----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 225
Query: 593 FLLRCFLRNPVERPSA----VELLEHPFIRNANYQNL 625
L ++ +R A +E+ H F N+ +L
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDL 262
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 80/298 (26%), Positives = 132/298 (44%), Gaps = 42/298 (14%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G GT+ +VY G ++ T A+KE+ + ++ I+ E+ +L LKH NIV
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDLKHANIVTL 69
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
+ + L + EY+ + +Y+ + I V+ F +L GL Y H +HR
Sbjct: 70 HDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 541
D+K NLL++ G +KLADFG+A+ + + S + W P I G+ +
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILL-----GSTDYS 183
Query: 542 LAVDIWSLGCTVIEMLTGKP--PWSEFEGP-QAMFKVLNRTP---PIPEMLSSE------ 589
+D+W +GC EM TG+P P S E +F++L TP P +LS+E
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG-TPTEETWPGILSNEEFKSYN 242
Query: 590 -------------------GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628
G + L + +R SA E ++HP+ + +P
Sbjct: 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-21
Identities = 77/290 (26%), Positives = 137/290 (47%), Gaps = 25/290 (8%)
Query: 340 MPHIMEKP-SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
+P E P S +P++ + L+GR + ++ T + + ++ D+ ++A
Sbjct: 52 LPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAY 111
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---IT 455
E+ L H IV+++ DD L + +EY G +N+ +++ ++
Sbjct: 112 A----RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ 167
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT---GLSY 512
E V I+ L +HS +HRD+K AN+ + +G++KL DFG +K + L
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--- 569
S G+P ++APE+ + + + D+WSLG + E+LT P F+GP
Sbjct: 228 ASSFCGTPYYLAPELWE-------RKRYSKKADMWSLGVILYELLTLHRP---FKGPSQR 277
Query: 570 QAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
+ M +VL + P P +SS K L +NP RP+ +LL F++
Sbjct: 278 EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-21
Identities = 78/277 (28%), Positives = 135/277 (48%), Gaps = 25/277 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
++G+G+FG V + + T AIK + +I DD EC +E+ + L K
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDD--DVEC-TMVEKRVLALSG-KPP 61
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ Q + D LY +EYV+ G + +++ R E + I GL +LHS
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSK 120
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWMAPEVIKAVMQK 534
I+RD+K N+++D+ G +K+ADFGM K G++ + + G+P+++APE+I Q
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-TFCGTPDYIAPEIIA--YQP 177
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VLNRTPPIPEMLSSEGKDF 593
G +VD W+ G + EML G+ P+ E E +F+ ++ P+ +S E
Sbjct: 178 YGK-----SVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAI 231
Query: 594 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
++P +R ++ EH F R +++ L
Sbjct: 232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 74/275 (26%), Positives = 116/275 (42%), Gaps = 43/275 (15%)
Query: 360 KLIGRGTFGSVYIGTNRE-----TGAS-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+G G FG VY GT + +G A+K + D + E +K E ++ +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK----EAHLMSNF 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR------HIL 467
H NIV+ G ++++ YI +E + G + Y+R+ + + +
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 468 NGLAYLHSTNTIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSY---ELSLKGS 519
G YL + IHRD+ N LV DA VVK+ DFG+A+ + Y E
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN- 577
WMAPE + DG K D+WS G + E+LT G+ P+ +VL
Sbjct: 177 VRWMAPESL-----LDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQH 225
Query: 578 -----RTPPIPEMLSSEGKDFLLRCFLRNPVERPS 607
R PE + + C+ ++P ERP+
Sbjct: 226 VTAGGRLQK-PENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 75/267 (28%), Positives = 124/267 (46%), Gaps = 27/267 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASC---AIKEVDIIPDDPKSAECIKQ---LEQEIKVLGHL 413
K+IG G FG V G + G AIK + K+ KQ E ++G
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-------KAGSSDKQRLDFLTEASIMGQF 62
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H NI++ G + I EY+ GS+++++RE+ T + R I +G+ YL
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG--SP-NWMAPEVIKA 530
N +HRD+ N+LV+++ V K++DFG+++ L + KG P W APE I
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI-- 180
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 587
K A D+WS G + E+++ G+ P+ + + V + R PP P
Sbjct: 181 -----AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-PMDCP 234
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLEH 614
S +L C+ ++ ERP+ +++
Sbjct: 235 SALYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 50/290 (17%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G GT+ +V+ G ++ T A+KE+ + ++ I+ E+ +L +LKH NIV
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR----EVSLLKNLKHANIVTL 68
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHSTNTIH 480
+ + L + EY+ + +Y+ ++C ++ + V+ F +L GL+Y H +H
Sbjct: 69 HDIIHTERCLTLVFEYLD-SDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILH 126
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K NLL++ G +KLADFG+A+ + + S + W P + G+ +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLL-----GSTEY 181
Query: 541 ALAVDIWSLGCTVIEMLTGKP------------------------PW------SEFEG-- 568
+ +D+W +GC + EM TG+P W EF
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241
Query: 569 -PQAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
PQ + L N P L ++G D L L R SA L H +
Sbjct: 242 FPQYRAQPLINHAP----RLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 5e-21
Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 33/286 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHL-KHE 416
++IGRG++ V + ++T A+K + +++ DD E I ++ E V H
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD----EDIDWVQTEKHVFETASNHP 56
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V + + L+ +E+V G + +++ R + E R ++ I L +LH
Sbjct: 57 FLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+DA G +KL D+GM K S G+PN++APE+++
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG----- 170
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW--------SEFEGPQAMFKV-LNRTPPIPEML 586
+VD W+LG + EM+ G+ P+ + +F+V L + IP L
Sbjct: 171 --EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL 228
Query: 587 SSEGKDFLLRCFL-RNPVER------PSAVELLEHPFIRNANYQNL 625
S + +L+ FL ++P ER ++ HPF RN ++ L
Sbjct: 229 SVKASS-VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLL 273
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 87/309 (28%), Positives = 136/309 (44%), Gaps = 58/309 (18%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYI------------GTNRETGASCAIKEVDIIPDDPKSAE 398
P++ K KL G G FG V++ G G + + D K+A
Sbjct: 3 PRQQLRLKEKL-GEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR 61
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--RE------H 450
+EIK++ LK+ NI++ G V DD L + EY+ G +N+++ RE H
Sbjct: 62 --NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 451 CRDITESIVRNF---TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507
+I + N I +G+ YL S N +HRD+ N LV +K+ADFGM+++L
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 508 TGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM--LTGKP 561
Y ++G WMA E I K A D+W+ G T+ EM L +
Sbjct: 180 YSGDY-YRIQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEMFTLCKEQ 231
Query: 562 PWS------------EFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 609
P+S EF Q L++TP P + ++RC+ R+ +RP+
Sbjct: 232 PYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVF----KLMMRCWSRDIKDRPTFN 287
Query: 610 ELLEHPFIR 618
++ H F+R
Sbjct: 288 KI--HHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-21
Identities = 72/259 (27%), Positives = 129/259 (49%), Gaps = 32/259 (12%)
Query: 360 KLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
K +G G FG V++ T N+ T A+K + P S ++ E V+ L+H+ +
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMK-----PGSMS-VEAFLAEANVMKTLQHDKL 63
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGLAYLHSTN 477
V+ + + V + +YI E++ GS+ +++ + + +F+ I G+A++ N
Sbjct: 64 VKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQK 534
IHRD++ AN+LV AS V K+ADFG+A+ + Y + +G+ W APE I
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINF---- 177
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-----LNRTPPIPEMLSS 588
+ D+WS G ++E++T G+ P+ P+ + + + R PE L
Sbjct: 178 ---GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY- 233
Query: 589 EGKDFLLRCFLRNPVERPS 607
+ ++RC+ P ERP+
Sbjct: 234 ---NIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-21
Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 10/208 (4%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K + +G G++ +VY G ++ G A+K + + ++ I+ E +L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR----EASLLK 58
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH NIV + + L + EYVH + +Y+ +H + V+ F +L GL+
Sbjct: 59 GLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
Y+H +HRD+K NLL+ +G +KLADFG+A+ + S+ S + W P +
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL- 176
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTG 559
G+ + + +D+W +GC +EM+ G
Sbjct: 177 ----GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 84/303 (27%), Positives = 126/303 (41%), Gaps = 69/303 (22%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G +G+VY + +G A+K V + ++ + +K L H NIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 422 YGS----------------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
E VD L YL+ V P + +++ R
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGL-----------PAETIKDLMRQ 116
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG---SPNW 522
L GL +LH+ +HRD+K N+LV + G VKLADFG+A+ S +++L + +
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWY 173
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLN-- 577
APEV+ +Q A VD+WS+GC EM KP + SE + +F ++
Sbjct: 174 RAPEVL---LQS----TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 226
Query: 578 ------------------RTP-PI----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
R P P+ PE+ G LL NP +R SA L+H
Sbjct: 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEI-EESGAQLLLEMLTFNPHKRISAFRALQH 285
Query: 615 PFI 617
PF
Sbjct: 286 PFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 70/255 (27%), Positives = 119/255 (46%), Gaps = 23/255 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K +G G FG V++G + A+K + P + ++ +E ++ L+H+ +V
Sbjct: 12 KKLGAGQFGEVWMGYYNNS-TKVAVKTLK-----PGTMS-VQAFLEEANLMKTLQHDKLV 64
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Y ++ +YI EY+ GS+ +++ E + + ++ +F+ I G+AY+ N
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQIAEGMAYIERKN 123
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIKAVMQKD 535
IHRD++ AN+LV S + K+ADFG+A+ + Y K W APE I
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF----- 178
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKD 592
+ D+WS G + E++T GK P+ M L R P E E D
Sbjct: 179 --GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM-SALQRGYRMPRMENCPDELYD 235
Query: 593 FLLRCFLRNPVERPS 607
+ C+ ERP+
Sbjct: 236 IMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 74/267 (27%), Positives = 129/267 (48%), Gaps = 30/267 (11%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ G++IG G FG+V G TG A+K + K + +E V+ L
Sbjct: 6 QKLTLGEIIGEGEFGAVLQG--EYTGQKVAVKNI-------KCDVTAQAFLEETAVMTKL 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI-VRNFTRHILNGLAY 472
H+N+V+ G ++ + LYI +E + G++ ++R R + I + F+ + G+ Y
Sbjct: 57 HHKNLVRLLGV-ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-HLTGL-SYELSLKGSPNWMAPEVIKA 530
L S +HRD+ N+LV GV K++DFG+A+ G+ + +L +K W APE +K
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALK- 170
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPEML 586
+ K + D+WS G + E+ + G+ P+ + E + + K P PE
Sbjct: 171 ------HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEP--PEGC 222
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLE 613
++ + C+ P +RPS +L E
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLRE 249
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 72/260 (27%), Positives = 114/260 (43%), Gaps = 28/260 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
IG G FG V++G E AIK + + A + +E +V+ L H +VQ
Sbjct: 12 IGSGQFGLVWLGYWLEK-RKVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481
YG + + E++ G ++ Y+R ++ + + G+AYL S+N IHR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAVMQKDGNPK 539
D+ N LV + VVK++DFGM + + Y S K W +PEV K
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-------SK 177
Query: 540 LALAVDIWSLGCTVIEMLT-GKPPWSE------FEGPQAMFKVLNRTPPIPEMLSSEGKD 592
+ D+WS G + E+ + GK P+ E A F++ P + S +
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK-----PRLASQSVYE 232
Query: 593 FLLRCFLRNPVERPSAVELL 612
+ C+ P +RPS LL
Sbjct: 233 LMQHCWKERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 71/274 (25%), Positives = 122/274 (44%), Gaps = 44/274 (16%)
Query: 360 KLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK---VLGHL 413
++IG+G FG VY GT + CA+K ++ I D ++++EQ +K ++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-------LEEVEQFLKEGIIMKDF 53
Query: 414 KHENIVQYYGSEVVDDHL-YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
H N++ G + + + L Y+ G + ++R + T + F + G+ Y
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---------ELSLKGSPNWM 523
L S +HRD+ N ++D S VK+ADFG+A+ + Y +L +K WM
Sbjct: 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN----- 577
A E ++ K D+WS G + E++T G PP+ + + F +
Sbjct: 170 ALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYLLQG 218
Query: 578 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
R PE + +L C+ P RP+ EL
Sbjct: 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 6e-20
Identities = 78/300 (26%), Positives = 136/300 (45%), Gaps = 45/300 (15%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
E P + + GK +G G FG V +G +++ V ++ DD +
Sbjct: 6 EDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS 65
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EH 450
+ + ++E +K++G KH+NI+ G+ D LY+ +EY G++ Y+R E+
Sbjct: 66 DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122
Query: 451 CRDITE--------SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502
DI + + T + G+ YL S IHRD+ N+LV + V+K+ADFG
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 182
Query: 503 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
+A+ + + Y K + N WMAPE + + + D+WS G + E+
Sbjct: 183 LARDVNNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLMWEI 232
Query: 557 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
T G P+ + +FK+L + P ++E + C+ P RP+ +L+E
Sbjct: 233 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 84/294 (28%), Positives = 127/294 (43%), Gaps = 58/294 (19%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQ 420
IG GTF V +R+TG AIK + KS E + L +EI+ L L H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKC---MKKHFKSLEQVNNL-REIQALRRLSPHPNILR 62
Query: 421 YYGSEVVDDHLYIYLEYVHP---GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
EV+ D L V ++ ++ R + E V+++ +L L ++H
Sbjct: 63 LI--EVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWM-APEVIKAVMQKD 535
HRDIK N+L+ ++KLADFG + + Y + S W APE + D
Sbjct: 121 IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYI--STRWYRAPE----CLLTD 173
Query: 536 G--NPKLALAVDIWSLGCTVIEMLTGKP--PWS-EFEGPQAMFKVLNRTPP--------- 581
G PK +DIW++GC E+L+ P P + E + + VL TP
Sbjct: 174 GYYGPK----MDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG-TPDAEVLKKFRK 228
Query: 582 -------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
+P S+EG D L + +P ER +A + L HP+
Sbjct: 229 SRHMNYNFPSKKGTGLRKLLPNA-SAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 19/280 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG V R TG A K ++ + E + E++I L + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQI--LEKVNSQFVV 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNT 478
+ D L + L ++ G + ++ E + IL GL LH NT
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
++RD+K N+L+D G ++++D G+A + G+ +MAPEV+ N
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLN-------NQ 176
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS----EGKDFL 594
+ L+ D W LGC + EM+ G+ P+ + +V R E+ S+ E K
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236
Query: 595 LRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 629
++P +R A E+ HPF RN N++ L M
Sbjct: 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 9e-20
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 29/285 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG V R TG A K+++ + E + E++I L + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI--LEKVNSRFVV 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNT 478
+ D L + L ++ G + ++ E + I GL LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
++RD+K N+L+D G ++++D G+A + G+ +MAPEV+K N
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVK-------NE 176
Query: 539 KLALAVDIWSLGCTVIEMLTGKPP---------WSEFEGPQAMFKVLNRTPPIPEMLSSE 589
+ + D W LGC + EM+ GK P E E +V E S
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-----RVKEDQEEYSEKFSEA 231
Query: 590 GKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 629
+ + ++P R A E+ HPF R AN++ L M
Sbjct: 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 9e-20
Identities = 71/277 (25%), Positives = 135/277 (48%), Gaps = 17/277 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHEN 417
K+IGRG FG V + + T A+K ++ + K AE C ++ E+ + V G +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKW-EMLKRAETACFRE-ERNVLVNGDCQWIT 64
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Y + +++LY+ ++Y G + + + + E + R + ++ + +H +
Sbjct: 65 TLHYAFQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRDIK N+L+D +G ++LADFG + G G+P++++PE+++A+ +D
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM--ED 180
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEG 590
G K D WSLG + EML G+ P+ + K++N P +S E
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240
Query: 591 KDFLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL 625
KD + R C + + + +H F +++N+
Sbjct: 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI 277
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 9e-20
Identities = 75/278 (26%), Positives = 127/278 (45%), Gaps = 25/278 (8%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
P+ P +W GK +G G FG V T S A+ +V + P +
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS 80
Query: 400 IKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITE 456
++ L E+K++ HL HENIV G+ + + + EY G + ++R +T
Sbjct: 81 EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
+ +F+ + G+A+L S N IHRD+ N+L+ +VK+ DFG+A+ + S +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV- 199
Query: 517 KGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 571
KG+ WMAPE I N D+WS G + E+ + G P+
Sbjct: 200 KGNARLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252
Query: 572 MFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS 607
+K++ + PE +E D + C+ +P++RP+
Sbjct: 253 FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 9e-20
Identities = 74/283 (26%), Positives = 131/283 (46%), Gaps = 29/283 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
++IGRG++ V + ++ A+K V +++ DD E I ++ E V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD----EDIDWVQTEKHVFEQASSNP 56
Query: 418 -IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V + L++ +EYV+ G + +++ R + E R + I L +LH
Sbjct: 57 FLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHER 115
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+DA G +KL D+GM K G S G+PN++APE+++
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG----- 170
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWS------EFEGPQAMFKVLNRTP-PIPEMLSS 588
+ +VD W+LG + EM+ G+ P+ + +F+V+ P IP LS
Sbjct: 171 --EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSV 228
Query: 589 EGKDFLLRCFLRNPVERPSA------VELLEHPFIRNANYQNL 625
+ L ++P ER ++ H F R+ ++ L
Sbjct: 229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-19
Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 58/273 (21%)
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
Q+ +E++VL IV +YG+ D + I +E++ GS+++ ++E + I E I+
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGK 107
Query: 462 FTRHILNGLAYLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520
+ +L GLAYL + I HRD+K +N+LV++ G +KL DFG++ L S S G+
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTR 166
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG--------------------- 559
++M+PE ++ ++ DIWS+G +++E+ G
Sbjct: 167 SYMSPERLQGT-------HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVV 219
Query: 560 --------------KPPWSEFEG-------PQAMFKVL----NRTPP-IPE-MLSSEGKD 592
+PP G A+F++L N PP +P + + + ++
Sbjct: 220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQE 279
Query: 593 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625
F+ +C ++NP ER L+ H FI+ + + +
Sbjct: 280 FVNKCLIKNPAERADLKMLMNHTFIKRSEVEEV 312
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 68/251 (27%), Positives = 125/251 (49%), Gaps = 20/251 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G FG V++GT T AIK + P++ QE +++ L+H+ +V
Sbjct: 14 LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEA------FLQEAQIMKKLRHDKLVPL 66
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
Y + V ++ +YI E++ GS+ +++E + + + + I +G+AY+ N IH
Sbjct: 67 Y-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNP 538
RD++ AN+LV + V K+ADFG+A+ + Y K W APE A +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYG---- 178
Query: 539 KLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV-LNRTPPIPEMLSSEGKDFLLR 596
+ + D+WS G + E++T G+ P+ + + +V P P+ + +
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238
Query: 597 CFLRNPVERPS 607
C+ ++P ERP+
Sbjct: 239 CWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 77/263 (29%), Positives = 123/263 (46%), Gaps = 52/263 (19%)
Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 450
PD K+A +E+K+L LK NI++ G V +D L + EY+ G +N+++ H
Sbjct: 56 PDANKNAR--NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH 113
Query: 451 CRD------------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492
D I+ S + + I +G+ YL S N +HRD+ N LV
Sbjct: 114 HLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173
Query: 493 SGVVKLADFGMAKHLTGLSYELSLKGSP----NWMAPEVIKAVMQKDGNPKLALAVDIWS 548
+ +K+ADFGM+++L Y ++G WMA E I +M K A D+W+
Sbjct: 174 NLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECI--LMG-----KFTTASDVWA 225
Query: 549 LGCTVIEMLT--GKPPWSEFEGPQAM------FK------VLNRTPPIPEMLSSEGKDFL 594
G T+ E+L + P+ E Q + F+ L R PP P+ L + +
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY----ELM 281
Query: 595 LRCFLRNPVERPSAVELLEHPFI 617
L+C+ R+ ERPS ++ H F+
Sbjct: 282 LQCWSRDCRERPSFSDI--HAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 70/253 (27%), Positives = 110/253 (43%), Gaps = 20/253 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEV-DIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
IGRG FG V+ G R A+K + +P D K+ + QE ++L H NIV+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-----KFLQEARILKQYSHPNIVR 57
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
G +YI +E V G ++R + + + G+ YL S + IH
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKDGN 537
RD+ N LV V+K++DFGM++ Y + +K P W APE +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY------- 170
Query: 538 PKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFL 594
+ + D+WS G + E + G P++ Q + R P PE+ +
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC-PELCPDAVYRLM 229
Query: 595 LRCFLRNPVERPS 607
RC+ +P +RPS
Sbjct: 230 ERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 71/277 (25%), Positives = 136/277 (49%), Gaps = 17/277 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE--CIKQLEQEIKVLGHLKHEN 417
K+IGRG FG V + + A+K ++ + K AE C ++ E+++ V G +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKW-EMLKRAETACFRE-ERDVLVNGDNQWIT 64
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ Y + +++LY+ ++Y G + + + + E + R + ++ + +H +
Sbjct: 65 TLHYAFQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKGSPNWMAPEVIKAVMQKD 535
+HRDIK N+L+D +G ++LADFG L G G+P++++PE+++A+ +D
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM--ED 180
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-----PPIPEMLSSEG 590
G K D WSLG + EML G+ P+ + K++N P +S +
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240
Query: 591 KDFLLR--CFLRNPVERPSAVELLEHPFIRNANYQNL 625
KD + R C + + + + +HPF ++ N+
Sbjct: 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI 277
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 16/226 (7%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
++G G +G V ++ET AIK+ D ++ E + +E+K+L LK ENIV+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK---FKDSEENEEVKETTLRELKMLRTLKQENIVE 64
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ LY+ EYV + + E + VR++ ++ + + H + +H
Sbjct: 65 LKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWM-APEVIKAVMQKDGNP 538
RDIK NLL+ + V+KL DFG A++L+ G + + + W +PE++ G P
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL------GAP 177
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP 581
AVD+WS+GC + E+ G+P + SE + + KVL P
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 4e-19
Identities = 77/292 (26%), Positives = 139/292 (47%), Gaps = 42/292 (14%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K IG G FG V++ ++ T K + + + KS QL E+ V+ LKH+N
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKS-----QLVIEVNVMRELKHKN 73
Query: 418 IVQYYGSEV--VDDHLYIYLEYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAY 472
IV+Y + + LYI +E+ G ++R +++ + I E + + TR +L+ LAY
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133
Query: 473 LHS-------TNTIHRDIKGANLLV-----------------DASGVVKLADFGMAKHLT 508
H+ +HRD+K N+ + + + K+ DFG++K++
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193
Query: 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
S S G+P + +PE++ + + D+W+LGC + E+ +GK P+ +
Sbjct: 194 IESMAHSCVGTPYYWSPELLLHETKSYDDKS-----DMWALGCIIYELCSGKTPFHKANN 248
Query: 569 PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR-NPVERPSAVELLEHPFIRN 619
+ L R P +P S+ + L++ L + ERPSA++ L + I+N
Sbjct: 249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300
|
Length = 1021 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-19
Identities = 80/310 (25%), Positives = 134/310 (43%), Gaps = 70/310 (22%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
++IG+G++G V + TG AIK+++ + + A I + EIK+L L+H +IV
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR---EIKLLRLLRHPDIV 62
Query: 420 QYYG-------SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
+ E D +Y+ E + S V + D+T + F +L L Y
Sbjct: 63 EIKHIMLPPSRREFKD--IYVVFELM--ESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------- 521
+H+ N HRD+K N+L +A +K+ DFG+A+ ++ +P
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLAR--------VAFNDTPTAIFWTDYVATR 170
Query: 522 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW------------SEFEG 568
+ APE+ + K A+DIWS+GC E+LTGKP + ++ G
Sbjct: 171 WYRAPELCGSFFSK-----YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225
Query: 569 ---PQAMFKVLN-----------RTPPIPEMLSSEGKDFLLRCFLR-----NPVERPSAV 609
P+ + +V N + P+P D L L +P +RP+A
Sbjct: 226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAE 285
Query: 610 ELLEHPFIRN 619
E L P+ +
Sbjct: 286 EALADPYFKG 295
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 87/317 (27%), Positives = 130/317 (41%), Gaps = 84/317 (26%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDIIPDD---PKSAECIKQLEQEIKVL 410
Q++ IG G +G V+ + + G A+K V + + P S +E+ VL
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI------REVAVL 55
Query: 411 GHLK---HENIVQYYGS----------------EVVDDHLYIYLEYV-HPGSINRYVREH 450
HL+ H N+V+ + E VD L YL+ V PG
Sbjct: 56 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--------- 106
Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
+ +++ +L GL +LHS +HRD+K N+LV +SG +KLADFG+A+ +
Sbjct: 107 ---VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 163
Query: 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------- 561
S+ + + APEV+ +Q A VD+WS+GC EM KP
Sbjct: 164 MALTSVVVTLWYRAPEVL---LQS----SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216
Query: 562 ---------------PWSEFEG-PQAMFK------VLNRTPPIPEMLSSEGKDFLLRCFL 599
W P+ F + I E+ GKD LL+C
Sbjct: 217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL----GKDLLLKCLT 272
Query: 600 RNPVERPSAVELLEHPF 616
NP +R SA L HP+
Sbjct: 273 FNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 21/269 (7%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++ ++ K++G G FG+VY G G + I I ++ + + E ++
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMA 64
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+ H ++V+ G + + + + + G + YV EH +I ++ N+ I G+
Sbjct: 65 SMDHPHLVRLLGV-CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 528
YL +HRD+ N+LV + VK+ DFG+A+ L G E + G WMA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP----PWSEFEGPQAMFKVLNRTPPI 582
K D+WS G T+ E++T GKP P E P + K P
Sbjct: 184 HY-------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI--PDLLEK--GERLPQ 232
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
P + + + +++C++ + RP EL
Sbjct: 233 PPICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 9e-19
Identities = 87/335 (25%), Positives = 136/335 (40%), Gaps = 86/335 (25%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ-----LEQEIK 408
S + K K IG G FG V + +T A A+K + + A+ + + ++ E
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTL-------RKADVLMRNQAAHVKAERD 53
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGS------INRYVREHCRDITESIVRNF 462
+L +E +V+ Y S D+LY ++Y+ PG I + E E + R +
Sbjct: 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRLGIFE------EDLARFY 106
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHL 507
+ + +H IHRDIK N+L+D G +KL DFG+ H
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 508 TGLSYEL-----------------------------SLKGSPNWMAPEVIKAVMQKDGNP 538
S E SL G+PN++APEV+ + G
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL----LRTGYT 222
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-----RTPPIPEMLSSEGKDF 593
+L D WS+G + EML G+PP+ + KV+N P + LS E D
Sbjct: 223 QLC---DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK-LSREASDL 278
Query: 594 LLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 625
+LR +R A E+ HPF + ++ +L
Sbjct: 279 ILR-LCCGAEDRLGKNGADEIKAHPFFKGIDFASL 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 9e-19
Identities = 72/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G FG V + TG A K++D KS E + LE+EI L + IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 422 YGSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ HL + + ++ G + ++ R + V +++ I G+ +LHS + ++
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K N+L+D G +L+D G+A L G+ +MAPE++K
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK-------EEPY 171
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP-----EMLSSEGKDFLL 595
+ VD +++GC++ EM+ G+ P+ + + A ++ RT + + E KD +
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKD-IC 230
Query: 596 RCFL-RNPVERPSAVEL----LEHPFIRNANYQNL 625
R FL + P +R + E +H F + N+ L
Sbjct: 231 RLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 9e-19
Identities = 84/325 (25%), Positives = 145/325 (44%), Gaps = 54/325 (16%)
Query: 349 ASPK----KSQWQKGKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS---A 397
A PK +++ GK +G G FG V IG +++ V ++ DD +
Sbjct: 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLS 62
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--------- 448
+ + ++E +K++G KH+NI+ G+ D LY+ +EY G++ Y+R
Sbjct: 63 DLVSEMEM-MKMIG--KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDY 119
Query: 449 --EHCRDITESI----VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502
+ C+ E + + + + G+ YL S IHRD+ N+LV V+K+ADFG
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 503 MAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
+A+ + + Y K + N WMAPE + + + D+WS G + E+
Sbjct: 180 LARDVHNIDY---YKKTTNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGVLLWEI 229
Query: 557 LT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
T G P+ + +FK+L + P + E + C+ P +RP+ +L+E
Sbjct: 230 FTLGGSPYPGIP-VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
Query: 614 H-----PFIRNANYQNLSVPMRVFS 633
Y +LSVP +S
Sbjct: 289 DLDRVLTVTSTDEYLDLSVPFEQYS 313
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-18
Identities = 86/311 (27%), Positives = 135/311 (43%), Gaps = 58/311 (18%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K+IGRG FG V + ++TG A+K + D E + + E +L +V
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILR--KADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ + S +LY+ +E++ PG + ++E + + + + +H I
Sbjct: 65 KMFYSFQDKRNLYLIMEFL-PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFI 123
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHL-----------------TGLSYE--------- 513
HRDIK NLL+DA G VKL+DFG+ L + S++
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 514 ----------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
S G+P+++APEV MQ G KL D WSLG + EML G PP+
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVF---MQT-GYNKLC---DWWSLGVIMYEMLIGYPPF 236
Query: 564 SEFEGPQAMF-KVLNRT------PPIPEMLSSEGKDFLLRCFL--RNPVERPSAVELLEH 614
E PQ + KV+N P +P +S + KD +LR N + E+ H
Sbjct: 237 CS-ETPQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSH 293
Query: 615 PFIRNANYQNL 625
PF ++ ++
Sbjct: 294 PFFEGVDWGHI 304
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 68/281 (24%), Positives = 123/281 (43%), Gaps = 21/281 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG V R TG A K+++ + E + E++I L + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQI--LEKVNSRFVV 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD--ITESIVRNFTRHILNGLAYLHSTN 477
+ D L + L ++ G + ++ H + E + I GL LH
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
++RD+K N+L+D G ++++D G+A H+ G+ +MAPEV+K N
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK-------N 175
Query: 538 PKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSS----EGKDF 593
+ + D W+LGC + EM+ G+ P+ + + +V + E S + +
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235
Query: 594 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 629
++P ER A E+ EHP + N++ L M
Sbjct: 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGM 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 79/301 (26%), Positives = 136/301 (45%), Gaps = 52/301 (17%)
Query: 351 PKKSQWQK-------GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPDDPKS--- 396
P+ +W+ GK +G G FG V IG ++E V ++ D
Sbjct: 8 PEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL 67
Query: 397 AECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------E 449
++ I ++E +K++G KH+NI+ G+ D LY+ +EY G++ Y+R E
Sbjct: 68 SDLISEMEM-MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 124
Query: 450 HCRDITESIVRNFT--------RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501
+C + T+ + + G+ YL S IHRD+ N+LV V+K+ADF
Sbjct: 125 YCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 184
Query: 502 GMAKHLTGLSYELSLKGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE 555
G+A+ + + Y K + N WMAPE + + + D+WS G + E
Sbjct: 185 GLARDIHHIDY---YKKTTNGRLPVKWMAPEALFDRIYTHQS-------DVWSFGVLLWE 234
Query: 556 MLT-GKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
+ T G P+ + +FK+L + P ++E + C+ P +RP+ +L+
Sbjct: 235 IFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293
Query: 613 E 613
E
Sbjct: 294 E 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 70/290 (24%), Positives = 125/290 (43%), Gaps = 48/290 (16%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLK 414
GK +G G FG V T V + + ++ S+E ++ L E +L +
Sbjct: 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE-LRDLLSEFNLLKQVN 61
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-----------------------C 451
H ++++ YG+ D L + +EY GS+ ++RE
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511
R +T + +F I G+ YL +HRD+ N+LV +K++DFG+++ +
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV---- 177
Query: 512 YELS--LKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
YE +K S WMA E + + + D+WS G + E++T G P+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS-------DVWSFGVLLWEIVTLGGNPY 230
Query: 564 SEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
P+ +F +L + PE S E + +L C+ + P +RP+ ++
Sbjct: 231 PGI-APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-18
Identities = 85/311 (27%), Positives = 137/311 (44%), Gaps = 58/311 (18%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
K+IGRG FG V + ++TG A+K + D E + + E +L +V
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILR--KADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ + S +LY+ +E++ PG + +TE + + + + +H I
Sbjct: 65 KMFYSFQDKLNLYLIMEFL-PGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLT---------GLSYEL---------------- 514
HRDIK NLL+D+ G VKL+DFG+ L L++ L
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAE 183
Query: 515 -----------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
S G+P+++APE V + G KL D WSLG + EML G PP+
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPE----VFMQTGYNKLC---DWWSLGVIMYEMLIGYPPF 236
Query: 564 SEFEGPQAMF-KVLNRT------PPIPEMLSSEGKDFLLR--CFLRNPVERPSAVELLEH 614
E PQ + KV+N P +P +S + KD +LR C + + P E+ +
Sbjct: 237 CS-ETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293
Query: 615 PFIRNANYQNL 625
PF +++++
Sbjct: 294 PFFEGVDWEHI 304
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 81/310 (26%), Positives = 137/310 (44%), Gaps = 49/310 (15%)
Query: 359 GKLIGRGTFGSVY----IGTNRETGASCAIKEVDIIPD---DPKSAECIKQLEQEIKVLG 411
GK +G G FG V G ++ V ++ D D A+ I ++E +K++G
Sbjct: 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL-MKLIG 75
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------EHCRDITESIVRNFT- 463
KH+NI+ G + LY+ +EY G++ ++R ++ DIT+ +
Sbjct: 76 --KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 464 -------RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
+ G+ YL S IHRD+ N+LV V+K+ADFG+A+ + + Y
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY---Y 190
Query: 517 KGSPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP 569
K + N WMAPE + + + D+WS G + E+ T G P+
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQS-------DVWSFGILMWEIFTLGGSPYPGIP-V 242
Query: 570 QAMFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA----NYQ 623
+ +FK+L + P + E + C+ P +RP+ +L+E A Y
Sbjct: 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302
Query: 624 NLSVPMRVFS 633
+LS+P +S
Sbjct: 303 DLSMPFEQYS 312
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-18
Identities = 76/291 (26%), Positives = 136/291 (46%), Gaps = 36/291 (12%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 404
E + K W +++G G G+V G A+K VD+ + S + +
Sbjct: 24 EATAKEQAKKYWIS-RVLGSGATGTVLCAKRVSDGEPFAVKVVDM---EGMSEADKNRAQ 79
Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDH--------LYIYLEYVHPGSINRYVREHCRDITE 456
E+ L + +IV+ + D + + L+Y + G + + ++ +
Sbjct: 80 AEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAK---- 135
Query: 457 SIVRNFTRH--------ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
R F H +L + ++HS + IHRDIK AN+L+ ++G+VKL DFG +K
Sbjct: 136 -TNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194
Query: 509 G-LSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
+S ++ + G+P ++APE+ + +K + K D++SLG + E+LT K P+
Sbjct: 195 ATVSDDVGRTFCGTPYYVAPEIWR---RKPYSKK----ADMFSLGVLLYELLTLKRPFDG 247
Query: 566 FEGPQAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 615
+ M K L R P+P +S E ++ + +P RPS+ +LL P
Sbjct: 248 ENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 75/283 (26%), Positives = 129/283 (45%), Gaps = 26/283 (9%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421
+G+G FG V R TG A K+++ K + + E ++L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLN--KKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 422 -YGSEVVDDHLYIYLEYVHPGSINRY----VREHCRDITESIVRNFTRHILNGLAYLHST 476
Y + D L + + ++ G + RY V E E +T I++GL +LH
Sbjct: 59 AYAFQTKTD-LCLVMTIMNGGDL-RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+D G V+++D G+A L G S G+P +MAPE+++
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ------ 170
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNRTPPIPEMLSSEGK 591
+ +VD ++LG T+ EM+ + P+ + E + ++LN + P+ S K
Sbjct: 171 -GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASK 229
Query: 592 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 629
F ++P +R + L HP R+ N++ L M
Sbjct: 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGM 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 82/326 (25%), Positives = 132/326 (40%), Gaps = 66/326 (20%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S + K K +G G FG V + +T A A+K + D + ++ E +L
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR--KKDVLLRNQVAHVKAERDILAEA 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+E +V+ Y S D+LY ++Y+ PG + E + R + + + +
Sbjct: 59 DNEWVVRLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGLSYEL---- 514
H IHRDIK N+L+D G +KL DFG+ H+ S +
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177
Query: 515 -----------------------------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545
SL G+PN++APE V+ + G +L D
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTGYTQLC---D 230
Query: 546 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----PIPEMLSSEGKDFLLRCFLRN 601
WS+G + EML G+PP+ + KV+N P LS E D +++ R
Sbjct: 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRG 289
Query: 602 PVER---PSAVELLEHPFIRNANYQN 624
P +R A E+ HPF + ++ +
Sbjct: 290 PEDRLGKNGADEIKAHPFFKTIDFSS 315
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 62/281 (22%), Positives = 113/281 (40%), Gaps = 42/281 (14%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
IG+G FG V+ + V ++ ++ SA+ ++E ++ H NIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIV 71
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR--------------- 464
+ G V + + EY+ G +N ++R S+ + +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 465 ------HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 518
+ G+AYL +HRD+ N LV + VVK+ADFG+++++ Y K
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY---YKA 188
Query: 519 SPN------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 571
S N WM PE I + D+W+ G + E+ + G P+ +
Sbjct: 189 SENDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 572 MFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
++ V + P+ E + + C+ + P +RPS +
Sbjct: 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 71/272 (26%), Positives = 122/272 (44%), Gaps = 25/272 (9%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++++K K++G G FG+VY G G I + S + K++ E V+
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+ + ++ + G + + + + + G + YVREH +I + N+ I G+
Sbjct: 65 SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 528
YL +HRD+ N+LV VK+ DFG+AK L E +G WMA E I
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP----PWSEFEGPQAMFKVLNRTP-- 580
+ + D+WS G TV E++T KP P SE +L +
Sbjct: 184 LHRIYTHQS-------DVWSYGVTVWELMTFGSKPYDGIPASEISS------ILEKGERL 230
Query: 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
P P + + + +++C++ + RP EL+
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 72/300 (24%), Positives = 139/300 (46%), Gaps = 53/300 (17%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHL 413
++Q +G G +GSV + A+K++ P +S ++ +E+++L H+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS----RPFQSLIHARRTYRELRLLKHM 71
Query: 414 KHENIVQ----YYGSEVVDDHLYIYLEYVHPGS-INRYVREHCRDITESIVRNFTRHILN 468
KHEN++ + + +++ +YL G+ +N V+ C+ +++ V+ +L
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLR 129
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEV 527
GL Y+HS IHRD+K +N+ V+ +++ DFG+A+ E++ + W APE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEI 186
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--PWSEF-------------EGPQAM 572
+ M + VDIWS+GC + E+L GK P +++ P+ +
Sbjct: 187 MLNWMHYNQ------TVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240
Query: 573 FKV--------LNRTPPIPEMLSSE--------GKDFLLRCFLRNPVERPSAVELLEHPF 616
K+ + P +P+ + D L + + + +R SA E L HP+
Sbjct: 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-17
Identities = 72/272 (26%), Positives = 130/272 (47%), Gaps = 17/272 (6%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENIV 419
+IGRG FG VY +TG A+K +D K E + E+ + ++ IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ D L L+ ++ G ++ ++ +H +E+ +R + I+ GL ++H+ +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
+RD+K AN+L+D G V+++D G+A + S+ G+ +MAPEV++ + D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDS--- 175
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLNRTPPIPEMLSSEGKDFLLR 596
+ D +SLGC + ++L G P+ + + L +P+ S E + L
Sbjct: 176 ---SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232
Query: 597 CFLRNPVER-----PSAVELLEHPFIRNANYQ 623
R+ R A E+ EHPF R+ ++Q
Sbjct: 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 68/259 (26%), Positives = 118/259 (45%), Gaps = 24/259 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
++IG G FG V G + G +E+ + KS KQ E ++G H
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
NI+ G + I E++ G+++ ++R++ T + R I G+ YL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGS-P-NWMAPEVIKA 530
N +HRD+ N+LV+++ V K++DFG+++ L + +Y SL G P W APE I
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 587
K A D+WS G + E+++ G+ P+ + + + R PP +
Sbjct: 186 -------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD-CP 237
Query: 588 SEGKDFLLRCFLRNPVERP 606
+ +L C+ ++ RP
Sbjct: 238 TALHQLMLDCWQKDRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 8e-17
Identities = 84/325 (25%), Positives = 132/325 (40%), Gaps = 64/325 (19%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S + K K +G G FG V + +T A A+K + D + + ++ E +L
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR--KKDVLNRNQVAHVKAERDILAEA 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+E +V+ Y S D+LY ++Y+ PG + E + R + + + +
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGM---------------AKHLTGLSYE----- 513
H IHRDIK N+L+D G +KL DFG+ H+ S E
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 514 ----------------------------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545
SL G+PN++APE V+ + G +L D
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE----VLLRKGYTQLC---D 230
Query: 546 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEM--LSSEGKDFL--LRCFL 599
WS+G + EML G+PP+ + KV+N T IP LS E D + L C
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA 290
Query: 600 RNPVERPSAVELLEHPFIRNANYQN 624
+ R A ++ HPF ++ +
Sbjct: 291 EERLGRNGADDIKAHPFFSEVDFSS 315
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 71/290 (24%), Positives = 111/290 (38%), Gaps = 56/290 (19%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI--IPDDPKSAECIKQLEQEIKVLGHLK 414
+ +G G FG VY G R +V + +P+ + L E ++
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMSKFN 67
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-------ITESIVRNFTRHIL 467
H+NIV+ G +I LE + G + ++RE R +T + R +
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE-NRPRPERPSSLTMKDLLFCARDVA 126
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYE-------LSLK 517
G YL + IHRDI N L+ G V K+ADFGMA+ + SY L +K
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 576
WM PE A + K D+WS G + E+ + G P+ + M
Sbjct: 187 ----WMPPE---AFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---- 231
Query: 577 NRTPPIPEMLSSEGK------------DFLLRCFLRNPVERPSAVELLEH 614
E ++ G+ + C+ P +RP+ +LE
Sbjct: 232 -------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 15/266 (5%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++ +K KL+G G FG+V+ G G S I D + +++ + +G
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
L H IV+ G L + + GS+ +VR+H + + N+ I G+
Sbjct: 65 SLDHAYIVRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVI 528
YL +HR++ N+L+ + +V++ADFG+A L + K WMA E I
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP--PIPEM 585
+ D+WS G TV EM++ G P++ P + +L + P++
Sbjct: 184 LF-------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR-PHEVPDLLEKGERLAQPQI 235
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVEL 611
+ + +++C++ + RP+ EL
Sbjct: 236 CTIDVYMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 66/280 (23%), Positives = 116/280 (41%), Gaps = 19/280 (6%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+++G+G FG V R TG A K+++ + E + E+ I L + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRI--LEKVNSRFVV 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNT 478
+ D L + L ++ G + ++ E + + GL L
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
++RD+K N+L+D G ++++D G+A + G+ +MAPEVI N
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVIN-------NE 176
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGKDFL 594
K + D W LGC + EM+ G+ P+ + + + +V E S + K
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236
Query: 595 LRCFLRNPVER-----PSAVELLEHPFIRNANYQNLSVPM 629
+NP ER A + +HP +N N++ L M
Sbjct: 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANM 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 71/258 (27%), Positives = 116/258 (44%), Gaps = 24/258 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ---EIKVLGHLKHE 416
K+IG G FG V G + G +E+ + K+ KQ E ++G H
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGK----REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
NI+ G + I EY+ GS++ ++R+H T + R I +G+ YL
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTG---LSYELSLKGSP-NWMAPEVIKAVM 532
+HRD+ N+LV+++ V K++DFG+++ L +Y P W APE I
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-- 183
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 588
K A D+WS G + E+++ G+ P+ E Q + K + R P P +
Sbjct: 184 -----RKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPA-PMDCPA 236
Query: 589 EGKDFLLRCFLRNPVERP 606
+L C+ ++ ERP
Sbjct: 237 ALHQLMLDCWQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 71/274 (25%), Positives = 129/274 (47%), Gaps = 17/274 (6%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-EIKVLGHLKHENIV 419
+IGRG FG VY +TG A+K +D K E + E+ + ++ IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ D L L+ ++ G ++ ++ +H +E +R + I+ GL ++H+ +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
+RD+K AN+L+D G V+++D G+A + S+ G+ +MAPEV++ D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDS--- 175
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSSEGKDFLLR 596
+ D +SLGC + ++L G P+ + + + L +P+ S E K L
Sbjct: 176 ---SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232
Query: 597 CFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
R+ +R A E+ EH F + ++Q +
Sbjct: 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 18/276 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++ +K K++G G FG+VY G G + I + + S + K++ E V+
Sbjct: 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMA 64
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+ + + G + + + + + G + YVRE+ I + N+ I G++
Sbjct: 65 GVGSPYVCRLLGI-CLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP---NWMAPEVI 528
YL +HRD+ N+LV + VK+ DFG+A+ L E G WMA E I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF---EGPQAMFKVLNRTPPIPE 584
+ + D+WS G TV E++T G P+ E P + K P P
Sbjct: 184 L-------HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK--GERLPQPP 234
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
+ + + +++C++ + RP EL+ F R A
Sbjct: 235 ICTIDVYMIMVKCWMIDSECRPRFRELV-DEFSRMA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 83/331 (25%), Positives = 138/331 (41%), Gaps = 86/331 (25%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-- 417
K+IG+G FG V + ++TG A+K + +E K+ +Q L H+K E
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTL-------LKSEMFKK-DQ----LAHVKAERDV 54
Query: 418 --------IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+V Y S +LY+ +E++ G + + ++ +E + R + +
Sbjct: 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLA 113
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA-------------KHLTG------- 509
+ +H IHRDIK N+L+D G +KL+DFG++ K L G
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 510 ----------LSYELSLK------------------GSPNWMAPEVIKAVMQKDGNPKLA 541
++ +S K G+P+++APE+ + Q G
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF--LQQGYGQ---- 227
Query: 542 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN--RTPPIPE--MLSSEGKDFLLR 596
D WSLG + E L G PP+ E + K++N T P+ LS E +D + R
Sbjct: 228 -ECDWWSLGAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR 285
Query: 597 --CFLRNPVERPSAVELLEHPFIRNANYQNL 625
N + R A E+ HPF R ++ +
Sbjct: 286 LITNAENRLGRGGAHEIKSHPFFRGVDWDTI 316
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 66/261 (25%), Positives = 118/261 (45%), Gaps = 24/261 (9%)
Query: 362 IGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FG+V G +++ + A+K I+ +D +L +E V+ L + IV
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK---ILKNDNNDPALKDELLREANVMQQLDNPYIV 59
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ G + + +E G +N++++++ + +TE + + G+ YL TN +
Sbjct: 60 RMIGI-CEAESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKAVMQKD 535
HRD+ N+L+ K++DFG++K L Y+ G P W APE +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY---- 173
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ--AMFKVLNRTPPIPEMLSSEGKD 592
K + D+WS G + E + G+ P+ +G + M + R P+ E D
Sbjct: 174 ---KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-ECPQRCPPEMYD 229
Query: 593 FLLRCFLRNPVERP--SAVEL 611
+ C+ ERP + VEL
Sbjct: 230 LMKLCWTYGVDERPGFAVVEL 250
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 68/282 (24%), Positives = 119/282 (42%), Gaps = 37/282 (13%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGAS-----CAIKEVDIIPDDPKSAECIKQLEQEI 407
+S Q+ +GRG FG V++ + +K + D+ + +E+
Sbjct: 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE----NLQSEFRREL 59
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF-TRHI 466
+ L H+N+V+ G + Y+ LEY G + +++R + T+
Sbjct: 60 DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 467 LN-------GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLK 517
+ G+ +L + +HRD+ N LV + VK++ ++K + Y +
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 576
W+APE AV + D + K D+WS G + E+ T G+ P+ + VL
Sbjct: 180 IPLRWLAPE---AVQEDDFSTK----SDVWSFGVLMWEVFTQGELPFYGLSDEE----VL 228
Query: 577 NRTP------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
NR P+PE S + RC+ NP +RPS EL+
Sbjct: 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 30/275 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCA---IKEVDIIPDDPKSAECIKQLE--QEIKVLGHLKHE 416
IG G FG V +G G S A +KE+ SA +QL QE++ L H
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELR------ASATPDEQLLFLQEVQPYRELNHP 55
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRH-ILNGLAY 472
N++Q G + + LE+ G + Y+R + + V + +GL +
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIK 529
LH + IH D+ N + A VK+ D+G+A Y ++ P W+APE+++
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR------TPPI 582
Q +IWSLG T+ E+ T P+ + Q + +V+ P +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQL 235
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVE---LLEH 614
S + + C+L +P RP+A E LL +
Sbjct: 236 DLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-14
Identities = 65/254 (25%), Positives = 104/254 (40%), Gaps = 24/254 (9%)
Query: 377 ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS-EVVDDHLYIYL 435
TG AIK + D P+ + +E + L H NIV S E L+
Sbjct: 1 MTGHEVAIKLLRT--DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVF 58
Query: 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495
EYV PG R V + +L+ LA H+ +HRD+K N++V +GV
Sbjct: 59 EYV-PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 496 ---VKLADFGMAKHLTG--------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV 544
K+ DFG+ L G L+ + G+P + APE Q G P
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE------QLRGEPVTP-NS 170
Query: 545 DIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PIPEMLSSEGKDFLLRCFLR-NP 602
D+++ G +E LTG+ + +++ L+ +P ++ +LR L +P
Sbjct: 171 DLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDP 230
Query: 603 VERPSAVELLEHPF 616
+R ++ L F
Sbjct: 231 RQRAASAPALAERF 244
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 64/258 (24%), Positives = 122/258 (47%), Gaps = 22/258 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAI---KEVDIIPDDPKSAECIKQLEQE-IKVLGHLKHEN 417
+G+GTF ++Y G R + +EV ++ S E ++ L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+V+ YG V D+++ + EYV G ++ ++ +++ + + + + L YL
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 478 TIHRDIKGANLLVDASGV-------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
+H ++ G N+LV G+ +KL+D G+ +T LS E ++ P W+APE I
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREERVERIP-WIAPECI-- 176
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 589
++G L +A D WS G T++E+ + G+ P S + +P +E
Sbjct: 177 ---RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQHRLPMPDCAE 232
Query: 590 GKDFLLRCFLRNPVERPS 607
+ + +C+ +P +RPS
Sbjct: 233 LANLINQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 40/272 (14%)
Query: 362 IGRGTFGSVYIG-----TNRETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 414
+G G FG VY G R + S AIK + ++AE Q E QE +++ L+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLK------ENAEPKVQQEFRQEAELMSDLQ 66
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILN---- 468
H NIV G + + EY+ G ++ ++ + D+ + L+
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 469 ---------GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 519
G+ YL S + +HRD+ N LV VK++DFG+++ + Y S
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 520 P---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 575
WM PE A++ K DIWS G + E+ + G P+ F + + +
Sbjct: 187 LLPVRWMPPE---AILYG----KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 576 LNRTP-PIPEMLSSEGKDFLLRCFLRNPVERP 606
+R P PE + ++ C+ P RP
Sbjct: 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 65/258 (25%), Positives = 117/258 (45%), Gaps = 23/258 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKHENIV 419
+G+GTF ++ G RE G + + +++ D + + ++ L H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
YG V D + EYV GS++ Y++++ I S + + L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 480 HRDIKGANLLV-----DASG---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
H ++ N+L+ +G +KL+D G++ +T L E+ L+ P W+ PE I+
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERIP-WVPPECIE-- 177
Query: 532 MQKDGNPK-LALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 589
NP+ L+LA D WS G T+ E+ +G P S + Q + +P +E
Sbjct: 178 -----NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQFYEDRHQLPAPKWTE 231
Query: 590 GKDFLLRCFLRNPVERPS 607
+ + +C P RPS
Sbjct: 232 LANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 74/316 (23%), Positives = 127/316 (40%), Gaps = 67/316 (21%)
Query: 361 LIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+IGRG +V + + TG ++ +++ + + E + L+ E+ V H NI
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINL---EACTNEMVTFLQGELHVSKLFNHPNI 61
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 477
V Y + + D+ L++ ++ GS + H D ++E + + +L L Y+H
Sbjct: 62 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG 121
Query: 478 TIHRDIKGANLLVDASGVVKL----ADFGMAKHLTGLSY-----ELSLKGSPNWMAPEVI 528
+HR +K +++L+ G V L ++ M H L + S+K P W++PEV+
Sbjct: 122 YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVL 180
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP------- 581
+ +Q DI+S+G T E+ G P+ + Q + + LN T P
Sbjct: 181 QQNLQGYDAKS-----DIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235
Query: 582 IP---------------------------------------EMLSSEGKDFLLRCFLRNP 602
IP S F+ +C RNP
Sbjct: 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNP 295
Query: 603 VERPSAVELLEHPFIR 618
RPSA LL H F +
Sbjct: 296 DARPSASTLLNHSFFK 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 36/273 (13%)
Query: 361 LIGRGTFGSVYIGT--NRETGASCA--IKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
L+ GTFG ++ G + + G +K V D S + L QE +L L H+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLSHQ 68
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHP--GSINRYVREHCRDITESIVRNFTRH--------I 466
NI+ ++D ++ Y + G++ ++++ CR + + + I
Sbjct: 69 NILPILHV-CIEDGEPPFVLYPYMNWGNLKLFLQQ-CRLGEANNPQALSTQQLVHMAIQI 126
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----W 522
G++YLH IH+DI N ++D VK+ D +++ L + Y L + N W
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-CLGDNENRPVKW 185
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPP 581
MA E + N + + A D+WS G + E++T G+ P+ E + P M L
Sbjct: 186 MALESLV-------NKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFEMAAYLKDGYR 237
Query: 582 IPEMLSSEGKDF--LLRCFLRNPVERPSAVELL 612
+ + ++ + F + C+ +P ERPS +L+
Sbjct: 238 LAQPINCPDELFAVMACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 362 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 414
+G+G+FG VY G + E AIK V+ ++A +++E E V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN------EAASMRERIEFLNEASVMKEFN 67
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR---------NFTRH 465
++V+ G + +E + G + Y+R ++ + V+
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 521
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y KG
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 185
Query: 522 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 575
WM+PE + KDG D+WS G + E+ T + P+ Q + V
Sbjct: 186 RWMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238
Query: 576 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
L++ P+ML + + C+ NP RPS +E++
Sbjct: 239 LLDKPDNCPDMLF----ELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 40/279 (14%)
Query: 359 GKLIGRGTFGSVYIG--TNRETGASCAIKEVDI-------IPDDPKSAECIKQLEQE--I 407
GK +G G FGSV G ++ A+K + I + D A C+K+ + +
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 408 KVLGHLKHENIVQYYGSEVV------DDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
+++G + Y S VV L+ +L Y G +Y+ T+ +V+
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLP------TQMLVK- 116
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS---LKG 518
F I +G+ YL S + IHRD+ N +++ + V +ADFG++K + Y K
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL- 576
W+A E + + D+WS G T+ E+ T G+ P+ E + ++ L
Sbjct: 177 PVKWIAIESL-------ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLR 228
Query: 577 --NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
NR P+ L + C+L NP +RPS L
Sbjct: 229 QGNRLKQPPDCLDGL-YSLMSSCWLLNPKDRPSFETLRC 266
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 69/321 (21%), Positives = 132/321 (41%), Gaps = 68/321 (21%)
Query: 362 IGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
IGRG SVY+ + TG ++ D+ + + E +K L+ E+ + +H NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDL---ENCTEEHLKALQNEVVLSHFFRHPNIM 62
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNT 478
+ L++ ++ GS N ++ + + ++E+++ N L GL YLH
Sbjct: 63 TSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122
Query: 479 IHRDIKGANLLVDASGVVKLAD----FGMAKH--LTGLSYE---LSLKGSPNWMAPEVIK 529
IHR+IK +++L+ G+V L+ + + ++ + Y+ S P W++PE+++
Sbjct: 123 IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLR 181
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------- 580
+ + DI+S+G T E+ TG+ P+ + Q + + L P
Sbjct: 182 QDLY-----GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236
Query: 581 --------------------------------------PIPEMLSSEGKDFLLRCFLRNP 602
P + S ++ + C ++P
Sbjct: 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP 296
Query: 603 VERPSAVELLEHPFIRNANYQ 623
+RPSA LL H F + Q
Sbjct: 297 EKRPSASSLLSHAFFKQVKEQ 317
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 46/230 (20%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---------QEIK 408
+G +GRGT+G VY R+ G DD A +KQ+E +EI
Sbjct: 5 EGCKVGRGTYGHVY-KAKRKDGK-----------DDRDYA--LKQIEGTGISMSACREIA 50
Query: 409 VLGHLKHENIV--QYYGSEVVDDHLYIYLEYV-----HPGSINRYVREHCRDIT--ESIV 459
+L LKH N++ Q D +++ +Y H +R + + + + +V
Sbjct: 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 110
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELS 515
++ IL+G+ YLH+ +HRD+K AN+LV G VK+AD G A+ L+
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 516 ----LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+ + + APE++ G A+DIW++GC E+LT +P
Sbjct: 171 DLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 66/281 (23%), Positives = 117/281 (41%), Gaps = 34/281 (12%)
Query: 355 QWQKGK---LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKV 409
+W K +IG G FG V ++ G AIK + + S + + E++V
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEV 60
Query: 410 LGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRD 453
L L H NI+ G+ +LY+ +EY G++ ++R+
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513
++ + +F + G+ YL IHRD+ N+LV + V K+ADFG+++ +
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180
Query: 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 572
+ WMA E + + + D+WS G + E+++ G P+ +
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAELY 233
Query: 573 FKV-LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
K+ P E D + +C+ P ERPS ++L
Sbjct: 234 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 71/285 (24%), Positives = 130/285 (45%), Gaps = 49/285 (17%)
Query: 359 GKLIGRGTFGSVYIGT-NRETGAS--CAIK--EVDI-----IPDDPKSAECIKQLEQE-- 406
GK++G G FGSV G +++ G+ A+K ++DI I + A C+K +
Sbjct: 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 407 IKVLGHLKHENIVQYYGSEVV------DDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460
+K++G + +Q +V L+ +L Y G + + +++++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP------LQTLLK 117
Query: 461 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-------E 513
F I G+ YL + N IHRD+ N ++ V +ADFG++K + Y +
Sbjct: 118 -FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 572
+ +K W+A I+++ + K D+W+ G T+ E+ T G+ P+ E + +
Sbjct: 177 MPVK----WIA---IESLADRVYTSK----SDVWAFGVTMWEIATRGQTPYPGVENHE-I 224
Query: 573 FKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ L NR PE E D + C+ +P +RP+ +L E
Sbjct: 225 YDYLRHGNRLKQ-PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 46/230 (20%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE---------QEIK 408
+G +GRGT+G VY R+ G D+ + A +KQ+E +EI
Sbjct: 5 EGCKVGRGTYGHVY-KAKRKDGK-----------DEKEYA--LKQIEGTGISMSACREIA 50
Query: 409 VLGHLKHENIV--QYYGSEVVDDHLYIYLEYV-----HPGSINRYVREHCR--DITESIV 459
+L LKH N++ Q D +++ +Y H +R + + + + S+V
Sbjct: 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMV 110
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELS 515
++ IL+G+ YLH+ +HRD+K AN+LV G VK+AD G A+ L+
Sbjct: 111 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 170
Query: 516 ----LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+ + + APE++ G A+DIW++GC E+LT +P
Sbjct: 171 DLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 62/254 (24%), Positives = 109/254 (42%), Gaps = 22/254 (8%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---CIKQLEQEIKVLGHLKHENI 418
+G G FG V G + K++D+ K+ ++ +E +++ L + I
Sbjct: 3 LGSGNFGCVKKGVYKMRK-----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V+ G + L + +E G +N+++ +IT S V + G+ YL N
Sbjct: 58 VRMIGV-CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP---NWMAPEVIKAVMQK 534
+HRD+ N+L+ K++DFG++K L SY + W APE I
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF---- 172
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM-FKVLNRTPPIPEMLSSEGKD 592
K + D+WS G T+ E + G+ P+ + +GP+ M F + P E
Sbjct: 173 ---RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229
Query: 593 FLLRCFLRNPVERP 606
+ C++ +RP
Sbjct: 230 LMKDCWIYKWEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 79/284 (27%), Positives = 127/284 (44%), Gaps = 53/284 (18%)
Query: 360 KLIGRGTFGSVYIG--TNRETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLKH 415
K IG G FG V +G + T A +KE+ + SA +Q++ +E + L+H
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRV------SASVQEQMKFLEEAQPYRSLQH 54
Query: 416 ENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI------VRNFTRHIL 467
N++Q G +EV + +E+ G + Y+R CR E + ++ I
Sbjct: 55 SNLLQCLGQCTEVTP--YLLVMEFCPLGDLKGYLRS-CR-KAELMTPDPTTLQRMACEIA 110
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------ 521
GL +LH N IH D+ N L+ A VK+ D+G++ Y+ +P+
Sbjct: 111 LGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH----NKYKEDYYVTPDQLWVPL 166
Query: 522 -WMAPEVIKAVMQKDGNPKLALAVD------IWSLGCTVIEMLT-GKPPWSEFEGPQAMF 573
W+APE++ V GN L VD +WSLG T+ E+ G P+ Q +
Sbjct: 167 RWIAPELVDEV---HGN---LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT 220
Query: 574 KVLNRTP---PIPEM---LSSEGKDFLLRCFLRNPVERPSAVEL 611
+ P P + LS + + C+L+ P +RPSA E+
Sbjct: 221 YTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 65/278 (23%), Positives = 126/278 (45%), Gaps = 41/278 (14%)
Query: 359 GKLIGRGTFGSV---YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
G+++G+G FGSV + + + A+K ++ D S+ I++ +E + H
Sbjct: 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVK---MLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 416 ENIVQYYGSEV---VDDHLYI---YLEYVHPGSINRY-----VREHCRDITESIVRNFTR 464
N+++ G + L I L ++ G ++ + + E + + F
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-------TGLSYELSLK 517
I +G+ YL S N IHRD+ N +++ + V +ADFG++K + G + +L +K
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 576
W+A E + + D+W+ G T+ E++T G+ P++ E + ++ L
Sbjct: 181 ----WLALESL-------ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNYL 228
Query: 577 ---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
NR P+ L + + + +C+ P RPS L
Sbjct: 229 IKGNRLKQPPDCL-EDVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-12
Identities = 68/292 (23%), Positives = 120/292 (41%), Gaps = 55/292 (18%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+LIG+G G VY+ + A+K+ I D ++ K+ +E K+ L H IV
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKK--IREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 420 QYYGSEVVDDHLYIYLEYVHP---GSINRYVRE--------HCRDITESIVRNFTRHILN 468
Y D +Y + Y+ S+ + V + + + + F + I
Sbjct: 66 PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK-ICA 124
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS------------- 515
+ Y+HS +HRD+K N+L+ G V + D+G A +L
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 516 ------LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 569
+ G+P++MAPE + G P + + DI++LG + +MLT P+ +G
Sbjct: 185 MTIPGKIVGTPDYMAPERLL------GVPA-SESTDIYALGVILYQMLTLSFPYRRKKGR 237
Query: 570 QAMFKVLNRTPP---------IPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
+ ++ + IP LS ++ +P ER S+V+ L
Sbjct: 238 KISYR--DVILSPIEVAPYREIPPFLSQ----IAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 60/201 (29%)
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 521
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ + +P
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM----TPYVVTR 181
Query: 522 -WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-------------------- 560
+ APEVI + K+ VDIWS+GC + EM+ G
Sbjct: 182 YYRAPEVILGMGYKEN-------VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234
Query: 561 PPWSEFE---GPQAMFKVLNRT--PPIP-EML-----------------SSEGKDFLLRC 597
P EF P V NR E L +S+ +D L +
Sbjct: 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294
Query: 598 FLRNPVERPSAVELLEHPFIR 618
+ +P +R S + L+HP+I
Sbjct: 295 LVIDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 31/266 (11%)
Query: 361 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+IG G FG V ++ G + AIK + + + +LE K LGH H NI
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCK-LGH--HPNI 65
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVR-------------EH--CRDITESIVRNFT 463
+ G+ +LYI +EY G++ ++R EH +T + F
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ G+ YL IHRD+ N+LV + K+ADFG+++ + + WM
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWM 185
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI 582
A E + + + D+WS G + E+++ G P+ + +++ L + +
Sbjct: 186 AIESLNYSVYTTKS-------DVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRM 237
Query: 583 --PEMLSSEGKDFLLRCFLRNPVERP 606
P E + + +C+ P ERP
Sbjct: 238 EKPRNCDDEVYELMRQCWRDRPYERP 263
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/273 (22%), Positives = 106/273 (38%), Gaps = 42/273 (15%)
Query: 362 IGRGTFGSVYIG----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
+G FG +Y G + AIK + D + + + +QE ++ L H N
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK----DINNPQQWGEFQQEASLMAELHHPN 68
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYV---REH----CRDITESIVRNFTRH----- 465
IV G + + + EY++ G ++ ++ H C + V++ H
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 466 ----ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN 521
I G+ YL S +H+D+ N+L+ VK++D G+++ + Y + P
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY---YRVQPK 185
Query: 522 ------WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 574
WM PE I K + DIWS G + E+ + G P+ F + +
Sbjct: 186 SLLPIRWMPPEAIMY-------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 575 VLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERP 606
V R P E + C+ P RP
Sbjct: 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 50/202 (24%), Positives = 73/202 (36%), Gaps = 55/202 (27%)
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ IL GL YLH+ IHRD+K N+ ++ V + D G A+ L L G+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN 223
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA------------ 571
APEV+ K DIWS G + EML P + FE P +
Sbjct: 224 APEVL-------ARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPSTPEEYVKSCHSH 274
Query: 572 MFKVLNRTPPIPEMLSSEGKDFLLRCFLR------------------------------- 600
+ K+++ PE + L+R F+
Sbjct: 275 LLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKM 334
Query: 601 ---NPVERPSAVELLEHPFIRN 619
+ RPSA E+L +P
Sbjct: 335 LTFDAAMRPSAEEILNYPMFAQ 356
|
Length = 357 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 69/279 (24%), Positives = 118/279 (42%), Gaps = 46/279 (16%)
Query: 362 IGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLE--QEIKVLGHLK 414
+G+G+FG VY G R E A+K V+ +SA +++E E V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN------ESASLRERIEFLNEASVMKGFT 67
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR---------NFTRH 465
++V+ G + +E + G + Y+R + + R
Sbjct: 68 CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP----- 520
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y KG
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPV 185
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV---- 575
WMAPE + KDG + D+WS G + E+ + + P+ Q + V
Sbjct: 186 RWMAPESL-----KDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238
Query: 576 -LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
L++ PE ++ D + C+ NP RP+ +E++
Sbjct: 239 YLDQPDNCPERVT----DLMRMCWQFNPKMRPTFLEIVN 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 40/169 (23%), Positives = 56/169 (33%), Gaps = 29/169 (17%)
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
L L LH + + L+ G V + P +MAPE
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKLDGSV------------AFKTPEQSRPDPYFMAPE 74
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKVLNRTPPIPEM 585
VI+ DI+SLG T+ E L + P++ E E + +LN P
Sbjct: 75 VIQGQSY-------TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR 127
Query: 586 LSSEG---------KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625
S +DF+ C R P R +A L H A L
Sbjct: 128 DRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 13/207 (6%)
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
E LG H NIV+ G + + I EY+ G+++ ++R+H + +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSLKGSPNWM 523
+ +G+ YL +H+ + +LV++ V K++ F + + +S K W
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTP 580
APE I+ + A D+WS G + E+++ G+ P+ + G + V + R P
Sbjct: 176 APEAIQY-------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP 228
Query: 581 PIPEMLSSEGKDFLLRCFLRNPVERPS 607
P + +L C+ + ERP
Sbjct: 229 A-PRNCPNLLHQLMLDCWQKERGERPR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 6e-11
Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 20/186 (10%)
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
YY + H+ I ++Y+ G + +++ ++E+ V+ R ++ L LH N IH
Sbjct: 75 YYSVTTLKGHVLI-MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 481 RDIKGANLLVD-ASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
DIK N+L D A + L D+G+ K + T Y+ G+ ++ +PE IK
Sbjct: 133 NDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD----GTLDYFSPEKIK----GHNY- 183
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGKDFL 594
++ D W++G E+LTGK P+ E E +++ K + P + +S DF
Sbjct: 184 --DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF- 240
Query: 595 LRCFLR 600
++ L+
Sbjct: 241 VQSMLK 246
|
Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 7e-11
Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 31/271 (11%)
Query: 361 LIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+IG G FG V ++ G AIK + + +LE K LGH H NI
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGH--HPNI 58
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-------------NRYVREH--CRDITESIVRNFT 463
+ G+ +LY+ +EY G++ + + ++ + +F
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ G+ YL IHRD+ N+LV + V K+ADFG+++ + + WM
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPPI 582
A E + + + D+WS G + E+++ G P+ + +++ L + +
Sbjct: 179 AIESLNYSVYTTNS-------DVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRL 230
Query: 583 --PEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
P E D + +C+ P ERPS ++
Sbjct: 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 18/163 (11%)
Query: 461 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520
+F+ + G+++L S N IHRD+ N+L+ + K+ DFG+A+ + S +KG+
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNA 276
Query: 521 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 575
WMAPE I N D+WS G + E+ + G P+ +K+
Sbjct: 277 RLPVKWMAPESIF-------NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329
Query: 576 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS---AVELLE 613
+ + PE SE D + C+ +P++RP+ V+L+E
Sbjct: 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 76/314 (24%), Positives = 129/314 (41%), Gaps = 68/314 (21%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++Q+ K IG G G V + G + A+K++ + A K+ +E+ +L +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKCVN 78
Query: 415 HENIV--------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
H+NI+ Q E D +L + L + + +H R + +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER------MSYLLYQM 132
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ + + APE
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPWSEF 566
VI + K+ VDIWS+GC + E++ G P +EF
Sbjct: 193 VILGMGYKEN-------VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245
Query: 567 EG---PQAMFKVLNRTPPIP--------------------EMLSSEGKDFLLRCFLRNPV 603
P V NR P P ++ +S+ +D L + + +P
Sbjct: 246 MNRLQPTVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304
Query: 604 ERPSAVELLEHPFI 617
+R S E L HP+I
Sbjct: 305 KRISVDEALRHPYI 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 520
F+ + NG+ +L S N +HRD+ N+L+ +VK+ DFG+A+ + S +S KGS
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS-KGSTF 302
Query: 521 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 576
WMAPE I N D+WS G + E+ T G P+ E + + +
Sbjct: 303 LPLKWMAPESIF-------NNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355
Query: 577 NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
R + P S E + + +C+ RP +L+
Sbjct: 356 KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 44/163 (26%), Positives = 76/163 (46%), Gaps = 21/163 (12%)
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYEL 514
++ + G+ +L S IHRD+ N+L+ + VVK+ DFG+A+ ++ L
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 573
LK WMAPE I + + D+WS G + E+ + G P+ + +
Sbjct: 244 PLK----WMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292
Query: 574 KVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ L + P+ + E +L C+ P +RP+ EL+EH
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 6e-10
Identities = 57/196 (29%), Positives = 89/196 (45%), Gaps = 51/196 (26%)
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWM 523
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ ++ + +
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 185
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPW 563
APEVI + K+ VDIWS+GC + EM+ K P
Sbjct: 186 APEVILGMGYKEN-------VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 564 SEFEG---PQAMFKVLNR------TPP--IPEML-----------SSEGKDFLLRCFLRN 601
EF P V NR T P P+ L +S+ +D L + + +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
Query: 602 PVERPSAVELLEHPFI 617
P +R S E L+HP+I
Sbjct: 299 PAKRISVDEALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 51/196 (26%)
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM- 523
+L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ ++ +
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYR 192
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK--------------------PPW 563
APEVI + K+ VDIWS+GC + EM+ G P
Sbjct: 193 APEVILGMGYKEN-------VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 564 SEFEG---PQAMFKVLNR--------TPPIPEML-----------SSEGKDFLLRCFLRN 601
EF P V NR P++L +S+ +D L + + +
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 602 PVERPSAVELLEHPFI 617
+R S E L+HP+I
Sbjct: 306 ASKRISVDEALQHPYI 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 25/158 (15%)
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYELSLKGSPN 521
G+ +L S IHRD+ N+L+ + VVK+ DFG+A+ ++ L LK
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK---- 240
Query: 522 WMAPEVI--KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 578
WMAPE I K + D+WS G + E+ + G P+ + + + L
Sbjct: 241 WMAPESIFDKVYTTQS---------DVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKE 291
Query: 579 TPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ PE + E +L C+ NP +RP+ EL+E
Sbjct: 292 GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 25/164 (15%)
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK-------HLTGLSYEL 514
++ + G+ +L S IHRD+ N+L+ + VVK+ DFG+A+ ++ S L
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 515 SLKGSPNWMAPEVI--KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 571
LK WMAPE I K + D+WS G + E+ + G P+ + +
Sbjct: 239 PLK----WMAPESIFDKVYTTQS---------DVWSFGVLLWEIFSLGASPYPGVQINEE 285
Query: 572 MFKVLNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+ L + PE + E +L C+ +P ERP+ L+E
Sbjct: 286 FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 15/153 (9%)
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 520
F+ + G+ +L S N IHRD+ N+L+ V K+ DFG+A+ + S +KG+
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYVVKGNAR 275
Query: 521 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 576
WMAPE I + + D+WS G + E+ + GK P+ +K++
Sbjct: 276 LPVKWMAPESIFDCV-------YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328
Query: 577 NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPS 607
R + P+ E + C+ P ERP+
Sbjct: 329 KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT 361
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 27/209 (12%)
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
N+V + V +D +++ L++ G + ++ + I E V+ + ++ L LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-IPEECVKRWAAEMVVALDALHRE 104
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG---SPNWMAPEVIKAVMQ 533
+ RD+ N+L+D G ++L F + E S G + APEV
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-----EDSCDGEAVENMYCAPEV------ 153
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKP-PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592
G + A D WSLG + E+LTGK G + T IPE +S E +
Sbjct: 154 -GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-----HTTLNIPEWVSEEARS 207
Query: 593 FLLRCFLRNPVERPSA-----VELLEHPF 616
L + NP ER A ++ HPF
Sbjct: 208 LLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 461 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520
+FT + G+ +L S N +HRD+ N+L+ +VK+ DFG+A+ + S +S KGS
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-KGST 299
Query: 521 ----NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 575
WMAPE I N L+ D+WS G + E+ + G P+ +
Sbjct: 300 FLPVKWMAPESIF------DNLYTTLS-DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352
Query: 576 LNRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+ + P+ + E D +++C+ P +RPS + L +
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 13/151 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI-----KQLEQEIKVLGHLK 414
K I RG FG VY+G + A+K V K A+ I Q++ E L K
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKLYAVKVV-------KKADMINKNMVHQVQAERDALALSK 62
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
IV Y S +++Y+ +EY+ G + + + E + + + L YLH
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH 121
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAK 505
IHRD+K N+L+ G +KL DFG++K
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 53/226 (23%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 400 IKQLEQEIKVLGHLKHENIVQYYG--SEVVDD--HLYIYLEYVHPGSINRYVREHCRDIT 455
I E EIK L + NI++ YG ++VDD L + LEY G + + + +D++
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLS 120
Query: 456 ESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514
+ GL L+ TN ++++ + LV + +K+ G+ K L+ ++
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK- 179
Query: 515 SLKGSPNWMA---PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--P 569
+ N+M +++ + + + DI+SLG + E+ TGK P FE
Sbjct: 180 ----NVNFMVYFSYKMLNDIFSE-----YTIKDDIYSLGVVLWEIFTGKIP---FENLTT 227
Query: 570 QAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
+ ++ ++ N + +P E K + C + ++RP+ E+L
Sbjct: 228 KEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 54/239 (22%), Positives = 98/239 (41%), Gaps = 24/239 (10%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIK----------Q 402
+W+ KLIG G FG VY + A+ +++ + ++ E +
Sbjct: 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIA 72
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESI 458
L + I + HL I +YYG + +I LE + + + R C++ + +
Sbjct: 73 LWKNIHNIDHL---GIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKN--KKL 127
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH--LTGLSYELSL 516
++N + +L L Y+H H DIK N++VD + + D+G+A H + G E S
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS- 186
Query: 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 575
K + + A + + D+ SLG +++ K PW F +
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245
|
Length = 294 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 63/268 (23%), Positives = 114/268 (42%), Gaps = 41/268 (15%)
Query: 362 IGRGTFGSVYIGT-----NRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLK 414
+GRGT +Y G + E KE+ +I DP + + ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H++IV YG V D + E+V G ++ ++ +T + + + L+YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 475 STNTIHRDIKGANLLVDASGV-------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
+ +H ++ N+L+ G+ +KL+D G+ +T LS + ++ P W+APE
Sbjct: 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERIP-WIAPEC 179
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEM-LTGKPPWSE--------FEGPQAMFKVLNR 578
++ + L++A D WS G T+ E+ G+ P + F Q M
Sbjct: 180 VE------DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLV---- 229
Query: 579 TPPIPEMLSSEGKDFLLRCFLRNPVERP 606
TP E+ D + C +P +RP
Sbjct: 230 TPSCKEL-----ADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 39/112 (34%), Positives = 63/112 (56%), Gaps = 12/112 (10%)
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK-VL 576
G+P+++APE++ + K P AVD W+LG + E LTG PP+++ E PQ +F+ +L
Sbjct: 542 GTPDYLAPELL---LGKPHGP----AVDWWALGVCLFEFLTGIPPFND-ETPQQVFQNIL 593
Query: 577 NRTPPIP---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625
NR P P E LS ++ + +P +R EL +HP +++NL
Sbjct: 594 NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENL 645
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 26/268 (9%)
Query: 362 IGRGTFGSV-----YIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
IG G FG V Y T A +KE+ + E ++Q + L+H
Sbjct: 3 IGNGWFGKVLLSEIYTDT---GVARVVVKELKANASSKEQNEFLQQGDPYRI----LQHP 55
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR---EHCRDITESIVRNFTRHILNGLAYL 473
NI+Q G V + EY G + Y+ H R+ +++ I G+ ++
Sbjct: 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKA 530
H N +H D+ N + + VK+ D+G+ Y E W+APE++
Sbjct: 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMFKVLNR------TPPIP 583
+ ++W+LG T+ E+ P+S + + V+ P +
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVEL 611
S + L C+L +P +R +A E+
Sbjct: 236 LPYSERWYEVLQFCWL-SPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY-LEYVHPGSINRYVREHCRDITESIVR 460
QLE EI LG L HENI++ E++ Y + + + ++ + D + +
Sbjct: 209 QLENEILALGRLNHENILKI--EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 461 NFTRHILNGL----AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG--LSYEL 514
TR I+ L Y+H IHRDIK N+ ++ G + L DFG A +++
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
G+ +PE ++ DG ++ DIWS G +++ML+
Sbjct: 327 GWVGTVATNSPE----ILAGDGYCEIT---DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 38/271 (14%)
Query: 362 IGRGTFGSVYIG-----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+G FG VY G E + AIK + D ++ + E + L+H
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK----DKAEGPLREEFKHEAMMRSRLQHP 68
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDI----TESIVRN--------- 461
NIV G + L + Y ++ ++ R D+ + V++
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP- 520
I G+ +L S + +H+D+ N+LV VK++D G+ + + Y L G+
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY-YKLMGNSL 187
Query: 521 ---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 576
WM+PE A+M K ++ DIWS G + E+ + G P+ + + +
Sbjct: 188 LPIRWMSPE---AIMYG----KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
Query: 577 NR-TPPIPEMLSSEGKDFLLRCFLRNPVERP 606
NR P P+ + +L C+ P RP
Sbjct: 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 35/107 (32%), Positives = 47/107 (43%), Gaps = 9/107 (8%)
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE--LSLKGSPN 521
R +L + YLH IHRDIK N+ ++ G V L DFG A ++ G+
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIA 248
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
APE++ AVDIWS G + EM T E +G
Sbjct: 249 TNAPELL-------ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 47/180 (26%), Positives = 83/180 (46%), Gaps = 18/180 (10%)
Query: 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495
E+V G ++ +R+ + + + + + L+YL N +H ++ N+L+ G+
Sbjct: 96 EFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155
Query: 496 -------VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 548
+KL+D G++ T LS E ++ P W+APE + GN L+ A D WS
Sbjct: 156 AEGTSPFIKLSDPGVS--FTALSREERVERIP-WIAPECV-----PGGN-SLSTAADKWS 206
Query: 549 LGCTVIEM-LTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPS 607
G T++E+ G+ P E P + + +PE E + +C P +RPS
Sbjct: 207 FGTTLLEICFDGEVPLKE-RTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPS 265
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 32/78 (41%), Positives = 44/78 (56%), Gaps = 6/78 (7%)
Query: 452 RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGL 510
RDI ++++ R +L GL LH +HRDIK NLLV G VK+ DFG A + TG+
Sbjct: 306 RDI--NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI 363
Query: 511 SYELSLKG--SPNWMAPE 526
++ L G P + PE
Sbjct: 364 NFN-PLYGMLDPRYSPPE 380
|
Length = 507 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 44/178 (24%), Positives = 63/178 (35%), Gaps = 38/178 (21%)
Query: 401 KQLEQEIKVLGHLKHENIVQY-----YGSEV--VDDH----LYIYLEYVHPGSINRYVRE 449
K +EI +L + H I+ + S V V L+ Y++ P + + +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI-- 188
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
R +L LAYLH IHRD+K N+ +D L DFG A L
Sbjct: 189 -----------TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL-----AVDIWSLGCTVIEMLTGKPP 562
G W ++ + LAL DIWS G + EM
Sbjct: 238 HPDTPQCYG---WS------GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 37/119 (31%), Positives = 51/119 (42%), Gaps = 22/119 (18%)
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHL-TGLSY--- 512
I++ R IL L LHST +HRD+K N++ SG K+ D G A L G++Y
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAV---------------DIWSLGCTVIEM 556
E L P + APE Q P +A DI+S G ++M
Sbjct: 316 EFLL--DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 10/113 (8%)
Query: 446 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505
Y+ R + + V R +L+ + Y+H IHRDIK N+LV+ + L DFG A
Sbjct: 249 YLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308
Query: 506 HLTG---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE 555
G + + G+ + APEV+ G+P +VDIWS G + E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLA------GDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 9/118 (7%)
Query: 342 HIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP 394
+I P P S+W+ G+++G G FG V GT S + +V + P
Sbjct: 18 YIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKP 77
Query: 395 KSAECIKQ-LEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH 450
+ KQ L E+K++ HL H NIV G+ +YI EY G + Y+ ++
Sbjct: 78 TARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 0.001
Identities = 20/74 (27%), Positives = 32/74 (43%), Gaps = 10/74 (13%)
Query: 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492
I +EY+ G + V E +VR + A LH +H D+ +N +V
Sbjct: 413 IVMEYIG-GKDLKDVLEG----NPELVRKVGEIV----AKLHKAGIVHGDLTTSNFIVRD 463
Query: 493 SGVVKLADFGMAKH 506
+ L DFG+ K+
Sbjct: 464 DRLY-LIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 21/86 (24%), Positives = 34/86 (39%), Gaps = 20/86 (23%)
Query: 427 VDDHLY-IYLEYVHPG-----SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
VD I +EY+ G I E R+I + + LH +H
Sbjct: 67 VDPDNKTIVMEYIE-GKPLKDVIEEGNDELLREIGRLVGK------------LHKAGIVH 113
Query: 481 RDIKGANLLVDASGVVKLADFGMAKH 506
D+ +N++V + L DFG+ K+
Sbjct: 114 GDLTTSNIIVRDDKLY-LIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 741 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.66 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.41 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.34 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.1 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.05 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.02 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.89 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.83 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.78 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.66 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.65 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.55 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.53 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.44 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.43 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.34 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.08 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.86 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.86 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.8 | |
| PLN02236 | 344 | choline kinase | 96.58 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.56 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.35 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.24 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.14 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.04 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.98 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.77 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.38 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.33 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.31 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.67 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.34 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.95 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.9 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=477.55 Aligned_cols=265 Identities=32% Similarity=0.513 Sum_probs=235.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccH--HHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA--ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~--~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
..+.|.+.+.||+|+||.|.+|..+.||+.||||++...+...... .-...+++|++||++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 6678999999999999999999999999999999998655444322 12234679999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC---CcEEEeecccchh
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAKH 506 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~---g~vKL~DFGLA~~ 506 (741)
..||||||++||+|.+++..+ +.+.|..-+.+++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|+.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999999999999876 679999999999999999999999999999999999999766 6899999999999
Q ss_pred ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH-HHHHHhccCCCC---
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVLNRTPPI--- 582 (741)
Q Consensus 507 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~-~~~~i~~~~~~i--- 582 (741)
........++|||+.|.|||++.+ .|...+..++||||||||||-+|+|.+||.+..... ...+|..+...+
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~----kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLAS----KGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred cccceehhhhcCCccccChhheec----CCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 988888999999999999999975 244556679999999999999999999999877666 667777665443
Q ss_pred -CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 583 -PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 583 -P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
...+++++.+||.+||..||++|||+.|+|+||||+...
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 356899999999999999999999999999999998654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=483.12 Aligned_cols=258 Identities=36% Similarity=0.618 Sum_probs=238.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
..+|.++++||+|||++||.+++..+|+.||+|+|..... ......+.+.+||+|.+.|+|||||++|++|++.+.+|
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l--~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL--KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh--cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 3689999999999999999999999999999999874221 22334467899999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-c
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~-~ 511 (741)
||+|+|+.|+|..+++. .+.++|.+++.|++||+.||.|||+++|+|||||..||||+++.+|||+|||||..+... .
T Consensus 95 ivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999999999984 478999999999999999999999999999999999999999999999999999998754 7
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~ 591 (741)
...+.||||.|+|||++.+ ..++..+||||+|||||-||.|++||+..+-.+.+.+|......+|..++.+++
T Consensus 174 rk~TlCGTPNYIAPEVl~k-------~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~ 246 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNK-------SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAK 246 (592)
T ss_pred ccceecCCCcccChhHhcc-------CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHH
Confidence 7789999999999999973 567889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+||.+||+.||.+|||+++||.|+||+..
T Consensus 247 dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 247 DLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 99999999999999999999999999543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=453.54 Aligned_cols=264 Identities=32% Similarity=0.526 Sum_probs=239.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
...++|+++++||+|+||+||+++.+.+++.||+|++++...-. ....+....|..||..++||+||+++..|++.+.
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~--~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE--KKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh--hhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence 34568999999999999999999999999999999987543322 2345778899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-C
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-G 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~-~ 509 (741)
+|||+||+.||+|+..|++. +.++|..++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+||||++... .
T Consensus 100 LylVld~~~GGeLf~hL~~e-g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQRE-GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEEeccCCccHHHHHHhc-CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999999999876 679999999999999999999999999999999999999999999999999998554 4
Q ss_pred cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCCCccCCH
Q 004633 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSS 588 (741)
Q Consensus 510 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~ 588 (741)
.....++|||+.|||||++.+ ..|+.++|+|||||+||||++|.+||.+.+..+++.+|+... ...|..++.
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~-------~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~ 251 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLG-------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSE 251 (357)
T ss_pred CCccccccCCccccChHHHhc-------CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCH
Confidence 456667899999999999984 478889999999999999999999999999999999999887 666777999
Q ss_pred HHHHHHHHhhhcCCCCCC----CHHHHHcCccccccccCC
Q 004633 589 EGKDFLLRCFLRNPVERP----SAVELLEHPFIRNANYQN 624 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRP----Ta~ElLqHpwf~~~~~~~ 624 (741)
++++||+++|.+||++|. .+.+|-+||||...+|..
T Consensus 252 ~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 252 EARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred HHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 999999999999999996 689999999999887653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-53 Score=451.08 Aligned_cols=263 Identities=32% Similarity=0.567 Sum_probs=237.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc-
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD- 429 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~- 429 (741)
....+.+.++.||+|..|+||+|+++.|++.+|+|+|... ......+++.+|++|++.++|||||.+||+|..++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~----~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN----IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc----CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 3445788999999999999999999999999999998532 34566788999999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
.++|+||||+||+|+++++.. +.++|..+..++.+|++||.|||+ ++||||||||+||||+..|+|||||||.++.+.
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 599999999999999999776 679999999999999999999995 999999999999999999999999999999886
Q ss_pred CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCC-----CcHHHHHHHhc-cCCCC
Q 004633 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-----EGPQAMFKVLN-RTPPI 582 (741)
Q Consensus 509 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~-----~~~~~~~~i~~-~~~~i 582 (741)
.. ...+++||..|||||.+.+ ..|+.++||||||++++||.+|+.||... ...+.+..|+. ..+.+
T Consensus 231 nS-~a~tfvGT~~YMsPERi~g-------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~l 302 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERISG-------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRL 302 (364)
T ss_pred hh-hcccccccccccChhhhcC-------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCC
Confidence 65 6678999999999999974 57889999999999999999999999874 55677888887 45678
Q ss_pred Ccc-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccCCCC
Q 004633 583 PEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLS 626 (741)
Q Consensus 583 P~~-ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~~~~~ 626 (741)
|.. +++++++||..||++||.+|+++.|+|+|||++.....++.
T Consensus 303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd 347 (364)
T KOG0581|consen 303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD 347 (364)
T ss_pred CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence 886 99999999999999999999999999999999877655443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-52 Score=454.87 Aligned_cols=263 Identities=30% Similarity=0.539 Sum_probs=239.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecc
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD 429 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~ 429 (741)
.....|.+++.||+|+||+|++|.+..+|..||+|+++............+.+.+|+.+|+.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4566899999999999999999999999999999977654222111234567779999999999 999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchhc-
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHL- 507 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-g~vKL~DFGLA~~~- 507 (741)
.+|||||||.||+|+++|.+ .+.+.|.+++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999988 5789999999999999999999999999999999999999999 99999999999988
Q ss_pred cCcccccccCCCCCCCChHHHHHhhhcCCCC-CCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccC
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP-KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 586 (741)
Q Consensus 508 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~-~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~l 586 (741)
.......+.+||+.|+|||++.+ .. +.+.++||||||||||.|++|+.||.+.+...+..+|..+...+|..+
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~------~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSG------KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCC------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc
Confidence 45667778999999999999985 23 446899999999999999999999999888889999999999999999
Q ss_pred -CHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 587 -SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 587 -s~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+.++++||.+||..||.+|+|+.+|++|+||+..
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 9999999999999999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-52 Score=455.31 Aligned_cols=263 Identities=29% Similarity=0.564 Sum_probs=238.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l 431 (741)
..+|..++.||+|+|++|++|+++.+++.||||++.+... ....-++.+..|-.+|.+| .||.||+||..|+++..+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I--ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI--IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH--HhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 4589999999999999999999999999999999863211 1122235677899999999 799999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|+|+||+++|+|.++|++. +.|+|..++.|+.||+.||+|||++|||||||||+|||||.||++||+|||-|+.+.+..
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999886 789999999999999999999999999999999999999999999999999998774321
Q ss_pred --------------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc
Q 004633 512 --------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 577 (741)
Q Consensus 512 --------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~ 577 (741)
...+++||..|.+||+|. +...+.++|||+||||||+|+.|.+||.+.++-.++++|+.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~-------~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~ 301 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLN-------DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA 301 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhc-------CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence 114589999999999997 46778899999999999999999999999999999999999
Q ss_pred cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccCCC
Q 004633 578 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625 (741)
Q Consensus 578 ~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~~~~ 625 (741)
....+|+.+++.++|||+++|..||.+|+|++||.+||||...+|.++
T Consensus 302 l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 302 LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL 349 (604)
T ss_pred hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence 999999999999999999999999999999999999999999887763
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-52 Score=461.45 Aligned_cols=259 Identities=33% Similarity=0.545 Sum_probs=241.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.-|.+++-||.|+-|.|.+|++..||+.+|||+|.+... ........+++||.||+.|.||||+++|++++++.++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~--~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE--LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccc--cccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 459999999999999999999999999999999875422 222334578899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|+||++||.|++++..+ +.++|.++.++++||+.||.|||..+|+||||||+|+||+..+++||+|||+|..-.++...
T Consensus 90 vlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 99999999999999886 67999999999999999999999999999999999999999999999999999988888888
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dL 593 (741)
.+.||+|.|.|||++.| .+|.+.++||||+|||||.||+|++||++.+...++.++..+...+|..++.++++|
T Consensus 169 eTSCGSPHYA~PEIV~G------~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdL 242 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSG------RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDL 242 (786)
T ss_pred cccCCCcccCCchhhcC------CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHH
Confidence 89999999999999985 577788999999999999999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 594 LLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 594 I~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
|.+||..||++|+|++||++|||+....
T Consensus 243 Lr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 243 LRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999999997643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=431.29 Aligned_cols=259 Identities=33% Similarity=0.603 Sum_probs=233.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|.+.+.||+|+||+||+|+++.++..||||.|..... ..+..+.+..||+||+.|+|||||.+++++...+.+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l---~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL---NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc---CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 45689999999999999999999999999999999875322 455567788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC------CcEEEeecccch
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS------GVVKLADFGMAK 505 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~------g~vKL~DFGLA~ 505 (741)
|||||||.||+|.+||+.+ +.++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+
T Consensus 85 ~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999999886 579999999999999999999999999999999999999764 369999999999
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC---CCC
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPI 582 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---~~i 582 (741)
.+.......+.||++.|||||+++. ..|+.|+|+||+|+|||+|++|+.||......+.+..+..+. +.+
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~-------~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~ 236 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMS-------QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL 236 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHh-------ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch
Confidence 9998888889999999999999973 578889999999999999999999999988888777665433 445
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+..++..+.+|+...|.+|+.+|.+..+.+.|+++....
T Consensus 237 ~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 237 PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 667888899999999999999999999999999986543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=427.07 Aligned_cols=256 Identities=29% Similarity=0.511 Sum_probs=223.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
..|+.+.++|+|+||+||+|+++.||+.||||++.-.. ......+-..+||++|++|+|+|+|.++++|.....++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese---dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE---DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC---ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEE
Confidence 36899999999999999999999999999999876332 334555667899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-Cccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSY 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~-~~~~ 512 (741)
|+|||+..-|.+ +......++++.++.|++|++.|+.|||+++||||||||+||||+..|.+||||||+|+.+. ....
T Consensus 79 VFE~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EeeecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 999999665555 44556779999999999999999999999999999999999999999999999999999987 4555
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--------------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-------------- 578 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-------------- 578 (741)
.+.++.|+||+|||++.| +..|+..+||||+||++.||++|.+.|.+....+.+..|...
T Consensus 158 YTDYVATRWYRaPELLvG------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVG------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred hhhhhhhhhccChhhhcc------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 667889999999999985 678999999999999999999999999998888877765421
Q ss_pred C-----CCCC------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 579 T-----PPIP------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 579 ~-----~~iP------------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
. ..+| ..++.-+.||++.||..||++|++.+|+|.|+||..
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 0 0111 135678899999999999999999999999999954
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-51 Score=421.03 Aligned_cols=261 Identities=31% Similarity=0.555 Sum_probs=240.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
..++|++++.||.|+||+|.+++.+.+|..+|+|++++.. -.....++...+|..+|+.+.||+||++++.|.+.+.+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~--vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK--VVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH--HHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence 4568999999999999999999999999999999987422 23344567788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
||||||+.||.|+.++++. +.++|..++.|+.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+...+.
T Consensus 120 ymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999999999874 77999999999999999999999999999999999999999999999999999988765
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~ 591 (741)
+.+.||||.|+|||+++. ..|..++|+|+|||++|||+.|.+||.+.+..++..+|+.+...+|..++.+++
T Consensus 198 -T~TlCGTPeYLAPEii~s-------k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~k 269 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS-------KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAK 269 (355)
T ss_pred -EEEecCCccccChHHhhc-------CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHH
Confidence 557899999999999983 678889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHcCccccccccCC
Q 004633 592 DFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQN 624 (741)
Q Consensus 592 dLI~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~~~~ 624 (741)
+||+++|+.|-.+|. ..++|..||||+..++..
T Consensus 270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred HHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 999999999999994 578999999999876643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=430.87 Aligned_cols=258 Identities=52% Similarity=0.913 Sum_probs=224.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc--e
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--H 430 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~--~ 430 (741)
...|..++.||+|+||+||++.++.+|..+|||.+.... ....+.+++|+.+|.+|+|||||+++|...... .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-----~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-----SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-----chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 456999999999999999999999999999999987541 111577899999999999999999999755544 6
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccC
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTG 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~-~g~vKL~DFGLA~~~~~ 509 (741)
++|+|||+.+|+|.+++...++.++|..++.+.+||++||+|||++|||||||||+||||+. +|.+||+|||+++....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999999999887657999999999999999999999999999999999999999 79999999999987764
Q ss_pred ----cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCC-CCcHHHHHHHhcc--CCCC
Q 004633 510 ----LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAMFKVLNR--TPPI 582 (741)
Q Consensus 510 ----~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~-~~~~~~~~~i~~~--~~~i 582 (741)
........||+.|||||++.. +...+.++|||||||++.||+||+.||.. ....+.+..+... .+.+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~i 244 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEI 244 (313)
T ss_pred ccccccccccccCCccccCchhhcC------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCC
Confidence 223446789999999999973 11223589999999999999999999998 5566666666543 3689
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
|..++.++++||.+||.+||++||||.++|+|||.+...
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 999999999999999999999999999999999997654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-51 Score=442.24 Aligned_cols=259 Identities=29% Similarity=0.497 Sum_probs=229.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecc-
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~- 429 (741)
..++|.+.++||.|+||.||+|+.+.+|+.||||.++..-. .-.++ .-.||++.|++|+ |||||+|.+++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~--s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY--SWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc--cHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 34689999999999999999999999999999998764221 12222 2357999999998 999999999999988
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+|||||+ -.|+++++++.+.++|..++.|+.||++||+|+|.+|++||||||+||||.....|||+|||||+.+..
T Consensus 84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 9999999997 789999999889999999999999999999999999999999999999999899999999999999988
Q ss_pred cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-----------
Q 004633 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----------- 578 (741)
Q Consensus 510 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~----------- 578 (741)
....+.++.|+||+|||+|.. ...|+.++||||+|||++|+.+-++.|.+.++.+.+.+|..-
T Consensus 163 kpPYTeYVSTRWYRAPEvLLr------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLR------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred CCCcchhhhcccccchHHhhh------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 777788899999999999985 578999999999999999999999999999998888877421
Q ss_pred --------CCCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 579 --------TPPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 579 --------~~~iP-----------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
...+| ..++.++.+||.+||.+||++||||.|+|+||||+...
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 01111 23789999999999999999999999999999998654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=437.87 Aligned_cols=269 Identities=30% Similarity=0.508 Sum_probs=235.6
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
....++|+++++||+|+||.||+|+.+.||+.||+|++++.. -.....++.+..|-.||...++++||+||..|++.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~--M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSE--MLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHH--HHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 345678999999999999999999999999999999987432 233455678899999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+||||||++||++..+|... +.|+|+.++.|+.+++.||+.||+.|+|||||||+|+|||..|++||.||||+.-+..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred eeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999999999776 7799999999999999999999999999999999999999999999999999842210
Q ss_pred -------------------------c-----c------------------cccccCCCCCCCChHHHHHhhhcCCCCCCC
Q 004633 510 -------------------------L-----S------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLA 541 (741)
Q Consensus 510 -------------------------~-----~------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s 541 (741)
. . ...+.+|||.|||||++.+ ..|+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-------kgY~ 366 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-------KGYG 366 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-------CCCC
Confidence 0 0 0113679999999999984 4688
Q ss_pred ccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCCc--cCCHHHHHHHHHhhhcCCCCCC---CHHHHHcC
Q 004633 542 LAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--MLSSEGKDFLLRCFLRNPVERP---SAVELLEH 614 (741)
Q Consensus 542 ~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~--~ls~el~dLI~~cL~~DP~kRP---Ta~ElLqH 614 (741)
..+|+|||||||||||.|.+||...+..+...+|++.. ..+|. .++.+++|||.+||. ||++|. .++||.+|
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 99999999999999999999999999999999998654 44553 578999999999999 999997 59999999
Q ss_pred ccccccccCCCCCcc
Q 004633 615 PFIRNANYQNLSVPM 629 (741)
Q Consensus 615 pwf~~~~~~~~~~~~ 629 (741)
|||+..+|..+....
T Consensus 446 PfF~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 446 PFFKGVDWDHLREMP 460 (550)
T ss_pred CccccCCcchhhcCC
Confidence 999999988766543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=443.88 Aligned_cols=264 Identities=28% Similarity=0.495 Sum_probs=240.1
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeec
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD 428 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~ 428 (741)
.....+|.++++||+|.||+|+++..+.+++.||||++++ +.-...+.++.++.|.+|+.... ||.+++++..|+.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK--~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKK--GDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeec--cceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 4456789999999999999999999999999999999874 33344455677888999998885 99999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
+++|+||||+.||++..+++ .+.++|..++.|+..|+.||.|||++||||||||.+|||||.+|++||+||||++...
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred CeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999999554443 3679999999999999999999999999999999999999999999999999999765
Q ss_pred -CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCC
Q 004633 509 -GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS 587 (741)
Q Consensus 509 -~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls 587 (741)
....+.++||||.|||||++.+ ..|+.++|+|+|||+|||||.|..||.+.++++....|++..+.+|-.++
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e-------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls 592 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTE-------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 592 (694)
T ss_pred CCCCccccccCChhhcChhhhcc-------CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence 5667789999999999999984 57999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccccCC
Q 004633 588 SEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQN 624 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPT-----a~ElLqHpwf~~~~~~~ 624 (741)
.++.++|+++|.+||++|.. +++|.+||||+..+|..
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 99999999999999999974 68999999999988754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=404.41 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=225.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|...++||+|.||.||+|++.++|+.||||+|+....... ......+||++|+.++|+|||.++++|-..+.+.|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG---i~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG---INRTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC---ccHHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 479999999999999999999999999999999986432211 12356789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|+||++ .+|+..|++....++..+++.|+.|+++||+|||++.|+||||||+|+||+.+|.+||+|||+|+.+......
T Consensus 79 VfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 79 VFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 999997 8999999998889999999999999999999999999999999999999999999999999999998754433
Q ss_pred c-ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-----C------
Q 004633 514 L-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----P------ 581 (741)
Q Consensus 514 ~-s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-----~------ 581 (741)
. ..+.|+||+|||++.| ...|+..+||||.|||+.||+.|.+.|.+.++.+.+..|+.... .
T Consensus 158 ~~~~V~TRWYRAPELLfG------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFG------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cccceeeeeccChHHhcc------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 3 3378999999999997 45678899999999999999999999999988888777754210 0
Q ss_pred -----------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 582 -----------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 582 -----------------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+....+.++.|||.+||..||.+|+++.|+|+|+||+..
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 112356888999999999999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=433.73 Aligned_cols=258 Identities=28% Similarity=0.498 Sum_probs=225.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--c
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--D 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~ 429 (741)
....|+.+++||+|+||.||+|++..+|+.||+|.|+....+. +......+||.||++|+|||||+|.+...+. +
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~---~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE---GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC---cchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 3467999999999999999999999999999999998654333 3345667899999999999999999988776 6
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|||+|||+ -||.-++......|++.+++.||+||+.||+|||.+||+|||||..|||||.+|++||+|||||+.+..
T Consensus 192 siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 8999999998 688888877777899999999999999999999999999999999999999999999999999997765
Q ss_pred cc--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--------
Q 004633 510 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------- 579 (741)
Q Consensus 510 ~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-------- 579 (741)
.. ..+..+.|.||+|||+|.| ...|+.++||||+||||.||+.|++.|.+..+.+.+.+|+...
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLG------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred CCCcccccceEEeeccChHHhcC------CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 43 3456678999999999996 5688999999999999999999999999998888877775311
Q ss_pred --CCCC-------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 580 --PPIP-------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 580 --~~iP-------------------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
..+| ..+++.+.+|+..||..||.+|.||.++|+++||..
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 1122 236789999999999999999999999999999954
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=424.69 Aligned_cols=257 Identities=39% Similarity=0.660 Sum_probs=230.6
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
......|...++||+|+.|.||.|+...+++.||||.+.+..... .+.+.+|+.+|+.++|+|||++++.|...+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-----keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-----KELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-----hhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 344567999999999999999999999999999999998644332 246788999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+||||++||+|.+.+... .++|.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+..
T Consensus 344 eLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 999999999999999999764 499999999999999999999999999999999999999999999999999988765
Q ss_pred cc-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-cCC--CCCcc
Q 004633 510 LS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTP--PIPEM 585 (741)
Q Consensus 510 ~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-~~~--~iP~~ 585 (741)
.. ...+.+|||+|||||++.. ..|+.++||||||++++||+-|.+||-..+....++.|.. +.+ ..++.
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtr-------k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTR-------KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEK 494 (550)
T ss_pred ccCccccccCCCCccchhhhhh-------cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccc
Confidence 44 5667899999999999973 6789999999999999999999999998888777777754 333 45788
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+++++++||.+||+.|+++|++|.|||+||||+..
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999999999544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=410.94 Aligned_cols=246 Identities=33% Similarity=0.551 Sum_probs=217.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecc-eeeecce-
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG-SEVVDDH- 430 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g-~~~~~~~- 430 (741)
..+|++.++||+|+||+||++++..+|..||.|.|.. +.........+..|+.+|++|+|||||++|+ .|..+..
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f---~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF---GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch---hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 3479999999999999999999999999999998763 2233445567889999999999999999999 4544444
Q ss_pred EEEEEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHh--CC--eecccCCCcceEecCCCcEEEeeccc
Q 004633 431 LYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHS--TN--TIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs--~g--IVHRDIKP~NILLd~~g~vKL~DFGL 503 (741)
++||||||.+|+|..+|+. ..+.++|..+|.++.||+.||..||. .. |+||||||.||+|+.+|.|||+||||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 9999999999999999953 45779999999999999999999998 44 99999999999999999999999999
Q ss_pred chhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-C
Q 004633 504 AKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-P 581 (741)
Q Consensus 504 A~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-~ 581 (741)
++.+... ....+++|||+||+||++.+ ..|+.++||||+||++|||+.-+.||.+.+-.+...+|.++.. +
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~-------~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHE-------SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP 247 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhc-------CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC
Confidence 9988653 45567899999999999984 5789999999999999999999999999988888888887755 4
Q ss_pred CC-ccCCHHHHHHHHHhhhcCCCCCCCH
Q 004633 582 IP-EMLSSEGKDFLLRCFLRNPVERPSA 608 (741)
Q Consensus 582 iP-~~ls~el~dLI~~cL~~DP~kRPTa 608 (741)
+| ..+|.++..||..|+..|++.||+.
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 77 7899999999999999999999985
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=406.73 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=228.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||+||+|.++.+|+.||||++..... ......+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV--IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEE
Confidence 369999999999999999999999999999999864211 122334668899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
||||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~ 155 (291)
T cd05612 79 LMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--T 155 (291)
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--c
Confidence 99999999999999765 56999999999999999999999999999999999999999999999999999876542 2
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dL 593 (741)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......+|..++..+++|
T Consensus 156 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l 228 (291)
T cd05612 156 WTLCGTPEYLAPEVIQS-------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDL 228 (291)
T ss_pred ccccCChhhcCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHH
Confidence 34579999999999863 45678999999999999999999999988888888888888888898999999999
Q ss_pred HHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 004633 594 LLRCFLRNPVERPS-----AVELLEHPFIRNAN 621 (741)
Q Consensus 594 I~~cL~~DP~kRPT-----a~ElLqHpwf~~~~ 621 (741)
|++||..||.+|++ ++++++|+||+...
T Consensus 229 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred HHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 99999999999995 99999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=413.86 Aligned_cols=258 Identities=29% Similarity=0.501 Sum_probs=229.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|++.+.||+|+||+||+|+++.+++.||||++..... ......+.+.+|+.+|+.++|||||++++++..++.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI--LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 45689999999999999999999999999999999864211 1123346788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|+||||+.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999999999765 568999999999999999999999999999999999999999999999999998764432
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~ 591 (741)
....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+......+|..++..++
T Consensus 173 --~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 243 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQS-------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRAR 243 (329)
T ss_pred --ceecCChhhcCHHHHcC-------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHH
Confidence 34679999999999863 456789999999999999999999999888777888888888888999999999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 004633 592 DFLLRCFLRNPVERPS-----AVELLEHPFIRNAN 621 (741)
Q Consensus 592 dLI~~cL~~DP~kRPT-----a~ElLqHpwf~~~~ 621 (741)
+||.+||..||.+|++ ++++++||||....
T Consensus 244 ~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred HHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 9999999999999997 79999999997643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=431.78 Aligned_cols=255 Identities=33% Similarity=0.566 Sum_probs=235.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|.+.+.||+|+||+||+|+.+.+.+.||||.+.+... ....++.+.+|++|++.|+|||||.++++|+...++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr---~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR---NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC---chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 479999999999999999999999999999999875443 34456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
|+|||.| +|+.+|.+. +.++|+.++.|+.|++.||.|||+++|+|||+||.|||++.+|.+||+|||+|+.+.... .
T Consensus 79 Vte~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred Eehhhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee
Confidence 9999987 999999775 679999999999999999999999999999999999999999999999999999886543 3
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d 592 (741)
...+.|||.|||||++.+ ..|+..+|+||||||+|||++|++||......+.+..|+......|...+.+++.
T Consensus 157 ltsikGtPlYmAPElv~e-------~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~n 229 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEE-------QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVN 229 (808)
T ss_pred eeeccCcccccCHHHHcC-------CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHH
Confidence 446789999999999974 5788999999999999999999999999888899999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 593 FLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 593 LI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
||+.+|.+||.+|+|-.+++.|||++..
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 9999999999999999999999999753
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=413.07 Aligned_cols=252 Identities=29% Similarity=0.472 Sum_probs=222.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecC
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 439 (741)
++||+|+||+||+|+++.+|+.||||+++.... ........+.+|+.+|+.++||||+++++++..++.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 479999999999999999999999999874211 122334567889999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccCC
Q 004633 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKG 518 (741)
Q Consensus 440 gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~G 518 (741)
+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceec
Confidence 99999999764 5799999999999999999999999999999999999999999999999999976432 223345679
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhh
Q 004633 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 598 (741)
Q Consensus 519 T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~cL 598 (741)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+......+|..++.++.+||++||
T Consensus 158 t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L 230 (323)
T cd05571 158 TPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLL 230 (323)
T ss_pred CccccChhhhcC-------CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence 999999999863 4678899999999999999999999998877777777877788889999999999999999
Q ss_pred hcCCCCCC-----CHHHHHcCccccccc
Q 004633 599 LRNPVERP-----SAVELLEHPFIRNAN 621 (741)
Q Consensus 599 ~~DP~kRP-----Ta~ElLqHpwf~~~~ 621 (741)
..||++|| ++.++++|+||....
T Consensus 231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 231 KKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred cCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999 899999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=418.71 Aligned_cols=267 Identities=28% Similarity=0.457 Sum_probs=229.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc---------ccHHHHHHHHHHHHHHhhcCCCCeeee
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP---------KSAECIKQLEQEIKVLGHLKHENIVQY 421 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~---------~~~~~ik~l~~Ei~iL~~L~HPNIVkl 421 (741)
...++|++++.||+|.||+|.+|++..+++.||||++.+.+... ....-++++.+||.||++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34568999999999999999999999999999999986433211 111124578999999999999999999
Q ss_pred cceeee--cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEe
Q 004633 422 YGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 499 (741)
Q Consensus 422 ~g~~~~--~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~ 499 (741)
+++..+ .+.+|||+|||..|.+...-.. ...+++.+++.|+++++.||+|||.+|||||||||.|+||+++|+|||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 998765 4679999999999988765433 2339999999999999999999999999999999999999999999999
Q ss_pred ecccchhccC------cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHH
Q 004633 500 DFGMAKHLTG------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 573 (741)
Q Consensus 500 DFGLA~~~~~------~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~ 573 (741)
|||.+..+.. ........|||.|||||.+.+.. ...+.+.+.||||+||+||.|+.|+.||.+....+...
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~---~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN---SFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC---CccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 9999987632 22223467999999999987521 13466789999999999999999999999999999999
Q ss_pred HHhccCCCCCcc--CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 574 KVLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 574 ~i~~~~~~iP~~--ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+|++....+|.. +.++++|||++||++||++|+++.+|..|||.....
T Consensus 330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 999999888876 799999999999999999999999999999997654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=402.59 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=235.4
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
....++|++.++||+|.|+.||++.++.+|+.+|+|+|...+-... ..+.+++|++|.+.|+|||||+|.+.+..++
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~---~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR---DFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc---cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 4456789999999999999999999999999999999875443222 3467899999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC---CCcEEEeecccchh
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKH 506 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~---~g~vKL~DFGLA~~ 506 (741)
..|||+|++.||+|..-|.++ ..++|..+..+++||+++|.|||.+||||||+||+|+|+.. .--|||+|||+|..
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred eeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999999998877665 56999999999999999999999999999999999999953 34699999999999
Q ss_pred ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCC---
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 583 (741)
Q Consensus 507 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP--- 583 (741)
+.+......+.|||.|||||+++ ...|+..+|||+.|+|||.||.|.+||.+.+...++..|+.+...++
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvr-------kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLK-------KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred eCCccccccccCCCcccCHHHhh-------cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc
Confidence 98777778899999999999998 35789999999999999999999999999999999999988776655
Q ss_pred -ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 584 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 584 -~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
..+++++++||++||..||.+|+|+.|+|+|||+.+-.
T Consensus 236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 46899999999999999999999999999999998654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=397.65 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=220.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|++.+.||+|+||+||+|.++.+|+.||||++...... .......+.+|+.+|+.++|+||+++++++..++.+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEE
Confidence 388999999999999999999999999999988643221 122234577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 9999999999888653 246899999999999999999999999999999999999999999999999999876544444
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH----HHHHHhccCCCCCccCCHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLNRTPPIPEMLSSE 589 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~----~~~~i~~~~~~iP~~ls~e 589 (741)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+......++..++.+
T Consensus 159 ~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 231 (285)
T cd05631 159 RGRVGTVGYMAPEVINN-------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSED 231 (285)
T ss_pred cCCCCCCCccCHhhhcC-------CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHH
Confidence 45679999999999963 467889999999999999999999998754422 2223334445677789999
Q ss_pred HHHHHHHhhhcCCCCCCC-----HHHHHcCcccccccc
Q 004633 590 GKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANY 622 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPT-----a~ElLqHpwf~~~~~ 622 (741)
+.+||++||..||++|++ ++++++||||...++
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 232 AKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 999999999999999997 899999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=411.44 Aligned_cols=258 Identities=25% Similarity=0.490 Sum_probs=236.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
..+.+|++.+.||+|+||+|.+|+....|+.||||.|+..+. +....+-.+.+||+||..|+|||||++|++|+..+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI--kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI--KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc--ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 456689999999999999999999999999999998875433 334445678999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
+.|||||..+|+|++||.+. +.++|.+++.|++||+.|+.|||.++++|||||.+|||||.++++||+||||+..+...
T Consensus 128 IvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999999999775 77999999999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHH
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 590 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el 590 (741)
....++||++-|.+||++.| .++-+..+|-|||||+||.|+.|..||++.+...++.+|..+...-|+ .+.++
T Consensus 207 kfLqTFCGSPLYASPEIvNG------~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA 279 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNG------TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDA 279 (668)
T ss_pred cHHHHhcCCcccCCccccCC------CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchH
Confidence 99999999999999999975 677788999999999999999999999999998888888887766555 46678
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
.-||+.||..||++|.|+++|-.|-|+.
T Consensus 280 ~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 280 SGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHHHHHhcCcccchhHHHHhhhheee
Confidence 9999999999999999999999997763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=405.56 Aligned_cols=268 Identities=29% Similarity=0.559 Sum_probs=235.5
Q ss_pred CCCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceee
Q 004633 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (741)
Q Consensus 347 ~~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~ 426 (741)
..+....+.|++.++||.|.-++||+|+...+++.||||++.+.+.. ..++.+.+|+..|..++|||||+++..|.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~----~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN----NDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh----hhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 35677788999999999999999999999999999999999865433 22678899999999999999999999999
Q ss_pred ecceEEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 427 VDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 427 ~~~~l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
.+..+|+||.||.+|++.++|+.. ...+.|..|..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+.
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence 999999999999999999999764 4569999999999999999999999999999999999999999999999999876
Q ss_pred hccCcc----cc-cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC
Q 004633 506 HLTGLS----YE-LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 580 (741)
Q Consensus 506 ~~~~~~----~~-~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~ 580 (741)
.+.... .. .+++||++|||||++... ...|+.++|||||||+..||.+|..||......+++..-+.+.+
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~-----~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p 249 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQ-----LHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP 249 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhc-----ccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC
Confidence 553321 12 567899999999997532 34688999999999999999999999999999998887777766
Q ss_pred CCC----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccC
Q 004633 581 PIP----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 623 (741)
Q Consensus 581 ~iP----------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~~ 623 (741)
+.+ ..++..++++|..||.+||.+|||++++|+|+||+.....
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 532 2367789999999999999999999999999999876543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-47 Score=408.55 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=228.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCC-cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg-~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
....+|++.+.||+|+||.||+|.++.++ ..||+|++..... ........+.+|+.+|+.++|||||++++++..++
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 34568999999999999999999977655 6899998864221 12233466889999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+||||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999999999765 5699999999999999999999999999999999999999999999999999986643
Q ss_pred cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHH
Q 004633 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 589 (741)
Q Consensus 510 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~e 589 (741)
. .....||+.|||||++.+ ..++.++||||||||+|||++|..||.+.+.......+......+|..++.+
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 254 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLN-------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN 254 (340)
T ss_pred C--cceecCChhhcCHHHHhC-------CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 2 235679999999999973 4567899999999999999999999998887777888888888889999999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHcCcccccccc
Q 004633 590 GKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY 622 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~~ 622 (741)
+.++|++||..||++|+ +++++++||||.+.++
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999999999999995 8999999999987553
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=401.95 Aligned_cols=259 Identities=28% Similarity=0.443 Sum_probs=224.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--ce
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH 430 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~~ 430 (741)
.++|++++.|++|+||.||+|+++.|++.||+|.++..+...... -.-.+||.+|.+++|||||.+.++.+-. +.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP---ItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP---ITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc---chhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 457999999999999999999999999999999998755432222 2346799999999999999999876643 57
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
+|||||||+ -+|..++......+...+++.++.|++.||+|||.+.|+|||||++|+|++..|.+||+|||||+.+...
T Consensus 152 iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999999998 7899999888778999999999999999999999999999999999999999999999999999998765
Q ss_pred c-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC----------
Q 004633 511 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------- 579 (741)
Q Consensus 511 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---------- 579 (741)
. ..+..+.|.||+|||+|.| ...|+.++||||+|||+.||+++++.|.+..+.+.+.+|+...
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLG------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred cccCcceEEEeeecCHHHhcC------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 3 3445678999999999996 5678999999999999999999999999988888877775310
Q ss_pred -CC--------------------CCcc-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 -PP--------------------IPEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 -~~--------------------iP~~-ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.. ++.. +++...+|+..+|..||++|.||+|.|+|.||....
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 00 1111 568999999999999999999999999999998643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=405.51 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=222.4
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecC
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 439 (741)
++||+|+||.||+|+++.+|+.||||++..... ........+.+|+++|+.++||||+++++++..++.+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 479999999999999999999999999874221 122345678889999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccCC
Q 004633 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKG 518 (741)
Q Consensus 440 gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~G 518 (741)
+|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... .......+|
T Consensus 79 ~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccC
Confidence 99999988664 5699999999999999999999999999999999999999999999999999876432 222334679
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhh
Q 004633 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 598 (741)
Q Consensus 519 T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~cL 598 (741)
|+.|+|||++.+ ..++.++|||||||+||||++|+.||...+..+....+......+|..++.++.+||.+||
T Consensus 158 t~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L 230 (328)
T cd05593 158 TPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLL 230 (328)
T ss_pred CcCccChhhhcC-------CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHc
Confidence 999999999863 4577899999999999999999999988777777777777777889999999999999999
Q ss_pred hcCCCCCC-----CHHHHHcCcccccccc
Q 004633 599 LRNPVERP-----SAVELLEHPFIRNANY 622 (741)
Q Consensus 599 ~~DP~kRP-----Ta~ElLqHpwf~~~~~ 622 (741)
.+||++|+ ++.|+++|+||....+
T Consensus 231 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 231 IKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999997 8999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=409.12 Aligned_cols=259 Identities=30% Similarity=0.500 Sum_probs=221.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|+++++||+|+||+||+|+++.+|+.||||++..... ........+.+|+.+|+.++|+||+++++++.+++.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM--LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEE
Confidence 369999999999999999999999999999999874211 123345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-- 511 (741)
||||+.||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 79 v~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 79 IMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred EECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 99999999999999765 569999999999999999999999999999999999999999999999999987543211
Q ss_pred -------------------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHH
Q 004633 512 -------------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 554 (741)
Q Consensus 512 -------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLy 554 (741)
.....+||+.|+|||++.+ ..++.++||||||||+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-------TGYNKECDWWSLGVIMY 230 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-------CCCCCeeeeecchhHHH
Confidence 1113469999999999863 45788999999999999
Q ss_pred HHhhCCCCCCCCCcHHHHHHHhccC--CCCCc--cCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccccccccC
Q 004633 555 EMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE--MLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQ 623 (741)
Q Consensus 555 ELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~--~ls~el~dLI~~cL~~DP~kRPT---a~ElLqHpwf~~~~~~ 623 (741)
||++|..||......+....++... ..+|. .+++++++||.+||. +|.+|++ +.|+|+||||+...+.
T Consensus 231 el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 231 EMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999887777766665432 23333 478999999999996 9999997 9999999999876543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=408.64 Aligned_cols=259 Identities=29% Similarity=0.460 Sum_probs=219.8
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||+|+||+||+|.++.+++.||||++.... ....+....+.+|+.+|..++|+||+++++.+.+++.+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKAD--MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHH--HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEE
Confidence 36999999999999999999999999999999986421 1123345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-- 511 (741)
||||++||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 79 IMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999999999765 579999999999999999999999999999999999999999999999999987543210
Q ss_pred ----------------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHh
Q 004633 512 ----------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557 (741)
Q Consensus 512 ----------------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELL 557 (741)
.....+||+.|+|||++.+ ..++.++|||||||+||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-------CCCCCchhhhhhHHHHHHHH
Confidence 0124579999999999863 45778999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHhcc--CCCCCc--cCCHHHHHHHHHhhhcCCC---CCCCHHHHHcCccccccccC
Q 004633 558 TGKPPWSEFEGPQAMFKVLNR--TPPIPE--MLSSEGKDFLLRCFLRNPV---ERPSAVELLEHPFIRNANYQ 623 (741)
Q Consensus 558 tGk~PF~~~~~~~~~~~i~~~--~~~iP~--~ls~el~dLI~~cL~~DP~---kRPTa~ElLqHpwf~~~~~~ 623 (741)
+|+.||.+....+...++... ...+|. .+++++++||.+|+. +|+ .||+++||++||||+..++.
T Consensus 231 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 231 IGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred hCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence 999999988777777777653 233443 478999999999875 444 45899999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=401.27 Aligned_cols=249 Identities=30% Similarity=0.456 Sum_probs=220.5
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCC
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 441 (741)
||+|+||+||+|+++.+++.||+|++..... ........+.+|+.+|++++|||||++++++..++.+||||||+.+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI--VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 7999999999999999999999999863211 12233466788999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccCCCC
Q 004633 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSP 520 (741)
Q Consensus 442 sL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~GT~ 520 (741)
+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... .......+||+
T Consensus 79 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 999999764 5699999999999999999999999999999999999999999999999999976432 22334567999
Q ss_pred CCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhc
Q 004633 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR 600 (741)
Q Consensus 521 ~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~cL~~ 600 (741)
.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....++.....+|..++.++++||.+||..
T Consensus 158 ~y~aPE~~~~-------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 230 (312)
T cd05585 158 EYLAPELLLG-------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR 230 (312)
T ss_pred ccCCHHHHcC-------CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCC
Confidence 9999999863 457889999999999999999999999888888888888888888999999999999999999
Q ss_pred CCCCCC---CHHHHHcCcccccc
Q 004633 601 NPVERP---SAVELLEHPFIRNA 620 (741)
Q Consensus 601 DP~kRP---Ta~ElLqHpwf~~~ 620 (741)
||++|+ ++.|+|+||||...
T Consensus 231 dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 231 DPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CHHHcCCCCCHHHHHcCCCcCCC
Confidence 999997 58999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=401.97 Aligned_cols=260 Identities=32% Similarity=0.492 Sum_probs=215.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
.....+|+++++||+|+||+||+|+++.+++.||||++.... .....+.+.+|+++|+.++|+|||++++++..++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH----EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC----cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 334567999999999999999999999999999999985321 2344567889999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+||||+++|+|.... ...+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 146 ~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred eEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999999999999987542 356788899999999999999999999999999999999999999999999987643
Q ss_pred cc-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH---HHHHH-hccCCCCCc
Q 004633 510 LS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ---AMFKV-LNRTPPIPE 584 (741)
Q Consensus 510 ~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~---~~~~i-~~~~~~iP~ 584 (741)
.. ......||..|+|||++..... ...+++.++||||||||||||++|+.||......+ ....+ .......+.
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDLN--HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPA 298 (353)
T ss_pred ccccccccccCccccCccccccccc--cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCC
Confidence 22 2234579999999998753211 12345678999999999999999999997433222 22222 233445667
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.++.++++||.+||..||++|||+.|+|+|+||...
T Consensus 299 ~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 299 TASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 889999999999999999999999999999999764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=413.95 Aligned_cols=260 Identities=29% Similarity=0.504 Sum_probs=234.5
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeec
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD 428 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~ 428 (741)
......|++++.||+|.||.||+|+.+.+|+.+|+|++.+..... ......+.+|+.||++|. |||||+++++|++.
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~--~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG--KEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc--cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 445668999999999999999999999999999999987544322 224567889999999998 99999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC----CcEEEeecccc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADFGMA 504 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~----g~vKL~DFGLA 504 (741)
..+|+|||+|.||+|++.|... .++|.++..+++||+.+++|||+.||+||||||+|||+... +.+||+|||++
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999999999876 49999999999999999999999999999999999999643 47999999999
Q ss_pred hhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCC-
Q 004633 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP- 583 (741)
Q Consensus 505 ~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP- 583 (741)
............+||+.|+|||++. ...|+..+||||+|+++|.|++|..||.+........++..+...+.
T Consensus 187 ~~~~~~~~~~~~~Gtp~y~APEvl~-------~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~ 259 (382)
T KOG0032|consen 187 KFIKPGERLHTIVGTPEYVAPEVLG-------GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS 259 (382)
T ss_pred eEccCCceEeeecCCccccCchhhc-------CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC
Confidence 9988866777899999999999996 35788999999999999999999999999998888888887765443
Q ss_pred ---ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 584 ---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 584 ---~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
..++..+++||.+||..||.+|+|+.++|+|||++..
T Consensus 260 ~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 260 EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 4679999999999999999999999999999999875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=388.88 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=211.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||+||+|+++.+++.||||++...... ....+.+.+|+.+++.++|+||+++++++..++.+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN---EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc---ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEE
Confidence 3699999999999999999999999999999998743221 2234567789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-- 511 (741)
||||+.++.|..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 78 v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 78 VFEYVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 999999887765543 34569999999999999999999999999999999999999999999999999998764322
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCC----------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---------- 581 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~---------- 581 (741)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG-------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cccccccccccCCcHHHcC-------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 2224568999999999863 35778999999999999999999999876654443332211000
Q ss_pred ----------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 582 ----------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 582 ----------------------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
....++.++++||++||..||++|||++|+|+||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 012367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=393.54 Aligned_cols=258 Identities=25% Similarity=0.442 Sum_probs=211.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++.+.||+|+||+||+|+++.+++.||||++........ ...+.+|+.+|+.++||||+++++++..++.+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT----PFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc----chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEE
Confidence 4689999999999999999999999999999999864332211 234667999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-c
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~-~ 511 (741)
+||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc
Confidence 9999996 6788888776667999999999999999999999999999999999999999999999999998754322 2
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH-HHHHHh---ccCC-------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVL---NRTP------- 580 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~-~~~~i~---~~~~------- 580 (741)
......||+.|+|||++.+ ...++.++|||||||++|||++|..||.+..... .+..+. ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLG------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred cCCCCcccCCCCChHHHcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence 2234568999999999863 3457789999999999999999999998754432 222221 1000
Q ss_pred -C------------CC---------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 581 -P------------IP---------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 581 -~------------iP---------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
. .+ ..++.++++||.+||+.||++|+|+.|+|+||||+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0 00 02357889999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=403.37 Aligned_cols=253 Identities=30% Similarity=0.472 Sum_probs=222.1
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecC
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 439 (741)
++||+|+||.||+|+++.+|..||+|++..... ........+.+|+++|+.++||||+++++++..++.+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 479999999999999999999999999874211 122334567789999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccCC
Q 004633 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKG 518 (741)
Q Consensus 440 gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~G 518 (741)
+|+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... ........|
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccC
Confidence 99999988664 5699999999999999999999999999999999999999999999999999876432 222334679
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhh
Q 004633 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCF 598 (741)
Q Consensus 519 T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~cL 598 (741)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+......+|..+++++.+||.+||
T Consensus 158 t~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L 230 (323)
T cd05595 158 TPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 230 (323)
T ss_pred CcCcCCcccccC-------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHc
Confidence 999999999863 4577899999999999999999999998877777777777777888999999999999999
Q ss_pred hcCCCCCC-----CHHHHHcCcccccccc
Q 004633 599 LRNPVERP-----SAVELLEHPFIRNANY 622 (741)
Q Consensus 599 ~~DP~kRP-----Ta~ElLqHpwf~~~~~ 622 (741)
..||++|+ ++.++++|+||....+
T Consensus 231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 231 KKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred cCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 99999998 8999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=391.33 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=213.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
..+|++.++||.|+||+||+|.++.++..||+|+++...... ....+.+|+.+|+.++||||+++++++..++..|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG----APCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC----cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 457999999999999999999999999999999986432221 1235678999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
+||||+.+ +|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 99999985 8999887665668999999999999999999999999999999999999999999999999997653322
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-----------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----------- 580 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~----------- 580 (741)
......||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLG------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred cccCceecccccChHHhcC------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 2234568999999999863 34577899999999999999999999987766555444321100
Q ss_pred --------CC-----------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 581 --------PI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 --------~i-----------P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.+ ...++.++++||.+||..||.+|+|++|+|+||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 01 12467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=403.55 Aligned_cols=258 Identities=31% Similarity=0.525 Sum_probs=223.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||+|+||+||+|++..+|+.||||++..... ........+.+|+++|..++|+||+++++++.+++.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM--IKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEE
Confidence 379999999999999999999999999999999874211 112334678889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-- 511 (741)
||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 79 VMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999999775 679999999999999999999999999999999999999999999999999997664432
Q ss_pred ----------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCC
Q 004633 512 ----------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563 (741)
Q Consensus 512 ----------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF 563 (741)
......||+.|+|||++.+ ..++.++||||||||||||++|+.||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-------TPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCceeeEecchhhhhhccCCCCC
Confidence 2234569999999999874 36788999999999999999999999
Q ss_pred CCCCcHHHHHHHhc--cCCCCCc--cCCHHHHHHHHHhhhcCCCCCCC-HHHHHcCcccccccc
Q 004633 564 SEFEGPQAMFKVLN--RTPPIPE--MLSSEGKDFLLRCFLRNPVERPS-AVELLEHPFIRNANY 622 (741)
Q Consensus 564 ~~~~~~~~~~~i~~--~~~~iP~--~ls~el~dLI~~cL~~DP~kRPT-a~ElLqHpwf~~~~~ 622 (741)
..........++.. ....+|. .+++++.+||.+||. ||.+|++ ++|+|+||||+...+
T Consensus 231 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 231 YSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred CCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 98887777777765 3334443 359999999999997 9999999 999999999987544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=406.06 Aligned_cols=268 Identities=27% Similarity=0.451 Sum_probs=236.6
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
.......|++++.||.|.-|+||+|..+.++..+|+|++++... ....-+.+++.|.+||+.++||.++.||..|+.+
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l--~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESL--ASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHH--hhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 34445679999999999999999999999999999999874322 2244467788999999999999999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 429 DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
+..|||||||.||+|..+.+++ .+.+++..++.|+.+++.||+|||-+|||+|||||+||||.++|+|-|.||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999775 567999999999999999999999999999999999999999999999999986321
Q ss_pred c----------------------------------C-c----------------------ccccccCCCCCCCChHHHHH
Q 004633 508 T----------------------------------G-L----------------------SYELSLKGSPNWMAPEVIKA 530 (741)
Q Consensus 508 ~----------------------------------~-~----------------------~~~~s~~GT~~Y~APEvl~~ 530 (741)
. . . ....+++||-.|+|||++.|
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 0 0 0 11224779999999999985
Q ss_pred hhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCc--cCCHHHHHHHHHhhhcCCCCCCC-
Q 004633 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPS- 607 (741)
Q Consensus 531 ~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~--~ls~el~dLI~~cL~~DP~kRPT- 607 (741)
...+.++|+|+|||+|||||.|..||.+.+..+.+.+|+.....+|+ .++..++|||+++|.+||.+|..
T Consensus 310 -------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 310 -------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred -------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcc
Confidence 45677999999999999999999999999999999999999888886 46899999999999999999998
Q ss_pred ---HHHHHcCccccccccCCC
Q 004633 608 ---AVELLEHPFIRNANYQNL 625 (741)
Q Consensus 608 ---a~ElLqHpwf~~~~~~~~ 625 (741)
|.||-+||||+..+|.-+
T Consensus 383 ~rGA~eIK~HpFF~gVnWaLi 403 (459)
T KOG0610|consen 383 KRGAAEIKRHPFFEGVNWALI 403 (459)
T ss_pred ccchHHhhcCccccCCChhhe
Confidence 999999999999988743
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=398.93 Aligned_cols=255 Identities=29% Similarity=0.502 Sum_probs=221.7
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH---hhcCCCCeeeecceeeecceEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL---GHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL---~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
|++.++||+|+||+||+|.++.+|+.||||+++.... ......+.+.+|++++ +.++||||+++++++...+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 7889999999999999999999999999999874211 1122345566666655 5667999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~ 511 (741)
|||||+.||+|..++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ..
T Consensus 79 lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999999988865 4699999999999999999999999999999999999999999999999999875432 22
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~ 591 (741)
......||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+......+|..++.++.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 229 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTE-------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAI 229 (324)
T ss_pred cccccccCccccCHhHhcC-------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 3345679999999999863 457789999999999999999999999888888888888888888899999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 004633 592 DFLLRCFLRNPVERP-----SAVELLEHPFIRNAN 621 (741)
Q Consensus 592 dLI~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~ 621 (741)
+||.+||..||.+|| ++.++++|+||+...
T Consensus 230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 999999999999999 799999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=407.49 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=216.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|++++.||+|+||+||+|+++.+++.||||++.... .........+.+|+++|+.++|+|||++++++.+.+.+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKD--VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH--hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 6899999999999999999999999999999986421 12234456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc----
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---- 510 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~---- 510 (741)
|||+.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+...
T Consensus 80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 80 MDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999999765 56999999999999999999999999999999999999999999999999997543100
Q ss_pred --------------------------------------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchh
Q 004633 511 --------------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 546 (741)
Q Consensus 511 --------------------------------------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDV 546 (741)
....+.+||+.|+|||++.+ ..++.++||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di 231 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-------KGYTQLCDW 231 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-------CCCCCccce
Confidence 01124579999999999863 457789999
Q ss_pred hhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--cCCCCCc--cCCHHHHHHHHHhhh--cCCCCCCCHHHHHcCcccccc
Q 004633 547 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPE--MLSSEGKDFLLRCFL--RNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 547 WSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP~--~ls~el~dLI~~cL~--~DP~kRPTa~ElLqHpwf~~~ 620 (741)
||||||+|||++|..||...+..+...+++. ....+|. .+++++++||.+||. .++..|+++.|+++||||+..
T Consensus 232 wSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999999999999988776666666653 2334443 579999999999665 455569999999999999764
Q ss_pred c
Q 004633 621 N 621 (741)
Q Consensus 621 ~ 621 (741)
.
T Consensus 312 ~ 312 (381)
T cd05626 312 D 312 (381)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=402.02 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=221.6
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecC
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 439 (741)
++||+|+||+||+|.++.+|+.||+|++..... ........+.+|+++++.++||||+++++++..++.+||||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 479999999999999999999999999874221 122334567789999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 440 gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
+|+|..++... ..+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+++.... ........
T Consensus 79 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccccc
Confidence 99999988664 569999999999999999999997 7999999999999999999999999999875432 22333467
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++||||||||||||++|+.||...+.......+......+|..+++++.+||.+|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 230 (325)
T cd05594 158 GTPEYLAPEVLED-------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGL 230 (325)
T ss_pred CCcccCCHHHHcc-------CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999863 457789999999999999999999999887777777777777888999999999999999
Q ss_pred hhcCCCCCC-----CHHHHHcCcccccccc
Q 004633 598 FLRNPVERP-----SAVELLEHPFIRNANY 622 (741)
Q Consensus 598 L~~DP~kRP-----Ta~ElLqHpwf~~~~~ 622 (741)
|+.||++|+ ++.++++|+||....+
T Consensus 231 L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred hhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999997 9999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=411.36 Aligned_cols=262 Identities=27% Similarity=0.483 Sum_probs=244.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...-|.+.+.||+|-|+.|.+|++--+|+.||||+|++.+.+... ...+..|++.|+.++|||||+||++......+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s---t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS---TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh---hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 345699999999999999999999999999999999876655332 35688899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEec-CCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd-~~g~vKL~DFGLA~~~~~~ 510 (741)
|||+|+-++|+|++||.++...+.|+.+++||.||+.|+.|||...||||||||+||.+- .-|.|||.|||++..+...
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999999999999989999999999999999999999999999999999998764 5699999999999999988
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHH
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 590 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el 590 (741)
....+.||+..|.|||+|.| +.+..+++||||||||||.|++|++||...+..+.+-.|+.....+|..++.++
T Consensus 173 ~kL~TsCGSLAYSAPEILLG------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eC 246 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLG------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKEC 246 (864)
T ss_pred chhhcccchhhccCchhhhc------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHH
Confidence 88899999999999999985 667788999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
++||..||..||++|.+.+||..++|++..+.
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 99999999999999999999999999987653
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=398.48 Aligned_cols=259 Identities=29% Similarity=0.502 Sum_probs=219.3
Q ss_pred CeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecce
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH 430 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k---~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~ 430 (741)
+|++++.||+|+||+||+|++. .+++.||+|++...... ......+.+.+|+.+|+.++ |+||+++++++..++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 4899999999999999999864 47899999998642211 12233456788999999995 9999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
+|+||||+.+|+|.+++.+. ..+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+...
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 99999999999999999764 56999999999999999999999999999999999999999999999999999865332
Q ss_pred c--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC----cHHHHHHHhccCCCCCc
Q 004633 511 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFKVLNRTPPIPE 584 (741)
Q Consensus 511 ~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~----~~~~~~~i~~~~~~iP~ 584 (741)
. ......||+.|||||++.+ ...++.++||||||||||||++|+.||.... .......+......++.
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRG------KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS 232 (332)
T ss_pred CCCccccccCCccccCHHHhcC------CCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 2 2334679999999999863 2346779999999999999999999996432 23344455666778888
Q ss_pred cCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNAN 621 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~ 621 (741)
.++..+.+||.+||..||++|+ +++++++||||+...
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 8999999999999999999999 889999999997644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=407.11 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=218.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|+++++||+|+||+||+|.++.+++.||||++..... ...+..+.+.+|+++|+.++|||||++++++.+.+.+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM--FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH--HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEE
Confidence 369999999999999999999999999999998863211 123345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-- 511 (741)
||||+.||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 79 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 79 IMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999999999764 679999999999999999999999999999999999999999999999999996432100
Q ss_pred ----------------------------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCccch
Q 004633 512 ----------------------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVD 545 (741)
Q Consensus 512 ----------------------------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asD 545 (741)
.....+||+.|+|||++.+ ..++.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~D 230 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-------QGYGQECD 230 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-------CCCCCcee
Confidence 0012469999999999863 45788999
Q ss_pred hhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--CCCCCc--cCCHHHHHHHHHhhhcCCCCC---CCHHHHHcCcccc
Q 004633 546 IWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE--MLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIR 618 (741)
Q Consensus 546 VWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~--~ls~el~dLI~~cL~~DP~kR---PTa~ElLqHpwf~ 618 (741)
|||||||||||++|..||......+.+..+... ...+|. .++.++++||.+||. +|.+| +++.|+++||||+
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~ 309 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFR 309 (377)
T ss_pred eEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcC
Confidence 999999999999999999887776666666542 234444 478999999999997 77765 5999999999998
Q ss_pred cccc
Q 004633 619 NANY 622 (741)
Q Consensus 619 ~~~~ 622 (741)
...+
T Consensus 310 ~~~~ 313 (377)
T cd05629 310 GVDW 313 (377)
T ss_pred CCCH
Confidence 6554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=399.10 Aligned_cols=252 Identities=28% Similarity=0.474 Sum_probs=220.6
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|+++.+++.||||++..... ......+.+..|+.++..+ +||||+++++++...+.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH--hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 479999999999999999999999999863211 1122345667788888876 6999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccc
Confidence 999999998765 5699999999999999999999999999999999999999999999999999875432 22334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+......+|..++.++++||.+|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 230 (320)
T cd05590 158 GTPDYIAPEILQE-------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF 230 (320)
T ss_pred cCccccCHHHHcC-------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999863 457789999999999999999999999988888888888888888889999999999999
Q ss_pred hhcCCCCCCCH------HHHHcCccccccc
Q 004633 598 FLRNPVERPSA------VELLEHPFIRNAN 621 (741)
Q Consensus 598 L~~DP~kRPTa------~ElLqHpwf~~~~ 621 (741)
|.+||++|+++ +++++||||....
T Consensus 231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 231 MTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred cccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999998 9999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=408.38 Aligned_cols=255 Identities=32% Similarity=0.554 Sum_probs=220.9
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcE-EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~-vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
......+..+.+.||+|+||+||+|.++. .. ||||++.....+. +..+.|.+|+.+|.+|+|||||+++|++..
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~---~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDD---ESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcCh---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34444566777789999999999999884 55 9999886433222 226789999999999999999999999988
Q ss_pred cc-eEEEEEeecCCCChhhhhhh-ccccccHHHHHHHHHHHHHHHHHHHhCC-eecccCCCcceEecCCC-cEEEeeccc
Q 004633 428 DD-HLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTN-TIHRDIKGANLLVDASG-VVKLADFGM 503 (741)
Q Consensus 428 ~~-~l~LVmEy~~gGsL~~lI~~-~~~~lse~~i~~i~~QIl~aL~yLHs~g-IVHRDIKP~NILLd~~g-~vKL~DFGL 503 (741)
.. .++|||||+++|+|.+++.. ....++...+..|+.||++||.|||+++ |||||||++||||+.++ ++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 87 79999999999999999987 3678999999999999999999999999 99999999999999998 999999999
Q ss_pred chhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHh--ccCC
Q 004633 504 AKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTP 580 (741)
Q Consensus 504 A~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~--~~~~ 580 (741)
++..... .......||+.|||||++.+. ...|+.++||||||||||||+||+.||.+....+....+. +..+
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~-----~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGE-----KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP 265 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCC-----CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9877654 233336899999999999742 3578999999999999999999999999988876666664 4567
Q ss_pred CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 581 ~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+|..+++.+..||++||..||.+||++.+++.
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 788889999999999999999999999999985
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=396.54 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=224.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC-CCeeeecceeeecceEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H-PNIVkl~g~~~~~~~l~L 433 (741)
+|++.+.||+|+||.||+|+++.+++.||||++..... ......+.+..|++++..+.| ++|+++++++...+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 58999999999999999999999999999999864211 112334567789999999976 568899999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-Cccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSY 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~-~~~~ 512 (741)
||||++||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.... ....
T Consensus 79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999999999999765 568999999999999999999999999999999999999999999999999987532 2223
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d 592 (741)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+......+|..++.++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS 230 (324)
T ss_pred eeeecCCccccChhhhcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 335679999999999863 4577899999999999999999999998888888888888888889999999999
Q ss_pred HHHHhhhcCCCCCCCH-----HHHHcCcccccccc
Q 004633 593 FLLRCFLRNPVERPSA-----VELLEHPFIRNANY 622 (741)
Q Consensus 593 LI~~cL~~DP~kRPTa-----~ElLqHpwf~~~~~ 622 (741)
||.+||.+||.+|+++ +++++||||+..++
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 9999999999999976 89999999987543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=406.28 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=217.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|+++++||+|+||+||+|+++.+++.||||++.... .........+.+|+++|++++|+|||++++++.+++.+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~--~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKD--VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHH--hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 5999999999999999999999999999999886321 12234456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc----
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---- 510 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~---- 510 (741)
||||.||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 80 MDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999999765 56899999999999999999999999999999999999999999999999997533100
Q ss_pred --------------------------------------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchh
Q 004633 511 --------------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 546 (741)
Q Consensus 511 --------------------------------------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDV 546 (741)
....+.+||+.|+|||++.+ ..++.++||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~Di 231 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDW 231 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-------CCCCCeeeE
Confidence 00123579999999999863 457789999
Q ss_pred hhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--CCCCC--ccCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccccc
Q 004633 547 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP--EMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRN 619 (741)
Q Consensus 547 WSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP--~~ls~el~dLI~~cL~~DP~kRPT---a~ElLqHpwf~~ 619 (741)
||||||||||++|+.||...+..+...++... ...+| ..+++++.+||.+|+ .+|++|++ ++|+++||||+.
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred EechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 99999999999999999987777666666542 22333 468999999999976 59999997 999999999976
Q ss_pred cc
Q 004633 620 AN 621 (741)
Q Consensus 620 ~~ 621 (741)
..
T Consensus 311 ~~ 312 (382)
T cd05625 311 ID 312 (382)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=399.13 Aligned_cols=266 Identities=27% Similarity=0.424 Sum_probs=226.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||+||+|.++.+|+.||||+++.... ...+..+.+.+|+.+++.++|+||+++++++.+++.+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL--LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEE
Confidence 369999999999999999999999999999999874211 123345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~- 512 (741)
||||+++|+|.+++.+....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999999987656799999999999999999999999999999999999999999999999999987644322
Q ss_pred -ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCC--ccCC
Q 004633 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP--EMLS 587 (741)
Q Consensus 513 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP--~~ls 587 (741)
.....||+.|+|||++...... +...++.++||||||||+|||++|+.||........+.+++... ..+| ..++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGD-GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVS 237 (330)
T ss_pred eeecccCCccccCHHHhcccccc-ccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCC
Confidence 2234699999999998643221 23467889999999999999999999998877777777665432 2333 3578
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccC
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 623 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~~ 623 (741)
.++.+||.+||. ||.+|||++++++||||+...+.
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 999999999998 99999999999999999876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=398.34 Aligned_cols=257 Identities=29% Similarity=0.486 Sum_probs=221.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||.||+|+++.+++.||||++..... ......+.+.+|+.+|..++||||+++++++...+.+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEE
Confidence 369999999999999999999999999999999874211 112334678889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ..
T Consensus 79 v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~ 155 (333)
T cd05600 79 AMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA 155 (333)
T ss_pred EEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--cc
Confidence 99999999999999764 5689999999999999999999999999999999999999999999999999976644 33
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCC------cc
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP------EM 585 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP------~~ 585 (741)
....||+.|+|||++.+ ..++.++||||||||||||++|..||...+..+....+.... ...| ..
T Consensus 156 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 228 (333)
T cd05600 156 NSVVGSPDYMAPEVLRG-------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN 228 (333)
T ss_pred CCcccCccccChhHhcC-------CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccc
Confidence 45679999999999863 367889999999999999999999998877666655554321 1112 14
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
++.++.+||.+||..+|.+|+++.|+++|+||....+
T Consensus 229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 229 LSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred cCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 6899999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=397.31 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=220.6
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|+++.+++.||||++..... ...+..+.+..|++++..+ +||||+++++++..++.+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 479999999999999999999999999864211 1123345567788998866 7999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..... ........
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccc
Confidence 999999998765 5699999999999999999999999999999999999999999999999999875432 22334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+......+|..++.++.+||.+|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 230 (321)
T cd05591 158 GTPDYIAPEILQE-------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAF 230 (321)
T ss_pred cCccccCHHHHcC-------CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999863 457889999999999999999999999988888888888888888888999999999999
Q ss_pred hhcCCCCCC-------CHHHHHcCccccccc
Q 004633 598 FLRNPVERP-------SAVELLEHPFIRNAN 621 (741)
Q Consensus 598 L~~DP~kRP-------Ta~ElLqHpwf~~~~ 621 (741)
|.+||++|+ ++.++++||||....
T Consensus 231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred hccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 999999999 999999999997644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=394.60 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=225.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~L 433 (741)
+|++.++||+|+||+||+|+++.+++.||||++..... ......+.+..|+.++..+ +|++|+++++++...+.+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 58999999999999999999999999999999874221 1222345567788888877 58999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-ccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSY 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~ 512 (741)
||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ...
T Consensus 79 v~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999999999998765 5699999999999999999999999999999999999999999999999999975432 223
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d 592 (741)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+......+|..++.++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 230 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA 230 (323)
T ss_pred cccCCCChhhcCHHHhcC-------CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 345679999999999863 4578899999999999999999999999888888888888888889999999999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHcCcccccccc
Q 004633 593 FLLRCFLRNPVERPS-----AVELLEHPFIRNANY 622 (741)
Q Consensus 593 LI~~cL~~DP~kRPT-----a~ElLqHpwf~~~~~ 622 (741)
||.+||.+||.+|++ ..++++|+||+..++
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999999999999997 489999999986553
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=397.00 Aligned_cols=254 Identities=31% Similarity=0.475 Sum_probs=220.7
Q ss_pred eeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 359 GKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k---~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
+++||+|+||.||+|++. .+++.||||+++..... ........+.+|+.+|+.++||||+++++++..++.+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHH-hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 368999999999999864 57889999998742111 11223356778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-ccccc
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYEL 514 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~ 514 (741)
||+.||+|.+++... ..+.+..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .....
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 80 EYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred eCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 999999999999765 5688999999999999999999999999999999999999999999999999875432 23334
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 594 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI 594 (741)
...||+.|+|||++.+ ..++.++|||||||+||||++|+.||...+....+..+......+|..++.++.+||
T Consensus 159 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 231 (323)
T cd05584 159 TFCGTIEYMAPEILMR-------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLL 231 (323)
T ss_pred ccCCCccccChhhccC-------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 5679999999999863 346779999999999999999999999888888888888888888999999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHcCccccccc
Q 004633 595 LRCFLRNPVERP-----SAVELLEHPFIRNAN 621 (741)
Q Consensus 595 ~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~ 621 (741)
.+||.+||++|+ +++++++||||....
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999999 899999999997654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=391.57 Aligned_cols=258 Identities=26% Similarity=0.470 Sum_probs=209.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec-----c
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----D 429 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~-----~ 429 (741)
+|++.++||+|+||.||+|+++.+|..||||++..... .......+.+|+++|+.++||||+++++++... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE---HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc---cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 59999999999999999999999999999998863221 122235678899999999999999999987643 3
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 5899999995 7898888664 5699999999999999999999999999999999999999999999999999976532
Q ss_pred cc----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHh---------
Q 004633 510 LS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--------- 576 (741)
Q Consensus 510 ~~----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~--------- 576 (741)
.. ......||+.|+|||++.+. ...++.++|||||||++|||++|+.||.+.+....+..+.
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhcc-----ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 21 12345799999999998631 2457789999999999999999999998765433221111
Q ss_pred -----------------ccCCCC-----CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 577 -----------------NRTPPI-----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 577 -----------------~~~~~i-----P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
...... -..+++++.+||.+||..||++|||++|+|+||||+....
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000011 1236788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=405.24 Aligned_cols=257 Identities=30% Similarity=0.475 Sum_probs=216.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||+|+||+||+|+++.+++.||||++.... .........+.+|+++|+.++|+||+++++.+..++.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKAD--VLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHH--HHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEE
Confidence 36999999999999999999999999999999886321 1112234668899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc---
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--- 510 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~--- 510 (741)
||||++||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+...
T Consensus 79 v~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 79 VMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999999765 56899999999999999999999999999999999999999999999999997533100
Q ss_pred -----------------------------------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhH
Q 004633 511 -----------------------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 549 (741)
Q Consensus 511 -----------------------------------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSL 549 (741)
......+||+.|||||++.+ ..++.++|||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSl 230 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-------TGYTQLCDWWSV 230 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-------CCCCcceeeeec
Confidence 00123579999999999863 457789999999
Q ss_pred HHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCC--ccCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCccccccc
Q 004633 550 GCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP--EMLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNAN 621 (741)
Q Consensus 550 GvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP--~~ls~el~dLI~~cL~~DP~kRP---Ta~ElLqHpwf~~~~ 621 (741)
|||||||++|+.||.+....+....+.... ..++ ..++.++.+||.+|+ .+|.+|+ ++.|+++||||+...
T Consensus 231 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 231 GVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred cceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999999999999999877766666555432 2223 358899999999976 5999999 999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=396.69 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=215.7
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|+++.+++.||||+++.... ...+..+.+.+|+.++..+ +||||+++++++..++.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV--NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 479999999999999999999999999874221 1233456688899999998 6999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-CcccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~-~~~~~~s~~ 517 (741)
+||+|.+++.+. +.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++... ........+
T Consensus 79 ~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccccc
Confidence 999999988664 579999999999999999999999999999999999999999999999999987532 223334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC---------cHHHHHHHhccCCCCCccCCH
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---------GPQAMFKVLNRTPPIPEMLSS 588 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~---------~~~~~~~i~~~~~~iP~~ls~ 588 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .......+......+|..++.
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 230 (329)
T cd05588 158 GTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSV 230 (329)
T ss_pred CCccccCHHHHcC-------CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999863 457789999999999999999999996321 122344556667788889999
Q ss_pred HHHHHHHHhhhcCCCCCCC------HHHHHcCccccccc
Q 004633 589 EGKDFLLRCFLRNPVERPS------AVELLEHPFIRNAN 621 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPT------a~ElLqHpwf~~~~ 621 (741)
++.+||.+||..||.+|++ ++++++||||....
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999999999999987 79999999997654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=382.62 Aligned_cols=258 Identities=29% Similarity=0.542 Sum_probs=236.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
..++|++++.||+|-||.||+|+.++++-.||+|++.+.. -.......++.+|++|...|+||||+++|++|.++..+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq--i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ--ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH--HHHhcchhhhhheeEeecccCCccHHhhhhheecccee
Confidence 3467999999999999999999999999999999986433 22333457899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
||++||...|+|+..|+.. ...++|...+.|++|++.||.|||.++|+||||||+|+|++..|.+||+|||-+.... .
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-S 176 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-C
Confidence 9999999999999999743 4569999999999999999999999999999999999999999999999999987655 5
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHH
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 590 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el 590 (741)
....+.|||..|.+||+..+ ..++..+|+|++|++.||++.|.+||......+.+.+|......+|..++.++
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~-------~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a 249 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEG-------RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGA 249 (281)
T ss_pred CCceeeecccccCCHhhcCC-------CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhH
Confidence 66778999999999999874 46778999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
+|||.+||.++|.+|.+..|+++|||+..
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999999999864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=382.40 Aligned_cols=253 Identities=30% Similarity=0.511 Sum_probs=207.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc---CCCCeeeecceeee--
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV-- 427 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~-tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L---~HPNIVkl~g~~~~-- 427 (741)
.+|++.+.||+|+||+||+|++.. ++..||||+++......... ..+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch---HHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 379999999999999999999864 46889999987543322221 2345577766665 69999999998752
Q ss_pred ---cceEEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004633 428 ---DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 428 ---~~~l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGL 503 (741)
...+++||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456999999997 6888888653 34589999999999999999999999999999999999999999999999999
Q ss_pred chhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC---
Q 004633 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--- 580 (741)
Q Consensus 504 A~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~--- 580 (741)
++............||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....+.+.+++....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred eEeccCCcccccccccccccChHHHhC-------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 987655444445679999999999863 4577899999999999999999999998777666666543210
Q ss_pred ------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 581 ------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 ------------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.+...++..+++||.+||..||++|||+.|+|+||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112467888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=393.36 Aligned_cols=252 Identities=27% Similarity=0.498 Sum_probs=217.2
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||.||+|+++.+|+.||||+++..... .......+..|+.++..+ +||||+++++++..++.+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL--IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 4799999999999999999999999998742111 112234566788888755 8999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-CcccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~-~~~~~~s~~ 517 (741)
.||+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ........+
T Consensus 79 ~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccC
Confidence 999999998764 568999999999999999999999999999999999999999999999999987532 222334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+....+.+|..++.++++||.+|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (316)
T cd05620 158 GTPDYIAPEILQG-------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKL 230 (316)
T ss_pred CCcCccCHHHHcC-------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999863 457889999999999999999999999887777777777777788888999999999999
Q ss_pred hhcCCCCCCCH-HHHHcCccccccc
Q 004633 598 FLRNPVERPSA-VELLEHPFIRNAN 621 (741)
Q Consensus 598 L~~DP~kRPTa-~ElLqHpwf~~~~ 621 (741)
|..||++|+++ +++++|+||+...
T Consensus 231 l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 231 FERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred ccCCHHHcCCChHHHHcCCCcCCCC
Confidence 99999999997 5899999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=400.42 Aligned_cols=260 Identities=29% Similarity=0.477 Sum_probs=221.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||+||+|.++.+++.||||++.... ....+....+.+|+.+|..++|+||+++++.+.+++.+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKAD--MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 36999999999999999999999999999999986321 1123345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-- 511 (741)
||||+.||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 79 v~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 79 IMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999999999765 569999999999999999999999999999999999999999999999999987542210
Q ss_pred ----------------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHh
Q 004633 512 ----------------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557 (741)
Q Consensus 512 ----------------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELL 557 (741)
.....+||+.|+|||++.+ ..++.++|||||||+||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-------TGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-------CCCCCcceeccccceeeecc
Confidence 0124579999999999863 45778999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHhcc--CCCCCc--cCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCccccccccCC
Q 004633 558 TGKPPWSEFEGPQAMFKVLNR--TPPIPE--MLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNANYQN 624 (741)
Q Consensus 558 tGk~PF~~~~~~~~~~~i~~~--~~~iP~--~ls~el~dLI~~cL~~DP~kRP---Ta~ElLqHpwf~~~~~~~ 624 (741)
+|+.||..........++... ...+|. .++.++++||.+|+ .||.+|+ +++|+++||||+..++..
T Consensus 231 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 231 IGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 999999988777777777643 233443 37899999999977 4999998 589999999998876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=395.12 Aligned_cols=252 Identities=30% Similarity=0.481 Sum_probs=216.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH-HHhhcCCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~-iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|+++.+|+.||||++...... .....+.+..|.. +++.++||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL--KKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh--hhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 4799999999999999999999999998642111 1122234445544 567899999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
.+|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .......+
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccccc
Confidence 999999998764 5799999999999999999999999999999999999999999999999999875432 22334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....++.....++..++.++.+||++|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 230 (323)
T cd05575 158 GTPEYLAPEVLRK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGL 230 (323)
T ss_pred CChhhcChhhhcC-------CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999863 457789999999999999999999999888778888888887788888999999999999
Q ss_pred hhcCCCCCCCH----HHHHcCccccccc
Q 004633 598 FLRNPVERPSA----VELLEHPFIRNAN 621 (741)
Q Consensus 598 L~~DP~kRPTa----~ElLqHpwf~~~~ 621 (741)
|..||.+|+++ .++++||||....
T Consensus 231 l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 231 LQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred hhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999987 6999999997644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=392.15 Aligned_cols=252 Identities=30% Similarity=0.526 Sum_probs=216.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|.++.+++.||||+++..... .....+.+..|..++..+ +||||+++++++..++.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL--EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh--hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4799999999999999999999999998742211 112234455667777654 7999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
.||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .......+
T Consensus 79 ~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccccc
Confidence 999999998764 5699999999999999999999999999999999999999999999999999976432 23334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+....+.+|..++.++.+||.+|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~ 230 (316)
T cd05592 158 GTPDYIAPEILKG-------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKL 230 (316)
T ss_pred CCccccCHHHHcC-------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999863 457789999999999999999999999888877888888777888899999999999999
Q ss_pred hhcCCCCCCCH-HHHHcCccccccc
Q 004633 598 FLRNPVERPSA-VELLEHPFIRNAN 621 (741)
Q Consensus 598 L~~DP~kRPTa-~ElLqHpwf~~~~ 621 (741)
|..||.+|+++ .++++|+||....
T Consensus 231 l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 231 FERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred ccCCHHHcCCChHHHHcCcccCCCC
Confidence 99999999986 5899999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=401.15 Aligned_cols=265 Identities=28% Similarity=0.445 Sum_probs=225.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
....+|++.++||+|+||+||+|+++.+++.||+|++..... ......+.+.+|+.+|+.++||||+++++++.+++.
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM--IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 345689999999999999999999999999999999863211 112223457789999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
+||||||+.||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999999865 35899999999999999999999999999999999999999999999999999766432
Q ss_pred c--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCCc--
Q 004633 511 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE-- 584 (741)
Q Consensus 511 ~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~-- 584 (741)
. .....+||+.|+|||++.+. .....++.++|||||||+||||++|+.||.+......+.++.... ..+|.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 272 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI 272 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccC---CCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence 2 22346799999999998642 113457889999999999999999999999888777777776543 34444
Q ss_pred cCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCcccccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANY 622 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~k--RPTa~ElLqHpwf~~~~~ 622 (741)
.++.++++||.+||..+|.+ |++++|+++||||+...+
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 57999999999999999988 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=394.82 Aligned_cols=258 Identities=31% Similarity=0.505 Sum_probs=220.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee----
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---- 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~---- 427 (741)
....|...+.||+|+||.|+.|.++.+|+.||||++.... ...-..++..+|+++|+.++|+|||.+++++..
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F---~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF---ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh---hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3456777899999999999999999999999999875222 234445788899999999999999999998876
Q ss_pred -cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 428 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 428 -~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
-..+|+|+|+| +.+|...|+.. ..++++.++.++.||++||+|+|+.+|+||||||.|||++.+..+||+|||||+.
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence 24699999999 58999999774 5599999999999999999999999999999999999999999999999999998
Q ss_pred ccC---cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-----
Q 004633 507 LTG---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----- 578 (741)
Q Consensus 507 ~~~---~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~----- 578 (741)
... ....+.++.|+||+|||++.. ...|+.++||||+||||.||++|++.|.+.+....+..|+.-
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLN------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhc------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 853 344456788999999999974 467899999999999999999999999988776665544321
Q ss_pred ------------------CCCCC--------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 579 ------------------TPPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 579 ------------------~~~iP--------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.+..| ...++.+.+||++||..||.+|+|++|+|+|||+...
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11111 3578999999999999999999999999999999754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=410.60 Aligned_cols=257 Identities=41% Similarity=0.661 Sum_probs=229.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
....|...++||+|+||.||+|.+..+++.||||++++.. ..+.++.+++|+.+|.+++++||.++|+.|..+..+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~----~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE----AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhh----cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 3456888899999999999999999999999999998643 234467889999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
+++||||.||++.++++-. ..+.|..+..++++++.||.|||.++.+|||||+.||||..+|.|||+|||++..+....
T Consensus 87 wiiMey~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHHhcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999999999663 456999999999999999999999999999999999999999999999999998876543
Q ss_pred c-ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 004633 512 Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 589 (741)
Q Consensus 512 ~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e 589 (741)
. ..+++||++|||||++++ ..|+.++||||||++.|||++|.+||.....+..++.|-.. .+.+...+++.
T Consensus 166 ~rr~tfvGTPfwMAPEVI~~-------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~ 238 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIKQ-------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPP 238 (467)
T ss_pred hccccccccccccchhhhcc-------ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHH
Confidence 3 378999999999999983 46888999999999999999999999998887666666443 33455678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+++||..||++||+.||+|.++|+|+|++..
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 9999999999999999999999999999874
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=391.65 Aligned_cols=253 Identities=29% Similarity=0.477 Sum_probs=221.1
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|.++.+++.||||+++.... ........+.+|+++++.+ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH--hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 479999999999999999999999999874211 1122345677899999888 6999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
.||+|..++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .......+
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccccee
Confidence 999999998765 5699999999999999999999999999999999999999999999999999875322 22333457
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+......+|..++.++.+||++|
T Consensus 158 g~~~y~aPE~~~~-------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 230 (318)
T cd05570 158 GTPDYIAPEILSY-------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSF 230 (318)
T ss_pred cCccccCHHHhcC-------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHH
Confidence 9999999999863 457789999999999999999999999888777777888888888889999999999999
Q ss_pred hhcCCCCCCCH-----HHHHcCcccccccc
Q 004633 598 FLRNPVERPSA-----VELLEHPFIRNANY 622 (741)
Q Consensus 598 L~~DP~kRPTa-----~ElLqHpwf~~~~~ 622 (741)
|..||.+||++ .++++||||+...+
T Consensus 231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 231 LTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred ccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999 99999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=392.98 Aligned_cols=253 Identities=28% Similarity=0.489 Sum_probs=215.4
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|+++.+++.||+|+++.... ......+.+.+|+.++.++ +|||||++++++..++.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh--cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 479999999999999999999999999874321 1233456678899988877 7999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
.+|+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... ........
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccccc
Confidence 999999988664 5699999999999999999999999999999999999999999999999999975432 22334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCC---------CcHHHHHHHhccCCCCCccCCH
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF---------EGPQAMFKVLNRTPPIPEMLSS 588 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~---------~~~~~~~~i~~~~~~iP~~ls~ 588 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........+......+|..++.
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~ 230 (329)
T cd05618 158 GTPNYIAPEILRG-------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 230 (329)
T ss_pred CCccccCHHHHcC-------CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCH
Confidence 9999999999863 45778999999999999999999999531 1122334456667788999999
Q ss_pred HHHHHHHHhhhcCCCCCCC------HHHHHcCcccccccc
Q 004633 589 EGKDFLLRCFLRNPVERPS------AVELLEHPFIRNANY 622 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPT------a~ElLqHpwf~~~~~ 622 (741)
++.+||.+||..||++|++ +.++++||||+..++
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 9999999999999999998 589999999987543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=381.86 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=220.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|++.++||+|+||+||++.+..+++.||||++..... ........+.+|+.+|+.++|+||+++++.+..++.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh--hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 38899999999999999999999999999998863221 1122235577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 9999999999888653 346899999999999999999999999999999999999999999999999999876544443
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHH----HHHhccCCCCCccCCHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM----FKVLNRTPPIPEMLSSE 589 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~----~~i~~~~~~iP~~ls~e 589 (741)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+....... ..+......++..++..
T Consensus 159 ~~~~~~~~y~aPE~~~~-------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd05605 159 RGRVGTVGYMAPEVVKN-------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEA 231 (285)
T ss_pred ccccCCCCccCcHHhcC-------CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHH
Confidence 45679999999999863 45778999999999999999999999876543322 23334445667779999
Q ss_pred HHHHHHHhhhcCCCCCC-----CHHHHHcCcccccccc
Q 004633 590 GKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY 622 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~~ 622 (741)
+.+||.+||..||++|| +++++++|+||...++
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 232 ARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred HHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 99999999999999999 9999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=390.55 Aligned_cols=259 Identities=31% Similarity=0.568 Sum_probs=222.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC-eeeecceeeecc--
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDD-- 429 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPN-IVkl~g~~~~~~-- 429 (741)
...|+.+++||+|+||+||+|+.+.+|+.||+|+++....++.. -....+|+.+|+.|+|+| ||.+++++..++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~---P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGV---PSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCC---CchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 34588899999999999999999999999999999876553222 234567999999999999 999999998877
Q ss_pred ----eEEEEEeecCCCChhhhhhhcc---ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004633 430 ----HLYIYLEYVHPGSINRYVREHC---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (741)
Q Consensus 430 ----~l~LVmEy~~gGsL~~lI~~~~---~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFG 502 (741)
.++||+||++ -+|.+++.... ..++...++.+++||+.||+|||++||+||||||.||||+..|.+||+|||
T Consensus 87 ~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred cccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence 8999999997 78999997765 368889999999999999999999999999999999999999999999999
Q ss_pred cchhcc-CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--
Q 004633 503 MAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-- 579 (741)
Q Consensus 503 LA~~~~-~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-- 579 (741)
+|+.+. +.......++|.+|+|||++.| ...|+..+||||+|||++||++++..|.+..+.+.+..|....
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlG------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLG------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcC------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 999876 3344556789999999999986 4568889999999999999999999999998888887775311
Q ss_pred C----------------CCC------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 P----------------PIP------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 ~----------------~iP------------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+ .++ ...+.++.+++.+||+.+|.+|.|+..+|+|+||....
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 0 111 11235899999999999999999999999999998764
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=392.79 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=220.1
Q ss_pred eeEEeecCCeEEEEEEE---CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 359 GKLIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~---k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
++.||+|+||+||++++ +.+|+.||+|++..... .......+.+|+++|++++||||+++++++..++.+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 77 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLIL 77 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh---hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEE
Confidence 36899999999999976 45789999999874221 1122345678999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-cccc
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYEL 514 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~-~~~~ 514 (741)
||+.+|+|.+++.+. ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ....
T Consensus 78 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 78 DFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCcee
Confidence 999999999999664 56999999999999999999999999999999999999999999999999999765443 2334
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHH
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 594 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI 594 (741)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+......+|..++.++.+||
T Consensus 157 ~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 229 (318)
T cd05582 157 SFCGTVEYMAPEVVNR-------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 229 (318)
T ss_pred cccCChhhcCHHHHcC-------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 5679999999999863 356789999999999999999999999888878888888777888999999999999
Q ss_pred HHhhhcCCCCCCC-----HHHHHcCccccccc
Q 004633 595 LRCFLRNPVERPS-----AVELLEHPFIRNAN 621 (741)
Q Consensus 595 ~~cL~~DP~kRPT-----a~ElLqHpwf~~~~ 621 (741)
.+||+.||++||+ ++++++|+||....
T Consensus 230 ~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 230 RALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 9999999999999 78899999997643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=384.92 Aligned_cols=268 Identities=26% Similarity=0.461 Sum_probs=240.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc---cHHHHHHHHHHHHHHhhcC-CCCeeeecceeeec
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~---~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~ 428 (741)
...|.--++||+|..++|.+|..+.+|+.+|+|+|........ ..+..+.-.+|+.||+++. ||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3467788999999999999999999999999999986553322 2344556678999999995 99999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
..+++|+|+|+.|.|+|++... ..++|...+.||+||+.|+.|||.++||||||||+|||++++.++||.|||+|+.+.
T Consensus 96 sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999775 679999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCC----c
Q 004633 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----E 584 (741)
Q Consensus 509 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP----~ 584 (741)
........||||+|+|||.+.... +++.+.|+..+|+|++|+|||-||.|.+||....+.-++..|+.+...+. .
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m-~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWa 253 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSM-YENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWA 253 (411)
T ss_pred CchhHHHhcCCCcccChhheeeec-ccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchh
Confidence 888888999999999999997543 45678899999999999999999999999998888888888888776553 4
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
.++.+.+|||.+||+.||.+|+|++|+|.||||.....
T Consensus 254 dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 254 DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 68899999999999999999999999999999965543
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=398.80 Aligned_cols=264 Identities=26% Similarity=0.436 Sum_probs=222.6
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
....+|++.++||+|+||.||+|+++.+++.||+|++..... ........+.+|+.+++.++||||+++++++..++.
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 345689999999999999999999999999999999863211 112223567789999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
+|+||||+.||+|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999999999653 5899999999999999999999999999999999999999999999999999876432
Q ss_pred c--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCCc--
Q 004633 511 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE-- 584 (741)
Q Consensus 511 ~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~-- 584 (741)
. ...+.+||+.|||||++.+. .+...++.++|||||||+||||++|+.||...+....+.+++... ..+|.
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 272 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272 (370)
T ss_pred CceecccCCCCcccCCHHHHhcc---CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence 2 22356799999999999742 122357889999999999999999999999887777777776532 34454
Q ss_pred cCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNAN 621 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~k--RPTa~ElLqHpwf~~~~ 621 (741)
.++..++++|.+||..++.+ |+++.|+++||||+...
T Consensus 273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 46999999999999855543 89999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=387.66 Aligned_cols=256 Identities=27% Similarity=0.539 Sum_probs=216.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
..++|++.+.||+|+||.||+|+++.+|..||+|++... ........+.+|+++|++++||||+++++++..++.+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE----IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc----cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 356899999999999999999999999999999988742 1234456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhC-CeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~-gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999999999764 5689999999999999999999986 6999999999999999999999999999766432
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-------------
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN------------- 577 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~------------- 577 (741)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.. .++.
T Consensus 158 -~~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AIFGRPVVDGEEGEPHS 228 (331)
T ss_pred -ccccCCCCcCcCCHhHhcC-------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcccccccccCCccc
Confidence 2334579999999999863 45788999999999999999999999765433221 1111
Q ss_pred ----------------------------------c-CCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 578 ----------------------------------R-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 578 ----------------------------------~-~~~iP-~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
. .+..+ ..++.++++||.+||.+||++|||+.|+|+|+||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0 11111 24678999999999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=386.71 Aligned_cols=253 Identities=29% Similarity=0.465 Sum_probs=216.1
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHH-HHHhhcCCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI-KVLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei-~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|+++.+++.||+|++...... .......+.+|+ .+++.++|||||++++++...+.+||||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL--KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH--HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 4799999999999999999999999998642111 112233444555 4678899999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
+||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... ........
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccccc
Confidence 999999888654 5689999999999999999999999999999999999999999999999999875422 22334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|..||...+.......+......+|...+.++.++|.+|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 230 (321)
T cd05603 158 GTPEYLAPEVLRK-------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGL 230 (321)
T ss_pred CCcccCCHHHhcC-------CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999863 457789999999999999999999999887777777888777788888999999999999
Q ss_pred hhcCCCCCCCH----HHHHcCcccccccc
Q 004633 598 FLRNPVERPSA----VELLEHPFIRNANY 622 (741)
Q Consensus 598 L~~DP~kRPTa----~ElLqHpwf~~~~~ 622 (741)
|.+||.+|+++ .|+++|+||....+
T Consensus 231 l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 231 LHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred ccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 99999999865 59999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=405.39 Aligned_cols=255 Identities=27% Similarity=0.490 Sum_probs=211.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec---
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--- 428 (741)
...+|+++++||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++|+|||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 3457999999999999999999999999999999875311 1234699999999999999999876432
Q ss_pred -----ceEEEEEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEe
Q 004633 429 -----DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLA 499 (741)
Q Consensus 429 -----~~l~LVmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g-~vKL~ 499 (741)
..+++||||+.+ +|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 247899999985 67666642 346799999999999999999999999999999999999998664 79999
Q ss_pred ecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC
Q 004633 500 DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 579 (741)
Q Consensus 500 DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~ 579 (741)
|||+|+.+..........||+.|+|||++.+ ...|+.++||||||||||||++|.+||.+....+.+.+++...
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 287 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLG------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL 287 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999988765555556789999999999863 3467889999999999999999999998876655554443210
Q ss_pred -----------------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 580 -----------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 580 -----------------------------~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
..+|...+.++++||.+||.+||.+|+|+.|+|+||||.....
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0134457889999999999999999999999999999986543
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=389.43 Aligned_cols=264 Identities=25% Similarity=0.412 Sum_probs=219.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||+|+||+||+++++.+++.||||++.... .......+.+.+|+.++..++|+||+++++++..++.+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE--MLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH--HhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEE
Confidence 47999999999999999999999999999999986321 1122234567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~- 512 (741)
||||+.||+|.+++.+....+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999999977666799999999999999999999999999999999999999999999999999876543222
Q ss_pred -ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCC---ccC
Q 004633 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP---EML 586 (741)
Q Consensus 513 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP---~~l 586 (741)
.....||+.|||||++.+... +...++.++|||||||++|||++|+.||......+....+.... ..++ ..+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMED--GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred cccceeccccccCHHHHhhccc--cccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 122469999999999974211 13457789999999999999999999998877666666665432 2222 347
Q ss_pred CHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccccc
Q 004633 587 SSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNAN 621 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~k--RPTa~ElLqHpwf~~~~ 621 (741)
+.++++||++||..++++ |++++++++||||....
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 999999999999754443 78999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=390.53 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=215.7
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHH-HHHhhcCCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI-KVLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei-~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
+.||+|+||+||+|+++.+++.||+|++...... .......+..|. .+++.++|+||+++++++..++.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL--KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHH--hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 4799999999999999999999999998642211 111223344444 4578889999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
.||+|.+++... ..+.+..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .......+
T Consensus 79 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccccc
Confidence 999999999764 5688999999999999999999999999999999999999999999999999976432 22334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.+..+......++..++.++.++|++|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 230 (325)
T cd05602 158 GTPEYLAPEVLHK-------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGL 230 (325)
T ss_pred CCccccCHHHHcC-------CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHH
Confidence 9999999999863 457789999999999999999999999888777777887777777788999999999999
Q ss_pred hhcCCCCCCCHH----HHHcCcccccccc
Q 004633 598 FLRNPVERPSAV----ELLEHPFIRNANY 622 (741)
Q Consensus 598 L~~DP~kRPTa~----ElLqHpwf~~~~~ 622 (741)
|++||.+|+++. ++++|+||....+
T Consensus 231 l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 231 LQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred cccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 999999999865 8999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=369.81 Aligned_cols=256 Identities=46% Similarity=0.859 Sum_probs=221.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
+.|++++.||+|+||.||+|.+..+++.||+|++.............+.+.+|++++++++||||+++++++..++.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 35999999999999999999999999999999987543333333445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
||||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999999999765 56899999999999999999999999999999999999999999999999999765432211
Q ss_pred ----cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--cCCCCCccCC
Q 004633 514 ----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 587 (741)
Q Consensus 514 ----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP~~ls 587 (741)
....|+..|+|||++.+ ..++.++||||||+++|||++|+.||...+.......+.. ....++..++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISG-------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVS 233 (263)
T ss_pred cccccCCCcCccccCcceecc-------CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCC
Confidence 23468899999999863 3477899999999999999999999988766665555443 3445777899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.++.++|.+||..+|++|||+.|+|+|+||
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 234 PDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=388.54 Aligned_cols=253 Identities=28% Similarity=0.525 Sum_probs=216.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
+.||+|+||+||+|+++.+++.||||+++..... .......+..|..++..+ +||||+++++++.+++.+||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL--MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh--hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 4799999999999999999999999998742110 112234456677787764 8999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-CcccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~-~~~~~~s~~ 517 (741)
.||+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .........
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeec
Confidence 999999999764 568999999999999999999999999999999999999999999999999987532 222334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+....+....+.+|..++.++++||.+|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~ 230 (316)
T cd05619 158 GTPDYIAPEILLG-------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKL 230 (316)
T ss_pred CCccccCHHHHcC-------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence 9999999999863 457889999999999999999999999887777777776666777888999999999999
Q ss_pred hhcCCCCCCCHH-HHHcCcccccccc
Q 004633 598 FLRNPVERPSAV-ELLEHPFIRNANY 622 (741)
Q Consensus 598 L~~DP~kRPTa~-ElLqHpwf~~~~~ 622 (741)
|..||++|+++. ++++||||+...+
T Consensus 231 l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 231 FVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred hccCHhhcCCChHHHHcCcccCCCCH
Confidence 999999999996 9999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=382.07 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=215.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
..+|++.+.||+|+||+||+|+++.+++.||+|+++....... ...+.+|+.+++.++|+||+++++++..++..|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc----chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 3579999999999999999999999999999999875432221 234667999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
+||||+.+ +|.+++......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 99999984 8888887665668999999999999999999999999999999999999999999999999997653322
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC------------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------ 579 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------ 579 (741)
......+|+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLG------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ccccccccccccCCHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 2223468999999999863 3457789999999999999999999998766554443332110
Q ss_pred -------CCC-----------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 -------PPI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 -------~~i-----------P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
..+ ...++.++++||.+||..||.+|+|+.|+|+|+||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 001 124688999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=387.40 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=224.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~L 433 (741)
+|+..+.||+|+||+||+|.++.+|+.||||++..... ......+.+..|+.++..+. |++|+++++++..++.+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV--IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 47889999999999999999999999999999874211 11223456778889998886 5788899999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-cc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~-~~ 512 (741)
||||++||+|.+++... ..+++.++..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 99999999999998765 56999999999999999999999999999999999999999999999999999764322 22
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~d 592 (741)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+......+|..++.++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 230 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVS 230 (323)
T ss_pred ccCccCCccccCHHHHcC-------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHH
Confidence 335679999999999863 4577899999999999999999999999888888888888888889999999999
Q ss_pred HHHHhhhcCCCCCCC-----HHHHHcCcccccccc
Q 004633 593 FLLRCFLRNPVERPS-----AVELLEHPFIRNANY 622 (741)
Q Consensus 593 LI~~cL~~DP~kRPT-----a~ElLqHpwf~~~~~ 622 (741)
||.+||.+||.+|++ .+++++|+||+...+
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 999999999999997 579999999986543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=405.70 Aligned_cols=257 Identities=31% Similarity=0.522 Sum_probs=236.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce-E
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-L 431 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~-l 431 (741)
.+.|..+++||+|+||.+++++++.++..+++|.|......... .+...+|+.++.+++|||||.+++.|+.++. +
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~---r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l 79 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE---RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLL 79 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh---hHHHHHHHHHHHhccCCCeeeeccchhcCCceE
Confidence 35799999999999999999999999999999999865443322 2367789999999999999999999999998 9
Q ss_pred EEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
+|||+||+||+|.+.|.+.. ..++|+.+..|+.||+.||.|||++.|+|||||+.|||++.++.|||+|||+|+.+...
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999999997754 67999999999999999999999999999999999999999999999999999999876
Q ss_pred c-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCCCccCCH
Q 004633 511 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSS 588 (741)
Q Consensus 511 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~ 588 (741)
. ...+.+||+.||.||++. +..|+.++|||||||++|||++-+++|.+.+-...+.+|.... .++|..++.
T Consensus 160 ~~~a~tvvGTp~YmcPEil~-------d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~ 232 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILS-------DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSS 232 (426)
T ss_pred hhhhheecCCCcccCHHHhC-------CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccH
Confidence 6 777899999999999997 4688999999999999999999999999999999999998776 789999999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
+++.+|+.||.++|+.||++.++|.+|.+..
T Consensus 233 el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 233 ELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999999988763
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=379.73 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=212.4
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCC
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 441 (741)
||+|+||+||+|.++.+++.||+|++..... ......+.+..|+++|+.++|+||+++++++..++.+|+||||++||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL--KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH--hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 7999999999999999999999998864221 12223456778999999999999999999999999999999999999
Q ss_pred Chhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cccccC
Q 004633 442 SINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 517 (741)
Q Consensus 442 sL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~~s~~ 517 (741)
+|..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.... ......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence 99988743 23568999999999999999999999999999999999999999999999999997664322 223457
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH----HHHHHHhccCCCCCccCCHHHHHH
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLNRTPPIPEMLSSEGKDF 593 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~----~~~~~i~~~~~~iP~~ls~el~dL 593 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+......++..++.++.+|
T Consensus 159 g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (280)
T cd05608 159 GTPGFMAPELLQG-------EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSF 231 (280)
T ss_pred CCcCccCHHHhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHH
Confidence 9999999999863 45678999999999999999999999765432 233344445556677899999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 004633 594 LLRCFLRNPVERP-----SAVELLEHPFIRNAN 621 (741)
Q Consensus 594 I~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~ 621 (741)
|.+||+.||++|+ +++++++||||+...
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 232 CEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 9999999999999 889999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=374.83 Aligned_cols=252 Identities=28% Similarity=0.481 Sum_probs=205.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc---CCCCeeeecceeee----
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV---- 427 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L---~HPNIVkl~g~~~~---- 427 (741)
+|++.+.||+|+||+||+|+++.+++.||+|.++........ ...+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL---PLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC---chHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 589999999999999999999999999999998753322111 12344566666555 79999999998764
Q ss_pred -cceEEEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 428 -DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 428 -~~~l~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
...+++||||+. ++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 345899999998 58888886532 458999999999999999999999999999999999999999999999999998
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC------
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------ 579 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------ 579 (741)
............||..|+|||++.+ ..++.++|||||||++|||++|++||........+.++....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQ-------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred cccCcccCCCccccccccCchHhhC-------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 7654444445678999999999863 457889999999999999999999998776655554443210
Q ss_pred -----C----------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 -----P----------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 -----~----------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
. .....++.++.+||.+||..||++|||+.|+|+||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=390.50 Aligned_cols=252 Identities=29% Similarity=0.458 Sum_probs=215.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH-HHhhcCCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK-VLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~-iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|+++.+|+.||||++..... ........+..|.. +++.++||||+++++++..++.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV--LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 479999999999999999999999999864211 11122344555554 577899999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.... .......+
T Consensus 79 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccccc
Confidence 999999988664 5799999999999999999999999999999999999999999999999999875432 23334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHh
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~c 597 (741)
||+.|+|||++.+ ..++.++|||||||++|||++|..||...+..+....++.....++..++..+.++|.+|
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~l 230 (325)
T cd05604 158 GTPEYLAPEVIRK-------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEEL 230 (325)
T ss_pred CChhhCCHHHHcC-------CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHH
Confidence 9999999999863 456789999999999999999999999888777778888777777778999999999999
Q ss_pred hhcCCCCCCCH----HHHHcCccccccc
Q 004633 598 FLRNPVERPSA----VELLEHPFIRNAN 621 (741)
Q Consensus 598 L~~DP~kRPTa----~ElLqHpwf~~~~ 621 (741)
|.+||.+||++ .++++||||....
T Consensus 231 l~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 231 LEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred hccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 99999999876 6999999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=387.64 Aligned_cols=266 Identities=24% Similarity=0.399 Sum_probs=222.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.++||+|+||+||+++++.+++.||+|++.... .........+.+|+.++..++|+||+++++++..++.+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHH--HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEE
Confidence 36999999999999999999999999999999985321 1112233457889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~- 512 (741)
||||+.+|+|.+++.+....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999999987656799999999999999999999999999999999999999999999999999976533221
Q ss_pred -ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCC---ccC
Q 004633 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP---EML 586 (741)
Q Consensus 513 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP---~~l 586 (741)
.....||+.|+|||++.+... +...++.++|||||||+||||++|+.||...+..+.+.++.... ..+| ..+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMED--GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred eecccccCccccCHHHHhcccc--CCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 223579999999999974321 23457889999999999999999999999888777777776543 2233 357
Q ss_pred CHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccccccC
Q 004633 587 SSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANYQ 623 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~k--RPTa~ElLqHpwf~~~~~~ 623 (741)
+.++++||.+||..++.+ |++++|+++||||....+.
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 999999999999765444 6899999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=386.39 Aligned_cols=253 Identities=26% Similarity=0.468 Sum_probs=215.3
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
++||+|+||+||+|.++.+++.||+|++..... ...+..+.+.+|+.++.++ +|+||+++++++...+.+||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV--HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 479999999999999999999999999874211 1233456788899999888 5999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc-CcccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~-~~~~~~s~~ 517 (741)
.||+|..++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++... ........+
T Consensus 79 ~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceeccc
Confidence 999999988664 569999999999999999999999999999999999999999999999999997532 223334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCC------Cc-HHHHHHHhccCCCCCccCCHHH
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF------EG-PQAMFKVLNRTPPIPEMLSSEG 590 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~------~~-~~~~~~i~~~~~~iP~~ls~el 590 (741)
||+.|+|||++.+ ..++.++|||||||+||||++|+.||... .. ......+......+|..++..+
T Consensus 158 gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 230 (327)
T cd05617 158 GTPNYIAPEILRG-------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKA 230 (327)
T ss_pred CCcccCCHHHHCC-------CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999863 46788999999999999999999999632 12 2233445556667888999999
Q ss_pred HHHHHHhhhcCCCCCCC------HHHHHcCcccccccc
Q 004633 591 KDFLLRCFLRNPVERPS------AVELLEHPFIRNANY 622 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPT------a~ElLqHpwf~~~~~ 622 (741)
.++|.+||..||++|++ ++++++|+||....+
T Consensus 231 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 99999999999999997 579999999987653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=388.98 Aligned_cols=259 Identities=32% Similarity=0.502 Sum_probs=221.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc----
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---- 429 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~---- 429 (741)
-.|.-.+++|.|+||.||+|...++++.||||.+-..+. .-.+|+.||+.++|||||+++-+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC---------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 468999999999999999999999999999998753221 1235999999999999999998876432
Q ss_pred -eEEEEEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccc
Q 004633 430 -HLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMA 504 (741)
Q Consensus 430 -~l~LVmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-g~vKL~DFGLA 504 (741)
.+.+||||++ .+|.++++. .+..++.-.++-++.||++||.|||+.||+||||||.|||||.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 4678999997 789988874 24679999999999999999999999999999999999999976 99999999999
Q ss_pred hhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc------
Q 004633 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------ 578 (741)
Q Consensus 505 ~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~------ 578 (741)
+.+.......++..|++|+|||.+.| ...|+.+.||||.||||.||+.|++.|.+.+..+.+..|+.-
T Consensus 174 K~L~~~epniSYicSRyYRaPELifg------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFG------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcC------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 99988888889999999999999986 467889999999999999999999999998877766655321
Q ss_pred --------C---CC------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccCCCCCc
Q 004633 579 --------T---PP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628 (741)
Q Consensus 579 --------~---~~------------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~~~~~~~ 628 (741)
. .. +....++++.+|+.++|..+|.+|.++.|+|.||||......+...+
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~ 320 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLP 320 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCc
Confidence 0 00 22357899999999999999999999999999999987655544444
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=390.46 Aligned_cols=251 Identities=29% Similarity=0.439 Sum_probs=213.2
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc---CCCCeeeecceeeecceEEEEEeec
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L---~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
||+|+||+||+|+++.+++.||||++..... ........+..|..++..+ +||||+++++++...+.+||||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHH--hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 7999999999999999999999999863211 1122234455677777655 6999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccccccC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLK 517 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~~s~~ 517 (741)
.+|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .......+
T Consensus 79 ~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 999999998764 5699999999999999999999999999999999999999999999999999975432 23334567
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCc-cCCHHHHHHHHH
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-MLSSEGKDFLLR 596 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~-~ls~el~dLI~~ 596 (741)
||..|+|||++.+ ...++.++|||||||++|||++|+.||...+..+.+..+......++. .++.++++||++
T Consensus 158 gt~~y~aPE~~~~------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 231 (330)
T cd05586 158 GTTEYLAPEVLLD------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG 231 (330)
T ss_pred CCccccCHHHHcC------CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 9999999999863 345778999999999999999999999988777777777766666664 479999999999
Q ss_pred hhhcCCCCCC----CHHHHHcCccccccc
Q 004633 597 CFLRNPVERP----SAVELLEHPFIRNAN 621 (741)
Q Consensus 597 cL~~DP~kRP----Ta~ElLqHpwf~~~~ 621 (741)
||..||.+|| ++.|+++||||....
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 9999999998 799999999997643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=395.71 Aligned_cols=252 Identities=19% Similarity=0.356 Sum_probs=201.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC------CCeeeeccee
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH------ENIVQYYGSE 425 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H------PNIVkl~g~~ 425 (741)
...+|+++++||+|+||+||+|.+..+++.||||+++... ...+.+..|+.+++.++| .+|+++++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP------KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch------hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3578999999999999999999999999999999986321 222345567777776654 4588999888
Q ss_pred eec-ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCC---------
Q 004633 426 VVD-DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG--------- 494 (741)
Q Consensus 426 ~~~-~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g--------- 494 (741)
..+ +.+|||||++ |++|.+++.+. ..+++..++.|+.||+.||+|||. .|||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 765 5789999988 68888888765 569999999999999999999997 5999999999999998765
Q ss_pred -------cEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC
Q 004633 495 -------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (741)
Q Consensus 495 -------~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~ 567 (741)
.+||+|||++..... .....+||+.|||||++.+ ..|+.++||||||||||||++|+.||.+.+
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~-------~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG-------LGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998864322 2345689999999999974 457889999999999999999999998766
Q ss_pred cHHHHHHHhccCCCCCc------------------------------------------cCCHHHHHHHHHhhhcCCCCC
Q 004633 568 GPQAMFKVLNRTPPIPE------------------------------------------MLSSEGKDFLLRCFLRNPVER 605 (741)
Q Consensus 568 ~~~~~~~i~~~~~~iP~------------------------------------------~ls~el~dLI~~cL~~DP~kR 605 (741)
..+.+..+......+|. ..++.+.|||.+||.+||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 55443332211110000 113567799999999999999
Q ss_pred CCHHHHHcCcccccc
Q 004633 606 PSAVELLEHPFIRNA 620 (741)
Q Consensus 606 PTa~ElLqHpwf~~~ 620 (741)
||++|+|+||||...
T Consensus 430 ~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 430 LNARQMTTHPYVLKY 444 (467)
T ss_pred CCHHHHhcCcccccc
Confidence 999999999999764
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=391.83 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=222.1
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
.....+|++.+.||+|+||.||+|.++.+++.||+|++..... ......+.+.+|+.+++.++||||+++++++..++
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~--~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh--hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3445789999999999999999999999999999999863211 11223355778999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 999999999999999999653 589999999999999999999999999999999999999999999999999987643
Q ss_pred cc--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCC--
Q 004633 510 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIP-- 583 (741)
Q Consensus 510 ~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP-- 583 (741)
.. .....+||+.|||||++.+. .+...++.++|||||||+||||++|+.||...+......+++... ..+|
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQ---GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 271 (371)
T ss_pred CCcccccCcccCccccCHHHHhcc---CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCc
Confidence 22 22356799999999999742 112357889999999999999999999999887777777776533 2333
Q ss_pred ccCCHHHHHHHHHhhhcCCCC--CCCHHHHHcCccccccc
Q 004633 584 EMLSSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNAN 621 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~k--RPTa~ElLqHpwf~~~~ 621 (741)
..++.++++||.+||..++.+ |++++|+++|+||++..
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 272 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 368999999999999844433 78999999999997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=385.07 Aligned_cols=265 Identities=24% Similarity=0.382 Sum_probs=221.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||+||+++++.+++.||+|++..... ........+.+|+.++..++|+||+++++++..++.+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM--LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH--HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 479999999999999999999999999999999863211 112234557889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~- 512 (741)
||||+.||+|.+++.+....+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999999987556799999999999999999999999999999999999999999999999999976644322
Q ss_pred -ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCCc---cC
Q 004633 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPE---ML 586 (741)
Q Consensus 513 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~---~l 586 (741)
.....||+.|+|||++.+... +...++.++|||||||+||||++|+.||...+..+.+.++.... ..+|. .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMED--GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred eeccccCCcccCCHHHHhcccc--CCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 123569999999999874211 12356789999999999999999999999877777776666532 23333 46
Q ss_pred CHHHHHHHHHhhhcCCCC--CCCHHHHHcCcccccccc
Q 004633 587 SSEGKDFLLRCFLRNPVE--RPSAVELLEHPFIRNANY 622 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~k--RPTa~ElLqHpwf~~~~~ 622 (741)
+.++++||.+||..++.+ |++++++++|+||+...+
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 899999999999866544 579999999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=384.46 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=208.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-- 429 (741)
...+|++.+.||+|+||.||+|.++.+|..||||++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF---QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc---cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence 3468999999999999999999999999999999886422 12233456778999999999999999999886543
Q ss_pred ----eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 430 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 430 ----~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
.+|+||||+.+ +|.+.+. ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 57999999975 4555553 248899999999999999999999999999999999999999999999999998
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--------
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-------- 577 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-------- 577 (741)
............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 7655444445678999999999863 4577899999999999999999999987654433222211
Q ss_pred --------------cCCC--------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 578 --------------RTPP--------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 578 --------------~~~~--------------------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
..+. .....+.++++||.+||..||++|||+.|+|+||||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 1111 11124678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=394.59 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=205.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
....+|++++.||+|+||.||+|.++.+++.||||.... ..+.+|+++|+.|+|||||++++++..++.
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 157 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKF 157 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence 445689999999999999999999999999999996431 246789999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
.++||||+. ++|..++... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 158 ~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 158 TCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred eEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 999999995 7888888664 56899999999999999999999999999999999999999999999999999754322
Q ss_pred --ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc-------HHHHHHHhc----
Q 004633 511 --SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-------PQAMFKVLN---- 577 (741)
Q Consensus 511 --~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~-------~~~~~~i~~---- 577 (741)
.......||+.|+|||++.+ ..++.++||||||||||||++|+.||..... ...+..++.
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLAR-------DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred cccccccccCccCCCChhhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 22234679999999999863 4578899999999999999999988753211 111111111
Q ss_pred ----------------------cCCCCC---------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 578 ----------------------RTPPIP---------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 578 ----------------------~~~~iP---------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.....+ ..++.++.+||.+||..||++|||++|+|+||||+..
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000000 1246689999999999999999999999999999764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=408.46 Aligned_cols=262 Identities=35% Similarity=0.626 Sum_probs=236.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.+.|.|+..||.|+||+||+|..+.++...|.|+|.. +..+.++.+.-||.||..++||+||+||+.|..++.+|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 3468999999999999999999999999999998874 44566778888999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~ 511 (741)
|++|||.||-...++.+.++.+++.+|..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||++..... ..
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence 99999999999999999889999999999999999999999999999999999999999999999999999755432 34
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCC---CCccCCH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSS 588 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~---iP~~ls~ 588 (741)
...+++|||+|||||+......+ +..|+.++|||||||+|+||..+.+|-.+.+...++.+|....++ .|..++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~K--D~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~ 263 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFK--DQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR 263 (1187)
T ss_pred hhccccCCcccccchheeecccc--CCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence 45578999999999998754333 467999999999999999999999999999999999999876543 4788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.+.|||++||.+||..||++.|+|+||||++..
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 999999999999999999999999999998754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=388.53 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=212.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc-----
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----- 429 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~----- 429 (741)
+|++++.||+|+||+||+|.+..+|+.||||++.... ......+++.+|+++|+.++|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 77 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF---QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc---cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccc
Confidence 4789999999999999999999999999999875321 12233467889999999999999999999998776
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 78 EIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 7999999997 6788877554 5699999999999999999999999999999999999999999999999999976543
Q ss_pred cc--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc----------
Q 004633 510 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---------- 577 (741)
Q Consensus 510 ~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~---------- 577 (741)
.. ......+|+.|+|||++.+ ...++.++||||||||+|||++|+.||.+....+.+..+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMG------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcC------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 21 2223468999999999864 34577899999999999999999999987765544433321
Q ss_pred -------------cCC---------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 578 -------------RTP---------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 578 -------------~~~---------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
... .+....++++.+||.+||..||++|||+.|+|+||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 000 1223468899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=380.98 Aligned_cols=262 Identities=28% Similarity=0.447 Sum_probs=238.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
..+|..+++||+|+||+|.+|+.+.+|+.+|||++++.-. ...+.+..-..|-++|+..+||.+..|...|+..+.+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi--iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI--IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhe--eehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 3578999999999999999999999999999998863221 23344566678999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc-cCcc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLS 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~-~~~~ 511 (741)
+||||..||.|+..+.. .+.++|...+.+-..|+.||.|||+++||.||||.+|+|+|.+|++||+||||++.- ....
T Consensus 245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 99999999999999965 477999999999999999999999999999999999999999999999999999864 4556
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~ 591 (741)
...++||||.|+|||++. +..|+.++|+|.+|||||||++|++||...+.......|+.....+|..++++++
T Consensus 324 t~kTFCGTPEYLAPEVle-------DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAk 396 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAK 396 (516)
T ss_pred eeccccCChhhcCchhhc-------cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHH
Confidence 677899999999999997 5689999999999999999999999999999988989999999999999999999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHcCccccccccCC
Q 004633 592 DFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQN 624 (741)
Q Consensus 592 dLI~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~~~~ 624 (741)
.||..+|.+||.+|. .+.||.+|+||...+|+.
T Consensus 397 tLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 397 TLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred HHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 999999999999996 489999999999888754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=401.25 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=222.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCC-CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~t-g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||++++++..++.+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 44599999999999999999998887 788999976421 223345678899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 432 YIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
||||||++||+|.+++.+. ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999999988542 3458999999999999999999999999999999999999999999999999998765
Q ss_pred Ccc---cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCCCc
Q 004633 509 GLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPE 584 (741)
Q Consensus 509 ~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~ 584 (741)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..++.+. .+++.
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 293 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWER-------KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPC 293 (478)
T ss_pred CccccccccccCCCccccCHhHhCC-------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 432 2335679999999999863 467889999999999999999999999887777777776543 35677
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.++.++++||.+||..||++||+++++|.|+|++..
T Consensus 294 ~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 889999999999999999999999999999999753
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=370.10 Aligned_cols=256 Identities=29% Similarity=0.534 Sum_probs=227.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||.||++.+..+++.||+|++..... ......+.+.+|+++|++++||||+++++++..++.+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI--VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEE
Confidence 369999999999999999999999999999998864221 123345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||.||||+.++.+||+|||++...... .
T Consensus 79 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~ 155 (290)
T cd05580 79 VMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--T 155 (290)
T ss_pred EEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--C
Confidence 99999999999999775 57999999999999999999999999999999999999999999999999999876544 3
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dL 593 (741)
....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+......+|..++..++++
T Consensus 156 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 228 (290)
T cd05580 156 YTLCGTPEYLAPEIILS-------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDL 228 (290)
T ss_pred CCCCCCccccChhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHH
Confidence 34578999999998853 34667899999999999999999999887766677777777778888999999999
Q ss_pred HHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 004633 594 LLRCFLRNPVERP-----SAVELLEHPFIRNAN 621 (741)
Q Consensus 594 I~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~ 621 (741)
|.+||..||.+|+ +++|+++||||+...
T Consensus 229 i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999999999 999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=371.42 Aligned_cols=260 Identities=26% Similarity=0.441 Sum_probs=216.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
..++|++.+.||.|+||.||+|.++.+++.||+|.+........ ...+.+|+.+++.|+|+||+++++++..++.+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSL 79 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc----hhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence 45689999999999999999999999999999999875332211 23466799999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|+||||+. ++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 99999997 68988887766679999999999999999999999999999999999999999999999999997653222
Q ss_pred -cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc------------
Q 004633 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------------ 578 (741)
Q Consensus 512 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~------------ 578 (741)
......+++.|+|||++.+ ...++.++|||||||++|||++|++||...+..+.+..+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLG------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CcccccceeecccCcHHHhC------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 2223457899999999863 345778999999999999999999999876654443332210
Q ss_pred -------CCCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 579 -------TPPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 579 -------~~~iP-----------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
...++ ..++.++++||.+||..||.+|||+.|+|+|+||+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 00111 246889999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=383.71 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=208.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec---
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--- 428 (741)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc---cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 4568999999999999999999999999999999876422 2233446678899999999999999999988654
Q ss_pred ---ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 429 ---~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
..+|+||||+++ +|.+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999975 56666543 48899999999999999999999999999999999999999999999999998
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-------
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------- 578 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~------- 578 (741)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 7655444455679999999999863 45778999999999999999999999876544333222110
Q ss_pred ---------------CC--------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 579 ---------------TP--------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 579 ---------------~~--------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
.+ ..+...+.++++||.+||..||++|||+.|+|+||||..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00 011224568899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.89 Aligned_cols=258 Identities=24% Similarity=0.408 Sum_probs=216.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|++.++||+|+||.||+|.++.+++.||||.+..... ........+.+|+.+|+.++|+||+.+++.+..++.+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI--KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc--cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEE
Confidence 37889999999999999999999999999998864322 1223345577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|||+.||+|.+++... ...+++.++..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 9999999999988543 245899999999999999999999999999999999999999999999999999765443333
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH---HHHHHHh-ccCCCCCccCCHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVL-NRTPPIPEMLSSE 589 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~---~~~~~i~-~~~~~iP~~ls~e 589 (741)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+. .....++..++.+
T Consensus 159 ~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd05630 159 KGRVGTVGYMAPEVVKN-------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPD 231 (285)
T ss_pred cCCCCCccccChHHHcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHH
Confidence 34579999999999863 45778999999999999999999999865432 1222222 1223456778999
Q ss_pred HHHHHHHhhhcCCCCCCC-----HHHHHcCccccccc
Q 004633 590 GKDFLLRCFLRNPVERPS-----AVELLEHPFIRNAN 621 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPT-----a~ElLqHpwf~~~~ 621 (741)
+.+||.+||+.||++|+| ++|+++||||+...
T Consensus 232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN 268 (285)
T ss_pred HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccC
Confidence 999999999999999999 99999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=364.11 Aligned_cols=252 Identities=37% Similarity=0.597 Sum_probs=210.5
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
|++++.||+|+||+||+|.+..+++.||+|++.... ..........+|+.++++++|+||+++++++..++.+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE---IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT---HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc---ccccccchhhhhhhccccccccccccccccccccccccccc
Confidence 899999999999999999999999999999987532 11222233456999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc-cCccccc
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYEL 514 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~-~~~~~~~ 514 (741)
||+.+++|.+++.. ...+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++... .......
T Consensus 78 ~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 78 EYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999974 367999999999999999999999999999999999999999999999999998753 2223334
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC---cHHHHHHHhccCC----CCCccCC
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLNRTP----PIPEMLS 587 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~---~~~~~~~i~~~~~----~iP~~ls 587 (741)
...++..|+|||++.. ...++.++||||||+++|+|++|..||.... ....+.+...... .......
T Consensus 157 ~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQ------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKS 230 (260)
T ss_dssp SSSSSGGGSCHHHHTT------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSH
T ss_pred cccccccccccccccc------cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhH
Confidence 5678999999999861 3567789999999999999999999999873 2233333332111 1111224
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.++.++|.+||..||++||++.++++||||
T Consensus 231 ~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 231 EELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=384.42 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=209.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec---
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--- 428 (741)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ---NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc---CchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 35689999999999999999999999999999998864221 223345677899999999999999999987543
Q ss_pred ---ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 429 ---~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
..+|+||||+.+ +|.+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999975 66666643 48899999999999999999999999999999999999999999999999998
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC------
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------ 579 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------ 579 (741)
............||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+.+++...
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhC-------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 7655444455679999999999963 457789999999999999999999998776655544443210
Q ss_pred ----------------CC--------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 580 ----------------PP--------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 580 ----------------~~--------------------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
+. .....+.++++||.+||..||.+|||+.|+|+||||..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 01113467899999999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=379.83 Aligned_cols=256 Identities=28% Similarity=0.550 Sum_probs=213.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
..++|++.+.||+|+||.||+|.++.++..+|+|++.... .......+.+|+++|+.++|+|||++++++..++.+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence 3568999999999999999999999999999999886421 233446788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhC-CeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~-gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
||||||+.+|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+|.+||+|||++..+...
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999999999764 5689999999999999999999975 7999999999999999999999999999765432
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHH----------------
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK---------------- 574 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~---------------- 574 (741)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||......+....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229 (333)
T ss_pred -ccccCCCCccccCHHHhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence 2234579999999999863 4577899999999999999999999975433222110
Q ss_pred ----------------------------Hhcc-CCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 575 ----------------------------VLNR-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 575 ----------------------------i~~~-~~~iP-~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+... .+.++ ..++.++++||.+||.+||++|||+.|+|+|+||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 1111 11111 1357889999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=380.51 Aligned_cols=253 Identities=26% Similarity=0.463 Sum_probs=206.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG 423 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k-----~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g 423 (741)
....++|+++++||+|+||.||+|.+. .++..||||+++.. ......+.+.+|+.+|..+ +|||||++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG----ATASEHKALMSELKILIHIGNHLNVVNLLG 78 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc----cchHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence 345678999999999999999999752 34578999987532 1233346788999999999 8999999999
Q ss_pred eeeec-ceEEEEEeecCCCChhhhhhhcc---------------------------------------------------
Q 004633 424 SEVVD-DHLYIYLEYVHPGSINRYVREHC--------------------------------------------------- 451 (741)
Q Consensus 424 ~~~~~-~~l~LVmEy~~gGsL~~lI~~~~--------------------------------------------------- 451 (741)
++... +.+|+||||+++|+|.+++....
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 87754 46899999999999999986531
Q ss_pred ----------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc---ccccCC
Q 004633 452 ----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKG 518 (741)
Q Consensus 452 ----------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~G 518 (741)
..+++.++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..... .....+
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 2377888999999999999999999999999999999999999999999999986533211 123345
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHh-c-cCCCCCccCCHHHHHHHH
Q 004633 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-N-RTPPIPEMLSSEGKDFLL 595 (741)
Q Consensus 519 T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~-~-~~~~iP~~ls~el~dLI~ 595 (741)
+..|+|||++.+ ..++.++|||||||+||||++ |..||.+....+.+...+ . .....+..+++++.+||.
T Consensus 239 ~~~y~aPE~~~~-------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 311 (338)
T cd05102 239 PLKWMAPESIFD-------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIML 311 (338)
T ss_pred CccccCcHHhhc-------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 788999999863 457889999999999999997 999998765444333333 2 234556778999999999
Q ss_pred HhhhcCCCCCCCHHHHHc
Q 004633 596 RCFLRNPVERPSAVELLE 613 (741)
Q Consensus 596 ~cL~~DP~kRPTa~ElLq 613 (741)
+||..||++|||+.|+++
T Consensus 312 ~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 312 ACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHccCChhhCcCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=369.97 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=207.8
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCC
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 441 (741)
||+|+||+||+++++.+|+.||+|.+....... ....+.+..|+++|++++||||+++++++..+..+|+||||+.||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 799999999999999999999999886322111 112234567999999999999999999999999999999999999
Q ss_pred Chhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCC
Q 004633 442 SINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520 (741)
Q Consensus 442 sL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~GT~ 520 (741)
+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..........|+.
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence 999888653 2358899999999999999999999999999999999999999999999999998765544334567999
Q ss_pred CCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH----HHHHHHhccCCCC-CccCCHHHHHHHH
Q 004633 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLNRTPPI-PEMLSSEGKDFLL 595 (741)
Q Consensus 521 ~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~----~~~~~i~~~~~~i-P~~ls~el~dLI~ 595 (741)
.|+|||++.+ ..++.++|||||||++|||++|+.||...... +....+....... ...++.++++||.
T Consensus 159 ~y~aPE~~~~-------~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (277)
T cd05607 159 GYMAPEILKE-------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICR 231 (277)
T ss_pred CccCHHHHcc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHH
Confidence 9999999863 34788999999999999999999999765332 2223333333222 2468999999999
Q ss_pred HhhhcCCCCCCCH----HHHHcCccccccc
Q 004633 596 RCFLRNPVERPSA----VELLEHPFIRNAN 621 (741)
Q Consensus 596 ~cL~~DP~kRPTa----~ElLqHpwf~~~~ 621 (741)
+||+.||++||++ +++++|+||+..+
T Consensus 232 ~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 232 LFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred HHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 9999999999999 6788999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=402.85 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=219.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-C-----CCeeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-H-----ENIVQYYGS 424 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-H-----PNIVkl~g~ 424 (741)
....+|.+.++||+|+||.|.+|++..|++.||||+|+. ......+...|++||..|+ | -|||+++++
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 334489999999999999999999999999999999873 3455677888999999997 4 389999999
Q ss_pred eeecceEEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC--CcEEEeec
Q 004633 425 EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADF 501 (741)
Q Consensus 425 ~~~~~~l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~--g~vKL~DF 501 (741)
|...+++|||+|++. .+|+++|+.+ ...++...++.|+.||+.||.+||+.||||+|||||||||... ..|||+||
T Consensus 257 F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDF 335 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDF 335 (586)
T ss_pred cccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEec
Confidence 999999999999996 8999999874 4569999999999999999999999999999999999999754 47999999
Q ss_pred ccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--
Q 004633 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-- 579 (741)
Q Consensus 502 GLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-- 579 (741)
|.++......+ +++.+++|+|||++.| -.|+.+.||||||||++||++|.+.|.+.++.+.+..|++-.
T Consensus 336 GSSc~~~q~vy--tYiQSRfYRAPEVILG-------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 336 GSSCFESQRVY--TYIQSRFYRAPEVILG-------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred ccccccCCcce--eeeeccccccchhhcc-------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 99988766555 7889999999999995 578899999999999999999999999988877766553210
Q ss_pred --------------------------------------------------CCCCc-----------cCCHHHHHHHHHhh
Q 004633 580 --------------------------------------------------PPIPE-----------MLSSEGKDFLLRCF 598 (741)
Q Consensus 580 --------------------------------------------------~~iP~-----------~ls~el~dLI~~cL 598 (741)
...|. .-...+.|||++||
T Consensus 407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 00110 11256789999999
Q ss_pred hcCCCCCCCHHHHHcCccccccc
Q 004633 599 LRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 599 ~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.+||.+|+|+.|+|+||||+...
T Consensus 487 ~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 487 EWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred ccCchhcCCHHHHhcCccccccc
Confidence 99999999999999999998543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=386.41 Aligned_cols=254 Identities=39% Similarity=0.689 Sum_probs=228.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
-|.++++||+|+||.||+|.++++|+.+|||.+.+.. .+..+.+||.||++++.++||++||.|.....+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 4889999999999999999999999999999876421 235677799999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-cccc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~-~~~~ 513 (741)
||||..|++.++++-+.+.++|.++..+++..+.||+|||...-||||||..||||+.+|..||+|||+|..+.+ ....
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 999999999999998889999999999999999999999999999999999999999999999999999987754 3344
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC---CCCccCCHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSSEG 590 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls~el 590 (741)
.+..|||.|||||++... .|...+||||||++..||..|++||.+......++.|-...+ .-|+.++.++
T Consensus 187 NTVIGTPFWMAPEVI~EI-------GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F 259 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEI-------GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEF 259 (502)
T ss_pred CccccCcccccHHHHHHh-------ccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHH
Confidence 578899999999999863 466799999999999999999999999888777776654433 3467899999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
.|||++||.++|++|-|+.++++|+|+++...
T Consensus 260 ~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 260 NDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred HHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 99999999999999999999999999998654
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=368.27 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=219.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|+..++||+|+||+||+|.+..+++.||+|.+..... ........+.+|+++|+.++|+||+.+++.+..++.+|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI--KKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEE
Confidence 47889999999999999999999999999998864221 1122335577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 9999999999888653 346999999999999999999999999999999999999999999999999999765443333
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHH----HhccCCCCCccCCHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK----VLNRTPPIPEMLSSE 589 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~----i~~~~~~iP~~ls~e 589 (741)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||........... +......++..++.+
T Consensus 159 ~~~~g~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd05632 159 RGRVGTVGYMAPEVLNN-------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEE 231 (285)
T ss_pred cCCCCCcCccChHHhcC-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHH
Confidence 45679999999999863 4577899999999999999999999987654433222 233344566778999
Q ss_pred HHHHHHHhhhcCCCCCCC-----HHHHHcCcccccccc
Q 004633 590 GKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANY 622 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPT-----a~ElLqHpwf~~~~~ 622 (741)
+.+||.+||..||++||+ +.++++|+||+....
T Consensus 232 ~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 232 AKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred HHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 999999999999999999 899999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=356.61 Aligned_cols=256 Identities=56% Similarity=0.991 Sum_probs=223.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||+||+|.++.+++.|++|++..........+..+.+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 58889999999999999999998999999999876444444455677899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~ 514 (741)
|||+++++|.+++... ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 9999999999999765 468999999999999999999999999999999999999999999999999988765544344
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--cCCCCCccCCHHHHH
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 592 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP~~ls~el~d 592 (741)
...|+..|+|||.+.. ...++.++|||||||++|+|++|+.||..........++.. ....++..++.++++
T Consensus 160 ~~~~~~~y~~pe~~~~------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 160 SFKGSPYWMAPEVIAQ------QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred ccCCCcceeCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 5678999999999853 12377899999999999999999999987765554444433 344567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 593 FLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 593 LI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
||.+||..+|.+||++.++|+|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=363.78 Aligned_cols=253 Identities=30% Similarity=0.534 Sum_probs=209.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||+|.++.+++.||||++.....+. ...+.+.+|+.+++.++||||+++++++..++.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE---GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC---CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 4899999999999999999999999999999886432221 1235677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcc--ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 435 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 99997 68888875532 568999999999999999999999999999999999999999999999999997653321
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC------------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------ 579 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------ 579 (741)
......+++.|+|||++.+ ...++.++|||||||++|||++|+.||.+.........+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLG------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred cccCCcccccccChHHhcC------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 1223457899999999863 3456779999999999999999999998765544333221100
Q ss_pred -----------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 -----------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 -----------------~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
......++.++++||.+||..||++|||+.++++|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00123478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=359.85 Aligned_cols=255 Identities=49% Similarity=0.831 Sum_probs=220.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc----ccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP----KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~----~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
+|.+++.||.|+||.||+|.+..+++.||+|.+....... ...+..+.+.+|+.++++++||||+++++++..++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4889999999999999999999999999999886433221 123445678899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 99999999999999999765 56899999999999999999999999999999999999999999999999999876532
Q ss_pred c-------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCC
Q 004633 511 S-------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPI 582 (741)
Q Consensus 511 ~-------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~i 582 (741)
. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........+.++... ...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQ-------TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232 (267)
T ss_pred cccCCccccccccCCCcCccChhHhcc-------CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcC
Confidence 1 1123458899999999863 35677899999999999999999999887666655555443 4567
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
+..++.++.++|.+||..||.+||++.|+++|+||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 77889999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=365.42 Aligned_cols=261 Identities=36% Similarity=0.638 Sum_probs=224.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++.+.||.|+||+||+|.+..++..||+|++... .....+.+.+|+++++.++|+||+++++++..++.+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence 35699999999999999999999999999999998642 2334467888999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
+||||+++++|.+++.+....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999999999998766679999999999999999999999999999999999999999999999999987653322
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC---CCCccCCH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSS 588 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls~ 588 (741)
......|+..|+|||++..... ....++.++|||||||++|||++|+.||...+....+.++..... ..+..++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~--~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETF--KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS 236 (280)
T ss_pred ccceeecchhhcCHHHHhhccc--CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCH
Confidence 2234568999999999864211 124567899999999999999999999988777666666655432 34567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
++.++|.+||..||.+||++.++|+|+||...
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=354.12 Aligned_cols=253 Identities=29% Similarity=0.534 Sum_probs=220.5
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|.+.+.||+|+||.||+|.++.+++.|++|.+..... .......+.+|+++++.++||||+++++++..++..|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM---NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC---CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEE
Confidence 48899999999999999999999999999998864322 233456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
|||+.|++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++.+.... .
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999999764 4578999999999999999999999999999999999999999999999999988665432 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK 591 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~ 591 (741)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ...++..++.++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-------KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLA 230 (256)
T ss_pred hhccccCccccCHHHhcC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence 234568999999999863 35678999999999999999999999887766666666544 3455667899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
++|.+||+.+|++||++.++++|+|+
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=369.09 Aligned_cols=265 Identities=28% Similarity=0.489 Sum_probs=227.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|++.+.||+|+||+||+|.+..+++.||||.+.... .......+.+.+|+++|+.++|+||+++++.+...+..|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKE--MIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccc--cchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEE
Confidence 36999999999999999999999999999999886432 2223345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 434 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
||||+.|++|.+++... ...+++..++.++.||+.||+|||++||+|+||||+||||+.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999998753 3568999999999999999999999999999999999999999999999999986543211
Q ss_pred -----------------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCC
Q 004633 512 -----------------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562 (741)
Q Consensus 512 -----------------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~P 562 (741)
......||..|+|||++.+ ..++.++||||||+++|+|++|+.|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-------DGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-------CCCCchHHHHHHHHHHHHHhhCCCC
Confidence 1112468899999999863 3567899999999999999999999
Q ss_pred CCCCCcHHHHHHHhccCCCCCcc--CCHHHHHHHHHhhhcCCCCCCC----HHHHHcCccccccccCCCCC
Q 004633 563 WSEFEGPQAMFKVLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPS----AVELLEHPFIRNANYQNLSV 627 (741)
Q Consensus 563 F~~~~~~~~~~~i~~~~~~iP~~--ls~el~dLI~~cL~~DP~kRPT----a~ElLqHpwf~~~~~~~~~~ 627 (741)
|...+....+.++......++.. ++.+++++|++||..||++||+ ++|+|+|+||+...+..+..
T Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 232 FKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred CCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence 99888777777777665555554 6899999999999999999999 99999999998876655444
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=397.95 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=223.8
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
.....+|++.++||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~---~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM---SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC---CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 3445699999999999999999999999999999999875322 2344567889999999999999999988765432
Q ss_pred --------eEEEEEeecCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEE
Q 004633 430 --------HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 498 (741)
Q Consensus 430 --------~l~LVmEy~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL 498 (741)
.+++||||+.+|+|.++|... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 378999999999999998653 346899999999999999999999999999999999999999999999
Q ss_pred eecccchhccCc---ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHH
Q 004633 499 ADFGMAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV 575 (741)
Q Consensus 499 ~DFGLA~~~~~~---~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i 575 (741)
+|||+++.+... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||......+.+..+
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-------KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCC-------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999765432 22335679999999999863 45788999999999999999999999987777777666
Q ss_pred hcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 576 LNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 576 ~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+.. ...++..+++++.+||.+||..||.+||++.++|+|||++..
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 258 LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 654 345778899999999999999999999999999999998753
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=364.34 Aligned_cols=253 Identities=33% Similarity=0.534 Sum_probs=207.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||+|+++.+|+.||+|.+...... ......+.+|+++++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc---ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 589999999999999999999999999999998753222 12234577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~ 513 (741)
|||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.... ..
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 99997 57888876655679999999999999999999999999999999999999999999999999998654322 12
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCC-CCcHHHHHHHhcc--------------
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGPQAMFKVLNR-------------- 578 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~-~~~~~~~~~i~~~-------------- 578 (741)
....++..|+|||++.+ ...++.++|||||||++|||++|..||.. .+..+.+..+...
T Consensus 157 ~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 157 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCccccCCcChHHHhC------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 23467899999999864 34567899999999999999999888643 3333332222110
Q ss_pred ------CC---------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 579 ------TP---------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 579 ------~~---------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.. .....++.++++||.+||..||.+|||++|+|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 0112467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.21 Aligned_cols=253 Identities=29% Similarity=0.543 Sum_probs=216.5
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee-cceEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDHLYI 433 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~-~~~l~L 433 (741)
.|++.+.||+|+||.||++.++.+++.||+|.+.... ......+.+.+|+++++.++|+||+++++.+.. +..+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN---ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh---cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 4899999999999999999999999999999886422 223345668889999999999999999998764 446899
Q ss_pred EEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-c
Q 004633 434 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~-~ 511 (741)
||||+.+++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+... .
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999999763 345899999999999999999999999999999999999999999999999999766432 2
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEG 590 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el 590 (741)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+.... ..++..++.++
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPEL 230 (257)
T ss_pred ccccccCCcCccChhHhcC-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHH
Confidence 2234568999999999863 456779999999999999999999998776666555555443 35667789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.+||.+||..||++||++.++++||||
T Consensus 231 ~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 231 GELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=378.34 Aligned_cols=255 Identities=24% Similarity=0.436 Sum_probs=210.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec----
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~---- 428 (741)
..+|++++.||+|+||+||+|.+..+++.||||++.... ......+.+.+|+++|+.++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh---hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 467999999999999999999999999999999876321 1122345677899999999999999999987643
Q ss_pred --ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 429 --~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
..+|++||++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 3579999998 7889888754 4699999999999999999999999999999999999999999999999999986
Q ss_pred ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-------
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------- 579 (741)
Q Consensus 507 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------- 579 (741)
.... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 168 ~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 168 ADDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred cCCC--cCCccccccccCchHhcC------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 5432 234679999999999863 3457789999999999999999999998765544443332110
Q ss_pred ----------------CCCC--------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 ----------------PPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 ----------------~~iP--------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
...+ ...++.+.+||.+||..||++|||+.|+|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0111 23567789999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=356.48 Aligned_cols=256 Identities=45% Similarity=0.815 Sum_probs=216.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--ceE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL 431 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l 431 (741)
..|+++++||+|+||.||+|.++.+|..||||++............++.+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 469999999999999999999999999999998864333333344567889999999999999999999987663 568
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~- 510 (741)
++||||+.+++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 8999999999999998765 45899999999999999999999999999999999999999999999999998765421
Q ss_pred ---ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--CCCCCcc
Q 004633 511 ---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEM 585 (741)
Q Consensus 511 ---~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~~ 585 (741)
.......|+..|+|||++.+ ..++.++|||||||++|||++|+.||........+.++... .+.+|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISG-------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH 233 (265)
T ss_pred ccccccccCCCCccccChhhhcC-------CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchh
Confidence 11223568999999999863 35678999999999999999999999877655555544432 3446777
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
++..+.++|.+||. +|++||+++|+++|+|+.
T Consensus 234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 88999999999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=359.22 Aligned_cols=254 Identities=33% Similarity=0.567 Sum_probs=212.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||.||+|.++.+|+.||+|++....... ...+.+.+|+.+++.++|+||+++++++.....+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP---VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc---cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEE
Confidence 36999999999999999999999999999999886432221 123457789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
||||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... .
T Consensus 78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 78 VFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 99999999888877553 469999999999999999999999999999999999999999999999999998765433 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-------------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------- 579 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------- 579 (741)
.....++..|+|||++.+ ...++.++|||||||++|||++|+.||.+....+....+....
T Consensus 157 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 157 YTDYVATRWYRAPELLVG------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred ccCcccccccCCHHHHhC------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 234568899999999863 3456789999999999999999999998766554443332100
Q ss_pred ------CCCC------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 ------PPIP------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 ------~~iP------------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
...+ ..++..+.+||.+||..||++||++.|+++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0001 2457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=370.21 Aligned_cols=245 Identities=25% Similarity=0.460 Sum_probs=192.6
Q ss_pred eeEEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee--cceEEEE
Q 004633 359 GKLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIY 434 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k--~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~--~~~l~LV 434 (741)
+++||+|+||+||+|+++ .+++.||+|.+.... . ...+.+|+.+|+.++|||||++++++.. +..+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---I----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---C----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 578999999999999976 467889999875321 1 1346689999999999999999998854 4568999
Q ss_pred EeecCCCChhhhhhhc--------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEe----cCCCcEEEeecc
Q 004633 435 LEYVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFG 502 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~--------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILL----d~~g~vKL~DFG 502 (741)
|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 99986 5787776432 1358999999999999999999999999999999999999 456799999999
Q ss_pred cchhccCcc----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH---------
Q 004633 503 MAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--------- 569 (741)
Q Consensus 503 LA~~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~--------- 569 (741)
+++.+.... ......||+.|+|||++.+ ...++.++|||||||++|||++|++||......
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~ 231 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 231 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcC------CCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccH
Confidence 998764322 2234678999999999874 345788999999999999999999999643321
Q ss_pred HHHHHHhcc---C--------CCC---------------------------CccCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 004633 570 QAMFKVLNR---T--------PPI---------------------------PEMLSSEGKDFLLRCFLRNPVERPSAVEL 611 (741)
Q Consensus 570 ~~~~~i~~~---~--------~~i---------------------------P~~ls~el~dLI~~cL~~DP~kRPTa~El 611 (741)
..+..++.. . ..+ ....+.++.+||.+||..||++|||++|+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~ 311 (317)
T cd07868 232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 311 (317)
T ss_pred HHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHH
Confidence 111111110 0 000 01235678999999999999999999999
Q ss_pred HcCccc
Q 004633 612 LEHPFI 617 (741)
Q Consensus 612 LqHpwf 617 (741)
|+||||
T Consensus 312 l~hp~f 317 (317)
T cd07868 312 MQDPYF 317 (317)
T ss_pred hcCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=373.51 Aligned_cols=255 Identities=25% Similarity=0.464 Sum_probs=208.1
Q ss_pred EeeEEeec--CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 358 KGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 358 i~k~LG~G--~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
++++||+| +|++||++.++.+|+.||||.++.... ..+..+.+.+|+.+++.++|||||++++++..++.+|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC---TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc---cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 57889999 789999999999999999998864322 2344567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc---
Q 004633 436 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--- 511 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~--- 511 (741)
||+++|+|.+++..+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999999654 3458999999999999999999999999999999999999999999999998764432111
Q ss_pred -----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC------
Q 004633 512 -----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------ 580 (741)
Q Consensus 512 -----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~------ 580 (741)
......++..|+|||++.+. ...++.++|||||||++|||++|+.||.................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQN-----LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233 (327)
T ss_pred cccccccccccceecccChHHhhcc-----cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence 11123467889999998641 13577899999999999999999999986554443333222110
Q ss_pred ----------------------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 581 ----------------------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 581 ----------------------------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+....+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112356789999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=365.12 Aligned_cols=263 Identities=37% Similarity=0.609 Sum_probs=222.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
..+.|+++++||.|+||.||+|.+..++..||+|++.. ...+..+.+.+|+.+++.++|+||+++++.+..++.+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET-----KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc-----CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 34679999999999999999999999999999998763 2334456788899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~- 510 (741)
|+||||+.+++|..++.+....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999999999999988765567999999999999999999999999999999999999999999999999998754332
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC---CCCccCC
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLS 587 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls 587 (741)
.......++..|+|||++.+.... ...++.++|||||||++|||++|..||...+......++..... ..+..++
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMK--DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242 (292)
T ss_pred cccceecCCccccCceeecccccc--CCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence 122345689999999998532111 23467899999999999999999999987766555555543322 2355688
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.++.++|.+||..||++||+++++++||||....
T Consensus 243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 9999999999999999999999999999997654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=356.57 Aligned_cols=254 Identities=39% Similarity=0.773 Sum_probs=216.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-cccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~-~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
+|++++.||.|+||+||+|.. .+++.+|+|.+...... .........+.+|+.+|+.++|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 47889999988753322 1223445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc---
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--- 510 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~--- 510 (741)
||||+.+++|.+++.+. ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 80 FMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999999765 46899999999999999999999999999999999999999999999999998765321
Q ss_pred ----ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc---CCCCC
Q 004633 511 ----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIP 583 (741)
Q Consensus 511 ----~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~---~~~iP 583 (741)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+... .+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINE-------SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231 (265)
T ss_pred ccccccccccCCCccccChhhhcC-------CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCC
Confidence 11223568999999999863 34678999999999999999999999876655544444332 34567
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
..++.++.++|.+||..+|.+||++.|+|+||||
T Consensus 232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 7789999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=395.43 Aligned_cols=250 Identities=44% Similarity=0.828 Sum_probs=223.5
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCC
Q 004633 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHP 440 (741)
Q Consensus 361 ~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~g 440 (741)
+||+|+||+||.|+++.+....|||.|.. +......-+..||.+.++|+|.|||+++|.+..++.+-|+||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe-----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE-----KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc-----ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 79999999999999999999999998763 2334456688999999999999999999999999999999999999
Q ss_pred CChhhhhhhccccc--cHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccCcc-ccccc
Q 004633 441 GSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSL 516 (741)
Q Consensus 441 GsL~~lI~~~~~~l--se~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~-~g~vKL~DFGLA~~~~~~~-~~~s~ 516 (741)
|+|.++++..-+.+ .|..+..|.+||++||+|||++.|||||||-+|+||+. .|.+||.|||-++.+.+.. .+.++
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF 736 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF 736 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence 99999998876777 89999999999999999999999999999999999975 5999999999999887643 44578
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHH-HHHH--hccCCCCCccCCHHHHHH
Q 004633 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKV--LNRTPPIPEMLSSEGKDF 593 (741)
Q Consensus 517 ~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~-~~~i--~~~~~~iP~~ls~el~dL 593 (741)
.||..|||||++.. |-..|+.++|||||||++.||.||++||.+....+. ++++ ....+++|+.++.+++.|
T Consensus 737 TGTLQYMAPEvIDq-----G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQ-----GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred ccchhhhChHhhcc-----CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence 89999999999964 456799999999999999999999999988766554 3333 355689999999999999
Q ss_pred HHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 594 LLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 594 I~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
|.+|+..||.+||+|.++|+.||++..
T Consensus 812 ilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999999876
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=357.04 Aligned_cols=255 Identities=45% Similarity=0.856 Sum_probs=215.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee--cceEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLY 432 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~--~~~l~ 432 (741)
.|++++.||+|+||.||+|.+..++..||+|++...............+.+|+.+++.++|+||+++++.+.. .+.++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5899999999999999999999999999999887544333344456778999999999999999999998765 36789
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
++|||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 83 l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999764 458999999999999999999999999999999999999999999999999987653211
Q ss_pred ---cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--cCCCCCccC
Q 004633 512 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEML 586 (741)
Q Consensus 512 ---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP~~l 586 (741)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.+.++.. ..+.++..+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISG-------EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHI 234 (266)
T ss_pred cCCccccCCccccccCHHHhCC-------CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhc
Confidence 1123458899999999853 3567899999999999999999999988766655554432 234567778
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
+..++++| +||..+|++||+++|+++||||+
T Consensus 235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 89999999 67778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=354.27 Aligned_cols=255 Identities=38% Similarity=0.624 Sum_probs=218.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... .+..+.+.+|+.+++.++||||+++++++..++.+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-----GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-----hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence 467999999999999999999999999999999987432 123467889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
++|||+.+++|.+++......+++.+++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+....
T Consensus 77 l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred EEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999999999997765679999999999999999999999999999999999999999999999999997765432
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-----CCCccC
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-----PIPEML 586 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-----~iP~~l 586 (741)
......++..|+|||++.+.. ...++.++|||||||++|||++|+.||...........+..... ..+..+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~----~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVER----KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW 232 (262)
T ss_pred ccccccCCccccCchhhcccc----cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhh
Confidence 233456899999999986311 12567799999999999999999999988766555544433311 123346
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPF 616 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLqHpw 616 (741)
+.++.+||++||..||.+|||+.+++.|+|
T Consensus 233 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 233 SPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.67 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=215.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++++.||+|+||.||+|.++.+|..||+|++...... ......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE---GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc---chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 589999999999999999999999999999998753221 23346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--c
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--Y 512 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~--~ 512 (741)
|||+ +++|.+++......+++.+++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999 999999997766779999999999999999999999999999999999999999999999999998765432 1
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC------------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------------ 580 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~------------ 580 (741)
.....|+..|+|||++.+ ...++.++|||||||++|||++|.++|........+..++....
T Consensus 157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 157 YSHQVATRWYRAPELLYG------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred cccccCcccccCceeeec------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 234568999999998753 34567899999999999999999988877665554444332100
Q ss_pred ------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 581 ------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 581 ------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
.+...++.++.+||++||..||++||+++++|+||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01124578999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=357.08 Aligned_cols=253 Identities=29% Similarity=0.477 Sum_probs=221.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||.|+||.||+|.++.+++.||+|++..... ......+.+.+|++++++++||||+++++.+..++.+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC--VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh--cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 48999999999999999999999999999999874221 2223457889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~ 514 (741)
|||+.|++|.+++... ..+++..+..|+.||+.||.|||++||+|+||||+|||++.++.++|+|||++..........
T Consensus 79 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 79 VDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred EeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 9999999999999775 579999999999999999999999999999999999999999999999999998765544444
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc--HHHHHHHhc-cCCCCCccCCHHHH
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLN-RTPPIPEMLSSEGK 591 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~--~~~~~~i~~-~~~~iP~~ls~el~ 591 (741)
...|+..|+|||++.+ ..++.++||||||+++|+|++|..||..... ...+..... ....+|..++.++.
T Consensus 158 ~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (258)
T cd05578 158 STSGTPGYMAPEVLCR-------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAI 230 (258)
T ss_pred ccCCChhhcCHHHHcc-------cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHH
Confidence 5678999999999863 3467899999999999999999999987664 233333333 56677888999999
Q ss_pred HHHHHhhhcCCCCCCCH--HHHHcCccc
Q 004633 592 DFLLRCFLRNPVERPSA--VELLEHPFI 617 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa--~ElLqHpwf 617 (741)
++|.+||..||.+|+++ .|+++||||
T Consensus 231 ~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 231 DAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 99999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.58 Aligned_cols=259 Identities=35% Similarity=0.572 Sum_probs=220.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|++.+.||+|+||.||+|.+..++..+++|.+... .....+.+.+|+++++.++|+||+++++++..++..|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence 478899999999999999999999999999987531 233456788899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~ 513 (741)
|||+.+|+|..++......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 99999999999886655679999999999999999999999999999999999999999999999999987654322 22
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC---CCCCccCCHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSEG 590 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---~~iP~~ls~el 590 (741)
....|+..|+|||++..... ....++.++|||||||++|||++|+.||......+....+.... ...+..++.++
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238 (282)
T ss_pred ccccccccccCHhhccccCC--CCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence 34568999999999853211 13456789999999999999999999998877666666554432 23456788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
++||.+||..||.+||++.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=352.82 Aligned_cols=254 Identities=33% Similarity=0.623 Sum_probs=218.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||.|+||+||+|....++..+|+|++..... ......+.+|+++|+.++|+||+++++.+..++..|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc----chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 469999999999999999999999999999998763221 1245678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhc--cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 434 YLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~--~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++++++.+||+|||++..+....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999999764 2468999999999999999999999999999999999999999999999999997765432
Q ss_pred cc-----cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCC-CC--
Q 004633 512 YE-----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-IP-- 583 (741)
Q Consensus 512 ~~-----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~-iP-- 583 (741)
.. ....|+..|+|||++.. ...++.++|||||||++|||++|+.||......+...++...... ++
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQ------VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETG 230 (267)
T ss_pred cccccccccccCChhhcChHHHcc------ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCc
Confidence 22 34568999999999874 235678999999999999999999999887766666655544321 21
Q ss_pred ---ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 584 ---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 584 ---~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
..++.++.+||.+||..||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 2567899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.05 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=216.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||+|.++.+|+.||||.+...............+..|+++++.++|+||+++++++..++.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 48899999999999999999999999999999875433322233445677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~ 513 (741)
|||+ +|+|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++.+|.+||+|||++....... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 899999997754479999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--------------
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------------- 579 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-------------- 579 (741)
....++..|+|||.+.+ ...++.++|||||||++|||++|.++|......+.+.++....
T Consensus 160 ~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 160 THQVVTRWYRAPELLFG------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred cccccceeeeCHHHHhC------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 23456889999999853 3456789999999999999999988888766555444443210
Q ss_pred ---------C-----CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 ---------P-----PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 ---------~-----~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
. .+...++.++.+||.+||..||++|||+.|+|+|+||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0 01134578899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=352.96 Aligned_cols=250 Identities=40% Similarity=0.700 Sum_probs=217.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||.||+|..+.++..+++|.+... ...+.+.+|+++++.++|+||+++++.+..++.+|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 5799999999999999999999999999999988632 115678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
+|||+.+++|.+++......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... .
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999999999997766779999999999999999999999999999999999999999999999999998765433 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC---CCCCccCCHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSE 589 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---~~iP~~ls~e 589 (741)
.....|+..|+|||++.+ ..++.++||||||+|+|+|++|+.||...........+.... ...+..++.+
T Consensus 156 ~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQE-------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE 228 (256)
T ss_pred cccccCCccccCHHHHhc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHH
Confidence 234458999999999864 357789999999999999999999998766555444433221 2334567889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
+.++|.+||..||++|||+.|+|+|+||
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=388.87 Aligned_cols=251 Identities=28% Similarity=0.513 Sum_probs=221.0
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
.+......+++++.||+|-||.||+|.++. ...||+|.++..... ...+.+|+.||++|+|+|||++|+++..
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~------~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS------PEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC------hhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 455666778889999999999999999875 358999988743211 1456689999999999999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhh-ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 428 DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~-~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
++.+||||||+..|+|.++|+. .+..+...+...|+.||++||+||.++++|||||..+||||++++.+||+|||||+.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 9999999999999999999987 567899999999999999999999999999999999999999999999999999997
Q ss_pred ccCcccccccCC--CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCC
Q 004633 507 LTGLSYELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPI 582 (741)
Q Consensus 507 ~~~~~~~~s~~G--T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~i 582 (741)
+.++.+.....+ -..|.|||.+. ...++.++|||||||+||||+| |+.||.+....+.+..+..+ +.+-
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~-------~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALN-------YGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR 425 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHh-------hCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC
Confidence 666555544333 45799999997 3578899999999999999999 99999999999998888754 5678
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELL 612 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElL 612 (741)
|..+++++.++|+.||..+|++|||++.+.
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 899999999999999999999999999665
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=357.81 Aligned_cols=254 Identities=36% Similarity=0.594 Sum_probs=213.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
..+|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+.+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 457999999999999999999999999999999986432 122345778999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
+||||+++++|.+++... +.+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 83 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999999998765 569999999999999999999999999999999999999999999999999987654321
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCC-----CccC
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI-----PEML 586 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~i-----P~~l 586 (741)
......|+..|+|||++... ....++.++|||||||++|||++|..||...........+....... ...+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred ccccccCcccccChhhhccc----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 22345689999999997421 12356789999999999999999999997665544444333222111 1246
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPF 616 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLqHpw 616 (741)
+..+.+||.+||..||++||+++++++|||
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=380.02 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=202.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
...|++++.||+|+||.||+|.+..++..||+|+... .....|+.+|+.++|+|||++++++...+..+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----------cccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3479999999999999999999999999999996432 12345899999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
+||||+. ++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 9999995 688888877667799999999999999999999999999999999999999999999999999976544334
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCC-CCCCcH---------HHHHHHhcc----
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW-SEFEGP---------QAMFKVLNR---- 578 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF-~~~~~~---------~~~~~i~~~---- 578 (741)
.....||..|+|||++.+ ..++.++||||||||+|||+++..++ ...... ..+..++..
T Consensus 213 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 213 FLGLAGTVETNAPEVLAR-------DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred cccccccccccCCeecCC-------CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 445679999999999863 45788999999999999999855444 332111 111111110
Q ss_pred CCCCC------------------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 579 TPPIP------------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 579 ~~~iP------------------------------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
...++ ..++.++.+||.+||..||++|||+.|+|+||||++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00111 134667788999999999999999999999999975
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=365.22 Aligned_cols=253 Identities=31% Similarity=0.545 Sum_probs=212.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||.||++.+..++..+|+|.+... ...+...++.+|+++|++++||||+++++.+..++.+|+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE----IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEE
Confidence 3699999999999999999999999999999987632 123445678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
||||+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++...... .
T Consensus 77 v~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 154 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 154 (308)
T ss_pred EeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-c
Confidence 99999999999999765 668999999999999999999997 69999999999999999999999999998765332 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--------------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-------------- 578 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-------------- 578 (741)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+..... .++..
T Consensus 155 ~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 ANSFVGTRSYMSPERLQG-------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred cccCCCCcCccChhHhcC-------CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccc
Confidence 234678999999998853 34677999999999999999999999754432221 11110
Q ss_pred ------------------------CCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 579 ------------------------TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 579 ------------------------~~~iP-~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.+.+| ..++.++++||.+||..||++|||+.|+++||||...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 11111 1367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.89 Aligned_cols=255 Identities=36% Similarity=0.569 Sum_probs=212.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|++++.||+|+||.||+|.++.+++.||+|++..... .....+++|+.++++++||||+++++++..++.+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 34579999999999999999999999999999998864221 2234678899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 82 WICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999999999998664 568999999999999999999999999999999999999999999999999998664322
Q ss_pred -cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCC-----CCcc
Q 004633 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP-----IPEM 585 (741)
Q Consensus 512 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~-----iP~~ 585 (741)
......|+..|+|||.+.+. ....++.++|||||||++|||++|+.||...........+...... ....
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVE----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236 (267)
T ss_pred cccCccccCccccCHhHcccc----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccc
Confidence 22345689999999987531 1234677999999999999999999999765443333322222111 1234
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLqHpw 616 (741)
++..+.+||.+||..||++|||++++|+|.|
T Consensus 237 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 6889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=354.33 Aligned_cols=256 Identities=37% Similarity=0.757 Sum_probs=216.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-ccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~-~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
+|+.++.||+|+||.||+|.++.+++.||+|++....... ......+.+.+|+++|+.++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4889999999999999999999999999999987433222 223356789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEeecccchhccCcc-
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g-~vKL~DFGLA~~~~~~~- 511 (741)
||||+.|++|.+++.+. ..+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 99999999999999764 5689999999999999999999999999999999999998776 69999999987664321
Q ss_pred ----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH---HHHHHh--ccCCCC
Q 004633 512 ----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ---AMFKVL--NRTPPI 582 (741)
Q Consensus 512 ----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~---~~~~i~--~~~~~i 582 (741)
......|+..|+|||++.+ ..++.++|||||||++|+|++|..||....... .+..+. .....+
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRG-------EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI 232 (268)
T ss_pred cCCccccccccccceeCHhHhcc-------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCC
Confidence 1223468899999999863 356779999999999999999999997544322 222221 234556
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
+..++.++.++|.+||..||.+||++.++++||||+
T Consensus 233 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 233 PEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred chhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 777899999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=353.81 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=218.1
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCC
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 441 (741)
||.|+||.||+|.+..+++.||+|++..... ......+.+.+|+++++.++|+||+++++.+.+++.+|+||||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI--VETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc--hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 6999999999999999999999999864322 22334567899999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCCC
Q 004633 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN 521 (741)
Q Consensus 442 sL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~GT~~ 521 (741)
+|.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.+||+|||++.............|+..
T Consensus 79 ~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 79 ELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred cHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 999999765 4589999999999999999999999999999999999999999999999999987765433444578999
Q ss_pred CCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC--cHHHHHHHh--ccCCCCCccCCHHHHHHHHHh
Q 004633 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--GPQAMFKVL--NRTPPIPEMLSSEGKDFLLRC 597 (741)
Q Consensus 522 Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~--~~~~~~~i~--~~~~~iP~~ls~el~dLI~~c 597 (741)
|++||.+.+ ..++.++||||||+++|+|++|..||.... ..+...++. .....+|..++.++.++|.+|
T Consensus 158 ~~~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 230 (262)
T cd05572 158 YVAPEIILN-------KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQL 230 (262)
T ss_pred ccChhHhcC-------CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence 999999753 356788999999999999999999998766 555566666 445667777899999999999
Q ss_pred hhcCCCCCCC-----HHHHHcCccccccc
Q 004633 598 FLRNPVERPS-----AVELLEHPFIRNAN 621 (741)
Q Consensus 598 L~~DP~kRPT-----a~ElLqHpwf~~~~ 621 (741)
|..||++|++ ++|+++||||....
T Consensus 231 l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 231 LRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred ccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 9999999999 99999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.40 Aligned_cols=257 Identities=34% Similarity=0.637 Sum_probs=213.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeec---
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD--- 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~--- 428 (741)
...|++.+.||+|+||.||+|.++.+++.||+|++..... ....+.+|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4568999999999999999999999999999999864321 124577899999998 699999999988753
Q ss_pred ---ceEEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccc
Q 004633 429 ---DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (741)
Q Consensus 429 ---~~l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA 504 (741)
..+|+||||+.+|+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999999764 346899999999999999999999999999999999999999999999999999
Q ss_pred hhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CC
Q 004633 505 KHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PP 581 (741)
Q Consensus 505 ~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~ 581 (741)
...... .......|+..|+|||++.+... .+..++.++|||||||++|||++|+.||...........+.... ..
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDEN--PDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccC--cCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 765432 22334678999999999864211 13457889999999999999999999998765544444333221 22
Q ss_pred CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 582 iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.+..++.++.+||.+||..||.+|||+.|+++||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 334578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=389.04 Aligned_cols=267 Identities=27% Similarity=0.470 Sum_probs=218.7
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeec
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD 428 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~ 428 (741)
.....+|++++.||+||.++||++.... ...||+|.+.... .....+.-+.+||.+|.+|+ |.+||+||+|...+
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~---~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE---ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh---cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 3556789999999999999999998654 4556666554322 33455678899999999996 99999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
+.+||||||-+ -+|..+|++....+....++.|.+||+.||+++|..||||.||||.|+|| -.|.+||+|||+|..+.
T Consensus 433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence 99999999965 78999998876667767999999999999999999999999999999999 67899999999999886
Q ss_pred Ccc---cccccCCCCCCCChHHHHHhhhcCC----CCCCCccchhhhHHHHHHHHhhCCCCCCCCCc-HHHHHHHhccCC
Q 004633 509 GLS---YELSLKGSPNWMAPEVIKAVMQKDG----NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLNRTP 580 (741)
Q Consensus 509 ~~~---~~~s~~GT~~Y~APEvl~~~~~~~g----~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~-~~~~~~i~~~~~ 580 (741)
... ...+.+||+.||+||.+........ .-.++.++||||||||||+|+.|+.||..+.. ..-+..|.+...
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH 590 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence 644 3346789999999999986433211 12378899999999999999999999987753 334445554433
Q ss_pred --CCCccCCHH-HHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 581 --PIPEMLSSE-GKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 581 --~iP~~ls~e-l~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
++|..-... +.++++.||.+||++||++.|+|+|||++....
T Consensus 591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 455544444 999999999999999999999999999976443
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=427.64 Aligned_cols=259 Identities=44% Similarity=0.779 Sum_probs=228.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.-+|+.+..||.|.||.||-|.+..+|+..|+|.|++...+ ...++.+.+|+++|..|+|||||++||+..+.+.+|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~---~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD---HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc---cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34799999999999999999999999999999999876554 445577889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
|+||||+||+|.++++. ++..+|...+.+..|++.||.|||++|||||||||+||||+.+|.+|++|||.|..+.....
T Consensus 1311 IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999999854 57788999999999999999999999999999999999999999999999999988766532
Q ss_pred c-----cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH-HHHHHHh-ccCCCCCcc
Q 004633 513 E-----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVL-NRTPPIPEM 585 (741)
Q Consensus 513 ~-----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~-~~~~~i~-~~~~~iP~~ 585 (741)
+ ....||+.|||||++.+... .....++||||||||+.||+||+.||...+.. ++++++. +..+.+|+.
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~----kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKG----KGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER 1465 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhccccc----CCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh
Confidence 2 24679999999999987432 23455999999999999999999999877655 4445543 567889999
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
++.+.++||.+||..||++|+++.|+|+|.|-+.
T Consensus 1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred hhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 9999999999999999999999999999998754
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=356.49 Aligned_cols=255 Identities=39% Similarity=0.661 Sum_probs=220.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++..+..+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE----AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc----cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEE
Confidence 36899999999999999999999999999999886421 12234567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-cc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~-~~ 512 (741)
|+||+.+++|.+++... .+++..++.++.||+.||.|||+++|+|+||+|+|||++.++.++|+|||+++.+... ..
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999999999764 7899999999999999999999999999999999999999999999999999877543 22
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCcc-CCHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEM-LSSEG 590 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~-ls~el 590 (741)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+... .+.++.. ++.++
T Consensus 155 ~~~~~~~~~y~~PE~~~~-------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQ-------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF 227 (274)
T ss_pred cccccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHH
Confidence 334568999999999863 34788999999999999999999999877665555554433 2334444 78999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.++|.+||..||++|||++++++|+||....
T Consensus 228 ~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 228 KDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=348.90 Aligned_cols=253 Identities=27% Similarity=0.518 Sum_probs=219.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||+|.+..+++.+|||.+..... ..+..+.+.+|+.+|+.++|+||+++++.+..++.+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM---TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc---ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 58999999999999999999999999999999874322 223356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchhccCccc
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-g~vKL~DFGLA~~~~~~~~ 512 (741)
|||+.+++|.+++.+. ...+++..+..++.||+.||+|||++||+|+||||+|||++.+ +.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999999764 3458999999999999999999999999999999999999865 4689999999987755444
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK 591 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~ 591 (741)
.....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+... ...++..++.+++
T Consensus 158 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 230 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-------KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLR 230 (256)
T ss_pred ccccccCCcccCchhccC-------CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHH
Confidence 445678999999999863 34677999999999999999999999887766666555543 3456777899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
++|.+||..||++|||+.|+|+||||
T Consensus 231 ~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 231 QLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=359.93 Aligned_cols=262 Identities=31% Similarity=0.589 Sum_probs=218.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++++++|+||+++++.+..++.+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL----DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc----CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEE
Confidence 36899999999999999999999999999999886421 22334678889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhc--cccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 434 YLEYVHPGSINRYVREH--CRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~--~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
||||+++++|..++... ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++..+...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999988663 2368999999999999999999997 59999999999999999999999999999766432
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHH---HHhc-cCCCCCccC
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLN-RTPPIPEML 586 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~---~i~~-~~~~iP~~l 586 (741)
......|+..|+|||++.+... .....++.++|||||||++|||++|+.||.......... .+.. ....++..+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGP-NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -ccccCCCccCccCcchhcCCCC-CccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 2234568899999999864211 123356789999999999999999999997654433222 2332 334567779
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+.++.+||.+||..+|++||++.++++|+||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=357.27 Aligned_cols=252 Identities=30% Similarity=0.554 Sum_probs=210.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|++.++||+|+||.||+|.+..+++.||+|++... ...+..+.+.+|+++|++++||||+++++++...+..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 76 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD----ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISI 76 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC----CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEE
Confidence 3688999999999999999999999999999988642 123344678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
||||+++|+|..+ ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+... ..
T Consensus 77 v~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~ 150 (279)
T cd06619 77 CTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IA 150 (279)
T ss_pred EEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cc
Confidence 9999999998654 24788999999999999999999999999999999999999999999999999766433 23
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH-------HHHHHHhccC-CCC-Cc
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-------QAMFKVLNRT-PPI-PE 584 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~-------~~~~~i~~~~-~~i-P~ 584 (741)
....||..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.... ... ..
T Consensus 151 ~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd06619 151 KTYVGTNAYMAPERISG-------EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223 (279)
T ss_pred cCCCCChhhcCceeecC-------CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence 34679999999999863 35778999999999999999999999653221 1122222221 222 23
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
.++.++.+||.+||..||++||+++|+++|+||...+.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 47889999999999999999999999999999976643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=403.57 Aligned_cols=265 Identities=28% Similarity=0.490 Sum_probs=222.2
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
......+|++++.||+|+||+||+|+++.++..||+|++..... .......+..|+.+|+.|+|||||+++++|...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l---~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL---KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc---CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 34556789999999999999999999999999999999874322 233456788999999999999999999988654
Q ss_pred --ceEEEEEeecCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHhC-------CeecccCCCcceEecC----
Q 004633 429 --DHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHST-------NTIHRDIKGANLLVDA---- 492 (741)
Q Consensus 429 --~~l~LVmEy~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs~-------gIVHRDIKP~NILLd~---- 492 (741)
..+||||||+.+|+|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 5699999999999999999653 35699999999999999999999984 4999999999999964
Q ss_pred -------------CCcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhC
Q 004633 493 -------------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 559 (741)
Q Consensus 493 -------------~g~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtG 559 (741)
.+.+||+|||++..+..........||+.|+|||++.+. ...++.++||||||||||||++|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge-----~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE-----TKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc-----CCCCCchhHHHHHHHHHHHHHHC
Confidence 245999999999877554444566799999999998641 23577899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHhccCCCCC-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 560 KPPWSEFEGPQAMFKVLNRTPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 560 k~PF~~~~~~~~~~~i~~~~~~iP-~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+.||........+...+...+.++ ..++.++.+||..||..+|.+||++.|+|+|+|++...
T Consensus 240 k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999987666655555554444443 45789999999999999999999999999999997553
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=354.81 Aligned_cols=251 Identities=22% Similarity=0.405 Sum_probs=211.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k---~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
...+|++.+.||+|+||.||+|.++ ..+..||+|.++.. ......+.+.+|+.+|++++||||+++++++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG----CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 3457999999999999999999875 34568999987642 1223346788999999999999999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
+..+|||||+.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999999999997765679999999999999999999999999999999999999999999999999876543
Q ss_pred Cccccc--ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCc
Q 004633 509 GLSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 584 (741)
Q Consensus 509 ~~~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~ 584 (741)
...... ...++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+.+..+... ..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQY-------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR 231 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhh-------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC
Confidence 222111 2335678999999863 457789999999999999775 99999987776666655543 345677
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.++..+.++|.+||..+|.+||+++||++
T Consensus 232 ~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 232 NCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 88999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=352.58 Aligned_cols=258 Identities=37% Similarity=0.657 Sum_probs=215.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecc-
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~- 429 (741)
..++|++.+.||+|+||+||+|.++.+++.+++|++.... .....+.+|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE------DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc------hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 3468999999999999999999999999999999886422 1235688999999999 6999999999987644
Q ss_pred -----eEEEEEeecCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004633 430 -----HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (741)
Q Consensus 430 -----~l~LVmEy~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DF 501 (741)
.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 589999999999999998653 357899999999999999999999999999999999999999999999999
Q ss_pred ccchhccCcc-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC
Q 004633 502 GMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 580 (741)
Q Consensus 502 GLA~~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~ 580 (741)
|++....... ......|+..|+|||++..... ....++.++|||||||+||+|++|+.||...........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQ--PDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhccccc--ccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 9987654322 2234568999999999864322 134577899999999999999999999987666566665554322
Q ss_pred ---CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 581 ---PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 ---~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
..+..++.++++||.+||..||++|||+.|+++|||+
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=347.95 Aligned_cols=253 Identities=32% Similarity=0.514 Sum_probs=217.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee--cceEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLY 432 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~--~~~l~ 432 (741)
+|++.+.||.|+||.||+|.+..++..||+|++.... ......+++.+|+.+++.++|+||+++++.+.. +..+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc---CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 5899999999999999999999999999999886422 223445678899999999999999999997764 45689
Q ss_pred EEEeecCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHH-----hCCeecccCCCcceEecCCCcEEEeecccc
Q 004633 433 IYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLH-----STNTIHRDIKGANLLVDASGVVKLADFGMA 504 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLH-----s~gIVHRDIKP~NILLd~~g~vKL~DFGLA 504 (741)
++|||+.+++|.+++... ...+++..++.++.||+.||+||| +.+|+|+||||+|||++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999999653 456899999999999999999999 999999999999999999999999999999
Q ss_pred hhccCccc-ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCC
Q 004633 505 KHLTGLSY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPI 582 (741)
Q Consensus 505 ~~~~~~~~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~i 582 (741)
........ .....|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...+.......+.... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd08217 158 KILGHDSSFAKTYVGTPYYMSPEQLNH-------MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRI 230 (265)
T ss_pred ccccCCcccccccccCCCccChhhhcC-------CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCC
Confidence 87755433 334578999999999863 346788999999999999999999998877555555554433 356
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
+..++.++.++|.+||..+|++||++.+||+|||+
T Consensus 231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 77889999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=386.01 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=203.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++|+|+|||++++++..++..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 4579999999999999999999999999999995321 23567999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
|||||+. ++|..++......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9999995 78888887655679999999999999999999999999999999999999999999999999998664322
Q ss_pred --cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc-------HHHHHHHhcc-C--
Q 004633 512 --YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-------PQAMFKVLNR-T-- 579 (741)
Q Consensus 512 --~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~-------~~~~~~i~~~-~-- 579 (741)
......||+.|||||++.+ ..++.++||||||||||||++|..++..... ...+.+++.. .
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~-------~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAG-------DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred cccccccCCCcCCcCHHHHcC-------CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 1224569999999999863 4578899999999999999998765432111 1122222111 0
Q ss_pred -CCCC-------------------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 580 -PPIP-------------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 580 -~~iP-------------------------------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
..++ ..++.++.+||.+||..||.+|||+.|+|+|+||+.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0011 124568999999999999999999999999999964
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=360.59 Aligned_cols=255 Identities=36% Similarity=0.598 Sum_probs=216.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|++.+.||+|+||.||+|.++.+++.||+|.+...... ....+.+|+.+++.++|+||+++++.+..++..
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-----KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 346899999999999999999999999999999988742221 235678899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|+||||+.+++|.+++.+ ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred EEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999999999865 358899999999999999999999999999999999999999999999999987654332
Q ss_pred -cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-cC--CCCCccCC
Q 004633 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RT--PPIPEMLS 587 (741)
Q Consensus 512 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-~~--~~iP~~ls 587 (741)
......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+.. .. ...+..++
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (296)
T ss_pred cccCcccCCccccCHHHHcC-------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccC
Confidence 2223568999999999863 3467899999999999999999999987665444333332 21 23456788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
..+.+||.+||..||++||++.++++|+||...
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=354.59 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=206.8
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeec--ceEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD--DHLY 432 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~--~~l~ 432 (741)
|++.+.||+|+||.||+|.++.++..||+|+++...... .. ....+|+.+++++. |+||+++++++.++ +.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 678999999999999999999999999999876432221 11 23346888898885 99999999999887 8899
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
+||||+. |+|.+++......+++.+++.++.||+.||.|||+.||+||||||+|||++. +.+||+|||++..+.....
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 77 LVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred EEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9999997 5788888765567999999999999999999999999999999999999999 9999999999987755444
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--------------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-------------- 578 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-------------- 578 (741)
.....++..|+|||++.. ...++.++|||||||++|||++|..||...+..+.+..+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 155 YTEYISTRWYRAPECLLT------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred cCCCCCCcccCChhHhhc------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 344568999999998753 245677999999999999999999999876655444333211
Q ss_pred ----CCCC-----------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 579 ----TPPI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 579 ----~~~i-----------P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
...+ ...++.++++||.+||..||++||+++++|+||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0011 12467999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.93 Aligned_cols=253 Identities=30% Similarity=0.529 Sum_probs=219.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||++.++.+|+.||+|.+...... ....+.+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS---PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC---hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 589999999999999999999999999999998743222 22345788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~- 512 (741)
|||+.+++|.+++... ...+++.++..|+.||+.||.|||++||+|+||+|+|||++.++.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999999998764 23588999999999999999999999999999999999999999999999999976644322
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK 591 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el~ 591 (741)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....++.+. ...+..++.++.
T Consensus 158 ~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLR 230 (256)
T ss_pred hhhccCCccccCHHHhCC-------CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence 223458899999999863 356779999999999999999999998877766666665443 456778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
++|.+||..+|.+||++.++|+|+||
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=355.02 Aligned_cols=260 Identities=35% Similarity=0.630 Sum_probs=213.4
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceee--
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEV-- 426 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~-- 426 (741)
.....+|++.+.||+|+||+||+|.++.+++.+|+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH------DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc------chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 345668999999999999999999999999999999875321 1124577899999999 6999999999874
Q ss_pred ---ecceEEEEEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEee
Q 004633 427 ---VDDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500 (741)
Q Consensus 427 ---~~~~l~LVmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~D 500 (741)
.++.+|+||||++|++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 34579999999999999998753 235689999999999999999999999999999999999999999999999
Q ss_pred cccchhccCcc-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC
Q 004633 501 FGMAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 579 (741)
Q Consensus 501 FGLA~~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~ 579 (741)
||++..+.... ......|+..|+|||++...... ...++.++|||||||++|||++|+.||........+.++....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 245 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL--DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhhhc--cccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC
Confidence 99987664322 22345689999999998642211 2347789999999999999999999998766555444433221
Q ss_pred ---CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 ---PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 ---~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
...+..++.++.+||.+||..||++|||+.|+|+|+||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22355678899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=361.73 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=213.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--ce
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH 430 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~~ 430 (741)
..+|++.+.||+|+||.||+|.++.+|+.||+|+++....... ....+.+|+.+|++++|+||+++++++... +.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG---IPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC---CcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 4579999999999999999999999999999999875332211 112456799999999999999999988765 56
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
+|+||||+. ++|.+++......+++.+++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 899999997 4788888765567999999999999999999999999999999999999999999999999999876543
Q ss_pred c-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC----------
Q 004633 511 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---------- 579 (741)
Q Consensus 511 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---------- 579 (741)
. ......++..|+|||++.+ ...++.++|||||||++|||++|+.||...+..+.+..+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLG------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred cCCCCcccccccccChhhhcC------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 2 1222346888999999863 3457789999999999999999999998877666655544310
Q ss_pred ---------CCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 ---------PPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 ---------~~iP-----------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
..++ ..++.++.+||.+||..||++|||+.|+|+|+||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 0011 12578899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=346.61 Aligned_cols=253 Identities=28% Similarity=0.516 Sum_probs=219.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|+..++||.|+||.||.++...+++.+++|.+...... ....+++.+|+.+|++++|+||+++++++.+++.+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc---hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 589999999999999999999999999999988643222 23346688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
|||+.+|+|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 9999999999999764 4568999999999999999999999999999999999999999999999999997664433 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGK 591 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el~ 591 (741)
.....|++.|+|||++.+ ..++.++||||||+++|||++|..||......+....+..+. ...+..++.++.
T Consensus 158 ~~~~~~~~~y~ape~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd08221 158 AETVVGTPYYMSPELCQG-------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI 230 (256)
T ss_pred ccccCCCccccCHhhcCC-------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHH
Confidence 334568999999999863 346678999999999999999999998877777666665443 334566889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
++|.+||..||++||++.++|+|+|+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCcCC
Confidence 99999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=360.31 Aligned_cols=256 Identities=36% Similarity=0.609 Sum_probs=219.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|++.+.||.|+||+||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++..++.+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-----PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 44679999999999999999999999999999998864221 1235678899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|+||||+.+++|..++.+ ..+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999999999999865 358999999999999999999999999999999999999999999999999988765432
Q ss_pred c-ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc---CCCCCccCC
Q 004633 512 Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLS 587 (741)
Q Consensus 512 ~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~---~~~iP~~ls 587 (741)
. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+... ....+..++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242 (296)
T ss_pred ccCCCcCCCccccCcchhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCC
Confidence 2 223568999999998863 45677999999999999999999999887665555444332 223456789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
..+.+||.+||..||.+||++.++++|+||+...
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.53 Aligned_cols=249 Identities=30% Similarity=0.529 Sum_probs=215.5
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||++.++.+++.||+|.++.... ....+.+.+|+.+++.++|+||+++++.+..++.+|+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS----SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc----hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 58999999999999999999999999999999864321 23346778899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
|||+++|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999999999988653 3458999999999999999999999999999999999999999999999999997664322 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK 591 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~ 591 (741)
.....|+..|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+... ...++..++..+.
T Consensus 157 ~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-------MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229 (255)
T ss_pred cccccCCccccCHHHHcc-------CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHH
Confidence 234568999999999863 35778999999999999999999999887666665555443 3456778899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcC
Q 004633 592 DFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+||.+||..||++||++.+++.-
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 99999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.22 Aligned_cols=242 Identities=21% Similarity=0.308 Sum_probs=207.6
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee----cceEEEEE
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYL 435 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~----~~~l~LVm 435 (741)
..||+|++|.||+|.+ +|+.||||+++... .......+.+.+|+.+|++++|||||++++++.+ ...+++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFH--KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccc--cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence 6799999999999987 58999999886432 2334446778899999999999999999999876 34789999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~ 514 (741)
||+.+|+|.+++.+. ..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...... .
T Consensus 102 Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~ 178 (283)
T PHA02988 102 EYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--F 178 (283)
T ss_pred EeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--c
Confidence 999999999999765 568999999999999999999998 599999999999999999999999999998664322 2
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--cCCCCCccCCHHHHH
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 592 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--~~~~iP~~ls~el~d 592 (741)
...||..|+|||++.+. ...++.++|||||||++|||++|+.||.+....+....+.. ....+|..++.++++
T Consensus 179 ~~~~~~~y~aPE~~~~~-----~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~ 253 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDI-----FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKC 253 (283)
T ss_pred cccCcccccCHHHhhhc-----cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence 45689999999998742 24678899999999999999999999998877776666643 344566678999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHc
Q 004633 593 FLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 593 LI~~cL~~DP~kRPTa~ElLq 613 (741)
||.+||+.||++|||+.|+++
T Consensus 254 li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 254 IVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHhcCCcccCcCHHHHHH
Confidence 999999999999999999985
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=412.17 Aligned_cols=272 Identities=27% Similarity=0.408 Sum_probs=237.5
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
.....+|.++++||+|+||.|.+++.+.+++.||+|++.+... ........|..|-.||..-+.+=||+++.+|.++.
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eM--lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEM--LKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHH--hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3456789999999999999999999999999999998764110 11111245778999999989999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
++||||||+.||+|..++.+.. .++|..++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.+..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 9999999999999999998875 899999999999999999999999999999999999999999999999999877654
Q ss_pred cc--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--CCCCC--
Q 004633 510 LS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP-- 583 (741)
Q Consensus 510 ~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP-- 583 (741)
+. .....+|||.|++||+|+... ++...|+..+|+||+||++|||+.|..||....-.+.+-+|++. ...+|
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~--~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~ 305 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQG--DGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE 305 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhc--CCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc
Confidence 33 334578999999999998642 23468999999999999999999999999999999999999876 45666
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccccccccCCCCC
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQNLSV 627 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPT---a~ElLqHpwf~~~~~~~~~~ 627 (741)
..+|.++++||.++|. +|+.|.. ++++..||||.+.+|.++..
T Consensus 306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~ 351 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRE 351 (1317)
T ss_pred cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhh
Confidence 5689999999999776 8899988 99999999999999876654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=389.05 Aligned_cols=240 Identities=33% Similarity=0.590 Sum_probs=217.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.....++-||.|+.|.||+|+.+ ++.||||+++. .-+.+|+-|++|+|+|||.+.|+|...-.+||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e------------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE------------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc--CceehhHHHhh------------hhhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 34455678999999999999876 68999997752 23458999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|||||..|-|...|+.. ..++...+..|.++|+.||.|||.++|||||||.-||||+.+..|||+|||-++........
T Consensus 190 iMEfCa~GqL~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK 268 (904)
T ss_pred eeeccccccHHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhh
Confidence 99999999999999775 67999999999999999999999999999999999999999999999999999999888888
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--CCCCCccCCHHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGK 591 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~~ls~el~ 591 (741)
++++||..|||||+++ +..+.+++|||||||||||||||..||.+.+...++.-+-.. ..++|..++..++
T Consensus 269 MSFaGTVaWMAPEvIr-------nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIR-------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFK 341 (904)
T ss_pred hhhhhhHhhhCHHHhh-------cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHH
Confidence 9999999999999997 578899999999999999999999999998887666655433 3577899999999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHP 615 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHp 615 (741)
-||++||.-.|..||++.|||.|-
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHH
Confidence 999999999999999999999884
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=354.03 Aligned_cols=259 Identities=35% Similarity=0.622 Sum_probs=215.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeec--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD-- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~-- 428 (741)
...+|++.+.||+|+||.||+|.++.+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 3567999999999999999999999999999999875321 1234677899999999 799999999988754
Q ss_pred ---ceEEEEEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004633 429 ---DHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (741)
Q Consensus 429 ---~~l~LVmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFG 502 (741)
+.+|+||||+.+|+|.+++.. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 358999999999999998853 33568999999999999999999999999999999999999999999999999
Q ss_pred cchhccCcc-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-
Q 004633 503 MAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP- 580 (741)
Q Consensus 503 LA~~~~~~~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~- 580 (741)
++....... ......|+..|+|||++..... .+..++.++|||||||++|||++|+.||........+..+.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ--YDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCC--cccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 998664322 2234568999999999864211 122467899999999999999999999988776666655543322
Q ss_pred --CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 581 --PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 581 --~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
..+..+..++.+||.+||..||++||++.|+++||||+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23556778999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=387.90 Aligned_cols=262 Identities=27% Similarity=0.449 Sum_probs=240.4
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
......|.+.+.||+|.|++|.+|++..++..||||+|+....+ ......+.+|+++|..|+|||||+++.+.+.+.
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln---~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN---PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC---hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 34456799999999999999999999999999999988754433 333445889999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+||||+.+|++++++.++ +.+.+.+++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++..+..
T Consensus 129 ~lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999999999887 4577799999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHH
Q 004633 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSE 589 (741)
Q Consensus 510 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~e 589 (741)
.....+.+|++.|.|||++.+ ..+.++.+|+||+|+|||-|+.|.+||++..-.+.....+.+...+|..++.+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g------~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~d 281 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNG------KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCD 281 (596)
T ss_pred cccccccCCCCCccChHhhcC------cccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeech
Confidence 888889999999999999985 45677899999999999999999999999888888888888889999999999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+.+||+++|.++|.+|++.+++++|.|+-...
T Consensus 282 ce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 282 CEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred hHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 99999999999999999999999999986543
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.30 Aligned_cols=252 Identities=44% Similarity=0.775 Sum_probs=210.8
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
......||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 33446899999999999999999999999987632 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhccccc--cHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccCcc-
Q 004633 436 EYVHPGSINRYVREHCRDI--TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~l--se~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~-~g~vKL~DFGLA~~~~~~~- 511 (741)
||+.+++|.+++......+ ++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999999997654445 88899999999999999999999999999999999976 6799999999987654322
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHH-HHH--HhccCCCCCccCCH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFK--VLNRTPPIPEMLSS 588 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~-~~~--i~~~~~~iP~~ls~ 588 (741)
......|+..|+|||++.+ +...++.++||||||+++|+|++|+.||........ ... .......+|..+++
T Consensus 165 ~~~~~~~~~~~~aPE~~~~-----~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDK-----GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA 239 (268)
T ss_pred ccccCCCCccccChhhhcc-----ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence 2223468999999999853 123467899999999999999999999976543322 222 22344567788999
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
++++||.+||..+|.+|||+.|+++||||
T Consensus 240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 240 EAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.13 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=204.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC----------------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~----------------tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H 415 (741)
...+|++.++||+|+||.||+|.+.. ++..||+|++... ........+.+|+++|..++|
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~h 78 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD----ANKNARNDFLKEVKILSRLKD 78 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC----CCHHHHHHHHHHHHHHhhcCC
Confidence 35689999999999999999998643 3447999987632 123345678899999999999
Q ss_pred CCeeeecceeeecceEEEEEeecCCCChhhhhhhcc------------------ccccHHHHHHHHHHHHHHHHHHHhCC
Q 004633 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC------------------RDITESIVRNFTRHILNGLAYLHSTN 477 (741)
Q Consensus 416 PNIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~------------------~~lse~~i~~i~~QIl~aL~yLHs~g 477 (741)
||||++++++...+..+|||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++|
T Consensus 79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999999985431 23677889999999999999999999
Q ss_pred eecccCCCcceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHH
Q 004633 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 554 (741)
Q Consensus 478 IVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLy 554 (741)
|+||||||+||||+.++.+||+|||+++.+..... .....++..|||||++.+ ..++.++|||||||++|
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~ 231 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-------GKFTTASDVWAFGVTLW 231 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-------CCCCchhhhHHHHHHHH
Confidence 99999999999999999999999999976543221 123345789999999863 35788999999999999
Q ss_pred HHhh--CCCCCCCCCcHHHHHHHhc--------cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 555 EMLT--GKPPWSEFEGPQAMFKVLN--------RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 555 ELLt--Gk~PF~~~~~~~~~~~i~~--------~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
||++ +..||......+.+..+.. .....+..++..+.+||.+||..||++|||+.||.+
T Consensus 232 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 9986 6788887665554433221 112235567899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=354.07 Aligned_cols=254 Identities=27% Similarity=0.479 Sum_probs=206.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++.+.||+|+||+||+|.++.+++.||||.+........ ...+.+|+++++.++|+||+++++++..++..|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA----PFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC----chhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 4679999999999999999999999999999999874332211 123567999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-c
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~-~ 511 (741)
+||||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 80 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 9999998 4899988776567899999999999999999999999999999999999999999999999998754321 1
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc-HHHHHHHhc---cC--------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLN---RT-------- 579 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~-~~~~~~i~~---~~-------- 579 (741)
......++..|+|||++.+ ...++.++|||||||++|||++|+.||.+... .+.+..+.. ..
T Consensus 159 ~~~~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLG------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred cccccccccccCCcHHhhc------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 1122357889999999863 24567799999999999999999999976552 222221111 00
Q ss_pred ----------------C---CCCccCC--HHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 ----------------P---PIPEMLS--SEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 ----------------~---~iP~~ls--~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
. .....++ .++.++|.+||..||++|||+.|+|+|+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=376.86 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=206.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~--tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
...+|.+++.||+|+||.||+|.... ++..||+|.+... +.+.+|+++|+.|+|||||++++++..+.
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----------~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----------KTPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 34689999999999999999997653 5678999976521 23457999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+||||+. ++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9999999996 688888844 46799999999999999999999999999999999999999999999999999976644
Q ss_pred ccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc---HHHHHHHhcc-----
Q 004633 510 LSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMFKVLNR----- 578 (741)
Q Consensus 510 ~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~---~~~~~~i~~~----- 578 (741)
... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+... ...+..++..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLAL-------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred ccccccccccccccCccCHhHhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 322 224579999999999863 4577899999999999999999999976432 1112111110
Q ss_pred ----------------------C--CCCC-----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccC
Q 004633 579 ----------------------T--PPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 623 (741)
Q Consensus 579 ----------------------~--~~iP-----~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~~ 623 (741)
. ..++ ..++.++.+||.+||..||++|||+.|+|.||||......
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 0 0111 1346788999999999999999999999999999865543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.49 Aligned_cols=257 Identities=48% Similarity=0.842 Sum_probs=215.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----cccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~-----~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
+|.+.+.||.|+||.||+|.+..+|+.||+|.++..... .......+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 589999999999999999999999999999988642211 112334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999999776 5689999999999999999999999999999999999999999999999999976543
Q ss_pred cc---cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--CCCCCc
Q 004633 510 LS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPE 584 (741)
Q Consensus 510 ~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~ 584 (741)
.. ......|+..|+|||++... ...++.++||||||+|+|||++|..||...+..+.+.++... ...++.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSY-----SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPP 235 (272)
T ss_pred cccccccccccCCccccCHHHhccc-----cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCc
Confidence 21 12345689999999998641 124678999999999999999999999776655555444322 222332
Q ss_pred ----cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 585 ----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 585 ----~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.++.++.++|.+||..||++||+++++|+||||
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 236 DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 458899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=355.09 Aligned_cols=254 Identities=34% Similarity=0.535 Sum_probs=211.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.++||+|+||.||+|.++.+++.||+|++...... ....+.+.+|+++|+.++|+||+++++++..++..|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD---KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc---chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEE
Confidence 3699999999999999999999999999999987542221 1234567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
||||++++.|..++... ..+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++..+.... .
T Consensus 78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 78 VFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 99999999998877553 458999999999999999999999999999999999999999999999999997664322 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-------------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------- 579 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------- 579 (741)
.....++..|+|||++.+ ...++.++|||||||++|||++|++||......+....+....
T Consensus 157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 157 YTDYVATRWYRAPELLVG------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred cCcccceeeccCcHHhcc------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 223568899999999863 3456778999999999999999999997665444333322100
Q ss_pred ------CC------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 ------PP------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 ------~~------------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.. ....++..+.+||.+||..||++||++.++++|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=360.31 Aligned_cols=256 Identities=37% Similarity=0.606 Sum_probs=217.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 44689999999999999999999999999999998864221 1235578899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|+||||+++++|.+++.+ ..+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||++.......
T Consensus 92 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999999999865 358899999999999999999999999999999999999999999999999987654332
Q ss_pred c-ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-cC--CCCCccCC
Q 004633 512 Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RT--PPIPEMLS 587 (741)
Q Consensus 512 ~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-~~--~~iP~~ls 587 (741)
. .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.. .. ...+..++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLS 242 (297)
T ss_pred cCcCcccCCccccCHHHHcC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccC
Confidence 2 223568999999999863 4567899999999999999999999977655443333222 11 22456788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
..+++||.+||..||++||+++++|+||||+...
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 9999999999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=378.63 Aligned_cols=268 Identities=25% Similarity=0.406 Sum_probs=236.1
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
......|..-++||+||||.||-|+.+.||+.+|+|.+.+........ .....+|-.||.+++.+.||.+-.+|+..+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g--e~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG--ETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh--hHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 445667899999999999999999999999999999876433222222 245677899999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 430 HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
.++|||..|.||+|.-+|.+.+ ..++|..++.|+.+|+.||++||+.+||+|||||+|||||+.|+|+|.|+|||..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999999997763 479999999999999999999999999999999999999999999999999999998
Q ss_pred CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC----cHHHHHHHhccCCCCCc
Q 004633 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE----GPQAMFKVLNRTPPIPE 584 (741)
Q Consensus 509 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~----~~~~~~~i~~~~~~iP~ 584 (741)
........+||.+|||||++.. ..|+...|+|+|||+||||+.|+.||.... .+++-..++....++++
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~n-------e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~ 411 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQN-------EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD 411 (591)
T ss_pred CCCccccccCcccccCHHHHcC-------CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc
Confidence 8887777899999999999983 569999999999999999999999997543 23455566777788999
Q ss_pred cCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccccCCCC
Q 004633 585 MLSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQNLS 626 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~~~~~~ 626 (741)
..++++++|.+.+|.+||++|. .+.++.+||||+..+++.+.
T Consensus 412 kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rle 458 (591)
T KOG0986|consen 412 KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLE 458 (591)
T ss_pred ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHh
Confidence 9999999999999999999997 57799999999998876543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=355.12 Aligned_cols=252 Identities=28% Similarity=0.446 Sum_probs=213.5
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCC
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 441 (741)
||+|+||+||+|.++.+|+.||+|++..... ........+.+|+++|+.++||||+++++++...+.+|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL--KKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh--hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 6999999999999999999999998864221 11223445678999999999999999999999999999999999999
Q ss_pred Chhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCC
Q 004633 442 SINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520 (741)
Q Consensus 442 sL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~GT~ 520 (741)
+|.+++.... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............++.
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCC
Confidence 9999997643 369999999999999999999999999999999999999999999999999998765443334456889
Q ss_pred CCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc----HHHHHHHhccCCCCCccCCHHHHHHHHH
Q 004633 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPEMLSSEGKDFLLR 596 (741)
Q Consensus 521 ~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~~~~iP~~ls~el~dLI~~ 596 (741)
.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+......++..+++++.++|.+
T Consensus 159 ~y~~PE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 231 (277)
T cd05577 159 GYMAPEVLQG-------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA 231 (277)
T ss_pred CcCCHHHhcC-------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHH
Confidence 9999999863 3377899999999999999999999976543 2233333444556777889999999999
Q ss_pred hhhcCCCCCC-----CHHHHHcCcccccccc
Q 004633 597 CFLRNPVERP-----SAVELLEHPFIRNANY 622 (741)
Q Consensus 597 cL~~DP~kRP-----Ta~ElLqHpwf~~~~~ 622 (741)
||..||.+|| ++.++++||||...++
T Consensus 232 ~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 232 LLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred HccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 9999999999 8999999999976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.95 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=208.4
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHH-HHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecC
Q 004633 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (741)
Q Consensus 361 ~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~-~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 439 (741)
+||+|+||.||+|.+..+++.||||++..........+ .......++++++...||||+.+++++..++.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999874332211111 11122233445556689999999999999999999999999
Q ss_pred CCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCC
Q 004633 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 519 (741)
Q Consensus 440 gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~GT 519 (741)
||+|.+++... ..+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||++..+.... .....|+
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGT 158 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCC
Confidence 99999988664 569999999999999999999999999999999999999999999999999997664322 2345799
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC---cHHHHHHHhccCCCCCccCCHHHHHHHHH
Q 004633 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLNRTPPIPEMLSSEGKDFLLR 596 (741)
Q Consensus 520 ~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~---~~~~~~~i~~~~~~iP~~ls~el~dLI~~ 596 (741)
..|+|||++.+ ...++.++||||+||++|||++|+.||.... .......+......++..++.++.++|.+
T Consensus 159 ~~y~aPE~~~~------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 159 HGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCcCcHHhcC------CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH
Confidence 99999999863 2357789999999999999999999998663 22333334444566777889999999999
Q ss_pred hhhcCCCCCC-----CHHHHHcCcccccccc
Q 004633 597 CFLRNPVERP-----SAVELLEHPFIRNANY 622 (741)
Q Consensus 597 cL~~DP~kRP-----Ta~ElLqHpwf~~~~~ 622 (741)
||..||.+|+ ++.++++||||+...+
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 9999999999 9999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=359.45 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=218.2
Q ss_pred CCCCeEEe-eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeee--
Q 004633 352 KKSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV-- 427 (741)
Q Consensus 352 ~~~~Y~i~-k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~-- 427 (741)
...+|.+- ++||-|-.|+|..|.++.||+.+|+|++.- . ...++|+++.-.. .|||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s----~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------S----PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------C----HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 34567664 689999999999999999999999997652 1 2355688876655 49999999998764
Q ss_pred --cceEEEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC---CCcEEEeec
Q 004633 428 --DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADF 501 (741)
Q Consensus 428 --~~~l~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~---~g~vKL~DF 501 (741)
...+.||||.++||+|+..|++++ ..++|.++..|++||..||.|||+.+|.||||||+|+|++. +..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 356899999999999999998863 45999999999999999999999999999999999999975 457999999
Q ss_pred ccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc----HHHHHHHhc
Q 004633 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLN 577 (741)
Q Consensus 502 GLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~ 577 (741)
|+|+.........+.+.||+|.|||++. ...|+...|+||+|||||.||+|.+||....+ ..+..+|..
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg-------~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~ 281 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLG-------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT 281 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhC-------chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence 9999887777778899999999999985 45788999999999999999999999986543 345667778
Q ss_pred cCCCCCc----cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 578 RTPPIPE----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 578 ~~~~iP~----~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+...+|. .+|++++|+|+.+|..+|.+|.|++|++.|||+....
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 8777774 5789999999999999999999999999999997543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.27 Aligned_cols=258 Identities=36% Similarity=0.650 Sum_probs=213.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeee---
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV--- 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~--- 427 (741)
....|++.+.||.|+||.||+|.++.+++.||+|++... ......+..|+.+++.+ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT------EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 346799999999999999999999999999999987642 12235678899999998 69999999998853
Q ss_pred ---cceEEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004633 428 ---DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 428 ---~~~l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGL 503 (741)
.+.+|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 46789999999999999999763 34588999999999999999999999999999999999999999999999999
Q ss_pred chhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC--
Q 004633 504 AKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-- 580 (741)
Q Consensus 504 A~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-- 580 (741)
+...... .......|+..|+|||++... ......++.++|||||||++|||++|..||...........+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 245 (282)
T cd06636 168 SAQLDRTVGRRNTFIGTPYWMAPEVIACD--ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 245 (282)
T ss_pred hhhhhccccCCCcccccccccCHhhcCcc--cCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence 8765432 223346689999999987531 11234577899999999999999999999987665544444333221
Q ss_pred CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 ~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.....++.++.+||.+||..||.+|||+.|+|+||||
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=358.09 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=212.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--ceE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL 431 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l 431 (741)
.+|++.+.||.|+||.||+|.++.+++.+|+|.++..... ......+.+|+.+|+.++||||+++++++... +..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK---EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc---ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 4799999999999999999999999999999998743322 22234567899999999999999999998877 889
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~- 510 (741)
||||||+. ++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999997 5899988765556999999999999999999999999999999999999999999999999999876543
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-----------
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----------- 579 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~----------- 579 (741)
.......++..|+|||++.+ ...++.++||||||+++|||++|..||........+.++....
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLG------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred cccccccccccccCchhhcC------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 22233457899999999863 2346779999999999999999999998776655444432110
Q ss_pred --------------------CCCCcc-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 --------------------PPIPEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 --------------------~~iP~~-ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
..++.. ++..+.+||++||..||++|||+.|+|+|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112233 58889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.90 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=217.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||++.++.+++.||+|.+..... ........+.+|+.+++.++||||+++++.+..++.+|+|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL--ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 68999999999999999999999999999998764211 1223446788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc----
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL---- 510 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~---- 510 (741)
|||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 80 MEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999999765 56899999999999999999999999999999999999999999999999998632100
Q ss_pred ------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc
Q 004633 511 ------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR 578 (741)
Q Consensus 511 ------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~ 578 (741)
.......|+..|+|||.+.+ ..++.++|||||||++|||++|..||.+....+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~ 231 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 01112457889999998752 45778999999999999999999999887766666666554
Q ss_pred CCCCC---ccCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccccccc
Q 004633 579 TPPIP---EMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNAN 621 (741)
Q Consensus 579 ~~~iP---~~ls~el~dLI~~cL~~DP~kRPT---a~ElLqHpwf~~~~ 621 (741)
....+ ..++.++.++|.+||..||++||+ +.++|+||||....
T Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 43333 357899999999999999999997 79999999997644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=350.57 Aligned_cols=254 Identities=33% Similarity=0.579 Sum_probs=216.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||.|+||.||+|.++.+++.||+|.+..... .+..+.+.+|+++++.++||||+++++.+..++.+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 76 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN----EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISI 76 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC----hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEE
Confidence 368889999999999999999999999999998864322 2445678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
||||+.+++|.+++......+++..+..++.||+.||+|||+ .||+|+||||+||+++.++.+||+|||++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999999999997765679999999999999999999999 9999999999999999999999999999876643222
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC-----cHHHHHHHhcc-CCCCCcc-
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-----GPQAMFKVLNR-TPPIPEM- 585 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~-----~~~~~~~i~~~-~~~iP~~- 585 (741)
. ...|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..+.+..+... .+.++..
T Consensus 157 ~-~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd06605 157 K-TFVGTSSYMAPERIQG-------NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGK 228 (265)
T ss_pred h-cccCChhccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhh
Confidence 2 2678999999999863 357789999999999999999999997542 22333333332 2334444
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
++.++.++|.+||..||++|||+.|++.||||+.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 8899999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.19 Aligned_cols=246 Identities=26% Similarity=0.449 Sum_probs=191.6
Q ss_pred EeeEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee--cceEEE
Q 004633 358 KGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYI 433 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~--tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~--~~~l~L 433 (741)
.+.+||+|+||+||+|+++. ++..||+|.+.... . ...+.+|+++|+.++|||||++++++.. +..+|+
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---I----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---C----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 45789999999999999764 56889999875321 1 1346789999999999999999998854 467899
Q ss_pred EEeecCCCChhhhhhhc--------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEe----cCCCcEEEeec
Q 004633 434 YLEYVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADF 501 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~--------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILL----d~~g~vKL~DF 501 (741)
||||+. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 999987 4777776421 1348899999999999999999999999999999999999 56679999999
Q ss_pred ccchhccCcc----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH--------
Q 004633 502 GMAKHLTGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-------- 569 (741)
Q Consensus 502 GLA~~~~~~~----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~-------- 569 (741)
|+++.+.... ......||+.|+|||++.+ ...++.++|||||||++|||++|++||......
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~ 230 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFH 230 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcC------CCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccccc
Confidence 9998764322 1224568999999999863 345788999999999999999999999643221
Q ss_pred -HHHHHHhcc--------------CC------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHH
Q 004633 570 -QAMFKVLNR--------------TP------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVE 610 (741)
Q Consensus 570 -~~~~~i~~~--------------~~------------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~E 610 (741)
..+..+... .. ......+..+.+||.+||..||.+|||+.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e 310 (317)
T cd07867 231 HDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQ 310 (317)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHH
Confidence 111111000 00 001123567889999999999999999999
Q ss_pred HHcCccc
Q 004633 611 LLEHPFI 617 (741)
Q Consensus 611 lLqHpwf 617 (741)
+|+||||
T Consensus 311 ~l~hp~f 317 (317)
T cd07867 311 ALQDPYF 317 (317)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=360.70 Aligned_cols=259 Identities=25% Similarity=0.453 Sum_probs=222.9
Q ss_pred eEE-eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEEE
Q 004633 356 WQK-GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 356 Y~i-~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~L 433 (741)
|++ .++||+|+||.|--|....+|..||||+|++++.. ...++.+|++++.+++ |+||++|+++|++++.+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH-----sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH-----SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCch-----HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 444 57899999999999999999999999999865432 3467899999999996 9999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC---cEEEeecccchhccC-
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTG- 509 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g---~vKL~DFGLA~~~~~- 509 (741)
|||.+.||.|...|+++ +.++|.++..++++|+.||.|||.+||.||||||+|||..... -|||+||.|+..+.-
T Consensus 154 VfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred EEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 99999999999999886 7799999999999999999999999999999999999997654 589999999854422
Q ss_pred -------cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC---------------
Q 004633 510 -------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--------------- 567 (741)
Q Consensus 510 -------~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~--------------- 567 (741)
.....+.+|+..|||||+..-... ...+|+.++|.||||+|||.||.|.+||.+.-
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~--qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVD--QATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhcc--ccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 112345789999999999874332 24678999999999999999999999997532
Q ss_pred cHHHHHHHhccCCCCCc----cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 568 GPQAMFKVLNRTPPIPE----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 568 ~~~~~~~i~~~~~~iP~----~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
+...+..|..+...+|+ .++.+++|||..+|.+|+.+|.++.++++|||++....
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 23445667788888886 48999999999999999999999999999999986543
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=339.27 Aligned_cols=252 Identities=53% Similarity=0.966 Sum_probs=220.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--ceEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLY 432 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l~ 432 (741)
+|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.++++++|+||+++++.+... +.++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS---EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc---hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 488999999999999999999999999999998643322 34557889999999999999999999999888 8999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
+||||+.+++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 78 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999999997753 799999999999999999999999999999999999999999999999999987765443
Q ss_pred ---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC-cHHHHHHHh--ccCCCCCccC
Q 004633 513 ---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-GPQAMFKVL--NRTPPIPEML 586 (741)
Q Consensus 513 ---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~-~~~~~~~i~--~~~~~iP~~l 586 (741)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.... .......+. .....++..+
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRG-------EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHL 229 (260)
T ss_pred cccccCCCCCccccCHhhhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCccc
Confidence 345678999999998863 337789999999999999999999998766 233333333 2445677888
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
+.++.+||.+||..||.+||++.|+++||||
T Consensus 230 ~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 230 SEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=354.83 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=205.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-- 429 (741)
..++|++.+.||+|+||.||+|.++.+++.||||++....... .....+.+|++++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE---GFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC---CchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3457999999999999999999999999999999886432211 11234567999999999999999999876543
Q ss_pred ------eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004633 430 ------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 430 ------~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGL 503 (741)
..|+||||+. ++|.+++......+++.+++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4699999997 578888876555799999999999999999999999999999999999999999999999999
Q ss_pred chhccCccc-----ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc
Q 004633 504 AKHLTGLSY-----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR 578 (741)
Q Consensus 504 A~~~~~~~~-----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~ 578 (741)
+..+..... .....++..|+|||++.+ ...++.++||||||+++|||++|..||...+.......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcC------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 976643221 123457889999999863 234677899999999999999999999876554332221110
Q ss_pred C-------------------CCCC-------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 579 T-------------------PPIP-------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 579 ~-------------------~~iP-------------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
. ..++ ...+..+.+||.+||..||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 0011 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.58 Aligned_cols=254 Identities=32% Similarity=0.539 Sum_probs=213.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||.||+|.++.+++.||||+++.... .....+.+.+|+++|+.++|+||+++++++..++.+|+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED---DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc---cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEE
Confidence 369999999999999999999999999999998764322 22334678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-- 511 (741)
||||+.++.|..++.+. ..+++.+++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+....
T Consensus 78 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 78 VFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred EEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 99999987777666543 569999999999999999999999999999999999999999999999999998765543
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC------------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------ 579 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------ 579 (741)
......++..|+|||++.+ ...++.++||||||+++|+|++|+.||......+.+..+....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 157 PLTDYVATRWYRAPELLVG------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred cccCcccccCCcCCchhcC------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 2334568899999999864 2367789999999999999999999998765544433321100
Q ss_pred --------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 --------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 --------------------~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
..++..++.++++||++||..||++||+++++++|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01233458999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=383.93 Aligned_cols=257 Identities=35% Similarity=0.605 Sum_probs=226.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
..|.-++.||.|+||.||.|++..+.+.||||.+...... ..+-..++.+|+++|++|+|||+|.+.|+|.-+...||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ--s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ--SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccc--cHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 4588889999999999999999999999999988643332 23445778999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|||||- |+-.|++.-+.+.+-|-+|..|+.+.+.||.|||+.+.||||||..|||+++.|.|||+|||.|..... .
T Consensus 104 VMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---A 179 (948)
T KOG0577|consen 104 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---A 179 (948)
T ss_pred HHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---h
Confidence 999996 778888877778899999999999999999999999999999999999999999999999999987654 3
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCCC-ccCCHHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIP-EMLSSEGK 591 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP-~~ls~el~ 591 (741)
.+++|||+|||||++.... .+.|+-++|||||||+.+||...++|+...+....++.|.... +.++ ..++..++
T Consensus 180 nsFvGTPywMAPEVILAMD----EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~ 255 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 255 (948)
T ss_pred hcccCCccccchhHheecc----ccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHH
Confidence 4789999999999997542 2457779999999999999999999999999999988886543 3343 46899999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.||..||.+-|.+|||.+++|+|+|+...
T Consensus 256 ~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 256 NFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 99999999999999999999999999654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=350.29 Aligned_cols=261 Identities=30% Similarity=0.536 Sum_probs=210.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHH-HhhcCCCCeeeecceeeecceEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKV-LGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~i-L~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
++|++.+.||+|+||.||+|.++.+|+.||||.++..... .. ...+..|+.+ ++.++|+||+++++++..++.+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS---QE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc---HH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEE
Confidence 3699999999999999999999999999999988643211 11 2334455554 66678999999999999999999
Q ss_pred EEEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhC-CeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 433 IYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~-gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
+||||++ |+|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+.
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9999997 678777754 234689999999999999999999997 99999999999999999999999999998765
Q ss_pred CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC-cHHHHHHHhcc-CCCCC-cc
Q 004633 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-GPQAMFKVLNR-TPPIP-EM 585 (741)
Q Consensus 509 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~-~~~~~~~i~~~-~~~iP-~~ 585 (741)
.........|+..|+|||++.+... ...++.++|||||||++|||++|+.||.... ..+.+..+... ...++ ..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPELN---QKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEK 232 (283)
T ss_pred cccccccccCCccccChhhcCCccc---ccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccc
Confidence 4333334568999999998864211 1346789999999999999999999997533 23333343332 23333 35
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
++.++.+||.+||..+|++||++.++++|+||+....
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 7899999999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=345.25 Aligned_cols=250 Identities=30% Similarity=0.543 Sum_probs=216.1
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCC
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 441 (741)
||.|+||.||+|.+..+|+.+++|++.... .......+.+.+|+.+++.++|+||+++++.+..++..|+||||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh--hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 689999999999999999999999886322 122345677889999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc---------c
Q 004633 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---------Y 512 (741)
Q Consensus 442 sL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~---------~ 512 (741)
+|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++....... .
T Consensus 79 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 79 DLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999999775 479999999999999999999999999999999999999999999999999987653321 1
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccC--CHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML--SSEG 590 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~l--s~el 590 (741)
.....++..|+|||.+.+ ..++.++||||||+++|||++|..||......+....+.......+... +..+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd05579 158 DKRIVGTPDYIAPEVILG-------QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEA 230 (265)
T ss_pred ccCcccCccccCHHHhcC-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHH
Confidence 223568889999999863 3367799999999999999999999988777777766666555666655 8999
Q ss_pred HHHHHHhhhcCCCCCCCH---HHHHcCccccccc
Q 004633 591 KDFLLRCFLRNPVERPSA---VELLEHPFIRNAN 621 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa---~ElLqHpwf~~~~ 621 (741)
.+||.+||..+|++|||+ .++|+||||...+
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred HHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 999999999999999999 9999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=373.73 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=209.4
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeec
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY 422 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~t-----g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~ 422 (741)
+....++|++++.||+|+||.||+|++..+ +..||||+++... ..+....+.+|+.+|+.+ +|+|||+++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA----HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC----CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 345566899999999999999999986544 3579999886321 223346788999999999 899999999
Q ss_pred ceeeecceEEEEEeecCCCChhhhhhhcc---------------------------------------------------
Q 004633 423 GSEVVDDHLYIYLEYVHPGSINRYVREHC--------------------------------------------------- 451 (741)
Q Consensus 423 g~~~~~~~l~LVmEy~~gGsL~~lI~~~~--------------------------------------------------- 451 (741)
+++...+.+||||||+.+|+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999985421
Q ss_pred ------------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004633 452 ------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (741)
Q Consensus 452 ------------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~- 512 (741)
..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 2378889999999999999999999999999999999999999999999999976543221
Q ss_pred --ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc--CCCCCccCC
Q 004633 513 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLS 587 (741)
Q Consensus 513 --~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~--~~~iP~~ls 587 (741)
.....++..|||||++.+ ..++.++|||||||++|||++ |+.||........+.+++.. ....+..++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFD-------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAP 341 (374)
T ss_pred eeccCCCCccceeCHHHhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCC
Confidence 112235678999999862 457889999999999999997 99999876655544444432 334566789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+++++|.+||..||++|||+.++++
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.54 Aligned_cols=255 Identities=29% Similarity=0.490 Sum_probs=208.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecce--
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH-- 430 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~-- 430 (741)
++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 77 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE---EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNG 77 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc---cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCC
Confidence 3699999999999999999999999999999987653221 112346778999999995 6999999999887665
Q ss_pred ---EEEEEeecCCCChhhhhhhcc----ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecc
Q 004633 431 ---LYIYLEYVHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFG 502 (741)
Q Consensus 431 ---l~LVmEy~~gGsL~~lI~~~~----~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~-~g~vKL~DFG 502 (741)
+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 78 KPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred CceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 7888875432 35899999999999999999999999999999999999998 8999999999
Q ss_pred cchhccCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-
Q 004633 503 MAKHLTGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP- 580 (741)
Q Consensus 503 LA~~~~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~- 580 (741)
++..+... .......+++.|+|||++.+ ...++.++||||||+++|+|++|..||.+.+..+...++.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLG------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhC------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 98765332 11122357889999999863 34567899999999999999999999988766655544432100
Q ss_pred -------------------C--------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 581 -------------------P--------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 581 -------------------~--------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
. ....++.++.+||.+||..||.+||++.|+|.||||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 0124788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=354.18 Aligned_cols=252 Identities=27% Similarity=0.418 Sum_probs=204.8
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHH---HHhhcCCCCeeeecceeeecceEEEEEee
Q 004633 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK---VLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (741)
Q Consensus 361 ~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~---iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 437 (741)
+||+|+||.||++.+..+++.||+|++..........+ ....+|.. ++...+|+||+.+++++..++..|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH--HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 48999999999999999999999998864332211111 22333443 34445799999999999999999999999
Q ss_pred cCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccC
Q 004633 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 517 (741)
Q Consensus 438 ~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~ 517 (741)
+.+|+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 79 ~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcC
Confidence 9999999998765 569999999999999999999999999999999999999999999999999987554322 22356
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH--HHHH-HHhccCCCCCccCCHHHHHHH
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEGKDFL 594 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~--~~~~-~i~~~~~~iP~~ls~el~dLI 594 (741)
||..|+|||++.+ ...++.++|||||||++|||++|..||...... ..+. ........++..++.++.++|
T Consensus 157 ~~~~y~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (279)
T cd05633 157 GTHGYMAPEVLQK------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLL 230 (279)
T ss_pred CCcCccCHHHhcC------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHH
Confidence 8999999998752 245678999999999999999999999754322 2222 222334567778999999999
Q ss_pred HHhhhcCCCCCC-----CHHHHHcCcccccccc
Q 004633 595 LRCFLRNPVERP-----SAVELLEHPFIRNANY 622 (741)
Q Consensus 595 ~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~~ 622 (741)
.+||..||.+|+ ++.|+++||||+..++
T Consensus 231 ~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 231 EGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 999999999999 6999999999987553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=344.13 Aligned_cols=255 Identities=49% Similarity=0.868 Sum_probs=215.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||+|.+..++..||+|+++..... ....+.+.+|+.+++.++|+||+++++.+...+.+++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc---hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 589999999999999999999999999999998754322 45567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc-
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE- 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~- 513 (741)
+||+++++|.+++... ..+++..++.|+.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 78 MEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred EecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999999764 45899999999999999999999999999999999999999999999999999876543221
Q ss_pred ----cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH-HHHHHhc-cCCCCCccC-
Q 004633 514 ----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVLN-RTPPIPEML- 586 (741)
Q Consensus 514 ----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~-~~~~i~~-~~~~iP~~l- 586 (741)
....++..|+|||++.+.. ...++.++||||||+++|||++|+.||...+... ....+.. ....+|...
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGK----GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232 (264)
T ss_pred cccccCCcCCcCccChhhccCCC----CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccc
Confidence 1346789999999986421 1247789999999999999999999997654333 2222222 233455544
Q ss_pred -CHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 587 -SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 587 -s~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
+..+.+||.+||..||.+|||+.+++.|||+
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.52 Aligned_cols=255 Identities=37% Similarity=0.650 Sum_probs=215.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC---CCCeeeecceeeecceE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHL 431 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~---HPNIVkl~g~~~~~~~l 431 (741)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |+||+++++++..+...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC----CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 4888999999999999999999999999999876421 1233456888999999997 99999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|+||||+.+++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 78 ~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999999999865 368999999999999999999999999999999999999999999999999997765432
Q ss_pred -cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCc-cCCH
Q 004633 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPE-MLSS 588 (741)
Q Consensus 512 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~-~ls~ 588 (741)
......|+..|+|||.+.+ ...++.++|||||||++|+|++|..||...........+... ...++. .++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITE------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSK 229 (277)
T ss_pred cccccccCCcceeCHHHhcc------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCH
Confidence 2234568999999999863 345677999999999999999999999877655444333222 223333 3788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
++.++|.+||..||++||++.++++|+||++..
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=343.83 Aligned_cols=254 Identities=37% Similarity=0.622 Sum_probs=219.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||+|.++.+++.|+||++..... ......+.+|+.++..++|+||+++++++...+.+++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD----EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 68999999999999999999999999999998864221 14456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|||+++++|.+++... ..+++..+..++.||+.||.|||+ +|++||||+|+||+++.++.++|+|||++..+......
T Consensus 78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999999765 679999999999999999999999 99999999999999999999999999999876543332
Q ss_pred c-ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC---cHHHHHHHhc-cCCCCCcc-CC
Q 004633 514 L-SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE---GPQAMFKVLN-RTPPIPEM-LS 587 (741)
Q Consensus 514 ~-s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~---~~~~~~~i~~-~~~~iP~~-ls 587 (741)
. ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ..+....+.. ....++.. ++
T Consensus 157 ~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-------ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFS 229 (264)
T ss_pred ccceeecccccCHhhhCC-------CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCC
Confidence 2 4568899999998763 367789999999999999999999998764 3333444433 23345555 88
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
..+.++|.+||..+|++||++.|+++|||++..
T Consensus 230 ~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 230 PEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=377.33 Aligned_cols=255 Identities=28% Similarity=0.434 Sum_probs=217.5
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
.|+....+..+++.||+|.||+||+|.+.. .||||++++.. -..+.++.|++|+.+|++-+|.||+-+.|++..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~---pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDD---PTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCC---CCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 566677788999999999999999999874 59999987643 335577899999999999999999999999987
Q ss_pred cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
... .||+.+|+|-+|+.+|+.....|.....+.|++||++||.|||.++|||||||.+||||.+++.|||+||||+...
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 777 9999999999999999887778999999999999999999999999999999999999999999999999999654
Q ss_pred c---CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-----
Q 004633 508 T---GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----- 579 (741)
Q Consensus 508 ~---~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~----- 579 (741)
. +........|...|||||+++. + ....|++.+||||||||+|||++|.+||.....+++++.+-.+.
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRm--q--d~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRM--Q--DDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhh--c--ccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence 2 2333334568889999999983 2 25689999999999999999999999999555555555544331
Q ss_pred CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 580 ~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..+-..++.++++|+..||..++++||.+.+||.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1233567789999999999999999999999985
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.39 Aligned_cols=253 Identities=30% Similarity=0.532 Sum_probs=209.5
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|++.+.||.|+||.||+|+++.+|+.||||++..... .......+.+|++++++++||||+++++++..++..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc---ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 48899999999999999999999999999998764321 122235678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 435 LEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
|||+. ++|..++... ...+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..+.... .
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 99996 6888887553 3568999999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC------------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------------ 580 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~------------ 580 (741)
.....++..|+|||++.+ ...++.++|||||||++|||++|+.||...+......++.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 157 YTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cccccccccccCCeEEec------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 223457889999998753 33467789999999999999999999987665554444332100
Q ss_pred -----------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 581 -----------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 -----------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.+...++.+++++|.+||..||.+|||++++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0123467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.81 Aligned_cols=254 Identities=32% Similarity=0.562 Sum_probs=223.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~ 432 (741)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... ......+.+.+|+.+++++. |+||+++++++..++.++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL--IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc--cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEE
Confidence 379999999999999999999999999999998864221 12233467888999999998 999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
+||||+.+++|.+++.+. ..+++..++.|+.||+.||.|||+.|++|+||||+||+++.+|.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 999999999999999775 479999999999999999999999999999999999999999999999999987654322
Q ss_pred --------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHH
Q 004633 512 --------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA 571 (741)
Q Consensus 512 --------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~ 571 (741)
......|+..|+|||++.+ ..++.++||||||+++|+|++|..||........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-------KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-------CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 1223457899999998763 3477899999999999999999999998877666
Q ss_pred HHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCH----HHHHcCccc
Q 004633 572 MFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSA----VELLEHPFI 617 (741)
Q Consensus 572 ~~~i~~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa----~ElLqHpwf 617 (741)
...+......++..+++.+.+||.+||..||.+||++ +++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 231 FQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 7777777778888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.52 Aligned_cols=257 Identities=34% Similarity=0.572 Sum_probs=216.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
...|.....||+|+||.||++.+..++..||||++... .....+.+.+|+.+++.++|+||+++++.+...+..|
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 34566678899999999999999999999999987531 2233466889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
+||||+.+++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 96 lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 96 VVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 99999999999998854 358999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC---CCCCccCCH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSS 588 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---~~iP~~ls~ 588 (741)
......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........+..+.... ......++.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSS 246 (292)
T ss_pred cCceeecCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCH
Confidence 2234568999999999853 356779999999999999999999998766655544443322 222335788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccccccC
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 623 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~~ 623 (741)
.+.++|.+||..||.+|||++|+|+|+||+.....
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 99999999999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=344.96 Aligned_cols=255 Identities=44% Similarity=0.815 Sum_probs=217.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--ceE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL 431 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l 431 (741)
..|++++.||+|+||.||+|.++.++..||+|++...............+.+|++++++++|+||+++++.+.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 469999999999999999999999999999998754322222344567889999999999999999999988664 468
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~- 510 (741)
++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 9999999999999999764 45899999999999999999999999999999999999999999999999999865431
Q ss_pred ---ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--CCCCCcc
Q 004633 511 ---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEM 585 (741)
Q Consensus 511 ---~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP~~ 585 (741)
.......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........+.++... ...+|..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~ 233 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISG-------EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG 233 (264)
T ss_pred ccCccccccCCcccccCHhhhcC-------CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcc
Confidence 11123568999999999863 34677899999999999999999999887766666655532 3457888
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
++.++.++|.+||. ++..||++.+++.|||+
T Consensus 234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.62 Aligned_cols=250 Identities=25% Similarity=0.450 Sum_probs=212.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg-----~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
.+|++.+.||+|+||.||+|.....+ ..||+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN----AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC----CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 46899999999999999999876554 67999987532 2234456788999999999999999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC
Q 004633 429 DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~ 493 (741)
+..|++|||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 99999999999999999996531 457889999999999999999999999999999999999999
Q ss_pred CcEEEeecccchhccCcc---cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcH
Q 004633 494 GVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP 569 (741)
Q Consensus 494 g~vKL~DFGLA~~~~~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~ 569 (741)
+.+||+|||+++...... ......+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-------GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-------CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999997653322 1223456889999998863 457789999999999999998 99999987777
Q ss_pred HHHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 570 QAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 570 ~~~~~i~~~~-~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+....+.... ...+..++.++.+||.+||+.||.+||++.||+++
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 234 EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7666665443 45677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=348.33 Aligned_cols=252 Identities=31% Similarity=0.551 Sum_probs=210.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||.|++|+||+|+++.+|..||||+++...... ....+.+|+.++++++|+||+++++++...+..+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG----TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc----chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 4899999999999999999999999999999987533221 124566799999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcc--ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 435 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
|||+.+ +|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+....
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 999985 8888886543 458999999999999999999999999999999999999999999999999997654322
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC------------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------ 579 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------------ 579 (741)
......++..|++||++.+ ...++.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLG------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ccccccccccccChHHhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 1223457899999999863 3456789999999999999999999998776655544433210
Q ss_pred ------CC-----------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 ------PP-----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 ------~~-----------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.. +...++.+++++|.+||+.||.+||++.|+++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=350.70 Aligned_cols=255 Identities=38% Similarity=0.643 Sum_probs=218.8
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
..|+..+.||.|+||.||+|.++.++..||||++.... .......+.+|+++++.+.|+||+++++.+..+...|+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc----cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 35888999999999999999999999999999886421 12345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
||||+.||+|.+++.. ..+++..+..++.||+.||+|||+++++|+||+|+|||++.++.++|+|||++..+.... .
T Consensus 80 v~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 80 IMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 9999999999999865 468999999999999999999999999999999999999999999999999997664432 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK 591 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-~~~~iP~~ls~el~ 591 (741)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||...........+.. ....++..++..+.
T Consensus 158 ~~~~~~~~~y~apE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQ-------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFK 230 (277)
T ss_pred cccccCcccccCHhHhcc-------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHH
Confidence 223468899999999863 3567899999999999999999999987766555444432 23445567889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
++|.+||..+|++||++.++++|+||....
T Consensus 231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 231 EFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 999999999999999999999999996544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=338.57 Aligned_cols=253 Identities=32% Similarity=0.597 Sum_probs=220.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|+||.||++.+..++..||+|++..... ..+....+.+|+++++.++|+||+++++.+...+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM---SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC---ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 58999999999999999999999999999999864322 234456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 435 LEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|||+++++|.+++... ...+++..+..++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999999764 3679999999999999999999999999999999999999999999999999997665433
Q ss_pred -cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 004633 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 589 (741)
Q Consensus 512 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e 589 (741)
......|++.|+|||.+.+ ..++.++||||+|+++|+|++|..||...+..+........ ...++..++.+
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQN-------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230 (258)
T ss_pred ceecceeeeecccChhHhcc-------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2334568999999998753 34677999999999999999999999887766665555443 44566788999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
+.++|.+||..+|++|||+.++|+||||
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=345.95 Aligned_cols=250 Identities=26% Similarity=0.478 Sum_probs=212.9
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
....+|++.+.||+|+||.||+|.++.+++.||+|++... ......+.+|+++|+.++|+||+++++++..++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 76 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC------chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC
Confidence 3456799999999999999999999999999999987521 1123567889999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
+++||||+.+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999999999999653 34589999999999999999999999999999999999999999999999999987654
Q ss_pred ccccc--ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 004633 510 LSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 585 (741)
Q Consensus 510 ~~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ 585 (741)
..... ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+... ....+..
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEG 229 (263)
T ss_pred ceeeccCCCCCccccCCHHHhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence 32221 2234668999998863 456789999999999999998 99999887666655555443 4456778
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
++.++.++|.+||..||++||++.++++
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=350.30 Aligned_cols=254 Identities=29% Similarity=0.472 Sum_probs=205.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
...|++.+.||+|+||.||+|.++.+|+.||||++....... ....+.+|+.+|+.++|+||+++++++..++..|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG----VPFTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC----CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 357999999999999999999999999999999986433221 1234567999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
+||||+. ++|.+++......+.+..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++......
T Consensus 80 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred EEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9999996 67777765544568889999999999999999999999999999999999999999999999987643221
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH-HHHHHHhcc------------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR------------ 578 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~-~~~~~i~~~------------ 578 (741)
......++..|+|||++.+ ...++.++|||||||++|||++|..||...... +.+.++...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLG------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCCCccccccccCCceeec------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhh
Confidence 2233457899999998763 234677899999999999999999999765432 222222110
Q ss_pred --CCC---------CC---------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 579 --TPP---------IP---------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 579 --~~~---------iP---------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.+. .+ ...+.++.++|.+||..||.+|||+.|+|.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 00 0125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=371.01 Aligned_cols=254 Identities=26% Similarity=0.456 Sum_probs=208.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG 423 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~-----k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g 423 (741)
.....+|++++.||+|+||+||+|++ ..++..||||+++... .....+.+.+|+.+|+.+ +|||||++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA----HLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc----CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 33456799999999999999999974 3456789999876322 122345688899999999 7999999999
Q ss_pred eeeecceEEEEEeecCCCChhhhhhhcc----------------------------------------------------
Q 004633 424 SEVVDDHLYIYLEYVHPGSINRYVREHC---------------------------------------------------- 451 (741)
Q Consensus 424 ~~~~~~~l~LVmEy~~gGsL~~lI~~~~---------------------------------------------------- 451 (741)
++...+..|+|||||+||+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986431
Q ss_pred ----------------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 452 ----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 452 ----------------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 1467888999999999999999999999999999999999999999999999986643
Q ss_pred cccc---cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc--CCCCC
Q 004633 510 LSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIP 583 (741)
Q Consensus 510 ~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~--~~~iP 583 (741)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||........+.+.+.. ....+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 339 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339 (375)
T ss_pred cccccccCCCCCCcceeChhHhcC-------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC
Confidence 2211 12334667999999863 457889999999999999998 89999876655444444432 23445
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
...+.++++||.+||..||++||++.|+++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 6678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.08 Aligned_cols=250 Identities=41% Similarity=0.733 Sum_probs=215.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.+.||+|++|.||++.+..+++.+++|++..... ...+.+.+|+++++.++|+||+++++.+..++..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 48899999999999999999999999999998864221 3456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~ 514 (741)
|||+.+++|.+++......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++..........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 99999999999997765679999999999999999999999999999999999999999999999999998775543234
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-cCCCCCc--cCCHHHH
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPE--MLSSEGK 591 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-~~~~iP~--~ls~el~ 591 (741)
...|+..|++||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.. ....++. .++.++.
T Consensus 156 ~~~~~~~~~~PE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (253)
T cd05122 156 TMVGTPYWMAPEVING-------KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK 228 (253)
T ss_pred ceecCCcccCHHHHcC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHH
Confidence 5678999999999863 3467899999999999999999999987755554444432 2223332 3489999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCcc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPF 616 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHpw 616 (741)
++|.+||..||++|||+.|+|+|||
T Consensus 229 ~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHccCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=344.10 Aligned_cols=243 Identities=26% Similarity=0.470 Sum_probs=204.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecC
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 439 (741)
+.||+|+||.||+|+++.+++.||+|.+... ...+....+.+|+++|+.++|+||+++++++..++.+||||||+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET----LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 4699999999999999999999999987521 223445678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc---cc
Q 004633 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SL 516 (741)
Q Consensus 440 gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~---s~ 516 (741)
+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... ..
T Consensus 77 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 77 GGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999999997765678999999999999999999999999999999999999999999999999987654322111 11
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHHHHH
Q 004633 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFL 594 (741)
Q Consensus 517 ~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP~~ls~el~dLI 594 (741)
.++..|+|||.+.+ ..++.++||||||||+|||++ |..||...........+.. .....+..++..+.+||
T Consensus 157 ~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 229 (252)
T cd05084 157 QIPVKWTAPEALNY-------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLM 229 (252)
T ss_pred CCceeecCchhhcC-------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHH
Confidence 22456999999863 357789999999999999997 9999987665554444433 23456677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHc
Q 004633 595 LRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 595 ~~cL~~DP~kRPTa~ElLq 613 (741)
.+||..||++|||+.++++
T Consensus 230 ~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 230 ERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=363.08 Aligned_cols=253 Identities=25% Similarity=0.414 Sum_probs=207.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec---
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--- 428 (741)
...+|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc---cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 3468999999999999999999999999999999875322 1223345677899999999999999999987644
Q ss_pred ---ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 429 ---~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
...|+||||+. ++|.+++... +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 35799999996 5788777543 8999999999999999999999999999999999999999999999999998
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC------
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------ 579 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------ 579 (741)
............|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+.+++...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhC-------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 7655444445678999999999863 457789999999999999999999998765544333322100
Q ss_pred ----------------CC--------------C-------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 580 ----------------PP--------------I-------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 580 ----------------~~--------------i-------P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
.. + +...+.++++||.+||..||++|||+.|+|+||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 00 0 112456789999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=344.36 Aligned_cols=246 Identities=29% Similarity=0.494 Sum_probs=209.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||.||++..+. +..+|+|.+.... .. ...+.+|+.+|+.++||||+++++++...+.+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~---~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA---MS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC---cc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 569999999999999999998764 5679999865221 11 2467789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
||||+++|+|.+++......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999999999765556899999999999999999999999999999999999999999999999999765432222
Q ss_pred c--ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhccC-CCCCccCCHH
Q 004633 514 L--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSE 589 (741)
Q Consensus 514 ~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~e 589 (741)
. ...++..|+|||++.+ ..++.++||||||+++|||++ |+.||......+.+..+.... ...|...+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 229 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNF-------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMT 229 (256)
T ss_pred ccCCCCCchhhCChhhccc-------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 1 2235668999999852 357789999999999999999 999998887777777766543 3456678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+.+||.+||..||++||++.++++
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=339.54 Aligned_cols=244 Identities=30% Similarity=0.521 Sum_probs=212.0
Q ss_pred eEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEe
Q 004633 360 KLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~t---g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 436 (741)
+.||+|+||.||+|.+... +..||+|++..... ....+.+.+|+++++.++|+||+++++++...+.+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS----EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc----hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 4799999999999999876 88999998764322 1145778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhhc--------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 437 YVHPGSINRYVREH--------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 437 y~~gGsL~~lI~~~--------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
|+.+++|.+++... ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999999875 4679999999999999999999999999999999999999999999999999998765
Q ss_pred Ccc---cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-cCCCCC
Q 004633 509 GLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIP 583 (741)
Q Consensus 509 ~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP 583 (741)
... ......++..|+|||.+.. ..++.++|||||||++|||++ |..||......+....+.. .....+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKD-------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP 229 (262)
T ss_pred cccccccccCCCcCccccCHHHhcc-------CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 432 2234557889999998863 357789999999999999999 6999998877666666654 344667
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
..++.++.++|.+||..||++||++.|++++
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 230 EYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 7889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.38 Aligned_cols=258 Identities=29% Similarity=0.494 Sum_probs=211.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|++|+||+|.++.+|+.||||.+...... ....+.+.+|+++++.++|+||+++++++..++..|+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc---ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 4799999999999999999999999999999987643221 1233567789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccCcc
Q 004633 434 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~-~g~vKL~DFGLA~~~~~~~ 511 (741)
||||+. ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 999996 5777777543 233688999999999999999999999999999999999985 5679999999997653321
Q ss_pred -cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-----------
Q 004633 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----------- 579 (741)
Q Consensus 512 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~----------- 579 (741)
......+++.|+|||++.+ ...++.++|||||||++|+|++|..||......+.+.+++...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLG------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred cccccCceeecccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 1223457899999999863 3457789999999999999999999998776665555443210
Q ss_pred ----------CC--------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 ----------PP--------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 ----------~~--------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.. ....++.++.++|.+||..||++||++.++|+|+||++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 00 1134688999999999999999999999999999998754
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.86 Aligned_cols=253 Identities=29% Similarity=0.548 Sum_probs=215.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|.+.+.||+|+||.||+|.++.+|..||+|.+....... ...+.+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV---KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc---hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 4899999999999999999999999999999987532211 2235677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEeecccchhccCccc
Q 004633 435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g-~vKL~DFGLA~~~~~~~~ 512 (741)
|||+.+++|.+++.... ..+++..+..++.||+.||.|||+++|+|+||||+|||++.++ .+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999999996643 3579999999999999999999999999999999999999886 469999999977654322
Q ss_pred -ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 004633 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 590 (741)
Q Consensus 513 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el 590 (741)
.....|+..|+|||++.+ ..++.++||||||+++|||++|..||...+..+....+... ...++..++.++
T Consensus 158 ~~~~~~~~~~~~ape~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDL 230 (257)
T ss_pred cccccCCCccccCHHHHcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHH
Confidence 123458999999998853 35678999999999999999999999877665555554433 334556788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.++|.+||..+|++|||+.|+++|+||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.75 Aligned_cols=254 Identities=39% Similarity=0.662 Sum_probs=216.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
..|++.+.||+|+||.||+|.+..++..||+|.+.... .....+.+.+|+++++.++|+||+++++++..++..|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE----AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc----chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 45788899999999999999999999999999876322 12345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..+.... .
T Consensus 80 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 80 IMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 9999999999998865 468999999999999999999999999999999999999999999999999997665432 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGK 591 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~ 591 (741)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+... ...++..++.++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQ-------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFK 230 (277)
T ss_pred hhcccCcccccCHHHhCc-------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHH
Confidence 223468999999999863 35678999999999999999999999876555444443322 3345556789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 592 dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
++|.+||..+|++||++.++++|+||...
T Consensus 231 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 231 EFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 99999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=347.51 Aligned_cols=250 Identities=30% Similarity=0.530 Sum_probs=211.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~-----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
..+|.+.+.||+|+||.||+|.+.. ++..||||.+... ...+..+.+.+|+++|+.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET----ASNDARKDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc----CCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence 4579999999999999999998753 4678999987532 223345678899999999999999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhhcc-------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHC-------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 494 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~-------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g 494 (741)
.+..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 999999999999999999996542 3478899999999999999999999999999999999999999
Q ss_pred cEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHH
Q 004633 495 VVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ 570 (741)
Q Consensus 495 ~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~ 570 (741)
.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|||++ |..||......+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~ 232 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhcc-------CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999976533221 123345788999999863 457789999999999999998 999998877777
Q ss_pred HHHHHhccCC-CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 571 AMFKVLNRTP-PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 571 ~~~~i~~~~~-~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
....+..+.. ..+..++.+++++|.+||..||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 233 VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7666665433 445678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=349.39 Aligned_cols=255 Identities=28% Similarity=0.514 Sum_probs=214.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
..+|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+++++.++||||+++++++...+.+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA----KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC----cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence 467999999999999999999999999999999876421 2334567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
+||||+++|+|.+++.+. +.+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999999999998764 568999999999999999999997 69999999999999999999999999998755332
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH-----------HHHHHHhcc-C
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-----------QAMFKVLNR-T 579 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~-----------~~~~~i~~~-~ 579 (741)
......|+..|+|||++.+ ..++.++|||||||++|+|++|..||...... +....+... .
T Consensus 158 ~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 158 IADTFVGTSTYMSPERIQG-------GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred ccCccccCcccCCHHHHcc-------CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 2234578999999999863 35677999999999999999999999864432 222233322 2
Q ss_pred CCCCcc-CCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 580 PPIPEM-LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 580 ~~iP~~-ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
..++.. ++.++.+||.+||..||++|||+.|+++|+||...
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 233333 78899999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=352.71 Aligned_cols=254 Identities=31% Similarity=0.510 Sum_probs=203.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--ce
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DH 430 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~--tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~~ 430 (741)
+|++.++||+|+||.||+|.++. ++..||+|.+..... ........+.+|+.+++.++||||+++++++.+. +.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCce
Confidence 58999999999999999999988 899999999875321 1122235567899999999999999999999988 88
Q ss_pred EEEEEeecCCCChhhhhhhc----cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC----CCcEEEeecc
Q 004633 431 LYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA----SGVVKLADFG 502 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~----~g~vKL~DFG 502 (741)
+|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 79 VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999999975 666666432 136899999999999999999999999999999999999999 8999999999
Q ss_pred cchhccCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH--------
Q 004633 503 MAKHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-------- 570 (741)
Q Consensus 503 LA~~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~-------- 570 (741)
++..+..... .....++..|+|||++.+ ...++.++|||||||+||||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 9986643222 223467899999999863 3456779999999999999999999997554321
Q ss_pred -HHHHHhc--------------------------cCCCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 004633 571 -AMFKVLN--------------------------RTPPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELL 612 (741)
Q Consensus 571 -~~~~i~~--------------------------~~~~iP-----------~~ls~el~dLI~~cL~~DP~kRPTa~ElL 612 (741)
.+..++. ....++ ...+.++.++|.+||..||++|||+.|++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 1111100 001111 14667899999999999999999999999
Q ss_pred cCccc
Q 004633 613 EHPFI 617 (741)
Q Consensus 613 qHpwf 617 (741)
+||||
T Consensus 312 ~~~~f 316 (316)
T cd07842 312 EHPYF 316 (316)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.97 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=212.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~t---g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
..+|.+.+.||+|+||+||+|.++.+ ...||||.++.. ........+.+|+.+++.++|+||+++++.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG----SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC----CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence 35799999999999999999998754 457999987532 22334456888999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
..++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999999999987666799999999999999999999999999999999999999999999999999987752
Q ss_pred ccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCc
Q 004633 510 LSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 584 (741)
Q Consensus 510 ~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~ 584 (741)
... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..||......+....+... ..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAY-------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM 231 (266)
T ss_pred cccceeccCCCCCccccChhhhcc-------CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 111 112234678999998863 457789999999999999998 99999877766666665543 335567
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.++..+.+||.+||..+|++||++.|++++
T Consensus 232 ~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 232 DCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.74 Aligned_cols=261 Identities=24% Similarity=0.415 Sum_probs=213.6
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecce
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS 424 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~-----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~ 424 (741)
.....+|++.++||+|+||.||+|..+. .+..||+|.+... ........+.+|+.+++.++|+||++++++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES----ASLRERIEFLNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3456789999999999999999997653 3457999976522 112223457789999999999999999999
Q ss_pred eeecceEEEEEeecCCCChhhhhhhcc---------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCc
Q 004633 425 EVVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (741)
Q Consensus 425 ~~~~~~l~LVmEy~~gGsL~~lI~~~~---------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~ 495 (741)
+...+..|+||||+.+|+|.+++.+.. ..++...+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~ 157 (288)
T cd05061 78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT 157 (288)
T ss_pred EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc
Confidence 999999999999999999999996532 23466788999999999999999999999999999999999999
Q ss_pred EEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHH
Q 004633 496 VKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 571 (741)
Q Consensus 496 vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~ 571 (741)
+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+.
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~ 230 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-------GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhcc-------CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999976543221 112235678999999863 356789999999999999998 8999988776666
Q ss_pred HHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc------Cccccccc
Q 004633 572 MFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE------HPFIRNAN 621 (741)
Q Consensus 572 ~~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq------Hpwf~~~~ 621 (741)
...+... ....+..++..++++|.+||..||++|||+.++++ ||||+..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 231 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 6555543 34566778899999999999999999999999987 88887654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.77 Aligned_cols=256 Identities=27% Similarity=0.482 Sum_probs=207.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec----
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~---- 428 (741)
.++|++.++||+|+||.||+|.++.+|+.||||++..... ......+.+|+.+|+.++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH----QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc----chhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 4689999999999999999999999999999998863211 22345677899999999999999999976544
Q ss_pred -ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 429 -~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 80 FNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred cceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 35899999997 578877754 46999999999999999999999999999999999999999999999999998765
Q ss_pred cCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---c--
Q 004633 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---R-- 578 (741)
Q Consensus 508 ~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~---~-- 578 (741)
..... .....||..|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+....+..+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 43221 123568999999998753 34577899999999999999999999976543322221110 0
Q ss_pred ---------------------CCC-----CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 579 ---------------------TPP-----IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 579 ---------------------~~~-----iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
... ....++.++.+||.+||..||++|||+.|+++||||....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000 0123578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=345.39 Aligned_cols=253 Identities=40% Similarity=0.661 Sum_probs=217.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
-|++.+.||.|+||.||+|.+..++..||||++... ......+.+.+|+.+++.++|+||+++++++..++..|+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE----EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 488899999999999999999999999999987532 1223346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~ 513 (741)
|||+.+++|.+++.. ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..+.... ..
T Consensus 81 ~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 81 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 999999999999865 458999999999999999999999999999999999999999999999999987654322 12
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 592 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~d 592 (741)
....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+... ...++..++.++.+
T Consensus 159 ~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQ-------SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKE 231 (277)
T ss_pred ccccCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHH
Confidence 23568999999998863 34567899999999999999999999877665555554433 33456678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 593 FLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 593 LI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+|.+||..+|.+||++.++++|+||.+.
T Consensus 232 ~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 232 FVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 9999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=334.72 Aligned_cols=252 Identities=49% Similarity=0.864 Sum_probs=220.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|.+.+.||+|++|.||++.+..+++.||+|.+.... ........+.+|++++++++|+||+++++++..++..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK---IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc---cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 5889999999999999999999999999999886432 2234557899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-c
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-E 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~-~ 513 (741)
|||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 78 LEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred EecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence 9999999999999765 6799999999999999999999999999999999999999999999999999987654332 2
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHh-ccCCCCCccCCHHHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGKD 592 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~-~~~~~iP~~ls~el~d 592 (741)
....++..|+|||.+.+ ..++.++|||+||+++|+|++|..||..........++. .....++..++.++.+
T Consensus 157 ~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (254)
T cd06627 157 ASVVGTPYWMAPEVIEM-------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKD 229 (254)
T ss_pred cccccchhhcCHhhhcC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence 34568999999998863 236789999999999999999999998766555444443 4455677788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 593 FLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 593 LI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
+|.+||..+|++|||+.+++.|+||
T Consensus 230 ~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 230 FLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.19 Aligned_cols=253 Identities=23% Similarity=0.401 Sum_probs=209.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeeccee
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~-----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~ 425 (741)
...++|++.+.||+|+||.||+|.++. ++..||||++... ........+.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 456689999999999999999998652 3567999986421 1122345688999999999999999999999
Q ss_pred eecceEEEEEeecCCCChhhhhhhcc---------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004633 426 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (741)
Q Consensus 426 ~~~~~l~LVmEy~~gGsL~~lI~~~~---------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~v 496 (741)
..++..++||||+.+|+|.+++.+.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 99999999999999999999996532 235678899999999999999999999999999999999999999
Q ss_pred EEeecccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHH
Q 004633 497 KLADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 572 (741)
Q Consensus 497 KL~DFGLA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~ 572 (741)
||+|||+++.+...... ....++..|||||++.+ ..++.++|||||||++|||++ |..||.+....+..
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~ 231 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999998765432211 12345778999999863 457789999999999999998 78999887766665
Q ss_pred HHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 573 FKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 573 ~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
..+... ....+..++..+.++|.+||..||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 232 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 555443 345677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.19 Aligned_cols=252 Identities=31% Similarity=0.502 Sum_probs=209.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.+.||+|+||.||+|+++.+++.||||.+..... ........+.+|+++|+.++||||+++++++...+..++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM--MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc--CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 479999999999999999999999999999998764322 233445678889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 434 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
||||+++|+|.+++.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999999988853 2345899999999999999999999999999999999999999999999999998766432
Q ss_pred cc-ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc--HHHHHHHhc-cCCCC-Ccc
Q 004633 511 SY-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLN-RTPPI-PEM 585 (741)
Q Consensus 511 ~~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~--~~~~~~i~~-~~~~i-P~~ 585 (741)
.. .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+.. ..++. +..
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEH 232 (267)
T ss_pred hHHHhcCCCCccccChhhhcc-------CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhh
Confidence 22 223568999999999863 3467789999999999999999999965432 222233222 12222 245
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
++..+.++|.+||..+|++||++.++++.
T Consensus 233 ~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 233 YSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred cCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 78899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=352.81 Aligned_cols=255 Identities=35% Similarity=0.605 Sum_probs=215.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
...|.....||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++.+..++..|
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 94 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELW 94 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEE
Confidence 3456667789999999999999999999999999864221 12356788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS- 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~- 511 (741)
+||||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 95 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999999999998755 458999999999999999999999999999999999999999999999999997654322
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC---CCCccCCH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSS 588 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~---~iP~~ls~ 588 (741)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+.+..+..... ..+..++.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISR-------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISP 245 (297)
T ss_pred cccceecCccccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCH
Confidence 2234568999999999863 3567899999999999999999999987666555554433221 22345788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
++.++|.+||..+|++||++.++++|+||....
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.46 Aligned_cols=250 Identities=30% Similarity=0.518 Sum_probs=207.5
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH-hhcCCCCeeeecceeeecceEEEEEeec
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL-~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
+.||+|+||.||+|.+..+|+.||||++..... ........+..|..++ ..++|+||+++++++..++.+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDM--IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhh--hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 679999999999999999999999998763211 1122233445555544 4558999999999999999999999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCC
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 518 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~G 518 (741)
.+++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++..... .....|
T Consensus 80 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCC
Confidence 999999999764 5689999999999999999999999999999999999999999999999999876433 234568
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCC----CCccCCHHHHHHH
Q 004633 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP----IPEMLSSEGKDFL 594 (741)
Q Consensus 519 T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~----iP~~ls~el~dLI 594 (741)
+..|+|||.+.+ ..++.++||||||+++|||++|..||...+.......+...... ....++.++.++|
T Consensus 156 ~~~y~~pe~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 228 (260)
T cd05611 156 TPDYLAPETILG-------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI 228 (260)
T ss_pred CcCccChhhhcC-------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence 999999999863 23678999999999999999999999887776666655543322 3345789999999
Q ss_pred HHhhhcCCCCCC---CHHHHHcCcccccccc
Q 004633 595 LRCFLRNPVERP---SAVELLEHPFIRNANY 622 (741)
Q Consensus 595 ~~cL~~DP~kRP---Ta~ElLqHpwf~~~~~ 622 (741)
.+||..||++|| +++|+|.||||+..++
T Consensus 229 ~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 229 NRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 999999999999 5589999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.58 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=208.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecce
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~--~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 430 (741)
++|++.++||+|+||.||+|+++.++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++...+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF----ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc----CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 579999999999999999999988775 4688876522 1223346788899999999 79999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCc
Q 004633 431 LYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~ 495 (741)
+|+||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 999999999999999996532 24889999999999999999999999999999999999999999
Q ss_pred EEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 004633 496 VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 574 (741)
Q Consensus 496 vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~ 574 (741)
+||+|||++..............+..|+|||++.+ ..++.++|||||||++|||++ |..||......+...+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~ 230 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-------SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK 230 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999864332211112223567999998863 457789999999999999997 9999988777666666
Q ss_pred Hhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 575 VLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 575 i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+... ....+..++.++.+||.+||..||.+||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 231 LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6543 345667789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.65 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=207.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEE--EEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecc
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASC--AIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDD 429 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~v--AVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~ 429 (741)
-++|++.+.||+|+||.||+|.++.++..+ |+|.+.. .........+.+|++++.++ +|+||+++++++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~----~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc----cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 457999999999999999999998887654 6665432 12234456788899999999 8999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC
Q 004633 430 HLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 494 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g 494 (741)
.+|+||||+++|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999996532 2578999999999999999999999999999999999999999
Q ss_pred cEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHH
Q 004633 495 VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMF 573 (741)
Q Consensus 495 ~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~ 573 (741)
.+||+|||++.............++..|+|||++.+ ..++.++|||||||++|||++ |..||......+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 162 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred cEEeCccccCcccchhhhcccCCCcccccCHHHHhc-------cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 999999999864322211222234678999998863 356789999999999999998 999998776665555
Q ss_pred HHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 574 KVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 574 ~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.+... ....+..++.++.+||.+||..+|++||+++++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 235 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54433 234556688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.73 Aligned_cols=250 Identities=30% Similarity=0.539 Sum_probs=211.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceee
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k-----~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~ 426 (741)
.+..|.+.+.||+|+||+||++... .++..+|+|.+.. ........+.+|+.+|++++|+||+++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-----ASDNARKDFHREAELLTNLQHEHIVKFYGVCV 77 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC-----cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 4567999999999999999999853 3456689997753 22334567889999999999999999999999
Q ss_pred ecceEEEEEeecCCCChhhhhhhcc------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC
Q 004633 427 VDDHLYIYLEYVHPGSINRYVREHC------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 494 (741)
Q Consensus 427 ~~~~l~LVmEy~~gGsL~~lI~~~~------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g 494 (741)
..+.+|+||||+.+++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999999996542 2489999999999999999999999999999999999999999
Q ss_pred cEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHH
Q 004633 495 VVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ 570 (741)
Q Consensus 495 ~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~ 570 (741)
.+||+|||+++.+..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||......+
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~ 230 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999976543221 122335778999999863 457789999999999999998 999998877777
Q ss_pred HHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 571 AMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 571 ~~~~i~~~~-~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
....+.... ...+..++.++.+||.+||..||.+|||+.++++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 231 VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 766666544 3456678999999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.12 Aligned_cols=252 Identities=29% Similarity=0.547 Sum_probs=208.5
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
|++.+.||.|++|+||+|.++.+|..||+|++...... ....+.+.+|+++++.++|+||+++++++..++..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED---EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc---ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 67889999999999999999999999999988743222 122245778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004633 436 EYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~ 513 (741)
||+. ++|.+++.... ..+++..+..++.||+.||+|||+++++||||+|+|||++.++.+||+|||++..+.... ..
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 9995 68999886643 368999999999999999999999999999999999999999999999999997653221 11
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--------------
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-------------- 579 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-------------- 579 (741)
....++..|+|||++.+ ...++.++||||||+++|+|++|+.||...+......++....
T Consensus 157 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 157 THEVVTLWYRAPEILLG------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred CccccccCCCCCceeec------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 23356889999998753 2346778999999999999999999998766544443332110
Q ss_pred ---------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 ---------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 ---------------~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
......++.++.++|.+||+.||++|||++|+++|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=344.44 Aligned_cols=257 Identities=31% Similarity=0.527 Sum_probs=210.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--ceE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHL 431 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l 431 (741)
++|+..+.||.|++|.||+|.++.+++.||+|.+..... ......+.+|+++|+.++|+||+++++++... +.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN----PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc----hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeE
Confidence 368999999999999999999999999999998864221 23446788999999999999999999988654 478
Q ss_pred EEEEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 432 YIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
|+||||+++++|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999999988753 33568999999999999999999999999999999999999999999999999987654
Q ss_pred CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC-----cHHHHHHHhcc-CCCC
Q 004633 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-----GPQAMFKVLNR-TPPI 582 (741)
Q Consensus 509 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~-----~~~~~~~i~~~-~~~i 582 (741)
... .....++..|+|||.+.+ ..++.++||||||||+|+|++|..||.... ..+....+... ...+
T Consensus 157 ~~~-~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 157 NSL-AGTFTGTSFYMAPERIQG-------KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred ccc-cccccCCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence 322 123467889999999863 457789999999999999999999998652 12233333321 1111
Q ss_pred C------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 583 P------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 583 P------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
+ ..+++++.+||.+||..||.+|||+.|+++|+||+....
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 1 234678999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=366.45 Aligned_cols=265 Identities=27% Similarity=0.441 Sum_probs=232.8
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeec
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD 428 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~ 428 (741)
.....+|..+.+||+|+||+|.+|..+.+.+.+|||+++..-. .+.+.++--..|-++|... +-|.+++++..|+.-
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVi--iQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVI--IQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhcccee--eecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 4456789999999999999999999999999999998863211 1111122233466777766 468999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc-
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL- 507 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~- 507 (741)
+.+|+||||+.||+|--.|++. +.+-|..+..|+.+|+-||-|||++|||+||||.+||||+.+|++||+|||+++..
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred hheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999999999999775 67999999999999999999999999999999999999999999999999999864
Q ss_pred cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCC
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLS 587 (741)
Q Consensus 508 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls 587 (741)
.+...+.+++|||.|+|||++. ...|+.++|+||+||+||||+.|++||++.++.+....|......+|..++
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~-------YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslS 574 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIA-------YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLS 574 (683)
T ss_pred cCCcceeeecCCCcccccceEE-------ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccccc
Confidence 3455667899999999999986 467899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccccCC
Q 004633 588 SEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQN 624 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPT-----a~ElLqHpwf~~~~~~~ 624 (741)
.++.++++..|.+.|.+|.. -.+|-.||||+..+|..
T Consensus 575 kEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 575 KEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred HHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 99999999999999999974 46899999999887754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=332.88 Aligned_cols=256 Identities=31% Similarity=0.523 Sum_probs=221.0
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|..+++||+|+||+||+|+++++++.||+|.++...++.... ....+||.+|+.|+|.|||+++++...+..+-+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp---ssalreicllkelkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc---HHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence 5888999999999999999999999999999998766554433 3566799999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~ 513 (741)
+|||+ .+|..+....++.++.+.++.++.|+++||.|||+++++||||||.|+||+.+|++||+|||+++.+.-.. ..
T Consensus 80 fe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 80 FEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 99997 78888888877889999999999999999999999999999999999999999999999999999886433 22
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhccC-----------CC
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-----------PP 581 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~-----------~~ 581 (741)
...+.|.+|++|.++.| ..-|+...|+||.|||+.||.. |++.|.+.+-.+.+.+|+... ..
T Consensus 159 saevvtlwyrppdvlfg------akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred eceeeeeeccCcceeee------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 23457999999999986 3567889999999999999987 888899888877777765310 01
Q ss_pred CC------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 582 IP------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 582 iP------------------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+| +.+....+||++++|..+|.+|++++++|+||||...
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 11 1245677899999999999999999999999999754
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=347.88 Aligned_cols=255 Identities=29% Similarity=0.519 Sum_probs=206.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec----
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~---- 428 (741)
..+|++.++||+|+||.||+|.++.+++.||||++........ ....+.+|+++|+.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC---cchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 5689999999999999999999999999999998864322211 113456799999999999999999987543
Q ss_pred ----ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccc
Q 004633 429 ----DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (741)
Q Consensus 429 ----~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA 504 (741)
..+|+||||+.+ +|..++......+++..++.++.||++||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 347999999974 677766655567999999999999999999999999999999999999999999999999999
Q ss_pred hhccCccc------------ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHH
Q 004633 505 KHLTGLSY------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM 572 (741)
Q Consensus 505 ~~~~~~~~------------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~ 572 (741)
........ .....|++.|+|||++.+ ...++.++||||||||+|||++|++||.+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhC------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 76543221 112357889999999863 345678999999999999999999999876665544
Q ss_pred HHHhccCC-----------------------CCC-------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 573 FKVLNRTP-----------------------PIP-------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 573 ~~i~~~~~-----------------------~iP-------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
..+..... ..+ ..+..++.+||.+||..||++|||+.|++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 44332100 000 2345788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.09 Aligned_cols=251 Identities=23% Similarity=0.411 Sum_probs=209.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k----~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
..+|++.+.||+|+||+||+|... .++..||+|.+... ...+....+.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI----NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC----CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 357899999999999999999853 45678999987631 2234456788999999999999999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhc----------------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC
Q 004633 429 DHLYIYLEYVHPGSINRYVREH----------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~----------------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~ 492 (741)
+..|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999998532 124788899999999999999999999999999999999999
Q ss_pred CCcEEEeecccchhccCcc---cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCc
Q 004633 493 SGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568 (741)
Q Consensus 493 ~g~vKL~DFGLA~~~~~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~ 568 (741)
++.+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..||.+...
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhcc-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999998654322 1223446778999999863 357789999999999999998 9999987765
Q ss_pred HHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 569 PQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 569 ~~~~~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
......+... ....+..++.++.++|.+||+.||++||++.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 233 QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 5555544433 345667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.48 Aligned_cols=252 Identities=24% Similarity=0.415 Sum_probs=211.4
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeeccee
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~t-----g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~ 425 (741)
...++|++.+.||+|+||.||+|.++.. +..||+|.+... ........+.+|+.+|+.++|+||+++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN----ASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc----cCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 4567899999999999999999988654 478999986521 1223345678899999999999999999999
Q ss_pred eecceEEEEEeecCCCChhhhhhhcc---------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004633 426 VVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (741)
Q Consensus 426 ~~~~~l~LVmEy~~gGsL~~lI~~~~---------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~v 496 (741)
...+..|+||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 99999999999999999999996431 236788999999999999999999999999999999999999999
Q ss_pred EEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHH
Q 004633 497 KLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 572 (741)
Q Consensus 497 KL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~ 572 (741)
||+|||+++.+..... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 231 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-------GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhc-------CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH
Confidence 9999999986643321 223446789999999863 357789999999999999998 99999887766655
Q ss_pred HHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 573 FKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 573 ~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..+... ...+|..++.++.++|.+||..+|++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 555433 34667788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=342.54 Aligned_cols=249 Identities=26% Similarity=0.474 Sum_probs=212.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|+++++||.|+||.||+|.++. +..+|+|++... .......+.+|+.+|+.++|+||+++++++...+..
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD-----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc-----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence 34579999999999999999999988 899999987632 122245688899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
++||||+++|+|.+++.+. ...+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999999999763 346899999999999999999999999999999999999999999999999999776433
Q ss_pred ccc-cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 004633 511 SYE-LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 587 (741)
Q Consensus 511 ~~~-~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls 587 (741)
... ....++..|+|||++.+ ..++.++||||||+++|+|++ |+.||......+.+..+... ....+..++
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASH-------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCP 230 (261)
T ss_pred cccccCCCCceEecCHHHHcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCC
Confidence 221 12345678999998853 456789999999999999998 89999887766666666543 345567889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..+.++|.+||..||.+|||+.++++
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 231 QEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.25 Aligned_cols=254 Identities=36% Similarity=0.614 Sum_probs=216.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
..|...+.||+|++|.||++.++.+++.+++|++.... ....+.+.+|+.+++.++|+||+++++++...+..|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence 45777789999999999999999999999999876321 2223567889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-c
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~ 512 (741)
|+||+.|++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 94 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 94 VMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred EEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 9999999999999876 468999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCC---CCccCCHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSE 589 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~---iP~~ls~e 589 (741)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+....+..+...... .+..++..
T Consensus 172 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (285)
T cd06648 172 RKSLVGTPYWMAPEVISR-------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPR 244 (285)
T ss_pred cccccCCccccCHHHhcC-------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHH
Confidence 233568999999999853 34678999999999999999999999877665555555443222 12347899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+.+||.+||..+|++||++.++++|+||+...
T Consensus 245 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 245 LRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.64 Aligned_cols=258 Identities=34% Similarity=0.598 Sum_probs=216.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
...|++.+.||+|+||+||+|.+..+++.||+|++.... ....+..+.+.+|+++++.++||||+++++++..++..|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc--cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 356999999999999999999999999999999885322 223344567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
+||||+. |+|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++......
T Consensus 92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 9999997 5777777655567999999999999999999999999999999999999999999999999998755332
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCC-CccCCHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPI-PEMLSSEG 590 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~i-P~~ls~el 590 (741)
....|+..|+|||++.+. ....++.++||||||+++|||++|+.||...+.......+... ...+ +..++.++
T Consensus 169 -~~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred -CCccCCccccCceeeecc----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 245688999999987531 1245778999999999999999999999877665555554432 2222 34578899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+++|.+||..||++||++.+++.|+||...
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.36 Aligned_cols=256 Identities=25% Similarity=0.462 Sum_probs=213.5
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQY 421 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~t-----g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl 421 (741)
.+.....+|++.+.||+|+||.||++..+.. ...+|+|.+... ........+.+|+.+++.+ +|+||+++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC----CCHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 4566677899999999999999999987643 367999987632 1233346688999999999 79999999
Q ss_pred cceeeecceEEEEEeecCCCChhhhhhhc---------------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCc
Q 004633 422 YGSEVVDDHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (741)
Q Consensus 422 ~g~~~~~~~l~LVmEy~~gGsL~~lI~~~---------------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~ 486 (741)
++++..++.+|+||||+.+|+|..++... ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 99999999999999999999999998642 346899999999999999999999999999999999
Q ss_pred ceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCC
Q 004633 487 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 562 (741)
Q Consensus 487 NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~P 562 (741)
|||++.++.+||+|||+++.+..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p 234 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFTLGGSP 234 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-------CCcCcccceeehhhHHHHHhcCCCCC
Confidence 99999999999999999987654321 112234678999998853 457789999999999999997 9999
Q ss_pred CCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 563 WSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 563 F~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
|......+....+... ....+..++.++.+||.+||..||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 235 YPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9887666655554433 235667788999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.03 Aligned_cols=260 Identities=28% Similarity=0.493 Sum_probs=216.8
Q ss_pred CeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecce
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k---~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 430 (741)
.|++.+.||.|+||.||+|.+. .+|..||+|++..... .......+.+.+|+++|+.+ +|+||+.+++.+..+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI-VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh-hhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe
Confidence 3889999999999999999875 4789999999864211 11122345678899999999 59999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 80 LHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999999765 56899999999999999999999999999999999999999999999999999776442
Q ss_pred c--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc----HHHHHHHhccCCCCCc
Q 004633 511 S--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPE 584 (741)
Q Consensus 511 ~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~~~~iP~ 584 (741)
. ......|+..|+|||.+.+ +...++.++||||||+++|+|++|..||..... .+....+.....+++.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRG-----GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233 (290)
T ss_pred cccccccccCCcccCChhhccC-----CCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc
Confidence 2 2224568999999999863 123466789999999999999999999964322 2333444455667788
Q ss_pred cCCHHHHHHHHHhhhcCCCCCC-----CHHHHHcCccccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNAN 621 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRP-----Ta~ElLqHpwf~~~~ 621 (741)
.++..+.+||.+||..||++|+ ++++++.|+||....
T Consensus 234 ~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 234 EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 8999999999999999999997 899999999998765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=344.00 Aligned_cols=252 Identities=29% Similarity=0.510 Sum_probs=210.5
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec--ceEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYI 433 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--~~l~L 433 (741)
|++.+.||.|+||.||+|.+..+++.+|+|++.... ........+.+|+.+++.++|+||+++++++... +..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN---EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc---ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 688999999999999999999999999999987532 1122335677899999999999999999999888 89999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-- 511 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-- 511 (741)
||||+. ++|..++......+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred Eecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 999997 58988887655679999999999999999999999999999999999999999999999999998665432
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-----------
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----------- 580 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~----------- 580 (741)
......++..|+|||.+.+ ...++.++||||||+++|||++|+.||...+....+..+.....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 157 DYTNRVITLWYRPPELLLG------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cccccccccccCCceeeEc------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 1223457889999998753 23567899999999999999999999988776555444432100
Q ss_pred --------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 581 --------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 --------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.+...++.++.++|.+||..||.+||+++++++|+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0011138899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=353.25 Aligned_cols=251 Identities=28% Similarity=0.463 Sum_probs=208.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcE----EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~----vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
...+|++.+.||+|+||+||+|.+..++.. ||||+++.. ......+++.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 346799999999999999999998766654 888887521 223345678889999999999999999998876
Q ss_pred cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
. ..++|+||+.+|+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 4 578999999999999999876667899999999999999999999999999999999999999999999999999876
Q ss_pred cCccccc---ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-cCCCC
Q 004633 508 TGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPI 582 (741)
Q Consensus 508 ~~~~~~~---s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~i 582 (741)
....... ...++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+.. ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232 (316)
T ss_pred cCCCcceeccCCccceeecChHHhcc-------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence 5432222 2234678999999863 457789999999999999997 9999987655443332222 23345
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+..++.++.++|.+||..||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 233 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 66788999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=341.21 Aligned_cols=248 Identities=31% Similarity=0.498 Sum_probs=209.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
..+|++++.||+|+||+||+|.++. +..+|+|.+.... .. ...+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---cc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence 3579999999999999999998764 4569999875321 11 245788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
+||||+.+|+|.+++......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999999999977555789999999999999999999999999999999999999999999999999876544322
Q ss_pred cc--ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhccC-CCCCccCCH
Q 004633 513 EL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT-PPIPEMLSS 588 (741)
Q Consensus 513 ~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~ 588 (741)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+.... ...+...+.
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLY-------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE 228 (256)
T ss_pred eecCCCccChhhCCHHHHhc-------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 21 2235678999999863 357779999999999999998 999998877766666665543 334566789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.++++|.+||..||++||++.+++++
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=348.34 Aligned_cols=259 Identities=29% Similarity=0.501 Sum_probs=209.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~ 432 (741)
++|+..+.||+|+||.||++.+..+++.||||.+..... ......+.+|+.++.++. |+|||++++++..++..+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD----EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC----hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 357778899999999999999999999999998764222 133467888999999996 999999999999999999
Q ss_pred EEEeecCCCChhhhh---hh-ccccccHHHHHHHHHHHHHHHHHHHhC-CeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 433 IYLEYVHPGSINRYV---RE-HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 433 LVmEy~~gGsL~~lI---~~-~~~~lse~~i~~i~~QIl~aL~yLHs~-gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
++|||+.+ +|.++. .. ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||++..+
T Consensus 80 ~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99999874 444433 22 235699999999999999999999974 9999999999999999999999999999876
Q ss_pred cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH-HHHHHHhccC-CCC---
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRT-PPI--- 582 (741)
Q Consensus 508 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~-~~~~~i~~~~-~~i--- 582 (741)
..........|+..|+|||++.+.. ...++.++|||||||++|||++|+.||...... +.+.++.... +.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSA----RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNS 234 (288)
T ss_pred ccCCccccccCccCccCHHHhcccc----ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCc
Confidence 5444444456899999999986411 136788999999999999999999999765422 2222332221 122
Q ss_pred -CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 583 -PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 583 -P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+..++.++.+||.+||..||++|||++++++|+||+...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 224789999999999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.70 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=209.2
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-- 429 (741)
...+|++.+.||+|+||.||+|.++.+|+.||||+++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE---GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc---CchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 3457999999999999999999999999999999987532211 12245678999999999999999999887654
Q ss_pred --------eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004633 430 --------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (741)
Q Consensus 430 --------~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DF 501 (741)
.+|+||||+.+ +|..++......+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999986 677777665557999999999999999999999999999999999999999999999999
Q ss_pred ccchhccCccc--ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc--
Q 004633 502 GMAKHLTGLSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-- 577 (741)
Q Consensus 502 GLA~~~~~~~~--~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~-- 577 (741)
|++..+..... .....++..|+|||++.+ ...++.++|||||||++|||++|++||...+..+.+..+..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLG------EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99987644321 122346788999998853 23467799999999999999999999987665544433322
Q ss_pred -cCC---------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 578 -RTP---------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 578 -~~~---------------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
... .....++..+.++|.+||..||.+||++.++++|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 100 0112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.50 Aligned_cols=249 Identities=27% Similarity=0.484 Sum_probs=209.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
...++|++.++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT------MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP 75 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc------hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678999999999999999999865 56779999865311 124578889999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.|+||||+.+|+|.+++... ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999999999653 35688999999999999999999999999999999999999999999999999987644
Q ss_pred cccc--cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 004633 510 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 585 (741)
Q Consensus 510 ~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ 585 (741)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+... ..+.+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228 (261)
T ss_pred CceeccCCCccceecCCHHHhcc-------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 2211 22345678999999863 356778999999999999998 99999887666666655543 2334456
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
++.++.++|.+||..+|++||+++++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 229 CPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.65 Aligned_cols=247 Identities=29% Similarity=0.483 Sum_probs=207.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|++.+.||+|+||.||+|.++ ++..+|+|++.... .. ...+.+|+++++.++|+||+++++++...+..|+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~---~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA---MS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC---CC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 46899999999999999999876 46789999875211 11 1356779999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
||||++|++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999999775567899999999999999999999999999999999999999999999999999765432211
Q ss_pred c--ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 004633 514 L--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 589 (741)
Q Consensus 514 ~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e 589 (741)
. ...++..|+|||.+.+ ..++.++|||||||++|||++ |+.||......+....+... ....+..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDY-------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTE 229 (256)
T ss_pred ccCCCCCCccccCHHHhcc-------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence 1 1123457999999863 457789999999999999998 89999877666666555443 34556678999
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+.++|.+||..+|++|||+.|+++.
T Consensus 230 ~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 230 VYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=340.11 Aligned_cols=249 Identities=24% Similarity=0.408 Sum_probs=207.0
Q ss_pred eEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce--
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-- 430 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~t---g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~-- 430 (741)
|++++.||+|+||.||+|....+ +..||||.++.. .........+.+|+.+|+.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD---IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC---cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 67899999999999999987654 478999987642 2223345678899999999999999999998765544
Q ss_pred ----EEEEEeecCCCChhhhhhhc-----cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004633 431 ----LYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (741)
Q Consensus 431 ----l~LVmEy~~gGsL~~lI~~~-----~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DF 501 (741)
.++||||+.+|+|..++... ...+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+||
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999988442 235899999999999999999999999999999999999999999999999
Q ss_pred ccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc
Q 004633 502 GMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 577 (741)
Q Consensus 502 GLA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~ 577 (741)
|+++.+...... ....++..|+|||.+. ...++.++|||||||++|||++ |..||.+....+....+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-------DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcc-------cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999866433211 1123567899999885 2457789999999999999999 9999988777666665554
Q ss_pred -cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 578 -RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 578 -~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.....+..++.++.++|.+||..||.+||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 231 GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3455677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=334.46 Aligned_cols=252 Identities=31% Similarity=0.524 Sum_probs=218.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|++.++||+|+||.||++.++.+++.+|+|.+..... .......+.+|+++++.++|+||+++++++......|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM---SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc---cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 58999999999999999999999999999998864322 223345677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 435 LEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|||+++++|.+++.+. ...+++..++.++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999999998652 356899999999999999999999999999999999999999999999999999877554
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEG 590 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el 590 (741)
......|+..|++||.+.+ ..++.++|+||||+++|||++|+.||...+..+....+.... ..++..++.++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKG-------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDL 229 (256)
T ss_pred CcccccCCccccCHHHHCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHH
Confidence 3334568999999999863 456778999999999999999999998877665555554433 45666789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
+++|.+||..+|++||++.++++||++
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 230 QNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=342.91 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=209.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~-----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
...|++.+.||+|+||.||+|.++. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC----SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4579999999999999999999987 67889999765321 22233567889999999999999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhhcc------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC---cEEE
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHC------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKL 498 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g---~vKL 498 (741)
.+..++||||+.||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999996642 2589999999999999999999999999999999999998765 6999
Q ss_pred eecccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 004633 499 ADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 574 (741)
Q Consensus 499 ~DFGLA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~ 574 (741)
+|||+++.+...... .....+..|+|||++.+ ..++.++|||||||++|||++ |..||......+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhc-------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999876332211 12223567999999863 457889999999999999997 9999988766655554
Q ss_pred Hhc-cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 575 VLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 575 i~~-~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+.. .....+..++..+.++|.+||..||++||++.++|+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 234 VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 443 3345667789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.27 Aligned_cols=255 Identities=38% Similarity=0.635 Sum_probs=215.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
..+|.+.+.||+|+||+||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 4689999999999999999999999999999998753211 12356788999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
+||||+++++|.+++.+. .+++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 93 lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred EEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999999999763 588999999999999999999999999999999999999999999999999876544322
Q ss_pred -ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHh-ccCC--CCCccCCH
Q 004633 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-NRTP--PIPEMLSS 588 (741)
Q Consensus 513 -~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~-~~~~--~iP~~ls~ 588 (741)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+....+..+. ...+ ..+..++.
T Consensus 171 ~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 243 (293)
T ss_pred ccccccCChhhcCchhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCH
Confidence 223468899999999863 356779999999999999999999998765544333332 1222 23445788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.++++|.+||..+|++||++.+++.|+||+...
T Consensus 244 ~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=354.42 Aligned_cols=258 Identities=28% Similarity=0.468 Sum_probs=210.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec----
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~---- 428 (741)
..+|.+.+.||+|+||+||+|++..+++.||||.+..... .......+.+|+.+|+.++|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD---NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREA 80 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCccchHHheecccccc
Confidence 3579999999999999999999999999999998764221 122235667899999999999999999987654
Q ss_pred -ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 429 -~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
..+||||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 34899999996 6888888664 56999999999999999999999999999999999999999999999999999866
Q ss_pred cCc-ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc---------
Q 004633 508 TGL-SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--------- 577 (741)
Q Consensus 508 ~~~-~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~--------- 577 (741)
... .......++..|+|||++.. ...++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLN------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred CCCcccccccccccCccChHHHhc------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 443 22334568999999999863 23477899999999999999999999976543322211110
Q ss_pred --------------c---C-----CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 578 --------------R---T-----PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 578 --------------~---~-----~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
. . ......++.++.+||++||..||++|||++|+|+||||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0 0 011235789999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=343.33 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=205.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcE----EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~----vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
..+|++++.||+|+||+||+|.+..++.. +++|.+.. .........+..|+.++..+.||||+++++++. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD----RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc----ccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 46799999999999999999999887775 55665431 222344567888999999999999999999765 4
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
...++||||+.+|+|.+++......+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 56889999999999999998766779999999999999999999999999999999999999999999999999998654
Q ss_pred Cccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCC
Q 004633 509 GLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP 583 (741)
Q Consensus 509 ~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP 583 (741)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+..+ ....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF-------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQP 233 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC
Confidence 3221 123446778999999863 357889999999999999998 99999876654443333322 23445
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..++.++.++|.+||..||++|||+.|+++
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 234 QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 667889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.79 Aligned_cols=252 Identities=30% Similarity=0.529 Sum_probs=211.8
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.+|+.++|+||+++++++..++.+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES---EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc---chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 67789999999999999999999999999988643222 123467888999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-ccc
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL 514 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~~ 514 (741)
||+.+ +|.+++......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ...
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 99975 8888887755679999999999999999999999999999999999999999999999999997765433 222
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC--------------
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------------- 580 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-------------- 580 (741)
...++..|+|||.+.+ ...++.++||||||+++|+|++|+.||...+..+.+.++.....
T Consensus 157 ~~~~~~~~~~PE~~~~------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 157 HYVVTRWYRAPELLLG------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CccCcccccCcHHHhc------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 3458889999999863 23577899999999999999999999987766555444322100
Q ss_pred ----------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 581 ----------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 ----------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.+...++.++++||.+||..||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0122467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=358.77 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=206.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG 423 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~-----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g 423 (741)
....++|+++++||+|+||.||+|.+.. +++.||+|+++.. ......+.+.+|+.+++++ +|+||+++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG----ATASEYKALMTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC----CCHHHHHHHHHHHHHHHhhccCcchhheee
Confidence 3445689999999999999999997543 4578999987531 1233346678899999999 7999999999
Q ss_pred eeeec-ceEEEEEeecCCCChhhhhhhcc---------------------------------------------------
Q 004633 424 SEVVD-DHLYIYLEYVHPGSINRYVREHC--------------------------------------------------- 451 (741)
Q Consensus 424 ~~~~~-~~l~LVmEy~~gGsL~~lI~~~~--------------------------------------------------- 451 (741)
++... ..++++|||+.+|+|.++|....
T Consensus 79 ~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 79 ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred eEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 87654 56899999999999999985421
Q ss_pred ---------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc---ccccCCC
Q 004633 452 ---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGS 519 (741)
Q Consensus 452 ---------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT 519 (741)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... .....++
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 2578899999999999999999999999999999999999999999999999987643221 1233457
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc--CCCCCccCCHHHHHHHHH
Q 004633 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLR 596 (741)
Q Consensus 520 ~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~--~~~iP~~ls~el~dLI~~ 596 (741)
..|+|||++.+ ..++.++|||||||+||||++ |..||.+....+.+...+.. ....+..+++++.+++.+
T Consensus 239 ~~y~aPE~~~~-------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 239 LKWMAPESIFD-------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLD 311 (337)
T ss_pred ccccCcHHhcC-------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHH
Confidence 78999999863 467889999999999999998 99999875544444433322 334566788999999999
Q ss_pred hhhcCCCCCCCHHHHHcC
Q 004633 597 CFLRNPVERPSAVELLEH 614 (741)
Q Consensus 597 cL~~DP~kRPTa~ElLqH 614 (741)
||+.+|++||++.|+++|
T Consensus 312 cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 312 CWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=354.95 Aligned_cols=257 Identities=29% Similarity=0.509 Sum_probs=210.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee----cc
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DD 429 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~----~~ 429 (741)
.+|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+|+.++|+||+++++++.. ..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD---VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc---cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 679999999999999999999999999999998864221 12234567789999999999999999998763 35
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred eEEEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 6899999996 6898888654 5599999999999999999999999999999999999999999999999999976543
Q ss_pred cc-----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-------
Q 004633 510 LS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN------- 577 (741)
Q Consensus 510 ~~-----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~------- 577 (741)
.. ......|+..|+|||++.+ ...++.++|||||||++|||++|+.||.+.+....+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLS------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred cCcCCCcccccccccccccChHHhcC------CcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 22 1224568999999999863 23577899999999999999999999987654433322211
Q ss_pred -------------------cCCCC-----CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 578 -------------------RTPPI-----PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 578 -------------------~~~~i-----P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
..... ...++.++.++|++||+.||++||++.++++||||....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00111 134689999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=334.60 Aligned_cols=246 Identities=33% Similarity=0.550 Sum_probs=216.7
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCC
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 441 (741)
||+|+||.||++.+..+++.||+|++..... ........+.+|+.+++.++|+||+++++.+..++..|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI--IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh--cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 6999999999999999999999998864322 22334567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-ccccccCCCC
Q 004633 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SYELSLKGSP 520 (741)
Q Consensus 442 sL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~-~~~~s~~GT~ 520 (741)
+|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++...... .......++.
T Consensus 79 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999999765 46899999999999999999999999999999999999999999999999999776443 2233456899
Q ss_pred CCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhc
Q 004633 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLR 600 (741)
Q Consensus 521 ~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~cL~~ 600 (741)
.|++||.+.+ ...+.++|+||||+++|+|++|..||...+..+....+......++..++.++.++|++||..
T Consensus 158 ~~~~Pe~~~~-------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 230 (250)
T cd05123 158 EYLAPEVLLG-------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQK 230 (250)
T ss_pred cccChHHhCC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999863 346778999999999999999999998777666667777777788888999999999999999
Q ss_pred CCCCCCCH---HHHHcCccc
Q 004633 601 NPVERPSA---VELLEHPFI 617 (741)
Q Consensus 601 DP~kRPTa---~ElLqHpwf 617 (741)
||++||++ +++++||||
T Consensus 231 ~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 231 DPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CHhhCCCcccHHHHHhCCCC
Confidence 99999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=354.78 Aligned_cols=254 Identities=26% Similarity=0.471 Sum_probs=205.9
Q ss_pred eEEeec--CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEee
Q 004633 360 KLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (741)
Q Consensus 360 k~LG~G--~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 437 (741)
+.||+| +||+||+|.+..+|+.||||++..... ..+..+.+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC---TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 456666 999999999999999999998764322 234457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc----
Q 004633 438 VHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---- 512 (741)
Q Consensus 438 ~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~---- 512 (741)
+.+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999998764 24589999999999999999999999999999999999999999999999986543321110
Q ss_pred ----ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC--------
Q 004633 513 ----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-------- 580 (741)
Q Consensus 513 ----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-------- 580 (741)
.....++..|+|||++.+. ...++.++|||||||++|||++|+.||........+..++....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQD-----LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT 235 (328)
T ss_pred cccccccccCccCccChhhhcCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence 0112346679999998641 23467899999999999999999999987665544443332211
Q ss_pred ---------------------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 581 ---------------------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 581 ---------------------------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
..+..++..+++||.+||..||++|||+.|+|+|+||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 11223567899999999999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=354.95 Aligned_cols=254 Identities=28% Similarity=0.490 Sum_probs=207.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec----
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~---- 428 (741)
..+|++.+.||.|+||.||+|.++.+|+.||+|++..... ...+.+.+|+++|+.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 4689999999999999999999999999999999864322 3346688899999999999999999876554
Q ss_pred ----------ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC-CCcEE
Q 004633 429 ----------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVK 497 (741)
Q Consensus 429 ----------~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~-~g~vK 497 (741)
..+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+|
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEE
Confidence 35899999997 588888754 35899999999999999999999999999999999999974 56799
Q ss_pred EeecccchhccCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHH
Q 004633 498 LADFGMAKHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 573 (741)
Q Consensus 498 L~DFGLA~~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~ 573 (741)
|+|||++..+..... .....|+..|+|||++.+ ...++.++|||||||++|||++|+.||......+...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhC------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999976533211 122357889999998753 2356779999999999999999999998766544444
Q ss_pred HHhccCC------------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 574 KVLNRTP------------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 574 ~i~~~~~------------------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.++...+ .+...++.++.+||.+||..||++|||+.|+|+|+||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 3322110 0113477899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=352.92 Aligned_cols=261 Identities=30% Similarity=0.456 Sum_probs=211.5
Q ss_pred CCCeE-EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHH---------HHHHHHHHHHHHhhcCCCCeeeec
Q 004633 353 KSQWQ-KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE---------CIKQLEQEIKVLGHLKHENIVQYY 422 (741)
Q Consensus 353 ~~~Y~-i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~---------~ik~l~~Ei~iL~~L~HPNIVkl~ 422 (741)
..+|. +.+.||.|+||+||+|.++.+++.||||++........... ....+.+|+++|+.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 56889999999999999999999999999864322211000 112467899999999999999999
Q ss_pred ceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004633 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (741)
Q Consensus 423 g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFG 502 (741)
+++..++.+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 99999999999999997 6899888654 569999999999999999999999999999999999999999999999999
Q ss_pred cchhccCc---------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC
Q 004633 503 MAKHLTGL---------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (741)
Q Consensus 503 LA~~~~~~---------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~ 567 (741)
++...... .......++..|+|||++.+ ...++.++|||||||++|||++|+.||...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG------AEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhccc------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99765411 11112346889999999863 3456789999999999999999999998877
Q ss_pred cHHHHHHHhccC---C-------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 568 GPQAMFKVLNRT---P-------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 568 ~~~~~~~i~~~~---~-------------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
..+.+..+.... . ......+.++.++|.+||..||++||+++|+|.|+||+.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~ 318 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKS 318 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCC
Confidence 665554443210 0 011235788999999999999999999999999999986
Q ss_pred cc
Q 004633 620 AN 621 (741)
Q Consensus 620 ~~ 621 (741)
..
T Consensus 319 ~~ 320 (335)
T PTZ00024 319 DP 320 (335)
T ss_pred CC
Confidence 54
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.73 Aligned_cols=255 Identities=28% Similarity=0.523 Sum_probs=214.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|.+.+.||+|+||+||++.+...+..+++|+++..............+..|+.+++.++||||+++++++...+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58999999999999999999988888788887765443322222334577899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-
Q 004633 435 LEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL- 510 (741)
Q Consensus 435 mEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~- 510 (741)
|||+.+++|.+++.+ ....+++.+++.++.||+.||.|||++||+|+||||+||+++. +.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 2356899999999999999999999999999999999999974 67999999998766432
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 589 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e 589 (741)
.......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+... .+.++..++.+
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKH-------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQ 232 (260)
T ss_pred ccccCCCCCcCccCHHHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHH
Confidence 22334568999999998753 34567899999999999999999999876666655555443 34456678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
+.++|.+||..||++||++.|+++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=344.40 Aligned_cols=250 Identities=22% Similarity=0.383 Sum_probs=210.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~-----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
.+|++.+.||+|+||+||+|.+.. ++..||||++... ......+.+.+|+.++..++|||||++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK----AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC----CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 458889999999999999998754 3578999987632 1233456788999999999999999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhc---------------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC
Q 004633 429 DHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~---------------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~ 493 (741)
+..++++||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 1347888999999999999999999999999999999999999
Q ss_pred CcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcH
Q 004633 494 GVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP 569 (741)
Q Consensus 494 g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~ 569 (741)
+.+||+|||+++....... .....+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 233 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhc-------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999886643221 123345789999999863 356789999999999999998 88999887777
Q ss_pred HHHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 570 QAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 570 ~~~~~i~~~~-~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+....+.... ..++..++.++.+||.+||+.+|++||++.+|+..
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 234 DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7776666543 35677899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=338.69 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=204.1
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec-----
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----- 428 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~--~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~----- 428 (741)
|.++++||+|+||.||+|++..++. .||+|.++... ......+.+.+|+.+|+.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI---CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 4578999999999999999987775 58999876421 2234456788899999999999999999876432
Q ss_pred -ceEEEEEeecCCCChhhhhhh-----ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004633 429 -DHLYIYLEYVHPGSINRYVRE-----HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (741)
Q Consensus 429 -~~l~LVmEy~~gGsL~~lI~~-----~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFG 502 (741)
...++||||+.+|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 247899999999999988742 22348899999999999999999999999999999999999999999999999
Q ss_pred cchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc
Q 004633 503 MAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR 578 (741)
Q Consensus 503 LA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~ 578 (741)
+++.+..... .....+++.|+|||.+.+ ..++.++|||||||++|||++ |+.||......+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-------RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccC-------CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9987643221 112345778999998863 457789999999999999999 89999887666655555543
Q ss_pred C-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 579 T-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 579 ~-~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
. ...+..++..+.++|.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 231 NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3 34566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=370.17 Aligned_cols=253 Identities=29% Similarity=0.492 Sum_probs=224.5
Q ss_pred eEE--eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 356 WQK--GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 356 Y~i--~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
|++ .++||.|.||+||-|+++.+|+.||||+|++.+-..+.. .++++|+.||+.++||.||.+.-.|+..+.+++
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe---sqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE---SQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchH---HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 555 589999999999999999999999999998766544443 578899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC---cEEEeecccchhccCc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGL 510 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g---~vKL~DFGLA~~~~~~ 510 (741)
|||.+.|.-|..++....+.++|...+.++.||+.||.|||.++|||+||||+|||+.... .+||||||+|+.+...
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 9999998888888877778899999999999999999999999999999999999997543 7999999999999998
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCC----ccC
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EML 586 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP----~~l 586 (741)
....+.+|||.|+|||+|+ +..|...-||||+|+|+|--|.|..||.+.+. +-.+|.+....+| ..+
T Consensus 721 sFRrsVVGTPAYLaPEVLr-------nkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~PW~ei 791 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLR-------NKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPNPWSEI 791 (888)
T ss_pred hhhhhhcCCccccCHHHHh-------hccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCCchhhc
Confidence 9999999999999999998 45677899999999999999999999976543 3334444433333 568
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
++++.|||..+|+....+|.+.++.|.|+|+++.
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999999864
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=337.72 Aligned_cols=249 Identities=27% Similarity=0.479 Sum_probs=209.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
....+|++.+.||+|+||.||+|.+.. ++.||||.++.... ..+.+.+|+.++++++|+||+++++++...+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM------DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP 75 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc------cHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence 345679999999999999999999754 57899998763211 13457889999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 431 LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 76 IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999999999997643 4689999999999999999999999999999999999999999999999999987653
Q ss_pred ccccc--ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 004633 510 LSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 585 (741)
Q Consensus 510 ~~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ 585 (741)
..... ...++..|+|||++.+ ..++.++||||||+++|||++ |+.||.+......+..+... ....+..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALY-------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG 228 (261)
T ss_pred CcccccCCCcCceeccCcccccc-------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 22111 1123457999998753 457789999999999999999 99999887766666655443 2345667
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
++..+.++|.+||..||.+||++.++++
T Consensus 229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 229 CPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 8999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=342.10 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=200.7
Q ss_pred CeEEeeEE--eecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceE
Q 004633 355 QWQKGKLI--GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 355 ~Y~i~k~L--G~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l 431 (741)
.|.+.+.+ |.|+||.||++.++.++..+|+|++...... . .|+.++..+ +|+||+++++.+..++.+
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--------A--IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--------h--hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 45565555 9999999999999999999999998642211 0 122222222 699999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g-~vKL~DFGLA~~~~~~ 510 (741)
|+||||+++|+|.+++... ..+++.+++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 9999999999999999775 4799999999999999999999999999999999999999998 9999999998765432
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH----HHHHHhccCCCCCccC
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLNRTPPIPEML 586 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~----~~~~i~~~~~~iP~~l 586 (741)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..........+..+
T Consensus 164 ---~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKG-------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233 (267)
T ss_pred ---ccCCCCCcccChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccccc
Confidence 23568999999999863 346778999999999999999999997554322 1222223344556678
Q ss_pred CHHHHHHHHHhhhcCCCCCCC-HHHHHcCccccc
Q 004633 587 SSEGKDFLLRCFLRNPVERPS-AVELLEHPFIRN 619 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPT-a~ElLqHpwf~~ 619 (741)
+..+++||.+||+.||.+|++ ++|+|+|+||.+
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999999996 699999999964
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.60 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=212.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-- 429 (741)
..++|++.+.||+|+||.||+|.+..+|..||||++.... ........+.+|+.+|+.++|+||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4668999999999999999999999999999999875321 22333456788999999999999999999887654
Q ss_pred ----eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 430 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 430 ----~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
.+++||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 469999999 7899888864 468999999999999999999999999999999999999999999999999997
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-----
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP----- 580 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~----- 580 (741)
..... .....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+......+++....
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 167 QTDSE--MTGYVVTRWYRAPEVILN------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccC--ccccccCCcccCHHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 65432 234567999999999863 23467899999999999999999999987655444433322110
Q ss_pred --------------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 581 --------------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 581 --------------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.+...++.++.++|.+||..||++|||+.++++|+||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 11235678899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=347.00 Aligned_cols=256 Identities=25% Similarity=0.454 Sum_probs=210.3
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIV 419 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~-------tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIV 419 (741)
.+....++|.+++.||+|+||.||+|.+.. ++..+|+|.++.. ........+.+|+.+++.+ +|+||+
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD----ATEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC----CChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 445556789999999999999999998643 2356999987632 1223345688899999999 799999
Q ss_pred eecceeeecceEEEEEeecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 004633 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (741)
Q Consensus 420 kl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIK 484 (741)
++++++..++.+|+||||+.+|+|.+++.... ..+++.++..++.||+.||+|||++||+|||||
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 99999999999999999999999999997532 247889999999999999999999999999999
Q ss_pred CcceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CC
Q 004633 485 GANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 560 (741)
Q Consensus 485 P~NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk 560 (741)
|+|||++.++.+||+|||++..+..... .....++..|+|||++.+ ..++.++|||||||++|||++ |.
T Consensus 168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~el~~~g~ 240 (307)
T cd05098 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTLGG 240 (307)
T ss_pred HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-------CCCCcHHHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999976543221 111224578999999863 457789999999999999998 89
Q ss_pred CCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 561 PPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 561 ~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.||......+....+... ....+..++.++.+||.+||..+|.+||++.+++++
T Consensus 241 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 241 SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 999876655544444333 235677889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=338.78 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=207.0
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc---CCCCeeeecceeeecce--
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVVDDH-- 430 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L---~HPNIVkl~g~~~~~~~-- 430 (741)
|++.+.||+|+||.||+|.++.+++.||+|+++..... ......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE---EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc---chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 78899999999999999999999999999998743322 11224456687777666 59999999999988776
Q ss_pred ---EEEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 431 ---LYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 431 ---l~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999997 47888886542 3589999999999999999999999999999999999999999999999999977
Q ss_pred ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC------
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------ 580 (741)
Q Consensus 507 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~------ 580 (741)
+..........++..|+|||++.+ ..++.++|||||||++|||++|.+||......+.+.++.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQ-------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred ccCCcccccccccccccChHHhcc-------CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 654443344568899999999863 3567799999999999999999999988776665555542100
Q ss_pred ---------------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 581 ---------------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 ---------------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.....++..+.++|.+||..||.+||++.|+++|+||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0011346788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=351.53 Aligned_cols=257 Identities=30% Similarity=0.492 Sum_probs=215.5
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc-----
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD----- 429 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~----- 429 (741)
+|++.+.||.|+||.||+|++..+++.||||++..... .....+.+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD---DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc---cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 58999999999999999999999999999998864221 1333467888999999999999999999988775
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred ceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 7999999998 5888888664 4799999999999999999999999999999999999999999999999999987654
Q ss_pred cc----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCC----
Q 004633 510 LS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---- 581 (741)
Q Consensus 510 ~~----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~---- 581 (741)
.. ......++..|+|||++.+ ...++.++||||||+++|+|++|..||...+..+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLS------SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred cccccccccccccccCcCCceeeec------ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence 33 2334568999999999874 225778999999999999999999999887765554444321110
Q ss_pred ---------------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 582 ---------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 582 ---------------------------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
+...++.++.+||.+||.+||++||+++++|+||||+....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 11236789999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=384.00 Aligned_cols=254 Identities=27% Similarity=0.450 Sum_probs=212.8
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecce-eee
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGS-EVV 427 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~-~~~ 427 (741)
.+...++++.++|.+|||+.||+|++...|..||+|.+... ....++.+.+||.+|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-----CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 44566789999999999999999999998899999987642 3556778899999999997 9999999993 221
Q ss_pred ---c---ceEEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCC--eecccCCCcceEecCCCcEEE
Q 004633 428 ---D---DHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKL 498 (741)
Q Consensus 428 ---~---~~l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~g--IVHRDIKP~NILLd~~g~vKL 498 (741)
+ -+++|.||||.||.|-+++.++ ...|+|.+|.+||.|+++||.+||..+ |||||||-|||||..+|..||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1 2588999999999999999653 345999999999999999999999887 999999999999999999999
Q ss_pred eecccchhccCcc----------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc
Q 004633 499 ADFGMAKHLTGLS----------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (741)
Q Consensus 499 ~DFGLA~~~~~~~----------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~ 568 (741)
||||.|......- ......-|+.|+|||++.-. .+..+++|+|||+|||+||-|+....||++...
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly----sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~ 263 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY----SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK 263 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh----cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence 9999986432111 11122358999999998632 245789999999999999999999999987533
Q ss_pred HHHHHHHhccCCCCCc--cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcc
Q 004633 569 PQAMFKVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616 (741)
Q Consensus 569 ~~~~~~i~~~~~~iP~--~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpw 616 (741)
..|+++...+|. .++..+++||+.||+.||++||++-|++.+-+
T Consensus 264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 456777777775 68999999999999999999999999997643
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=334.93 Aligned_cols=250 Identities=28% Similarity=0.505 Sum_probs=211.6
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
+....+|++.++||+|+||.||+|.++. +..||||.+..... . .+.+.+|+.+++.++|+||+++++++..+.
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~---~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM---S---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc---C---HHHHHHHHHHHhhCCCCCEeeeeeeeecCC
Confidence 3556789999999999999999999764 57799998763211 1 246788999999999999999999999889
Q ss_pred eEEEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 430 HLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
..++||||+++++|.+++.+.. ..+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.
T Consensus 75 ~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 75 PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999999999999997643 468999999999999999999999999999999999999999999999999987664
Q ss_pred Ccccc--cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCc
Q 004633 509 GLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 584 (741)
Q Consensus 509 ~~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~ 584 (741)
..... ....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.+......+.++... ....+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 227 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANY-------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPP 227 (261)
T ss_pred chhhhhhhccCCCccccCHHHhcc-------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 32211 12234678999998863 457789999999999999998 99999887776666666543 345566
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..+.++.++|.+||..||++||+++++++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=337.52 Aligned_cols=251 Identities=32% Similarity=0.537 Sum_probs=208.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|++.+.||+|+||.||+|.++.++..||||.+..... ........+.+|+.+++.++|+||+++++++..++..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh--hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 468999999999999999999999999999998764321 223344678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 434 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999998864 2345899999999999999999999999999999999999999999999999998766432
Q ss_pred c-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH--HHHHHHhcc-CCCC-Ccc
Q 004633 511 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVLNR-TPPI-PEM 585 (741)
Q Consensus 511 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~--~~~~~i~~~-~~~i-P~~ 585 (741)
. ......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...... .....+... ..+. +..
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~-------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232 (267)
T ss_pred CcccccccCCcCccCHHHhcC-------CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccc
Confidence 2 2234568999999999863 35677899999999999999999999754332 222222221 1222 345
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
++.+++++|.+||..||++|||+.+|++
T Consensus 233 ~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 233 YSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 7899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.96 Aligned_cols=251 Identities=31% Similarity=0.537 Sum_probs=209.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|++.+.||+|+||.||+|.++.+|+.||+|.++.... ......+.+.+|++++++++|+||+++++++..++..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM--MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc--cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 479999999999999999999999999999998864322 222334678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 434 YLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
||||+.+|+|..++.. ....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999999854 2345899999999999999999999999999999999999999999999999998765432
Q ss_pred c-cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc--HHHHHHHhc-cCCCCCc-c
Q 004633 511 S-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLN-RTPPIPE-M 585 (741)
Q Consensus 511 ~-~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~--~~~~~~i~~-~~~~iP~-~ 585 (741)
. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .+....+.. ...+.+. .
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHE-------NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADH 232 (267)
T ss_pred CcccceecCCccccCHHHhcc-------CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhh
Confidence 2 2234568999999999863 3567899999999999999999999965432 122223222 2233444 6
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
++.++.++|.+||..+|++|||+.+|++
T Consensus 233 ~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 233 YSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8889999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=337.79 Aligned_cols=250 Identities=27% Similarity=0.463 Sum_probs=209.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~---~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
..+|++++.||+|+||.||+|.++.++. .+|+|.++.. ......+.+.+|+.+|++++||||+++++++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 3579999999999999999999875543 6889877532 12334567889999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
..|+||||+++|+|.+++......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999999999987666789999999999999999999999999999999999999999999999999987643
Q ss_pred cccc----cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCC
Q 004633 510 LSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP 583 (741)
Q Consensus 510 ~~~~----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP 583 (741)
.... ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+... ..+.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP 231 (267)
T ss_pred ccceeeecCCCccceeecCHhHhcc-------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC
Confidence 2211 11223568999999863 457789999999999999886 99999887666655555543 23445
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..++..+.++|.+||+++|.+||++.++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 232 MDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=336.93 Aligned_cols=248 Identities=27% Similarity=0.517 Sum_probs=207.1
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
...++|++.+.||+|+||.||+|.+. ++..+|+|.+..... . ...+.+|+.+|++++|+||+++++++. ++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~ 74 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---S---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEP 74 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---C---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence 34568999999999999999999876 567799998763221 1 245788999999999999999999774 566
Q ss_pred EEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.|+||||+.+++|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 89999999999999999763 34589999999999999999999999999999999999999999999999999976644
Q ss_pred cccc--cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 004633 510 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 585 (741)
Q Consensus 510 ~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ 585 (741)
.... ....++..|+|||++.+ ..++.++||||||+++|||++ |..||.+.+..+....+... ..+.+..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD 227 (260)
T ss_pred cccccccCCCCCccccChHHHhc-------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 3221 12335668999998863 457789999999999999999 99999887776666666543 3456677
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+..+.+||.+||..||.+|||+.++++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 8999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=341.77 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=207.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCC----------------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETG----------------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg----------------~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HP 416 (741)
..+|++++.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+++|++++|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD----ASDNAREDFLKEVKILSRLSDP 79 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc----cCHHHHHHHHHHHHHHHhcCCC
Confidence 468999999999999999999876543 45799987632 1224457788999999999999
Q ss_pred CeeeecceeeecceEEEEEeecCCCChhhhhhhcc----------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCc
Q 004633 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (741)
Q Consensus 417 NIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~----------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~ 486 (741)
||+++++++..++..++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999999999999999999999999999996643 25899999999999999999999999999999999
Q ss_pred ceEecCCCcEEEeecccchhccCcc---cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh--CCC
Q 004633 487 NLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP 561 (741)
Q Consensus 487 NILLd~~g~vKL~DFGLA~~~~~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt--Gk~ 561 (741)
|||++.++.+||+|||+++...... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-------GKFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-------CCCCccchhhhhHHHHHHHHhcCCCC
Confidence 9999999999999999997654322 1223456788999999863 357789999999999999998 788
Q ss_pred CCCCCCcHHHHHHHhcc--------CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 562 PWSEFEGPQAMFKVLNR--------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 562 PF~~~~~~~~~~~i~~~--------~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
||......+.+..+... ....+..++.++.+||.+||+.||++|||+.||++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 233 PYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 88876665555444321 12234567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.13 Aligned_cols=249 Identities=26% Similarity=0.470 Sum_probs=209.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~---~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
.+|++.+.||+|+||.||+|.++.+++ .||||.+... ........+..|+.+++.++||||+++++++..++.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG----YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC----CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 468999999999999999999887765 5999987532 123445678999999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
.++||||+.+|+|.+++......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999999876667899999999999999999999999999999999999999999999999998765432
Q ss_pred cccc----ccCC--CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCC
Q 004633 511 SYEL----SLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPI 582 (741)
Q Consensus 511 ~~~~----s~~G--T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~i 582 (741)
.... ...| +..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 232 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP 232 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 2111 1112 457999999863 456789999999999999886 99999887766665555432 3345
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+..++..+.++|.+||..+|.+||++++++.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=363.97 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=208.6
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQY 421 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~t-----g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl 421 (741)
.+....++|+++++||+|+||.||+|.+... +..||||++... ......+.+.+|+++|+++. |||||++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~~Ei~~l~~l~~HpnIv~l 106 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT----ARSSEKQALMSELKIMTHLGPHLNIVNL 106 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC----CChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 3445567899999999999999999987533 346999987532 12233457889999999996 9999999
Q ss_pred cceeeecceEEEEEeecCCCChhhhhhhcc--------------------------------------------------
Q 004633 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHC-------------------------------------------------- 451 (741)
Q Consensus 422 ~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~-------------------------------------------------- 451 (741)
++++...+.+|||||||.+|+|.++|.+..
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 999999999999999999999999885421
Q ss_pred ---------------------------------------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCc
Q 004633 452 ---------------------------------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (741)
Q Consensus 452 ---------------------------------------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~ 486 (741)
..+++..+..++.||+.||+|||++||+||||||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~ 266 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR 266 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence 24778888999999999999999999999999999
Q ss_pred ceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCC
Q 004633 487 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 562 (741)
Q Consensus 487 NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~P 562 (741)
|||++.++.+||+|||+++.+..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt~g~~P 339 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-------NLYTTLSDVWSYGILLWEIFSLGGTP 339 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-------CCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999976543221 123346788999999863 457789999999999999997 9999
Q ss_pred CCCCCcHHHHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 563 WSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 563 F~~~~~~~~~~~i~~~--~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
|........+...+.. ....+..++.++.++|.+||..||++||++.++.+
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 340 YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 9876544444333322 34456778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=340.14 Aligned_cols=246 Identities=31% Similarity=0.562 Sum_probs=203.1
Q ss_pred EEeeEEeecCCeEEEEEEEC----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 357 QKGKLIGRGTFGSVYIGTNR----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 357 ~i~k~LG~G~fG~Vy~a~~k----~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.+.+.||.|.||.||+|.++ ..+..|+||.+.. ....+..+.+.+|+++|++++||||+++++++...+.++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP----SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST----TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc----ccccccceeeeeccccccccccccccccccccccccccc
Confidence 46789999999999999988 3456799998842 233444678899999999999999999999999888899
Q ss_pred EEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 433 IYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
+||||+.+|+|.++|... ...+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999876 5679999999999999999999999999999999999999999999999999998763211
Q ss_pred ---cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccC
Q 004633 512 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML 586 (741)
Q Consensus 512 ---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~l 586 (741)
......+...|+|||.+.. ..++.++||||||+++|||++ |+.||.+....+...++... ....+..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKD-------GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNC 230 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHH-------SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTS
T ss_pred cccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccccccccccccceeccch
Confidence 1223346778999999985 347889999999999999999 78999988777766666433 34567778
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+..+.++|.+||..||++||++.++++
T Consensus 231 ~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 231 PKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp BHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 999999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=338.32 Aligned_cols=247 Identities=28% Similarity=0.505 Sum_probs=205.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|++.++||+|+||.||+|.+..+ ..||+|++..... . .+.+.+|+.+++.++|+||+++++++. ++..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---S---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPI 75 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---C---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCc
Confidence 456799999999999999999988765 4699998763111 1 246788999999999999999998764 5668
Q ss_pred EEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
|+||||+.+|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999999763 345889999999999999999999999999999999999999999999999999766433
Q ss_pred ccc--cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccC
Q 004633 511 SYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML 586 (741)
Q Consensus 511 ~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~l 586 (741)
... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+....+....+... ....+..+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 228 (262)
T ss_pred ccccccCCcccceecCHhHhcc-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCcccc
Confidence 221 12346678999998753 457889999999999999999 89999887766666655443 23445678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+..+.+||.+||..||++||++.++++
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=341.25 Aligned_cols=249 Identities=27% Similarity=0.494 Sum_probs=209.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k-----~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
..+|++.++||+|+||.||++... .++..+|+|.+.. ........+.+|+++++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-----ASESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 457899999999999999999743 3566889997653 223345678999999999999999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhhcc--------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHC--------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~--------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~ 493 (741)
.+..++||||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999997642 248899999999999999999999999999999999999999
Q ss_pred CcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcH
Q 004633 494 GVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP 569 (741)
Q Consensus 494 g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~ 569 (741)
+.+||+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|||++ |.+||......
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 231 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-------RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-------CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence 9999999999875533221 112335778999998863 457889999999999999998 99999877766
Q ss_pred HHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 570 QAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 570 ~~~~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+....+... ....+..++..+.+||.+||..||.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 232 EAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 666655543 34556778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.73 Aligned_cols=240 Identities=24% Similarity=0.418 Sum_probs=199.1
Q ss_pred eEEeecCCeEEEEEEECCCCcE-------EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 360 KLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~-------vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
+.||+|+||.||+|.++.++.. +|+|.+.. ......+.+.+|+.+|+.++|||||++++++..++..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-----SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc-----hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 4699999999999998765543 77776542 22334567888999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCc--------EEEeecccc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--------VKLADFGMA 504 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~--------vKL~DFGLA 504 (741)
+||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++
T Consensus 76 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred EEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999999999876567899999999999999999999999999999999999987764 699999998
Q ss_pred hhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCC-CCCCCCCcHHHHHHHhccCCCCC
Q 004633 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSEFEGPQAMFKVLNRTPPIP 583 (741)
Q Consensus 505 ~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk-~PF~~~~~~~~~~~i~~~~~~iP 583 (741)
...... ....++..|+|||++.+ ...++.++|||||||++|||++|. .||...+... ..........+|
T Consensus 156 ~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (258)
T cd05078 156 ITVLPK---EILLERIPWVPPECIEN------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KLQFYEDRHQLP 225 (258)
T ss_pred cccCCc---hhccccCCccCchhccC------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HHHHHHccccCC
Confidence 765432 23568899999999863 235678999999999999999985 6665544433 333444556677
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
...+.++.+||.+||+.||++|||++++++.
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 7788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.25 Aligned_cols=257 Identities=42% Similarity=0.719 Sum_probs=219.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
....|+..+.||.|+||.||+|.+..++..|++|++..... ..+.+.+|+++|+.++|+||+++++.+..++..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ------NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch------hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 45569999999999999999999998999999999874222 345678899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|+||||+++++|.+++......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999999998764479999999999999999999999999999999999999999999999999987654322
Q ss_pred -cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCC--CccCC
Q 004633 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPI--PEMLS 587 (741)
Q Consensus 512 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~i--P~~ls 587 (741)
......++..|++||++.+ ..++.++||||||||+|+|++|+.||...........+.... ... +..++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKR-------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWS 243 (286)
T ss_pred hhhccccCCcccCCHhHhcC-------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCC
Confidence 2223458899999998853 356789999999999999999999998776655555444322 222 23478
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.++.+||.+||..+|.+||++.++|+|+||+...
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 244 PEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 9999999999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=374.52 Aligned_cols=255 Identities=34% Similarity=0.613 Sum_probs=218.3
Q ss_pred CCe-EEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce--
Q 004633 354 SQW-QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-- 430 (741)
Q Consensus 354 ~~Y-~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~-- 430 (741)
.+| +...+||+|+|-+||+|.+..+|..||.-.+++. +-....+.+.+|..|+.+|+.|+|+|||++|++|.+...
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~-d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIR-DVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHH-HhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 344 5578999999999999999999999986655432 223456667899999999999999999999999987654
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhC--CeecccCCCcceEecCC-CcEEEeecccchhc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVDAS-GVVKLADFGMAKHL 507 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~--gIVHRDIKP~NILLd~~-g~vKL~DFGLA~~~ 507 (741)
+.+|+|++..|+|..|++++ +.+....++.|++||+.||.|||++ .|||||||.+||||+.+ |.|||+|+|||+..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99999999999999999887 6799999999999999999999987 59999999999999865 99999999999987
Q ss_pred cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHH-HHHHhccCCC--CCc
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA-MFKVLNRTPP--IPE 584 (741)
Q Consensus 508 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~-~~~i~~~~~~--iP~ 584 (741)
...... ..+|||.|||||++. ..|.+.+||||||++|.||+|+.+||........ +.++..+..+ +-.
T Consensus 197 r~s~ak-svIGTPEFMAPEmYE--------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 197 RKSHAK-SVIGTPEFMAPEMYE--------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred hccccc-eeccCccccChHHHh--------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc
Confidence 665443 488999999999986 3688899999999999999999999998766554 4555555432 234
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.-.+++++||.+||.. ..+|+|+.|+|+|+||...
T Consensus 268 V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 4579999999999999 8999999999999999875
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.31 Aligned_cols=249 Identities=28% Similarity=0.523 Sum_probs=208.8
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~-----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
..+|.+.+.||+|+||.||+|.+.. ++..+++|.+.. ......+.+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-----PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-----ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 4579999999999999999998543 455688887642 223334678899999999999999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~ 492 (741)
.+..++||||+.+++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 999999999999999999996532 34789999999999999999999999999999999999999
Q ss_pred CCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCc
Q 004633 493 SGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEG 568 (741)
Q Consensus 493 ~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~ 568 (741)
++.+||+|||++........ .....++..|+|||.+.+ ..++.++||||||||+|||++ |+.||.....
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-------RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999976543221 223446789999998863 457789999999999999998 9999988777
Q ss_pred HHHHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 569 PQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 569 ~~~~~~i~~~~-~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+.+..+.... ...+..++.++.++|.+||..||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 232 TEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 66666555433 3455667899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.59 Aligned_cols=255 Identities=24% Similarity=0.440 Sum_probs=210.2
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECC-------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIV 419 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~-------tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIV 419 (741)
.+.....+|.+++.||+|+||.||+|++.. ....+|+|.++.. ........+.+|+++++.+ +||||+
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN----ATDKDLADLISEMELMKLIGKHKNII 81 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC----CChHHHHHHHHHHHHHHhccCCCCee
Confidence 445566789999999999999999998642 3456899986532 1233456788899999999 599999
Q ss_pred eecceeeecceEEEEEeecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 004633 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (741)
Q Consensus 420 kl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIK 484 (741)
++++++..++.+|+||||+.+|+|.+++.... ..+++.++..++.||+.||.|||++||+|||||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 161 (314)
T cd05099 82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161 (314)
T ss_pred eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 99999999999999999999999999996531 348889999999999999999999999999999
Q ss_pred CcceEecCCCcEEEeecccchhccCccc-cc--ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CC
Q 004633 485 GANLLVDASGVVKLADFGMAKHLTGLSY-EL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 560 (741)
Q Consensus 485 P~NILLd~~g~vKL~DFGLA~~~~~~~~-~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk 560 (741)
|+|||++.++.+||+|||+++....... .. ...++..|||||++.+ ..++.++|||||||++|||++ |.
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~~g~ 234 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGILMWEIFTLGG 234 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-------CCcCccchhhHHHHHHHHHHhCCC
Confidence 9999999999999999999986643221 11 1224567999999863 457789999999999999999 89
Q ss_pred CCCCCCCcHHHHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 561 PPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 561 ~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.||......+....+.... ...+..++.++++||.+||..||++|||+.|+++
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 235 SPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9998876665555554432 3556778899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.10 Aligned_cols=257 Identities=26% Similarity=0.474 Sum_probs=212.5
Q ss_pred CCCCCCCCCeEEeeEEeecCCeEEEEEEEC-------CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCe
Q 004633 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNR-------ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI 418 (741)
Q Consensus 347 ~~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k-------~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNI 418 (741)
+.+.....+|++++.||+|+||.||+|++. .++..||+|.+... ......+.+.+|+.+++.+ +||||
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i 83 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD----ATEKDLSDLVSEMEMMKMIGKHKNI 83 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc----cchHHHHHHHHHHHHHHhhccCCCc
Confidence 355667789999999999999999999753 23457999976521 2233456788999999999 79999
Q ss_pred eeecceeeecceEEEEEeecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccC
Q 004633 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDI 483 (741)
Q Consensus 419 Vkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDI 483 (741)
+++++++...+..|+||||+.+|+|.+++.... ..++...+..++.||+.||.|||++||+||||
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dl 163 (304)
T cd05101 84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL 163 (304)
T ss_pred hheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 999999999999999999999999999996531 24778889999999999999999999999999
Q ss_pred CCcceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-C
Q 004633 484 KGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559 (741)
Q Consensus 484 KP~NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-G 559 (741)
||+|||++.++.+||+|||+++.+..... .....++..|+|||++.+ ..++.++||||||+++|||++ |
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g 236 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLMWEIFTLG 236 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-------CCCCchhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999987643221 122345678999999863 457789999999999999998 8
Q ss_pred CCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 560 KPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 560 k~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
..||......+....+... ....+..++.++++||.+||..+|.+||++.|+++.
T Consensus 237 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 237 GSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 8999877666665555433 234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.76 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=207.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~----~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
...+|++.++||+|+||+||+|.+..++. .||+|++... ......+.+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN----TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC----CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 35689999999999999999999887776 4789987532 223345678899999999999999999998865
Q ss_pred cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
...+++|||+++|+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4578999999999999999876567999999999999999999999999999999999999999999999999999876
Q ss_pred cCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCC
Q 004633 508 TGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPI 582 (741)
Q Consensus 508 ~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~i 582 (741)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||...........+... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILH-------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhcc-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence 432221 12234678999999863 357789999999999999998 99999876655444433332 3345
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+..++.++.++|.+||..||++||++.++++
T Consensus 233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 233 PPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6678999999999999999999999999995
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.84 Aligned_cols=241 Identities=24% Similarity=0.421 Sum_probs=201.9
Q ss_pred EEeecCCeEEEEEEE--CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeec
Q 004633 361 LIGRGTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 361 ~LG~G~fG~Vy~a~~--k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
.||+|+||.||+|.+ +.++..+|+|+++... ......+.+.+|+.+|+.++|+||+++++++. .+..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC---CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence 689999999999965 4567899999876322 23345577889999999999999999999875 45679999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc----cc
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----EL 514 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~----~~ 514 (741)
.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++........ ..
T Consensus 78 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 78 ELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999999764 5699999999999999999999999999999999999999999999999999976643221 11
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHH
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 592 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~d 592 (741)
...++..|+|||.+.. ..++.++|||||||++|||++ |..||......+....+... ...+|..++.++.+
T Consensus 157 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 229 (257)
T cd05116 157 HGKWPVKWYAPECMNY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYD 229 (257)
T ss_pred CCCCCccccCHhHhcc-------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 2234678999998852 356779999999999999998 99999887766666555543 34677789999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHc
Q 004633 593 FLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 593 LI~~cL~~DP~kRPTa~ElLq 613 (741)
||.+||+.||++||++.+|.+
T Consensus 230 li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 230 LMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHhccCchhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.33 Aligned_cols=250 Identities=27% Similarity=0.487 Sum_probs=209.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~---~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
...|+..+.||+|+||.||+|.++.++. .+|||.++... .......+..|+++++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY----TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 3478999999999999999999887665 68888775321 1233456888999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
..|+||||+.+++|.+++.+....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999999987667799999999999999999999999999999999999999999999999999876543
Q ss_pred ccccc----ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCC
Q 004633 510 LSYEL----SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP 583 (741)
Q Consensus 510 ~~~~~----s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP 583 (741)
..... ....+..|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ..+.+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 232 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAY-------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP 232 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhc-------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCC
Confidence 21111 1123457999999863 456789999999999999997 99999877766666655443 23344
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..++.++.++|.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 233 MDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.57 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=213.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce-
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH- 430 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~- 430 (741)
..++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.+++.++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc---chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 4568999999999999999999999999999999875321 122334567789999999999999999998876654
Q ss_pred -----EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 431 -----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 431 -----l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
+|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 6799998865 469999999999999999999999999999999999999999999999999998
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCC----
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---- 581 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~---- 581 (741)
..... .....++..|+|||++.+ ...++.++|||||||++|||++|+.||.+.+....+..++.....
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhC------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 66432 234568999999999863 235678999999999999999999999877665555444332110
Q ss_pred ---------------------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 582 ---------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 582 ---------------------------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
....++.++.+||.+||..||++|||+.|||+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 1123588999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.58 Aligned_cols=245 Identities=30% Similarity=0.492 Sum_probs=208.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|++.+.||.|+||.||+|... |+.||+|.+.... ...+++.+|+.+++.++|+||+++++++..++..
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL 75 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch------hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence 3457999999999999999999875 7899999886321 1356788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999999997643 26899999999999999999999999999999999999999999999999999876332
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCH
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS 588 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~ 588 (741)
.. ...++..|+|||.+.+ ..++.++||||||+++|||++ |..||......+....+... ....+..+++
T Consensus 156 ~~--~~~~~~~~~ape~~~~-------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05039 156 QD--SGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPP 226 (256)
T ss_pred cc--cCCCcccccCchhhcC-------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCH
Confidence 22 2345678999998853 356779999999999999997 99999887665555444433 3455677899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
++.++|.+||..+|++||++.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.08 Aligned_cols=249 Identities=25% Similarity=0.423 Sum_probs=196.8
Q ss_pred eEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEee
Q 004633 360 KLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~--tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 437 (741)
+.||+|+||+||+|.... ....+|+|.+... ........+.+|+.+++.++|+||+++++.+...+.+|+||||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS----ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc----CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 369999999999996543 3456777765421 2233446678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcc----ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004633 438 VHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (741)
Q Consensus 438 ~~gGsL~~lI~~~~----~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~- 512 (741)
+.+|+|.+++.... ....+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999999997642 2346788899999999999999999999999999999999999999999999865433221
Q ss_pred --ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-C-----CCCC
Q 004633 513 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T-----PPIP 583 (741)
Q Consensus 513 --~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~-----~~iP 583 (741)
.....++..|+|||++...........++.++|||||||++|||++ |..||......+.+..++.. . +.++
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 1223456789999998743221123456789999999999999999 88999877666555554432 1 2234
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..++..+.+++..|| .||++|||+++|++
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 567889999999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.86 Aligned_cols=247 Identities=26% Similarity=0.499 Sum_probs=204.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
...+|++.+.||+|+||.||+|.+..+ ..+|+|.+.... . ..+.+.+|+++++.++|+||+++++++. .+..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---M---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI 75 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---c---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence 345799999999999999999988665 469999765311 1 1245778999999999999999998774 5668
Q ss_pred EEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||+.||+|+||||+|||+++++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999999999764 234889999999999999999999999999999999999999999999999999765432
Q ss_pred ccc--cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccC
Q 004633 511 SYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML 586 (741)
Q Consensus 511 ~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~l 586 (741)
... ....++..|+|||.+.+ ..++.++||||||+++|||++ |..||.+....+....+... ....+..+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC 228 (260)
T ss_pred cccccCCCccchhhCCHHHhcc-------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 221 12345678999998753 457789999999999999999 99999887666665555443 33456778
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+..+.++|.+||.+||++||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.47 Aligned_cols=243 Identities=26% Similarity=0.460 Sum_probs=200.2
Q ss_pred eEEeecCCeEEEEEEECCCCcE--EEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecceEEEEEe
Q 004633 360 KLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLE 436 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~--vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~l~LVmE 436 (741)
++||+|+||.||+|+++.++.. +|+|.+... ........+.+|+.+++++ +||||+++++++...+.+|+|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc----CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence 4699999999999999888764 577766521 2233445788899999999 79999999999999999999999
Q ss_pred ecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004633 437 YVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (741)
Q Consensus 437 y~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DF 501 (741)
|+.+|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCC
Confidence 999999999996532 24789999999999999999999999999999999999999999999999
Q ss_pred ccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-C
Q 004633 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T 579 (741)
Q Consensus 502 GLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~ 579 (741)
|++..............+..|+|||++. ...++.++|||||||++|||++ |..||.+....+....+... .
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~-------~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 229 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHc-------cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC
Confidence 9986432211112223466799999885 2457789999999999999997 99999877666655555433 3
Q ss_pred CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 580 ~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
...+..++.++.+||.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 230 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 3456678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=339.00 Aligned_cols=251 Identities=31% Similarity=0.511 Sum_probs=208.3
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LV 434 (741)
|++.+.||+|+||+||+|....+++.||||.+...... .......+|+..++.++ |+||+++++++..++..|+|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc----hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 78899999999999999999999999999987632211 11123456899999999 99999999999999999999
Q ss_pred EeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 435 LEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
|||+ +|+|.+++.... ..+++.++..++.||+.+|.|||++||+|+||||+|||++.++.++|+|||++.........
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 9999 789998887653 46899999999999999999999999999999999999999999999999999876554333
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-------------
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------------- 580 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~------------- 580 (741)
....|+..|+|||++.+ ...++.++||||||+++|||++|+.||......+.+.++.....
T Consensus 156 ~~~~~~~~~~aPE~~~~------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 156 TDYVSTRWYRAPEILLR------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred CCCCCcccccCceeeec------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 44568999999998753 34567799999999999999999999987765554443321000
Q ss_pred -----------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 581 -----------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 -----------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
......+.++.+||++||..||++|||++|++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0011236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.95 Aligned_cols=260 Identities=34% Similarity=0.570 Sum_probs=219.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
....|...+.||+|+||.||+|++..++..||+|++..... ...+....+.+|+++|+.++|+|||++++++..++..
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK--QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 34458999999999999999999999999999998864322 2344556788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
||||||+. |+|.+++......+++.++..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 101 ~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 101 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred EEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 99999997 577777766556799999999999999999999999999999999999999999999999999875433
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC--CCCccCCHH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSE 589 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~--~iP~~ls~e 589 (741)
.....|+..|+|||++.+.. ...++.++|||||||++|||++|+.||...+.......+..... .....++..
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252 (317)
T ss_pred -cccccCCccccChhhhhcCC----CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHH
Confidence 23456899999999985311 23467799999999999999999999988776666666654332 223467889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+++||.+||..+|.+||++.++++|+|+....
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 99999999999999999999999999996543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.41 Aligned_cols=247 Identities=32% Similarity=0.556 Sum_probs=210.7
Q ss_pred eEEeeEEeecCCeEEEEEEECCCC----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg----~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
+++.+.||.|+||.||+|.+...+ ..||+|++.... ..+..+.+..|+.+|+.++|+||+++++++.+.+..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA----DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC----ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCee
Confidence 457889999999999999998766 889999885322 122456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhhhcccc-ccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 432 YIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~-lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
|++|||+.+++|.+++...... +++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999999999765444 999999999999999999999999999999999999999999999999999766543
Q ss_pred cccc--ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccC
Q 004633 511 SYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEML 586 (741)
Q Consensus 511 ~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~l 586 (741)
.... ...++..|+|||.+. ...++.++||||||+++|+|++ |..||...........+... ....+..+
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~-------~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLK-------DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENC 229 (258)
T ss_pred cccccccCCCcccccChHHhc-------cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcC
Confidence 2221 133678999999885 2457789999999999999998 89999887776666665543 34556678
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+.++.++|.+||..||++|||+.|+++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 230 PPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.11 Aligned_cols=261 Identities=30% Similarity=0.488 Sum_probs=215.9
Q ss_pred CeEEeeEEeecCCeEEEEEEEC---CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeecce
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDH 430 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k---~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~~~ 430 (741)
+|++.+.||+|+||.||++++. .++..||||+++.... .......+.+.+|+.++..+ +|+||+++++.+..++.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~-~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI-VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH-HhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE
Confidence 4889999999999999999864 4678899998863211 11223345688899999999 59999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||+.|++||||||.|||++.++.++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999998764 56899999999999999999999999999999999999999999999999998765433
Q ss_pred cc--ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc----HHHHHHHhccCCCCCc
Q 004633 511 SY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTPPIPE 584 (741)
Q Consensus 511 ~~--~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~~~~iP~ 584 (741)
.. .....|+..|+|||.+.+. ....+.++||||||+++|||++|..||..... .+....+.......+.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGG-----SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK 233 (288)
T ss_pred cccccccccCCccccCHHHhcCC-----CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc
Confidence 21 2235689999999998642 12356789999999999999999999964322 2333445556667788
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCcccccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANY 622 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPT---a~ElLqHpwf~~~~~ 622 (741)
.++.++.++|.+||+.||++||| +.++|+|+||+...+
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 89999999999999999999998 578899999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=343.68 Aligned_cols=254 Identities=26% Similarity=0.477 Sum_probs=210.5
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEE-----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeec
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTN-----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY 422 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~Vy~a~~-----k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~ 422 (741)
+....++|++.+.||+|+||.||+|.+ ..++..||+|+++... .....+.+.+|+++++++ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 105 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA----HSSEREALMSELKIMSHLGNHENIVNLL 105 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC----ChHHHHHHHHHHHHHHhccCCCCcceEE
Confidence 445566899999999999999999975 3345689999875321 233346788999999999 799999999
Q ss_pred ceeeecceEEEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004633 423 GSEVVDDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (741)
Q Consensus 423 g~~~~~~~l~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DF 501 (741)
+++...+.+|+||||+.+|+|.+++.... ..+++.++..|+.||+.||.|||+++|+|+||||+|||++.++.+||+||
T Consensus 106 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred EEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence 99999999999999999999999997543 34899999999999999999999999999999999999999999999999
Q ss_pred ccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc
Q 004633 502 GMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 577 (741)
Q Consensus 502 GLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~ 577 (741)
|+++.+..... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+...+...
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~ 258 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK 258 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhcc-------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH
Confidence 99986643221 112346788999999863 356789999999999999998 9999987766555544443
Q ss_pred c--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 578 R--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 578 ~--~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
. ....+...+.++.+||.+||..+|++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2 22345567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=336.38 Aligned_cols=250 Identities=28% Similarity=0.458 Sum_probs=210.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~----~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
...+|++++.||+|+||+||+|.++.+|. .+|+|.+... ........+.+|+.+|+.++|+||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE----TSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC----CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34689999999999999999999887765 5888876532 124445678899999999999999999998876
Q ss_pred cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
+..++||||+.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 7899999999999999999876667999999999999999999999999999999999999999999999999999876
Q ss_pred cCcccccc---cCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCC
Q 004633 508 TGLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPI 582 (741)
Q Consensus 508 ~~~~~~~s---~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~i 582 (741)
........ ..++..|+|||.+.. ..++.++|||||||++|||++ |+.||......+....+... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILH-------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ 232 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhc-------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC
Confidence 53322111 223568999998852 456789999999999999998 99999887766655555543 3455
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+...+.++.++|.+||..||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 233 PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 6678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=338.32 Aligned_cols=252 Identities=32% Similarity=0.562 Sum_probs=210.4
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
|++.+.||+|+||.||+|+...+++.||+|++..... .....+.+..|+.+++.++|+||+++++++...+.+++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE---EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc---cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 6788999999999999999999999999999875331 1222356678999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-ccc
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YEL 514 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~~ 514 (741)
||+. ++|.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++....... ...
T Consensus 78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 9998 58999997754579999999999999999999999999999999999999999999999999997764432 222
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC---------------
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--------------- 579 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--------------- 579 (741)
...++..|+|||.+.+ ...++.++|||||||++|||++|..||......+.+.++....
T Consensus 157 ~~~~~~~~~aPE~~~~------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 157 HEVVTLWYRAPEILLG------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ccccCcCcCChHHhcC------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 3456788999999863 2367789999999999999999999998776555544432210
Q ss_pred ---C-----------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 580 ---P-----------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 580 ---~-----------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
. .....++.++.++|.+||..||++||++++++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 0011347889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.96 Aligned_cols=244 Identities=28% Similarity=0.490 Sum_probs=204.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceee-ecce
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-VDDH 430 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~-~~~~ 430 (741)
...+|++.+.||+|+||.||++... |..||+|.++.. ...+.+.+|+.+++.++|+||+++++++. .++.
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 3457999999999999999999765 788999987521 12356788999999999999999999754 4567
Q ss_pred EEEEEeecCCCChhhhhhhccc-cccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 431 LYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~-~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.|+||||+++|+|.+++.+... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999999999999976433 488999999999999999999999999999999999999999999999999876543
Q ss_pred cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCC
Q 004633 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 587 (741)
Q Consensus 510 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls 587 (741)
.. ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||......+....+... ....+..++
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225 (256)
T ss_pred cC--CCCccceeecCHHHHcc-------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Confidence 22 23345678999998863 457789999999999999997 99999876665555555433 334566789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..+.++|.+||..||++|||+.++++
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=329.53 Aligned_cols=243 Identities=28% Similarity=0.465 Sum_probs=203.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecC
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 439 (741)
++||+|+||.||+|... ++..+|+|++... ...+....+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED----LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCc----CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 47999999999999865 6889999987532 123334568889999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc--ccC
Q 004633 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLK 517 (741)
Q Consensus 440 gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~--s~~ 517 (741)
+++|.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... ...
T Consensus 76 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 76 GGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 999999997665678999999999999999999999999999999999999999999999999987543322111 123
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHH
Q 004633 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLL 595 (741)
Q Consensus 518 GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~ 595 (741)
++..|+|||++.+ ..++.++||||||+++|||++ |..||...........+... ....+..++.++.+||.
T Consensus 156 ~~~~y~aPE~~~~-------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (250)
T cd05085 156 IPIKWTAPEALNY-------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQ 228 (250)
T ss_pred CcccccCHHHhcc-------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 4667999999863 356789999999999999998 99999887666665555433 23456678999999999
Q ss_pred HhhhcCCCCCCCHHHHHcC
Q 004633 596 RCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 596 ~cL~~DP~kRPTa~ElLqH 614 (741)
+||..+|++||++.|+++.
T Consensus 229 ~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 229 RCWDYKPENRPKFSELQKE 247 (250)
T ss_pred HHcccCcccCCCHHHHHHH
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.05 Aligned_cols=248 Identities=25% Similarity=0.444 Sum_probs=204.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~-----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
+|++.+.||+|+||.||+|.+.. ....+|+|.+... ........+.+|+.+|+.++||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC----CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 48899999999999999998753 2356888876531 12333467889999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhc-----------------------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCc
Q 004633 430 HLYIYLEYVHPGSINRYVREH-----------------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~-----------------------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~ 486 (741)
..|+||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 999999999999999988542 134788999999999999999999999999999999
Q ss_pred ceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCC
Q 004633 487 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 562 (741)
Q Consensus 487 NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~P 562 (741)
|||+++++.+||+|||+++.+..... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..|
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p 229 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-------HIYTTQSDVWSFGVLLWEIVTLGGNP 229 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-------CCcchHhHHHHHHHHHHHHHhcCCCC
Confidence 99999999999999999976533221 122345778999998853 457789999999999999998 9999
Q ss_pred CCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 563 WSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 563 F~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
|.+....+....+... ....+..++.++.+||.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 230 YPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9877655544443322 33456778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=333.90 Aligned_cols=242 Identities=25% Similarity=0.441 Sum_probs=200.8
Q ss_pred EEeecCCeEEEEEEEC--CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeec
Q 004633 361 LIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 361 ~LG~G~fG~Vy~a~~k--~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
.||+|+||.||+|.++ .++..||+|++... ......+.+.+|+.+|++++|+||+++++++. .+..++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~----~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc----cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence 4899999999999875 44567999987532 22334467889999999999999999999875 45789999999
Q ss_pred CCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc----cc
Q 004633 439 HPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----EL 514 (741)
Q Consensus 439 ~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~----~~ 514 (741)
.+|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... ..
T Consensus 77 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999999976556799999999999999999999999999999999999999999999999999975533211 11
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-cCCCCCccCCHHHHH
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKD 592 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP~~ls~el~d 592 (741)
...++..|+|||++.+ ..++.++|||||||++|||++ |..||......+....+.. .....+..++.++.+
T Consensus 157 ~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 229 (257)
T cd05115 157 AGKWPLKWYAPECINF-------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229 (257)
T ss_pred CCCCCcccCCHHHHcc-------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1223578999999863 356789999999999999996 9999988776666555543 334567788999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcC
Q 004633 593 FLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 593 LI~~cL~~DP~kRPTa~ElLqH 614 (741)
+|.+||..||++||++.++++.
T Consensus 230 li~~c~~~~~~~Rp~~~~i~~~ 251 (257)
T cd05115 230 LMKDCWIYKWEDRPNFAKVEER 251 (257)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=350.95 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=209.8
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeec--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD-- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~-- 428 (741)
...+|++.+.||+|+||.||+|.+..+|+.+|||++...... ......+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN---ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc---chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 356799999999999999999999999999999987532111 22234577899999999 999999999988654
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
..+|+||||+. ++|..++... .+.+..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 36899999997 5899888664 68899999999999999999999999999999999999999999999999998664
Q ss_pred Ccc------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC---
Q 004633 509 GLS------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--- 579 (741)
Q Consensus 509 ~~~------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--- 579 (741)
... ......||..|+|||++.+ ...++.++|||||||++|+|++|+.||.+....+...++....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLG------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred cccccccCcchhcccccccccCceeeec------cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 322 1223568999999998753 3456778999999999999999999997655444333221110
Q ss_pred ----------------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 ----------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 ----------------------------~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
......++.++.+||.+||..||.+|||+.++++|+|++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 011123688999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=375.03 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=197.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCC-CcEEEEEEeec------------CCCCcccHHHHHHHHHHHHHHhhcCCCCe
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDI------------IPDDPKSAECIKQLEQEIKVLGHLKHENI 418 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~t-g~~vAVK~i~~------------~~~~~~~~~~ik~l~~Ei~iL~~L~HPNI 418 (741)
...+|++++.||+|+||+||+|..+.. +..+++|.+.. .+...........+++|+.+|+.|+|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 456899999999999999999987543 22233331110 00001122345678899999999999999
Q ss_pred eeecceeeecceEEEEEeecCCCChhhhhhhc----cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC
Q 004633 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG 494 (741)
Q Consensus 419 Vkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g 494 (741)
|++++++..++..|+|||++. ++|..++... ........++.|+.||+.||.|||++|||||||||+||||+.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999996 5666666432 12344677889999999999999999999999999999999999
Q ss_pred cEEEeecccchhccCcc--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCC-CCCCC--cH
Q 004633 495 VVKLADFGMAKHLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFE--GP 569 (741)
Q Consensus 495 ~vKL~DFGLA~~~~~~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~P-F~~~~--~~ 569 (741)
.+||+|||+++.+.... ......||..|+|||++.+ ..++.++||||||||||||++|..+ |.... ..
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-------DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-------CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 99999999998765432 2234679999999999863 4578899999999999999998764 43221 11
Q ss_pred HHHHHHhccC----CCCC----------------------------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 570 QAMFKVLNRT----PPIP----------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 570 ~~~~~i~~~~----~~iP----------------------------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
..+.+++... ..+| ..++.++.++|.+||..||.+|||+.|+|+||||
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 2222222100 0000 1245678889999999999999999999999999
Q ss_pred cccc
Q 004633 618 RNAN 621 (741)
Q Consensus 618 ~~~~ 621 (741)
....
T Consensus 458 ~~~~ 461 (501)
T PHA03210 458 SAEE 461 (501)
T ss_pred hcCC
Confidence 7543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=333.44 Aligned_cols=248 Identities=27% Similarity=0.490 Sum_probs=207.0
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
....+|+++++||+|+||.||+|..+ +++.||+|.+..... . ...+.+|+.+|+.++|+||+++++++ ..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~---~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 74 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---S---PEAFLAEANLMKQLQHPRLVRLYAVV-TQEP 74 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---c---HHHHHHHHHHHHhcCCcCeeeEEEEE-ccCC
Confidence 44568999999999999999999865 578899998763221 1 24678899999999999999999876 4567
Q ss_pred EEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 431 LYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.|+||||+.+|+|.+++... ...+++.++..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999999998653 34689999999999999999999999999999999999999999999999999976653
Q ss_pred cccc--cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCcc
Q 004633 510 LSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEM 585 (741)
Q Consensus 510 ~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ 585 (741)
.... ....++..|+|||++.+ ..++.++||||||+++|||++ |+.||.+....+....+... ..+.+..
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDN 227 (260)
T ss_pred CCcccccCCcccccccCHHHhcc-------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Confidence 2221 22345678999998863 356779999999999999998 99999887766655555433 3455677
Q ss_pred CCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 586 ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
++.++.++|.+||..+|++||+++++++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.89 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=202.0
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
|.+++.+|.| |.||.++.+.+++.||||++.... ...+..+.+.+|+.+|+.++|+||+++++++..++..|++|
T Consensus 4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 78 (314)
T cd08216 4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDS---CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVS 78 (314)
T ss_pred hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccc---cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEE
Confidence 3444444444 556666667789999999987421 22345578999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc--
Q 004633 436 EYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-- 512 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~-- 512 (741)
||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||.+........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 999999999999764 34689999999999999999999999999999999999999999999999999865532211
Q ss_pred ------ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-------
Q 004633 513 ------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------- 579 (741)
Q Consensus 513 ------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------- 579 (741)
.....++..|+|||++.+. ...++.++|||||||++|||++|+.||..............+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQN-----LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred cccccccccccccccccCHHHhcCC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence 1234578899999998631 1346789999999999999999999998765443332221110
Q ss_pred ---------------------------CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 580 ---------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 580 ---------------------------~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
......++.++.+||.+||..||++|||+.|+|+||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00112235688999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.48 Aligned_cols=247 Identities=28% Similarity=0.479 Sum_probs=207.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+..... . ...+.+|++++++++||||+++++++......|+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~---~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM---S---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC---C---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 479999999999999999998764 67899998753211 1 2357789999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccc
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~ 513 (741)
||||+.+++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999999776567899999999999999999999999999999999999999999999999998765432211
Q ss_pred --cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHH
Q 004633 514 --LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSE 589 (741)
Q Consensus 514 --~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~e 589 (741)
....++..|+|||.+.+ ..++.++||||||+++|||++ |..||...........+... ....+...+.+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSF-------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229 (256)
T ss_pred ccCCCccchhhcCHhHhcc-------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence 12235678999998863 357789999999999999998 99999877666666555433 33345667899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 590 GKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 590 l~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+.+|+.+||..+|++||++.+++++
T Consensus 230 ~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 230 VYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHcccChhhCCCHHHHHHh
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=331.55 Aligned_cols=241 Identities=29% Similarity=0.481 Sum_probs=200.7
Q ss_pred eEEeecCCeEEEEEEECCCC---cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEe
Q 004633 360 KLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg---~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 436 (741)
++||+|+||.||+|.+...+ ..||+|.+..... ....+.+.+|+.+|+.++|+|||++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI----AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 47999999999999876554 7899998763221 134467888999999999999999999765 456899999
Q ss_pred ecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc--
Q 004633 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-- 514 (741)
Q Consensus 437 y~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~-- 514 (741)
|+.+|+|.+++... ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||+++.+.......
T Consensus 76 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 76 LAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred eCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999999999775 479999999999999999999999999999999999999999999999999998664322211
Q ss_pred --ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 004633 515 --SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 590 (741)
Q Consensus 515 --s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el 590 (741)
...++..|+|||.+.+ ..++.++|||||||++|||++ |..||...+..+....+... ....+..++..+
T Consensus 155 ~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 227 (257)
T cd05060 155 TTAGRWPLKWYAPECINY-------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEI 227 (257)
T ss_pred ccCccccccccCHHHhcC-------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 1123567999998853 457889999999999999998 99999887766655555433 335667789999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+++|.+||..||++||++.++++
T Consensus 228 ~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 228 YSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=342.87 Aligned_cols=256 Identities=36% Similarity=0.610 Sum_probs=215.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|...+.||+|+||+||+|++..+|..|++|++..... ........+.+|+.+++.++|+||+++++++.+.+..|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK--QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc--CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 47778899999999999999999999999998864322 2234456788899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~ 514 (741)
|||+. |+|.+++......+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..... ..
T Consensus 100 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~ 175 (313)
T cd06633 100 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---AN 175 (313)
T ss_pred EecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CC
Confidence 99996 677777766556799999999999999999999999999999999999999999999999999864332 23
Q ss_pred ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CC-CCccCCHHHHH
Q 004633 515 SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PP-IPEMLSSEGKD 592 (741)
Q Consensus 515 s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~-iP~~ls~el~d 592 (741)
...|+..|+|||++... ....++.++|||||||++|||++|..||...+.......+.... .. ....++..+++
T Consensus 176 ~~~~~~~y~aPE~~~~~----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 176 SFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred CccccccccChhhcccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 45689999999998531 12346779999999999999999999998877666555554332 22 22356788999
Q ss_pred HHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 593 FLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 593 LI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
||.+||+.+|.+||++.+++.|+||+..
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=348.00 Aligned_cols=257 Identities=26% Similarity=0.470 Sum_probs=212.7
Q ss_pred CCCCCCCCCeEEeeEEeecCCeEEEEEEECCC-------CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCe
Q 004633 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRET-------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENI 418 (741)
Q Consensus 347 ~~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~t-------g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNI 418 (741)
+.++....+|++++.||+|+||.||+|++... +..||+|.++.. ......+.+.+|+.+++++ +|+||
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD----ATDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc----cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence 46677778999999999999999999986432 236899976531 2233456788999999999 79999
Q ss_pred eeecceeeecceEEEEEeecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccC
Q 004633 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDI 483 (741)
Q Consensus 419 Vkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDI 483 (741)
+++++++..++.+|+||||+.+|+|.+++.... ..++..++..++.||+.||.|||++||+||||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dl 160 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL 160 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 999999999999999999999999999996531 24778889999999999999999999999999
Q ss_pred CCcceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-C
Q 004633 484 KGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559 (741)
Q Consensus 484 KP~NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-G 559 (741)
||+|||++.++.+||+|||+++.+..... .....++..|+|||++.+ ..++.++|||||||+||||++ |
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g 233 (334)
T cd05100 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-------RVYTHQSDVWSFGVLLWEIFTLG 233 (334)
T ss_pred ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-------CCcCchhhhHHHHHHHHHHHhcC
Confidence 99999999999999999999976643221 112234567999999863 457789999999999999998 8
Q ss_pred CCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 560 KPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 560 k~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
..||.+....+....+... ....+..++.++.+||.+||..+|++||++.|++++
T Consensus 234 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 234 GSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 9999887766665555443 335567788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.88 Aligned_cols=253 Identities=34% Similarity=0.562 Sum_probs=212.9
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|....+||+|+||.||++..+.+++.||||++... .......+.+|+.+++.++|+||+++++.+...+..|+|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 95 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence 455568899999999999999999999999987532 122345688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc-cc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YE 513 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~-~~ 513 (741)
|||+.+++|.+++.. ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 96 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 96 MEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred EecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 999999999998754 358999999999999999999999999999999999999999999999999987654322 22
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC---CCCCccCCHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---PPIPEMLSSEG 590 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~---~~iP~~ls~el 590 (741)
....|+..|+|||.+.+ ..++.++||||+|+++|+|++|..||......+....+.... ......++..+
T Consensus 174 ~~~~~~~~y~~pE~~~~-------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (292)
T cd06657 174 KSLVGTPYWMAPELISR-------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL 246 (292)
T ss_pred cccccCccccCHHHhcC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHH
Confidence 33568999999998752 346779999999999999999999998766555444433221 12234578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.++|.+||..||.+||++.++|+|+||....
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=331.54 Aligned_cols=242 Identities=30% Similarity=0.530 Sum_probs=204.1
Q ss_pred eEEeecCCeEEEEEEECC-CCc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEe
Q 004633 360 KLIGRGTFGSVYIGTNRE-TGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~-tg~--~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 436 (741)
++||+|+||.||+|.+.. .+. .||||.+...... ...+.+.+|+.++++++|+||+++++++.. ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 478999999999999865 333 5899987642211 556788999999999999999999999888 88999999
Q ss_pred ecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc----
Q 004633 437 YVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 511 (741)
Q Consensus 437 y~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~---- 511 (741)
|+.+|+|.+++.+.. ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999999997754 568999999999999999999999999999999999999999999999999998764321
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc--cCCCCCccCCH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSS 588 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~--~~~~iP~~ls~ 588 (741)
......++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+.. .....+..++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT-------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQ 228 (257)
T ss_pred cccCCCCCceecCHHHhcc-------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCH
Confidence 1113457789999998863 457789999999999999998 9999987777666655543 22345567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+.++|.+||..+|++||++.++++
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHHHHH
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=329.39 Aligned_cols=242 Identities=29% Similarity=0.517 Sum_probs=204.6
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecC
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~ 439 (741)
++||+|+||.||+|.+.. ++.||+|.+..... .+....+.+|++++++++|+||+++++++...+..|+||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP----PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC----HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCC
Confidence 479999999999999888 99999998763221 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccc---cc
Q 004633 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SL 516 (741)
Q Consensus 440 gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~---s~ 516 (741)
+++|.+++.+....+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||++.......... ..
T Consensus 76 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 76 GGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 999999997765678999999999999999999999999999999999999999999999999997654322111 12
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHH
Q 004633 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFL 594 (741)
Q Consensus 517 ~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI 594 (741)
.++..|+|||++.+ ..++.++|||||||++|||++ |..||...........+... ....+..++.++.++|
T Consensus 156 ~~~~~y~~PE~~~~-------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 228 (251)
T cd05041 156 QIPIKWTAPEALNY-------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM 228 (251)
T ss_pred cceeccCChHhhcc-------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence 23567999998863 357789999999999999998 89999877665555544432 3345677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHc
Q 004633 595 LRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 595 ~~cL~~DP~kRPTa~ElLq 613 (741)
.+||..+|.+|||+.|+|+
T Consensus 229 ~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 229 LQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=380.43 Aligned_cols=150 Identities=29% Similarity=0.478 Sum_probs=136.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
..+|+++++||+|+||+||+|++..+++.||||+++... .........+.+|+.++..++|+|||++++++...+.+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~--~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKAD--MINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhh--ccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEE
Confidence 467999999999999999999999999999999986422 223445577889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
|||||+.|++|.+++... ..+++..++.|+.||+.||+|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999764 568999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=337.39 Aligned_cols=251 Identities=24% Similarity=0.446 Sum_probs=209.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceee
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k-----~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~ 426 (741)
...+|++.+.||+|+||.||+|.+. .++..||+|++... ......+.+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC----cCHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 3467999999999999999999875 36788999987531 22344567889999999999999999999999
Q ss_pred ecceEEEEEeecCCCChhhhhhhcc---------------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCC
Q 004633 427 VDDHLYIYLEYVHPGSINRYVREHC---------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 485 (741)
Q Consensus 427 ~~~~l~LVmEy~~gGsL~~lI~~~~---------------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP 485 (741)
.++..|+||||+.+|+|.+++.... ..+++.++..++.||+.||.|||++||+||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 9999999999999999999996431 2477888999999999999999999999999999
Q ss_pred cceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCC
Q 004633 486 ANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKP 561 (741)
Q Consensus 486 ~NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~ 561 (741)
+|||++.++.+||+|||++..+..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~el~~~~~~ 231 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYGMQ 231 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-------CCCCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999876533221 112234667999998863 457789999999999999997 888
Q ss_pred CCCCCCcHHHHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 562 PWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 562 PF~~~~~~~~~~~i~~~~-~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
||.+....+....+.... ...+..++.++.+||.+||..||++|||+.|+++
T Consensus 232 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 232 PYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 998777666666655443 3446678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=340.61 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=204.2
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCC--------------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETG--------------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg--------------~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNI 418 (741)
..+|++.+.||+|+||.||+|++..++ ..||+|.+... ........+.+|+++|++++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----VTKTARNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC----CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 468999999999999999999875432 35899987532 123345678899999999999999
Q ss_pred eeecceeeecceEEEEEeecCCCChhhhhhhcc-----------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcc
Q 004633 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 487 (741)
Q Consensus 419 Vkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~-----------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~N 487 (741)
+++++++...+..++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999999999999999999999999985431 236888999999999999999999999999999999
Q ss_pred eEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh--CCCC
Q 004633 488 LLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPP 562 (741)
Q Consensus 488 ILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt--Gk~P 562 (741)
||++.++.+||+|||++..+..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..|
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwSlG~~l~el~~~~~~~p 232 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-------GKFTTASDVWAFGVTLWEMFTLCKEQP 232 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-------CCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999976533221 112345678999998863 457889999999999999988 7788
Q ss_pred CCCCCcHHHHHHHhc--------cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 563 WSEFEGPQAMFKVLN--------RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 563 F~~~~~~~~~~~i~~--------~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
|......+.+..+.. .....+..++..+.+||.+||..||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 233 YSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 887766555443321 112335567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.05 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=208.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec---
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~--- 428 (741)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ---SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch---hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 45789999999999999999999999999999998763211 122345677899999999999999999987643
Q ss_pred ---ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 429 ---~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
..+|+++|++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478888887 7899888754 358999999999999999999999999999999999999999999999999987
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC------
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------ 579 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------ 579 (741)
.... ......|+..|+|||++.+ ...++.++|||||||++|||++|+.||........+..+....
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 169 HTDD--EMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred cccc--cccccccCCCccCHHHHhC------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 6533 2234568999999999863 2356779999999999999999999997665544333322110
Q ss_pred -----------------CCCC--------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 -----------------PPIP--------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 -----------------~~iP--------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
..++ ...+.++++||.+||..||.+|+++.++|.|+||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0111 13578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.43 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=205.1
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG 423 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k-----~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g 423 (741)
....++|++++.||+|+||+||+|++. .+++.||||+++... .......+.+|+.+|.++ +|+|||++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~h~niv~~~~ 78 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA----THSEHRALMSELKILIHIGHHLNVVNLLG 78 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC----ChHHHHHHHHHHHHHHhccCCccHhhhcc
Confidence 344568999999999999999999853 467889999886321 223346788899999999 6899999999
Q ss_pred eeeec-ceEEEEEeecCCCChhhhhhhcc---------------------------------------------------
Q 004633 424 SEVVD-DHLYIYLEYVHPGSINRYVREHC--------------------------------------------------- 451 (741)
Q Consensus 424 ~~~~~-~~l~LVmEy~~gGsL~~lI~~~~--------------------------------------------------- 451 (741)
++... ..+++||||+.+|+|.+++....
T Consensus 79 ~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (343)
T cd05103 79 ACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSL 158 (343)
T ss_pred eeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcc
Confidence 87654 56899999999999999986421
Q ss_pred ---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc---c
Q 004633 452 ---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY---E 513 (741)
Q Consensus 452 ---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~---~ 513 (741)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 159 SDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred ccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence 2367788899999999999999999999999999999999999999999999976533211 1
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHh-c-cCCCCCccCCHHH
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-N-RTPPIPEMLSSEG 590 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~-~-~~~~iP~~ls~el 590 (741)
....++..|+|||++.+ ..++.++|||||||++|||++ |..||........+...+ . .....|..+++++
T Consensus 239 ~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (343)
T cd05103 239 GDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 311 (343)
T ss_pred CCCCCCcceECcHHhcC-------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHH
Confidence 12335678999999863 457789999999999999997 999998765443333332 2 2345567788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.++|.+||..||++|||+.||++|
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=335.03 Aligned_cols=247 Identities=30% Similarity=0.464 Sum_probs=198.3
Q ss_pred CCe-EEeeEEeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 354 SQW-QKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 354 ~~Y-~i~k~LG~G~fG~Vy~a~~----k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
++| ++.+.||+|+||+||++.. ..++..||+|+++... .......+.+|+++|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345 9999999999999988753 3568899999876421 122345678899999999999999999987653
Q ss_pred --ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 429 --~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
..+|+||||+.+|+|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 4689999999999999999763 599999999999999999999999999999999999999999999999999986
Q ss_pred ccCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH------------
Q 004633 507 LTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ------------ 570 (741)
Q Consensus 507 ~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~------------ 570 (741)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKE-------NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcc-------cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence 643221 112335677999998863 356789999999999999999999986432110
Q ss_pred --HHHHHh--ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 571 --AMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 571 --~~~~i~--~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+.... ....+.+..++.++.++|.+||..||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011111 1122346678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.50 Aligned_cols=254 Identities=29% Similarity=0.464 Sum_probs=207.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc---
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~--- 429 (741)
..+|.+.+.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ---SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc---cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 4589999999999999999999999999999998764221 1223356788999999999999999999887543
Q ss_pred ---eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 430 ---~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
.+|+||||+. ++|..++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 91 EFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 4699999996 46666542 3589999999999999999999999999999999999999999999999999876
Q ss_pred ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-------
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------- 579 (741)
Q Consensus 507 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------- 579 (741)
.... .....++..|+|||++.+ ...++.++|||||||++|||++|+.||.+.+....+..++...
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 167 ADAE--MTGYVVTRWYRAPEVILN------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCC--CCCceeeecccChhhhcC------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 5332 224567899999999863 2346789999999999999999999998766544444332210
Q ss_pred ----------------CCC--------CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 580 ----------------PPI--------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 ----------------~~i--------P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
... ...++.++.+||.+||..||++||++.|+|.|+||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 001 123678899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=341.24 Aligned_cols=258 Identities=33% Similarity=0.573 Sum_probs=216.7
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
...|+..+.||+|+||.||+|+++.++..||+|.+..... .......++.+|+++++.++|+||+++++++...+..|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK--QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 3458889999999999999999999999999998864222 22334567888999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
+||||+. |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9999996 6788877655567899999999999999999999999999999999999999999999999998765432
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-C-CCccCCHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-P-IPEMLSSEG 590 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-~-iP~~ls~el 590 (741)
....|+..|+|||.+.+.. ...++.++|||||||++|+|++|..||...+.......+..... . ....++..+
T Consensus 169 -~~~~~~~~y~aPE~~~~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMD----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243 (308)
T ss_pred -ccccCCccccCHHHHhhcc----cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHH
Confidence 2456899999999986321 23467799999999999999999999988766655555543322 2 234688899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.+||.+||..+|++||++.++++|+|+...
T Consensus 244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=337.95 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=203.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC----------------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRE----------------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~----------------tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HP 416 (741)
.++|++.+.||+|+||+||++.+.. ++..||+|++... ........+.+|+.+|+.++|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~~E~~~l~~l~~~ 79 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED----ANKNARNDFLKEIKIMSRLKDP 79 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc----CCHHHHHHHHHHHHHHHhCCCC
Confidence 4579999999999999999986432 3456899987532 1233446788999999999999
Q ss_pred CeeeecceeeecceEEEEEeecCCCChhhhhhhcc----------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCc
Q 004633 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC----------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (741)
Q Consensus 417 NIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~----------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~ 486 (741)
||+++++++..++..|+||||+.+|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 80 NIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred CcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 99999999999999999999999999999986532 23677899999999999999999999999999999
Q ss_pred ceEecCCCcEEEeecccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh--CCC
Q 004633 487 NLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKP 561 (741)
Q Consensus 487 NILLd~~g~vKL~DFGLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt--Gk~ 561 (741)
|||++.++.+||+|||+++.+..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-------GKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-------CCccchhhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999976543221 112334678999998763 357889999999999999998 789
Q ss_pred CCCCCCcHHHHHHHh--------ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 562 PWSEFEGPQAMFKVL--------NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 562 PF~~~~~~~~~~~i~--------~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
||......+.+.... ....+.+..++..+.+||.+||..||++||++.++++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 233 PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred CccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 997765555443221 1122345667899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=332.12 Aligned_cols=251 Identities=27% Similarity=0.474 Sum_probs=208.9
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~t---g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
...+|++.++||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT----SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC----CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 456799999999999999999987654 3468889765321 13345678899999999999999999998765
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
+..|+||||+.+|+|.+++......+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 56789999999999999997765568999999999999999999999999999999999999999999999999997665
Q ss_pred Cccccc--ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCc
Q 004633 509 GLSYEL--SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 584 (741)
Q Consensus 509 ~~~~~~--s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~ 584 (741)
...... ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||......+....+... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP 231 (270)
T ss_pred cccceecCCCCccccccChhhhcc-------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 432211 2234568999998752 357789999999999999996 99999887766666555443 345677
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.++.++.++|.+||..+|.+|||+.++++.
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=337.99 Aligned_cols=264 Identities=31% Similarity=0.525 Sum_probs=213.9
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeec
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD 428 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~ 428 (741)
....++|++.+.||+|+||.||+|.++.+++.||||.+..... ......+.+|+.++..+. |+||+++++++..+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN----KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC----hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 4456789999999999999999999999999999999864321 222345666777776665 99999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
..+|+||||+. +.|..++......+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99999999985 57777776655679999999999999999999997 69999999999999999999999999999876
Q ss_pred cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc-HHHHHHHhccC-CCCC--
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLNRT-PPIP-- 583 (741)
Q Consensus 508 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~-~~~~~~i~~~~-~~iP-- 583 (741)
..........++..|+|||.+.+.. ....++.++||||||+++|||++|+.||..... .+.+..++... ..++
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPD---PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN 242 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCC---CccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence 5443333446888999999986311 023477899999999999999999999976433 33444444332 2222
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
..++.++.+||.+||..||.+||+++++++|+||+...
T Consensus 243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 24789999999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.97 Aligned_cols=261 Identities=28% Similarity=0.476 Sum_probs=209.5
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee-
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV- 427 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~----~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~- 427 (741)
..+|++.+.||+|+||.||+|..+.+.. .+|||.++..++... .-...-+||.+++.|+|+|||.|..+|..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG---iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG---ISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC---cCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 4579999999999999999997766543 689998875443221 11235579999999999999999999987
Q ss_pred cceEEEEEeecCCCChhhhhhhc----cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC----CcEEEe
Q 004633 428 DDHLYIYLEYVHPGSINRYVREH----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLA 499 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~----~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~----g~vKL~ 499 (741)
+..++|++||.+ -+|..+|+-+ .+.++...++.|+.||+.||.|||++=|+||||||.||||..+ |.|||+
T Consensus 100 d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 788999999997 6788888543 3568999999999999999999999999999999999999877 899999
Q ss_pred ecccchhccCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH------
Q 004633 500 DFGMAKHLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP------ 569 (741)
Q Consensus 500 DFGLA~~~~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~------ 569 (741)
|||+++.+...-. ....+.|.+|+|||+|.| ...|+.++|||++|||+.||++-.+.|.+.+..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG------a~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~P 252 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG------ARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNP 252 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcc------cccccchhhhHHHHHHHHHHHccCccccchhhhcccCCC
Confidence 9999998865332 224567999999999996 467899999999999999999999998654321
Q ss_pred ---HHHHHH---hccC--------CCCCcc--------------------------CCHHHHHHHHHhhhcCCCCCCCHH
Q 004633 570 ---QAMFKV---LNRT--------PPIPEM--------------------------LSSEGKDFLLRCFLRNPVERPSAV 609 (741)
Q Consensus 570 ---~~~~~i---~~~~--------~~iP~~--------------------------ls~el~dLI~~cL~~DP~kRPTa~ 609 (741)
+.+.+| ++.. ..+|+. -++...+|+.+||..||.+|+|++
T Consensus 253 fq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~ 332 (438)
T KOG0666|consen 253 FQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAE 332 (438)
T ss_pred chHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHH
Confidence 222333 3211 012211 245588999999999999999999
Q ss_pred HHHcCccccccccC
Q 004633 610 ELLEHPFIRNANYQ 623 (741)
Q Consensus 610 ElLqHpwf~~~~~~ 623 (741)
|+|+|+||+.....
T Consensus 333 qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 333 QALEHPYFTEDPLP 346 (438)
T ss_pred HHhcccccccCCCC
Confidence 99999999876544
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.90 Aligned_cols=239 Identities=22% Similarity=0.376 Sum_probs=195.4
Q ss_pred EEeecCCeEEEEEEECCCC------------------------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC
Q 004633 361 LIGRGTFGSVYIGTNRETG------------------------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416 (741)
Q Consensus 361 ~LG~G~fG~Vy~a~~k~tg------------------------~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HP 416 (741)
.||+|+||.||+|....++ ..||+|++.. ........+.+|+.+++.++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP-----SHRDIALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh-----HHHHHHHHHHHHHHHHhcCCCC
Confidence 6999999999999753221 3478887642 1233345678899999999999
Q ss_pred CeeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC--
Q 004633 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-- 494 (741)
Q Consensus 417 NIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g-- 494 (741)
||+++++++..+...||||||+++|+|..++.+....+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999999999977556789999999999999999999999999999999999997654
Q ss_pred -----cEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHh-hCCCCCCCCCc
Q 004633 495 -----VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEG 568 (741)
Q Consensus 495 -----~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELL-tGk~PF~~~~~ 568 (741)
.+||+|||++...... ....++..|+|||.+.+ ...++.++|||||||++|||+ +|+.||.....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG------GNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cCccceeeecCCccccccccc---cccccCCcccCchhhcC------CCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 4899999998654322 22357889999998863 245788999999999999995 69999987654
Q ss_pred HHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 569 PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 569 ~~~~~~i~~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.+. .........++.....++.++|.+||..+|++|||+.++|++
T Consensus 228 ~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 228 SEK-ERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHH-HHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 433 233334445566677899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=344.36 Aligned_cols=255 Identities=30% Similarity=0.512 Sum_probs=205.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCC--CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeec---
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD--- 428 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~t--g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~--- 428 (741)
+|.+.+.||+|+||.||++++..+ +..||||++..... .....+.+.+|+.+++++ +|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS---KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc---cchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 489999999999999999999988 89999998763221 122345677899999999 599999999875432
Q ss_pred -ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 429 -~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
..+|++|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 45889999986 6888888654 56999999999999999999999999999999999999999999999999999765
Q ss_pred cCcc-----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc----
Q 004633 508 TGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---- 578 (741)
Q Consensus 508 ~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~---- 578 (741)
.... ......||..|+|||++.+ ...++.++|||||||++|+|++|+.||...+....+..++..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLS------FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhC------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 4321 1223568999999999863 345678999999999999999999999876544333322210
Q ss_pred ----------------------C--CC---CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 579 ----------------------T--PP---IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 579 ----------------------~--~~---iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
. .. ....++.++.+||.+||..||++|||+.|+++|||++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 00 112357899999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=332.15 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=208.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECC----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceee
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~ 426 (741)
...++|++.++||+|+||.||+|.+.. ++..|++|.+.. .......+.+.+|+.+|+.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD----HASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 346789999999999999999999876 357789997652 123444577889999999999999999999866
Q ss_pred e-cceEEEEEeecCCCChhhhhhhcc-------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEE
Q 004633 427 V-DDHLYIYLEYVHPGSINRYVREHC-------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 498 (741)
Q Consensus 427 ~-~~~l~LVmEy~~gGsL~~lI~~~~-------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL 498 (741)
. ....++++||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEE
Confidence 5 467899999999999999986532 35899999999999999999999999999999999999999999999
Q ss_pred eecccchhccCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHH
Q 004633 499 ADFGMAKHLTGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 574 (741)
Q Consensus 499 ~DFGLA~~~~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~ 574 (741)
+|||+++.+...... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 231 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-------KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY 231 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-------CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 999999866432211 12346778999999863 457789999999999999998 9999988766555544
Q ss_pred Hhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 575 VLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 575 i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+... ....+..+++++.++|.+||..||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 232 LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4433 22345567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=331.50 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=195.0
Q ss_pred eEEeecCCeEEEEEEECC--CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEee
Q 004633 360 KLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~--tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 437 (741)
+.||+|+||.||+|.... ++..+|+|.++... .......+.+|+.+++.++||||+++++++.+...+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA----SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence 469999999999998653 45679999775322 122335688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhhcc----ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc-
Q 004633 438 VHPGSINRYVREHC----RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (741)
Q Consensus 438 ~~gGsL~~lI~~~~----~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~- 512 (741)
+.+|+|.+++.... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999999996532 2456778889999999999999999999999999999999999999999999975433221
Q ss_pred --ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-cCC-----CCC
Q 004633 513 --ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTP-----PIP 583 (741)
Q Consensus 513 --~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~-----~iP 583 (741)
.....|+..|+|||++.+.........++.++|||||||++|||++ |+.||......+....... ... .+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 1234578889999998632111001245779999999999999996 9999987665554433322 211 222
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
...+..+.++|.+|| .+|++|||++||++
T Consensus 237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 346788999999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=328.88 Aligned_cols=244 Identities=27% Similarity=0.517 Sum_probs=198.7
Q ss_pred eEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceee-ecceEEEEE
Q 004633 360 KLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV-VDDHLYIYL 435 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~---tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~-~~~~l~LVm 435 (741)
+.||+|+||.||+|.+.. ++..||||.+... ......+.+.+|+.+++.++||||+++++++. .++..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc----CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 468999999999998653 3457999976422 22334567888999999999999999999765 456689999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc----
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS---- 511 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~---- 511 (741)
||+.+|+|.+++.+....+.+..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999999997765567888889999999999999999999999999999999999999999999997654321
Q ss_pred -cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCH
Q 004633 512 -YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS 588 (741)
Q Consensus 512 -~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~ 588 (741)
......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+... ....+..++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229 (262)
T ss_pred cccccCcCCccccChhHhcc-------CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCH
Confidence 1113345778999998863 357789999999999999999 56777776665555555443 3345667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 589 el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.+.++|.+||..+|++||++.|+++.
T Consensus 230 ~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 230 PLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=332.75 Aligned_cols=248 Identities=29% Similarity=0.487 Sum_probs=199.6
Q ss_pred CCeEEeeEEeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee--
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-- 427 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~----k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~-- 427 (741)
.+|++.+.||+|+||+||+|.. ..++..||||++... .....+.+.+|+++|+.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 4799999999999999999974 457889999987632 23345678899999999999999999997654
Q ss_pred cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
...+++||||+.+|+|.+++.+....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 34689999999999999999765566899999999999999999999999999999999999999999999999999876
Q ss_pred cCcccc----cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH-------------
Q 004633 508 TGLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ------------- 570 (741)
Q Consensus 508 ~~~~~~----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~------------- 570 (741)
...... ....++..|+|||++.+ ..++.++|||||||++|||++|..++.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE-------SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMI 231 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc-------CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccc
Confidence 432211 11223456999999863 356789999999999999999877654322110
Q ss_pred --HHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 571 --AMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 571 --~~~~i~~~--~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+..++.. ..+.+..++.++.+||.+||..+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01112221 22345678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=365.96 Aligned_cols=266 Identities=26% Similarity=0.422 Sum_probs=240.5
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
.....+++++..||-|+||.|-++..+.....+|+|++++... ......+.+..|-.||..++.|.||++|..|.++.
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI--VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI--VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc--cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 4445677888999999999999999887666799998875432 22334467889999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+||+||-|-||+|+..++++ +.+++..++.|+..+++|++|||.+|||+|||||+|+|++.+|.+||.|||+|+.+..
T Consensus 494 yvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999999999886 6799999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC--CCCCccCC
Q 004633 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--PPIPEMLS 587 (741)
Q Consensus 510 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~--~~iP~~ls 587 (741)
...+-++||||.|.|||++. +...+.++|.|||||++||||+|.+||.+.+....+..|+.+. ..+|..+.
T Consensus 573 g~KTwTFcGTpEYVAPEIIL-------nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~ 645 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIIL-------NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRIT 645 (732)
T ss_pred CCceeeecCCcccccchhhh-------ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccc
Confidence 99999999999999999997 4567789999999999999999999999999999999998764 46789999
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHcCccccccccCCC
Q 004633 588 SEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 625 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPT-----a~ElLqHpwf~~~~~~~~ 625 (741)
..+.+||+++...+|.+|.. +.+|-+|.||...+|..+
T Consensus 646 k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 646 KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 99999999999999999975 899999999998887644
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=335.45 Aligned_cols=250 Identities=28% Similarity=0.470 Sum_probs=202.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEE----CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec-
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTN----RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD- 428 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~----k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~- 428 (741)
.-|++.+.||+|+||.||+|.+ +.++..||+|.++.. ........+.+|+.+|+.++|+||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE----SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc----ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 4579999999999999999985 457889999987532 1233456789999999999999999999988775
Q ss_pred -ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 429 -~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
...++||||++|++|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 5689999999999999999765556899999999999999999999999999999999999999999999999999876
Q ss_pred cCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC--------------cH
Q 004633 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--------------GP 569 (741)
Q Consensus 508 ~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~--------------~~ 569 (741)
..... .....|+..|+|||++.+ ..++.++|||||||++|||+++..|+.... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~-------~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ-------SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc-------CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH
Confidence 43221 123456778999998853 457789999999999999999876643211 01
Q ss_pred HHHHHHh--ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 570 QAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 570 ~~~~~i~--~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
......+ ....+.+..++.++.+||.+||+.||++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1111111 12234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=356.86 Aligned_cols=256 Identities=26% Similarity=0.444 Sum_probs=210.8
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQY 421 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k-----~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl 421 (741)
.+....++|.+++.||+|+||.||+|+++ .++..||||+++... .......+.+|+++|..+. |||||++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA----RSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC----ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 35556678999999999999999999864 345689999986421 1223356889999999997 9999999
Q ss_pred cceeeecceEEEEEeecCCCChhhhhhhcc--------------------------------------------------
Q 004633 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHC-------------------------------------------------- 451 (741)
Q Consensus 422 ~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~-------------------------------------------------- 451 (741)
++++..++.++|||||+.+|+|.+++....
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 999999999999999999999999996431
Q ss_pred -----------------------------------------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 004633 452 -----------------------------------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (741)
Q Consensus 452 -----------------------------------------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIK 484 (741)
..+++..+..|+.||+.||+|||++||+|||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 135677888999999999999999999999999
Q ss_pred CcceEecCCCcEEEeecccchhccCcc---cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CC
Q 004633 485 GANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 560 (741)
Q Consensus 485 P~NILLd~~g~vKL~DFGLA~~~~~~~---~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk 560 (741)
|+|||++.++.+||+|||+++.+.... ......++..|||||.+.+ ..++.++|||||||++|||++ |.
T Consensus 267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGvil~e~l~~g~ 339 (401)
T cd05107 267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-------NLYTTLSDVWSFGILLWEIFTLGG 339 (401)
T ss_pred cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-------CCCCcHhHHHHHHHHHHHHHHcCC
Confidence 999999999999999999997653321 1223457889999999863 456789999999999999998 89
Q ss_pred CCCCCCCcHHHHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 561 PPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 561 ~PF~~~~~~~~~~~i~~~--~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.||......+.....+.. ....|..++.++.+||.+||..+|.+||++.+|++.
T Consensus 340 ~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 340 TPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999876655555444432 345677789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.41 Aligned_cols=249 Identities=27% Similarity=0.504 Sum_probs=207.0
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
.....+|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+++|+.++|+||+++++.+.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~ 73 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG------SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E 73 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC------hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C
Confidence 345678999999999999999999865 4567999976521 2234578889999999999999999998877 7
Q ss_pred eEEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 430 HLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
..|++|||+.+|+|.+++.+. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++..+.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 74 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 889999999999999999763 3457888999999999999999999999999999999999999999999999997664
Q ss_pred Ccccc--cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCc
Q 004633 509 GLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPE 584 (741)
Q Consensus 509 ~~~~~--~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~ 584 (741)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+.......+... ....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINF-------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 226 (260)
T ss_pred CCCcccccCCcccccccCHhHhcc-------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcc
Confidence 32221 12335677999999863 457779999999999999998 99999887766665555443 234456
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.++.++.++|.+||..||++||++.++++
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 78899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.82 Aligned_cols=259 Identities=28% Similarity=0.536 Sum_probs=222.7
Q ss_pred CCCCCCCCCCeEEeeEEeecCCeEEEEEEECCCCc---E-EEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeee
Q 004633 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---S-CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQY 421 (741)
Q Consensus 346 ~~~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~---~-vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl 421 (741)
+..|...-++..+.++||+|+||.||+|..+..+. . ||||..+. ......+.++++.+|+++|++++|||||++
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~--~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG--SSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc--cccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 34566667777888999999999999999876432 3 89997653 222456778899999999999999999999
Q ss_pred cceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004633 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (741)
Q Consensus 422 ~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DF 501 (741)
||+...+..+|||||+|.||+|.++|++....++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+||
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999999999998777999999999999999999999999999999999999999999999999
Q ss_pred ccchhccCccccccc-CCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc--
Q 004633 502 GMAKHLTGLSYELSL-KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-- 577 (741)
Q Consensus 502 GLA~~~~~~~~~~s~-~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-- 577 (741)
||++........... .--..|+|||.+.. ..|+.++|||||||++||+++ |..||.+....++..+|..
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~-------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~ 379 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNT-------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG 379 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhcc-------CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC
Confidence 998765422222111 23568999999973 478899999999999999999 8999999999888888843
Q ss_pred cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 578 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 578 ~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
...+.|...+.++..++.+||..||++|+++.++.+
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 345667788899999999999999999999999875
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=332.36 Aligned_cols=240 Identities=21% Similarity=0.370 Sum_probs=194.4
Q ss_pred eEEeecCCeEEEEEEECCC------------CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 360 KLIGRGTFGSVYIGTNRET------------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~t------------g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
+.||+|+||.||+|..... ...|++|++.. ........+.+|+.+++.++|||||++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~-----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh-----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4699999999999985422 23578887543 123334567889999999999999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCc-------EEEee
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV-------VKLAD 500 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~-------vKL~D 500 (741)
+...++||||+.+|+|..++......+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999999998766567999999999999999999999999999999999999987664 89999
Q ss_pred cccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHh-hCCCCCCCCCcHHHHHHHhccC
Q 004633 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMFKVLNRT 579 (741)
Q Consensus 501 FGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELL-tGk~PF~~~~~~~~~~~i~~~~ 579 (741)
||++...... ....|+..|+|||.+.. ...++.++|||||||++|||+ .|..||......+. .......
T Consensus 156 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~ 225 (262)
T cd05077 156 PGIPITVLSR---QECVERIPWIAPECVED------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQ 225 (262)
T ss_pred CCCCccccCc---ccccccccccChhhhcC------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcC
Confidence 9998655322 23457889999998752 345778999999999999997 58888876543332 2233333
Q ss_pred CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 580 ~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.......+.++.+||.+||..||++||++.+||++
T Consensus 226 ~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 33344456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=363.89 Aligned_cols=265 Identities=29% Similarity=0.461 Sum_probs=224.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
..++-|++++.||-|+||.|.+++...|...||+|.+++ .+-.....+..++.|-.||...+.+-||+||..|.+++.
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK--aDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK--ADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHH--HHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 345678999999999999999999999999999998763 333344556678899999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG- 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~- 509 (741)
+|+||||++||++-.+|.+. +-|.|..++.|+.+|.+|+++.|.+|+|||||||+|||||.+|++||+||||+.-+.-
T Consensus 704 LYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999999999999886 5699999999999999999999999999999999999999999999999999853310
Q ss_pred --------------c----------------------------ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhh
Q 004633 510 --------------L----------------------------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 547 (741)
Q Consensus 510 --------------~----------------------------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVW 547 (741)
+ ......+||+.|+|||+|. ...|+..+|+|
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~-------r~g~~q~cdww 855 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA-------RTGYTQLCDWW 855 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc-------ccCccccchhh
Confidence 0 0111367999999999997 35688899999
Q ss_pred hHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--CCCCC--ccCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCcccccc
Q 004633 548 SLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP--EMLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNA 620 (741)
Q Consensus 548 SLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--~~~iP--~~ls~el~dLI~~cL~~DP~kRP---Ta~ElLqHpwf~~~ 620 (741)
|.|||||||+.|++||.+....+...++++- ...++ ..++.++.+||.++ ..++++|. .++||..||||+..
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCcccccc
Confidence 9999999999999999988777776666542 23333 56899999999985 45888887 47789999999988
Q ss_pred ccCCCC
Q 004633 621 NYQNLS 626 (741)
Q Consensus 621 ~~~~~~ 626 (741)
++..+.
T Consensus 935 DfsslR 940 (1034)
T KOG0608|consen 935 DFSSLR 940 (1034)
T ss_pred chHhhh
Confidence 776543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=327.35 Aligned_cols=238 Identities=24% Similarity=0.440 Sum_probs=194.4
Q ss_pred eEEeecCCeEEEEEEECCCC----------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 360 KLIGRGTFGSVYIGTNRETG----------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg----------~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
+.||+|+||.||+|.++.++ ..+++|++.... .. ...+.+|+.+|+.++|+||+++++++.. +
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hh-HHHHHHHHHHHHcCCCcchhheeeEEec-C
Confidence 47999999999999998776 347777654211 11 4678889999999999999999998887 7
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC-------cEEEeecc
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-------VVKLADFG 502 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g-------~vKL~DFG 502 (741)
..++||||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 78999999999999999987655799999999999999999999999999999999999999888 89999999
Q ss_pred cchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhccCCC
Q 004633 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPP 581 (741)
Q Consensus 503 LA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~~~ 581 (741)
++..... .....++..|+|||++.+. ...++.++|||||||++|||++ |..||......+...... ....
T Consensus 154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~ 224 (259)
T cd05037 154 IPITVLS---REERVERIPWIAPECIRNG-----QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHR 224 (259)
T ss_pred ccccccc---ccccccCCCccChhhhcCC-----CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCC
Confidence 9986544 2234577889999998641 1367889999999999999999 688887765433322222 2223
Q ss_pred CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 582 iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+......+.++|.+||..+|.+|||+.++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 225 LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 33334489999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=381.44 Aligned_cols=252 Identities=27% Similarity=0.512 Sum_probs=220.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCC-Cc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeeccee
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRET-GA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~t-g~----~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~ 425 (741)
......+++..||+|.||.||.|..... |. .||||.++... ..+.+.+|.+|..+|..++|||||+++|++
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~----~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS----SEQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC----CHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 4456788999999999999999998753 32 38888776432 344567899999999999999999999999
Q ss_pred eecceEEEEEeecCCCChhhhhhhc------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEe
Q 004633 426 VVDDHLYIYLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 499 (741)
Q Consensus 426 ~~~~~l~LVmEy~~gGsL~~lI~~~------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~ 499 (741)
.+.+..+|++|||+||+|..||++. ...++..++..|+.||++|++||+++++|||||..+|+||++...|||+
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence 9999999999999999999999886 5679999999999999999999999999999999999999999999999
Q ss_pred ecccchhccCcccc-cccCC--CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHH
Q 004633 500 DFGMAKHLTGLSYE-LSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 575 (741)
Q Consensus 500 DFGLA~~~~~~~~~-~s~~G--T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i 575 (741)
|||||+.+....+. ....+ -..|||||.+.. ..++.++|||||||+|||+++ |..||.+.+..+++..+
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-------~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~ 917 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-------GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV 917 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-------cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence 99999966443332 22222 248999999983 578899999999999999999 99999999998888755
Q ss_pred h-ccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 576 L-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 576 ~-~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+ +++.+.|.+++..+.++|.+||..+|++||++..|++
T Consensus 918 ~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 918 LEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 4 5678899999999999999999999999999999997
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=331.07 Aligned_cols=251 Identities=24% Similarity=0.440 Sum_probs=209.3
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCC-----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRET-----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~t-----g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
.+.|++.+.||+|+||+||+|+.+.+ .+.|++|.+... ........+.+|+++|++++|+||+++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT----KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc----cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 46799999999999999999997643 467888876532 223345678899999999999999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhhcc--------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEe
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHC--------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 499 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~--------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~ 499 (741)
.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 999999999999999999997643 158999999999999999999999999999999999999999999999
Q ss_pred ecccchhccCcc--cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHh
Q 004633 500 DFGMAKHLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 576 (741)
Q Consensus 500 DFGLA~~~~~~~--~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~ 576 (741)
|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||........+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~ 232 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-------DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ 232 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH
Confidence 999987543221 1223346778999998863 345678999999999999998 889998776666666665
Q ss_pred ccCC--CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 577 NRTP--PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 577 ~~~~--~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.... ..+..++..+.++|.+||..||++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 4433 3456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=374.90 Aligned_cols=250 Identities=27% Similarity=0.483 Sum_probs=217.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC-----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceee
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~-----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~ 426 (741)
...+.+..+.||+|.||+||+|+... +...||||.++. ........+|++|+++|..|+|||||+|+|++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd----~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD----KAENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc----cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 34567888999999999999997542 345799998763 233445678999999999999999999999999
Q ss_pred ecceEEEEEeecCCCChhhhhhhcc---------cc----ccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC
Q 004633 427 VDDHLYIYLEYVHPGSINRYVREHC---------RD----ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (741)
Q Consensus 427 ~~~~l~LVmEy~~gGsL~~lI~~~~---------~~----lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~ 493 (741)
.++.+|||+|||..|||.+||+-+. .. ++..+...|+.||+.||.||-++.+|||||..+|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 9999999999999999999996431 22 8889999999999999999999999999999999999999
Q ss_pred CcEEEeecccchhccCcccccccC---CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcH
Q 004633 494 GVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP 569 (741)
Q Consensus 494 g~vKL~DFGLA~~~~~~~~~~s~~---GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~ 569 (741)
..|||+||||++.+...++..... --.+||+||.+. ..+|+.++||||+||||||+++ |+.||.+....
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl-------y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL-------YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh-------cCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 999999999999876655443221 245899999998 4689999999999999999998 99999999999
Q ss_pred HHHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 004633 570 QAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612 (741)
Q Consensus 570 ~~~~~i~~~~-~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElL 612 (741)
+++..|..+. ..-|+.++.++.+||..||..+|.+||++.||-
T Consensus 713 EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 713 EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 9999988664 567899999999999999999999999999985
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=379.25 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=205.3
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|+++++||+|+||.||+|++..+|+.||||++..... ......+++.+|+++++.++|||||++++++.+++..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~--~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS--ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc--cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 579999999999999999999999999999999863221 223445678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhc----------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004633 434 YLEYVHPGSINRYVREH----------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~----------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGL 503 (741)
||||++||+|.+++... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999999988542 12355677889999999999999999999999999999999999999999999
Q ss_pred chhccCcc-------------------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCC
Q 004633 504 AKHLTGLS-------------------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564 (741)
Q Consensus 504 A~~~~~~~-------------------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~ 564 (741)
++...... .....+||+.|||||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-------~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-------VPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-------CCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 97652110 1112469999999999863 457889999999999999999999998
Q ss_pred CCCcHHHHHHHh-ccCCCC--CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 565 EFEGPQAMFKVL-NRTPPI--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 565 ~~~~~~~~~~i~-~~~~~i--P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
............ ...... ...++..+.+++.+||..||++|++..+.|.+
T Consensus 233 ~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred CcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 755443333221 111111 13578899999999999999999876665544
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.29 Aligned_cols=243 Identities=28% Similarity=0.500 Sum_probs=201.3
Q ss_pred eEEeecCCeEEEEEEECCCC------cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 360 KLIGRGTFGSVYIGTNRETG------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg------~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
+.||+|+||.||+|+++... ..+|||.+... ........+.+|+.+|+.++||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG----ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc----cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEE
Confidence 36999999999999986543 67999976521 112334568889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhc------cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC-----cEEEeecc
Q 004633 434 YLEYVHPGSINRYVREH------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-----VVKLADFG 502 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~------~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g-----~vKL~DFG 502 (741)
||||+.+|+|.+++... ...+++.++..++.||+.||.|||+++|+|+||||+|||++.++ .+||+|||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999999652 23478899999999999999999999999999999999999887 89999999
Q ss_pred cchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-
Q 004633 503 MAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN- 577 (741)
Q Consensus 503 LA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~- 577 (741)
++..+..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||......+....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 229 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLD-------GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHcc-------CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC
Confidence 9976543221 112345788999999863 457889999999999999998 9999987766665555443
Q ss_pred cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 578 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 578 ~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.....+..++..+.+||.+||..+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 334566778999999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.85 Aligned_cols=251 Identities=26% Similarity=0.466 Sum_probs=205.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~----~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
...+|++.+.||+|+||.||+|.+..+|. .||+|.+... ........+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET----TGPKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc----CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 45679999999999999999999988776 4677766421 223333467889999999999999999998865
Q ss_pred cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
. ..++++||+.+|+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4 578999999999999999876667899999999999999999999999999999999999999999999999999876
Q ss_pred cCcccc---cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-cCCCC
Q 004633 508 TGLSYE---LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPI 582 (741)
Q Consensus 508 ~~~~~~---~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~i 582 (741)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.........+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHY-------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ 232 (303)
T ss_pred cCcccccccCCCccccccCCHHHhcc-------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence 543221 12335778999998853 457789999999999999997 9999987654433332222 22344
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+..++.++.++|.+||..+|++||++.++++.
T Consensus 233 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 233 PPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.46 Aligned_cols=253 Identities=25% Similarity=0.477 Sum_probs=211.2
Q ss_pred CeEEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCC-----cccHHHHHHHHHHHHHHhh-cCCCCeeeecceeee
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDD-----PKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVV 427 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~-tg~~vAVK~i~~~~~~-----~~~~~~ik~l~~Ei~iL~~-L~HPNIVkl~g~~~~ 427 (741)
.|++.+.||+|+||.||+|.++. .++.+|+|.+...... ......+.++..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999988 6789999988643211 1233455667789998875 789999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeeccc
Q 004633 428 DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGL 503 (741)
++..++||||+.|++|.+++.. ....+++..++.++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998743 34568999999999999999999996 7899999999999999999999999999
Q ss_pred chhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC-CC
Q 004633 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP-PI 582 (741)
Q Consensus 504 A~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~-~i 582 (741)
+.............|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKN-------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred eeecccccccccccCcccCcChhhhcC-------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 987655444445678999999999863 3467899999999999999999999987766655555544332 22
Q ss_pred C-ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 583 P-EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 583 P-~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+ ..++.++.++|.+||..||++||++.|+..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 2 2678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.52 Aligned_cols=256 Identities=28% Similarity=0.495 Sum_probs=208.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee-cce
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDH 430 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~-~~~ 430 (741)
...+|++.+.||+|+||.||+|.++.+++.||||++..... .....+.+.+|+.+++.++||||+++++++.. .+.
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS---TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc---ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 45689999999999999999999999999999998753221 12234567789999999999999999998876 567
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~ 510 (741)
.|+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++.....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~- 160 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP- 160 (328)
T ss_pred EEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence 89999998 5688888864 3588899999999999999999999999999999999999999999999999875533
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-------------
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN------------- 577 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~------------- 577 (741)
......++..|+|||++.+ ...++.++|||||||++|+|++|+.||...+.......+.+
T Consensus 161 -~~~~~~~~~~y~aPE~~~~------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLT------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred -CcCCCcccccccCceeeec------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 2234567899999998753 24577899999999999999999999976554222111110
Q ss_pred -------------cCCCCC-----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 578 -------------RTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 578 -------------~~~~iP-----~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.....+ ..++.++.++|.+||+.+|++|||+++++.|+||....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 001111 24678999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=335.32 Aligned_cols=262 Identities=30% Similarity=0.514 Sum_probs=223.9
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~ 432 (741)
++.+.+..||.|+-|+|++++.+.+|...|||.+... .+.+..+++...+.++...+ .|+||+.+|+|..+..++
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt----~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT----GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc----CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 4567778999999999999999999999999988743 34555678888888877665 899999999999999999
Q ss_pred EEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|.||.+. .-++.+++.....++|..+-.+..-++.||.||.+ +||+|||+||+|||||+.|++||||||++..+.+..
T Consensus 168 IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 168 ICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 9999984 44556666666789999999999999999999985 699999999999999999999999999998887766
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCC-CcHHHHHHHhccCCC-CC--ccCC
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVLNRTPP-IP--EMLS 587 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~-~~~~~~~~i~~~~~~-iP--~~ls 587 (741)
......|-+.|||||.+.- .....|+.++|||||||+|+||.||+.||.+. .+.+.+.++++..++ +| ..++
T Consensus 247 AhtrsAGC~~YMaPERidp----~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDP----PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS 322 (391)
T ss_pred ccccccCCccccCccccCC----CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence 6666779999999998853 33678999999999999999999999999975 456777788775543 33 2489
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccCC
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 624 (741)
Q Consensus 588 ~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~~~ 624 (741)
+++++|+..||.+|+.+||...++|+|||+...+...
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence 9999999999999999999999999999998665443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.41 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=194.9
Q ss_pred eEEeecCCeEEEEEEECCCC--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEee
Q 004633 360 KLIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg--~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 437 (741)
+.||+|+||+||+|....++ ..+++|.+... ......+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN----ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC----CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 36999999999999754332 34556654421 1223356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc---
Q 004633 438 VHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--- 511 (741)
Q Consensus 438 ~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~--- 511 (741)
+.+|+|.+++.+. ...+.+..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999999753 2346777888999999999999999999999999999999999999999999986432211
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhccC------CCCCc
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRT------PPIPE 584 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~------~~iP~ 584 (741)
......|+..|+|||++....+......++.++|||||||++|||++ |..||......+.+..++... +.++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 12245688999999998532111112345779999999999999997 678888776666665554322 23445
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+++.+.++|..|| .+|++||+++|+++
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 57899999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=323.16 Aligned_cols=241 Identities=28% Similarity=0.480 Sum_probs=201.1
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
.+|++.+.||+|+||.||++. .+++.||+|.++.. .....+.+|+.+++.++|+||+++++++..+ ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 579999999999999999986 46788999987531 1124678899999999999999999988654 4799
Q ss_pred EEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 434 YLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997643 35899999999999999999999999999999999999999999999999998754322
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHH
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEG 590 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el 590 (741)
......+..|+|||.+.+ ..++.++|||||||++|||++ |+.||......+....+... ....+..++.++
T Consensus 154 ~~~~~~~~~y~~pe~~~~-------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (254)
T cd05083 154 VDNSKLPVKWTAPEALKH-------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADV 226 (254)
T ss_pred CCCCCCCceecCHHHhcc-------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHH
Confidence 112334678999998853 357789999999999999997 99999887665555544433 233456788999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.++|.+||..+|++||++.++++
T Consensus 227 ~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 227 YVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=358.57 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=217.3
Q ss_pred cCCcccCCCCCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCC
Q 004633 339 VMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN 417 (741)
Q Consensus 339 ~~p~~~~~~~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPN 417 (741)
+.+.++..........+|.+...||.|+|+.|..+.+..+++.+++|++..... +..+|+.++... +|||
T Consensus 307 va~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---------~~~~e~~~~~~~~~h~n 377 (612)
T KOG0603|consen 307 VAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---------DNQDEIPISLLVRDHPN 377 (612)
T ss_pred cChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheecccccc---------ccccccchhhhhcCCCc
Confidence 344445544455677889999999999999999999999999999999875422 234577666655 6999
Q ss_pred eeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEe-cCCCcE
Q 004633 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV-DASGVV 496 (741)
Q Consensus 418 IVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILL-d~~g~v 496 (741)
|+++++++.+..++|+|||++.||.|.+.|... ..+. .++..|+.||+.||.|||++|||||||||+|||+ +..|++
T Consensus 378 iv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~l 455 (612)
T KOG0603|consen 378 IVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHL 455 (612)
T ss_pred ceeecceecCCceeeeeehhccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcE
Confidence 999999999999999999999999999988764 2233 7888999999999999999999999999999999 588999
Q ss_pred EEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH-HHHHHH
Q 004633 497 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV 575 (741)
Q Consensus 497 KL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~-~~~~~i 575 (741)
+|+|||.++..... ..+.+-|..|.|||++. ...|++++||||||++||+||+|+.||...... ++...+
T Consensus 456 rltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i 526 (612)
T KOG0603|consen 456 RLTYFGFWSELERS--CDTPALTLQYVAPEVLA-------IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI 526 (612)
T ss_pred EEEEechhhhCchh--hcccchhhcccChhhhc-------cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence 99999999987665 44557799999999997 357899999999999999999999999866555 333333
Q ss_pred hccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 576 LNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 576 ~~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.. +++...+|.++++||.+||+.||.+|+++.|++.|+||
T Consensus 527 ~~--~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 527 QM--PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cC--CccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 32 34448899999999999999999999999999999999
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=325.91 Aligned_cols=250 Identities=31% Similarity=0.508 Sum_probs=204.0
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECC----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee-
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV- 427 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~- 427 (741)
..+|++.+.||+|+||.||+|.... ++..||||++...... ...+.+.+|+++++.+.|+||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE----QHRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch----HHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 3568889999999999999998653 4789999988642221 345678999999999999999999998877
Q ss_pred -cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 428 -DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 428 -~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
....++||||+.+++|.+++......+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 5579999999999999999987655799999999999999999999999999999999999999999999999999987
Q ss_pred ccCcccc----cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH------------
Q 004633 507 LTGLSYE----LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ------------ 570 (741)
Q Consensus 507 ~~~~~~~----~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~------------ 570 (741)
....... ....++..|+|||.+.+ ..++.++|||||||++|||++|..||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT-------SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc-------CCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccccc
Confidence 6532211 11234567999998863 356778999999999999999999986532211
Q ss_pred --HHHHHhcc--CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 571 --AMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 571 --~~~~i~~~--~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+...+.. ....+..++.++.+||.+||..+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11222222 22335567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=328.07 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=212.4
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
-...++|++.+.||+|||+-||+++...+++.||+|+|... ..+.++...+|++..++++||||++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~-----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH-----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc-----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 34567999999999999999999999999999999988642 2445677889999999999999999999765443
Q ss_pred -----eEEEEEeecCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHhCC--eecccCCCcceEecCCCcEEEe
Q 004633 430 -----HLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVDASGVVKLA 499 (741)
Q Consensus 430 -----~l~LVmEy~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs~g--IVHRDIKP~NILLd~~g~vKL~ 499 (741)
..||++.|...|+|.+.|... +..++|.++..|+.+|++||++||+.. ++||||||.|||+.+.+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 499999999999999998552 446999999999999999999999998 9999999999999999999999
Q ss_pred ecccchhccC----c------ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC--
Q 004633 500 DFGMAKHLTG----L------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-- 567 (741)
Q Consensus 500 DFGLA~~~~~----~------~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~-- 567 (741)
|||.++...- . ........|..|+|||++.- ..+...++++|||||||+||+|+.|..||+..-
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v----k~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV----KSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec----ccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 9999865421 1 11223457999999999863 234578899999999999999999999997432
Q ss_pred cHHHHHHHhccCCCCCc--cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 568 GPQAMFKVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 568 ~~~~~~~i~~~~~~iP~--~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+......+.+....+|. .+++.+.+||+.||+.||.+||++.+++.+
T Consensus 248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 22233344455555553 389999999999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.35 Aligned_cols=229 Identities=24% Similarity=0.327 Sum_probs=191.2
Q ss_pred cCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCCChh
Q 004633 365 GTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSIN 444 (741)
Q Consensus 365 G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~ 444 (741)
|.||+||+|+++.+++.||+|.+.... ...+|...+....||||+++++++...+..|+||||+.||+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 899999999999999999999886321 1233455555567999999999999999999999999999999
Q ss_pred hhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCCCCCC
Q 004633 445 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA 524 (741)
Q Consensus 445 ~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~A 524 (741)
+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.... ....++..|+|
T Consensus 74 ~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~a 150 (237)
T cd05576 74 SHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCA 150 (237)
T ss_pred HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccC
Confidence 999765 459999999999999999999999999999999999999999999999999886654422 23456788999
Q ss_pred hHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCC
Q 004633 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVE 604 (741)
Q Consensus 525 PEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~cL~~DP~k 604 (741)
||.+. ...++.++||||+||++|||++|..||...... .. ......+|..++..+++||.+||+.||++
T Consensus 151 PE~~~-------~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 219 (237)
T cd05576 151 PEVGG-------ISEETEACDWWSLGAILFELLTGKTLVECHPSG--IN--THTTLNIPEWVSEEARSLLQQLLQFNPTE 219 (237)
T ss_pred CcccC-------CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--cc--cccccCCcccCCHHHHHHHHHHccCCHHH
Confidence 99864 235677899999999999999999887643211 00 11123467788999999999999999999
Q ss_pred CCCH-----HHHHcCccc
Q 004633 605 RPSA-----VELLEHPFI 617 (741)
Q Consensus 605 RPTa-----~ElLqHpwf 617 (741)
|+++ +++++||||
T Consensus 220 R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 220 RLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred hcCCCccchHHHHcCCCC
Confidence 9985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=364.43 Aligned_cols=261 Identities=36% Similarity=0.649 Sum_probs=228.5
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeee--
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV-- 427 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~-- 427 (741)
.....|++.++||.|.||.||+++.+.+++.+|+|+.....+. .+.++.|++||+.+. |||++.+|++|..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~------deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE------EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc------cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3445699999999999999999999999999999987653322 145667999999884 9999999998864
Q ss_pred ---cceEEEEEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004633 428 ---DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 428 ---~~~l~LVmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGL 503 (741)
++++|||||||.||+.-|+++.. +..+.|+.+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeee
Confidence 46899999999999999999763 56799999999999999999999999999999999999999999999999999
Q ss_pred chhccC-cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCC-
Q 004633 504 AKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP- 581 (741)
Q Consensus 504 A~~~~~-~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~- 581 (741)
+..+.. .....+.+|||+|||||++....+. +..|+..+|+|||||+.+||.-|.+|+.+......++.|-...++
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~--d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESP--DATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCC--CCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 987754 3345578899999999999765443 467889999999999999999999999999998888888654432
Q ss_pred --CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 582 --IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 582 --iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
-|+.++.++.+||..||.+|-++||+..++|+|||++.
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 36789999999999999999999999999999999984
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=334.20 Aligned_cols=266 Identities=26% Similarity=0.446 Sum_probs=231.7
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEV 426 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~ 426 (741)
.+.....+|.++.+||+|+|++|.+++.++|.+.+|+|++++.-. ...+.+..++.|-.+..+. +||.+|-++..|.
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~--nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELV--NDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhc--CCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 556667789999999999999999999999999999999874221 2233456677888888777 5999999999999
Q ss_pred ecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 427 ~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
.+..+++|.||+.||+|...++++ +.++|+.++.+..+|+.||.|||++|||.||||.+|+||+..|++||+|+|+++.
T Consensus 322 tesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 322 TESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred ccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 999999999999999999988776 6799999999999999999999999999999999999999999999999999987
Q ss_pred cc-CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCC-------CCcHHH-HHHHhc
Q 004633 507 LT-GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-------FEGPQA-MFKVLN 577 (741)
Q Consensus 507 ~~-~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~-------~~~~~~-~~~i~~ 577 (741)
.. ....+.++||||.|+|||+++| ..|+..+|+|+||++|+||+.|+.||+- .+.++. ++-|+.
T Consensus 401 ~l~~gd~tstfcgtpnyiapeilrg-------eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile 473 (593)
T KOG0695|consen 401 GLGPGDTTSTFCGTPNYIAPEILRG-------EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE 473 (593)
T ss_pred CCCCCcccccccCCCcccchhhhcc-------cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence 54 4556678999999999999984 6789999999999999999999999962 222333 445567
Q ss_pred cCCCCCccCCHHHHHHHHHhhhcCCCCCC------CHHHHHcCccccccccC
Q 004633 578 RTPPIPEMLSSEGKDFLLRCFLRNPVERP------SAVELLEHPFIRNANYQ 623 (741)
Q Consensus 578 ~~~~iP~~ls~el~dLI~~cL~~DP~kRP------Ta~ElLqHpwf~~~~~~ 623 (741)
+...+|..++-.+..+++..|.+||.+|. .+.++..|+||+..+|.
T Consensus 474 kqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 474 KQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred hcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 88899999999999999999999999995 47899999999987654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=326.56 Aligned_cols=254 Identities=20% Similarity=0.273 Sum_probs=190.7
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHH-H-----HHHHHHHHHHhhcCCCCeee
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAEC-I-----KQLEQEIKVLGHLKHENIVQ 420 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~t---g~~vAVK~i~~~~~~~~~~~~-i-----k~l~~Ei~iL~~L~HPNIVk 420 (741)
.....+|++.++||+|+||+||+|.+..+ +..+|+|+............. . .....++..+..+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34557899999999999999999998887 667788765432221111100 0 11223444566778999999
Q ss_pred ecceeeecc----eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004633 421 YYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (741)
Q Consensus 421 l~g~~~~~~----~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~v 496 (741)
+++.+.... ..+++||++. .++.+++... ...++..++.|+.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 998765543 3578888875 4566665443 346788999999999999999999999999999999999999999
Q ss_pred EEeecccchhccCcc--------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc
Q 004633 497 KLADFGMAKHLTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568 (741)
Q Consensus 497 KL~DFGLA~~~~~~~--------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~ 568 (741)
||+|||+|+.+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-------~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-------ACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-------CCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999998663211 1123469999999999863 4678899999999999999999999987633
Q ss_pred HH-HH--------HHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 569 PQ-AM--------FKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 569 ~~-~~--------~~i~~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.. .+ ..+...... ....+.++.+++..||..+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 239 NGNLIHAAKCDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred chHHHHHhHHHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22 11 122222222 3346899999999999999999999999985
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=344.48 Aligned_cols=247 Identities=28% Similarity=0.473 Sum_probs=197.5
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc-eEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-HLY 432 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-~l~ 432 (741)
+.|....+||+|+||.||+|.... |..||||.+...... . .++|.+|+.+|.+++|||||+|+|+|.+.+ +.+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~---~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQ---G--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCc---c--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 567788899999999999999765 489999976532211 1 345999999999999999999999999998 599
Q ss_pred EEEeecCCCChhhhhhhccc-cccHHHHHHHHHHHHHHHHHHHhCC---eecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 433 IYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTN---TIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 433 LVmEy~~gGsL~~lI~~~~~-~lse~~i~~i~~QIl~aL~yLHs~g---IVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
||+||+.+|+|.++|..... .++|....+|+.++++||+|||+.. |||||||+.|||||++.+.||+|||+|+...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 99999999999999987655 8999999999999999999999753 9999999999999999999999999997665
Q ss_pred C-ccccccc-CCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC--cH----HHHHHHhcc--
Q 004633 509 G-LSYELSL-KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE--GP----QAMFKVLNR-- 578 (741)
Q Consensus 509 ~-~~~~~s~-~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~--~~----~~~~~i~~~-- 578 (741)
. .....+. .||.+|+|||.+.. ...+.++||||||+||.||++|+.+.+... .. +.....+..
T Consensus 229 ~~~~~~~~~~~gt~gY~~PEy~~~-------g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 229 EGDTSVSTTVMGTFGYLAPEYAST-------GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred ccccceeeecCCCCccCChhhhcc-------CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 4 3333333 89999999999863 467889999999999999999998876432 11 111111111
Q ss_pred -----CCCCC-ccCC-----HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 579 -----TPPIP-EMLS-----SEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 579 -----~~~iP-~~ls-----~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.+.+. .... ..+..+..+|+..+|.+||++.|+++
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11121 1222 23556788999999999999999764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.87 Aligned_cols=249 Identities=22% Similarity=0.410 Sum_probs=202.1
Q ss_pred eEEeeEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc---
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~---tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~--- 429 (741)
|.+.+.||+|+||.||+|.++. ++..||||++.... ......+++.+|+++|+.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI---FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc---CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 6788999999999999998654 57889999876322 22334567889999999999999999999876542
Q ss_pred ---eEEEEEeecCCCChhhhhhhc-----cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeec
Q 004633 430 ---HLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADF 501 (741)
Q Consensus 430 ---~l~LVmEy~~gGsL~~lI~~~-----~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DF 501 (741)
..++++||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998887432 124789999999999999999999999999999999999999999999999
Q ss_pred ccchhccCccc---ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc
Q 004633 502 GMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 577 (741)
Q Consensus 502 GLA~~~~~~~~---~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~ 577 (741)
|+++....... .....++..|++||.+.. ..++.++|||||||++|||++ |+.||...+..+....+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLAD-------NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhc-------CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc
Confidence 99986543221 112345678999998863 456779999999999999999 8999987766555555543
Q ss_pred c-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 578 R-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 578 ~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
. ....+..++..+.+++.+||..+|++||++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 231 GNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 334456678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=371.34 Aligned_cols=257 Identities=29% Similarity=0.486 Sum_probs=203.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee----
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---- 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~---- 427 (741)
...+|+.+++||+||||.||+++++-+|..||||+|.... .......+.+|+++|.+|+|||||++|.++.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~----s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA----SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch----HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 3457899999999999999999999999999999887533 34445778999999999999999998843210
Q ss_pred --------------------------------------------------------------------------------
Q 004633 428 -------------------------------------------------------------------------------- 427 (741)
Q Consensus 428 -------------------------------------------------------------------------------- 427 (741)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ---------------------------c--------ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHH
Q 004633 428 ---------------------------D--------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472 (741)
Q Consensus 428 ---------------------------~--------~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~y 472 (741)
+ -.+||-||||+..+|.++|..+...-....+|.+++||++||+|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 0 13689999999999999987753222578899999999999999
Q ss_pred HHhCCeecccCCCcceEecCCCcEEEeecccchhcc-------------------CcccccccCCCCCCCChHHHHHhhh
Q 004633 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------------------GLSYELSLKGSPNWMAPEVIKAVMQ 533 (741)
Q Consensus 473 LHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~-------------------~~~~~~s~~GT~~Y~APEvl~~~~~ 533 (741)
+|++|||||||||.||+|++++.|||+|||+|+... .....++.+||..|+|||++.+..
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~- 791 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS- 791 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc-
Confidence 999999999999999999999999999999997621 011344678999999999997531
Q ss_pred cCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc-HHHHHHHhccCCCCCcc----CCHHHHHHHHHhhhcCCCCCCCH
Q 004633 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLNRTPPIPEM----LSSEGKDFLLRCFLRNPVERPSA 608 (741)
Q Consensus 534 ~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~-~~~~~~i~~~~~~iP~~----ls~el~dLI~~cL~~DP~kRPTa 608 (741)
...|+.++|||||||||+||+. ||....+ ..++..+-.+..+.+.. --+.-..+|+.||+.||.+||||
T Consensus 792 ---~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 792 ---SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred ---cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence 1368999999999999999996 4654332 23333333333333311 12456789999999999999999
Q ss_pred HHHHcCccccc
Q 004633 609 VELLEHPFIRN 619 (741)
Q Consensus 609 ~ElLqHpwf~~ 619 (741)
.|+|++.|+..
T Consensus 866 ~eLL~s~llpp 876 (1351)
T KOG1035|consen 866 TELLNSELLPP 876 (1351)
T ss_pred HHHhhccCCCc
Confidence 99999999973
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.38 Aligned_cols=259 Identities=27% Similarity=0.463 Sum_probs=213.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee----
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---- 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~---- 427 (741)
..+.|....+||+|.||.||+|+.+.+|+.||+|++-......... ....+|+++|+.|+|+||+.+++.+..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp---italreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc---HHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 4567999999999999999999999999999999765433222222 245679999999999999999987653
Q ss_pred ----cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeeccc
Q 004633 428 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 428 ----~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGL 503 (741)
...+||||.+|+ -+|..++......++..+++.++++++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+
T Consensus 92 ~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 245999999997 788888877767899999999999999999999999999999999999999999999999999
Q ss_pred chhccCcc-----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc-
Q 004633 504 AKHLTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN- 577 (741)
Q Consensus 504 A~~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~- 577 (741)
++.+.... .....+.|.+|++||.+.| +..|+.+.|||..||||.||++|.+.|.+..+.+.+..|-.
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG------~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG------DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhc------ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 98774322 1223456999999999985 67889999999999999999999999988776665544421
Q ss_pred -c--------------------CCCCCc-------------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 578 -R--------------------TPPIPE-------------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 578 -~--------------------~~~iP~-------------~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+ ..++|+ .-++++.+||.+||..||.+|+++.++|.|.||...
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 011221 124688999999999999999999999999999653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=354.04 Aligned_cols=243 Identities=31% Similarity=0.545 Sum_probs=203.0
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc----
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD---- 429 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~---- 429 (741)
.-|...+.||+|+||.||+++++.+|+.||||.++... ...-.+..-+|+++|++|+|+|||+++++.+...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~----~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES----SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc----ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 56889999999999999999999999999999887432 1222356778999999999999999999876544
Q ss_pred --eEEEEEeecCCCChhhhhhh--ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEec--CCC--cEEEeec
Q 004633 430 --HLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASG--VVKLADF 501 (741)
Q Consensus 430 --~l~LVmEy~~gGsL~~lI~~--~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd--~~g--~vKL~DF 501 (741)
.-.+|||||.||+|+..+.+ +...++|.++..++.++..||.|||++|||||||||.||++- .+| .-||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 46899999999999999965 456799999999999999999999999999999999999984 334 5899999
Q ss_pred ccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH----HHHHHhc
Q 004633 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ----AMFKVLN 577 (741)
Q Consensus 502 GLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~----~~~~i~~ 577 (741)
|.|+.+.++....++.||..|.+||++.. ..+|+..+|.|||||++|+++||..||....+.. .+..++.
T Consensus 169 G~Arel~d~s~~~S~vGT~~YLhPel~E~------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t 242 (732)
T KOG4250|consen 169 GAARELDDNSLFTSLVGTEEYLHPELYER------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT 242 (732)
T ss_pred cccccCCCCCeeeeecCchhhcChHHHhh------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence 99999999998899999999999999874 4688999999999999999999999997665543 3333322
Q ss_pred c---------------------CCCCCccCCHHHH----HHHHHhhhcCCCCCC
Q 004633 578 R---------------------TPPIPEMLSSEGK----DFLLRCFLRNPVERP 606 (741)
Q Consensus 578 ~---------------------~~~iP~~ls~el~----dLI~~cL~~DP~kRP 606 (741)
+ ..++|..++..+. ..|..+|..+|++|.
T Consensus 243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 1234445554444 467788999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.31 Aligned_cols=240 Identities=38% Similarity=0.658 Sum_probs=204.4
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCCChhh
Q 004633 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINR 445 (741)
Q Consensus 366 ~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~~ 445 (741)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+++++.++|+||+++++.+......+++|||+.+++|..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 689999999999999999998864322111 4678899999999999999999999999999999999999999999
Q ss_pred hhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCCCCCCh
Q 004633 446 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 525 (741)
Q Consensus 446 lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~AP 525 (741)
++.... .+++..+..++.+|+.+|.|||+.||+|+||+|.||+++.++.++|+|||++.............++..|++|
T Consensus 77 ~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~p 155 (244)
T smart00220 77 LLKKRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAP 155 (244)
T ss_pred HHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCH
Confidence 997653 3899999999999999999999999999999999999999999999999999877654444556789999999
Q ss_pred HHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH-HHHHHhccCCCCCcc---CCHHHHHHHHHhhhcC
Q 004633 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKVLNRTPPIPEM---LSSEGKDFLLRCFLRN 601 (741)
Q Consensus 526 Evl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~-~~~~i~~~~~~iP~~---ls~el~dLI~~cL~~D 601 (741)
|.+.+ ..++.++|||+||+++|+|++|..||....... ....+.......... ++.++.++|.+||..|
T Consensus 156 E~~~~-------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 228 (244)
T smart00220 156 EVLLG-------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKD 228 (244)
T ss_pred HHHcc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCC
Confidence 99862 456779999999999999999999998744433 333333333333222 8899999999999999
Q ss_pred CCCCCCHHHHHcCccc
Q 004633 602 PVERPSAVELLEHPFI 617 (741)
Q Consensus 602 P~kRPTa~ElLqHpwf 617 (741)
|++||++.++++|+||
T Consensus 229 p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 229 PEKRLTAEEALQHPFF 244 (244)
T ss_pred chhccCHHHHhhCCCC
Confidence 9999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=333.34 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=209.9
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC--C----Ceeeec
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--E----NIVQYY 422 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H--P----NIVkl~ 422 (741)
......+|.+.+.||+|+||.|..|.+.+++..||||+++.. ..+.+...-||++|++|.+ | -+|++.
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V------~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV------DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH------HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 344577999999999999999999999999999999988732 2334556679999999942 3 378899
Q ss_pred ceeeecceEEEEEeecCCCChhhhhhh-ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC---------
Q 004633 423 GSEVVDDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--------- 492 (741)
Q Consensus 423 g~~~~~~~l~LVmEy~~gGsL~~lI~~-~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~--------- 492 (741)
++|...+++|||+|.+ |-++++++++ ....++...++.+.+||+++|+|||+++++|.||||+|||+..
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence 9999999999999998 4699999977 4567999999999999999999999999999999999999831
Q ss_pred -----------CCcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCC
Q 004633 493 -----------SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561 (741)
Q Consensus 493 -----------~g~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~ 561 (741)
.-.|||+|||.|+..... ..+.+.|..|+|||++.| -.++..+||||+||||+||++|..
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLg-------LGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILG-------LGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheec-------cCcCCccCceeeeeEEEEeeccce
Confidence 236899999999765443 356788999999999986 356779999999999999999999
Q ss_pred CCCCCCcHH---HHHHHhccCC------------------CCCcc-------------------------CCHHHHHHHH
Q 004633 562 PWSEFEGPQ---AMFKVLNRTP------------------PIPEM-------------------------LSSEGKDFLL 595 (741)
Q Consensus 562 PF~~~~~~~---~~~~i~~~~~------------------~iP~~-------------------------ls~el~dLI~ 595 (741)
.|...+..+ ++..|++..+ .+++. -..++.|||+
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 998776554 4444443111 11111 1146789999
Q ss_pred HhhhcCCCCCCCHHHHHcCcccccc
Q 004633 596 RCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 596 ~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
+||..||.+|+|+.|+|.||||...
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhcC
Confidence 9999999999999999999999753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=332.86 Aligned_cols=253 Identities=30% Similarity=0.432 Sum_probs=211.0
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~ 429 (741)
+...+...+.++||+|-||.|.+|.... +.+||+|.++.. ......+.|.+||++|.+|+|||||+++|+|..++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~----a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPD----ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcc----cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 3445678999999999999999998654 789999987632 22334578999999999999999999999999999
Q ss_pred eEEEEEeecCCCChhhhhhhcccc-ccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~-lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
.++|||||+++|+|.+||.++... +.......|+.||+.||+||.+.++|||||.++|||++.++++||+|||+++.+.
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999999999876322 3555667799999999999999999999999999999999999999999999765
Q ss_pred Cccccc-c--cCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh--CCCCCCCCCcHHHHHHHhc---c--
Q 004633 509 GLSYEL-S--LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT--GKPPWSEFEGPQAMFKVLN---R-- 578 (741)
Q Consensus 509 ~~~~~~-s--~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt--Gk~PF~~~~~~~~~~~i~~---~-- 578 (741)
...+.. . .+-..+|||+|.+. ..+++.++|||+||++|||+++ ...||.....++...+.-. .
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsil-------lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESIL-------LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHH-------hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 433322 1 23357999999987 3578999999999999999875 7889988877766655432 1
Q ss_pred ---CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 579 ---TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 579 ---~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.+..|..++..+.+||.+||..|-++||+++++..+
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 234577899999999999999999999999998653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=349.12 Aligned_cols=262 Identities=22% Similarity=0.274 Sum_probs=182.5
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCC----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecce--
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRET----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS-- 424 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~t----g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~-- 424 (741)
...++|+++++||+|+||+||+|++..+ +..||||.+..... .+ ....| .++...+.+++.++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e---~~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VE---IWMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hH---HHHHH--HHHhhchhhHHHHHHhhh
Confidence 3456899999999999999999999998 99999998653211 11 01111 1122222333332222
Q ss_pred ----eeecceEEEEEeecCCCChhhhhhhcccc-------------------ccHHHHHHHHHHHHHHHHHHHhCCeecc
Q 004633 425 ----EVVDDHLYIYLEYVHPGSINRYVREHCRD-------------------ITESIVRNFTRHILNGLAYLHSTNTIHR 481 (741)
Q Consensus 425 ----~~~~~~l~LVmEy~~gGsL~~lI~~~~~~-------------------lse~~i~~i~~QIl~aL~yLHs~gIVHR 481 (741)
...++.++|||||+.+++|.+++...... ..+..+..|+.||+.||+|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 23556799999999999999998653211 1234577899999999999999999999
Q ss_pred cCCCcceEecC-CCcEEEeecccchhccCc--ccccccCCCCCCCChHHHHHhhhcCC---------------CCCCCcc
Q 004633 482 DIKGANLLVDA-SGVVKLADFGMAKHLTGL--SYELSLKGSPNWMAPEVIKAVMQKDG---------------NPKLALA 543 (741)
Q Consensus 482 DIKP~NILLd~-~g~vKL~DFGLA~~~~~~--~~~~s~~GT~~Y~APEvl~~~~~~~g---------------~~~~s~a 543 (741)
||||+||||+. ++.+||+|||+|+.+... .......||+.|||||++....+... ...+..+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 589999999999865432 22335678999999998753221110 0124557
Q ss_pred chhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhcc--------------C--------CCCCccCCHHHHHHHHHhhhcC
Q 004633 544 VDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--------------T--------PPIPEMLSSEGKDFLLRCFLRN 601 (741)
Q Consensus 544 sDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~--------------~--------~~iP~~ls~el~dLI~~cL~~D 601 (741)
+||||||||||||+++..++... ...+..++.. . ..+.......+.+||.+||.+|
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 79999999999999987665431 1111111110 0 0011112344669999999999
Q ss_pred CCCCCCHHHHHcCccccccccC
Q 004633 602 PVERPSAVELLEHPFIRNANYQ 623 (741)
Q Consensus 602 P~kRPTa~ElLqHpwf~~~~~~ 623 (741)
|++|||+.|+|+||||+.....
T Consensus 438 P~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 438 GRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cccCCCHHHHhCCcCcCCCCcc
Confidence 9999999999999999876544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.60 Aligned_cols=265 Identities=27% Similarity=0.465 Sum_probs=221.3
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC--CcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~--~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
...++|.++.+||+|||+.||+|.+....+.||||+-.+.+. +.+...+.+...+|.+|.+.|+||.||++|++|..+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 334689999999999999999999999999999998765553 334556678889999999999999999999999755
Q ss_pred -ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhC--CeecccCCCcceEecC---CCcEEEeecc
Q 004633 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVDA---SGVVKLADFG 502 (741)
Q Consensus 429 -~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~--gIVHRDIKP~NILLd~---~g~vKL~DFG 502 (741)
+.+|-|+|||+|.+|..||+.+ +.++|.+++.|+.||+.||.||.+. .|||-||||.||||-. -|.+||+|||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 6799999999999999999876 7799999999999999999999976 5999999999999943 4799999999
Q ss_pred cchhccCcccc--------cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHH-HHH
Q 004633 503 MAKHLTGLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMF 573 (741)
Q Consensus 503 LA~~~~~~~~~--------~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~-~~~ 573 (741)
|++.+.+..+. ....||.||++||.+.-. ..-+.++.++||||+|||+|..+.|+.||......+ ++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg---kePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG---KEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecC---CCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99998776544 235699999999987521 124678899999999999999999999997654332 222
Q ss_pred --HHhcc---CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 574 --KVLNR---TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 574 --~i~~~---~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
.|++. ..+..+.++.++++||++||+.--++|+...|+-.||||..
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 12221 22333568999999999999999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=346.58 Aligned_cols=254 Identities=26% Similarity=0.469 Sum_probs=224.6
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCc---EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceee
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~---~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~ 426 (741)
+.......|.++||.|.||.||+|+.+..|+ .||||.++. +.......+|..|+.||.+.+|||||+|.|+..
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~----GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA----GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc----CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 3445667899999999999999999998774 599998873 334455678999999999999999999999999
Q ss_pred ecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 427 VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 427 ~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
....++||+|||++|+|+.||+++.+.++..++..+++.|+.||+||-++++|||||...||||+.+..+|++||||++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 99999999999999999999999989999999999999999999999999999999999999999999999999999998
Q ss_pred ccCcc--cccccCC--CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhcc-CC
Q 004633 507 LTGLS--YELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TP 580 (741)
Q Consensus 507 ~~~~~--~~~s~~G--T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~-~~ 580 (741)
+.++. ...+..| -.+|.|||.+. ..+++.++||||+||||||.++ |..||.+....+.+..|..+ +.
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa-------~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL 853 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIA-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL 853 (996)
T ss_pred cccCCCccccccCCccceeecChhHhh-------hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC
Confidence 75543 2222223 46899999997 4678999999999999999886 99999999999999888754 56
Q ss_pred CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 581 ~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
+.|-.++..+..|+..||++|-.+||.+.||+.+
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 7778999999999999999999999999999863
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.48 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=218.5
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCC-Cc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRET-GA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~t-g~--~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
...+..++++||+|.||.|++|.++.. |+ .||||.++..... .....|.+|+.+|.+|+|+|+|+|||+..+
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~----~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN----AIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc----hhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 345678899999999999999998764 33 4899988743322 155789999999999999999999998876
Q ss_pred ceEEEEEeecCCCChhhhhhh-ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 429 DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~-~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
..+.||||++.+|+|.+.|++ ....|....+..|+.||+.||.||-.+++|||||...||||.....|||+||||.+.+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 789999999999999999987 5567889999999999999999999999999999999999999999999999999988
Q ss_pred cCcccccccC----CCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-cCCC
Q 004633 508 TGLSYELSLK----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPP 581 (741)
Q Consensus 508 ~~~~~~~s~~----GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~ 581 (741)
..+....... --..|+|||.|+ ...++.++|||++||+||||++ |..||.+....+++.+|-. ...+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLr-------h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLR-------HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLP 335 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhc-------cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCC
Confidence 7654433222 245799999997 4678899999999999999998 8999999999988888864 3457
Q ss_pred CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 582 iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
-|+.+++++.+++++||..+|++|||+..|.+.-+.
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 789999999999999999999999999998654444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=303.17 Aligned_cols=251 Identities=25% Similarity=0.447 Sum_probs=209.3
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeec--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD-- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~-- 428 (741)
..++|++.+++|+|.|+.||.|....+.++++||+++..+ .+.+.+|++||+.|. |||||+++++..+.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--------KKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--------HHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 4578999999999999999999999999999999987432 357889999999997 99999999987765
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchhc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHL 507 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-g~vKL~DFGLA~~~ 507 (741)
....||+||+.+.+...+. ..++..+++.++.||+.||.|||++||+|||+||.|+|||.. ..++|+|+|||...
T Consensus 108 ktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred cCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 4578999999998887765 458899999999999999999999999999999999999865 67999999999988
Q ss_pred cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCC-CCCcHHHHHHHh---c------
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS-EFEGPQAMFKVL---N------ 577 (741)
Q Consensus 508 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~-~~~~~~~~~~i~---~------ 577 (741)
.........+.+++|--||++.. ...|+.+-|||||||+|..|+..+-||. +.+..+.+-+|. +
T Consensus 184 Hp~~eYnVRVASRyfKGPELLVd------y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 184 HPGKEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred CCCceeeeeeehhhcCCchheee------chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 76655556678999999999974 3567789999999999999999988874 444443333221 1
Q ss_pred ------------------cCCC------CC----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 578 ------------------RTPP------IP----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 578 ------------------~~~~------iP----~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.... ++ ..+++++.|||.++|..|-.+|+||.|++.||||...
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0000 00 1246999999999999999999999999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=330.94 Aligned_cols=268 Identities=18% Similarity=0.237 Sum_probs=190.7
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEEC----------------CCCcEEEEEEeecCCCCcccHHHH----------HHHH
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNR----------------ETGASCAIKEVDIIPDDPKSAECI----------KQLE 404 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k----------------~tg~~vAVK~i~~~~~~~~~~~~i----------k~l~ 404 (741)
...++|++.++||+|+||+||+|.+. ..+..||||.+...... ...+.+ +...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchhH
Confidence 34678999999999999999999752 23567999988642211 111111 1233
Q ss_pred HHHHHHhhcCCCCe-----eeecceeee--------cceEEEEEeecCCCChhhhhhhcc--------------------
Q 004633 405 QEIKVLGHLKHENI-----VQYYGSEVV--------DDHLYIYLEYVHPGSINRYVREHC-------------------- 451 (741)
Q Consensus 405 ~Ei~iL~~L~HPNI-----Vkl~g~~~~--------~~~l~LVmEy~~gGsL~~lI~~~~-------------------- 451 (741)
.|+.++.+++|.++ +++++++.. ++..||||||+.+|+|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 47777777876654 667776643 356899999999999999886421
Q ss_pred ---ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccc--cCCCCCCCChH
Q 004633 452 ---RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPE 526 (741)
Q Consensus 452 ---~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s--~~GT~~Y~APE 526 (741)
..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+........ ..+|+.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1235677889999999999999999999999999999999999999999999976543222222 23489999999
Q ss_pred HHHHhhhcCCC-------------CCC--CccchhhhHHHHHHHHhhCCC-CCCCCCcHHH-----------HHHHhccC
Q 004633 527 VIKAVMQKDGN-------------PKL--ALAVDIWSLGCTVIEMLTGKP-PWSEFEGPQA-----------MFKVLNRT 579 (741)
Q Consensus 527 vl~~~~~~~g~-------------~~~--s~asDVWSLGvVLyELLtGk~-PF~~~~~~~~-----------~~~i~~~~ 579 (741)
++......... ..| ....||||+|||||+|++|.. ||........ +..+....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 98532110000 001 224799999999999999986 7754221111 11111122
Q ss_pred C--CCCccCCHHHHHHHHHhhhcCC---CCCCCHHHHHcCccccc
Q 004633 580 P--PIPEMLSSEGKDFLLRCFLRNP---VERPSAVELLEHPFIRN 619 (741)
Q Consensus 580 ~--~iP~~ls~el~dLI~~cL~~DP---~kRPTa~ElLqHpwf~~ 619 (741)
. .....+++.++|||.+||.++| .+|+|+.|+|+||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 2 2234578999999999999866 68999999999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.45 Aligned_cols=253 Identities=25% Similarity=0.457 Sum_probs=220.1
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
.|+....+..+-.+||-|.||.||.|.++.-...||||.++. ..-.+++|.+|..+|+.|+|||+|+|+|+|..
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE------DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh------cchhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 677778888889999999999999999999999999998762 12235678999999999999999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
+-.+|||+|||..|.|.+||++-. ..++.-.+..++.||..||+||..+++|||||...|+||.++..|||+||||++.
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999999998743 3466667788899999999999999999999999999999999999999999999
Q ss_pred ccCcccccc--cCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-cCCCC
Q 004633 507 LTGLSYELS--LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPI 582 (741)
Q Consensus 507 ~~~~~~~~s--~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~i 582 (741)
+.++.++.. ..-...|.|||-|. ...++.++|||+|||+|||+.| |-.||.+.+..+++..+.+ ....-
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLA-------yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~ 487 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLA-------YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG 487 (1157)
T ss_pred hcCCceecccCccCcccccCccccc-------ccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC
Confidence 988766543 23356899999986 3578899999999999999998 8999999877666554443 34567
Q ss_pred CccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 583 P~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
|+.|++.+.+||..||+++|.+||++.|+-+
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 8999999999999999999999999998854
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=331.56 Aligned_cols=248 Identities=27% Similarity=0.517 Sum_probs=213.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCC--Cc--EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRET--GA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~t--g~--~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
+....+.++||+|-||.||+|.+..- |+ .||||..+... ..+..+.|..|..+|+.++|||||+++|++. +
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~----t~d~tekflqEa~iMrnfdHphIikLIGv~~-e 462 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC----TPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-E 462 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC----ChhhHHHHHHHHHHHHhCCCcchhheeeeee-c
Confidence 33456667999999999999987643 33 48888765321 2223567889999999999999999999875 4
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
...|||||++..|.|..|++.+...++...+..|+.||+.||.|||+..+|||||..+|||+.....|||+||||++.+.
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 57899999999999999999988889999999999999999999999999999999999999999999999999999998
Q ss_pred CcccccccCC--CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhc-cCCCCCc
Q 004633 509 GLSYELSLKG--SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPE 584 (741)
Q Consensus 509 ~~~~~~s~~G--T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~-~~~~iP~ 584 (741)
+..+...-.| ...|||||-+. ...++.++|||.|||+|||++. |..||.+....+.+-.+.+ .+.+.|+
T Consensus 543 d~~yYkaS~~kLPIKWmaPESIN-------fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~ 615 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESIN-------FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPP 615 (974)
T ss_pred ccchhhccccccceeecCccccc-------hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCC
Confidence 8766655455 45799999886 3578899999999999999987 9999999888887777765 4578899
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELL 612 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElL 612 (741)
.+++.+..|+.+||+.||.+||++.||.
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 9999999999999999999999987654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=313.56 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=214.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHH-hhcCCCCeeeecceeeecce
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL-GHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL-~~L~HPNIVkl~g~~~~~~~ 430 (741)
.....+-+..||.|+||+|++..++.+|+..|||.|+.... ....+++..|.+.. +.-+.||||++||+...++.
T Consensus 62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~----~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI----EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc----hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 34556778899999999999999999999999999985443 12235667777654 44468999999999999999
Q ss_pred EEEEEeecCCCChhhhhhh----ccccccHHHHHHHHHHHHHHHHHHH-hCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 431 LYIYLEYVHPGSINRYVRE----HCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~----~~~~lse~~i~~i~~QIl~aL~yLH-s~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
.||.||+|+ .+|..+.+. +...++|+.+-.|..-++.||.||- +..||||||||+||||+..|.|||||||++.
T Consensus 138 cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 999999997 555544422 2356999999999999999999998 5689999999999999999999999999998
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc-HHHHHHHhccCCCC--
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG-PQAMFKVLNRTPPI-- 582 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~-~~~~~~i~~~~~~i-- 582 (741)
.+.+........|-..|||||.+.. .+..|+.++||||||++|||+.||+.||...+. .+.+..++.+.+++
T Consensus 217 qLv~SiAkT~daGCrpYmAPERi~p-----~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 217 QLVDSIAKTVDAGCRPYMAPERIDP-----SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred hHHHHHHhhhccCCccccChhccCC-----ccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence 8766555556779999999998863 133589999999999999999999999987654 45566666665543
Q ss_pred -Cc---cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 583 -PE---MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 583 -P~---~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+. .++..++.+|..||.+|-..||...++++++|++...
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 22 3789999999999999999999999999999997544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=335.91 Aligned_cols=260 Identities=35% Similarity=0.596 Sum_probs=226.8
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
..+.+|.++.++|.|+||.||+|+++.+++..|+|+|+..+.+. ++-++.||-+++.++|||||.+++.+.-.+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-----~~~iqqei~~~~dc~h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-----FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-----ccccccceeeeecCCCcChHHHHhhhhhhcC
Confidence 34668999999999999999999999999999999999866543 3457789999999999999999999999999
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG- 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~- 509 (741)
+||+||||.||+|.+.-.-. +.++|.++....+..++||+|||++|-+|||||-.|||+++.|.|||+|||.+..+..
T Consensus 87 lwicMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred cEEEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999999999976554 7799999999999999999999999999999999999999999999999999877654
Q ss_pred cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCC-----Cc
Q 004633 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI-----PE 584 (741)
Q Consensus 510 ~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~i-----P~ 584 (741)
-....++.||++|||||+..-. ....|...+|||++|+...||-.-++|..+......++......+.. +.
T Consensus 166 i~KrksfiGtpywmapEvaave----rkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~ 241 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVE----RKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKT 241 (829)
T ss_pred hhhhhcccCCccccchhHHHHH----hcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCc
Confidence 3445678999999999997532 23467889999999999999999999988777777766665443332 34
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.+++.+.+|++.+|.++|++||+++.+|+|+|+...
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 688999999999999999999999999999999653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=305.52 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=208.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-- 429 (741)
...+|.-++.+|.|.- .|..|.+.-.++.||+|.+-..... ....++..+|..+|..+.|+|||+++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n---~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN---QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc---CccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 4458999999999999 8888999999999999987543222 222367889999999999999999999986543
Q ss_pred ----eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 430 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 430 ----~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
.+|+||||+. ++|...+.- .++-..+..|+.|+++|++|||+.||+||||||+||++..++.+||.|||+|+
T Consensus 91 ~~~~e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 91 EEFQEVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHhHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 4899999997 778887763 37888999999999999999999999999999999999999999999999998
Q ss_pred hccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC------
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------ 579 (741)
Q Consensus 506 ~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~------ 579 (741)
.-...-....++.|++|.|||++.+. .|...+||||+||++.||++|+..|.+.+..+.+.++....
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~~-------~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILGM-------GYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCcccccCchhheeeccCchheecc-------CCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 76554345567899999999999863 37789999999999999999999998876665555443210
Q ss_pred ---------------------C----CCCc-----------cCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 580 ---------------------P----PIPE-----------MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 580 ---------------------~----~iP~-----------~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
. .+|. .-...+++|+.+||..||++|++++++|+|||++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 0111 1235678999999999999999999999999997
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.82 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=212.1
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC------CCCeeeecc
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK------HENIVQYYG 423 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~------HPNIVkl~g 423 (741)
+..-.+|.+....|+|-|++|..|.+..-|..||||+|.. ....-+.-.+|++||++|. --|+|+|+.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn------NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN------NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec------chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3445678888899999999999999999999999999873 2233355677999999995 248999999
Q ss_pred eeeecceEEEEEeecCCCChhhhhhhcc--ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEee
Q 004633 424 SEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLAD 500 (741)
Q Consensus 424 ~~~~~~~l~LVmEy~~gGsL~~lI~~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-g~vKL~D 500 (741)
.|....++|||+|-+. ..|.++|++.+ ..|....++.|+.||+.||..|-..||+|.||||+||||++. ..+||||
T Consensus 502 ~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred HhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeecc
Confidence 9999999999999986 78999998754 457889999999999999999999999999999999999876 5799999
Q ss_pred cccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCC
Q 004633 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP 580 (741)
Q Consensus 501 FGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~ 580 (741)
||.|.....+.. +.+..+..|.|||++.| -.|+...|+||+||+||||.||+..|.+....+++...+....
T Consensus 581 fGSA~~~~enei-tPYLVSRFYRaPEIiLG-------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG 652 (752)
T KOG0670|consen 581 FGSASFASENEI-TPYLVSRFYRAPEIILG-------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG 652 (752)
T ss_pred Cccccccccccc-cHHHHHHhccCcceeec-------CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence 999977655443 33456889999999985 4678899999999999999999999999887777654433222
Q ss_pred CCCcc------------------------------------------------------------CCHHHHHHHHHhhhc
Q 004633 581 PIPEM------------------------------------------------------------LSSEGKDFLLRCFLR 600 (741)
Q Consensus 581 ~iP~~------------------------------------------------------------ls~el~dLI~~cL~~ 600 (741)
++|.. +-..+++||.+||..
T Consensus 653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L 732 (752)
T KOG0670|consen 653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL 732 (752)
T ss_pred CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence 22210 125788999999999
Q ss_pred CCCCCCCHHHHHcCccccc
Q 004633 601 NPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 601 DP~kRPTa~ElLqHpwf~~ 619 (741)
||++|+|..|+|+||||+.
T Consensus 733 dP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 733 DPEKRITVNQALKHPFITE 751 (752)
T ss_pred ChhhcCCHHHHhcCCcccC
Confidence 9999999999999999964
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=350.07 Aligned_cols=236 Identities=23% Similarity=0.381 Sum_probs=186.4
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.|...++||+|+||.||+|+++.++..||||++..... ....|+++|++++|||||++++++..++..|+|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 35566789999999999999999999999998753211 112468899999999999999999999999999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHH---hCCeecccCCCcceEecCCCcEEEeecccchhccCcc
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH---STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLH---s~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~ 511 (741)
|||+++|+|.++++. +++..+..|+.||+.||+||| +.+|+||||||+|||++.++..++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-- 834 (968)
T ss_pred EeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence 999999999999953 789999999999999999999 6799999999999999999888875 666544322
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH--HH--HHHH-h---------c
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QA--MFKV-L---------N 577 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~--~~--~~~i-~---------~ 577 (741)
.....||+.|||||++. ...++.++|||||||++|||++|+.||...... .. +.+. . .
T Consensus 835 -~~~~~~t~~y~aPE~~~-------~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 906 (968)
T PLN00113 835 -DTKCFISSAYVAPETRE-------TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906 (968)
T ss_pred -CCCccccccccCccccc-------CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence 12346899999999875 246788999999999999999999998543211 11 1110 0 0
Q ss_pred c----CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 578 R----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 578 ~----~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
. ....+.....++.+++.+||..||++|||+.|+++.
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0 001111122356789999999999999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=310.80 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=199.8
Q ss_pred CCCCC-CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-----C---CCee
Q 004633 349 ASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----H---ENIV 419 (741)
Q Consensus 349 ~~~~~-~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-----H---PNIV 419 (741)
...+. .+|.+.++||+|-|++||+|++..+.+.||+|+++ ....+.+....||++|++++ | ..||
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK------SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK------SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe------hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 34555 79999999999999999999999999999999987 33445566788999999984 3 3699
Q ss_pred eecceeeec----ceEEEEEeecCCCChhhhhhh-ccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecC-
Q 004633 420 QYYGSEVVD----DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDA- 492 (741)
Q Consensus 420 kl~g~~~~~----~~l~LVmEy~~gGsL~~lI~~-~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~- 492 (741)
+|++.|... .++|||+|++ |..|..+|+. ..+.++...++.|++||+.||.|||. .||||.||||+||||..
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 999999864 4799999999 5667777754 56889999999999999999999995 59999999999999810
Q ss_pred --------------------------------------------------------------------------------
Q 004633 493 -------------------------------------------------------------------------------- 492 (741)
Q Consensus 493 -------------------------------------------------------------------------------- 492 (741)
T Consensus 225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n 304 (590)
T KOG1290|consen 225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN 304 (590)
T ss_pred ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence
Q ss_pred ---------------------------------C----------------------------------------------
Q 004633 493 ---------------------------------S---------------------------------------------- 493 (741)
Q Consensus 493 ---------------------------------~---------------------------------------------- 493 (741)
.
T Consensus 305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~ 384 (590)
T KOG1290|consen 305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI 384 (590)
T ss_pred cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence 0
Q ss_pred ------CcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC
Q 004633 494 ------GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (741)
Q Consensus 494 ------g~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~ 567 (741)
-.|||+|||-|+.+.. ..+..+.|+.|+||||+.| ..|+..+||||++|+++||+||...|+..+
T Consensus 385 ~~~~~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllG-------sgY~~~ADiWS~AC~~FELaTGDyLFePhs 455 (590)
T KOG1290|consen 385 PLPECDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLG-------SGYSTSADIWSTACMAFELATGDYLFEPHS 455 (590)
T ss_pred CCCccceeEEEeeccchhhhhh--hhchhhhhhhccCcceeec-------CCCCCchhHHHHHHHHHHhhcCceeecCCC
Confidence 0256677776655422 1123457899999999985 578889999999999999999999996432
Q ss_pred c------HHHHHHHhccCC------------------------------------------CCCccCCHHHHHHHHHhhh
Q 004633 568 G------PQAMFKVLNRTP------------------------------------------PIPEMLSSEGKDFLLRCFL 599 (741)
Q Consensus 568 ~------~~~~~~i~~~~~------------------------------------------~iP~~ls~el~dLI~~cL~ 599 (741)
+ ++-+..|+.... .++..-..++.+||.-||+
T Consensus 456 G~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe 535 (590)
T KOG1290|consen 456 GENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE 535 (590)
T ss_pred CCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence 2 222222221111 1111223567899999999
Q ss_pred cCCCCCCCHHHHHcCccccccc
Q 004633 600 RNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 600 ~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
.+|++|+||.++|+|||+....
T Consensus 536 f~PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 536 FDPEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred cCccccccHHHHhcCccccCCC
Confidence 9999999999999999997654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=326.47 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=211.4
Q ss_pred CCCCCCCCeEEeeEEeecCCeEEEEEEECC---C----CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCee
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE---T----GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIV 419 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~---t----g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIV 419 (741)
.++.......+.+.||+|.||.|++|..+. . ...||||.++.... ....+.+..|+++|+.+. |+|||
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~----~~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS----SSEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC----cHHHHHHHHHHHHHHHhcCCcchh
Confidence 445555566788899999999999997441 1 34689997653222 244578999999999995 99999
Q ss_pred eecceeeecceEEEEEeecCCCChhhhhhhcc---------------ccccHHHHHHHHHHHHHHHHHHHhCCeecccCC
Q 004633 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (741)
Q Consensus 420 kl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~---------------~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIK 484 (741)
.++|++..++.+++|+||+..|+|..+++... ..++..++..++.||+.||+||++.++|||||.
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 99999999999999999999999999998765 348999999999999999999999999999999
Q ss_pred CcceEecCCCcEEEeecccchhccCccccc--ccCCC--CCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-C
Q 004633 485 GANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGS--PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559 (741)
Q Consensus 485 P~NILLd~~g~vKL~DFGLA~~~~~~~~~~--s~~GT--~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-G 559 (741)
.+||||+.+..+||+|||+|+......+.. .-.|+ ..|||||.+. ...|+.++||||+||+||||++ |
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~-------~~~ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF-------DRVFTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc-------cCcccccchhhHHHHHHHHHhhCC
Confidence 999999999999999999998765433332 12232 3599999997 3578899999999999999998 9
Q ss_pred CCCCCCCC-cHHHHHHHhc-cCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 560 KPPWSEFE-GPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 560 k~PF~~~~-~~~~~~~i~~-~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
..||.+.. ..+.+..+.. .....|..++.++.++|+.||..+|++||++.|+.+
T Consensus 519 ~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 519 GTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99999866 3344333333 355889999999999999999999999999999985
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=309.44 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=193.1
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHh--hcCCCCeeeecceeeecc-
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG--HLKHENIVQYYGSEVVDD- 429 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~--~L~HPNIVkl~g~~~~~~- 429 (741)
....++.++||+|.||.||+|+.. ++.||||++.. +....+..|-+|.. .|+|+||++++++.....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~--------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE--------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH--------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 334778899999999999999876 59999998763 22244556666655 457999999999877655
Q ss_pred ---eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh---------CCeecccCCCcceEecCCCcEE
Q 004633 430 ---HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS---------TNTIHRDIKGANLLVDASGVVK 497 (741)
Q Consensus 430 ---~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs---------~gIVHRDIKP~NILLd~~g~vK 497 (741)
.++||+||.+.|+|.+||+.+ .+++....+++.-|++||+|||+ ..|+|||||..||||..|+...
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 799999999999999999875 59999999999999999999995 3699999999999999999999
Q ss_pred EeecccchhccC---cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCC------------C
Q 004633 498 LADFGMAKHLTG---LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------------P 562 (741)
Q Consensus 498 L~DFGLA~~~~~---~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~------------P 562 (741)
|+|||||..+.. .......+||.+|||||+|.|+.+... ..--.+.||||+|.|||||++.-. |
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d-~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD-RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc-HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 999999987754 233445789999999999999877652 233357999999999999998533 3
Q ss_pred CCCC----CcHHHHHH-Hh--ccCCCCCccC-----CHHHHHHHHHhhhcCCCCCCCHHHH
Q 004633 563 WSEF----EGPQAMFK-VL--NRTPPIPEML-----SSEGKDFLLRCFLRNPVERPSAVEL 611 (741)
Q Consensus 563 F~~~----~~~~~~~~-i~--~~~~~iP~~l-----s~el~dLI~~cL~~DP~kRPTa~El 611 (741)
|... -..+.++. ++ ..++.+|..+ -.-+++.|+.||+.|++.|.|+.=+
T Consensus 436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 3311 01122222 22 3456666543 3567899999999999999998644
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=299.35 Aligned_cols=256 Identities=27% Similarity=0.466 Sum_probs=207.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec-----c
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD-----D 429 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~-----~ 429 (741)
+.+-.+-||.|+||.||.+.+-.+|+.||+|++.... .....-+++.+|+++|...+|.||+..++...-. .
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf---q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF---QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH---HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 3445678999999999999999999999999764321 2233347889999999999999999998866543 3
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
.+|+|+|++. .+|..+|..- ..++.+.++-+++||++||+|||+.+|+||||||.|+|++.+..+||||||+|+....
T Consensus 131 EiYV~TELmQ-SDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 131 ELYVLTELMQ-SDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHHH-hhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 5789999986 7888888664 5699999999999999999999999999999999999999999999999999987654
Q ss_pred ccc--ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhc----------
Q 004633 510 LSY--ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---------- 577 (741)
Q Consensus 510 ~~~--~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~---------- 577 (741)
... .+..+.|.+|+|||++.|. ..|+.++||||+|||+.||+..+..|......+.+..|.+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGa------RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGA------RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcc------hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 322 2234579999999999974 4677799999999999999999999987666555443321
Q ss_pred -------------cCCCCC-----------ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 578 -------------RTPPIP-----------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 578 -------------~~~~iP-----------~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+..+.| .....+..+++.++|..||++|++.++.+.|++.....
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 122222 12346788999999999999999999999999986543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=324.06 Aligned_cols=243 Identities=30% Similarity=0.506 Sum_probs=194.6
Q ss_pred EeeEEeecCCeE-EEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEEEEE
Q 004633 358 KGKLIGRGTFGS-VYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 358 i~k~LG~G~fG~-Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVm 435 (741)
--+++|.|+-|+ ||+|... |+.||||.+- .++.....+||..|+.-+ |||||++|+...+...+||.+
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll--------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE--GREVAVKRLL--------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC--CceehHHHHh--------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 346789999885 7999875 6899999764 445567889999999985 999999999999999999999
Q ss_pred eecCCCChhhhhhhccc--c-ccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC---C--CcEEEeecccchhc
Q 004633 436 EYVHPGSINRYVREHCR--D-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---S--GVVKLADFGMAKHL 507 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~--~-lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~---~--g~vKL~DFGLA~~~ 507 (741)
|+|. -+|.+++..... . ......+.++.|++.||++||+.+||||||||.||||+. + ..++|.|||+++.+
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9997 799999976311 1 111456789999999999999999999999999999976 3 47999999999988
Q ss_pred cCccc----ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhC-CCCCCCCCcHHHHHHHhccCCCC
Q 004633 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNRTPPI 582 (741)
Q Consensus 508 ~~~~~----~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtG-k~PF~~~~~~~~~~~i~~~~~~i 582 (741)
..... ..+..||-+|+|||++... .-..++||||||||+|+.++| ..||.+.-. ...+|+.+...+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~-------~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L 732 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRED-------RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTL 732 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhcc-------ccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccce
Confidence 65432 3356699999999999853 224489999999999999995 999976432 233455544332
Q ss_pred C---ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 583 P---EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 583 P---~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
- .....+++|||.+||..||..||+|.++|.||||-..
T Consensus 733 ~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 733 VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 2 1122289999999999999999999999999999654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=317.28 Aligned_cols=249 Identities=29% Similarity=0.481 Sum_probs=212.4
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCc----EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeec
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~----~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
..+.+.+++||.|+||+||+|.+--.|+ +||||++.... ..+....+.+|+-+|..|+|||+++|++++...
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t----~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s 770 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT----SPKASIELLDEALRMASLDHPNLLRLLGVCMLS 770 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC----CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence 3457788999999999999998865554 57888765322 233345688899999999999999999998876
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
. +.||++|+++|.|.++++.+...+..++...|..||++||.|||++++|||||-.+||||..-..|||.|||+|+.+.
T Consensus 771 ~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 771 T-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred h-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 6 899999999999999999998999999999999999999999999999999999999999999999999999999887
Q ss_pred CcccccccCC---CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHh-ccCCCCC
Q 004633 509 GLSYELSLKG---SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIP 583 (741)
Q Consensus 509 ~~~~~~s~~G---T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~-~~~~~iP 583 (741)
.........| -+.|||-|.+. ...|+.++|||||||++|||+| |..|+.+....++-..+. ..+...|
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~-------~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqP 922 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIR-------IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQP 922 (1177)
T ss_pred cccccccccccccCcHHHHHHHhh-------ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCC
Confidence 6554443332 45788888876 4689999999999999999998 999999887665544333 3346778
Q ss_pred ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 584 ~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
+.++.++..+|.+||..|+..||+++++..
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 999999999999999999999999998875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-31 Score=257.55 Aligned_cols=213 Identities=39% Similarity=0.681 Sum_probs=186.5
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCC
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPG 441 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gG 441 (741)
||+|++|.||++....+++.+++|++....... ....+.+|+.+++.++|++|+++++++......+++|||+.|+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999998889999999887432211 3467889999999999999999999999999999999999999
Q ss_pred ChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC-CCcEEEeecccchhccCcc-cccccCCC
Q 004633 442 SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLS-YELSLKGS 519 (741)
Q Consensus 442 sL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~-~g~vKL~DFGLA~~~~~~~-~~~s~~GT 519 (741)
+|.+++......+++..++.++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||++....... ......+.
T Consensus 77 ~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 77 SLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCC
Confidence 999999765346899999999999999999999999999999999999999 8999999999997665432 12335578
Q ss_pred CCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhh
Q 004633 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 599 (741)
Q Consensus 520 ~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~cL~ 599 (741)
..|++||.+... ..++.+.|+|+||+++|+| ..+.++|.+||.
T Consensus 157 ~~~~~pe~~~~~------~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 157 PAYMAPEVLLGK------GYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCccChhHhccc------CCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhh
Confidence 899999998631 2567789999999999999 788999999999
Q ss_pred cCCCCCCCHHHHHcCc
Q 004633 600 RNPVERPSAVELLEHP 615 (741)
Q Consensus 600 ~DP~kRPTa~ElLqHp 615 (741)
.||++||++.++++|+
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 9999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=295.31 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=195.1
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHh--hcCCCCeeeecceeeec-
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG--HLKHENIVQYYGSEVVD- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~--~L~HPNIVkl~g~~~~~- 428 (741)
...+.++.+.||+|.||.||+|.++ |+.||||++.-.. .+.+.+|.+|.+ .|+|+||+.++++...+
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd--------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~ 278 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD--------ERSWFRETEIYQTVMLRHENILGFIAADNKDN 278 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccc--------hhhhhhHHHHHHHHHhccchhhhhhhccccCC
Confidence 4568999999999999999999998 7999999986311 134555666665 45899999999976544
Q ss_pred ---ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh--------CCeecccCCCcceEecCCCcEE
Q 004633 429 ---DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS--------TNTIHRDIKGANLLVDASGVVK 497 (741)
Q Consensus 429 ---~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs--------~gIVHRDIKP~NILLd~~g~vK 497 (741)
.++|||++|.+.|+|+|||.. ..++.+...+++.-++.||++||- -.|.|||||..||||..+|..-
T Consensus 279 gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 279 GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 369999999999999999977 469999999999999999999994 2499999999999999999999
Q ss_pred EeecccchhccCcc-----cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhC----------CCC
Q 004633 498 LADFGMAKHLTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPP 562 (741)
Q Consensus 498 L~DFGLA~~~~~~~-----~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtG----------k~P 562 (741)
|+|+|||....... .....+||.+|||||+|...++...-..| ..+||||||+||||++.. ++|
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesy-k~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESY-KRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhh-hHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999997664432 22356799999999999876554322222 368999999999999752 578
Q ss_pred CCCCC----cHHHHHHHh---ccCCCCCccCC-----HHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 563 WSEFE----GPQAMFKVL---NRTPPIPEMLS-----SEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 563 F~~~~----~~~~~~~i~---~~~~~iP~~ls-----~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
|.+.- ..+.+.+++ ...+.+|..+. ..+..+|+.||..||..|.|+-.|.+
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 86542 334455543 33455665443 34557899999999999999877654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-33 Score=308.35 Aligned_cols=204 Identities=26% Similarity=0.419 Sum_probs=175.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC--Cccc-HHHHHHHHHHHHHHhhcC---CCCeeeecceeee
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DPKS-AECIKQLEQEIKVLGHLK---HENIVQYYGSEVV 427 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~--~~~~-~~~ik~l~~Ei~iL~~L~---HPNIVkl~g~~~~ 427 (741)
..|..++.||+|+||.|++|.++++...|+||.|.+.+. +.+. ..-+-.+-.||.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 469999999999999999999999999999999864331 1100 001122557999999997 9999999999999
Q ss_pred cceEEEEEeecC-CCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 428 DDHLYIYLEYVH-PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 428 ~~~l~LVmEy~~-gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
++.+||+||-.. |-+|+++|..+ ..++|.+++.|++|++.|+++||++||||||||-+|+.++.+|.+||+|||.|..
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999754 56999999665 6799999999999999999999999999999999999999999999999999977
Q ss_pred ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCC
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (741)
Q Consensus 507 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~ 565 (741)
...... ..++||..|.|||++.| ..+.+..-|||+||++||-++....||..
T Consensus 720 ~ksgpf-d~f~gtv~~aapevl~g------~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 TKSGPF-DVFVGTVDYAAPEVLGG------EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hcCCCc-ceeeeeccccchhhhCC------CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 655433 36789999999999975 56778889999999999999999988864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=270.60 Aligned_cols=223 Identities=25% Similarity=0.444 Sum_probs=185.3
Q ss_pred CCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeee
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVV 427 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~ 427 (741)
.+...+....+..||+|+||.|-+.++..+|...|+|.+...-. ....+++.+|+.+..+. ..|.+|.+||.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn----~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN----SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC----hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 55666778889999999999999999999999999998864322 33346677788776554 69999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhh---ccccccHHHHHHHHHHHHHHHHHHHhC-CeecccCCCcceEecCCCcEEEeeccc
Q 004633 428 DDHLYIYLEYVHPGSINRYVRE---HCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~---~~~~lse~~i~~i~~QIl~aL~yLHs~-gIVHRDIKP~NILLd~~g~vKL~DFGL 503 (741)
++.+||.||.++ .+|..+.++ ++..++|..+-+|+..++.||+|||++ .|+|||+||.||||+.+|.|||||||+
T Consensus 117 egdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 117 EGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 999999999997 677666543 467899999999999999999999965 899999999999999999999999999
Q ss_pred chhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCC-CcHHHHHHHhccC
Q 004633 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVLNRT 579 (741)
Q Consensus 504 A~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~-~~~~~~~~i~~~~ 579 (741)
+-.+.+.-......|-..|||||.+..... +..|+.++||||||++++||.+++.||+.. ...+.+.+++...
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n---~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELN---QKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccC---cccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 987765444444678999999999976443 336899999999999999999999999865 4455666666543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=258.08 Aligned_cols=214 Identities=36% Similarity=0.589 Sum_probs=181.5
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
|.+++.||.|++|+||++....+++.+|+|.+...... ...+.+.+|++.++.++|+||+++++.+......++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE----KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch----HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 67889999999999999999998999999988642211 24578889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcc--cc
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YE 513 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~--~~ 513 (741)
||+.+++|.+++......+++..+..++.|++.+|.|||+++++|+||++.||+++.++.++|+|||++..+.... ..
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999999997753338999999999999999999999999999999999999999999999999998775542 23
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCC-CCcH-HHHHHHhccC
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE-FEGP-QAMFKVLNRT 579 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~-~~~~-~~~~~i~~~~ 579 (741)
....++..|++||.+. ....++.++|||+||+++|||++|+.||.. .+.. .+...+..+.
T Consensus 157 ~~~~~~~~~~~pe~~~------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 157 KTVKGTPFYLAPEVLL------GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cceeccCCcCCHhHhc------CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 3456888999999984 134566699999999999999999999977 4444 4445555544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.65 Aligned_cols=252 Identities=28% Similarity=0.476 Sum_probs=200.7
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECC---CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeee
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRE---TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVV 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~---tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~ 427 (741)
....|.+.++||+|+|++||++.+.. ..+.||+|.|..... ..++.+|+++|..+. +.||+++.+.+..
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-------p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-------PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-------chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 34569999999999999999999887 778999998875322 246889999999996 8999999999999
Q ss_pred cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchh
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKH 506 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-g~vKL~DFGLA~~ 506 (741)
+++..+||||++..+..+++.. ++..+++.+++.++.||.++|.+|||||||||.|+|.+.. +.-.|+|||||..
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999999988888744 7789999999999999999999999999999999999754 7788999999962
Q ss_pred cc-----------------C-----------------ccc-----------ccccCCCCCCCChHHHHHhhhcCCCCCCC
Q 004633 507 LT-----------------G-----------------LSY-----------ELSLKGSPNWMAPEVIKAVMQKDGNPKLA 541 (741)
Q Consensus 507 ~~-----------------~-----------------~~~-----------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s 541 (741)
.. . ..+ .....||++|+|||++.++ +..+
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~------~~Qt 256 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC------PRQT 256 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc------cCcC
Confidence 10 0 000 0124499999999999863 4556
Q ss_pred ccchhhhHHHHHHHHhhCCCCCCCC-CcHHHHHHH---h-----------ccC------C---C----------------
Q 004633 542 LAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKV---L-----------NRT------P---P---------------- 581 (741)
Q Consensus 542 ~asDVWSLGvVLyELLtGk~PF~~~-~~~~~~~~i---~-----------~~~------~---~---------------- 581 (741)
.++||||.|+|+.-+++++.||... +....+..+ + .+. . .
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 7999999999999999999998532 111111111 0 000 0 0
Q ss_pred ------------CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 582 ------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 582 ------------iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.-+..+..+.+|+.+||..||.+|+|++++|+||||...
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 001245688999999999999999999999999999754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=310.05 Aligned_cols=199 Identities=21% Similarity=0.283 Sum_probs=148.4
Q ss_pred hcCC-CCeeeeccee-------eecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccC
Q 004633 412 HLKH-ENIVQYYGSE-------VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI 483 (741)
Q Consensus 412 ~L~H-PNIVkl~g~~-------~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDI 483 (741)
.+.| .||++++++| ...+.++++|||+ +++|.++|......+++.+++.|++||+.||+|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 5888888877 2334678889987 57999999765567999999999999999999999999999999
Q ss_pred CCcceEecC-------------------CCcEEEeecccchhccCcc-----------------cccccCCCCCCCChHH
Q 004633 484 KGANLLVDA-------------------SGVVKLADFGMAKHLTGLS-----------------YELSLKGSPNWMAPEV 527 (741)
Q Consensus 484 KP~NILLd~-------------------~g~vKL~DFGLA~~~~~~~-----------------~~~s~~GT~~Y~APEv 527 (741)
||+||||+. ++.+||+|||+++...... ......||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999965 3456666666665321100 0112458999999999
Q ss_pred HHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccC-CCCCccCCHHHHHHHHHhhhcCCCCCC
Q 004633 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERP 606 (741)
Q Consensus 528 l~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~-~~iP~~ls~el~dLI~~cL~~DP~kRP 606 (741)
+.+ ..|+.++||||||||||||++|..|+..... .+..+.... +...........+++.+||..||.+||
T Consensus 187 ~~~-------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rp 257 (793)
T PLN00181 187 DNG-------SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRP 257 (793)
T ss_pred hcc-------CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCc
Confidence 863 4578899999999999999999988754321 122221111 111111245677899999999999999
Q ss_pred CHHHHHcCcccccc
Q 004633 607 SAVELLEHPFIRNA 620 (741)
Q Consensus 607 Ta~ElLqHpwf~~~ 620 (741)
++.|+|+||||...
T Consensus 258 s~~eil~h~~~~~~ 271 (793)
T PLN00181 258 SMSELLQSEFINEP 271 (793)
T ss_pred ChHHHhhchhhhhh
Confidence 99999999999753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=263.62 Aligned_cols=255 Identities=22% Similarity=0.369 Sum_probs=203.4
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecc-eeeecc
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYG-SEVVDD 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g-~~~~~~ 429 (741)
..++|.+.+.||+|.||.+.+|.++.+...+++|.+.. ....+++|.+|...--.|. |.|||..|+ +|+..+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~------p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR------PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc------chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 45689999999999999999999999999999998753 2334578889998777775 899999887 588889
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEec--CCCcEEEeecccchhc
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASGVVKLADFGMAKHL 507 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd--~~g~vKL~DFGLA~~~ 507 (741)
.++++|||++.|+|..-+.. ..+.|...+.++.|++.||.|||++++||||||.+||||- +...|||||||+.+..
T Consensus 96 ~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999999998866 4589999999999999999999999999999999999994 3358999999998654
Q ss_pred cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH----HHHHHHhc-cCCCC
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP----QAMFKVLN-RTPPI 582 (741)
Q Consensus 508 ~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~----~~~~~i~~-~~~~i 582 (741)
... .....-+..|.+||++... ..+.-.....+|||.||||+|.+++|++||...... ..+.+... ..+..
T Consensus 174 g~t--V~~~~~~~~y~~pe~~~~~--~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 174 GTT--VKYLEYVNNYHAPELCDTV--VNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred Cce--ehhhhhhcccCCcHHHhhc--cccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 321 1123346789999998754 333445677899999999999999999999743221 12222222 23334
Q ss_pred C---ccCCHHHHHHHHHhhhcCCCCC---CCHHHHHcCcccc
Q 004633 583 P---EMLSSEGKDFLLRCFLRNPVER---PSAVELLEHPFIR 618 (741)
Q Consensus 583 P---~~ls~el~dLI~~cL~~DP~kR---PTa~ElLqHpwf~ 618 (741)
| .-+++.+..+.++-|..++++| .++....+..|.+
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 4 4578999999999999999999 6777777777764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-27 Score=237.08 Aligned_cols=256 Identities=34% Similarity=0.558 Sum_probs=207.3
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC-CeeeecceeeecceEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-NIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HP-NIVkl~g~~~~~~~l~LV 434 (741)
|.+.+.||.|+||.||++.+. ..+++|.+....... ......+.+|+.+++.+.|+ +|+++++.+......+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK--SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc--hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence 788999999999999999987 788999876433221 23457788999999999988 799999999888889999
Q ss_pred EeecCCCChhhhhhhcc--ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC-cEEEeecccchhccCcc
Q 004633 435 LEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLS 511 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~--~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g-~vKL~DFGLA~~~~~~~ 511 (741)
+||+.+++|.+++.... ..+.+..+..++.|++.+|.|+|+.|++||||||+|||++..+ .++|+|||++..+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999999997776643 2699999999999999999999999999999999999999988 79999999998665433
Q ss_pred -------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc----HHHHHHHhccCC
Q 004633 512 -------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----PQAMFKVLNRTP 580 (741)
Q Consensus 512 -------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~----~~~~~~i~~~~~ 580 (741)
......||..|+|||.+.+.. ...+....|+|++|+++++++.|..||..... ......+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLS----LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCC----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 235678999999999987410 14677799999999999999999999877664 333333333322
Q ss_pred C-CCccC--------CHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 581 P-IPEML--------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 581 ~-iP~~l--------s~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
. ..... ...+.+++..++..+|..|.+..+...+.|....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 2 21111 1578999999999999999999999988666543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=258.20 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=208.2
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecce
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG-----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGS 424 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg-----~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~ 424 (741)
...+.++++..++.+|+||.||.|.+++.. +.|-+|.++. . ...-.+..+..|.-+|..+.|||+..+.++
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~---~-AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ---H-ASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh---c-ccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 345667899999999999999999877533 3355554431 1 223345677889999999999999999998
Q ss_pred eeec-ceEEEEEeecCCCChhhhhh-----h--ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004633 425 EVVD-DHLYIYLEYVHPGSINRYVR-----E--HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (741)
Q Consensus 425 ~~~~-~~l~LVmEy~~gGsL~~lI~-----~--~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~v 496 (741)
...+ +.-++++.+..-|.|..++. + ....++..++..++.||+.||+|||++||||.||..+|++|++.-.|
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 7655 45778888998999999997 2 23457888889999999999999999999999999999999999999
Q ss_pred EEeecccchhccCccccc---ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHH
Q 004633 497 KLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 572 (741)
Q Consensus 497 KL~DFGLA~~~~~~~~~~---s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~ 572 (741)
||+|=.|++.+-...+.. .......||++|.+. +..|+.++||||||++||||++ |+.||.+.+..++.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~-------n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ-------NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHh-------hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 999999998776544432 122356899999998 3578889999999999999998 99999999988887
Q ss_pred HHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 573 FKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 573 ~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
.-+.++ +...|-.+++++..+|..||..+|++||+++|+..
T Consensus 509 ~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 509 HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 776654 45678899999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=234.61 Aligned_cols=160 Identities=29% Similarity=0.331 Sum_probs=130.6
Q ss_pred CChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCcccccccCCCC
Q 004633 441 GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSP 520 (741)
Q Consensus 441 GsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~GT~ 520 (741)
|+|.+++......+++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++...... ..||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 7899999876667999999999999999999999999 999999999999999 99987654422 36899
Q ss_pred CCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH-HHHHHHhccCCC-------CCccCCH--HH
Q 004633 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPP-------IPEMLSS--EG 590 (741)
Q Consensus 521 ~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~-~~~~~i~~~~~~-------iP~~ls~--el 590 (741)
.|||||++.+ ..++.++||||||||+|||++|+.||...... ..+..+...... .+..++. ++
T Consensus 69 ~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (176)
T smart00750 69 YFMAPEVIQG-------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF 141 (176)
T ss_pred cccChHHhcC-------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence 9999999963 45778999999999999999999999765443 223333322111 1223344 69
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
+++|.+||..||++||++.|+++|+|+..
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=289.61 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=207.8
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCC-CCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 357 ~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~-~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
....++|.|+||.|+.+......+.++.|.+.... ......+....+..|+.+-..|+|+||+..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 56789999999999999888877777777655221 12222333344778999999999999999888777777766679
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCc-----
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL----- 510 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~----- 510 (741)
|||++ +|+.++... ..+...++..+++||+.||+|||++||.|||||++|||++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99999 999999764 46999999999999999999999999999999999999999999999999999776432
Q ss_pred ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHH---------HHhccCCC
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---------KVLNRTPP 581 (741)
Q Consensus 511 ~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~---------~i~~~~~~ 581 (741)
.....++|+..|+|||++.+ ..+....+||||.|+|++.|++|+.||......+..+ ++..+...
T Consensus 479 ~~~~g~~gS~pY~apE~~~~------~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTG------KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hhhcCcccCCcCcCcccccc------cccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 23346789999999999975 3455578999999999999999999997554433321 11122223
Q ss_pred CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccccc
Q 004633 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 582 iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~ 622 (741)
+-..++.+.+.+|.+||+.||.+|+|+++|++.+||+....
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 34557889999999999999999999999999999987653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=251.93 Aligned_cols=184 Identities=17% Similarity=0.180 Sum_probs=138.4
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeee-ecceeeec
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ-YYGSEVVD 428 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~-tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVk-l~g~~~~~ 428 (741)
....+|+++++||+|+||+||+|+++. ++..||||++.............+.+.+|+++|++|+|+|||. +++ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----T 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----c
Confidence 345679999999999999999999886 6778899976421110012334567899999999999999985 543 2
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccC-CCcceEecCCCcEEEeecccchhc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI-KGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDI-KP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
+..||||||++|++|... ... . ...++.|+++||.|||++||+|||| ||+|||++.++.+||+|||+|+.+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 468999999999999732 111 1 1468899999999999999999999 999999999999999999999866
Q ss_pred cCcc---------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhh
Q 004633 508 TGLS---------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 547 (741)
Q Consensus 508 ~~~~---------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVW 547 (741)
.... ......+++.|+|||.+..... ......+...|-|
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~-~~~~~~~~~~dgW 210 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRER-KILARKSLPSRIW 210 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChhhh-ccccccccccCcE
Confidence 4322 1134568899999999864322 2223334456777
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-27 Score=268.17 Aligned_cols=243 Identities=26% Similarity=0.428 Sum_probs=211.0
Q ss_pred EEeecCCeEEEEEE---ECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEEEEEe
Q 004633 361 LIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLE 436 (741)
Q Consensus 361 ~LG~G~fG~Vy~a~---~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVmE 436 (741)
++|.|+||.|++++ ....|..+|+|+.+.......... ....|..++..++ ||.+|++...++.+..++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 47999999999874 334577899998764333222111 4456788888887 9999999999999999999999
Q ss_pred ecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccccccc
Q 004633 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516 (741)
Q Consensus 437 y~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~ 516 (741)
|..||+|...+.+. ..+.+...+.+...++.+++++|+.||+|||+|++||+++.+|++|+.|||+.+.+......
T Consensus 78 ~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred hcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99999999998765 67899999999999999999999999999999999999999999999999999887654433
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHH
Q 004633 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLR 596 (741)
Q Consensus 517 ~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~ 596 (741)
|||..|||||++.+ ...++|.||+|++++||++|..||.. +++..|+.....+|..++.++++++..
T Consensus 154 cgt~eymApEI~~g---------h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~ 220 (612)
T KOG0603|consen 154 CGTYEYRAPEIING---------HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQ 220 (612)
T ss_pred ccchhhhhhHhhhc---------cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHH
Confidence 99999999999973 34589999999999999999999988 777888888899999999999999999
Q ss_pred hhhcCCCCCCC-----HHHHHcCccccccccC
Q 004633 597 CFLRNPVERPS-----AVELLEHPFIRNANYQ 623 (741)
Q Consensus 597 cL~~DP~kRPT-----a~ElLqHpwf~~~~~~ 623 (741)
++.++|.+|.- +.|+++|+||...++.
T Consensus 221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 99999999964 5799999999987765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-25 Score=236.41 Aligned_cols=247 Identities=24% Similarity=0.309 Sum_probs=191.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCC-cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC----CCeeeeccee-eec
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH----ENIVQYYGSE-VVD 428 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg-~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H----PNIVkl~g~~-~~~ 428 (741)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|+.+|..+.. .++..+++.. ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 8999999999999999999998875 6788887764322111 146668888888862 6889999888 577
Q ss_pred ceEEEEEeecCCCChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC-----CcEEEeecc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-----GVVKLADFG 502 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-----g~vKL~DFG 502 (741)
+..||||+++ |.+|.++..... +.++...+..++.|++.+|++||+.|++||||||+|+++... ..+.|+|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 8899999998 789999886654 789999999999999999999999999999999999999765 369999999
Q ss_pred cch--hccCcc--------c-ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHH
Q 004633 503 MAK--HLTGLS--------Y-ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA 571 (741)
Q Consensus 503 LA~--~~~~~~--------~-~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~ 571 (741)
+++ .+.... . ...+.||..|+++.+..+ ...+.+.|+||++.++.||+.|.+||........
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-------~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~ 245 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-------IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL 245 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-------CccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence 998 322111 1 223559999999998874 4566789999999999999999999977654322
Q ss_pred HHHHh---ccCC-C-CCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 572 MFKVL---NRTP-P-IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 572 ~~~i~---~~~~-~-iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
..+.. .... . .....+.++.+++..+-..+...+|....+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 246 KSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22221 1111 1 233455777788777777899999988877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=210.55 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=195.7
Q ss_pred CCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC-CCeeeecceeeec
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVD 428 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H-PNIVkl~g~~~~~ 428 (741)
......|.+++.||.|+||.+|+|....+|+.||||+-...... -++..|.++.+.|++ ..|..+..+..++
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-------pqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-------PQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-------cchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 34567899999999999999999999999999999975432222 246678899998875 7888888888889
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC---CcEEEeecccch
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS---GVVKLADFGMAK 505 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~---g~vKL~DFGLA~ 505 (741)
+.-.|||+++ |-+|++++.--.+.++...+.-++.||+.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 9999999998 688888886545679999999999999999999999999999999999999643 579999999999
Q ss_pred hccCcc--------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcH---HHHHH
Q 004633 506 HLTGLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFK 574 (741)
Q Consensus 506 ~~~~~~--------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~---~~~~~ 574 (741)
.+.+.. ......||.+|.+--...+..+. ...|+-|+|.||.++.-|.+||.+.... +-..+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-------RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-------RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhh-------hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence 875532 22346699999998887765544 3679999999999999999999876443 33445
Q ss_pred HhccCCCCC-----ccCCHHHHHHHHHhhhcCCCCCCCH
Q 004633 575 VLNRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSA 608 (741)
Q Consensus 575 i~~~~~~iP-----~~ls~el~dLI~~cL~~DP~kRPTa 608 (741)
|.......+ ..++.++...|.-|-..--++-|..
T Consensus 236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 555444433 3578888888888877776777764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=219.14 Aligned_cols=242 Identities=24% Similarity=0.344 Sum_probs=187.8
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecc
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDD 429 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~ 429 (741)
...-.|.++++||+|+||.+++|.+.-+++.||||.-.+ .... -++..|.+..+.|. .++|.+.|.+..+..
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr---kS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR---KSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccc---cCCc----chHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 345579999999999999999999999999999996432 2222 35777888888886 699999998888888
Q ss_pred eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC-----CcEEEeecccc
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-----GVVKLADFGMA 504 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-----g~vKL~DFGLA 504 (741)
+-.||||++ |-+|+|+..--++.++...+..++.||+.-|+|+|++.+|.|||||+|+||..- ..|-|+|||+|
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 889999998 678888876556789999999999999999999999999999999999999643 46999999999
Q ss_pred hhccCccc--------ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCc---HHHHH
Q 004633 505 KHLTGLSY--------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG---PQAMF 573 (741)
Q Consensus 505 ~~~~~~~~--------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~---~~~~~ 573 (741)
+.+.+... ..+..||.+||+-....|..+ +...|+-|||-|+++.|-|.+||.+... .+...
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-------SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe 249 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-------SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE 249 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchh-------hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH
Confidence 98765432 235679999999888876444 4478999999999999999999987543 34444
Q ss_pred HHhccCCCCC-----ccCCHHHHHHHHHhhhcCCCCCCC
Q 004633 574 KVLNRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPS 607 (741)
Q Consensus 574 ~i~~~~~~iP-----~~ls~el~dLI~~cL~~DP~kRPT 607 (741)
+|-......| +.++.++...|+-.-..+-.+-|.
T Consensus 250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 4433222211 235555555555554445555554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-24 Score=247.87 Aligned_cols=223 Identities=28% Similarity=0.479 Sum_probs=177.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
+...+|..++.|-.|+||.||+++++.+.+.+|+|+-+ .. .+.+- ||.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk---q~--------lilRn--ilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK---QN--------LILRN--ILTFAGNPFVV----------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccc---cc--------hhhhc--cccccCCccee-----------
Confidence 44568999999999999999999999999999996321 11 01110 44444455554
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccC-
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG- 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~- 509 (741)
|+...+++.. +.++.+ ++.+++|||+.||+|||+||+|+||+.-|++||+|||+.+...-
T Consensus 136 ----------gDc~tllk~~-g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----------GDCATLLKNI-GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----------chhhhhcccC-CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 6666666543 334433 37899999999999999999999999999999999999865311
Q ss_pred ---------------cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHH
Q 004633 510 ---------------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK 574 (741)
Q Consensus 510 ---------------~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~ 574 (741)
.-.....+||+.|+|||++.. ..|+..+|+|+||+|+||.+.|..||.++..++++..
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~ 269 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 269 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhh-------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhh
Confidence 011224689999999999973 4688899999999999999999999999999888888
Q ss_pred HhccCCCCCc---cCCHHHHHHHHHhhhcCCCCCC---CHHHHHcCccccccccC
Q 004633 575 VLNRTPPIPE---MLSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRNANYQ 623 (741)
Q Consensus 575 i~~~~~~iP~---~ls~el~dLI~~cL~~DP~kRP---Ta~ElLqHpwf~~~~~~ 623 (741)
++.....+|+ .+.++++++|.++|..+|..|. .+-++.+|.||+..++.
T Consensus 270 visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 270 VISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 8877666664 5789999999999999999994 57799999999988765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=224.30 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=188.6
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCc-----------------------------------EEEEEEeecCCCCccc
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGA-----------------------------------SCAIKEVDIIPDDPKS 396 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~-----------------------------------~vAVK~i~~~~~~~~~ 396 (741)
..++|++++.||+|..+.||.|+...+|. +.|||.+-.+..+...
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 34679999999999999999987654321 2466765544444444
Q ss_pred HHHHHHHHHHHH------HH--------h-------h-cCCCCeeeecceeee---------------------------
Q 004633 397 AECIKQLEQEIK------VL--------G-------H-LKHENIVQYYGSEVV--------------------------- 427 (741)
Q Consensus 397 ~~~ik~l~~Ei~------iL--------~-------~-L~HPNIVkl~g~~~~--------------------------- 427 (741)
...++...+|+. .+ + + -+|||||++.++|.+
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 444555555531 11 1 1 269999999988754
Q ss_pred cceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEec--CCC--cEEEeeccc
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASG--VVKLADFGM 503 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd--~~g--~vKL~DFGL 503 (741)
...+|+||.-.+ -+|..|+-.+ ..+....+-++.|+++|+.|||.+||.|||+|.+||||. +|+ .+.|+|||+
T Consensus 315 ~~tlylvMkrY~-~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 315 PKTLYLVMKRYR-QTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred CceEEEehhcch-hhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 235799998775 6888888653 477788889999999999999999999999999999984 444 589999998
Q ss_pred chhcc-------CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHH--HHH
Q 004633 504 AKHLT-------GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--MFK 574 (741)
Q Consensus 504 A~~~~-------~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~--~~~ 574 (741)
+-.-. ..+......|...-||||+....-....--.| .++|.|+.|.+.||++....||....+... ..-
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny-~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNY-EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeecc-chhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence 74322 22334455688899999998753222111122 479999999999999999999987332211 111
Q ss_pred HhccCCCCCccCCHHHHHHHHHhhhcCCCCCCC---HHHHHcCccc
Q 004633 575 VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFI 617 (741)
Q Consensus 575 i~~~~~~iP~~ls~el~dLI~~cL~~DP~kRPT---a~ElLqHpwf 617 (741)
.....+.+|+.+++.+++|+..+|+.||.+|++ +..+|+--.|
T Consensus 471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 223456788999999999999999999999987 4466654333
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=206.36 Aligned_cols=144 Identities=19% Similarity=0.169 Sum_probs=112.3
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccH---------------------HHHHHHHHHHHHHhhcCCCC
Q 004633 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA---------------------ECIKQLEQEIKVLGHLKHEN 417 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~---------------------~~ik~l~~Ei~iL~~L~HPN 417 (741)
.+.||+|+||.||+|.+. +|+.||||+++......... ........|+++|..|.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 89999999997532111110 01233456999999998877
Q ss_pred eeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHH-HhCCeecccCCCcceEecCCCcE
Q 004633 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDASGVV 496 (741)
Q Consensus 418 IVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yL-Hs~gIVHRDIKP~NILLd~~g~v 496 (741)
|...+.+.. ...+|||||+.|++|...+.+. ..+++.++..++.||+.+|.|| |+.||+||||||+|||++ ++.+
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 744333222 2238999999998877654333 5689999999999999999999 799999999999999998 5789
Q ss_pred EEeecccchhc
Q 004633 497 KLADFGMAKHL 507 (741)
Q Consensus 497 KL~DFGLA~~~ 507 (741)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=200.52 Aligned_cols=147 Identities=16% Similarity=0.144 Sum_probs=114.9
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc---------------------HHHHHHHHHHHHHHhhcCCC
Q 004633 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS---------------------AECIKQLEQEIKVLGHLKHE 416 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~---------------------~~~ik~l~~Ei~iL~~L~HP 416 (741)
+.+.||+|+||.||+|.+. +|+.||||+++........ ......+++|++.+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998754221100 01123456899999999999
Q ss_pred CeeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCc
Q 004633 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGV 495 (741)
Q Consensus 417 NIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~ 495 (741)
+|.....+... ..||||||++|+++...+... ..+++.++..++.|++.+|.+||. +||+||||||+|||++ ++.
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 87544443332 248999999988654432222 457889999999999999999999 9999999999999998 899
Q ss_pred EEEeecccchhccC
Q 004633 496 VKLADFGMAKHLTG 509 (741)
Q Consensus 496 vKL~DFGLA~~~~~ 509 (741)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999986644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=212.26 Aligned_cols=242 Identities=23% Similarity=0.294 Sum_probs=155.8
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC----------CC------e
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH----------EN------I 418 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H----------PN------I 418 (741)
.+.+++.||.|+++.||.+++.+||+.+|+|++.... +. ....++.+++|.-....+.+ -. |
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~-~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DA-SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TT-HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-cc-chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 5788999999999999999999999999999987655 22 22235666666644443322 12 2
Q ss_pred eeecc---eeeecc--------eEEEEEeecCCCChhhhhhh---ccc---cccHHHHHHHHHHHHHHHHHHHhCCeecc
Q 004633 419 VQYYG---SEVVDD--------HLYIYLEYVHPGSINRYVRE---HCR---DITESIVRNFTRHILNGLAYLHSTNTIHR 481 (741)
Q Consensus 419 Vkl~g---~~~~~~--------~l~LVmEy~~gGsL~~lI~~---~~~---~lse~~i~~i~~QIl~aL~yLHs~gIVHR 481 (741)
+++-+ ++.... ..+++|+-+. ++|.+++.. ... .+.......+..|+++.+++||..||||+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 22221 111111 2356777764 788777642 111 12233334566899999999999999999
Q ss_pred cCCCcceEecCCCcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhc-CCCCCCCccchhhhHHHHHHHHhhCC
Q 004633 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK-DGNPKLALAVDIWSLGCTVIEMLTGK 560 (741)
Q Consensus 482 DIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~-~g~~~~s~asDVWSLGvVLyELLtGk 560 (741)
||||+|+|++.+|.++|+||+........... ...+..|.+||.......+ ...-.++.+.|.|+||+++|.|++|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999999887654432221 3456889999987653110 02345788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCC
Q 004633 561 PPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVER 605 (741)
Q Consensus 561 ~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~cL~~DP~kR 605 (741)
.||............+.... .+++.+++||.++|+.||++|
T Consensus 248 lPf~~~~~~~~~~~~f~~C~----~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEWDFSRCR----DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGGGGTTSS-------HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccccchhcC----CcCHHHHHHHHHHccCCcccC
Confidence 99986543322211222221 578899999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=207.07 Aligned_cols=173 Identities=13% Similarity=0.159 Sum_probs=132.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHH------HHHHHHHHhhcCCCCeeeecceee
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIKVLGHLKHENIVQYYGSEV 426 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~------l~~Ei~iL~~L~HPNIVkl~g~~~ 426 (741)
..+|++.++||.|+||.||++.. ++..+|||++..... ........ +++|+..+.+|.|++|..+.+++.
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~--~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK--RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcC--chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 56899999999999999999755 467899998863222 22333233 689999999999999999998866
Q ss_pred ec--------ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEE
Q 004633 427 VD--------DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 498 (741)
Q Consensus 427 ~~--------~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL 498 (741)
.. +..+|||||++|.+|.++.. +++ ....+|+.+|..||+.||+||||||.|||++.+| ++|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 44 35899999999999988732 333 2456999999999999999999999999999999 999
Q ss_pred eecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHh
Q 004633 499 ADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557 (741)
Q Consensus 499 ~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELL 557 (741)
+|||............ .++.. ..|..++|+|+||+++..+.
T Consensus 176 iDfg~~~~~~e~~a~d-----------~~vle-------r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAKD-----------RIDLE-------RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhHH-----------HHHHH-------hHhcccccccceeEeehHHH
Confidence 9999886653221110 02221 23446899999999988654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=200.41 Aligned_cols=191 Identities=16% Similarity=0.107 Sum_probs=142.2
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEEEEE
Q 004633 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 357 ~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVm 435 (741)
.+...|++|+||+||++.. .+.+++.+.+...+.-. ..-....+.+|+++|++|. |++|++++++ +..|++|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~-~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWL-RGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhh-hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 3567999999999997765 57778877655322210 1111225789999999996 5889999875 4479999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccC-CCcceEecCCCcEEEeecccchhccCccc--
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDI-KGANLLVDASGVVKLADFGMAKHLTGLSY-- 512 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDI-KP~NILLd~~g~vKL~DFGLA~~~~~~~~-- 512 (741)
||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 78 eyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99999998754421 1 1357889999999999999999999 79999999999999999999985543221
Q ss_pred ------------ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCC
Q 004633 513 ------------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567 (741)
Q Consensus 513 ------------~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~ 567 (741)
..-..+++.|+.|+...-.. ..--.+.++++.|+-+|.++|+..++..+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~-----~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLK-----RTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc-----cchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 01123789999999765311 111146799999999999999998876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-23 Score=241.64 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=185.7
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
+|...+.||++.|=+|.+|++.+ ..|+||++-+. ++...-.-.++..+|++ ...+++||.+.+.-+.+.+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e--G~vVvKVFvk~-~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE--GLVVVKVFVKQ-DPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC--ceEEEEEEecc-CCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 78899999999999999998765 34999988643 33333333344445566 5667899999999988888889999
Q ss_pred EeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc--cCc--
Q 004633 435 LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGL-- 510 (741)
Q Consensus 435 mEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~--~~~-- 510 (741)
-+|+. -+|+|.|..+ .-+.+-+.+.|+.||+.||..||+.||+|+|||.+||||+..+-+.|+||.--+.. ..+
T Consensus 100 Rqyvk-hnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 100 RQYVK-HNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHh-hhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99986 6888888664 55888899999999999999999999999999999999999999999999865432 111
Q ss_pred -cccc---ccCCCCCCCChHHHHHhh----hcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHHHHHHHhccCCC
Q 004633 511 -SYEL---SLKGSPNWMAPEVIKAVM----QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTPP 581 (741)
Q Consensus 511 -~~~~---s~~GT~~Y~APEvl~~~~----~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~~~~~i~~~~~~ 581 (741)
.+.. +-..-..|+|||.+.... ........+++.||||+|||++||++ |+++|.-.. +.+...+...
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~~~ 253 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGNAD 253 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccCcc
Confidence 1110 111234699999997633 11122337889999999999999988 899985311 1111111000
Q ss_pred CC-----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 582 IP-----EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 582 iP-----~~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.+ ..-+..++.||..|++.||.+|.+|++.|+.
T Consensus 254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 1123478999999999999999999999985
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=192.47 Aligned_cols=136 Identities=21% Similarity=0.316 Sum_probs=107.1
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-----CCCCeeeecceeeecc---
Q 004633 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-----KHENIVQYYGSEVVDD--- 429 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-----~HPNIVkl~g~~~~~~--- 429 (741)
-.++||+|+||.||. +..++.. +||++..... ...+.+.+|+++++.| .||||+++|++++++.
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc-----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 457899999999995 6666665 6888764221 1235688999999999 5799999999998873
Q ss_pred eEE-EEEee--cCCCChhhhhhhccccccHHHHHHHHHHHHHHH-HHHHhCCeecccCCCcceEecCC----CcEEEeec
Q 004633 430 HLY-IYLEY--VHPGSINRYVREHCRDITESIVRNFTRHILNGL-AYLHSTNTIHRDIKGANLLVDAS----GVVKLADF 501 (741)
Q Consensus 430 ~l~-LVmEy--~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL-~yLHs~gIVHRDIKP~NILLd~~----g~vKL~DF 501 (741)
.++ +|||| +.+|+|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 434 78999 5589999999663 36655 36688888887 99999999999999999999743 37999995
Q ss_pred ccch
Q 004633 502 GMAK 505 (741)
Q Consensus 502 GLA~ 505 (741)
+.+.
T Consensus 154 ~G~~ 157 (210)
T PRK10345 154 IGES 157 (210)
T ss_pred CCCc
Confidence 5443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=198.78 Aligned_cols=244 Identities=20% Similarity=0.322 Sum_probs=194.7
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++..+..+|.+.-.|..|+|+++. ..+++|++.+.. ......+.|..|.-.|+-..||||+.+++++.....+.+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~---~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVRE---VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC--cchhhhhhhhhh---cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 456677789999999999999874 456667665432 223334678889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCC-ee-cccCCCcceEecCCCcEEEe--ecccchhcc
Q 004633 434 YLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN-TI-HRDIKGANLLVDASGVVKLA--DFGMAKHLT 508 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~g-IV-HRDIKP~NILLd~~g~vKL~--DFGLA~~~~ 508 (741)
|..|++.|+|+..+.+. ..-++..++.+++.+|++|++|||+.. ++ ---|....++||++.+.+|. |--++.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---
Confidence 99999999999999775 334788899999999999999999874 33 34688999999999877764 322211
Q ss_pred CcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHh--ccCCCCCccC
Q 004633 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEML 586 (741)
Q Consensus 509 ~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~--~~~~~iP~~l 586 (741)
........|.||+||.++.... ...-.++|+|||+++||||.|...||.+....+.-.+|. +....+|+.+
T Consensus 342 ---qe~gr~y~pawmspealqrkpe----d~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi 414 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPE----DLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI 414 (448)
T ss_pred ---eccccccCcccCCHHHHhcCch----hcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence 1112335789999999985322 123358999999999999999999999998887766653 4567899999
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHH
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELL 612 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElL 612 (741)
+.....||..|+..||.+||.+..++
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999987765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-20 Score=191.03 Aligned_cols=149 Identities=18% Similarity=0.151 Sum_probs=116.6
Q ss_pred CCeEEeeEEeecCCeEEEEEE-ECCCCcEEEEEEeecCCCCcc-------------------cHHHHHHHHHHHHHHhhc
Q 004633 354 SQWQKGKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPK-------------------SAECIKQLEQEIKVLGHL 413 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~-~k~tg~~vAVK~i~~~~~~~~-------------------~~~~ik~l~~Ei~iL~~L 413 (741)
.-|++.+.||+|+||.||+|. +..+|+.||||+++....... .......+++|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358999999999999999998 667899999999875321100 011224567899999999
Q ss_pred CCCC--eeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCC-eecccCCCcceEe
Q 004633 414 KHEN--IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN-TIHRDIKGANLLV 490 (741)
Q Consensus 414 ~HPN--IVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~g-IVHRDIKP~NILL 490 (741)
.+.+ +.++++ . ...+|||||+.|++|..++... ..+.+.++..++.||+.+|.+||++| |+||||||+|||+
T Consensus 108 ~~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 108 YEAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred HhcCCCCCeeeE---e-cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 7532 333333 2 2358999999999887765332 34667778899999999999999999 9999999999999
Q ss_pred cCCCcEEEeecccchhcc
Q 004633 491 DASGVVKLADFGMAKHLT 508 (741)
Q Consensus 491 d~~g~vKL~DFGLA~~~~ 508 (741)
+ ++.++|+|||++....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=178.89 Aligned_cols=139 Identities=22% Similarity=0.300 Sum_probs=114.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc---cHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEe
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~---~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 436 (741)
+.||+|++|.||+|.+ +|..|++|+......... ......++.+|+.++..+.|++|+....++...+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 678899997542211111 11123467889999999999998877777777888999999
Q ss_pred ecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 437 y~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
|++|++|.+++.... . ....++.+|+.+|.+||..||+|+||+|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999986531 2 7889999999999999999999999999999998 88999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-21 Score=221.16 Aligned_cols=257 Identities=29% Similarity=0.437 Sum_probs=210.2
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCC-CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceE
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHL 431 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~t-g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l 431 (741)
..|.+.+.||+|+|+.|-++....+ ...+|+|.+.... ......+.+..|..+-..+. |.|++.+++.....+..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4577888899999999999877543 4557777665433 33444566777888888887 99999999999999999
Q ss_pred EEEEeecCCCChhhhh-hhccccccHHHHHHHHHHHHHHHHHHH-hCCeecccCCCcceEecCCC-cEEEeecccchhcc
Q 004633 432 YIYLEYVHPGSINRYV-REHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASG-VVKLADFGMAKHLT 508 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI-~~~~~~lse~~i~~i~~QIl~aL~yLH-s~gIVHRDIKP~NILLd~~g-~vKL~DFGLA~~~~ 508 (741)
++++||..||++.+.+ .......+...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .+|++|||+|..+.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999999999 555447888999999999999999999 99999999999999999999 99999999998775
Q ss_pred C-cc---cccccCC-CCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHH-HHHhcc----
Q 004633 509 G-LS---YELSLKG-SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNR---- 578 (741)
Q Consensus 509 ~-~~---~~~s~~G-T~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~-~~i~~~---- 578 (741)
. .. .....+| ++.|+|||.+.+. .+.+...|+||+|+++.-|++|..||......... ......
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~------~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGK------AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF 250 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccch------hhcCCCcccccccccccccccCCCCccccccccccceeeccccccc
Confidence 5 22 2234568 9999999998752 35567899999999999999999999765443322 112211
Q ss_pred CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 579 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 579 ~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
.......++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 251 ~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 251 TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 23345678899999999999999999999999999999987
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-19 Score=211.90 Aligned_cols=200 Identities=24% Similarity=0.289 Sum_probs=158.6
Q ss_pred CCCCCCCCCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC---CCCeeee
Q 004633 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQY 421 (741)
Q Consensus 345 ~~~~~~~~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~---HPNIVkl 421 (741)
......+....|.|-+.||+|+||+||+|.... |+.||+|+-+.-.. +. +.--.+++.+|+ -+-|+.+
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~--WE------fYI~~q~~~RLk~~~~~~~~~~ 759 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP--WE------FYICLQVMERLKPQMLPSIMHI 759 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc--ee------eeehHHHHHhhchhhhcchHHH
Confidence 333555667789999999999999999999877 99999997542111 11 111123333443 3556777
Q ss_pred cceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC-------CC
Q 004633 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-------SG 494 (741)
Q Consensus 422 ~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~-------~g 494 (741)
..++...+.-+||+||.+.|+|.+++. ..+.++|..+..|+.||+..|+.||..||||+||||+|+||.. .-
T Consensus 760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 760 SSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred HHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCccc
Confidence 777778888999999999999999997 4578999999999999999999999999999999999999942 23
Q ss_pred cEEEeecccchhc---cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCC
Q 004633 495 VVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561 (741)
Q Consensus 495 ~vKL~DFGLA~~~---~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~ 561 (741)
-++|||||.+..+ .........++|-.+--+|++.| ..++..+|.|.|+.++|-||.|+.
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-------rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-------RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-------CCCchhhhhHHHHHHHHHHHHHHH
Confidence 5999999998554 33334445678999999999863 678889999999999999999974
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.6e-19 Score=175.12 Aligned_cols=136 Identities=22% Similarity=0.308 Sum_probs=108.9
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc---cHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEee
Q 004633 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK---SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (741)
Q Consensus 361 ~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~---~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 437 (741)
.||+|+||.||+|.. +|..|++|+......... ......++.+|+++++.+.|++|.....++...+..+|||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 578899998543221111 112246688999999999988766555556667778999999
Q ss_pred cCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 438 ~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
++|++|.+++..... .++.||+.+|.+||+.||+|+||||+|||++ ++.++|+|||++...
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988755311 7899999999999999999999999999999 899999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.9e-19 Score=175.73 Aligned_cols=143 Identities=18% Similarity=0.176 Sum_probs=111.3
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc-----------------HHHHHHHHHHHHHHhhcCCCC
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----------------AECIKQLEQEIKVLGHLKHEN 417 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~-----------------~~~ik~l~~Ei~iL~~L~HPN 417 (741)
.|.+.+.||+|+||.||+|... +|+.||||++......... ........+|+.++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 7999999987642211000 011123678999999998874
Q ss_pred --eeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCc
Q 004633 418 --IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (741)
Q Consensus 418 --IVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~ 495 (741)
++..++ ....++||||++|++|..++.. .....++.+|+.+|.++|+.||+||||||+||||+.++.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 344433 3456899999999998776431 345678899999999999999999999999999999999
Q ss_pred EEEeecccchhccC
Q 004633 496 VKLADFGMAKHLTG 509 (741)
Q Consensus 496 vKL~DFGLA~~~~~ 509 (741)
++|+|||++..+..
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999966544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.5e-20 Score=202.41 Aligned_cols=242 Identities=23% Similarity=0.314 Sum_probs=165.5
Q ss_pred eEEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecc-------ee
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG-------SE 425 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~t---g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g-------~~ 425 (741)
+.+.+..+.++++.++..+...+ .+.++.+..++ ..........+++..+....|-+..-+.+ .+
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~-----d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADV-----DSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhc-----cchhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 45556666677776665544332 22233332221 12122233444555555554433333322 11
Q ss_pred e-----ecceEEEEEeecCCCChhhhhhh--ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEE
Q 004633 426 V-----VDDHLYIYLEYVHPGSINRYVRE--HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 498 (741)
Q Consensus 426 ~-----~~~~l~LVmEy~~gGsL~~lI~~--~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL 498 (741)
. ....+||.|++|...+|.++|.. .....+......|+.|+..|++| +|.+|||+||.||++..++.+||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 1 12358999999999999999953 34557788899999999999999 99999999999999999999999
Q ss_pred eecccchhccCcc-------cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhh-CCCCCCCCCcHH
Q 004633 499 ADFGMAKHLTGLS-------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ 570 (741)
Q Consensus 499 ~DFGLA~~~~~~~-------~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLt-Gk~PF~~~~~~~ 570 (741)
+|||+........ ......||.+||+||.+.+ ..|+.++||||||+||+||+. -...|+. ..
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-------~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~ 467 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-------QQYSEKVDIYALGLILAELLIQFSTQFER---IA 467 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh-------hhhhhhcchhhHHHHHHHHHHHhccHHHH---HH
Confidence 9999997765544 4456779999999999985 578899999999999999998 3322221 11
Q ss_pred HHHHHhccCCCCCcc---CCHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 571 AMFKVLNRTPPIPEM---LSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 571 ~~~~i~~~~~~iP~~---ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
.+..+-.+ .+|+. --++-.+|+.+||...|.+||++.+.--|.|.
T Consensus 468 t~~d~r~g--~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 468 TLTDIRDG--IIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhhhhhcC--CCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 22222222 33311 12455689999999999999988777777664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=194.84 Aligned_cols=204 Identities=27% Similarity=0.469 Sum_probs=161.9
Q ss_pred HhhcCCCCeeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCe-ecccCCCcce
Q 004633 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT-IHRDIKGANL 488 (741)
Q Consensus 410 L~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gI-VHRDIKP~NI 488 (741)
|+.+.|.|+.+++|.+.+...+++|.+||..|+|.+.+......+++-....++++|+.||.|||.-.| .|+.++..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 467899999999999999999999999999999999998877889999999999999999999998766 8999999999
Q ss_pred EecCCCcEEEeecccchhccCc---ccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCC
Q 004633 489 LVDASGVVKLADFGMAKHLTGL---SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE 565 (741)
Q Consensus 489 LLd~~g~vKL~DFGLA~~~~~~---~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~ 565 (741)
+++..-.+||.|||+....... .......-..-|.|||++.+..........+.+.||||+|+++||+++.+.||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998765421 1111112345699999998643222112356789999999999999999999975
Q ss_pred C----CcHHHHHHHhc-cCCCC-C-----ccCCHHHHHHHHHhhhcCCCCCCCHHHHHc
Q 004633 566 F----EGPQAMFKVLN-RTPPI-P-----EMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 566 ~----~~~~~~~~i~~-~~~~i-P-----~~ls~el~dLI~~cL~~DP~kRPTa~ElLq 613 (741)
. +..+.+..+.+ +...+ | ....+++..++++||..+|++||+++++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 2 22345555544 22111 1 134567999999999999999999998864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=197.40 Aligned_cols=142 Identities=19% Similarity=0.235 Sum_probs=113.4
Q ss_pred CCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCC--CCc-ccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecce
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP--DDP-KSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 354 ~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~--~~~-~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
..|...++||+|+||+||++.+.. ..+++|+..... ... ......+++.+|+++|+.++|++|+..+.++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345678999999999999998754 344444432111 111 111223568899999999999999988777777778
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
.++||||++|++|.+++. ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 899999999999999885 346789999999999999999999999999999 6789999999999754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=162.94 Aligned_cols=143 Identities=21% Similarity=0.261 Sum_probs=102.0
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHH-H------------------HHHHHHHHHHHhhcCCCC-
Q 004633 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE-C------------------IKQLEQEIKVLGHLKHEN- 417 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~-~------------------ik~l~~Ei~iL~~L~HPN- 417 (741)
+++.||+|+||+||+|.+. +|+.||||++........... . ......|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999976 789999998864321111110 0 011245666776665433
Q ss_pred -eeeecceeeecceEEEEEeecCCCChhhh-hhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCC
Q 004633 418 -IVQYYGSEVVDDHLYIYLEYVHPGSINRY-VREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG 494 (741)
Q Consensus 418 -IVkl~g~~~~~~~l~LVmEy~~gGsL~~l-I~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g 494 (741)
+.+.++. ...++||||+.|+.+... +... . . ..++..++.+++.++.+||. .||+||||||+|||++ ++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-h-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 3444432 246899999999654422 2221 1 1 16788999999999999999 9999999999999999 99
Q ss_pred cEEEeecccchhccC
Q 004633 495 VVKLADFGMAKHLTG 509 (741)
Q Consensus 495 ~vKL~DFGLA~~~~~ 509 (741)
.++|+|||++.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.3e-17 Score=167.57 Aligned_cols=140 Identities=18% Similarity=0.246 Sum_probs=105.9
Q ss_pred eeEEe-ecCCeEEEEEEECCCCcEEEEEEeecCC-------CC-cccHHHHHHHHHHHHHHhhcCCCCe--eeecceeee
Q 004633 359 GKLIG-RGTFGSVYIGTNRETGASCAIKEVDIIP-------DD-PKSAECIKQLEQEIKVLGHLKHENI--VQYYGSEVV 427 (741)
Q Consensus 359 ~k~LG-~G~fG~Vy~a~~k~tg~~vAVK~i~~~~-------~~-~~~~~~ik~l~~Ei~iL~~L~HPNI--Vkl~g~~~~ 427 (741)
+.+|| .||.|+||.+... +..++||.+.... .+ ........++.+|+.++..|.|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45677 7888888888664 7889999885311 11 0111234568899999999998775 667766443
Q ss_pred cce----EEEEEeecCC-CChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004633 428 DDH----LYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (741)
Q Consensus 428 ~~~----l~LVmEy~~g-GsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFG 502 (741)
+.. .+|||||++| .+|.+++.+ ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 322 3599999997 689888865 2455543 5789999999999999999999999999999999999999
Q ss_pred cchh
Q 004633 503 MAKH 506 (741)
Q Consensus 503 LA~~ 506 (741)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=147.10 Aligned_cols=132 Identities=20% Similarity=0.288 Sum_probs=111.1
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC--CCeeeecceeeecceEEEEE
Q 004633 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H--PNIVkl~g~~~~~~~l~LVm 435 (741)
+.+.||.|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.| .++++++.++...+..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEE
Confidence 45789999999999999754 7899998653211 3467889999999976 58999988888888999999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhC---CeecccCCCcceEecCCCcEEEeecccchh
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST---NTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~---gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
||+.|+.+..+ +......++.+++.+|++||.. +++|+||||+|||++..+.++|+|||++..
T Consensus 73 e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999888765 4456677899999999999985 799999999999999989999999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.1e-16 Score=177.10 Aligned_cols=265 Identities=23% Similarity=0.258 Sum_probs=205.5
Q ss_pred CCCCCCCCeEEeeEEee--cCCeEEEEEEE--CCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeec
Q 004633 348 SASPKKSQWQKGKLIGR--GTFGSVYIGTN--RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYY 422 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~--G~fG~Vy~a~~--k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~ 422 (741)
..+.....+.+.+.+|. |.+|.||.+.. ..++..+|+|.-++....... -.+=.+|+.....++ |+|.|+.+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~---~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD---SKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc---cccccchhhcccccCccccccccC
Confidence 44555667888999999 99999999998 889999999974322221111 122335666666675 99999999
Q ss_pred ceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHH----HHHHHHhCCeecccCCCcceEecCC-CcEE
Q 004633 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN----GLAYLHSTNTIHRDIKGANLLVDAS-GVVK 497 (741)
Q Consensus 423 g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~----aL~yLHs~gIVHRDIKP~NILLd~~-g~vK 497 (741)
..++..+.+||-+|+|. .+|..+....+..+++..++.++.+..+ ||.++|..+|+|-|+||+||++..+ ...+
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence 99999999999999996 8899998887778999999999999999 9999999999999999999999999 8999
Q ss_pred EeecccchhccCccccc------ccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCC--CcH
Q 004633 498 LADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF--EGP 569 (741)
Q Consensus 498 L~DFGLA~~~~~~~~~~------s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~--~~~ 569 (741)
++|||+...+....... ...|...|++||++++ -++.+.|||+||.|+.+..++...+... ...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--------l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--------LATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--------ccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 99999998876544222 2247788999999974 5677999999999999999876654322 111
Q ss_pred HHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCccccccccCCC
Q 004633 570 QAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625 (741)
Q Consensus 570 ~~~~~i~~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~~~~~ 625 (741)
..+.... ...++-...+.++...+..||+.+|..|++++.++.|.+++......+
T Consensus 336 ~~~r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~ 390 (524)
T KOG0601|consen 336 SQLRQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHL 390 (524)
T ss_pred ccccccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcc
Confidence 1111111 111222334667777999999999999999999999999986554443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-16 Score=185.65 Aligned_cols=267 Identities=24% Similarity=0.379 Sum_probs=214.0
Q ss_pred CCCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceE
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
..+.+.+.+-+-+|.++.++.+.-..+|...++|+....+.-.. ...+.+..+-.++-..++|.++.....+......
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~--~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT--NDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhcc--ccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 34567888899999999999999888888888876543222111 1122333344444445678888777667778889
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhcc---
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--- 508 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~--- 508 (741)
+|+|+|+.|++|...++.- ...+++-++.++..+.++++|||...++|||++|.|+|+..+|..++.|||+.....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred chhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999999999775 468888899999999999999999999999999999999999999999998442210
Q ss_pred ---C--------------------------cccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhC
Q 004633 509 ---G--------------------------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 559 (741)
Q Consensus 509 ---~--------------------------~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtG 559 (741)
+ ........||+.|.+||++.+. ..+.++|+|++|++++|.++|
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~-------~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR-------RHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc-------cCCCcchhhhhhhhhhhhhcC
Confidence 0 0112345689999999999853 455689999999999999999
Q ss_pred CCCCCCCCcHHHHHHHhccCCCCC---ccCCHHHHHHHHHhhhcCCCCCCCHH---HHHcCccccccccCCCCCc
Q 004633 560 KPPWSEFEGPQAMFKVLNRTPPIP---EMLSSEGKDFLLRCFLRNPVERPSAV---ELLEHPFIRNANYQNLSVP 628 (741)
Q Consensus 560 k~PF~~~~~~~~~~~i~~~~~~iP---~~ls~el~dLI~~cL~~DP~kRPTa~---ElLqHpwf~~~~~~~~~~~ 628 (741)
.+||......+....|.++..+.| ...+.++++++.++|..++.+|..+. ++-.|+||+..++.++..-
T Consensus 1032 ~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q 1106 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQ 1106 (1205)
T ss_pred CCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccc
Confidence 999999999889888888876655 56889999999999999999999877 9999999999888776543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.6e-14 Score=158.56 Aligned_cols=147 Identities=16% Similarity=0.148 Sum_probs=99.1
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc-----------------------------HHHHH------HH
Q 004633 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS-----------------------------AECIK------QL 403 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~-----------------------------~~~ik------~l 403 (741)
.+.||.|++|.||+|+.+ +|+.||||+.+..-..... .+..+ .+
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999975 6899999997532100000 01111 13
Q ss_pred HHHHHHHhhc----CCCCeeeeccee-eecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHH-HHHHHHhCC
Q 004633 404 EQEIKVLGHL----KHENIVQYYGSE-VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN-GLAYLHSTN 477 (741)
Q Consensus 404 ~~Ei~iL~~L----~HPNIVkl~g~~-~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~-aL~yLHs~g 477 (741)
.+|++.+.++ +|.+-|.+-.++ ...+..+|||||++|++|.++.......+ ....++.+++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 3455555544 232223322222 22445799999999999998875321122 23445666665 478899999
Q ss_pred eecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 478 IVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
++|+|+||.|||++.+|.++|+|||++..+..
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=164.33 Aligned_cols=145 Identities=17% Similarity=0.175 Sum_probs=101.1
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC-----------------------------cccHHHHHHHHH
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-----------------------------PKSAECIKQLEQ 405 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~-----------------------------~~~~~~ik~l~~ 405 (741)
.|.. +.||+|++|.||+|+.+.+|+.||||+++..-.. ....+..+.+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 7899999999999999988999999998632100 001123344555
Q ss_pred HHHHHhhcCCCCeeeecceeee-------------cceEEEEEeecCCCChhhhh--hhcc---ccccHHHHHHHHHHHH
Q 004633 406 EIKVLGHLKHENIVQYYGSEVV-------------DDHLYIYLEYVHPGSINRYV--REHC---RDITESIVRNFTRHIL 467 (741)
Q Consensus 406 Ei~iL~~L~HPNIVkl~g~~~~-------------~~~l~LVmEy~~gGsL~~lI--~~~~---~~lse~~i~~i~~QIl 467 (741)
|+.+++.. .|+.++...|.+ ....+|||||++|+.|.++. ...+ ..+.+..+..++.||+
T Consensus 200 ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 200 ELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred hhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 55555444 244444433332 33456999999999998753 2221 1356666666777765
Q ss_pred HHHHHHHhCCeecccCCCcceEecCCC----cEEEeecccchhccC
Q 004633 468 NGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKHLTG 509 (741)
Q Consensus 468 ~aL~yLHs~gIVHRDIKP~NILLd~~g----~vKL~DFGLA~~~~~ 509 (741)
..|++|+|+||.|||++.+| .++++|||++..+..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999888 999999999876643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.1e-13 Score=152.80 Aligned_cols=183 Identities=22% Similarity=0.355 Sum_probs=139.7
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
|.+ +..+-++.+.+-.|..+.++.+|.|++++.... +....+.+-++-|+.|+||||+++++.++.++.+|||+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEe
Confidence 444 444444444333577788899999998875332 33455677888999999999999999999999999999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHH-hCCeecccCCCcceEecCCCcEEEeecccchhccCccc-c
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH-STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-E 513 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLH-s~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~-~ 513 (741)
|-+. -|..++++ ++...+...+.||+.||.||| +.+++|++|.-.-|+|+..|.+||++|.++....+... .
T Consensus 89 ErV~--Pl~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~ 162 (690)
T KOG1243|consen 89 ERVR--PLETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA 162 (690)
T ss_pred eccc--cHHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc
Confidence 9985 66777755 447788889999999999998 67899999999999999999999999999876554332 1
Q ss_pred cccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhC
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG 559 (741)
Q Consensus 514 ~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtG 559 (741)
....---.|..|+.+.. -+...|.|-|||+++|++.|
T Consensus 163 ~~~~~~~s~~~P~~~~~---------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 163 KSLYLIESFDDPEEIDP---------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccchhhhcccChhhcCc---------cccchhhhhHHHHHHHHhCc
Confidence 11112234667776531 11357999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.8e-13 Score=130.95 Aligned_cols=128 Identities=16% Similarity=0.103 Sum_probs=95.6
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCee-eecceeeecceEEEEEee
Q 004633 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVDDHLYIYLEY 437 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIV-kl~g~~~~~~~l~LVmEy 437 (741)
.+.|+.|.++.||++... +..|++|+...... ....+++|+++++.+.+.+++ +++.. ..+..++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE------LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc------cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEe
Confidence 467899999999999865 78899997642211 112456799999988655543 44443 23345899999
Q ss_pred cCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCe-----ecccCCCcceEecCCCcEEEeecccchh
Q 004633 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 438 ~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gI-----VHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
++|.++... . .....++.+++.+|+.||..++ +|+|++|.|||++ ++.++|+|||.+..
T Consensus 73 i~G~~l~~~--~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTE--D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCccccc--c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 999988753 1 1123467899999999999885 9999999999998 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.3e-14 Score=158.07 Aligned_cols=252 Identities=25% Similarity=0.197 Sum_probs=187.2
Q ss_pred CCCCCeEEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeeeecceeeec
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNR-ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD 428 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~G~fG~Vy~a~~k-~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~ 428 (741)
-...+|.++..||.|.|+.|+.+..+ .++..|++|.+...-. ...+.+ .-..|+-+...| .|.+++.++..|...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhh-cchhhhhHhhHhhcccccCCCCCCcccc
Confidence 34567999999999999999998866 6788899997653211 111111 123456666656 499999999999999
Q ss_pred ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC-CcEEEeecccchhc
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHL 507 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-g~vKL~DFGLA~~~ 507 (741)
+..||-.|||+++++...+.- ...+.+...+.+..|++.++.++|++.++|+|+||.||++..+ +..++.|||++..+
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred ccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 999999999999998877733 2458899999999999999999999999999999999999876 88999999998753
Q ss_pred cCcccccccCCCCCCC-ChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccC
Q 004633 508 TGLSYELSLKGSPNWM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 586 (741)
Q Consensus 508 ~~~~~~~s~~GT~~Y~-APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~l 586 (741)
.- ......+.-+++ ..|++.. +..+..++|+++||.-++|.++|...-.... ....+..+..+.....
T Consensus 418 ~~--~~~~~~~~~r~~p~~~~~~e------~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p~~~~~ 486 (524)
T KOG0601|consen 418 AF--SSGVFHHIDRLYPIAEILLE------DYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTPNLPGL 486 (524)
T ss_pred ce--ecccccccccccccchhhcc------ccccccccccccccccccccccCcccCcccc---cceeeecccccCCCch
Confidence 21 112233344455 3565553 3456779999999999999999875422211 2233333433333334
Q ss_pred CHHHHHHHHHhhhcCCCCCCCHHHHHcCccc
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 587 s~el~dLI~~cL~~DP~kRPTa~ElLqHpwf 617 (741)
..++..+.+.++..++..|+.+.++..|.-|
T Consensus 487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 487 KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 4888899999999999999999999887654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-12 Score=132.99 Aligned_cols=143 Identities=16% Similarity=0.203 Sum_probs=103.7
Q ss_pred eeEEeecCCeEEEEEEECC------CCcEEEEEEeecCCC-----------Cc---------ccH-HHHHHHHHHHHHHh
Q 004633 359 GKLIGRGTFGSVYIGTNRE------TGASCAIKEVDIIPD-----------DP---------KSA-ECIKQLEQEIKVLG 411 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~------tg~~vAVK~i~~~~~-----------~~---------~~~-~~ik~l~~Ei~iL~ 411 (741)
...||.|.-+.||.|.... .+..+|||+++.... +. ... ......++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 357899999863221 10 001 11123458999999
Q ss_pred hcCC--CCeeeecceeeecceEEEEEeecCCCChhh-hhhhccccccHHHHHHHHHHHHHHHHHH-HhCCeecccCCCcc
Q 004633 412 HLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINR-YVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGAN 487 (741)
Q Consensus 412 ~L~H--PNIVkl~g~~~~~~~l~LVmEy~~gGsL~~-lI~~~~~~lse~~i~~i~~QIl~aL~yL-Hs~gIVHRDIKP~N 487 (741)
+|.- -++.+.+++ ..-+|||||+.++.+.. .+++ ..+++.++..++.|++.+|..| |+.||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9853 455566643 46789999998765432 2322 2356667788899999999999 89999999999999
Q ss_pred eEecCCCcEEEeecccchhcc
Q 004633 488 LLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 488 ILLd~~g~vKL~DFGLA~~~~ 508 (741)
||++ +|.+.|+|||.+....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9996 5789999999886553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.7e-13 Score=141.00 Aligned_cols=240 Identities=20% Similarity=0.324 Sum_probs=156.5
Q ss_pred EEEEEEECCCCcEEEEEEeecC--CCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecc-----eEEEEEeecCCC
Q 004633 369 SVYIGTNRETGASCAIKEVDII--PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-----HLYIYLEYVHPG 441 (741)
Q Consensus 369 ~Vy~a~~k~tg~~vAVK~i~~~--~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-----~l~LVmEy~~gG 441 (741)
.||++.+.+.|..|+.-.+... ++...+.+.++. -..-|-++-|.|||+++.++.+.. ...+++||+.-|
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~---vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssg 157 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRA---VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSG 157 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHH---HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccch
Confidence 4677777776666554333210 111111222222 223344567999999999886654 488999999999
Q ss_pred Chhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHhC--CeecccCCCcceEecCCCcEEEeecccchh---cc-Cc-c
Q 004633 442 SINRYVREH---CRDITESIVRNFTRHILNGLAYLHST--NTIHRDIKGANLLVDASGVVKLADFGMAKH---LT-GL-S 511 (741)
Q Consensus 442 sL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs~--gIVHRDIKP~NILLd~~g~vKL~DFGLA~~---~~-~~-~ 511 (741)
+|..+|++. ...+.....++|+.||+.||.|||+. -|+|+.+..+-|++..+|-+||+--.-... +. .. .
T Consensus 158 s~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~ 237 (458)
T KOG1266|consen 158 SLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREA 237 (458)
T ss_pred hHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHh
Confidence 999999763 35688899999999999999999975 699999999999999999888852111100 00 00 0
Q ss_pred cccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCC-CcHHHHHHHhccCCCCCccCCHHH
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVLNRTPPIPEMLSSEG 590 (741)
Q Consensus 512 ~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~-~~~~~~~~i~~~~~~iP~~ls~el 590 (741)
......+-++|.|||.=. ....+-++|||++|....||..|..--... ...+....+.+....+. ..--
T Consensus 238 Ek~~~~~~~g~~a~~sg~-------~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le---n~lq 307 (458)
T KOG1266|consen 238 EKSVNTSLPGFSAPESGT-------TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE---NGLQ 307 (458)
T ss_pred hhhccccCCccccCCcCc-------ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc---Cccc
Confidence 111123678899998522 234456899999999999998876532211 11111111111111111 1223
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHcCccccccc
Q 004633 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 591 ~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~~ 621 (741)
+++|.+||.-.|..||++.++|.||..-+..
T Consensus 308 r~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 308 RGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred cCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 5789999999999999999999999875543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.2e-11 Score=120.93 Aligned_cols=141 Identities=18% Similarity=0.198 Sum_probs=106.2
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC--CCeeeecceeeec---ceEEE
Q 004633 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVD---DHLYI 433 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H--PNIVkl~g~~~~~---~~l~L 433 (741)
.+.||.|.++.||++.... |..+++|+....... .....+.+|+++++.+.+ .++.+++.+.... +..++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~----~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL----PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC----cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 3678999999999998754 688999976432111 123467889999999975 3456666655543 36789
Q ss_pred EEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-------------------------------------- 475 (741)
Q Consensus 434 VmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-------------------------------------- 475 (741)
||||++|.+|...+.. ..+++.+...++.+++.+|.+||+
T Consensus 78 v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 78 VMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred EEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9999999998886642 346777777888888888888873
Q ss_pred ------------------CCeecccCCCcceEecC--CCcEEEeecccchh
Q 004633 476 ------------------TNTIHRDIKGANLLVDA--SGVVKLADFGMAKH 506 (741)
Q Consensus 476 ------------------~gIVHRDIKP~NILLd~--~g~vKL~DFGLA~~ 506 (741)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 67789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.5e-10 Score=113.87 Aligned_cols=147 Identities=22% Similarity=0.269 Sum_probs=110.1
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCC-CC--cccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEE
Q 004633 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DD--PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~-~~--~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LV 434 (741)
.+.+|-+|+-+.|+++.+. |+.+.||.-.... .. ....-..++..+|+++|.++.--.|.--.=+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5778899999999999764 7888888532111 11 11222346788899999998754554443346667777899
Q ss_pred EeecCC-CChhhhhhhccccccHHHH-HHHHHHHHHHHHHHHhCCeecccCCCcceEecCCC---cEEEeecccchh
Q 004633 435 LEYVHP-GSINRYVREHCRDITESIV-RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKH 506 (741)
Q Consensus 435 mEy~~g-GsL~~lI~~~~~~lse~~i-~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g---~vKL~DFGLA~~ 506 (741)
|||++| -++.+++......-.++.. ..++++|-+.|.-||.++|+|+||..+||||..+| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4788888776444444444 78999999999999999999999999999997665 358999999853
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.2e-11 Score=137.76 Aligned_cols=194 Identities=23% Similarity=0.321 Sum_probs=138.7
Q ss_pred HHHHHHHHHHh-CCeecccCCCcceEecCCCcEEEeecccchhccCccc-cc---------ccCCCCCCCChHHHHHhhh
Q 004633 465 HILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY-EL---------SLKGSPNWMAPEVIKAVMQ 533 (741)
Q Consensus 465 QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~-~~---------s~~GT~~Y~APEvl~~~~~ 533 (741)
+++.||.|+|. .++||+.|.|++|.++..|.+||+.|+.+....+... .. -..-...|.|||++.+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--- 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--- 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc---
Confidence 34489999995 5999999999999999999999999999866554211 11 1123567999999874
Q ss_pred cCCCCCCCccchhhhHHHHHHHHh-hCCCCCCCCCcHHHHHHHhc----cCCCCCccCCHHHHHHHHHhhhcCCCCCCCH
Q 004633 534 KDGNPKLALAVDIWSLGCTVIEML-TGKPPWSEFEGPQAMFKVLN----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSA 608 (741)
Q Consensus 534 ~~g~~~~s~asDVWSLGvVLyELL-tGk~PF~~~~~~~~~~~i~~----~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa 608 (741)
...+.++|+|||||++|-+. .|+..+.............+ ....+...++.++++-|.++|..+...||++
T Consensus 184 ----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 ----TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ----ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 45667999999999999998 57766665543332222111 2234557899999999999999999999999
Q ss_pred HHHHcCccccccccCCCCCcccccccccCCCCChhHHHHHhhhcCCCCCCchhhhccCCCCC
Q 004633 609 VELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPC 670 (741)
Q Consensus 609 ~ElLqHpwf~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~k~e~lp~~p~~~~r~r~lp~ 670 (741)
.+++..+||.+.....+.....+.. ....+..+-.......++..|..-+.++-+|+
T Consensus 260 ~~l~~~~ff~D~~~~aLrfLD~l~~-----kdn~qKs~Flk~Ls~~ip~fp~rv~~~kiLP~ 316 (700)
T KOG2137|consen 260 DLLLSIPFFSDPGLKALRFLDDLPQ-----KDNSQKSSFLKGLSKLIPTFPARVLFQKILPT 316 (700)
T ss_pred hhhhcccccCCchhhhhhhcccccc-----cCcHHHHHHHHHHHHhhccCCHHHHHHhhhhH
Confidence 9999999998876555444333222 22233333344455667777777777776664
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.6e-10 Score=113.04 Aligned_cols=135 Identities=19% Similarity=0.329 Sum_probs=99.5
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCC--Cc-ccH-HHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEE
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--DP-KSA-ECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL 435 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~--~~-~~~-~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVm 435 (741)
..+++|+-+.||.+... |..+++|. ++.+. .+ ... -...+-.+|+++|.+++--.|.--+=++.+.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~-Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKE-RIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEe-ecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 46789999999999664 44566664 22221 11 111 12345678999999987555544444456777788999
Q ss_pred eecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 436 EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 436 Ey~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
||++|..|.+++... ...+++.+-.-+.-||..||||+||.++||++..++ +.++||||+..
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999888664 146777888888999999999999999999997655 99999999863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.5e-09 Score=116.62 Aligned_cols=213 Identities=15% Similarity=0.176 Sum_probs=155.4
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeee----cceEEEEEeecCC-
Q 004633 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYLEYVHP- 440 (741)
Q Consensus 366 ~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~----~~~l~LVmEy~~g- 440 (741)
--.+.|+|....+|..|++|.+...+..... ....-+++++++.|.|||++.++|.. +..+++|++|.++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN-----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc-----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 3457899999999999999988533322111 12235778999999999999999874 3468999999886
Q ss_pred CChhhhhhh--------------ccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 441 GSINRYVRE--------------HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 441 GsL~~lI~~--------------~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
++|.++.-. .+...+|..+|.|+.||..||.++|+.|+.-+-|.+.+||++.+-.++|...|+...
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence 566665411 234588999999999999999999999999999999999999888888887777655
Q ss_pred ccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCC-CCCCCcHHH-HHHHhccCCCCCc
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQA-MFKVLNRTPPIPE 584 (741)
Q Consensus 507 ~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~P-F~~~~~~~~-~~~i~~~~~~iP~ 584 (741)
+..+. . |.+.+. .+-|.=.||.++..|.+|..- |......+. +. .+-.
T Consensus 443 l~~d~-----------~--~~le~~----------Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~-------~I~~ 492 (655)
T KOG3741|consen 443 LQEDP-----------T--EPLESQ----------QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT-------RITT 492 (655)
T ss_pred ecCCC-----------C--cchhHH----------hhhhHHHHHHHHHHHhhcccccccccchHHHHHH-------Hhhh
Confidence 54332 0 112211 146889999999999999532 111111111 11 2334
Q ss_pred cCCHHHHHHHHHhhhcCCCCCCCHHHHHcC
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 585 ~ls~el~dLI~~cL~~DP~kRPTa~ElLqH 614 (741)
.++.+++++|.-+...++++ -++.+++.+
T Consensus 493 ~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 493 TYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 58899999999999999887 677787765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.4e-09 Score=109.85 Aligned_cols=131 Identities=22% Similarity=0.291 Sum_probs=86.2
Q ss_pred EEEEEEECCCCcEEEEEEeecCCCC---------------------cccHHHHHHHHHHHHHHhhcCCC--Ceeeeccee
Q 004633 369 SVYIGTNRETGASCAIKEVDIIPDD---------------------PKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSE 425 (741)
Q Consensus 369 ~Vy~a~~k~tg~~vAVK~i~~~~~~---------------------~~~~~~ik~l~~Ei~iL~~L~HP--NIVkl~g~~ 425 (741)
.||.|... +|..+|||+.+..... ..........++|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999864 5789999998532110 11122345678999999999754 456666432
Q ss_pred eecceEEEEEeecC--CCChhhhhhhccccccHHHHHHHHHHHHHHHHH-HHhCCeecccCCCcceEecCCCcEEEeecc
Q 004633 426 VVDDHLYIYLEYVH--PGSINRYVREHCRDITESIVRNFTRHILNGLAY-LHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (741)
Q Consensus 426 ~~~~~l~LVmEy~~--gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~y-LHs~gIVHRDIKP~NILLd~~g~vKL~DFG 502 (741)
.-+|||||++ |..+..+... .++..+...++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred ----CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 3479999999 6556554322 23356677888888886655 579999999999999999877 89999999
Q ss_pred cchhcc
Q 004633 503 MAKHLT 508 (741)
Q Consensus 503 LA~~~~ 508 (741)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1e-08 Score=108.97 Aligned_cols=140 Identities=14% Similarity=0.114 Sum_probs=96.8
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHH----------HHHHHHHHHhhcCCCCe--eeecceeee
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK----------QLEQEIKVLGHLKHENI--VQYYGSEVV 427 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik----------~l~~Ei~iL~~L~HPNI--Vkl~g~~~~ 427 (741)
+++-+.....|+++.. .|+.|.||...... ..+..+ .+.+|+..+..|..-+| ...+++.+.
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~----~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~ 101 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTG----WGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGER 101 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCc----HHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEe
Confidence 4444444444666543 46788899653211 011111 36788888888743222 333333332
Q ss_pred -----cceEEEEEeecCCC-Chhhhhhhc-cccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecC-------C
Q 004633 428 -----DDHLYIYLEYVHPG-SINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-------S 493 (741)
Q Consensus 428 -----~~~l~LVmEy~~gG-sL~~lI~~~-~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~-------~ 493 (741)
...-+||||++++. +|.+++.+. .....+.....++.+|+..+.-||+.||+|+|+++.||||+. +
T Consensus 102 ~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 102 GSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCC
Confidence 23578999999986 798888542 234566778899999999999999999999999999999975 4
Q ss_pred CcEEEeecccch
Q 004633 494 GVVKLADFGMAK 505 (741)
Q Consensus 494 g~vKL~DFGLA~ 505 (741)
+.+.|+||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999885
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.8e-08 Score=106.23 Aligned_cols=140 Identities=19% Similarity=0.209 Sum_probs=104.1
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC--------------Cc---ccHHHHHHHHHHHHHHhhcCCC--
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD--------------DP---KSAECIKQLEQEIKVLGHLKHE-- 416 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~--------------~~---~~~~~ik~l~~Ei~iL~~L~HP-- 416 (741)
+.++..||.|.-+.||.|.+. .|.++|||.=+.-.. .. .........++|.++|++|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567899999999999999976 589999996432110 00 1112234567899999999644
Q ss_pred CeeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcE
Q 004633 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496 (741)
Q Consensus 417 NIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~v 496 (741)
.|.+.++ .+.-.+||||++|-.|...- +..+.+..++..|++-+.-+-..||||+|+..-|||++++|.+
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 6666665 34678999999997776543 2344555666777777766669999999999999999999999
Q ss_pred EEeecccchh
Q 004633 497 KLADFGMAKH 506 (741)
Q Consensus 497 KL~DFGLA~~ 506 (741)
.|+||--+..
T Consensus 242 ~vIDwPQ~v~ 251 (304)
T COG0478 242 VVIDWPQAVP 251 (304)
T ss_pred EEEeCccccc
Confidence 9999976543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.1e-08 Score=100.08 Aligned_cols=105 Identities=18% Similarity=0.241 Sum_probs=82.3
Q ss_pred HHHHHHHHHHhhcCCC--Ceeeecceeeec----ceEEEEEeecCCC-ChhhhhhhccccccHHHHHHHHHHHHHHHHHH
Q 004633 401 KQLEQEIKVLGHLKHE--NIVQYYGSEVVD----DHLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYL 473 (741)
Q Consensus 401 k~l~~Ei~iL~~L~HP--NIVkl~g~~~~~----~~l~LVmEy~~gG-sL~~lI~~~~~~lse~~i~~i~~QIl~aL~yL 473 (741)
.+..+|...+..|..- .+.+.+++.+.. ...+||||++++. +|.+++..... ++......++.+++..+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 3567788887777432 234444444432 2468999999984 79999876422 67778889999999999999
Q ss_pred HhCCeecccCCCcceEecCCC---cEEEeecccchh
Q 004633 474 HSTNTIHRDIKGANLLVDASG---VVKLADFGMAKH 506 (741)
Q Consensus 474 Hs~gIVHRDIKP~NILLd~~g---~vKL~DFGLA~~ 506 (741)
|++||+|+|+++.||||+.++ .+.|+||+.++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.5e-07 Score=101.96 Aligned_cols=239 Identities=18% Similarity=0.225 Sum_probs=153.2
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhc-CCCCeee--------ecceeeec
Q 004633 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ--------YYGSEVVD 428 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVk--------l~g~~~~~ 428 (741)
.+..||+|+-+.+|-.-.- +. .+.|++..-+.. ... +.+..|... .||-+-. ++|-- ..
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa-~~a-------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~ 82 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPA-AQA-------QKVAELAATPDAPLLNYRVAWPQATLHGGR-RG 82 (637)
T ss_pred CCccccCCccceeeecchh--hc-hhheeecCCCch-HHH-------HHHHHhccCCCCcchhhhhcccHHHhhCCC-cc
Confidence 4678999999999965322 22 344666532221 111 122333333 4654332 22211 12
Q ss_pred ceEEEEEeecCCCC-hhhhh-----hhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecc
Q 004633 429 DHLYIYLEYVHPGS-INRYV-----REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (741)
Q Consensus 429 ~~l~LVmEy~~gGs-L~~lI-----~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFG 502 (741)
..+-+.|..+.|.. +.+++ ++.+....+..+.+..+.|+.+.+-||+.|.+-+|+.++|||+.+++.|.|+|=.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence 23778888888753 33333 2234557889999999999999999999999999999999999999999999855
Q ss_pred cchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhC-CCCCCCCCcH-----HHHHHHh
Q 004633 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGP-----QAMFKVL 576 (741)
Q Consensus 503 LA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtG-k~PF~~~~~~-----~~~~~i~ 576 (741)
.-............+|...|.+||.-.-. ... +..-+...|.|.||+++++||.| +.||.+.... .....|.
T Consensus 163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~-sf~-g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 163 SFQINANGTLHLCPVGVSEFTPPELQTLP-SFV-GFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred ceeeccCCceEecccCccccCCHHHhccc-ccc-ccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 43333333444456799999999975411 111 12335578999999999999986 9999764211 0111111
Q ss_pred c---------c--CCC----CC-ccCCHHHHHHHHHhhhc--CCCCCCCHHH
Q 004633 577 N---------R--TPP----IP-EMLSSEGKDFLLRCFLR--NPVERPSAVE 610 (741)
Q Consensus 577 ~---------~--~~~----iP-~~ls~el~dLI~~cL~~--DP~kRPTa~E 610 (741)
. + ..+ +| ..+++++..|..+|+.. ++.-|||++.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1 1 111 11 35789999999999984 4678999763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.3e-09 Score=120.36 Aligned_cols=239 Identities=23% Similarity=0.211 Sum_probs=171.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC-eeeecceeeecceEEE
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDHLYI 433 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPN-IVkl~g~~~~~~~l~L 433 (741)
-|....-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++.+..++..++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 3556678899999999999877665544 6655421 22445889999999999 8888888888999999
Q ss_pred EEeecCCC-ChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEEeecccchhccCccc
Q 004633 434 YLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 434 VmEy~~gG-sL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~~~~ 512 (741)
+|+|+.+| +-...+......+.+-+...+.+.-+++|+|||+.-=+||| |||..+ +.+|+.||+....+.....
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~ 386 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK 386 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccc
Confidence 99999988 32222211123456667777888889999999998889999 887755 7899999999988776655
Q ss_pred ccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCc-----cCC
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE-----MLS 587 (741)
Q Consensus 513 ~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~-----~ls 587 (741)
..+..+|+.|+|||+..+ ..+....|+|++|.-..+|--|.+|-... ......+-++ +..+. .++
T Consensus 387 ~~t~~~~~~~~~pev~~~-------~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~-p~s~~L~~~~aw~ 456 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQE-------NTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNG-PNSPMLTDKSAWS 456 (829)
T ss_pred cccCCCCCCCCCchhhcc-------cccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCC-CCccccchhhhcC
Confidence 667889999999998873 45667899999999888888887765331 1111111000 00110 111
Q ss_pred H-HHHHHHHHhhhcCCCCCCCHHHHHcCccccc
Q 004633 588 S-EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 588 ~-el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~ 619 (741)
. .-.++...|+..-|..|+....++.|.+|..
T Consensus 457 ~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 457 PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 1 1124777889999999999999998888754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.1e-07 Score=107.08 Aligned_cols=142 Identities=20% Similarity=0.218 Sum_probs=92.2
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCC----------------------C-------cccHHHHHHHH------
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD----------------------D-------PKSAECIKQLE------ 404 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~----------------------~-------~~~~~~ik~l~------ 404 (741)
+-|+.++-|.||+|+.+. |+.||||+.+..-. . ..-.+..+.+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678999999999999876 99999998742110 0 00112222222
Q ss_pred HHHHHHhhcC-----CCCeeeecceeeecceEEEEEeecCCCChhhhhhhcccccc-----HHHHHHHHHHHHHHHHHHH
Q 004633 405 QEIKVLGHLK-----HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT-----ESIVRNFTRHILNGLAYLH 474 (741)
Q Consensus 405 ~Ei~iL~~L~-----HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~ls-----e~~i~~i~~QIl~aL~yLH 474 (741)
+|...+.+++ .++|.--.-+++..+.-.|+|||++|-.+.++..-....++ +..+..++.|+ =
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~-------~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQL-------L 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 3444444442 23332222223345667899999999999888532223344 33333334443 3
Q ss_pred hCCeecccCCCcceEecCCCcEEEeecccchhccC
Q 004633 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 475 s~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~~~ 509 (741)
..|++|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 48999999999999999999999999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.54 E-value=1e-06 Score=88.41 Aligned_cols=139 Identities=19% Similarity=0.310 Sum_probs=82.7
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC--Ceeeecceee---ecceEEE
Q 004633 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSEV---VDDHLYI 433 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HP--NIVkl~g~~~---~~~~l~L 433 (741)
++.|+.|..+.||++.... ..+++|+... ......+.+|+.+++.|... .+.+++.... .....++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~-------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~ 72 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP-------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL 72 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESS-------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCC-------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence 5789999999999998765 4899997542 13456788899999888532 3456665332 3345799
Q ss_pred EEeecCCCChhh----------------hhhh---c---cccccH------HHHHHH---------------HHHHHH-H
Q 004633 434 YLEYVHPGSINR----------------YVRE---H---CRDITE------SIVRNF---------------TRHILN-G 469 (741)
Q Consensus 434 VmEy~~gGsL~~----------------lI~~---~---~~~lse------~~i~~i---------------~~QIl~-a 469 (741)
+|++++|..+.. .+.+ . ...+.. .....+ ...+.. .
T Consensus 73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (239)
T PF01636_consen 73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL 152 (239)
T ss_dssp EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence 999999988777 1111 0 000000 000000 111222 3
Q ss_pred HHHHH-------hCCeecccCCCcceEec-CCCcEEEeecccchh
Q 004633 470 LAYLH-------STNTIHRDIKGANLLVD-ASGVVKLADFGMAKH 506 (741)
Q Consensus 470 L~yLH-------s~gIVHRDIKP~NILLd-~~g~vKL~DFGLA~~ 506 (741)
+..++ ...++|+|+.+.|||++ .++.+-|+||+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33333 24599999999999999 667778999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=7e-07 Score=91.84 Aligned_cols=143 Identities=14% Similarity=0.158 Sum_probs=99.4
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeec-CCCCcccHHHHHHHHHHHHHHhhcCCC--Ceeeecceeee----cceEEEE
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGSEVV----DDHLYIY 434 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~-~~~~~~~~~~ik~l~~Ei~iL~~L~HP--NIVkl~g~~~~----~~~l~LV 434 (741)
-|+||.+.|+..... |+.+-+|.-.. .........-...+.+|+..|+.|..- .+.+....... .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 467899999987654 34677786531 110000011124678899999888532 24444421111 1247899
Q ss_pred EeecCC-CChhhhhhhcc-ccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCc--EEEeecccchh
Q 004633 435 LEYVHP-GSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKH 506 (741)
Q Consensus 435 mEy~~g-GsL~~lI~~~~-~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~--vKL~DFGLA~~ 506 (741)
+|-+.| -+|.+++.+.. ...++.....++.+|+..|.-||+.|+.|+|+-+.|||++.+|. |+++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997765 57888875532 34677778899999999999999999999999999999987777 99999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.2e-06 Score=90.73 Aligned_cols=135 Identities=15% Similarity=0.185 Sum_probs=82.3
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC--eeeecceeeecceEEEEEee
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN--IVQYYGSEVVDDHLYIYLEY 437 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPN--IVkl~g~~~~~~~l~LVmEy 437 (741)
..||.|..+.||+. .|..+++|.... . ... ..+.+|.++|+.+..-+ +.+.+++....+...+|||+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~---~-~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~ 75 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNP---G-FDK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYEL 75 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCC---C-CCH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeee
Confidence 57899999999984 255677886542 1 111 34678999998886433 45667766777788999999
Q ss_pred cCCCC-hhhhh--------------hh-----cc---ccccHHH-HHHHHHH----------HHH-HHHHHH----hCCe
Q 004633 438 VHPGS-INRYV--------------RE-----HC---RDITESI-VRNFTRH----------ILN-GLAYLH----STNT 478 (741)
Q Consensus 438 ~~gGs-L~~lI--------------~~-----~~---~~lse~~-i~~i~~Q----------Il~-aL~yLH----s~gI 478 (741)
++|.+ +...+ .+ +. ....... ...+..+ +.. ...+|. ...+
T Consensus 76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 99864 11111 00 00 0011000 0011101 111 122222 1247
Q ss_pred ecccCCCcceEecCCCcEEEeecccchh
Q 004633 479 IHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 479 VHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
+|+|+.|.||++++++ +.|+||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.7e-06 Score=86.99 Aligned_cols=140 Identities=16% Similarity=0.229 Sum_probs=87.9
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHH------HHHHHHHHhhcCC---CCeeeecc
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ------LEQEIKVLGHLKH---ENIVQYYG 423 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~------l~~Ei~iL~~L~H---PNIVkl~g 423 (741)
..+|.+.+++-......|.+.. -+|+.+++|..+.... .....+.. ..+++..+..+.- -.+..++-
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~--r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENR--RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhh--hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3567777777777766666554 4578899997642111 11111111 2234444444432 22223222
Q ss_pred eee-----ecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCcEEE
Q 004633 424 SEV-----VDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKL 498 (741)
Q Consensus 424 ~~~-----~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~vKL 498 (741)
+.+ .-...+|+|||++|..|.++.. +.+ .+...|.++|.-||+.|++|+|++|.|++++.++ +++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~i 175 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRI 175 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEE
Confidence 222 2234678999999998877642 333 2445677889999999999999999999998555 999
Q ss_pred eecccchh
Q 004633 499 ADFGMAKH 506 (741)
Q Consensus 499 ~DFGLA~~ 506 (741)
+||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.7e-06 Score=89.15 Aligned_cols=141 Identities=14% Similarity=0.174 Sum_probs=97.0
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcc-------------------cHHHHHHHHHHHHHHhhcC--CCCe
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-------------------SAECIKQLEQEIKVLGHLK--HENI 418 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~-------------------~~~~ik~l~~Ei~iL~~L~--HPNI 418 (741)
..|..|.-+.||+|.. .++..+|+|+++....... .........+|+.-|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677777889999975 4588999999864322111 1112234567888787774 4444
Q ss_pred eeecceeeecceEEEEEeecCCC-ChhhhhhhccccccHHHHHHHHHHHHHHHHHHHh-CCeecccCCCcceEecCCCcE
Q 004633 419 VQYYGSEVVDDHLYIYLEYVHPG-SINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVV 496 (741)
Q Consensus 419 Vkl~g~~~~~~~l~LVmEy~~gG-sL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs-~gIVHRDIKP~NILLd~~g~v 496 (741)
.+-+.+. .-.|||||+... .-.-.|++ ..+...++..+..++++.|.-|-. .|+||+||..-|||+. +|.+
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 4444432 457999999644 11222222 223444788889999999988876 8999999999999998 8899
Q ss_pred EEeecccchhcc
Q 004633 497 KLADFGMAKHLT 508 (741)
Q Consensus 497 KL~DFGLA~~~~ 508 (741)
.|||||-|....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999886554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2e-06 Score=104.42 Aligned_cols=207 Identities=27% Similarity=0.358 Sum_probs=151.7
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeecceeeecce----EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHH
Q 004633 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474 (741)
Q Consensus 399 ~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~----l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLH 474 (741)
.+...+.|+..+..+.|+|++.++.+...+.. +.+..|||.+.++...+... ..++...++.+..++++||.|+|
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHH
Confidence 34556678888889999999999987655433 34556889999999988665 66899999999999999999999
Q ss_pred hCCeecccCCCc---ceEecCCCcEEEe--ecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhH
Q 004633 475 STNTIHRDIKGA---NLLVDASGVVKLA--DFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 549 (741)
Q Consensus 475 s~gIVHRDIKP~---NILLd~~g~vKL~--DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSL 549 (741)
+....|.-|--. +-.++.++.+.+. ||+..+.+..........-...|.++|.+... ........|+|.+
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~-----~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN-----TAKKSRLTDLWCL 378 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccc-----cchhhhhhHHHHH
Confidence 986655555444 4445566777777 99998887776666666677788888877531 1223345799999
Q ss_pred HHHHHHHhhCCCCCCCCCcHHHHHHHhccCCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 550 GCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 550 GvVLyELLtGk~PF~~~~~~~~~~~i~~~~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
|..+..+..|..+-... ......+ +........+++.+|+..+.++|+++.+++.|+|.+..
T Consensus 379 gll~~~~~~~~~i~~~~---~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKS---AVPVSLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HHHHhhhhhcCcccccc---cchhhhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 99999999876432111 1111111 11122277889999999999999999999999998643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=3.1e-06 Score=97.59 Aligned_cols=145 Identities=20% Similarity=0.179 Sum_probs=91.7
Q ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeecCCCC--------------------------cccHHHHHHHHHHHHHH---
Q 004633 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--------------------------PKSAECIKQLEQEIKVL--- 410 (741)
Q Consensus 360 k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~--------------------------~~~~~~ik~l~~Ei~iL--- 410 (741)
+-||.-+.|.||+|+.+. |+.||||+-+..-.+ ....+..+.+..|+..+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578999999999999887 999999986321100 01112223333333332
Q ss_pred -------hhcCCCC------eeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCC
Q 004633 411 -------GHLKHEN------IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477 (741)
Q Consensus 411 -------~~L~HPN------IVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~g 477 (741)
+.+.|-+ |.++| +.....-.|+||||+|..+.++-.-....++...+..-+.++..-+ |=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcC
Confidence 2223444 33343 2234567899999999988776432223466555444433332222 23568
Q ss_pred eecccCCCcceEecC----CCcEEEeecccchhccC
Q 004633 478 TIHRDIKGANLLVDA----SGVVKLADFGMAKHLTG 509 (741)
Q Consensus 478 IVHRDIKP~NILLd~----~g~vKL~DFGLA~~~~~ 509 (741)
++|.|-+|.||+++. ++.+.|.|||+...+..
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999983 67899999999877654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=6.4e-06 Score=85.25 Aligned_cols=135 Identities=16% Similarity=0.120 Sum_probs=81.9
Q ss_pred EEeecCC-eEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCeeeecceeeecceEEEEEeec
Q 004633 361 LIGRGTF-GSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYV 438 (741)
Q Consensus 361 ~LG~G~f-G~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~LVmEy~ 438 (741)
.|-.|.+ ..||++... +..+.||+..... ...+.+|+++++.+. +--+.+++++...++..++|||++
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 74 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV 74 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence 4455655 789998653 4678888654211 234667999988884 444557777776667789999999
Q ss_pred CCCChhhhhh----------------h-ccc-----cccHH---HHHHH---HH----------------HHHHHHHHH-
Q 004633 439 HPGSINRYVR----------------E-HCR-----DITES---IVRNF---TR----------------HILNGLAYL- 473 (741)
Q Consensus 439 ~gGsL~~lI~----------------~-~~~-----~lse~---~i~~i---~~----------------QIl~aL~yL- 473 (741)
+|..|..... + +.. .+... ..... +. .+...+..|
T Consensus 75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 154 (244)
T cd05150 75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE 154 (244)
T ss_pred CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence 9987664320 0 000 00000 00000 00 011112222
Q ss_pred ------HhCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 474 ------HSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 474 ------Hs~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12348999999999999998888999999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.9e-05 Score=96.40 Aligned_cols=145 Identities=16% Similarity=0.258 Sum_probs=89.1
Q ss_pred EeeEEeecCCeEEEEEEECCCC--cEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-CCCe--eeecceeeec---c
Q 004633 358 KGKLIGRGTFGSVYIGTNRETG--ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI--VQYYGSEVVD---D 429 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~tg--~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNI--Vkl~g~~~~~---~ 429 (741)
..+.|+.|.+..+|+......+ ..+++|+...... .. ....+.+|+++|+.|. |.+| .+++.++.+. +
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G 117 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG 117 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-Cc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC
Confidence 3577899999999998765432 3567775421110 01 1235778999999995 6654 6777666553 4
Q ss_pred eEEEEEeecCCCChhhh--------------------h---hhcc-c-----------cccHHHHHHHHHH---------
Q 004633 430 HLYIYLEYVHPGSINRY--------------------V---REHC-R-----------DITESIVRNFTRH--------- 465 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~l--------------------I---~~~~-~-----------~lse~~i~~i~~Q--------- 465 (741)
..|+||||++|..+.+. + +... . ..-+.++..|..|
T Consensus 118 ~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~ 197 (822)
T PLN02876 118 TAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGK 197 (822)
T ss_pred CceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccC
Confidence 67899999998654321 1 0000 0 0111233333222
Q ss_pred ------HHHHHHHHHh-----------CCeecccCCCcceEecCC--CcEEEeecccchh
Q 004633 466 ------ILNGLAYLHS-----------TNTIHRDIKGANLLVDAS--GVVKLADFGMAKH 506 (741)
Q Consensus 466 ------Il~aL~yLHs-----------~gIVHRDIKP~NILLd~~--g~vKL~DFGLA~~ 506 (741)
+...+.+|.. ..+||+|+++.|||++.+ ..+-|+||+++..
T Consensus 198 ~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 198 PPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2233556632 259999999999999753 3467999999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.4e-07 Score=110.18 Aligned_cols=211 Identities=18% Similarity=0.082 Sum_probs=150.6
Q ss_pred HHHHHHHHHHhhcCCCCeeeecceee--ecceEEEEEeecCCCChhhhhhhc---cccccHHHHHHHHHHHHHHHHHHHh
Q 004633 401 KQLEQEIKVLGHLKHENIVQYYGSEV--VDDHLYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHS 475 (741)
Q Consensus 401 k~l~~Ei~iL~~L~HPNIVkl~g~~~--~~~~l~LVmEy~~gGsL~~lI~~~---~~~lse~~i~~i~~QIl~aL~yLHs 475 (741)
+.+..|...++...|++++..+.-.. .....|++++|+.+|.++..|-+. ...+.+.-+.....+.+.+..-+|.
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33445555666778999988776443 234689999999999999999653 2345555666666666888888885
Q ss_pred C-----CeecccCCCcceEecCCCcEEEeecccchhc-cCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhH
Q 004633 476 T-----NTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 549 (741)
Q Consensus 476 ~-----gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~-~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSL 549 (741)
. -.+|++||+-|.+|..+..+|++++|+.+.. ..........+++.|+.+++.... .++.++|+|..
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~i-------k~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEI-------KFTKRSDILRR 1426 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHH-------hhhhHHHHHHH
Confidence 4 2789999999999999999999999999933 333444456789999999998753 34556999999
Q ss_pred HHHHHHHhhCCCCCCCCCcHHHHHHHhcc-CCCCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccc
Q 004633 550 GCTVIEMLTGKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 550 GvVLyELLtGk~PF~~~~~~~~~~~i~~~-~~~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~ 618 (741)
|+-+|++..|..+|....+......+.++ ...++...+.++-.....+|-..-..||.-...+..+.|.
T Consensus 1427 s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 99999999998877543333222222222 2244555566666666666776677888888877766653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.1e-05 Score=81.25 Aligned_cols=31 Identities=29% Similarity=0.389 Sum_probs=26.5
Q ss_pred CCeecccCCCcceEecCCCcEEEeecccchh
Q 004633 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 476 ~gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
.+++|+|+.+.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998776678999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=4.4e-05 Score=76.60 Aligned_cols=134 Identities=23% Similarity=0.284 Sum_probs=93.6
Q ss_pred CCCeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCee-eecceeeecceE
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVDDHL 431 (741)
Q Consensus 353 ~~~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIV-kl~g~~~~~~~l 431 (741)
....+..+.||+|++|.||++.++ |..+|+|+-+. +. -...++.|+++|..+.--++- ++|.+. ..
T Consensus 21 ~~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~---ds----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~ 87 (201)
T COG2112 21 KYELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR---DS----PRRNLEKEAKILEILAGEGVTPEVYFYG----ED 87 (201)
T ss_pred chhhhhhhhhhcccccEEEEeecc--CceEEEEEecC---Cc----chhhHHHHHHHHHHhhhcCCCceEEEec----hh
Confidence 344566789999999999999876 56899996542 11 125688899999998865553 344332 23
Q ss_pred EEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCC-CcceEecCCCcEEEeecccchhc
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK-GANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 432 ~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIK-P~NILLd~~g~vKL~DFGLA~~~ 507 (741)
++.|||++|-.|.+..... + +.-+..+++.-.-|-..||-|..|. |..++|..++.+.|+||.-|+..
T Consensus 88 ~i~me~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhhcCcchhhhhhcc----c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 4559999998887765321 1 2233445555455677899999985 66666667779999999998743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=9.3e-05 Score=75.94 Aligned_cols=137 Identities=14% Similarity=0.188 Sum_probs=79.4
Q ss_pred eeEEeecCCeEEEEEEECC-CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC-eeeecceeeecceEEEEEe
Q 004633 359 GKLIGRGTFGSVYIGTNRE-TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN-IVQYYGSEVVDDHLYIYLE 436 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~-tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPN-IVkl~g~~~~~~~l~LVmE 436 (741)
.+.|..|-...||++.... .++.|++|+...... ..-..++|+.+++.+...+ +.++++.+. -.+|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~------~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE------LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc------ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEE
Confidence 4677788888999987543 357888996542111 1112346888888885333 344443322 247999
Q ss_pred ecCCCChhhh--------------hh---hccccc----------c-HHHHHHHHHH----------------------H
Q 004633 437 YVHPGSINRY--------------VR---EHCRDI----------T-ESIVRNFTRH----------------------I 466 (741)
Q Consensus 437 y~~gGsL~~l--------------I~---~~~~~l----------s-e~~i~~i~~Q----------------------I 466 (741)
|++|.++... +. ...... . .+.+..|... +
T Consensus 73 ~i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 152 (235)
T cd05157 73 FIPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQL 152 (235)
T ss_pred eeCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHH
Confidence 9998765321 11 000001 0 1122222211 1
Q ss_pred HHHHHHH----H----hCCeecccCCCcceEecC-CCcEEEeecccch
Q 004633 467 LNGLAYL----H----STNTIHRDIKGANLLVDA-SGVVKLADFGMAK 505 (741)
Q Consensus 467 l~aL~yL----H----s~gIVHRDIKP~NILLd~-~g~vKL~DFGLA~ 505 (741)
...+..| - ..+++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 153 ~~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 153 RDEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1111111 1 236899999999999998 5789999999874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.0004 Score=71.30 Aligned_cols=130 Identities=23% Similarity=0.304 Sum_probs=90.8
Q ss_pred CCeEEeeEEeecCC-eEEEEEEECCCCcEEEEEEeec---CCCCc-----c--c------HHHHHHHHHHHHHHhhcC--
Q 004633 354 SQWQKGKLIGRGTF-GSVYIGTNRETGASCAIKEVDI---IPDDP-----K--S------AECIKQLEQEIKVLGHLK-- 414 (741)
Q Consensus 354 ~~Y~i~k~LG~G~f-G~Vy~a~~k~tg~~vAVK~i~~---~~~~~-----~--~------~~~ik~l~~Ei~iL~~L~-- 414 (741)
..++.++.||.|.- |.||++... |+.||+|+++. ...+. . . .....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 999999765 78999999431 11100 0 0 123345777887766664
Q ss_pred -CCCe--eeecceeeecc------------------eEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHH
Q 004633 415 -HENI--VQYYGSEVVDD------------------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473 (741)
Q Consensus 415 -HPNI--Vkl~g~~~~~~------------------~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yL 473 (741)
+.++ |+++|+..... ..-||.||+.... .+.. .=+.+|++-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHH
Confidence 5566 89999864331 1356777766433 1222 3356788888999
Q ss_pred HhCCeecccCCCcceEecCCCcEEEeecccc
Q 004633 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMA 504 (741)
Q Consensus 474 Hs~gIVHRDIKP~NILLd~~g~vKL~DFGLA 504 (741)
|..||+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999986 3479999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00023 Score=72.84 Aligned_cols=136 Identities=21% Similarity=0.326 Sum_probs=91.9
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCc-----------ccHHHHHHHHHHHHHHhhcC------CCCeeee
Q 004633 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-----------KSAECIKQLEQEIKVLGHLK------HENIVQY 421 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~-----------~~~~~ik~l~~Ei~iL~~L~------HPNIVkl 421 (741)
...||+|+.-.||.-- ......||++....... ......++..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4579999999999642 23456778776433000 00011344556666555554 7889999
Q ss_pred cceeeecceEEEEEeecCCC------ChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCC--
Q 004633 422 YGSEVVDDHLYIYLEYVHPG------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-- 493 (741)
Q Consensus 422 ~g~~~~~~~l~LVmEy~~gG------sL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~-- 493 (741)
||+.+++.-.-+|+|.+... +|.+++++. .+++ . +...|-+-..||-+++|+.+||+|.||++...
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 99999998899999987542 577777543 3555 3 33444455678889999999999999999643
Q ss_pred C--cEEEee-ccc
Q 004633 494 G--VVKLAD-FGM 503 (741)
Q Consensus 494 g--~vKL~D-FGL 503 (741)
| .+.|+| ||-
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 2 578887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0004 Score=74.97 Aligned_cols=79 Identities=13% Similarity=0.080 Sum_probs=54.1
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC---CCeeeecceeee---cc
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH---ENIVQYYGSEVV---DD 429 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H---PNIVkl~g~~~~---~~ 429 (741)
..-.+.||.|..+.||...... ..+.+|..+... . ...+..|.+.|+.|.- -.|.++++++.. .+
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~--~~~~~k~~~~~~----~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g 86 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ--GNPMPLMARSFS----T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG 86 (297)
T ss_pred hheeeecCCccceeEEEEEcCC--CCEEEEEecccc----c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence 3456789999999999985432 356777643210 1 1357789988888752 356677765543 46
Q ss_pred eEEEEEeecCCCCh
Q 004633 430 HLYIYLEYVHPGSI 443 (741)
Q Consensus 430 ~l~LVmEy~~gGsL 443 (741)
..+||||+++|+++
T Consensus 87 ~~~LVmE~i~G~~~ 100 (297)
T PRK10593 87 PDVLLLERLRGVSV 100 (297)
T ss_pred CeEEEEeccCCEec
Confidence 78999999998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00013 Score=76.41 Aligned_cols=133 Identities=17% Similarity=0.227 Sum_probs=74.8
Q ss_pred EeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-eeecceeeecceEEEEEeecCC
Q 004633 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLYIYLEYVHP 440 (741)
Q Consensus 362 LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l~LVmEy~~g 440 (741)
+..|-...+|+.. .++..+++|...... ....-...+|.++|+.+..-++ .+++... + -++||||++|
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~-----~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVC-----KALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccc-----ccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccC
Confidence 4557777899886 456778888643211 0100124678888888864323 2333322 2 3689999998
Q ss_pred CChhhh--------------hhh-cc-----ccccH-HHHHHHHHHH---------HHHHHHHHh--------CCeeccc
Q 004633 441 GSINRY--------------VRE-HC-----RDITE-SIVRNFTRHI---------LNGLAYLHS--------TNTIHRD 482 (741)
Q Consensus 441 GsL~~l--------------I~~-~~-----~~lse-~~i~~i~~QI---------l~aL~yLHs--------~gIVHRD 482 (741)
..+... +.+ +. ..++. ..+..+..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 765421 111 00 01111 1222222222 111222211 2589999
Q ss_pred CCCcceEecCCCcEEEeecccchh
Q 004633 483 IKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 483 IKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
+.+.|||++.++ +.|+||+.|..
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999877 78999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00037 Score=75.03 Aligned_cols=141 Identities=20% Similarity=0.207 Sum_probs=82.0
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC--Ceeeecce------eee
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGS------EVV 427 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HP--NIVkl~g~------~~~ 427 (741)
....+.|+.|-...||++... +..+++|++... ... ..+..|++++..|..- .|.+++.. ...
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~----~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKR----VKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCC----CCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 344667788888899988642 346778876431 111 2345577777777421 23343331 223
Q ss_pred cceEEEEEeecCCCChhh-----------hh---hhccccc----------cH-HHH--H----------HHHHHHHHHH
Q 004633 428 DDHLYIYLEYVHPGSINR-----------YV---REHCRDI----------TE-SIV--R----------NFTRHILNGL 470 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~-----------lI---~~~~~~l----------se-~~i--~----------~i~~QIl~aL 470 (741)
++..+++|||++|..+.. .+ +.....+ .. ... . .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 567899999999865421 11 1100111 00 000 0 0011233455
Q ss_pred HHHH-------hCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 471 AYLH-------STNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 471 ~yLH-------s~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
+++. ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5554 2689999999999999998878999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00014 Score=73.65 Aligned_cols=99 Identities=21% Similarity=0.182 Sum_probs=79.4
Q ss_pred HHHHHHHhhcCC-CCeeeecceeeecceEEEEEeecCCCChhhh---hhhccccccHHHHHHHHHHHHHHHHHHHh---C
Q 004633 404 EQEIKVLGHLKH-ENIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHS---T 476 (741)
Q Consensus 404 ~~Ei~iL~~L~H-PNIVkl~g~~~~~~~l~LVmEy~~gGsL~~l---I~~~~~~lse~~i~~i~~QIl~aL~yLHs---~ 476 (741)
..|.-+|+.+.+ +++.+++|++ + .++|.||+..+++... +.+ ....++....+|+.++++.+++|+. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G-~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---G-RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---C-CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358889999976 6999999987 2 3668899998766532 111 1346889999999999999999986 3
Q ss_pred CeecccCCCcceEecCCCcEEEeecccchhc
Q 004633 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 477 gIVHRDIKP~NILLd~~g~vKL~DFGLA~~~ 507 (741)
.+.-.|++++|+-|+++|.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 4777899999999999999999999977543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00042 Score=73.74 Aligned_cols=138 Identities=17% Similarity=0.190 Sum_probs=82.9
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC--Ceeeecce------eeecc
Q 004633 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYGS------EVVDD 429 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HP--NIVkl~g~------~~~~~ 429 (741)
-.+.|..|....+|+... ++..+++|+... . . ...+..|+++++.|.+- .+.+++.. ...++
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~ 87 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG 87 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC--C---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence 356777888789998864 345788887642 1 1 13466688888887432 24444431 23456
Q ss_pred eEEEEEeecCCCChhh----hh----------hhccccccH--------HHHH------------HHHHHHHHHHHHHHh
Q 004633 430 HLYIYLEYVHPGSINR----YV----------REHCRDITE--------SIVR------------NFTRHILNGLAYLHS 475 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~----lI----------~~~~~~lse--------~~i~------------~i~~QIl~aL~yLHs 475 (741)
..++||||++|..+.. .+ +.....+.. .... .....+..++.++-.
T Consensus 88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~ 167 (296)
T cd05153 88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA 167 (296)
T ss_pred ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence 6789999999877532 00 000000000 0000 011112334444443
Q ss_pred -------CCeecccCCCcceEecCCCcEEEeecccch
Q 004633 476 -------TNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 476 -------~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998888999999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00069 Score=76.27 Aligned_cols=82 Identities=16% Similarity=0.159 Sum_probs=54.3
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC-Cccc-HHHHHHHHHHHHHHhhcC---CCCeeeecceeeecceEEE
Q 004633 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-DPKS-AECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~-~~~~-~~~ik~l~~Ei~iL~~L~---HPNIVkl~g~~~~~~~l~L 433 (741)
.+.||.|.+..||++.....++.++||.-...-. .... .-...+...|.+.|+.+. -.++.++|.+ +++..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999865446899997431100 0010 112356677888888763 2457777755 4566889
Q ss_pred EEeecCCCC
Q 004633 434 YLEYVHPGS 442 (741)
Q Consensus 434 VmEy~~gGs 442 (741)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=7.1e-05 Score=81.19 Aligned_cols=141 Identities=13% Similarity=0.171 Sum_probs=98.6
Q ss_pred CeEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCC-------------Cc-ccHH-HHH--HHHHHHHHHhhcC-CC
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD-------------DP-KSAE-CIK--QLEQEIKVLGHLK-HE 416 (741)
Q Consensus 355 ~Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~-------------~~-~~~~-~ik--~l~~Ei~iL~~L~-HP 416 (741)
-+-+++.||-|.-+-||.+-+. .|...++|.-++-.. .. ...+ .+. ...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3578899999999999999875 478888885321110 00 1111 111 2457899998885 32
Q ss_pred -CeeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecccCCCcceEecCCCc
Q 004633 417 -NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495 (741)
Q Consensus 417 -NIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHRDIKP~NILLd~~g~ 495 (741)
-|.+.++ ....++|||++.|..|...-+- ..+..+...|+.-+.-|-.+|+||+|..--||||++++.
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 2344443 4567899999999888765421 123455666677777888999999999999999999999
Q ss_pred EEEeecccchhc
Q 004633 496 VKLADFGMAKHL 507 (741)
Q Consensus 496 vKL~DFGLA~~~ 507 (741)
+++|||--....
T Consensus 241 i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 241 IVVIDFPQMVST 252 (465)
T ss_pred EEEeechHhhcc
Confidence 999999765433
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00052 Score=73.40 Aligned_cols=76 Identities=16% Similarity=0.175 Sum_probs=46.3
Q ss_pred eeEEeecCCeEEEEEEECC------CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-eeecceeeecceE
Q 004633 359 GKLIGRGTFGSVYIGTNRE------TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHL 431 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~------tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l 431 (741)
++.|..|-.-.||++.... .++.+++|+...... ......+|++++..+...++ .++++.+. -
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~------~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~ 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE------LLIDRERELVVFARLSERNLGPKLYGIFP----N 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc------ceechHHHHHHHHHHHhCCCCCceEEEeC----C
Confidence 3456666667899887543 257888997543211 11245678888888853333 34444432 2
Q ss_pred EEEEeecCCCChh
Q 004633 432 YIYLEYVHPGSIN 444 (741)
Q Consensus 432 ~LVmEy~~gGsL~ 444 (741)
.+||||++|..+.
T Consensus 73 ~~v~e~i~G~~l~ 85 (302)
T cd05156 73 GRIEEFIPSRTLT 85 (302)
T ss_pred CchhheeCCCcCC
Confidence 3689999987664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.002 Score=69.47 Aligned_cols=137 Identities=17% Similarity=0.131 Sum_probs=75.7
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC-----CCCeeeecc---eeeecce
Q 004633 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----HENIVQYYG---SEVVDDH 430 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-----HPNIVkl~g---~~~~~~~ 430 (741)
.+.|+.|....+|+.... +..+++|++.. .. . +.+..|+.+++.|. -|.++...+ +....+.
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~~---~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~ 96 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER--LT---A---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK 96 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEecc--CC---h---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE
Confidence 456777887899988643 34688887641 11 1 23334556665553 344443211 1234567
Q ss_pred EEEEEeecCCCChhh-----------hhh---hccccc----------cH-HH-HH-----------HHHHH-HHHHHHH
Q 004633 431 LYIYLEYVHPGSINR-----------YVR---EHCRDI----------TE-SI-VR-----------NFTRH-ILNGLAY 472 (741)
Q Consensus 431 l~LVmEy~~gGsL~~-----------lI~---~~~~~l----------se-~~-i~-----------~i~~Q-Il~aL~y 472 (741)
.+++|||++|..+.. .+. .....+ .. .. +. ..+.+ +...++.
T Consensus 97 ~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 176 (319)
T PRK05231 97 PAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAF 176 (319)
T ss_pred EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHh
Confidence 899999999875421 111 000000 00 00 00 01111 1111222
Q ss_pred HH-------hCCeecccCCCcceEecCCCcEEEeecccch
Q 004633 473 LH-------STNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 473 LH-------s~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
+- ..|+||+|+++.|||++.+...-|+||+.+.
T Consensus 177 ~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 177 LASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred hhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 22 2489999999999999877667899999874
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0021 Score=71.08 Aligned_cols=145 Identities=19% Similarity=0.237 Sum_probs=98.0
Q ss_pred EEeeEEeecCCeEEEEEEECCCCcEEEEEEeec----CCCC----------------cccHHH-HHHHHHHHHHHhhcCC
Q 004633 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI----IPDD----------------PKSAEC-IKQLEQEIKVLGHLKH 415 (741)
Q Consensus 357 ~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~----~~~~----------------~~~~~~-ik~l~~Ei~iL~~L~H 415 (741)
.+..+|..|.-+.||.|.. .+|..+|||+++. .++. ...... .-..++|++-|.+|+.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4556788899999999874 5688899999852 1110 111222 2346778888888864
Q ss_pred CCeeeecceeeecceEEEEEeecCCCCh-hhhhhhccccccHHHHHHHHHHHHHHHHHH-HhCCeecccCCCcceEecCC
Q 004633 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDAS 493 (741)
Q Consensus 416 PNIVkl~g~~~~~~~l~LVmEy~~gGsL-~~lI~~~~~~lse~~i~~i~~QIl~aL~yL-Hs~gIVHRDIKP~NILLd~~ 493 (741)
-.|.---- ... ....|||+|+.+... .-.|+ ...++...+..+..|++.-|.-| |..++||.||.--|+|+ .+
T Consensus 226 aGIP~PeP-IlL-k~hVLVM~FlGrdgw~aPkLK--d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 226 AGIPCPEP-ILL-KNHVLVMEFLGRDGWAAPKLK--DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HD 300 (520)
T ss_pred cCCCCCCc-eee-ecceEeeeeccCCCCcCcccc--cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-EC
Confidence 44321111 111 234799999963322 22222 24578888999999999888887 46799999999999999 67
Q ss_pred CcEEEeecccchhc
Q 004633 494 GVVKLADFGMAKHL 507 (741)
Q Consensus 494 g~vKL~DFGLA~~~ 507 (741)
|.+.|||-+-+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 89999998876543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0031 Score=67.56 Aligned_cols=31 Identities=26% Similarity=0.355 Sum_probs=25.8
Q ss_pred CeecccCCCcceEecCCCc-EEEeecccchhc
Q 004633 477 NTIHRDIKGANLLVDASGV-VKLADFGMAKHL 507 (741)
Q Consensus 477 gIVHRDIKP~NILLd~~g~-vKL~DFGLA~~~ 507 (741)
.++|+|+++.|||++.++. +-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999987554 579999988643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0086 Score=65.62 Aligned_cols=126 Identities=13% Similarity=0.200 Sum_probs=72.5
Q ss_pred CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCC--CCeeeecceeeecc--eEEEEEeecCCCChhhhhhhccc--
Q 004633 379 GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH--ENIVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCR-- 452 (741)
Q Consensus 379 g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H--PNIVkl~g~~~~~~--~l~LVmEy~~gGsL~~lI~~~~~-- 452 (741)
++.+++. . +.............+|+++|+.+.- --+...++.+.++. ..|.||+|++|..+.........
T Consensus 48 ~~~~vlR-~---P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~ 123 (321)
T COG3173 48 GQKYVLR-K---PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGR 123 (321)
T ss_pred CceEEEe-c---CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchH
Confidence 6667766 2 1112223334567788888888753 22334455555444 67999999998543322211000
Q ss_pred -----------------------------cccHHHHHHHHHHH--------------HHHHHHHHh--------CCeecc
Q 004633 453 -----------------------------DITESIVRNFTRHI--------------LNGLAYLHS--------TNTIHR 481 (741)
Q Consensus 453 -----------------------------~lse~~i~~i~~QI--------------l~aL~yLHs--------~gIVHR 481 (741)
.....++..+..+. ..-..||+. ..++|+
T Consensus 124 ~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHG 203 (321)
T COG3173 124 QFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHG 203 (321)
T ss_pred HHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeC
Confidence 00111111121111 223344432 248999
Q ss_pred cCCCcceEecCCCcEEEeecccchhcc
Q 004633 482 DIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 482 DIKP~NILLd~~g~vKL~DFGLA~~~~ 508 (741)
|+++.||||+.++.+-|+||+++..-.
T Consensus 204 D~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 204 DYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CcccCCEEEeCCCeeEEEeccccccCC
Confidence 999999999999999999999987543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.016 Score=61.84 Aligned_cols=29 Identities=24% Similarity=0.332 Sum_probs=25.5
Q ss_pred CCeecccCCCcceEecCCCcEEEeecccch
Q 004633 476 TNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 476 ~gIVHRDIKP~NILLd~~g~vKL~DFGLA~ 505 (741)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999999763
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0037 Score=69.46 Aligned_cols=77 Identities=10% Similarity=0.124 Sum_probs=49.4
Q ss_pred EEeecCCeEEEEEEECCCCcEEEEEEee----cCCCCcccHHHHHHHHHHHHHHhhcC--CC-CeeeecceeeecceEEE
Q 004633 361 LIGRGTFGSVYIGTNRETGASCAIKEVD----IIPDDPKSAECIKQLEQEIKVLGHLK--HE-NIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 361 ~LG~G~fG~Vy~a~~k~tg~~vAVK~i~----~~~~~~~~~~~ik~l~~Ei~iL~~L~--HP-NIVkl~g~~~~~~~l~L 433 (741)
.||-|....||++.+...++.|+||.-. ..... ..-.+.+..-|...|+... -| .+.++| +.+++...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~--wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGES--WPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCC--CCCCccHHHHHHHHHHHhhccCccccCeEE--EEcccccee
Confidence 5789999999999976444689999642 11111 1112345556778887663 24 455666 456667789
Q ss_pred EEeecCCC
Q 004633 434 YLEYVHPG 441 (741)
Q Consensus 434 VmEy~~gG 441 (741)
|||++...
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99998643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.013 Score=64.59 Aligned_cols=140 Identities=11% Similarity=0.160 Sum_probs=78.8
Q ss_pred eEEeeEEeecCCeEEEEEEECC----CCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-eeecceeeecce
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRE----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDH 430 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~----tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~ 430 (741)
..-.+.|-.|-.-.+|++.... .++.|++|+..... ...+. ..+|+.+++.+..-++ .++++.+. ++
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-----~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~-~g- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-----ELFFD-RDDEIRTFECMSRHGQGPRLLGRFP-NG- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-----Ceeec-hHHHHHHHHHHHHcCCCCceEEEEC-Cc-
Confidence 3344555457777899986432 24678888654221 11122 3668888888854333 24445442 22
Q ss_pred EEEEEeecCCCChhhh----------h-------hhcc----c-cccHHHHHHHHHHH-----------------HHHHH
Q 004633 431 LYIYLEYVHPGSINRY----------V-------REHC----R-DITESIVRNFTRHI-----------------LNGLA 471 (741)
Q Consensus 431 l~LVmEy~~gGsL~~l----------I-------~~~~----~-~lse~~i~~i~~QI-----------------l~aL~ 471 (741)
.|+||++|.+|... + +... . ......+..++.++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 58999987765421 0 1100 0 11122333333222 11122
Q ss_pred HH----H----hCCeecccCCCcceEecC-CCcEEEeecccch
Q 004633 472 YL----H----STNTIHRDIKGANLLVDA-SGVVKLADFGMAK 505 (741)
Q Consensus 472 yL----H----s~gIVHRDIKP~NILLd~-~g~vKL~DFGLA~ 505 (741)
.| . ...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22 1 235899999999999986 4789999999875
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.015 Score=63.78 Aligned_cols=139 Identities=15% Similarity=0.200 Sum_probs=76.8
Q ss_pred EEeeEEeecCCeEEEEEEECCC---CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-eeecceeeecceEE
Q 004633 357 QKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLY 432 (741)
Q Consensus 357 ~i~k~LG~G~fG~Vy~a~~k~t---g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l~ 432 (741)
...+.|-.|=.-.+|++..... +..|++|+...... . .-.-.+|+.+++.+..-+| .++++++. ++
T Consensus 17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-----~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-----Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-----e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 3445555576778898875432 33788886542211 1 1123568888888864444 34555442 22
Q ss_pred EEEeecCCCChhh-------hh-------hh-cccc------c-cHHHHHHHHHHH----------------------HH
Q 004633 433 IYLEYVHPGSINR-------YV-------RE-HCRD------I-TESIVRNFTRHI----------------------LN 468 (741)
Q Consensus 433 LVmEy~~gGsL~~-------lI-------~~-~~~~------l-se~~i~~i~~QI----------------------l~ 468 (741)
+|.||++|..|.. .+ ++ +... . -...+..++.++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5899998776532 01 11 0001 1 122233333222 11
Q ss_pred HHHHHH----hC----CeecccCCCcceEecC-CCcEEEeecccch
Q 004633 469 GLAYLH----ST----NTIHRDIKGANLLVDA-SGVVKLADFGMAK 505 (741)
Q Consensus 469 aL~yLH----s~----gIVHRDIKP~NILLd~-~g~vKL~DFGLA~ 505 (741)
-+..+. .. -++|.|+.+.|||+++ ++.++|+||+.|.
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 122221 11 2789999999999975 5789999999874
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.0078 Score=67.77 Aligned_cols=80 Identities=15% Similarity=0.083 Sum_probs=52.6
Q ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeecCC-CCcccHHHHHHHHHHHHHHhhcC--CC-CeeeecceeeecceEEEE
Q 004633 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLK--HE-NIVQYYGSEVVDDHLYIY 434 (741)
Q Consensus 359 ~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~-~~~~~~~~ik~l~~Ei~iL~~L~--HP-NIVkl~g~~~~~~~l~LV 434 (741)
.+.||-|.-.-||++.+...++.|+||.-...- ....-.-...+..-|.++|+.+. -| .+.++| +.+++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence 678899999999999985445679998642111 11111122356667888888764 24 466676 4566777899
Q ss_pred EeecCC
Q 004633 435 LEYVHP 440 (741)
Q Consensus 435 mEy~~g 440 (741)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.04 Score=59.52 Aligned_cols=30 Identities=17% Similarity=0.201 Sum_probs=27.7
Q ss_pred CeecccCCCcceEecCCCcEEEeecccchh
Q 004633 477 NTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 477 gIVHRDIKP~NILLd~~g~vKL~DFGLA~~ 506 (741)
+++|+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.047 Score=61.88 Aligned_cols=79 Identities=20% Similarity=0.191 Sum_probs=49.7
Q ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCccc--HHHHHHHHHHHHHHhhcC---CCCeeeecceeeecceEE
Q 004633 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~--~~~ik~l~~Ei~iL~~L~---HPNIVkl~g~~~~~~~l~ 432 (741)
..+.||-|..-.||+..+. +..++||.-.....-... .-...+...|+..|+.+. -.++.++|.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678899999999998863 456888864311110000 011334455667776653 246777886554 5678
Q ss_pred EEEeecCC
Q 004633 433 IYLEYVHP 440 (741)
Q Consensus 433 LVmEy~~g 440 (741)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999987
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.012 Score=67.64 Aligned_cols=159 Identities=19% Similarity=0.345 Sum_probs=100.9
Q ss_pred HHHHHHHHhhcCCCCeeeecceeeec-ceEEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHHHhCCeecc
Q 004633 403 LEQEIKVLGHLKHENIVQYYGSEVVD-DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHR 481 (741)
Q Consensus 403 l~~Ei~iL~~L~HPNIVkl~g~~~~~-~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yLHs~gIVHR 481 (741)
+.--..+++.+.|+|..+++++-... ....+|||++. .+|++++..+. +-... ++ .+|+.|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~--l~~~s-------~~-------~~~~~~- 90 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN--LKDES-------LL-------AHGVLH- 90 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc--cchhh-------hc-------ccccce-
Confidence 34456788899999999999865543 45889999994 88888886642 11111 00 222222
Q ss_pred cCCCcceEecCCCcEEEeecccchhccCcccccccCCCCCCCChHHHHHhhhcCCCCCCCccchhhhHHHHHHHHhhCCC
Q 004633 482 DIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561 (741)
Q Consensus 482 DIKP~NILLd~~g~vKL~DFGLA~~~~~~~~~~s~~GT~~Y~APEvl~~~~~~~g~~~~s~asDVWSLGvVLyELLtGk~ 561 (741)
-| .++++| -++ ... | ...++++|||++|.|+.|+..|..
T Consensus 91 ----~~-------~~~~td-~~~----t~~-------------~------------~~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 91 ----LN-------IIYITD-HFL----TKY-------------P------------SPIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ----eh-------hhhccc-ccc----ccC-------------C------------CCCCcchhhhhHHHHHHHHHHhhH
Confidence 12 223444 111 000 0 011238999999999999999987
Q ss_pred CCCCCCcHHHHHHHhccCC------------CCCccCCHHHHHHHHHhhhcCCCCCCCHHHHHcCcccccc
Q 004633 562 PWSEFEGPQAMFKVLNRTP------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 562 PF~~~~~~~~~~~i~~~~~------------~iP~~ls~el~dLI~~cL~~DP~kRPTa~ElLqHpwf~~~ 620 (741)
.|......+....+..-.. .+-..++....+++++|+-..|..||...++++++-|...
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 7766544444333322110 1112356677889999999999999999999999988754
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.015 Score=59.13 Aligned_cols=30 Identities=37% Similarity=0.537 Sum_probs=21.3
Q ss_pred CeecccCCCcceEe-cCCCcEEEeecccchh
Q 004633 477 NTIHRDIKGANLLV-DASGVVKLADFGMAKH 506 (741)
Q Consensus 477 gIVHRDIKP~NILL-d~~g~vKL~DFGLA~~ 506 (741)
.++|.||.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 57899999999999 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.082 Score=57.25 Aligned_cols=76 Identities=18% Similarity=0.187 Sum_probs=47.1
Q ss_pred eEEeeEEeecCCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcC---CCCeeeecceeeecceEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---HENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~---HPNIVkl~g~~~~~~~l~ 432 (741)
.+..+.|+-|....+|+.. .+++.+.||+-.... ...+..|.+-|+.|. --.+.+.+++...++.-|
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~--------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~f 88 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG--------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAF 88 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG--------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh--------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCce
Confidence 4566789999999999876 667889999765211 135667888777773 345778888887777789
Q ss_pred EEEeecCCC
Q 004633 433 IYLEYVHPG 441 (741)
Q Consensus 433 LVmEy~~gG 441 (741)
|||||++.+
T Consensus 89 Llle~l~~~ 97 (288)
T PF03881_consen 89 LLLEFLEMG 97 (288)
T ss_dssp EEEE-----
T ss_pred EEEEeecCC
Confidence 999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.058 Score=60.64 Aligned_cols=83 Identities=14% Similarity=0.127 Sum_probs=46.4
Q ss_pred eEEeeEEeecCCeEEEEEEECCC-CcEEEEEE-eecCCCCcccHHHHHHHHHHHHHHhhcCCCCe-eeecceeeecceEE
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRET-GASCAIKE-VDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHLY 432 (741)
Q Consensus 356 Y~i~k~LG~G~fG~Vy~a~~k~t-g~~vAVK~-i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l~ 432 (741)
....+.|..|-...+|++..... +..+.+|. +...... ..+..-.-++|+++++.|..-++ .++++.+. -+
T Consensus 52 ~i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g 125 (383)
T PTZ00384 52 FIEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DF 125 (383)
T ss_pred cEEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC--CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CE
Confidence 34455665588889999875433 22332332 1111111 11111223568999999865443 45565553 26
Q ss_pred EEEeecCCCChh
Q 004633 433 IYLEYVHPGSIN 444 (741)
Q Consensus 433 LVmEy~~gGsL~ 444 (741)
+|.||++|..|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 999999987764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.17 Score=63.78 Aligned_cols=31 Identities=45% Similarity=0.670 Sum_probs=26.1
Q ss_pred CCeecccCCCcceEecCCC--cEE-Eeecccchh
Q 004633 476 TNTIHRDIKGANLLVDASG--VVK-LADFGMAKH 506 (741)
Q Consensus 476 ~gIVHRDIKP~NILLd~~g--~vK-L~DFGLA~~ 506 (741)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 454 999998753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.056 Score=59.62 Aligned_cols=131 Identities=19% Similarity=0.215 Sum_probs=76.4
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCC------eeeecce--eeecc--eEEEEE
Q 004633 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN------IVQYYGS--EVVDD--HLYIYL 435 (741)
Q Consensus 366 ~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPN------IVkl~g~--~~~~~--~l~LVm 435 (741)
.--.||+....+ | .+++|+.... .. ..++..|+.+|+.|.-.+ |..+=|. ....+ ..+-++
T Consensus 37 ~eN~~f~~~~~~-g-~~iLki~~~~----~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 37 EENSNFRVQTED-G-RYILKIYRPG----WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccCceEEEEecC-C-CeEEEEecCC----CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 445688876543 3 3488877642 11 245667888888884222 2222221 22334 788899
Q ss_pred eecCCCChhh-hhh--------------hcccc-----------ccHH----HH---------HHHHHHHHHHHHHHHh-
Q 004633 436 EYVHPGSINR-YVR--------------EHCRD-----------ITES----IV---------RNFTRHILNGLAYLHS- 475 (741)
Q Consensus 436 Ey~~gGsL~~-lI~--------------~~~~~-----------lse~----~i---------~~i~~QIl~aL~yLHs- 475 (741)
||++|..+.. .-. ...+. ..+. .. .....++...++.+.+
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999988772 110 00011 1111 00 0122334445555543
Q ss_pred -------CC--eecccCCCcceEecCCCc-EEEeecccch
Q 004633 476 -------TN--TIHRDIKGANLLVDASGV-VKLADFGMAK 505 (741)
Q Consensus 476 -------~g--IVHRDIKP~NILLd~~g~-vKL~DFGLA~ 505 (741)
.+ |||+|+.+.|||++.+.. +.++|||-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999998884 9999999774
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.088 Score=56.10 Aligned_cols=29 Identities=34% Similarity=0.437 Sum_probs=24.7
Q ss_pred eecccCCCcceEecCC--C---cEEEeecccchh
Q 004633 478 TIHRDIKGANLLVDAS--G---VVKLADFGMAKH 506 (741)
Q Consensus 478 IVHRDIKP~NILLd~~--g---~vKL~DFGLA~~ 506 (741)
|+|+|++.+|||+..+ | .++|+||-+++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 8999999999999655 3 699999988754
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.11 Score=54.43 Aligned_cols=102 Identities=18% Similarity=0.177 Sum_probs=65.6
Q ss_pred EEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCeeeecceeeecceEEEEEeecCCCChhhhhhhccccccHHHHH
Q 004633 381 SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR 460 (741)
Q Consensus 381 ~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy~~gGsL~~lI~~~~~~lse~~i~ 460 (741)
...+|++...+.... ...+..+.+++.+++ .|+++..- ..-.+-+|+|+|-.-. -..-
T Consensus 87 ~L~lKKi~slp~~~~----~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~----------i~~~---- 144 (308)
T PF07387_consen 87 PLFLKKIRSLPCCIN----DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK----------INFS---- 144 (308)
T ss_pred hhhhhhccCCCcccc----hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc----------cchh----
Confidence 345565554333211 134567888888765 58888742 4445789999984211 1111
Q ss_pred HHHHHHHHHHHHHH--hCCeecccCCCcceEecCCCcEEEeecccc
Q 004633 461 NFTRHILNGLAYLH--STNTIHRDIKGANLLVDASGVVKLADFGMA 504 (741)
Q Consensus 461 ~i~~QIl~aL~yLH--s~gIVHRDIKP~NILLd~~g~vKL~DFGLA 504 (741)
.++..=+.+|.-.| ..+.+|+|-.|+|||-|..|.+||.|=+..
T Consensus 145 N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 145 NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 12222245677778 347999999999999999999999997754
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.091 Score=59.26 Aligned_cols=60 Identities=23% Similarity=0.337 Sum_probs=44.7
Q ss_pred EEEEEeecCCCChhhhhhhccccccHHHHHHHHHHHHHHHHHH-HhCCeecccCCCcceEecC
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL-HSTNTIHRDIKGANLLVDA 492 (741)
Q Consensus 431 l~LVmEy~~gGsL~~lI~~~~~~lse~~i~~i~~QIl~aL~yL-Hs~gIVHRDIKP~NILLd~ 492 (741)
..|+-+|..|-.+..+++.. ..+|+..+.++.-.+.||--| --.+++|.|++|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 46777899999999998663 356666666666666665444 3568999999999999953
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.95 E-value=1.1 Score=49.18 Aligned_cols=70 Identities=16% Similarity=-0.005 Sum_probs=41.1
Q ss_pred CCeEEEEEEECCCCcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCC--Ceeee---cc--eeeecceEEEEEeec
Q 004633 366 TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--NIVQY---YG--SEVVDDHLYIYLEYV 438 (741)
Q Consensus 366 ~fG~Vy~a~~k~tg~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HP--NIVkl---~g--~~~~~~~l~LVmEy~ 438 (741)
.--.||+... .+|..+++|+.+... .. ...+..|++++..|.-. .|+.. -| ....++..+.+++++
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~---~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPER---WS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCccc---CC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 3446888764 346779999764211 11 23456688888777421 12322 12 233456788899999
Q ss_pred CCCC
Q 004633 439 HPGS 442 (741)
Q Consensus 439 ~gGs 442 (741)
+|..
T Consensus 110 ~G~~ 113 (325)
T PRK11768 110 GGRA 113 (325)
T ss_pred CCCC
Confidence 8764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.41 Score=54.92 Aligned_cols=76 Identities=12% Similarity=0.007 Sum_probs=43.9
Q ss_pred EeeEEeecCCeEEEEEEECCC--------CcEEEEEEeecCCCCcccHHHHHHHHHHHHHHhhcCCCCee-eecceeeec
Q 004633 358 KGKLIGRGTFGSVYIGTNRET--------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV-QYYGSEVVD 428 (741)
Q Consensus 358 i~k~LG~G~fG~Vy~a~~k~t--------g~~vAVK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIV-kl~g~~~~~ 428 (741)
..+.|..|=.-.+|++..... ++.|.+++.-... ...+ .-..|..+++.|..-+|- ++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t-----e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~-- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV-----DELY-NPISEFEVYKTMSKYRIAPQLLNTFS-- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc-----ccee-CHHHHHHHHHHHHHCCCCCceEEEeC--
Confidence 566676676678888875422 4567787653211 1112 234577777777543332 3444332
Q ss_pred ceEEEEEeecCCCCh
Q 004633 429 DHLYIYLEYVHPGSI 443 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL 443 (741)
-+.|.||++|-.|
T Consensus 181 --gg~I~efi~g~~l 193 (442)
T PTZ00296 181 --GGRIEEWLYGDPL 193 (442)
T ss_pred --CCEEEEeeCCccC
Confidence 3567899988744
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 741 | ||||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-46 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-46 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-45 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-42 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-42 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-40 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-40 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-40 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-40 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-40 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-40 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-40 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-39 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-39 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-39 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-39 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-39 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-39 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-38 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-38 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-38 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-37 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-36 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-36 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-35 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-35 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-35 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-35 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-35 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-35 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-35 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-35 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-34 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-34 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-34 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-34 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-34 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-34 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-34 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-34 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-34 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-34 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-34 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-34 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-34 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-34 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-33 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-33 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-33 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-33 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-33 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-33 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-33 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-33 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-33 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-33 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-33 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-33 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-33 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-33 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-33 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-33 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-33 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-33 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-32 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-29 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-28 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-28 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-28 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-28 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-28 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-27 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-27 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-27 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-27 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-27 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-27 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-26 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-26 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-26 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-26 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-26 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-26 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-26 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-26 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-26 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-26 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-26 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-26 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-26 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-26 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-26 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-26 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-26 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-26 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-26 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-26 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-26 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-26 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-26 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-26 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-26 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-26 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-26 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-26 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-26 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-25 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-25 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-25 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-25 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-25 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-25 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-25 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-25 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-25 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-25 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-25 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-25 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-25 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-25 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-25 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-25 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-25 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-25 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-25 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-25 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-25 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-25 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-25 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-25 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-25 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-25 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-25 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-25 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-25 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-25 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-25 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-25 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-25 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-25 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-25 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-25 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-25 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-25 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-25 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-24 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-24 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-24 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-24 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-24 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-24 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-24 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-24 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-24 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-24 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-24 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-24 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-24 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-24 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-24 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-24 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-24 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-24 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-24 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-24 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-24 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-24 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-24 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-24 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-24 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-24 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-24 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-24 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-24 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-24 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-24 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-24 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-24 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-24 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-24 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-23 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-23 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-23 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-23 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-23 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-23 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-23 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-23 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-23 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-23 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-23 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-23 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-23 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-23 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-23 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-23 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-23 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-23 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-22 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-22 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-22 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-22 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-22 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-22 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-22 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-22 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-22 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-22 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-22 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-22 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-22 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-22 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-22 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-22 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-22 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-22 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-22 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-22 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-22 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-22 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-22 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-22 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-22 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-22 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-22 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-22 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-22 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-21 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-21 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-21 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-21 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-21 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-21 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-21 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-21 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-21 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-21 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-21 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-21 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-21 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-21 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-21 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-21 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-21 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-21 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-21 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-21 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-21 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-21 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-21 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-21 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-21 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-21 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-21 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-21 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-21 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-21 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-21 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-21 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-21 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-21 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-21 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-20 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-20 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-20 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-20 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-20 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-20 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-20 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-20 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-20 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-20 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-20 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-20 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-20 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-20 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-20 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-20 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-20 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-20 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-20 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-20 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-20 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-20 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-20 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-20 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-20 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-20 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-20 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-20 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-20 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-20 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-20 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-20 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-20 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-20 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-20 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-20 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-20 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-20 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-20 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-20 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-20 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-20 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-20 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-20 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-20 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-19 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-19 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-19 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-19 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-19 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-19 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-19 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-19 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-19 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-19 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-19 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-19 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-19 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-19 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-19 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-19 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-18 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-18 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-18 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-18 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-18 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-18 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-18 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-18 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-18 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-18 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-18 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-17 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-17 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-17 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-17 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-16 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-16 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-16 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-16 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-16 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-15 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-15 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-15 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-15 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-15 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-15 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-15 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-15 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-15 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-15 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-15 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-15 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-15 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-15 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-15 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-15 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-14 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-12 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-12 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-10 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 |
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 414 bits (1066), Expect = e-141
Identities = 107/292 (36%), Positives = 161/292 (55%), Gaps = 17/292 (5%)
Query: 345 EKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE 404
+ + + ++G+GT+G VY G + AIKE+ + + + L
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE-----RDSRYSQPLH 67
Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI--TESIVRNF 462
+EI + HLKH+NIVQY GS + + I++E V GS++ +R + E + +
Sbjct: 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGL-SYELSLKGSP 520
T+ IL GL YLH +HRDIKG N+L++ SGV+K++DFG +K L G+ + G+
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKV--LN 577
+MAPE+I G A DIWSLGCT+IEM TGKPP+ E P AMFKV
Sbjct: 188 QYMAPEIID--KGPRG---YGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242
Query: 578 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 629
P IPE +S+E K F+L+CF +P +R A +LL F++ ++ + + P
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-128
Identities = 80/339 (23%), Positives = 132/339 (38%), Gaps = 31/339 (9%)
Query: 303 PQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLI 362
+ L ++ + +A L P +T + P + +
Sbjct: 10 AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKP---VDYEYREEVHWMTHQPRV 66
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
GRG+FG V+ +++TG CA+K+V + +E+ L IV Y
Sbjct: 67 GRGSFGEVHRMKDKQTGFQCAVKKVRLE----------VFRVEELVACAGLSSPRIVPLY 116
Query: 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRD 482
G+ + I++E + GS+ + ++ + E + L GL YLH+ +H D
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 483 IKGANLLVDASGV-VKLADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVMQKD 535
+K N+L+ + G L DFG A L + G+ MAPEV+ K
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM---GKP 232
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGKD 592
+ K VDIWS C ++ ML G PW+++ K+ + PP IP +
Sbjct: 233 CDAK----VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288
Query: 593 FLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRV 631
+ + PV R SA+EL L P +
Sbjct: 289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKG 327
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-118
Identities = 76/301 (25%), Positives = 141/301 (46%), Gaps = 26/301 (8%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
+ + + S + IGRG+F +VY G + ET A E+
Sbjct: 4 RNQQQDDIEELETKAVGM---SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DDHLYIYLEYVHPGSIN 444
D + ++ ++E ++L L+H NIV++Y S + + E + G++
Sbjct: 61 ---DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117
Query: 445 RYVREHCRDITESIVRNFTRHILNGLAYLHSTNT--IHRDIKGANLLVDA-SGVVKLADF 501
Y++ + ++R++ R IL GL +LH+ IHRD+K N+ + +G VK+ D
Sbjct: 118 TYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
G+A S+ ++ G+P +MAPE+ + K +VD+++ G ++EM T +
Sbjct: 177 GLATLKRA-SFAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEY 227
Query: 562 PWSEFEGPQAMFK-VLNRTPP--IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
P+SE + +++ V + P ++ E K+ + C +N ER S +LL H F +
Sbjct: 228 PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
Query: 619 N 619
Sbjct: 288 E 288
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-101
Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 37/296 (12%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
S +++ + + IG G FGSV+ R G AIK + +E+
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD---EQNALREV 61
Query: 408 KVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFT 463
L +H ++V+Y+ + DDH+ I EY + GS+ + E+ R E+ +++
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGV-------------------VKLADFGMA 504
+ GL Y+HS + +H DIK +N+ + + + K+ D G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
++ +G ++A EV++ PK DI++L TV+ +P
Sbjct: 182 TRISSPQ---VEEGDSRFLANEVLQ--ENYTHLPK----ADIFALALTVVCAAGAEPLPR 232
Query: 565 EFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
+ + + R P IP++LS E + L +P RPSA+ L++H + +A
Sbjct: 233 NGDQWHEIRQ--GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = 7e-98
Identities = 73/280 (26%), Positives = 134/280 (47%), Gaps = 19/280 (6%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K + K IG G V+ N E AIK V++ D ++ + EI L
Sbjct: 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLN 62
Query: 412 HLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
L+ + I++ Y E+ D ++Y+ +E + +N ++++ + I +++ +++L
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKSYWKNMLEA 120
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPE 526
+ +H +H D+K AN L+ G++KL DFG+A + T + S G+ N+M PE
Sbjct: 121 VHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 527 VIK----AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR--T 579
IK + K++ D+WSLGC + M GK P+ + + +++
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239
Query: 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
P++ + +D L C R+P +R S ELL HP+++
Sbjct: 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = 2e-97
Identities = 75/309 (24%), Positives = 125/309 (40%), Gaps = 12/309 (3%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
L + N L P +S + + P S + +Q+ +G G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 370 VYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD 429
V+ ++E G A+K PK + ++L + +H V+ +
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPK--DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLL 489
LY+ E S+ ++ + E+ V + R L LA+LHS +H D+K AN+
Sbjct: 131 ILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 490 VDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSL 549
+ G KL DFG+ L +G P +MAPE++ Q D++SL
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL----QGSYGTA----ADVFSL 241
Query: 550 GCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 609
G T++E+ EG Q + + P LSSE + L+ +P R +A
Sbjct: 242 GLTILEVACNMELPHGGEGWQQLRQ-GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAE 300
Query: 610 ELLEHPFIR 618
LL P +R
Sbjct: 301 ALLALPVLR 309
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = 7e-97
Identities = 77/334 (23%), Positives = 138/334 (41%), Gaps = 21/334 (6%)
Query: 298 RHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQ 357
H A + P S K +
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFE--RQHMDSPDLGTDDDDKASSSANECISVKGRIYS 59
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-- 415
K IG G V+ N E AIK V++ D ++ + EI L L+
Sbjct: 60 ILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHS 115
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ I++ Y E+ D ++Y+ +E + +N ++++ I +++ +++L + +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQ 173
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKGSPNWMAPEVIK--- 529
+H D+K AN L+ G++KL DFG+A + T + S G+ N+M PE IK
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 530 -AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNR--TPPIPEM 585
+ K++ D+WSLGC + M GK P+ + + +++ P++
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ +D L C R+P +R S ELL HP+++
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 7e-97
Identities = 74/288 (25%), Positives = 136/288 (47%), Gaps = 19/288 (6%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
+ S S K + K IG G V+ N E AIK V++ + + +
Sbjct: 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL---EEADNQTLDSY 73
Query: 404 EQEIKVLGHLKH--ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
EI L L+ + I++ Y E+ D ++Y+ +E + +N ++++ + I ++
Sbjct: 74 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-KSIDPWERKS 131
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL---TGLSYELSLKG 518
+ +++L + +H +H D+K AN L+ G++KL DFG+A + T + S G
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 519 SPNWMAPEVIK----AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMF 573
+ N+M PE IK + K++ D+WSLGC + M GK P+ + +
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250
Query: 574 KVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+++ P++ + +D L C R+P +R S ELL HP+++
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 298
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 6e-94
Identities = 84/300 (28%), Positives = 134/300 (44%), Gaps = 17/300 (5%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
V + + ++ K IGRG F VY G A+K+V
Sbjct: 7 GMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ 66
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
I D A+ +EI +L L H N+++YY S + D+ L I LE G ++R ++
Sbjct: 67 I--FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 449 EHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505
+ I E V + + + L ++HS +HRDIK AN+ + A+GVVKL D G+ +
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184
Query: 506 HLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW- 563
+ + SL G+P +M+PE I + N K DIWSLGC + EM + P+
Sbjct: 185 FFSSKTTAAHSLVGTPYYMSPERIH---ENGYNFK----SDIWSLGCLLYEMAALQSPFY 237
Query: 564 -SEFEGPQAMFKVLN-RTPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
+ K+ PP+P + S E + + C +P +RP + + +A
Sbjct: 238 GDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 3e-89
Identities = 96/274 (35%), Positives = 141/274 (51%), Gaps = 15/274 (5%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
W+ +G G FG VY N+ETGA A K ++ ++ ++ EI++L
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYIVEIEILAT 72
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
H IV+ G+ D L+I +E+ G+++ + E R +TE ++ R +L L +
Sbjct: 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAV 531
LHS IHRD+K N+L+ G ++LADFG++ L S G+P WMAPEV+
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 532 MQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEML 586
KD + K DIWSLG T+IEM +PP E + + K+ PP P
Sbjct: 193 TMKDTPYDYK----ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW 248
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
S E +DFL +NP RPSA +LLEHPF+ +
Sbjct: 249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 1e-88
Identities = 94/322 (29%), Positives = 152/322 (47%), Gaps = 21/322 (6%)
Query: 310 LESNNHLNAHPLPLP-------PGALSPPKSSVTSAVM--PHIMEKPSASPKKSQWQKGK 360
+ +H + H +P GA+ P + + + P + E + + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLR 60
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
IG G+FG+VY + AIK++ E + + +E++ L L+H N +Q
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--EKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
Y G + + ++ +EY GS + + H + + E + T L GLAYLHS N IH
Sbjct: 119 YRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K N+L+ G+VKL DFG A + + S G+P WMAPEVI A+ + + K
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYDGK- 233
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI--PEMLSSEGKDFLLRCF 598
VD+WSLG T IE+ KPP A++ + P S ++F+ C
Sbjct: 234 ---VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 290
Query: 599 LRNPVERPSAVELLEHPFIRNA 620
+ P +RP++ LL+H F+
Sbjct: 291 QKIPQDRPTSEVLLKHRFVLRE 312
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-86
Identities = 98/269 (36%), Positives = 156/269 (57%), Gaps = 18/269 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ + +G G++GSVY ++ETG AIK+V + D ++++ +EI ++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-------LQEIIKEISIMQQCDS 83
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
++V+YYGS + L+I +EY GS++ +R + +TE + + L GL YLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQK 534
IHRDIK N+L++ G KLADFG+A LT ++ ++ G+P WMAPEVI+ +
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ---EI 200
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGK 591
N DIWSLG T IEM GKPP+++ +A+F + PP PE+ S
Sbjct: 201 GYNCV----ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFIRNA 620
DF+ +C +++P +R +A +LL+HPF+R+A
Sbjct: 257 DFVKQCLVKSPEQRATATQLLQHPFVRSA 285
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 9e-86
Identities = 99/272 (36%), Positives = 145/272 (53%), Gaps = 18/272 (6%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
K ++ + + IG+G G+VY + TG AI+++++ K + EI V+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRE 73
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
K+ NIV Y S +V D L++ +EY+ GS+ V E C + E + R L L +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEF 131
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAV 531
LHS IHRDIK N+L+ G VKL DFG +T S ++ G+P WMAPEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-- 189
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSS 588
+K PK VDIWSLG IEM+ G+PP+ +A++ + P PE LS+
Sbjct: 190 -RKAYGPK----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244
Query: 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
+DFL RC + +R SA ELL+H F++ A
Sbjct: 245 IFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 1e-85
Identities = 85/305 (27%), Positives = 135/305 (44%), Gaps = 35/305 (11%)
Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
M S + ++ ++IG G V AIK +++
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---- 56
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ 453
+ +L +EI+ + H NIV YY S VV D L++ ++ + GS+ ++
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 454 -ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512
+ ES + R +L GL YLH IHRD+K N+L+ G V++ADFG++ L
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176
Query: 513 ELSLK------GSPNWMAPEVIKAVMQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSE 565
K G+P WMAPEV++ Q G + K DIWS G T IE+ TG P+ +
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVME---QVRGYDFK----ADIWSFGITAIELATGAAPYHK 229
Query: 566 FEGPQAMFKVLNRTPP----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 615
+ + + L PP + + + + C ++P +RP+A ELL H
Sbjct: 230 YPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289
Query: 616 FIRNA 620
F + A
Sbjct: 290 FFQKA 294
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 4e-85
Identities = 106/277 (38%), Positives = 149/277 (53%), Gaps = 16/277 (5%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
M+ A P++ + K + IG+G+FG V+ G + T AIK +D+ + + I+ +
Sbjct: 13 MQNLKADPEE-LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDI 67
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
+QEI VL + +YYGS + D L+I +EY+ GS + + E+ +
Sbjct: 68 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATIL 125
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNW 522
R IL GL YLHS IHRDIK AN+L+ G VKLADFG+A LT + G+P W
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP- 581
MAPEVIK Q + K DIWSLG T IE+ G+PP SE + +F + PP
Sbjct: 186 MAPEVIK---QSAYDSK----ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT 238
Query: 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
+ S K+F+ C + P RP+A ELL+H FI
Sbjct: 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 2e-84
Identities = 93/313 (29%), Positives = 153/313 (48%), Gaps = 19/313 (6%)
Query: 313 NNHLNAHPLPLPPGALSPPKSSVTSA-VMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 371
++H ++ + L L VT + + IG G+ G V
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVC 62
Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431
+ + +G A+K +D+ + + + L E+ ++ +H N+V+ Y S +V + L
Sbjct: 63 LAREKHSGRQVAVKMMDL-----RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117
Query: 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 491
++ +E++ G++ V + + E + +L LAYLH+ IHRDIK ++L+
Sbjct: 118 WVLMEFLQGGALTDIVSQVR--LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175
Query: 492 ASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLG 550
G VKL+DFG ++ + SL G+P WMAPEVI + + VDIWSLG
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS---RSLYATE----VDIWSLG 228
Query: 551 CTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI---PEMLSSEGKDFLLRCFLRNPVERPS 607
VIEM+ G+PP+ QAM ++ + PP +S +DFL R +R+P ER +
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288
Query: 608 AVELLEHPFIRNA 620
A ELL+HPF+
Sbjct: 289 AQELLDHPFLLQT 301
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 4e-84
Identities = 93/281 (33%), Positives = 147/281 (52%), Gaps = 23/281 (8%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
++ +L+G GT+G VY G + +TG AIK +D+ D+ ++++QEI +L
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE------EEEIKQEINMLKK 76
Query: 413 L-KHENIVQYYGS------EVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTR 464
H NI YYG+ +DD L++ +E+ GS+ ++ + E + R
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LSYELSLKGSPNWM 523
IL GL++LH IHRDIKG N+L+ + VKL DFG++ L + + G+P WM
Sbjct: 137 EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 524 APEVIKAVMQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP 581
APEVI D + K D+WSLG T IEM G PP + +A+F + P
Sbjct: 197 APEVIACDENPDATYDFK----SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 252
Query: 582 I--PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
+ S + + F+ C ++N +RP+ +L++HPFIR+
Sbjct: 253 RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-83
Identities = 82/318 (25%), Positives = 148/318 (46%), Gaps = 14/318 (4%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++ + + IG G+FG + + E G IKE++I S++ ++ +E+ VL ++K
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINI---SRMSSKEREESRREVAVLANMK 81
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYL 473
H NIVQY S + LYI ++Y G + + + E + ++ I L ++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVM 532
H +HRDIK N+ + G V+L DFG+A+ L + + G+P +++PE+ +
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE--- 198
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK 591
K N K DIW+LGC + E+ T K + + K+++ PP+ S + +
Sbjct: 199 NKPYNNK----SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRK 651
+ + F RNP +RPS +LE FI + P + L S + K
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAK-RIEKFLSPQLIAEEFCLKTFSKFGSQPIPAK 313
Query: 652 TESLPDSPETRVRNRKLP 669
+ + + + +K+
Sbjct: 314 RPASGQNSISVMPAQKIT 331
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 1e-76
Identities = 71/372 (19%), Positives = 130/372 (34%), Gaps = 69/372 (18%)
Query: 348 SASPKKSQWQKGKLIGRG--TFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ 405
S P+ ++ +IG+G +V + + TG ++ +++ + S E + L+
Sbjct: 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL---EACSNEMVTFLQG 75
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTR 464
E+ V H NIV Y + + D+ L++ ++ GS + H D + E + +
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG--------MAKHLTGLSYELSL 516
+L L Y+H +HR +K +++L+ G V L+ + +
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 517 KGSPNWMAPEVIKAVMQKDG--NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFK 574
W++PEV++ Q + K DI+S+G T E+ G P+ + Q + +
Sbjct: 196 VKVLPWLSPEVLQ---QNLQGYDAK----SDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 575 VLNRTPP----------------------------------------------IPEMLSS 588
LN T P S
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERA 648
F+ +C RNP RPSA LL H F + + + + +
Sbjct: 309 HFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQD 368
Query: 649 TRKTESLPDSPE 660
L + E
Sbjct: 369 HSGIFGLVTNLE 380
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-76
Identities = 79/294 (26%), Positives = 141/294 (47%), Gaps = 18/294 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +GRG +G V + +G A+K + + + K+L ++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE----QKRLLMDLDISMRT 62
Query: 414 -KHENIVQYYGSEVVDDHLYIYLEYVHPGS---INRYVREHCRDITESIVRNFTRHILNG 469
V +YG+ + ++I +E + S + V + + I E I+ I+
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 470 LAYLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
L +LHS + IHRD+K +N+L++A G VK+ DFG++ +L + G +MAPE I
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI--PEM 585
+ + G + DIWSLG T+IE+ + P+ + P Q + +V+ P +
Sbjct: 182 NPELNQKGYSVKS---DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGD 639
S+E DF +C +N ERP+ EL++HPF +++ + F ++ LGD
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT--LHESKGTDVASFVKLILGD 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 1e-75
Identities = 80/292 (27%), Positives = 126/292 (43%), Gaps = 31/292 (10%)
Query: 340 MPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
MP E ++ IG G++G + G KE+D +
Sbjct: 1 MPSRAED---------YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY---GSMTEAE 48
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRD---I 454
+ L E+ +L LKH NIV+YY + + LYI +EY G + + + ++ +
Sbjct: 49 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 455 TESIVRNFTRHILNGLAYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKHLT- 508
E V + L H + +HRD+K AN+ +D VKL DFG+A+ L
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 509 GLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG 568
S+ + G+P +M+PE + + N K DIWSLGC + E+ PP++ F
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMN---RMSYNEK----SDIWSLGCLLYELCALMPPFTAFSQ 221
Query: 569 PQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ K+ + IP S E + + R RPS E+LE+P I
Sbjct: 222 KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 3e-75
Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 37/280 (13%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
++ +LIG G FG V+ +R G + IK V + E + E+E+K L L H
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNE---KAEREVKALAKLDHV 64
Query: 417 NIVQYYGS----------------EVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIV 459
NIV Y G L+I +E+ G++ +++ + + + + +
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 519
I G+ Y+HS I+RD+K +N+ + + VK+ DFG+ L KG+
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 579
+M+PE I +D + VD+++LG + E+L FE + + R
Sbjct: 185 LRYMSPEQIS---SQDYGKE----VDLYALGLILAELLHVCDT--AFETSKFFTDL--RD 233
Query: 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
I ++ + K L + + P +RP+ E+L +
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 5e-74
Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 48/302 (15%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
S +++ ++G+G FG V N AIK++ + E + + E+ +L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR------HTEEKLSTILSEVMLLAS 58
Query: 413 LKHENIVQYYGSEVVDDH-------------LYIYLEYVHPGSINRYVREHCRDITESIV 459
L H+ +V+YY + + + L+I +EY G++ + +
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-- 517
R IL L+Y+HS IHRD+K N+ +D S VK+ DFG+AK++ L L
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 518 -------------GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS 564
G+ ++A EV+ N K +D++SLG EM+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDG--TGHYNEK----IDMYSLGIIFFEMIYPFSTGM 232
Query: 565 EFEGPQAMFKVLNR-----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
E + K L P + K + +P +RP A LL ++
Sbjct: 233 E---RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
Query: 620 AN 621
+
Sbjct: 290 KH 291
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-73
Identities = 81/292 (27%), Positives = 132/292 (45%), Gaps = 30/292 (10%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ 420
IGRG +GSV ++ +G A+K + D+ + KQL ++ V+ IVQ
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE----QKQLLMDLDVVMRSSDCPYIVQ 85
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGLAYLHST- 476
+YG+ + +I +E + Y I E I+ T + L +L
Sbjct: 86 FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPNWMAPEVIKAV 531
IHRDIK +N+L+D SG +KL DFG++ L S+ G +MAPE I
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-----SIAKTRDAGCRPYMAPERIDPS 200
Query: 532 MQKDG-NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI-----PE 584
+ G + + D+WSLG T+ E+ TG+ P+ ++ + +V+ PP
Sbjct: 201 ASRQGYDVR----SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 636
S +F+ C ++ +RP ELL+HPFI + + V V ++
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILD 308
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 2e-73
Identities = 65/317 (20%), Positives = 128/317 (40%), Gaps = 39/317 (12%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
K + ++G G G++ A+K + EC ++E+++L
Sbjct: 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--------ECFSFADREVQLLRE 73
Query: 413 L-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+H N+++Y+ +E YI +E ++ YV + + +GLA
Sbjct: 74 SDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 472 YLHSTNTIHRDIKGANLLV-----DASGVVKLADFGMAKHLTGLSYELS----LKGSPNW 522
+LHS N +HRD+K N+L+ ++DFG+ K L + S + G+ W
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---R 578
+APE++ +D VDI+S GC +++ G P+ + QA +
Sbjct: 193 IAPEMLS----EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD 248
Query: 579 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLG 638
+ ++ + + +P +RPSA +L+HPF + ++
Sbjct: 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE-----------KQLQFF 297
Query: 639 DKSHDQVERATRKTESL 655
D++E+ + +
Sbjct: 298 QDVSDRIEKESLDGPIV 314
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 1e-72
Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 15/277 (5%)
Query: 362 IGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQ 420
+G GT G V+ R+TG A+K++ + + K++ ++ V+ IVQ
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE----NKRILMDLDVVLKSHDCPYIVQ 88
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTI 479
+G+ + + ++I +E + + R I E I+ T I+ L YL I
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
HRD+K +N+L+D G +KL DFG++ L + G +MAPE I P
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP--PDPTKPD 205
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGP-QAMFKVLNRTPPI---PEMLSSEGKDFLL 595
+ D+WSLG +++E+ TG+ P+ + + + KVL PP+ S + + F+
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265
Query: 596 RCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVF 632
C ++ +RP +LLEH FI+ Y+ L V + +
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIK--RYETLEVDVASW 300
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 6e-71
Identities = 68/306 (22%), Positives = 129/306 (42%), Gaps = 42/306 (13%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+ + +GRG FG V+ N+ + AIK + + P +++ +E+K L L+H
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRL----PNRELAREKVMREVKALAKLEHP 63
Query: 417 NIVQYYGS------------EVVDDHLYIYLEYVHPGSINRYVREHCR--DITESIVRNF 462
IV+Y+ + +LYI ++ ++ ++ C + S+ +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-------------G 509
I + +LHS +HRD+K +N+ VVK+ DFG+ +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 569
+ G+ +M+PE I + K VDI+SLG + E+L P ++ E
Sbjct: 184 YARHTGQVGTKLYMSPEQIH---GNSYSHK----VDIFSLGLILFELLY--PFSTQMERV 234
Query: 570 QAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628
+ + V N + PP+ + +P+ERP A+ ++E+ + ++
Sbjct: 235 RTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG-KTV 293
Query: 629 MRVFSR 634
+R SR
Sbjct: 294 LRQRSR 299
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-70
Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 24/281 (8%)
Query: 348 SASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLE 404
+ + ++ G L+G+G+F VY + TG AIK +I A +++++
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQ 59
Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIY--LEYVHPGSINRYVREHCRDITESIVRNF 462
E+K+ LKH +I++ Y +D Y+Y LE H G +NRY++ + +E+ R+F
Sbjct: 60 NEVKIHCQLKHPSILELY--NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPN 521
I+ G+ YLHS +HRD+ +NLL+ + +K+ADFG+A L + L G+PN
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNR 578
+++PE+ + + D+WSLGC +L G+PP F+ + KV+
Sbjct: 178 YISPEIA---TRSAHGLE----SDVWSLGCMFYTLLIGRPP---FDTDTVKNTLNKVVLA 227
Query: 579 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+P LS E KD + + RNP +R S +L+HPF+
Sbjct: 228 DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 8e-67
Identities = 77/300 (25%), Positives = 142/300 (47%), Gaps = 33/300 (11%)
Query: 341 PHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAEC 399
P ++ P + ++ +G+ +G+G F + ++ +T A K I+P
Sbjct: 5 PEVLVDPR---SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK---IVPKSLLLKPHQ 58
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIY--LEYVHPGSINRYVREHCRDITES 457
+++ EI + L H+++V ++ +D+ +++ LE S+ + +TE
Sbjct: 59 REKMSMEISIHRSLAHQHVVGFH--GFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEP 115
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 517
R + R I+ G YLH IHRD+K NL ++ VK+ DFG+A T + Y+ K
Sbjct: 116 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERK 172
Query: 518 ----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QA 571
G+PN++APEV+ +K + + VD+WS+GC + +L GKPP FE +
Sbjct: 173 KVLCGTPNYIAPEVL---SKKGHSFE----VDVWSIGCIMYTLLVGKPP---FETSCLKE 222
Query: 572 MF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMR 630
+ ++ IP+ ++ + + +P RP+ ELL F + Y +P+
Sbjct: 223 TYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS-GYIPARLPIT 281
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-66
Identities = 70/310 (22%), Positives = 126/310 (40%), Gaps = 47/310 (15%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
W ++G+G +V+ G +++TG AIK + ++ + +E +VL
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63
Query: 413 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHI 466
L H+NIV+ + + ++ H + +E+ GS+ + E + ES R +
Sbjct: 64 LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 467 LNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNW 522
+ G+ +L +HR+IK N++ D V KL DFG A+ L +SL G+ +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 523 MAPEVIK-AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLN 577
+ P++ + AV++KD K VD+WS+G T TG P+ FEGP+ M+K++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 578 RTPP-------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
P + L L + + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 613 EHP-FIRNAN 621
I +
Sbjct: 302 AETSDILHRG 311
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-66
Identities = 82/331 (24%), Positives = 152/331 (45%), Gaps = 58/331 (17%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K +G G G V+ +++ +G A K + + Q+ +E++VL
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI----RNQIIRELQVLH 86
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
IV +YG+ D + I +E++ GS+++ +++ R I E I+ + ++ GL
Sbjct: 87 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 145
Query: 472 YLHST-NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
YL +HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 146 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ- 203
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW--------------------------- 563
++ DIWS+G +++EM G+ P
Sbjct: 204 ------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 564 -----------SEFEGPQAMFKVL----NRTPPI--PEMLSSEGKDFLLRCFLRNPVERP 606
+ P A+F++L N PP + S E +DF+ +C ++NP ER
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317
Query: 607 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 637
+L+ H FI+ ++ + + + S I L
Sbjct: 318 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 348
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 4e-66
Identities = 84/347 (24%), Positives = 156/347 (44%), Gaps = 35/347 (10%)
Query: 320 PLPLPPGA-----LSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGT 374
P P PG ++ P + + I E + ++ +G+ +G+G F + +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61
Query: 375 NRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
+ +T A K I+P +++ EI + L H+++V ++ +D+ ++
Sbjct: 62 DADTKEVFAGK---IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH--GFFEDNDFV 116
Query: 434 Y--LEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 491
+ LE S+ + +TE R + R I+ G YLH IHRD+K NL ++
Sbjct: 117 FVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175
Query: 492 ASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAPEVIKAVMQKDGNPKLALAVDIW 547
VK+ DFG+A T + Y+ K G+PN++APEV+ +K + + VD+W
Sbjct: 176 EDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVL---SKKGHSFE----VDVW 225
Query: 548 SLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVE 604
S+GC + +L GKPP FE + + ++ IP+ ++ + + +P
Sbjct: 226 SIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTA 282
Query: 605 RPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRK 651
RP+ ELL F + Y +P+ + + ++ + RK
Sbjct: 283 RPTINELLNDEFF-TSGYIPARLPITCLTIPPRFSIAPSSLDPSNRK 328
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 1e-65
Identities = 87/276 (31%), Positives = 143/276 (51%), Gaps = 22/276 (7%)
Query: 352 KKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
KK QW + G+ +G+G FG+VY+ +++ A+K + + A QL +E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK--AQLEKAGVEHQLRRE 59
Query: 407 IKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+++ HL+H NI++ YG +Y+ LEY G++ R +++ + E + +
Sbjct: 60 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITEL 118
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
N L+Y HS IHRDIK NLL+ ++G +K+ADFG + H S L G+ +++ PE
Sbjct: 119 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 177
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMF-KVLNRTPPIP 583
+I+ + + K VD+WSLG E L GKPP FE Q + ++ P
Sbjct: 178 MIE---GRMHDEK----VDLWSLGVLCYEFLVGKPP---FEANTYQETYKRISRVEFTFP 227
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ ++ +D + R NP +RP E+LEHP+I
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 5e-65
Identities = 80/314 (25%), Positives = 139/314 (44%), Gaps = 42/314 (13%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
K+ K++G G+ G+V G A+K + I + EIK+L
Sbjct: 14 KNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLI--------DFCDIALMEIKLLTE 64
Query: 413 LK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV------REHCRDITESIVRNFTRH 465
H N+++YY SE D LYI LE ++ V E+ + E + R
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGV-------------VKLADFGMAKHLTG--L 510
I +G+A+LHS IHRD+K N+LV S + ++DFG+ K L
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 511 SYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP-WSE 565
S+ +L G+ W APE+++ +L ++DI+S+GC +L+ GK P +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 566 FEGPQAMFK----VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
+ + + + L +E D + + +P++RP+A+++L HP +
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKS 303
Query: 622 YQNLSVPMRVFSRI 635
+ L ++V R+
Sbjct: 304 -KKLEFLLKVSDRL 316
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 78/288 (27%), Positives = 135/288 (46%), Gaps = 23/288 (7%)
Query: 349 ASPKKSQW-----QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
A K ++ G+ +G+G FG+VY+ ++ A+K + + QL
Sbjct: 4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEHQL 61
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
+EI++ HL+H NI++ Y +Y+ LE+ G + + +++H R E F
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFM 120
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
+ + L Y H IHRDIK NLL+ G +K+ADFG + H ++ G+ +++
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMCGTLDYL 179
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMF-KVLNRTP 580
PE+I+ K + K VD+W G E L G PP F+ +++N
Sbjct: 180 PPEMIE---GKTHDEK----VDLWCAGVLCYEFLVGMPP---FDSPSHTETHRRIVNVDL 229
Query: 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628
P LS KD + + +P +R ++EHP+++ AN + + P
Sbjct: 230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK-ANSRRVLPP 276
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 3e-62
Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 46/302 (15%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
W ++G+G +V+ G +++TG AIK + ++ + +E +VL
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VF-NNISFLRPVDVQMREFEVLKK 63
Query: 413 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREH--CRDITESIVRNFTRHI 466
L H+NIV+ + + ++ H + +E+ GS+ + E + ES R +
Sbjct: 64 LNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 467 LNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNW 522
+ G+ +L +HR+IK N++ D V KL DFG A+ L +SL G+ +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 523 MAPEVIK-AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLN 577
+ P++ + AV++KD K VD+WS+G T TG P+ FEGP+ M+K++
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 578 RTPP-------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
P + L L + + +
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
Query: 613 EH 614
Sbjct: 302 AE 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-62
Identities = 53/287 (18%), Positives = 99/287 (34%), Gaps = 37/287 (12%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+ + +G G F V + G A+K + + ++ ++E +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC-----HEQQDREEAQREADMHRLFN 84
Query: 415 HENIVQYYGSEVVDD----HLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHI 466
H NI++ + + ++ L + G+ I R + +TE + I
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGI 143
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT----------GLSYELSL 516
GL +H+ HRD+K N+L+ G L D G L +
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL 576
+ + ++ APE+ + + D+WSLGC + M+ G+ P ++ +
Sbjct: 204 RCTISYRAPELFSVQSHCVIDER----TDVWSLGCVLYAMMFGEGP---YDMVFQKGDSV 256
Query: 577 NR------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
+ P SS L +P +RP LL
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-59
Identities = 69/345 (20%), Positives = 144/345 (41%), Gaps = 55/345 (15%)
Query: 324 PPGALSPPKSSVTSAVMPHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASC 382
P G++ S+ ++ + ++ + K + ++ + + +G F + + +
Sbjct: 2 PLGSMKDILSNYSNLI--YLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFY 57
Query: 383 AIKEVD------------IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD- 429
A+K+ + D + E++++ +K+E + ++ +
Sbjct: 58 ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE--GIITNY 115
Query: 430 -HLYIYLEYVHPGSINRYVREHCR-------DITESIVRNFTRHILNGLAYLHSTNTI-H 480
+YI EY+ SI ++ I +++ + +LN +Y+H+ I H
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICH 175
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
RD+K +N+L+D +G VKL+DFG ++++ + +G+ +M PE +G
Sbjct: 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GSRGTYEFMPPEFFSNESSYNG---- 230
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEM-------------- 585
VDIWSLG + M P+S +F + + P
Sbjct: 231 -AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKST 289
Query: 586 -----LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625
LS+E DFL +NP ER ++ + L+H ++ + N ++L
Sbjct: 290 CSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-58
Identities = 80/294 (27%), Positives = 135/294 (45%), Gaps = 40/294 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---------------------IIPDD 393
Q+ IG+G++G V + N A+K +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVRE 449
+ I+Q+ QEI +L L H N+V+ EV+D DHLY+ E V+ G +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLV--EVLDDPNEDHLYMVFELVNQGPVMEVP-T 130
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
++E R + + ++ G+ YLH IHRDIK +NLLV G +K+ADFG++ G
Sbjct: 131 LKP-LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 510 LSYELSLK-GSPNWMAPEVIKAVMQK-DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
LS G+P +MAPE + + G A+D+W++G T+ + G+ P+ + E
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCPFMD-E 243
Query: 568 GPQAMF-KVLNRTPPIPE--MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
+ K+ ++ P+ ++ + KD + R +NP R E+ HP++
Sbjct: 244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-57
Identities = 64/274 (23%), Positives = 128/274 (46%), Gaps = 22/274 (8%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS--AECIKQLEQEIKVLG 411
++ + K IG+G FG V+ G + + AIK + + + ++ E ++ ++E+ ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+L H NIV+ YG ++ + + +E+V G + + + I S+ I G+
Sbjct: 79 NLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 472 YLHSTNT--IHRDIKGANLLVDASG-----VVKLADFGMAKHLTGLSYELSLKGSPNWMA 524
Y+ + N +HRD++ N+ + + K+ADFG+++ L G+ WMA
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--GLLGNFQWMA 194
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL----NRTP 580
PE I A ++ K D +S + +LTG+ P+ E+ + F + P
Sbjct: 195 PETIGA-EEESYTEK----ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249
Query: 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
IPE ++ + C+ +P +RP +++
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-57
Identities = 78/271 (28%), Positives = 126/271 (46%), Gaps = 30/271 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
++IG G FG VY G A+K PD+ S + I+ + QE K+ LKH NI
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDIS-QTIENVRQEAKLFAMLKHPNI 68
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+ G + + +L + +E+ G +NR + + I I+ N+ I G+ YLH
Sbjct: 69 IALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 479 ---IHRDIKGANLLVDASG--------VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
IHRD+K +N+L+ ++K+ DFG+A+ + ++S G+ WMAPEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAYAWMAPEV 185
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGPQAMFKVL--NRTPPIP 583
I+ + D+WS G V+ E+LTG+ P+ +G + V PIP
Sbjct: 186 IR---ASMFSKG----SDVWSYG--VLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ C+ +P RPS +L+
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-57
Identities = 74/278 (26%), Positives = 131/278 (47%), Gaps = 19/278 (6%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKH 415
K +G G G V + R+T AI+ + + A+ +E EI++L L H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 416 ENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
I++ D YI LE + G + V + R + E+ + + +L + YLH
Sbjct: 200 PCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH 256
Query: 475 STNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
IHRD+K N+L+ + ++K+ DFG +K L S +L G+P ++APEV+ +V
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV 316
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNR----TPPIPEML 586
N VD WSLG + L+G PP+SE ++ ++ + P + +
Sbjct: 317 GTAGYNRA----VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQN 624
S + D + + + +P R + E L HP++++ + +
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 8e-57
Identities = 71/278 (25%), Positives = 126/278 (45%), Gaps = 21/278 (7%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
A P W + +G G +G V + NR T + A+K I+ D ++ +C + +++EI
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IV-DMKRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+ L HEN+V++Y + Y++LEY G + + + E + F +
Sbjct: 58 INKMLNHENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQL 114
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWM 523
+ G+ YLH HRDIK NLL+D +K++DFG+A + E L G+ ++
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPI 582
APE++K A VD+WS G + ML G+ PW + + + +
Sbjct: 175 APELLK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 583 P--EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
+ + S L + + NP R + ++ + +
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-57
Identities = 84/330 (25%), Positives = 145/330 (43%), Gaps = 27/330 (8%)
Query: 348 SASPK--KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQ 402
S PK + ++ K +G G G V + R+T AIK + + A+
Sbjct: 2 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
+E EI++L L H I++ D YI LE + G + V + R + E+ +
Sbjct: 62 VETEIEILKKLNHPCIIKIK--NFFDAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKL 118
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKG 518
+ +L + YLH IHRD+K N+L+ + ++K+ DFG +K L S +L G
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178
Query: 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPPWSEFEGPQAMFK-- 574
+P ++APEV+ +V N VD WSLG VI L+G PP+SE ++
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRA----VDCWSLG--VILFICLSGYPPFSEHRTQVSLKDQI 232
Query: 575 ---VLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN-YQNLSVPMR 630
N P + +S + D + + + +P R + E L HP++++ + + +
Sbjct: 233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLS 292
Query: 631 VFSRINLGDKSHDQVERATRKTESLPDSPE 660
+ + Q +RK ++
Sbjct: 293 EENESTALPQVLAQP-STSRKRPREGEAEG 321
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-56
Identities = 79/277 (28%), Positives = 140/277 (50%), Gaps = 20/277 (7%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQE 406
P ++ K IG+G F V + + TG AIK II + +++L +E
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLFRE 64
Query: 407 IKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 464
++++ L H NIV+ + EV++ LY+ +EY G + Y+ H R + E R+ R
Sbjct: 65 VRIMKILNHPNIVKLF--EVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFR 121
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMA 524
I++ + Y H +HRD+K NLL+DA +K+ADFG + T + G+P + A
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPP 581
PE+ + G VD+WSLG + +++G P F+G + + +VL
Sbjct: 182 PELFQ------GKKYDGPEVDVWSLGVILYTLVSGSLP---FDGQNLKELRERVLRGKYR 232
Query: 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
IP +S++ ++ L R + NP++R + ++++ +I
Sbjct: 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-56
Identities = 66/290 (22%), Positives = 114/290 (39%), Gaps = 29/290 (10%)
Query: 346 KPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
+ + P ++ W+ + +G G FG V +++TG AIK+ S + ++
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR----QELSPKNRERW 59
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVD--------DHLYIYLEYVHPGSINRYV--REHCRD 453
EI+++ L H N+V EV D D + +EY G + +Y+ E+C
Sbjct: 60 CLEIQIMKKLNHPNVVSAR--EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG 117
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGL 510
+ E +R I + L YLH IHRD+K N+++ + K+ D G AK L
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177
Query: 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ 570
G+ ++APE++ QK VD WS G E +TG P+ P
Sbjct: 178 ELCTEFVGTLQYLAPELL---EQKKYTVT----VDYWSFGTLAFECITGFRPFLPNWQPV 230
Query: 571 AMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ ++ + L P + +++
Sbjct: 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQC 280
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 6e-56
Identities = 67/312 (21%), Positives = 117/312 (37%), Gaps = 41/312 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+ + +++ G F VY + +G A+K + E + + QE+ + L
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS-----NEEEKNRAIIQEVCFMKKLS 83
Query: 415 -HENIVQYYGSEVVD-------DHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTR 464
H NIVQ+ + + ++ L + G + ++ E ++ V
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 465 HILNGLAYLHSTNT--IHRDIKGANLLVDASGVVKLADFGMAKHLT-------------G 509
+ ++H IHRD+K NLL+ G +KL DFG A ++
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP 569
+ E++ +P + PE+I K DIW+LGC + + + P FE
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEK----QDIWALGCILYLLCFRQHP---FED- 255
Query: 570 QAMFKVLNRTPPIPEML--SSEGKDFLLRCFLRNPVERPSAVELLEHPF-IRNANYQNLS 626
A +++N IP + + NP ER S E++ I A N
Sbjct: 256 GAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315
Query: 627 VPMRVFSRINLG 638
P+ N G
Sbjct: 316 SPITELLEQNGG 327
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-55
Identities = 80/277 (28%), Positives = 130/277 (46%), Gaps = 33/277 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G G FG V++ R +G IK I D +S ++Q+E EI+VL L H NI
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIK---TINKD-RSQVPMEQIEAEIEVLKSLDHPNI 82
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRD--ITESIVRNFTRHILNGLAYL 473
++ + EV +D+ +Y+ E G + R V R ++E V + ++N LAY
Sbjct: 83 IKIF--EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 474 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
HS + +H+D+K N+L +K+ DFG+A+ + + G+ +MAPEV K
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK- 199
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN---RTPPIP 583
+D K DIWS G V+ +LTG P + + K
Sbjct: 200 ---RDVTFK----CDIWSAG--VVMYFLLTGCLPFTGTSL--EEVQQKATYKEPNYAVEC 248
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620
L+ + D L + ++P RPSA ++L H + + A
Sbjct: 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 25/266 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ IG G+FG+V+ G+ A+K I+ + AE + + +E+ ++ L+H NI
Sbjct: 42 KEKIGAGSFGTVHRAEWH--GSDVAVK---ILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC--RDITESIVRNFTRHILNGLAYLHST 476
V + G+ +L I EY+ GS+ R + + + E + + G+ YLH+
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 477 NT--IHRDIKGANLLVDASGVVKLADFGMA--KHLTGLSYELSLKGSPNWMAPEVIKAVM 532
N +HR++K NLLVD VK+ DFG++ K T LS + S G+P WMAPEV++
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK-SAAGTPEWMAPEVLR--- 212
Query: 533 QKDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSS 588
+ N K D++S G VI E+ T + PW Q + V + IP L+
Sbjct: 213 DEPSNEK----SDVYSFG--VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266
Query: 589 EGKDFLLRCFLRNPVERPSAVELLEH 614
+ + C+ P +RPS +++
Sbjct: 267 QVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-55
Identities = 73/314 (23%), Positives = 122/314 (38%), Gaps = 61/314 (19%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
IG+G++G V + +T A AIK ++ + + +++++ E++++ L H NI
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI----------------------------------- 443
+ Y + ++ + +E H G +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 444 ----NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVK 497
+ + E ++ N R I + L YLH+ HRDIK N L + S +K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 498 LADFGMAKHLTGLSYELSLK-----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 552
L DFG++K L+ G+P ++APEV+ + G D WS G
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP-----KCDAWSAGVL 265
Query: 553 VIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVER 605
+ +L G P + +VLN P LS +D L RN ER
Sbjct: 266 LHLLLMGAVPFPGVND--ADTISQVLNKKLCFENPNYNV-LSPLARDLLSNLLNRNVDER 322
Query: 606 PSAVELLEHPFIRN 619
A+ L+HP+I
Sbjct: 323 FDAMRALQHPWISQ 336
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-55
Identities = 75/322 (23%), Positives = 134/322 (41%), Gaps = 31/322 (9%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
+ S++H + H L P + A + P +SQ+Q G L+G G FGS
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHA--TKLAPGKEKEPLESQYQVGPLLGSGGFGS 58
Query: 370 VYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLKHE--NIVQYYG 423
VY G AIK + D ++ E+ +L + +++
Sbjct: 59 VYSGIRVSDNLPVAIK---HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL- 114
Query: 424 SEVVD--DHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ + D + LE P + ++ E + E + R+F +L + + H+ +H
Sbjct: 115 -DWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVLH 172
Query: 481 RDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPK 539
RDIK N+L+D G +KL DFG L Y G+ + PE I+ +
Sbjct: 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR------YHRY 225
Query: 540 LALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFL 599
+ +WSLG + +M+ G P FE + +++ + +SSE + + C
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIP---FEHDE---EIIRGQVFFRQRVSSECQHLIRWCLA 279
Query: 600 RNPVERPSAVELLEHPFIRNAN 621
P +RP+ E+ HP++++
Sbjct: 280 LRPSDRPTFEEIQNHPWMQDVL 301
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 4e-55
Identities = 72/279 (25%), Positives = 125/279 (44%), Gaps = 23/279 (8%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
A P W + +G G +G V + NR T + A+K I+ D ++ +C + +++EI
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IV-DMKRAVDCPENIKKEIC 57
Query: 409 VLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+ L HEN+V++Y + Y++LEY G + + + E + F +
Sbjct: 58 INKMLNHENVVKFY--GHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQL 114
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWM 523
+ G+ YLH HRDIK NLL+D +K++DFG+A + E L G+ ++
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM-FKVLNR---T 579
APE++K A VD+WS G + ML G+ PW + +
Sbjct: 175 APELLK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228
Query: 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
P ++ S L + + NP R + ++ + +
Sbjct: 229 NPWKKI-DSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-55
Identities = 65/265 (24%), Positives = 116/265 (43%), Gaps = 20/265 (7%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+ IG G+FG+VY G A+K ++ + + ++ + E+ VL +H NI
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+ + G L I ++ S+ ++ + + R G+ YLH+ +
Sbjct: 83 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 479 IHRDIKGANLLVDASGVVKLADFGMA--KHLTGLSYEL-SLKGSPNWMAPEVIKAVMQKD 535
IHRD+K N+ + VK+ DFG+A K S++ L GS WMAPEVI+
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------TPPIPEMLSSE 589
+ + D+++ G + E++TG+ P+S + +++ R +
Sbjct: 202 YSFQ----SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 590 GKDFLLRCFLRNPVERPSAVELLEH 614
K + C + ERPS +L
Sbjct: 258 MKRLMAECLKKKRDERPSFPRILAE 282
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-54
Identities = 46/340 (13%), Positives = 102/340 (30%), Gaps = 50/340 (14%)
Query: 320 PLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 376
S S V++++ + + +G ++G+ + T++
Sbjct: 36 VRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQ 95
Query: 377 ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK---------------------- 414
ETG S + + + IKQ+++E+ L L+
Sbjct: 96 ETGESFEVHVPYF--TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153
Query: 415 ---HENIVQYYGSEVVDDHLYIYLEYVHP--------GSINRYVREHCRDITESIVRNFT 463
+ +++ E L + Y + + H + + T
Sbjct: 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLT 212
Query: 464 RHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM 523
++ LA LH +H ++ ++++D G V L F S +
Sbjct: 213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV---VSSVSRGFE 269
Query: 524 APEVIKAVM----QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 579
PE+ +D + + D W+LG + + P ++ +
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329
Query: 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
IP+ + L +R ++ +E P
Sbjct: 330 KNIPQ----PVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 2e-54
Identities = 79/332 (23%), Positives = 132/332 (39%), Gaps = 36/332 (10%)
Query: 322 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 381
P + +Q+ K +G G +G V + ++ T
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 382 CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYL--EYVH 439
AIK II S +L +E+ VL L H NI++ Y + +D YL E
Sbjct: 65 RAIK---IIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY--DFFEDKRNYYLVMECYK 119
Query: 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVV 496
G + + + E + +L+G+ YLH N +HRD+K NLL+ + ++
Sbjct: 120 GGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178
Query: 497 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
K+ DFG++ G+ ++APEV++ K + K D+WS+G + +
Sbjct: 179 KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR----KKYDEK----CDVWSIGVILFIL 230
Query: 557 LTGKPPWSEFEGP--QAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSA 608
L G PP F G Q + KV +P +S KD + + + R SA
Sbjct: 231 LAGYPP---FGGQTDQEILRKVEKGKYTFDSPEWKN-VSEGAKDLIKQMLQFDSQRRISA 286
Query: 609 VELLEHPFIRN---ANYQNLSVPMR--VFSRI 635
+ LEHP+I+ + +P +
Sbjct: 287 QQALEHPWIKEMCSKKESGIELPSLANAIENM 318
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-54
Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 30/290 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLKHEN 417
+++G+G+FG V + ++ TG CA+K +I K + L +E+++L L H N
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVK---VISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 418 IVQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
I++ Y E +D Y YL E G + + R +E R +L+G+ Y+H
Sbjct: 88 IMKLY--EFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHK 144
Query: 476 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
+HRD+K NLL+ +++ DFG++ H G+ ++APEV+
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH--- 201
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEM 585
+ K D+WS G + +L+G PP E + KV P +
Sbjct: 202 -GTYDEK----CDVWSTGVILYILLSGCPPFNGANE--YDILKKVEKGKYTFELPQWKK- 253
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 635
+S KD + + P R SA + L+H +I+ + +SV +
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-54
Identities = 65/282 (23%), Positives = 131/282 (46%), Gaps = 29/282 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
++G+G+FG V +R T A+K +I + + +E+++L L H NI
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
++ + E+++D Y+ E G + + + R +E + + +G+ Y+H
Sbjct: 84 MKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKH 140
Query: 477 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
N +HRD+K N+L+ + +K+ DFG++ + G+ ++APEV++
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---- 196
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEML 586
+ K D+WS G + +L+G PP + + E + +V P +
Sbjct: 197 GTYDEK----CDVWSAGVILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWRT-I 249
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628
S + KD + + +P R +A + LEHP+I+ + + ++
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTIS 291
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-54
Identities = 79/270 (29%), Positives = 130/270 (48%), Gaps = 29/270 (10%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ + +++GRG FG V R AIK++ +S K E++ L +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQI-------ESESERKAFIVELRQLSRV 58
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLA 471
H NIV+ YG + + + +EY GS+ + E T + ++ G+A
Sbjct: 59 NHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 472 YLHSTNT---IHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
YLHS IHRD+K NLL+ A G V+K+ DFG A + + KGS WMAPEV
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEV 174
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMFKVL-NRTPPIPE 584
+ + + K D++S G + E++T + P+ E GP + M+ V PP+ +
Sbjct: 175 FE---GSNYSEK----CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK 227
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
L + + RC+ ++P +RPS E+++
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-54
Identities = 75/302 (24%), Positives = 133/302 (44%), Gaps = 30/302 (9%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLGH 412
++ G L+G G++G V + ET A+K I+ + +++EI++L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 413 LKHENIVQYYGSEVVDD----HLYIYLEYVHPGSIN--RYVREHCRDITESIVRNFTRHI 466
L+H+N++Q +V+ + +Y+ +EY G V E R + +
Sbjct: 63 LRHKNVIQLV--DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-R-FPVCQAHGYFCQL 118
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWM 523
++GL YLHS +H+DIK NLL+ G +K++ G+A+ L + + + + GSP +
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTP 580
PE+ + G VDIWS G T+ + TG P FEG +F + +
Sbjct: 179 PPEIANGLDTFSG-----FKVDIWSAGVTLYNITTGLYP---FEGDNIYKLFENIGKGSY 230
Query: 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDK 640
IP D L P +R S ++ +H + R + P+ + + D+
Sbjct: 231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR-KKHPPAEAPVPIPPSPDTKDR 289
Query: 641 SH 642
Sbjct: 290 WR 291
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-53
Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 17/266 (6%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+LIG+G FG VY G AI+ +I + + + +K ++E+ +HEN+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIR---LIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + G+ + HL I ++ VR+ + + R + I+ G+ YLH+
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL------SLKGSPNWMAPEVIKAVM 532
+H+D+K N+ D +G V + DFG+ L G +APE+I+ +
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 533 QKDGNPKLAL--AVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSS 588
KL D+++LG E+ + P+ ++++ + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 589 EGKDFLLRCFLRNPVERPSAVELLEH 614
E D LL C+ ERP+ +L++
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDM 296
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-53
Identities = 82/282 (29%), Positives = 139/282 (49%), Gaps = 27/282 (9%)
Query: 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLE 404
K K + G +G GTFG V IG ++ TG A+K I+ +S + + +++
Sbjct: 3 KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIK 59
Query: 405 QEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
+EI+ L +H +I++ Y +V+ ++ +EYV G + Y+ +H R + E R
Sbjct: 60 REIQNLKLFRHPHIIKLY--QVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRL 116
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GS 519
+ IL+ + Y H +HRD+K N+L+DA K+ADFG++ ++ + L+ GS
Sbjct: 117 FQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGS 173
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVL 576
PN+ APEVI G VDIWS G + +L G P F+ +F K+
Sbjct: 174 PNYAAPEVIS------GRLYAGPEVDIWSCGVILYALLCGTLP---FDDEHVPTLFKKIR 224
Query: 577 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
IPE L+ L+ +P++R + ++ EH + +
Sbjct: 225 GGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 4e-53
Identities = 98/335 (29%), Positives = 140/335 (41%), Gaps = 81/335 (24%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
S T + MEK ++ L+G G++G V N++TG AIK+
Sbjct: 9 SSGVDLGTENLYFQSMEK---------YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL 59
Query: 389 IIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSI 443
DD K A ++ EIK+L L+HEN+V EV Y+ E+V +I
Sbjct: 60 ESDDDKMVKKIA--MR----EIKLLKQLRHENLVNLL--EVCKKKKRWYLVFEFVD-HTI 110
Query: 444 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503
+ + +V+ + I+NG+ + HS N IHRDIK N+LV SGVVKL DFG
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 170
Query: 504 AKHLTGLSYELSLKGSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCT 552
A+ L +P W APE++ G+ K AVD+W++GC
Sbjct: 171 ARTL----------AAPGEVYDDEVATRWYRAPELLV------GDVKYGKAVDVWAIGCL 214
Query: 553 VIEMLTGKPPW---SEFEGPQAMFKVL-------------------NRTPPIPEM----- 585
V EM G+P + S+ + + L R P I E
Sbjct: 215 VTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLER 274
Query: 586 ----LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
LS D +C +P +RP ELL H F
Sbjct: 275 RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 5e-53
Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 29/279 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK----QLEQEIKVLGHLK 414
+++GRG V ++ T A+K +D+ SAE ++ +E+ +L +
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 415 -HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNG 469
H NI+Q + + + + +L + + G + + + ++E R R +L
Sbjct: 82 GHPNIIQLK--DTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEV 136
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
+ LH N +HRD+K N+L+D +KL DFG + L + G+P+++APE+I+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTP 580
M + VD+WS G VI +L G PP W + M +++ +P
Sbjct: 197 CSMNDNHPG-YGKEVDMWSTG--VIMYTLLAGSPPFWHRKQ--MLMLRMIMSGNYQFGSP 251
Query: 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ S KD + R + P +R +A E L HPF +
Sbjct: 252 EWDD-YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-53
Identities = 45/265 (16%), Positives = 98/265 (36%), Gaps = 24/265 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ G ++ G + G +K ++ S + +E L H N+
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVK---VLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 419 VQYYG--SEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHS 475
+ G H + ++ GS+ + E + +S F + G+A+LH+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 476 TNT--IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+ ++++D +++ + +P W+APE ++
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQK-KP 184
Query: 534 KDGNPKLALAVDIWSLGCTVI--EMLTGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSE 589
+D N + + D+WS V+ E++T + P+++ + KV P IP +S
Sbjct: 185 EDTNRR---SADMWSFA--VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPH 239
Query: 590 GKDFLLRCFLRNPVERPSAVELLEH 614
+ C +P +RP ++
Sbjct: 240 VSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 5e-53
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 33/276 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
IGRG++G V I + T A K IP E + + +QEI+++ L H NI
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAK---KIPK--YFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
++ Y E +D+ IYL E G + V ES + +L+ +AY H
Sbjct: 69 IRLY--ETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKL 125
Query: 477 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
N HRD+K N L +KL DFG+A + G+P +++P+V++
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE---- 181
Query: 534 KDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLNRTPPIPE----M 585
P+ D WS G V+ +L G PP + + + K+ T PE
Sbjct: 182 GLYGPE----CDEWSAG--VMMYVLLCGYPPFSAPTD--SEVMLKIREGTFTFPEKDWLN 233
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
+S + + + R ++P +R ++++ LEH +
Sbjct: 234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-53
Identities = 74/287 (25%), Positives = 130/287 (45%), Gaps = 33/287 (11%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-E 416
K +GRG F V ++ TG A K + + +C ++ EI VL K
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAK---FLKKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 417 NIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL 473
++ + EV ++ I L EY G I + + E ++E+ V + IL G+ YL
Sbjct: 90 RVINLH--EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 474 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
H N +H D+K N+L+ G +K+ DFGM++ + + G+P ++APE++
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN- 206
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPP 581
+P + A D+W++G +I +LT P E Q + +
Sbjct: 207 -----YDP-ITTATDMWNIG--IIAYMLLTHTSPFVGEDN--QETYLNISQVNVDYSEET 256
Query: 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628
+S DF+ ++NP +RP+A L H +++ +++NL P
Sbjct: 257 FSS-VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHP 302
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-52
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 36/276 (13%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+++G+G FG T+RETG +KE+ E + +E+KV+ L+H N+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELI-----RFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+++ G D L EY+ G++ ++ S +F + I +G+AYLHS N
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE---------------LSLKGSPNWM 523
IHRD+ N LV + V +ADFG+A+ + + ++ G+P WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 524 APEVIKAVMQKDGNP---KLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL---N 577
APE+I G K VD++S G + E++ ++ F +
Sbjct: 190 APEMIN------GRSYDEK----VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239
Query: 578 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
P +RC +P +RPS V+L
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-52
Identities = 83/322 (25%), Positives = 130/322 (40%), Gaps = 83/322 (25%)
Query: 343 IMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAEC 399
+MEK ++K IG G++G V+ NR+TG AIK+ DD K A
Sbjct: 1 MMEK---------YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-- 49
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVV--DDHLYIYLEYVHPGSINRYVREHCRDITES 457
++ EI++L LKH N+V EV L++ EY ++ + + R + E
Sbjct: 50 LR----EIRMLKQLKHPNLVNLL--EVFRRKRRLHLVFEYCD-HTVLHELDRYQRGVPEH 102
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK 517
+V++ T L + + H N IHRD+K N+L+ V+KL DFG A+ L
Sbjct: 103 LVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL---------- 152
Query: 518 GSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----- 561
P+ W +PE++ G+ + VD+W++GC E+L+G P
Sbjct: 153 TGPSDYYDDEVATRWYRSPELLV------GDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206
Query: 562 ---------------P----WSEFEGPQAMFKVLNRTPPIPE--------MLSSEGKDFL 594
F Q F + P +S L
Sbjct: 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQY-FSGVKIPDPEDMEPLELKFPNISYPALGLL 265
Query: 595 LRCFLRNPVERPSAVELLEHPF 616
C +P ER + +LL HP+
Sbjct: 266 KGCLHMDPTERLTCEQLLHHPY 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-52
Identities = 76/344 (22%), Positives = 137/344 (39%), Gaps = 50/344 (14%)
Query: 322 PLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGAS 381
+ A+ P + + + K + +G G +G V + + +
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63
Query: 382 CAIK--------EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
AIK + D+ + +++ EI +L L H NI++ + +V +D Y
Sbjct: 64 KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF--DVFEDKKYF 121
Query: 434 YL--EYVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484
YL E+ G + +++ E N + IL+G+ YLH N +HRDIK
Sbjct: 122 YLVTEFYEGGELFEQIINRHKF--------DECDAANIMKQILSGICYLHKHNIVHRDIK 173
Query: 485 GANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLA 541
N+L+ ++ +K+ DFG++ + G+ ++APEV+K K N K
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK----KKYNEK-- 227
Query: 542 LAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLNRTPPIPE----MLSSEGKDFLL 595
D+WS G + +L G PP + + Q + KV +S E K+ +
Sbjct: 228 --CDVWSCGVIMYILLCGYPPFGGQND--QDIIKKVEKGKYYFDFNDWKNISDEAKELIK 283
Query: 596 RCFLRNPVERPSAVELLEHPFIR----NANYQNLSVPMRVFSRI 635
+ +R +A E L +I+ N N + S +
Sbjct: 284 LMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNM 327
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-52
Identities = 79/285 (27%), Positives = 132/285 (46%), Gaps = 32/285 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G+G F V ++ TG A K II SA ++LE+E ++ L+H NI
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAK---IINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHST 476
V+ + S + Y+ + V G + V RE +E+ + + IL +AY HS
Sbjct: 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSN 124
Query: 477 NTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+HR++K NLL+ VKLADFG+A + G+P +++PEV+K
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK---- 180
Query: 534 KDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPE 584
+P + VDIW+ G VI +L G PP W E + ++ ++ +P
Sbjct: 181 --KDP-YSKPVDIWACG--VILYILLVGYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDT 233
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPM 629
++ E K + NP +R +A + L+ P+I N ++
Sbjct: 234 -VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHR 277
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-52
Identities = 65/335 (19%), Positives = 132/335 (39%), Gaps = 32/335 (9%)
Query: 341 PHIMEKPSASPKKSQ----WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDD 393
P +E + + + + +G G FG V+ ++E +K + ++ D
Sbjct: 7 PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE---YVHPGSINRYVREH 450
+ ++ EI +L ++H NI++ ++ ++ + L + + ++ H
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVL--DIFENQGFFQLVMEKHGSGLDLFAFIDRH 124
Query: 451 CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
R + E + R +++ + YL + IHRDIK N+++ +KL DFG A +L
Sbjct: 125 PR-LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 511 SYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE 567
G+ + APEV+ GNP +++WSLG T+ ++ + P+ E E
Sbjct: 184 KL---FYTFCGTIEYCAPEVLM------GNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
Query: 568 GPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSV 627
+ + P ++S E + P R + +L+ P++
Sbjct: 235 ------ETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV-TQPVNLADY 287
Query: 628 PMRVFSRINLGDKSHDQVERATRKTESLPDSPETR 662
R+N + SL D + +
Sbjct: 288 TWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQ 322
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-52
Identities = 85/300 (28%), Positives = 145/300 (48%), Gaps = 29/300 (9%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHL 413
+ + +G G+FG V + T+ +T A+K I K ++ ++E+EI L L
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLL 66
Query: 414 KHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+H +I++ Y +V+ + + +EY G + Y+ E R +TE R F + I+ +
Sbjct: 67 RHPHIIKLY--DVITTPTDIVMVIEYAG-GELFDYIVEKKR-MTEDEGRRFFQQIICAIE 122
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVI 528
Y H +HRD+K NLL+D + VK+ADFG++ +T ++ LK GSPN+ APEVI
Sbjct: 123 YCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVI 179
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEM 585
G VD+WS G + ML G+ P F+ +F KV + +P+
Sbjct: 180 N------GKLYAGPEVDVWSCGIVLYVMLVGRLP---FDDEFIPNLFKKVNSCVYVMPDF 230
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQV 645
LS + + R + +P++R + E+ P+ N N + PM + ++
Sbjct: 231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF-NVNLPDYLRPMEEVQGSYADSRIVSKL 289
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 4e-52
Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 41/288 (14%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
G+ +G G F V + TG A K I + +++E+E+ +L ++
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAK---FIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 415 HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 470
H NI+ + ++ ++ + L E V G + + +E +TE F + IL+G+
Sbjct: 67 HPNIITLH--DIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGV 121
Query: 471 AYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
YLHS H D+K N+++ + +KL DFG+A + + ++ G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN----- 577
++ P L L D+WS+G VI +L+G P E + Q +
Sbjct: 182 IVN------YEP-LGLEADMWSIG--VITYILLSGASPFLGETK--QETLTNISAVNYDF 230
Query: 578 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625
S KDF+ R +++P R + + LEH +I+ +N+
Sbjct: 231 DEEYFSN-TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-52
Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 29/279 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
++IG+G F V NRETG A+K VD+ + L++E + LKH +I
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDI-TESIVRNFTRHILNGLAYLHS 475
V+ + D LY+ E++ + V R + +E++ ++ R IL L Y H
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 476 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAV 531
N IHRD+K +L+ + S VKL FG+A L + G+P++MAPEV+K
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVK-- 206
Query: 532 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPI 582
P VD+W G VI +L+G P + + +F ++
Sbjct: 207 ----REP-YGKPVDVWGCG--VILFILLSGCLPFYGT---KERLFEGIIKGKYKMNPRQW 256
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
+S KD + R + +P ER + E L HP+++ +
Sbjct: 257 SH-ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 73/299 (24%), Positives = 131/299 (43%), Gaps = 41/299 (13%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
G+ +G G F V + TG A K I + + +E+E+ +L ++
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAK---FIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 415 HENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 470
H N++ + EV ++ + L E V G + + +E +TE F + ILNG+
Sbjct: 73 HPNVITLH--EVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 127
Query: 471 AYLHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
YLHS H D+K N+++ +K+ DFG+A + + ++ G+P ++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN----- 577
++ P L L D+WS+G VI +L+G P + + Q V
Sbjct: 188 IVN------YEP-LGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANVSAVNYEF 236
Query: 578 RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 636
S+ KDF+ R +++P +R + + L+HP+I+ + Q +
Sbjct: 237 EDEYFSN-TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNME 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-52
Identities = 62/344 (18%), Positives = 116/344 (33%), Gaps = 86/344 (25%)
Query: 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK----------------EVDIIP- 391
AS + ++ + +GRG FG V+ N+ + AIK EV +
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAK 60
Query: 392 ------------------------------------DDPKSAECIKQLEQEIKVLGHLKH 415
S + +I+ +
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYL 473
+N V +LYI ++ ++ ++ R D + + I + +L
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-------------GSP 520
HS +HRD+K +N+ VVK+ DFG+ + E ++ G+
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--- 577
+M+PE I + + K VDI+SLG + E+L E +++
Sbjct: 241 LYMSPEQIH---GNNYSHK----VDIFSLGLILFELLYSFSTQME------RVRIITDVR 287
Query: 578 --RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ P + + + +P ERP A +++E+ N
Sbjct: 288 NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-52
Identities = 82/379 (21%), Positives = 150/379 (39%), Gaps = 45/379 (11%)
Query: 261 SPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHP 320
S N ++ + R N R R+ + Q++ L E+ +A P
Sbjct: 8 SSGVDNKFNKERRRARREIRHLPNLN-REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66
Query: 321 LPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA 380
+ + +A ++ +IGRG V +R TG
Sbjct: 67 KGTENLYFQSMGPE------DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH 120
Query: 381 SCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYL- 435
A+K ++ + E + +E +L + H +I+ + + +++L
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI--DSYESSSFMFLV 178
Query: 436 -EYVHPG-------SINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGAN 487
+ + G +E R+ R +L +++LH+ N +HRD+K N
Sbjct: 179 FDLMRKGELFDYLTEKVAL--------SEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230
Query: 488 LLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIW 547
+L+D + ++L+DFG + HL L G+P ++APE++K M + VD+W
Sbjct: 231 ILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG-YGKEVDLW 289
Query: 548 SLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCF 598
+ G VI +L G PP W + M ++ +P + SS KD + R
Sbjct: 290 ACG--VILFTLLAGSPPFWHRRQ--ILMLRMIMEGQYQFSSPEWDD-RSSTVKDLISRLL 344
Query: 599 LRNPVERPSAVELLEHPFI 617
+P R +A + L+HPF
Sbjct: 345 QVDPEARLTAEQALQHPFF 363
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-52
Identities = 66/278 (23%), Positives = 129/278 (46%), Gaps = 35/278 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
++G+G+FG V +R T A+K +I + + +E+++L L H NI
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVK---VINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
++ + E+++D Y+ E G + + ++ +E + + +G+ Y+H
Sbjct: 84 MKLF--EILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHK 139
Query: 476 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
N +HRD+K N+L+ + +K+ DFG++ + G+ ++APEV++
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR--- 196
Query: 533 QKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIP 583
+ K D+WS G VI +L+G PP + + E + +V P
Sbjct: 197 -GTYDEK----CDVWSAG--VILYILLSGTPPFYGKNE--YDILKRVETGKYAFDLPQWR 247
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
+S + KD + + +P R +A + LEHP+I+ +
Sbjct: 248 T-ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-52
Identities = 48/356 (13%), Positives = 95/356 (26%), Gaps = 52/356 (14%)
Query: 307 KELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPH---IMEKPSASPKKSQWQKGKLIG 363
++LL+ L + + +VT+ V P S + + + + +
Sbjct: 12 RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLR 71
Query: 364 RGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG 423
G V++ + E A+K S +++L + L E+ +
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKV--FTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 424 SE--------------------------VVDDHLYIYLEYVH-----PGSINRYVREHCR 452
+ + + S +V
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512
D + T ++ A L S +H NL + G + L D +
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249
Query: 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQA 571
P AP A++ W LG ++ + P+ G +
Sbjct: 250 AS---SVPVTYAPR----EFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 572 MFKVLNRTPPIPEML--------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+K + P + L K + R + R +E +E P
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 74/304 (24%), Positives = 122/304 (40%), Gaps = 38/304 (12%)
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
PP T P ++ +++++ G L+G+G FG+V+ G AIK
Sbjct: 9 GPPAPPGTPTPPPGGKDR---EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIK--- 62
Query: 389 IIP----DDPKSAECIKQLEQEIKVL----GHLKHENIVQYYGSEVVD--DHLYIYLEYV 438
+IP E+ +L H +++ + + + + LE
Sbjct: 63 VIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL--DWFETQEGFMLVLERP 120
Query: 439 HPGS-INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVV 496
P + Y+ E + E R F ++ + + HS +HRDIK N+L+D G
Sbjct: 121 LPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA 179
Query: 497 KLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI-- 554
KL DFG L Y G+ + PE I + AL +WSLG ++
Sbjct: 180 KLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS------RHQYHALPATVWSLG--ILLY 230
Query: 555 EMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+M+ G P FE Q ++L P +S + + RC P RPS E+L
Sbjct: 231 DMVCGDIP---FERDQ---EILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284
Query: 615 PFIR 618
P+++
Sbjct: 285 PWMQ 288
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-51
Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +GRG FG V+ + + K + +++EI +L +H NI
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAK---FVK---VKGTDQVLVKKEISILNIARHRNI 63
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+ + S + L + E++ I R + E + ++ + L +LHS N
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHN 122
Query: 478 TIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
H DI+ N++ S +K+ +FG A+ L L +P + APEV +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ------ 176
Query: 536 GNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEML 586
+ ++ A D+WSLG + +L+G P +E Q + ++N E +
Sbjct: 177 HDV-VSTATDMWSLG--TLVYVLLSGINPFLAETN--QQIIENIMNAEYTFDEEAFKE-I 230
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
S E DF+ R ++ R +A E L+HP+++
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-50
Identities = 79/310 (25%), Positives = 135/310 (43%), Gaps = 32/310 (10%)
Query: 326 GALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIK 385
G + +++ + + +G+G F V ++ TG A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 386 EVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-N 444
II SA ++LE+E ++ L+H NIV+ + S + Y+ + V G +
Sbjct: 61 ---IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE 117
Query: 445 RYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLAD 500
V RE +E+ + + IL +AY HS +HR++K NLL+ VKLAD
Sbjct: 118 DIVAREF---YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 501 FGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLT 558
FG+A + G+P +++PEV+K + + VDIW+ G VI +L
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLK---KDPYSKP----VDIWACG--VILYILLV 225
Query: 559 GKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
G PP W E + ++ ++ +P ++ E K + NP +R +A +
Sbjct: 226 GYPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDT-VTPEAKSLIDSMLTVNPKKRITADQA 282
Query: 612 LEHPFIRNAN 621
L+ P+I N
Sbjct: 283 LKVPWICNRE 292
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 31/295 (10%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + +++G G F V++ R TG A+K I P + LE EI VL
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALK---CIKKSPAFRD--SSLENEIAVLKK 62
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGL 470
+KHENIV H Y+ ++ V G + +R + R TE + +L+ +
Sbjct: 63 IKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAV 119
Query: 471 AYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEV 527
YLH +HRD+K NLL + + + + DFG++K + G+P ++APEV
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACGTPGYVAPEV 178
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP-WSEFEGPQAMF-KVLN-----RTP 580
+ + AVD WS+G +L G PP + E E +F K+ +P
Sbjct: 179 LA-------QKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKEGYYEFESP 229
Query: 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 635
+ +S KDF+ ++P ER + + L HP+I + + V +I
Sbjct: 230 FWDD-ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQI 283
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 79/316 (25%), Positives = 142/316 (44%), Gaps = 32/316 (10%)
Query: 325 PGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTNRETGASC 382
G + P+ S + P KK ++ GK++G G+F +V + T
Sbjct: 2 DGTAAEPRPGAGS---LQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREY 58
Query: 383 AIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVH 439
AIK ++ II + + + E V+ L H V+ Y + D+ LY L Y
Sbjct: 59 AIKILEKRHIIKE--NKVPYVTR---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113
Query: 440 PGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLA 499
G + +Y+R E+ R +T I++ L YLH IHRD+K N+L++ +++
Sbjct: 114 NGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQIT 172
Query: 500 DFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEM 556
DFG AK L+ S + S G+ +++PE++ + K + D+W+LGC + ++
Sbjct: 173 DFGTAKVLSPESKQARANSFVGTAQYVSPELL----TEKSACK---SSDLWALGCIIYQL 225
Query: 557 LTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERP------SAV 609
+ G PP+ +F K++ PE + +D + + + + +R
Sbjct: 226 VAGLPPFRA-GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 284
Query: 610 ELLEHPFIRNANYQNL 625
L HPF + ++NL
Sbjct: 285 PLKAHPFFESVTWENL 300
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-50
Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 34/294 (11%)
Query: 341 PHIMEKPSASPKKS---QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSA 397
+ P P ++ K IG G FG + ++ T A+K I
Sbjct: 4 APVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAID 60
Query: 398 ECIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDIT 455
E +++EI L+H NIV++ EV+ HL I +EY G + + R +
Sbjct: 61 E---NVQREIINHRSLRHPNIVRFK--EVILTPTHLAIIMEYASGGELYERICNAGR-FS 114
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV--VKLADFGMAKHLTGLSYE 513
E R F + +L+G++Y HS HRD+K N L+D S +K+ DFG +K S
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174
Query: 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ--A 571
S G+P ++APEV+ D+WS G T+ ML G P FE P+
Sbjct: 175 KSTVGTPAYIAPEVLL------RQEYDGKIADVWSCGVTLYVMLVGAYP---FEDPEEPR 225
Query: 572 MFK-----VLNRTPPIPEM--LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
++ +L+ IP+ +S E + R F+ +P R S E+ H +
Sbjct: 226 DYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-50
Identities = 78/297 (26%), Positives = 133/297 (44%), Gaps = 41/297 (13%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQL 403
M + + ++Q + +G+G F V G A II SA ++L
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM---IINTKKLSARDHQKL 57
Query: 404 EQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI------TES 457
E+E ++ LKH NIV+ + S + H Y+ + V G E DI +E+
Sbjct: 58 EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG-------ELFEDIVAREYYSEA 110
Query: 458 IVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL 514
+ + IL + + H +HR++K NLL+ VKLADFG+A + G
Sbjct: 111 DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 515 S-LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQ 570
G+P +++PEV++ + VD+W+ G VI +L G PP W E +
Sbjct: 171 FGFAGTPGYLSPEVLR---KDPYGKP----VDLWACG--VILYILLVGYPPFWDEDQ--H 219
Query: 571 AMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
++ ++ +P ++ E KD + + NP +R +A E L+HP+I + +
Sbjct: 220 RLYQQIKAGAYDFPSPEWDT-VTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-50
Identities = 68/297 (22%), Positives = 125/297 (42%), Gaps = 37/297 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
G+ +G G F V + TG A K I + +++E+E+ +L +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAY 472
H N++ + + + LE V G + + +E ++E +F + IL+G+ Y
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 473 LHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
LH+ H D+K N+++ +KL DFG+A + ++ G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RT 579
P L L D+WS+G VI +L+G P + + Q + +
Sbjct: 191 N------YEP-LGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANITSVSYDFDE 239
Query: 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 636
S KDF+ + ++ +R + E L HP+I + Q V +
Sbjct: 240 EFFSH-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-50
Identities = 82/331 (24%), Positives = 142/331 (42%), Gaps = 46/331 (13%)
Query: 314 NHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPK-----------KSQWQKGKLI 362
+H + H + G + S++S S P ++ +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 363 GRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422
GRG VY + T A+K + K+ + K + EI VL L H NI++
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLK------KTVD-KKIVRTEIGVLLRLSHPNIIKLK 114
Query: 423 GSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ + LE V G + +R V + + +E + + IL +AYLH +H
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENGIVH 171
Query: 481 RDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGN 537
RD+K NLL +K+ADFG++K + ++ G+P + APE+++
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILR----GCAY 227
Query: 538 PKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSS 588
VD+WS+G +I +L G P + E G Q MF ++LN +P E +S
Sbjct: 228 GP---EVDMWSVG--IITYILLCGFEPFYDE-RGDQFMFRRILNCEYYFISPWWDE-VSL 280
Query: 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
KD + + + +P +R + + L+HP++
Sbjct: 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 8e-50
Identities = 78/384 (20%), Positives = 154/384 (40%), Gaps = 36/384 (9%)
Query: 269 SADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGAL 328
D + S + R + + + E + + + P
Sbjct: 11 GVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP 70
Query: 329 SPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVD 388
+P + + K A K +++G G FG V+ TG A K +
Sbjct: 71 APFDHRI-------VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV 447
+ + ++++ EI V+ L H N++Q Y + + + + +EYV G + +R +
Sbjct: 124 T-----RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178
Query: 448 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAK 505
E +TE F + I G+ ++H +H D+K N+L + +K+ DFG+A+
Sbjct: 179 DESYN-LTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
Query: 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP- 562
G+P ++APEV+ + ++ D+WS+G VI +L+G P
Sbjct: 238 RYKPREKLKVNFGTPEFLAPEVVN------YDF-VSFPTDMWSVG--VIAYMLLSGLSPF 288
Query: 563 WSEFEGPQAMFKVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
+ + + + +L + +S E K+F+ + ++ R SA E L+HP++
Sbjct: 289 LGDND-AETLNNILACRWDLEDEEFQD-ISEEAKEFISKLLIKEKSWRISASEALKHPWL 346
Query: 618 RNAN-YQNLSVPMRVFSRINLGDK 640
+ + LS + + D
Sbjct: 347 SDHKLHSRLSAQKKKNRGSDAQDF 370
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-49
Identities = 92/422 (21%), Positives = 171/422 (40%), Gaps = 56/422 (13%)
Query: 341 PHIMEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAE 398
P ++ K + G +G GTFG V +G + TG A+K I+ +S +
Sbjct: 2 PMAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLD 58
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVD--DHLYIYLEYVHPGSINRYVREHCRDITE 456
+ ++ +EI+ L +H +I++ Y +V+ +++ +EYV G + Y+ ++ R + E
Sbjct: 59 VVGKIRREIQNLKLFRHPHIIKLY--QVISTPSDIFMVMEYVSGGELFDYICKNGR-LDE 115
Query: 457 SIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL 516
R + IL+G+ Y H +HRD+K N+L+DA K+ADFG++ ++ + L
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---L 172
Query: 517 K---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QA 571
+ GSPN+ APEVI G VDIWS G + +L G P F+
Sbjct: 173 RTSCGSPNYAAPEVIS------GRLYAGPEVDIWSSGVILYALLCGTLP---FDDDHVPT 223
Query: 572 MF-KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN--ANYQNLSVP 628
+F K+ + P+ L+ L +P++R + ++ EH + + Y P
Sbjct: 224 LFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP 283
Query: 629 MRVFSRIN---------LGDKSHDQVERATRKTESLPDSPETR-----VRNRKLPCNSEV 674
+ I+ + S ++V P + NR++ ++
Sbjct: 284 SYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRN--HQDPLAVAYHLIIDNRRIMNEAK- 340
Query: 675 CPQCHAGTFNCATASRHSSCSTFGVHISLSTSNSHNFSPSSRNMPLGAVNNHPCAPLRSQ 734
+ A+ H++ F + ++ + Q
Sbjct: 341 ---------DFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQ 391
Query: 735 GQ 736
G
Sbjct: 392 GV 393
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 6e-49
Identities = 70/297 (23%), Positives = 126/297 (42%), Gaps = 37/297 (12%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP----DDPKSAECIKQLEQEIKVLGHLK 414
G+ +G G F V + TG A K I + C +++E+E+ +L +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYV-REHCRDITESIVRNFTRHILNGLAY 472
H NI+ + + + LE V G + + +E ++E +F + IL+G+ Y
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 473 LHSTNTIHRDIKGANLLV----DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
LH+ H D+K N+++ +KL DFG+A + ++ G+P ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMF-KVLN-----RT 579
P L L D+WS+G VI +L+G P + + Q +
Sbjct: 191 N------YEP-LGLEADMWSIG--VITYILLSGASPFLGDTK--QETLANITAVSYDFDE 239
Query: 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRIN 636
+ S KDF+ + ++ +R + E L HP+I + Q V +
Sbjct: 240 EFFSQ-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLE 295
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-48
Identities = 87/354 (24%), Positives = 147/354 (41%), Gaps = 83/354 (23%)
Query: 318 AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKS--QWQKGKLIGRGTFGSVYIGTN 375
AH G L P M +A S ++++ +G GT+G VY +
Sbjct: 2 AHHHHHHMGTLEAQTQG------PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAID 55
Query: 376 RETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432
T + AIK + + ++ P +A I+ E+ +L L+H NI++ + L+
Sbjct: 56 TVTNETVAIKRIRLEHEEEGVPGTA--IR----EVSLLKELQHRNIIELKSVIHHNHRLH 109
Query: 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492
+ EY + +Y+ + D++ ++++F ++NG+ + HS +HRD+K NLL+
Sbjct: 110 LIFEYAE-NDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167
Query: 493 S-----GVVKLADFGMAKHLTGLSYELSLKGSPN----------WM-APEVIKAVMQKDG 536
S V+K+ DFG+A+ G P W PE++ G
Sbjct: 168 SDASETPVLKIGDFGLAR----------AFGIPIRQFTHEIITLWYRPPEILL------G 211
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTP------------- 580
+ + +VDIWS+ C EML P + SE + +F+VL P
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GLPDDTTWPGVTALPD 270
Query: 581 ---------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ +L EG D L +PV+R SA LEHP+ +
Sbjct: 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH 324
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 66/275 (24%), Positives = 124/275 (45%), Gaps = 21/275 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-----QEIKVLGHLK 414
+ IG+G+FG V I +T A+K + +C+++ E +E++++ L+
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQIMQGLE 73
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H +V + S ++ +++ ++ + G + RY + E V+ F ++ L YL
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
+ IHRD+K N+L+D G V + DF +A L + ++ G+ +MAPE+
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF----SS 188
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW--SEFEGPQAMF-KVLNRTPPIPEMLSSEGK 591
+ AVD WSLG T E+L G+ P+ + + P S E
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248
Query: 592 DFLLRCFLRNPVER-PSAVELLEHPFIRNANYQNL 625
L + NP +R ++ P++ + N+ +
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-48
Identities = 85/309 (27%), Positives = 137/309 (44%), Gaps = 67/309 (21%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
+++K + IG GT+G+V+ NRET A+K V + DD P SA ++ EI +L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LR----EICLLK 56
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH+NIV+ + D L + E+ + +Y D+ IV++F +L GL
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---------- 521
+ HS N +HRD+K NLL++ +G +KLA+FG+A+ G P
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR----------AFGIPVRCYSAEVVTL 165
Query: 522 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVL 576
W P+V+ G + ++D+WS GC E+ P + + +F++L
Sbjct: 166 WYRPPDVLF------GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 577 ---------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVE 610
L++ G+D L NPV+R SA E
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 611 LLEHPFIRN 619
L+HP+ +
Sbjct: 280 ALQHPYFSD 288
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-48
Identities = 82/310 (26%), Positives = 136/310 (43%), Gaps = 67/310 (21%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVLG 411
++ + IG GT+G VY N G + A+K++ + +D P + I+ EI +L
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTT--IR----EISILK 55
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
LKH NIV+ Y L + E++ + + + + ++F +LNG+A
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---------- 521
Y H +HRD+K NLL++ G +K+ADFG+A+ G P
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLAR----------AFGIPVRKYTHEIVTL 164
Query: 522 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL- 576
W AP+V+ G+ K + +DIWS+GC EM+ G P + SE + +F++L
Sbjct: 165 WYRAPDVLM------GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218
Query: 577 --------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERPSAVEL 611
P+P + L G D L + +P +R +A +
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
Query: 612 LEHPFIRNAN 621
LEH + + N
Sbjct: 279 LEHAYFKENN 288
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-48
Identities = 61/274 (22%), Positives = 118/274 (43%), Gaps = 32/274 (11%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G G FG V+ + TG K ++ ++ EI ++ L H +
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINT-----PYPLDKYTVKNEISIMNQLHHPKL 110
Query: 419 VQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ + + +D + L E++ G + +R E + ++E+ V N+ R GL ++H
Sbjct: 111 INLH--DAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 167
Query: 476 TNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+ +H DIK N++ + VK+ DFG+A L + + APE++
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---- 223
Query: 534 KDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMFKVLN-----RTPPIPEM 585
P + D+W++G V+ +L+G P E + + + V
Sbjct: 224 --REP-VGFYTDMWAIG--VLGYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSS- 276
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+S E KDF+ + P +R + + LEHP+++
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-48
Identities = 82/329 (24%), Positives = 145/329 (44%), Gaps = 76/329 (23%)
Query: 345 EKPSASPKKSQWQKGKL--------IGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--- 393
+S +++ + +G + +G GT+G VY + G A+K + + +D
Sbjct: 4 HHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI 62
Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
P +A I+ EI +L L H NIV + L + E++ + + + E+
Sbjct: 63 PSTA--IR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTG 115
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513
+ +S ++ + +L G+A+ H +HRD+K NLL+++ G +KLADFG+A+
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-------- 167
Query: 514 LSLKGSPN----------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
G P W AP+V+ G+ K + +VDIWS+GC EM+TGKP
Sbjct: 168 --AFGIPVRSYTHEVVTLWYRAPDVLM------GSKKYSTSVDIWSIGCIFAEMITGKPL 219
Query: 563 W---SEFEGPQAMFKVL------------------NRTPPIPE---------MLSSEGKD 592
+ ++ + +F +L RT + E EG D
Sbjct: 220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGID 279
Query: 593 FLLRCFLRNPVERPSAVELLEHPFIRNAN 621
L +P +R SA + + HP+ ++ +
Sbjct: 280 LLSNMLCFDPNKRISARDAMNHPYFKDLD 308
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-47
Identities = 80/317 (25%), Positives = 134/317 (42%), Gaps = 66/317 (20%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLGH 412
+ K +G GT+ +VY G ++ T A+KE+ + ++ P +A I+ E+ +L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IR----EVSLLKD 56
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
LKH NIV + + L + EY+ + +Y+ + I V+ F +L GLAY
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN----------W 522
H +HRD+K NLL++ G +KLADFG+A+ K P W
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR----------AKSIPTKTYDNEVVTLW 165
Query: 523 M-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVL-- 576
P+++ G+ + +D+W +GC EM TG+P + + E +F++L
Sbjct: 166 YRPPDILL------GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT 219
Query: 577 ----------------NRTPPIPE---------MLSSEGKDFLLRCFLRNPVERPSAVEL 611
P L S+G D L + R SA +
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 612 LEHPFIRNANYQNLSVP 628
++HPF + + +P
Sbjct: 280 MKHPFFLSLGERIHKLP 296
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 80/367 (21%), Positives = 146/367 (39%), Gaps = 61/367 (16%)
Query: 344 MEKPSASPKKSQWQK-----------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
M+ Q + + IG G++ ++ T A+K II
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IID- 56
Query: 393 DPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYV- 447
KS + EI++L +H NI+ +V DD Y+Y+ E + G + ++ +
Sbjct: 57 --KSKRDPTE---EIEILLRYGQHPNIITLK--DVYDDGKYVYVVTELMKGGELLDKILR 109
Query: 448 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV----DASGVVKLADFGM 503
++ +E I + YLH+ +HRD+K +N+L +++ DFG
Sbjct: 110 QKF---FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 504 AKHLTGLSYELSLK-GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGK 560
AK L + L + N++APEV++ Q A DIWSLG V+ MLTG
Sbjct: 167 AKQLRAENGLLMTPCYTANFVAPEVLER--QGYD-----AACDIWSLG--VLLYTMLTGY 217
Query: 561 PP-WSEF-EGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
P + + P+ + ++ + +S KD + + +P +R +A +L
Sbjct: 218 TPFANGPDDTPEEILARIGSGKFSLSGGYWNS-VSDTAKDLVSKMLHVDPHQRLTAALVL 276
Query: 613 EHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESL-----PDSPETRVRNRK 667
HP+I + + Q + +L + A + +S S + R K
Sbjct: 277 RHPWIVHWD-QLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRSTLAQRRGIK 335
Query: 668 LPCNSEV 674
++ +
Sbjct: 336 KITSTAL 342
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-47
Identities = 82/362 (22%), Positives = 146/362 (40%), Gaps = 70/362 (19%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECIKQLEQ 405
+ +++K +G G F +VY ++ T AIK++ + ++A ++
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA--LR---- 61
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
EIK+L L H NI+ + ++ + +++ + ++++ +T S ++ +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN---- 521
L GL YLH +HRD+K NLL+D +GV+KLADFG+AK GSPN
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGSPNRAYT 170
Query: 522 ------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQA 571
W APE++ G + VD+W++GC + E+L P S+ +
Sbjct: 171 HQVVTRWYRAPELLF------GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 224
Query: 572 MFKVL--------------------NRTPPIP-----EMLSSEGKDFLLRCFLRNPVERP 606
+F+ L P IP + D + FL NP R
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284
Query: 607 SAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNR 666
+A + L+ + N + + K A ++ ++ E +
Sbjct: 285 TATQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKR--KRTEALEQGGLPK 342
Query: 667 KL 668
KL
Sbjct: 343 KL 344
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 5e-47
Identities = 92/353 (26%), Positives = 144/353 (40%), Gaps = 78/353 (22%)
Query: 312 SNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVY 371
S NA + L P + + ++ + K+IG G+FG V+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDG----KTGEQREIAYTNCKVIGNGSFGVVF 57
Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ----YYGSEVV 427
E+ AIK+ + D + +E++++ +KH N+V +Y +
Sbjct: 58 QAKLVESD-EVAIKK---VLQDKRFKN------RELQIMRIVKHPNVVDLKAFFYSNGDK 107
Query: 428 DDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHRD 482
D +++ L EYV P ++ R R + + + +++ + +L LAY+HS HRD
Sbjct: 108 KDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166
Query: 483 IKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPN-------WM-APEVIKAVMQ 533
IK NLL+D SGV+KL DFG AK L G PN + APE+I
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKILI--------AGEPNVSYICSRYYRAPELIF---- 214
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP---IPEM-- 585
G +DIWS GC + E++ G+P + S + + KVL TP I M
Sbjct: 215 --GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG-TPSREQIKTMNP 271
Query: 586 ----------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
+ D + R P R +A+E L HPF
Sbjct: 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-47
Identities = 65/314 (20%), Positives = 132/314 (42%), Gaps = 42/314 (13%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE 416
K K +G G+F ++++ + A+K II K E ++EI L + H
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVK---IIS---KRME--ANTQKEITALKLCEGHP 66
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ + H ++ +E ++ G + R ++ +E+ R +++ ++++H
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHD 124
Query: 476 TNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK-GSPNWMAPEVIKAV 531
+HRD+K NLL + + +K+ DFG A+ + L + ++ APE++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN-- 182
Query: 532 MQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEG-----PQAMFK-----VLNR 578
++G + + D+WSLG VI ML+G+ P S + K +
Sbjct: 183 --QNGYDE---SCDLWSLG--VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235
Query: 579 TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLG 638
+ +S E KD + +P +R L + ++++ + + ++
Sbjct: 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS----QLSSNPLMTPDIL 291
Query: 639 DKSHDQVERATRKT 652
S V + T
Sbjct: 292 GSSGAAVHTCVKAT 305
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-47
Identities = 91/331 (27%), Positives = 146/331 (44%), Gaps = 75/331 (22%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD--PKSAECIKQLEQEIKVLG 411
SQ+++ + +G GT+ +VY G N+ TG A+KEV + ++ P +A I+ EI ++
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IR----EISLMK 58
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVH---PGSI-NRYVREHCRDITESIVRNFTRHIL 467
LKHENIV+ Y ++ L + E++ + +R V R + ++V+ F +L
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN------ 521
GLA+ H +HRD+K NLL++ G +KL DFG+A+ G P
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR----------AFGIPVNTFSSE 168
Query: 522 ----WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF 573
W AP+V+ G+ + ++DIWS GC + EM+TGKP + ++ E + +F
Sbjct: 169 VVTLWYRAPDVLM------GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222
Query: 574 KVLNRTP--------------------------------PIPEMLSSEGKDFLLRCFLRN 601
++ TP E L DFL N
Sbjct: 223 DIM-GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281
Query: 602 PVERPSAVELLEHPFIRNANYQNLSVPMRVF 632
P R SA + L HP+ + R
Sbjct: 282 PDMRLSAKQALHHPWFAEYYHHASMGGSRSH 312
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 171 bits (433), Expect = 7e-47
Identities = 44/336 (13%), Positives = 103/336 (30%), Gaps = 47/336 (13%)
Query: 322 PLPPGALSPPKSSVTSAVMP---HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRET 378
S S V++++ + + +G ++G+ + T++ET
Sbjct: 43 TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 102
Query: 379 GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL----------------------KHE 416
G S + + + IKQ+++E+ L L K
Sbjct: 103 GESFEVHV--PYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160
Query: 417 NIVQYYGSEVVDDHLYIYLEYV-----------HPGSINRYVREHCRDITESIVRNFTRH 465
+ + + +++ + + + H + + T
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQ 219
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWM 523
++ LA LH +H ++ ++++D G V L F + +S P
Sbjct: 220 VIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT 279
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP 583
A ++ + + A D W+LG + + P ++ + IP
Sbjct: 280 AERMLP--FGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIP 337
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ + + L +R ++ +E P
Sbjct: 338 QPV----RALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 60/353 (16%), Positives = 114/353 (32%), Gaps = 59/353 (16%)
Query: 320 PLPLPPGALSPPKSSVTSAVMPHIMEK--------PSASPKKSQWQK------------- 358
P G + P V + ++ K S+ P +WQ
Sbjct: 3 PQMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQL 62
Query: 359 -------GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
L+G G F VY T + + ++ + P + Q ++ L
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHIL 467
+++Y + + + + E G+ IN Y + + + +V +F +L
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 468 NGLAYLHSTNTIHRDIKGANLLV-----------DASGVVKLADFGMAKHLTGLSYELSL 516
+ +H IH DIK N ++ D S + L D G + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 517 K---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF 573
+ + E++ K N + +D + + TV ML G + EG +
Sbjct: 243 TAKCETSGFQCVEMLS---NKPWNYQ----IDYFGVAATVYCMLFGTYMKVKNEGGECKP 295
Query: 574 KVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN--ANYQN 624
+ L R P +M +F +++LL + +Y N
Sbjct: 296 EGLFRRLPHLDMW----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTN 344
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 70/296 (23%), Positives = 124/296 (41%), Gaps = 50/296 (16%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+ +G+G +G V+ G+ + G + A+K I + + E E+ L+HE
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVK---IFSSRDEKSW---FRETELYNTVMLRHE 62
Query: 417 NIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
NI+ + S++ H L++ Y GS+ Y++ D + I +GLA+
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL--RIVLSIASGLAH 120
Query: 473 LHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GS 519
LH HRD+K N+LV +G +AD G+A + + +L + G+
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEFEGP 569
+MAPEV+ +Q D VDIW+ G + E+ KPP+ +
Sbjct: 181 KRYMAPEVLDETIQVD-CFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 570 QAMFKVL-------NRTPPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVELLE 613
F+ + + P IP S+ + C+ +NP R +A+ + +
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 70/314 (22%), Positives = 121/314 (38%), Gaps = 51/314 (16%)
Query: 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HE 416
+ ++G G V N T A+K II P ++ +E+++L + H
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPG--HIRSRVFREVEMLYQCQGHR 71
Query: 417 NIVQYYGSEVVDDHLYIYL--EYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYL 473
N+++ E ++ YL E + GSI + + E + + + L +L
Sbjct: 72 NVLELI--EFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFL 127
Query: 474 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLK--------GSPNW 522
H+ HRD+K N+L + VK+ DF + + + GS +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-WSEFEGPQAMFKVLNRT 579
MAPEV++A + D+WSLG VI +L+G PP +
Sbjct: 188 MAPEVVEA--FSEEASIYDKRCDLWSLG--VILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 580 PPIPEML------------------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN-A 620
+ S KD + + +R+ +R SA ++L+HP+++ A
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303
Query: 621 NYQNLSVPMRVFSR 634
L PM V R
Sbjct: 304 PENTLPTPM-VLQR 316
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-46
Identities = 88/314 (28%), Positives = 133/314 (42%), Gaps = 73/314 (23%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
P++ + K+IG G+FG VY ++G AIK+ + D + +E++++
Sbjct: 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDKRFKN------RELQIM 101
Query: 411 GHLKHENIVQ----YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRN 461
L H NIV+ +Y S D +Y+ L +YV P ++ R R + R + V+
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSP 520
+ + LAY+HS HRDIK NLL+D + V+KL DFG AK L +G P
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--------RGEP 212
Query: 521 N-------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGP 569
N + APE+I G ++D+WS GC + E+L G+P + S +
Sbjct: 213 NVSYICSRYYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266
Query: 570 QAMFKVLNRTPP---IPEM------------------------LSSEGKDFLLRCFLRNP 602
+ KVL TP I EM E R P
Sbjct: 267 VEIIKVLG-TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 603 VERPSAVELLEHPF 616
R + +E H F
Sbjct: 326 TARLTPLEACAHSF 339
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-46
Identities = 76/377 (20%), Positives = 140/377 (37%), Gaps = 47/377 (12%)
Query: 265 RNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLP 324
N + P+ P + R + K + +N++
Sbjct: 85 ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144
Query: 325 PGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAI 384
P + V + + +G G FG V+ T R TG + A
Sbjct: 145 PQPVEIKHDHV-----------------LDHYDIHEELGTGAFGVVHRVTERATGNNFAA 187
Query: 385 KEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSI- 443
K V + + +EI+ + L+H +V + + D+ + + E++ G +
Sbjct: 188 KFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242
Query: 444 NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADF 501
+ EH + ++E + R + GL ++H N +H D+K N++ S +KL DF
Sbjct: 243 EKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301
Query: 502 GMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTG 559
G+ HL G+ + APEV + + D+WS+G V+ +L+G
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAE-------GKPVGYYTDMWSVG--VLSYILLSG 352
Query: 560 KPP-WSEFEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
P E + V + +S +GKDF+ + L +P R + + L
Sbjct: 353 LSPFGGEND--DETLRNVKSCDWNMDDSAFSG-ISEDGKDFIRKLLLADPNTRMTIHQAL 409
Query: 613 EHPFIRNANYQNLSVPM 629
EHP++ N +
Sbjct: 410 EHPWLTPGNAPGRDSQI 426
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-46
Identities = 61/296 (20%), Positives = 120/296 (40%), Gaps = 50/296 (16%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
Q K IG+G +G V++G R G A+K + +++ E EI ++HE
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVK---VFFTTEEASW---FRETEIYQTVLMRHE 91
Query: 417 NIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
NI+ + +++ LY+ +Y GS+ Y++ + + ++GL +
Sbjct: 92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCH 149
Query: 473 LHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GS 519
LH+ HRD+K N+LV +G +AD G+A + E+ + G+
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----------KPPWSEFEGP 569
+M PEV+ + ++ + D++S G + E+ + P+ +
Sbjct: 210 KRYMPPEVLDESLNRNHFQSY-IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 570 QAMFKVL-------NRTPPIPEMLSSEGKDFLL-----RCFLRNPVERPSAVELLE 613
++ + P P SS+ + C+ NP R +A+ + +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-46
Identities = 81/329 (24%), Positives = 128/329 (38%), Gaps = 47/329 (14%)
Query: 317 NAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVY 371
LP PP PP P K KK+ +++G G G V
Sbjct: 24 PTPALPHPPAQPPPPPPQQ----FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79
Query: 372 IGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG----SEV 426
N+ T A+K ++ D + +E+++ + +IV+
Sbjct: 80 QIFNKRTQEKFALK---MLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYA 129
Query: 427 VDDHLYIYLEYVHPGSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKG 485
L I +E + G + +R + TE + I + YLHS N HRD+K
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189
Query: 486 ANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL 542
NLL + ++KL DFG AK T + + +P ++APEV+ +K
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--EKYD-----K 242
Query: 543 AVDIWSLGCTVIE--MLTGKPP-WSE--FEGPQAMF-KVLNRTP--PIPE--MLSSEGKD 592
+ D+WSLG VI +L G PP +S M ++ P PE +S E K
Sbjct: 243 SCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 300
Query: 593 FLLRCFLRNPVERPSAVELLEHPFIRNAN 621
+ P +R + E + HP+I +
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWIMQST 329
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-46
Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 21/280 (7%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K+IGRG F V + ++TG A+K + D++ C ++ E VL +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG--EVSCFRE---ERDVLVNGDRR 121
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
I Q + + +++LY+ +EY G + + + I + R + I+ + +H
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQK 534
+HRDIK N+L+D G ++LADFG L G L G+P++++PE+++AV
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN-----RTPPIPEMLSS 588
G D W+LG EM G+ P+ + + K+++ P + E +
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 589 EGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 625
E +D ++ L P R A + HPF ++ L
Sbjct: 301 EARD-FIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGL 339
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 80/319 (25%), Positives = 126/319 (39%), Gaps = 61/319 (19%)
Query: 340 MPHIMEKPSAS----PKKSQWQKG----------KLIGRGTFGSVYIGTNRETGASCAIK 385
M H S+ + + +K +++G G G V +R TG CA+K
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK 60
Query: 386 EVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG----SEVVDDHLYIYLEYVHP 440
++ D PK QE+ +IV L I +E +
Sbjct: 61 ---LLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110
Query: 441 GSI-NRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVV 496
G + +R + TE R I + +LHS N HRD+K NLL + V+
Sbjct: 111 GELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170
Query: 497 KLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
KL DFG AK T + +L+ +P ++APEV+ +K + D+WSLG V
Sbjct: 171 KLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGP--EKYD-----KSCDMWSLG--V 217
Query: 554 IE--MLTGKPP-WSE--FEGPQAMFKVLNR------TPPIPEMLSSEGKDFLLRCFLRNP 602
I +L G PP +S M + + P E +S + K + +P
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE-VSEDAKQLIRLLLKTDP 276
Query: 603 VERPSAVELLEHPFIRNAN 621
ER + + + HP+I +
Sbjct: 277 TERLTITQFMNHPWINQSM 295
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 83/278 (29%), Positives = 137/278 (49%), Gaps = 28/278 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
KL+G+GTFG V + + TG A+K + II D E +VL + +H
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVT---ESRVLQNTRHP 65
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ + D L +EY + G + ++ R TE R + I++ L YLHS
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLHSR 124
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQ 533
+ ++RDIK NL++D G +K+ DFG+ K G+S ++K G+P ++APEV+ +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL----E 178
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKD 592
+ + AVD W LG + EM+ G+ P+ + + +F +L P LS E K
Sbjct: 179 DNDYGR---AVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEIRFPRTLSPEAKS 234
Query: 593 FLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
L ++P +R A E++EH F + N+Q++
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-45
Identities = 88/316 (27%), Positives = 132/316 (41%), Gaps = 74/316 (23%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q ++ G+GTFG+V +G + TG S AIK+ + DP+ ++L Q ++ L L
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPR--FRNREL-QIMQDLAVL 76
Query: 414 KHENIVQ-----YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCR---DITESIVRNFT 463
H NIVQ Y E +Y+ + EYV P +++R R + R +++ F
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 464 RHILNGLAYLH--STNTIHRDIKGANLLVD-ASGVVKLADFGMAKHLTGLSYELSLKGSP 520
++ + LH S N HRDIK N+LV+ A G +KL DFG AK L+ P
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--------PSEP 187
Query: 521 N-------WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 561
N + APE+I GN AVDIWS+GC EM+ G+P
Sbjct: 188 NVAYICSRYYRAPELIF------GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL 241
Query: 562 --------------------PWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLR 600
++ + + + + E D L
Sbjct: 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQY 301
Query: 601 NPVERPSAVELLEHPF 616
P ER E L HP+
Sbjct: 302 LPEERMKPYEALCHPY 317
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 69/275 (25%), Positives = 133/275 (48%), Gaps = 25/275 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+ +G G+FG V++ +R G A+K + ++ K E E +L + H
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL--KQVEHTND---ERLMLSIVTHP 66
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
I++ +G+ +++ ++Y+ G + +R + + + + + L YLHS
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSK 125
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+ I+RD+K N+L+D +G +K+ DFG AK++ ++Y +L G+P+++APEV+
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVV----STKP 179
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLL 595
K ++D WS G + EML G P+ + + K+LN P + + KD L
Sbjct: 180 YNK---SIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAELRFPPFFNEDVKDLLS 235
Query: 596 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
R R+ +R ++ HP+ + ++ L
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 7e-44
Identities = 83/323 (25%), Positives = 146/323 (45%), Gaps = 38/323 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIK---EVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K+IGRG FG V + ++ T A+K + ++I + + E ++
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR--SDSAFFWE---ERDIMAFANSP 129
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+VQ + + D +LY+ +EY+ G + + D+ E R +T ++ L +HS
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSM 187
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L+D SG +KLADFG + G+ + G+P++++PEV+K+ +
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS---Q 244
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIP----EMLSSE 589
G+ D WS+G + EML G P+ + + K++N + +S E
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKE 303
Query: 590 GKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNLS--------VPMRVFSRINLG 638
K+ L+ FL + R E+ H F +N + + VP + S
Sbjct: 304 AKN-LICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP-DLSSD---I 358
Query: 639 DKSH-DQVERATRKTESLPDSPE 660
D S+ D +E + E+ P
Sbjct: 359 DTSNFDDLEEDKGEEETFPIPKA 381
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-44
Identities = 81/284 (28%), Positives = 128/284 (45%), Gaps = 36/284 (12%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++G+G +G V+ T TG A+K + +I + K K E +L +K
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVK 79
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGL 470
H IV + LY+ LEY+ G + R E + I L
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMAL 134
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEV 527
+LH I+RD+K N++++ G VKL DFG+ K + G+ +MAPE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEI 192
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEML 586
+ + G+ + AVD WSLG + +MLTG PP++ E + K+L +P L
Sbjct: 193 L----MRSGHNR---AVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKLNLPPYL 244
Query: 587 SSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
+ E +D L + RN R A E+ HPF R+ N++ L
Sbjct: 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL 288
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 77/327 (23%), Positives = 131/327 (40%), Gaps = 80/327 (24%)
Query: 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD------PKSAECI 400
P S S+++ IG G +G+VY + +G A+K V + P S +
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST--V 59
Query: 401 KQLEQEIKVLGHLK---HENIVQYYGSEVV-------DDHLYIYLEYVHPGSINRYVREH 450
+ E+ +L L+ H N+V+ +V + + + E+V + Y+ +
Sbjct: 60 R----EVALLRRLEAFEHPNVVRLM--DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA 112
Query: 451 -CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
+ +++ R L GL +LH+ +HRD+K N+LV + G VKLADFG+A+
Sbjct: 113 PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR---- 168
Query: 510 LSYELSLKGSPNWMAPEVI----KAVMQKDGNPKLAL------AVDIWSLGCTVIEMLTG 559
+ + P V+ +A P++ L VD+WS+GC EM
Sbjct: 169 ------IYSYQMALTPVVVTLWYRA-------PEVLLQSTYATPVDMWSVGCIFAEMFRR 215
Query: 560 KPPW---SEFEGPQAMFKVL-------------------NRTPPIP-----EMLSSEGKD 592
KP + SE + +F ++ P P + G
Sbjct: 216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQ 275
Query: 593 FLLRCFLRNPVERPSAVELLEHPFIRN 619
LL NP +R SA L+H ++
Sbjct: 276 LLLEMLTFNPHKRISAFRALQHSYLHK 302
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 75/275 (27%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K +G G+FG V + ++E+G A+K + ++ K E E ++L +
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV--KLKQIEHTLN---EKRILQAVNFP 101
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+V+ S + +LY+ +EYV G + ++R +E R + I+ YLHS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+ I+RD+K NLL+D G +++ DFG AK + G ++ +L G+P +APE+I G
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEII----LSKG 214
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGKDFLL 595
K AVD W+LG + EM G PP+ + P ++ K+++ P SS+ KD L
Sbjct: 215 YNK---AVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 596 RCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
+ +R ++ H + ++ +
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-43
Identities = 69/285 (24%), Positives = 126/285 (44%), Gaps = 34/285 (11%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+++GRG FG V+ + TG A K+++ + + E K+L +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAMV---EKKILAKVHSR 245
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNGLAY 472
IV + L + + ++ G I ++ E +T I++GL +
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEH 304
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIK 529
LH N I+RD+K N+L+D G V+++D G+A + + K G+P +MAPE++
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYAGTPGFMAPELLL 362
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF-KVLNRTPPIPEM 585
+ +VD ++LG T+ EM+ + P+ E + + +VL + P+
Sbjct: 363 -------GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415
Query: 586 LSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
S KDF ++P +R S L HP R+ +++ L
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 72/306 (23%), Positives = 113/306 (36%), Gaps = 68/306 (22%)
Query: 341 PHIMEKPSASPKKSQWQK-----GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK 395
PH+ K KK+ +++G G G V N+ T A+K ++ D
Sbjct: 2 PHV--KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD--- 53
Query: 396 SAECIKQLEQEIKVLGHL-KHENIVQYYG----SEVVDDHLYIYLEYVHPGSI-NRYVRE 449
+ +E+++ + +IV+ L I +E + G + +R
Sbjct: 54 ----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR 109
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKH 506
+ TE + I + YLHS N HRD+K NLL + ++KL DFG AK
Sbjct: 110 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169
Query: 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIE--MLTGKPP-W 563
TG Y+ S D+WSLG VI +L G PP +
Sbjct: 170 TTGEKYDKS----------------------------CDMWSLG--VIMYILLCGYPPFY 199
Query: 564 SE--FEGPQAMF-KVLN-----RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 615
S M ++ P E +S E K + P +R + E + HP
Sbjct: 200 SNHGLAISPGMKTRIRMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
Query: 616 FIRNAN 621
+I +
Sbjct: 259 WIMQST 264
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 70/261 (26%), Positives = 107/261 (40%), Gaps = 18/261 (6%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+ IGRG FG V+ G R A+K + + + QE ++L H NI
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVK---SCRET-LPPDLKAKFLQEARILKQYSHPNI 174
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V+ G +YI +E V G ++R + + G+ YL S
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSP-NWMAPEVIKAVMQKD 535
IHRD+ N LV V+K++DFGM++ Y S L+ P W APE +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL-----NY 289
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 592
G + + D+WS G + E + G P+ Q V R P PE+
Sbjct: 290 G--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC-PELCPDAVFR 346
Query: 593 FLLRCFLRNPVERPSAVELLE 613
+ +C+ P +RPS + +
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 66/311 (21%), Positives = 115/311 (36%), Gaps = 56/311 (18%)
Query: 348 SASPKKSQW------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
S P Q + IG+G FG V+ G R G A+K I + +
Sbjct: 30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVK---IFSSREERSW--- 81
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITES 457
E EI L+HENI+ + ++ D+ L++ +Y GS+ Y+ + +
Sbjct: 82 FREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM 141
Query: 458 IVRNFTRHILNGLAYLHSTNT--------IHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
I +GLA+LH HRD+K N+LV +G +AD G+A
Sbjct: 142 I--KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
Query: 510 LSYELSLK-----GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG----- 559
+ + + G+ +MAPEV+ + DI+++G E+
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGG 258
Query: 560 -----KPPWSEFEGPQAMFKVL-------NRTPPIPEMLSSEGKDFLL-----RCFLRNP 602
+ P+ + + + P IP S ++ C+ N
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318
Query: 603 VERPSAVELLE 613
R +A+ + +
Sbjct: 319 AARLTALRIKK 329
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-43
Identities = 66/279 (23%), Positives = 120/279 (43%), Gaps = 25/279 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
+++G+G FG V R TG A K+++ I E ++L +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALN---EKQILEKVNSR 244
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDI-TESIVRNFTRHILNGLAYLHS 475
+V + D L + L ++ G + ++ + E+ + I GL LH
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKD 535
++RD+K N+L+D G ++++D G+A H+ G+ +MAPEV+K
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK------ 358
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF-KVLNRTPPIPEMLSSEGK 591
N + + D W+LGC + EM+ G+ P+ + + + V E S + +
Sbjct: 359 -NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR 417
Query: 592 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
+ ++P ER SA E+ EHP + N++ L
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-42
Identities = 79/279 (28%), Positives = 132/279 (47%), Gaps = 29/279 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
KL+G+GTFG V + + TG A+K + I+ D E +VL + +H
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLT---ENRVLQNSRHP 208
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
+ S D L +EY + G + ++ R +E R + I++ L YLHS
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 477 -NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
N ++RD+K NL++D G +K+ DFG+ K G+ ++K G+P ++APEV++
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE--- 322
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 591
D AVD W LG + EM+ G+ P+ + + +F +L P L E K
Sbjct: 323 DNDYGR----AVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLGPEAK 377
Query: 592 DFLLRCFLRNPVER----PS-AVELLEHPFIRNANYQNL 625
L ++P +R A E+++H F +Q++
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 84/329 (25%), Positives = 136/329 (41%), Gaps = 80/329 (24%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTN-RETGASCAIKEVDIIPDD---PKSAEC 399
MEK Q++ IG G +G V+ + + G A+K V + + P S
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-- 58
Query: 400 IKQLEQEIKVLGHLK---HENIVQYYGSEVV-------DDHLYIYLEYVHPGSINRYVRE 449
I+ E+ VL HL+ H N+V+ + +V + L + E+V + Y+ +
Sbjct: 59 IR----EVAVLRHLETFEHPNVVRLF--DVCTVSRTDRETKLTLVFEHVD-QDLTTYL-D 110
Query: 450 HCRD--ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507
+ + +++ +L GL +LHS +HRD+K N+LV +SG +KLADFG+A+
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-- 168
Query: 508 TGLSYELSLKGSPNWMAPEVI----KAVMQKDGNPKLAL------AVDIWSLGCTVIEML 557
+ + V+ +A P++ L VD+WS+GC EM
Sbjct: 169 --------IYSFQMALTSVVVTLWYRA-------PEVLLQSSYATPVDLWSVGCIFAEMF 213
Query: 558 TGKP--------------------P----WSEFEG-PQAMFKVLNRTP--PIPEMLSSEG 590
KP P W P+ F + P + G
Sbjct: 214 RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 273
Query: 591 KDFLLRCFLRNPVERPSAVELLEHPFIRN 619
KD LL+C NP +R SA L HP+ ++
Sbjct: 274 KDLLLKCLTFNPAKRISAYSALSHPYFQD 302
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-42
Identities = 69/280 (24%), Positives = 130/280 (46%), Gaps = 23/280 (8%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
K+IGRG FG V + + A+K + +++ C ++ E VL + +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR--AETACFRE---ERDVLVNGDSK 134
Query: 417 NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST 476
I + + D++LY+ ++Y G + + + + E + R + ++ + +H
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQK 534
+ +HRDIK N+L+D +G ++LADFG L G G+P++++PE+++A +
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA--ME 252
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRT-----PPIPEMLSS 588
G + D WSLG + EML G+ P+ E + K++N P +S
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 589 EGKDFLLRCFLRNPVER---PSAVELLEHPFIRNANYQNL 625
KD L+R + + R + +HPF ++ N+
Sbjct: 312 NAKD-LIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 73/288 (25%), Positives = 131/288 (45%), Gaps = 37/288 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
++IGRG++ V + ++T A+K V + D+ + ++ E V H
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE--DIDWVQT---EKHVFEQASNH 69
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+V + + L+ +EYV+ G + +++ R + E R ++ I L YLH
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHE 128
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
I+RD+K N+L+D+ G +KL D+GM K GL + G+PN++APE++
Sbjct: 129 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL---- 182
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--------MF-KVLNRTPPIP 583
+ + +VD W+LG + EM+ G+ P+ +F +L + IP
Sbjct: 183 RGEDYGF---SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 584 EMLSSEGKDFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNL 625
LS + L ++P ER ++ HPF RN ++ +
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 76/323 (23%), Positives = 132/323 (40%), Gaps = 79/323 (24%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD---PKSAECIKQLEQEIKVL 410
S+++K IG+GTFG V+ +R+TG A+K+V + + P +A +EIK+L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL------REIKIL 70
Query: 411 GHLKHENIVQYYGSEVV----------DDHLYIYLEYV-HPGSINRYVREHCRDITESIV 459
LKHEN+V E+ +Y+ ++ H + + T S +
Sbjct: 71 QLLKHENVVNLI--EICRTKASPYNRCKGSIYLVFDFCEH--DLAGLLSNVLVKFTLSEI 126
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS 519
+ + +LNGL Y+H +HRD+K AN+L+ GV+KLADFG+A+ + L+
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-----FSLAKNSQ 181
Query: 520 PNWMAPEVI----KAVMQKDGNPKLAL-------AVDIWSLGCTVIEMLTGKPPW---SE 565
PN V+ + P+L L +D+W GC + EM T P +E
Sbjct: 182 PNRYTNRVVTLWYRP-------PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 566 FEGPQAMFKVL------------------NRTPPIPE-----------MLSSEGKDFLLR 596
+ ++ + + D + +
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 294
Query: 597 CFLRNPVERPSAVELLEHPFIRN 619
+ +P +R + + L H F +
Sbjct: 295 LLVLDPAQRIDSDDALNHDFFWS 317
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-42
Identities = 76/275 (27%), Positives = 137/275 (49%), Gaps = 25/275 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
K++G+G+FG V++ ++T AIK + ++ DD EC E +VL +H
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMV---EKRVLSLAWEH 77
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ + + ++L+ +EY++ G + +++ C S + I+ GL +LHS
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHS 136
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
++RD+K N+L+D G +K+ADFGM K + + G+P+++APE++
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEIL---- 190
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 591
+VD WS G + EML G+ P+ + + +F + P P L E K
Sbjct: 191 LGQKYNH---SVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPRWLEKEAK 246
Query: 592 DFLLRCFLRNPVER-PSAVELLEHPFIRNANYQNL 625
D L++ F+R P +R ++ +HP R N++ L
Sbjct: 247 DLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 281
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-42
Identities = 78/345 (22%), Positives = 147/345 (42%), Gaps = 44/345 (12%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKG-------KLI 362
+ +H + H +P + ++ S + + K+ G ++I
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60
Query: 363 GRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKHENI 418
GRG++ V + ++T A++ V + D+ + ++ E V H +
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE--DIDWVQT---EKHVFEQASNHPFL 115
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + + L+ +EYV+ G + +++ R + E R ++ I L YLH
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGI 174
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVMQKD 535
I+RD+K N+L+D+ G +KL D+GM K GL + G+PN++APE++ + +
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEIL----RGE 228
Query: 536 GNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA--------MF-KVLNRTPPIPEML 586
+VD W+LG + EM+ G+ P+ +F +L + IP L
Sbjct: 229 DYGF---SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285
Query: 587 SSEGKDFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNL 625
S + L ++P ER ++ HPF RN ++ +
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 69/274 (25%), Positives = 118/274 (43%), Gaps = 25/274 (9%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
K+++++K K++G G FG+VY G + AIK + + + L E
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEIL-DEA 68
Query: 408 KVLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
V+ + + ++ + G + + + + + G + YVREH +I + N+ I
Sbjct: 69 YVMASVDNPHVCRLLG--ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWM 523
G+ YL +HRD+ N+LV VK+ DFG+AK L E +G P WM
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTP 580
A E I D+WS G TV E++T G P+ + + R P
Sbjct: 187 ALESI-----LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
P + + + + +C++ + RP EL+
Sbjct: 240 Q-PPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-42
Identities = 80/285 (28%), Positives = 144/285 (50%), Gaps = 30/285 (10%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV--DIIPDDPKSAECIKQLEQEIKVLGHLK 414
K++G G +G V++ + +TG A+K + I K+ E + E +VL H++
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQVLEHIR 116
Query: 415 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+V + + + L++ L+Y++ G + ++ TE V+ + I+ L +L
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQIYVGEIVLALEHL 175
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAPEVIK 529
H I+RDIK N+L+D++G V L DFG++K ++ E G+ +MAP++++
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFVADETERAYDFCGTIEYMAPDIVR 233
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMF-KVLNRTPPIPEM 585
G+ K AVD WSLG + E+LTG P+ E + ++L PP P+
Sbjct: 234 G--GDSGHDK---AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288
Query: 586 LSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
+S+ KD + R +++P +R A E+ EH F + N+ +L
Sbjct: 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-41
Identities = 71/342 (20%), Positives = 123/342 (35%), Gaps = 103/342 (30%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ GK +G G+FG V + E+G A+K+ + DP+ +E+ ++ L
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK---VLQDPRYKN------RELDIMKVL 57
Query: 414 KHENIVQ--------------------------------------YYGSEVVDDHLYIYL 435
H NI++ + + +L + +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 436 EYVHPGSINRYVREHCR---DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA 492
EYV P ++++ ++ R I +++ + + + ++HS HRDIK NLLV++
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 493 -SGVVKLADFGMAKHLTGLSYELSLKGSPN-------WM-APEVIKAVMQKDGNPKLALA 543
+KL DFG AK L P+ + APE++ G + +
Sbjct: 177 KDNTLKLCDFGSAKKLI--------PSEPSVAYICSRFYRAPELML------GATEYTPS 222
Query: 544 VDIWSLGCTVIEMLTGKP--------------------PWSE---FEGPQAMFKVLNRTP 580
+D+WS+GC E++ GKP P E P
Sbjct: 223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282
Query: 581 PIP------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
E S D L + P R + E + HPF
Sbjct: 283 AKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 29/279 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
++G+G+FG V + + T A+K + +I DD EC E +VL K
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMV---EKRVLALPGKP 80
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ Q + D LY +EYV+ G + ++ + E + I GL +L S
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
I+RD+K N+++D+ G +K+ADFGM K + ++ K G+P+++APE+I
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAPEII---- 193
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 591
K +VD W+ G + EML G+ P+ E +F ++ P+ +S E
Sbjct: 194 AYQPYGK---SVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNVAYPKSMSKEAV 249
Query: 592 DFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
++P +R ++ EH F R +++ L
Sbjct: 250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 30/280 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGH-LKH 415
+++G+G+FG V + +ETG A+K + I+ DD EC E ++L H
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMT---EKRILSLARNH 83
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+ Q + D L+ +E+V+ G + +++ R E+ R + I++ L +LH
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHD 142
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
I+RD+K N+L+D G KLADFGM K G+ ++ G+P+++APE++
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEIL---- 196
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 591
Q+ AVD W++G + EML G P+ E +F +LN P L +
Sbjct: 197 QEMLYGP---AVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEVVYPTWLHEDAT 252
Query: 592 DFLLRCFLRNPVER------PSAVELLEHPFIRNANYQNL 625
L +NP R +L HPF + ++ L
Sbjct: 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 73/285 (25%), Positives = 128/285 (44%), Gaps = 40/285 (14%)
Query: 360 KLIGRGTFGSVYI---GTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLGHL 413
K++G+G+FG V++ + + A+K + + D E +L +
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--RVRTK----MERDILVEV 83
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGS----INRYVREHCRDITESIVRNFTRHILNG 469
H IV+ + + + LY+ L+++ G +++ V TE V+ + +
Sbjct: 84 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFYLAELALA 138
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPE 526
L +LHS I+RD+K N+L+D G +KL DFG++K + +E G+ +MAPE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 196
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEM 585
V+ + G+ + + D WS G + EMLTG P+ + + +L +P+
Sbjct: 197 VV----NRRGHTQ---SADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKLGMPQF 248
Query: 586 LSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
LS E + L F RNP R E+ H F ++ L
Sbjct: 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-40
Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 28/278 (10%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQLEQEIKVLG-HLKH 415
K+IG+G+FG V + ++ A+K + I+ + I E VL ++KH
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMS---ERNVLLKNVKH 98
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
+V + S D LY L+Y++ G + +++ R E R + I + L YLHS
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHS 157
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEVIKAVM 532
N ++RD+K N+L+D+ G + L DFG+ K + + + G+P ++APEV+
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVL---- 211
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLNRTPPIPEMLSSEGK 591
K + VD W LG + EML G PP+ M+ +LN+ + +++ +
Sbjct: 212 HKQPYDR---TVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKPLQLKPNITNSAR 267
Query: 592 DFLLRCFLRNPVER----PSAVELLEHPFIRNANYQNL 625
L ++ +R +E+ H F N+ +L
Sbjct: 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 66/264 (25%), Positives = 118/264 (44%), Gaps = 23/264 (8%)
Query: 359 GKLIGRGTFGSVYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+++G G FG VY G ++ + A+K D K + E ++ +L H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFM-SEAVIMKNLDH 72
Query: 416 ENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+IV+ G ++++ +I +E G + Y+ + + + ++ I +AYL
Sbjct: 73 PHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVM 532
S N +HRDI N+LV + VKL DFG+++++ Y + P WM+PE I
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI---- 186
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSE 589
+ A D+W + E+L+ GK P+ E + + R P P++
Sbjct: 187 -NFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-PDLCPPV 242
Query: 590 GKDFLLRCFLRNPVERPSAVELLE 613
+ RC+ +P +RP EL+
Sbjct: 243 LYTLMTRCWDYDPSDRPRFTELVC 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-40
Identities = 85/473 (17%), Positives = 169/473 (35%), Gaps = 34/473 (7%)
Query: 171 PTPLHNPKSISTRRRGFSHDLNIECANYSSRADIIPKSAPTSVFSSPAVSPQSSKTGNVF 230
T + + ++ I + + + + + + P
Sbjct: 153 GTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQK 212
Query: 231 SSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSP 290
+ +W+ L ++ + + S S+
Sbjct: 213 TKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGV 272
Query: 291 RKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSAS 350
+ L + + + + N A + + + K +
Sbjct: 273 DGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNN 332
Query: 351 PKKSQWQKG-----KLIGRGTFGSVYIGTNRETGASCAIKEV---DIIPDDPKSAECIKQ 402
+ + + ++G+G+FG V + + T A+K + +I DD EC
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMV 390
Query: 403 LEQEIKVLGH-LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
E +VL K + Q + D LY +EYV+ G + ++ + E
Sbjct: 391 ---EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVF 446
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---G 518
+ I GL +L S I+RD+K N+++D+ G +K+ADFGM K + ++ K G
Sbjct: 447 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCG 504
Query: 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-KVLN 577
+P+++APE+I K +VD W+ G + EML G+ P+ E +F ++
Sbjct: 505 TPDYIAPEII----AYQPYGK---SVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIME 556
Query: 578 RTPPIPEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
P+ +S E ++P +R ++ EH F R +++ L
Sbjct: 557 HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 74/311 (23%), Positives = 123/311 (39%), Gaps = 54/311 (17%)
Query: 342 HIMEKPSASPKKSQWQ-------KGKLIGRGTFGSVYIGT----NRETGASCAIKEVDII 390
I+ + + + + + +G G FG V + TG A+K +
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-- 59
Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVR 448
I L++EI++L +L HENIV+Y G +E + + + +E++ GS+ Y+
Sbjct: 60 --PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP 117
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
++ I + I G+ YL S +HRD+ N+LV++ VK+ DFG+ K +
Sbjct: 118 KNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 509 GLS--YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
Y + SP W APE + K +A D+WS G T+ E+LT
Sbjct: 178 TDKEYYTVKDDRDSPVFWYAPECL-----MQS--KFYIASDVWSFGVTLHELLTYCDSDS 230
Query: 564 SEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL--------------------LRCFLRNPV 603
S M P +M + + L +C+ P
Sbjct: 231 SPMALFLKMIG-----PTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPS 285
Query: 604 ERPSAVELLEH 614
R S L+E
Sbjct: 286 NRTSFQNLIEG 296
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 73/274 (26%), Positives = 121/274 (44%), Gaps = 24/274 (8%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT-NRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIK 408
+ + + +G G+FG V G + +G + A+K + PD E + +E+
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEAMDDFIREVN 73
Query: 409 VLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
+ L H N+++ YG VV + + E GS+ +R+H + + +
Sbjct: 74 AMHSLDHRNLIRLYG--VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWM 523
G+ YL S IHRD+ NLL+ +VK+ DFG+ + L Y + P W
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN---RT 579
APE +K + A D W G T+ EM T G+ PW G Q + K+ R
Sbjct: 192 APESLK-------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
Query: 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
P PE + + +++C+ P +RP+ V L +
Sbjct: 245 PR-PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-40
Identities = 72/300 (24%), Positives = 123/300 (41%), Gaps = 40/300 (13%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
++ + +G+G FGSV + TGA A+K++ + + ++EI
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-----HSGPDQQRDFQREI 75
Query: 408 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
++L L + IV+Y G L + +EY+ G + +++ H + S + ++
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKG-SP-N 521
I G+ YL S +HRD+ N+LV++ VK+ADFG+AK L Y + G SP
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP 580
W APE + D + D+WS G + E+ T S M P
Sbjct: 196 WYAPESL-----SDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
Query: 581 PIPEMLSS--EGK-------------DFLLRCFLRNPVERPSAVELLEH--PFIRNANYQ 623
+ +L EG+ + + C+ +P +RPS L +
Sbjct: 249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 76/291 (26%), Positives = 130/291 (44%), Gaps = 41/291 (14%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
++ + + +G+G FGSV + TG A+K++ + E ++ E+EI
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HSTEEHLRDFEREI 62
Query: 408 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
++L L+H+NIV+Y G +L + +EY+ GS+ Y+++H I + +T
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLSYELSLKG-SP-N 521
I G+ YL + IHRD+ N+LV+ VK+ DFG+ K L +++ G SP
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----------------GKPPWSE 565
W APE + + K ++A D+WS G + E+ T G +
Sbjct: 183 WYAPESL-----TES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 566 FEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ + N R P P+ E + C+ N +RPS +L
Sbjct: 236 MIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 62/300 (20%), Positives = 118/300 (39%), Gaps = 52/300 (17%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
Q ++ RG FG V+ A+K P + Q E E+ L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF------PIQDKQSWQNEYEVYSLPGM 75
Query: 414 KHENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
KHENI+Q+ G+E L++ + GS++ +++ + ++ + + + + G
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARG 133
Query: 470 LAYLHSTNT----------IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-- 517
LAYLH HRDIK N+L+ + +ADFG+A
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 518 -GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWS----EFEGP--- 569
G+ +MAPEV++ + + L +D++++G + E+ + E+ P
Sbjct: 194 VGTRRYMAPEVLEGAI--NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 570 --------QAMFKVL---NRTPPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVELLE 613
+ M +V+ + P + + + + C+ + R SA + E
Sbjct: 252 EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-40
Identities = 79/306 (25%), Positives = 136/306 (44%), Gaps = 61/306 (19%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
L+G G +G V T++ TG AIK+++ D P A + +EIK+L H KHENI+
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFA---LRTLREIKILKHFKHENII 72
Query: 420 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+ S + +YI E + ++R + + +++ ++ F L + LH
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------- 523
+N IHRD+K +NLL++++ +K+ DFG+A+ + + + S
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PW 563
APEV+ + A+D+WS GC + E+ +P P
Sbjct: 190 APEVMLTSAKYSR------AMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 564 SEF-------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVEL 611
S+ + K L P P +M + +G D L R + +P +R +A E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 612 LEHPFI 617
LEHP++
Sbjct: 304 LEHPYL 309
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-40
Identities = 72/261 (27%), Positives = 119/261 (45%), Gaps = 22/261 (8%)
Query: 359 GKLIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K +G G FG V +G + A+K +I + S + + QE + + L H
Sbjct: 13 LKELGSGQFGVVKLGKWKGQY--DVAVK---MIKEGSMSED---EFFQEAQTMMKLSHPK 64
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
+V++YG + +YI EY+ G + Y+R H + + S + + G+A+L S
Sbjct: 65 LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKD 535
IHRD+ N LVD VK++DFGM +++ Y S+ P W APEV
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVF-----HY 179
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 592
K + D+W+ G + E+ + GK P+ + + + KV R P + S
Sbjct: 180 F--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-PHLASDTIYQ 236
Query: 593 FLLRCFLRNPVERPSAVELLE 613
+ C+ P +RP+ +LL
Sbjct: 237 IMYSCWHELPEKRPTFQQLLS 257
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 27/266 (10%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
G+ IG G FG V+ G N + AIK + + K L QE +
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPAL--AVAIK---TCKNCTSDSVREKFL-QEALTMRQF 73
Query: 414 KHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
H +IV+ G V+ ++ ++I +E G + +++ + + + + + LAY
Sbjct: 74 DHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG-SP-NWMAPEVIKA 530
L S +HRDI N+LV ++ VKL DFG+++++ +Y + KG P WMAPE I
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI-- 189
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 587
+ A D+W G + E+L G P+ + + ++ N R P P
Sbjct: 190 ---NFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM-PPNCP 243
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLE 613
+ +C+ +P RP EL
Sbjct: 244 PTLYSLMTKCWAYDPSRRPRFTELKA 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 66/269 (24%), Positives = 110/269 (40%), Gaps = 22/269 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ IG G FG V++G AIK I + S E +E +V+ L H +
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKD-KVAIK---TIREGAMSEE---DFIEEAEVMMKLSHPKL 65
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
VQ YG + + + E++ G ++ Y+R + + G+AYL
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKDG 536
IHRD+ N LV + V+K++DFGM + + Y S P W +PEV
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF-----SFS 180
Query: 537 NPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDF 593
+ + D+WS G + E+ + GK P+ + + + R P + S+
Sbjct: 181 --RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-PRLASTHVYQI 237
Query: 594 LLRCFLRNPVERPSAVELLEH--PFIRNA 620
+ C+ P +RP+ LL +
Sbjct: 238 MNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 29/291 (9%)
Query: 349 ASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
SP +W +G G +G VY G ++ + A+K + +D E
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVE--- 54
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVR 460
+ +E V+ +KH N+VQ G + YI E++ G++ Y+RE R ++ ++
Sbjct: 55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 114
Query: 461 NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS- 519
I + + YL N IHRD+ N LV + +VK+ADFG+++ +TG +Y
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174
Query: 520 P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN 577
P W APE + K ++ D+W+ G + E+ T G P+ + Q +
Sbjct: 175 PIKWTAPESL-----AYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
Query: 578 --RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQN 624
R PE + + + C+ NP +RPS E+ + + ++ +
Sbjct: 228 DYRMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 4e-39
Identities = 76/351 (21%), Positives = 137/351 (39%), Gaps = 28/351 (7%)
Query: 287 LRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEK 346
L + F +R + + + + + + ++S
Sbjct: 320 LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTM 379
Query: 347 PSASPK---KSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECI 400
PS + + + G+ IG G FG V+ G + AIK + +
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVRE 436
Query: 401 KQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIV 459
K L QE + H +IV+ G V+ ++ ++I +E G + +++ + + +
Sbjct: 437 KFL-QEALTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASL 493
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG- 518
+ + LAYL S +HRDI N+LV ++ VKL DFG+++++ +Y + KG
Sbjct: 494 ILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 519 SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL 576
P WMAPE I + A D+W G + E+L G P+ + + ++
Sbjct: 554 LPIKWMAPESI-----NFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
Query: 577 N--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQ 623
N R P P + +C+ +P RP EL + Q
Sbjct: 607 NGERLPM-PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-39
Identities = 74/302 (24%), Positives = 129/302 (42%), Gaps = 54/302 (17%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G G +GSV ++ +G AIK++ A K+ +E+ +L H+
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA---KRAYRELLLLKHM 80
Query: 414 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
+HEN++ S Y+ + ++ + + + +E ++ +L
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL---KFSEEKIQYLVYQML 136
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPE 526
GL Y+HS +HRD+K NL V+ +K+ DFG+A+ E++ W APE
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRWYRAPE 193
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF 566
VI + M + VDIWS+GC + EMLTGK P +EF
Sbjct: 194 VILSWMHYNQ------TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 567 ------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHP 615
+ ++ + L +TP ++ S + D L + + +R +A + L HP
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 616 FI 617
F
Sbjct: 308 FF 309
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-39
Identities = 68/280 (24%), Positives = 125/280 (44%), Gaps = 27/280 (9%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVD---IIPDDPKSAECIKQLEQEIKVLGHLKHE 416
++IGRG FG VY +TG A+K +D I E +L +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--GETLALN---ERIMLSLVSTG 249
Query: 417 N---IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ IV + D L L+ ++ G ++ ++ +E+ +R + I+ GL ++
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHM 308
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
H+ ++RD+K AN+L+D G V+++D G+A + + G+ +MAPEV+ +
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVL---QK 364
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP--QAMF-KVLNRTPPIPEMLSSEG 590
+ D +SLGC + ++L G P+ + + + L +P+ S E
Sbjct: 365 GVAYDS---SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421
Query: 591 KDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
+ L R+ R A E+ E PF R+ ++Q +
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 7e-39
Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 48/302 (15%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPK 395
SA + + + +G+G FGSV + TG A+K++
Sbjct: 27 GSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----HS 81
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
+ E ++ E+EI++L L+H+NIV+Y G +L + +EY+ GS+ Y+++H
Sbjct: 82 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER 141
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT--GLS 511
I + +T I G+ YL + IHRD+ N+LV+ VK+ DFG+ K L
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201
Query: 512 YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT----------- 558
Y++ G SP W APE + + K ++A D+WS G + E+ T
Sbjct: 202 YKVKEPGESPIFWYAPESL-----TES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAE 254
Query: 559 -----GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVEL 611
G + + + N R P P+ E + C+ N +RPS +L
Sbjct: 255 FMRMIGNDKQGQMIVFHLIELLKNNGRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDL 313
Query: 612 LE 613
Sbjct: 314 AL 315
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-39
Identities = 76/322 (23%), Positives = 137/322 (42%), Gaps = 27/322 (8%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
K+++++K K++G G FG+VY G + AIK + + S + K++ E
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREAT-SPKANKEILDEA 68
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
V+ + + ++ + G + + + + + G + YVREH +I + N+ I
Sbjct: 69 YVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMA 524
G+ YL +HRD+ N+LV VK+ DFG+AK L E +G P WMA
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPP 581
E I D+WS G TV E++T G P+ + + R P
Sbjct: 188 LESI-----LHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240
Query: 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRN-ANYQNLSVPMRVFSRINLG 638
P + + + +++C++ + RP EL+ R+ Y + R+ +
Sbjct: 241 -PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP-SPT 298
Query: 639 DKSHDQVERATRKTESLPDSPE 660
D + + + + D+ E
Sbjct: 299 DSNFYRALMDEEDMDDVVDADE 320
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 30/293 (10%)
Query: 344 MEKPS-ASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK 395
PS A W K +G G FG V G R AIK + +
Sbjct: 6 KNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMI------KE 58
Query: 396 SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
+ + +E KV+ +L HE +VQ YG ++I EY+ G + Y+RE
Sbjct: 59 GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ 118
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 515
+ + + + YL S +HRD+ N LV+ GVVK++DFG+++++ Y S
Sbjct: 119 TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178
Query: 516 LKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAM 572
+ P W PEV+ K + DIW+ G + E+ + GK P+ F +
Sbjct: 179 VGSKFPVRWSPPEVL-----MYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA 231
Query: 573 FKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNAN 621
+ R P + S + + C+ ERP+ LL + + +
Sbjct: 232 EHIAQGLRLYR-PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 61/266 (22%), Positives = 113/266 (42%), Gaps = 24/266 (9%)
Query: 358 KGKLIGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ K +G G FG+V G ++ + A+K I+ ++ +L E V+ L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDN 77
Query: 416 ENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
IV+ G + + + +E G +N+Y++++ R + + + + G+ YL
Sbjct: 78 PYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE 134
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKA 530
+N +HRD+ N+L+ K++DFG++K L Y+ G P W APE I
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI-- 192
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLS 587
K + D+WS G + E + G+ P+ +G + + R P
Sbjct: 193 ---NYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-PAGCP 246
Query: 588 SEGKDFLLRCFLRNPVERPSAVELLE 613
E D + C+ + RP +
Sbjct: 247 REMYDLMNLCWTYDVENRPGFAAVEL 272
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 68/274 (24%), Positives = 124/274 (45%), Gaps = 25/274 (9%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGT----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
K+++ +K K++G G FG+V+ G IK +I D + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK---VIEDKSGRQS-FQAVTDHM 66
Query: 408 KVLGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
+G L H +IV+ G + L + +Y+ GS+ +VR+H + ++ N+ I
Sbjct: 67 LAIGSLDHAHIVRLLG--LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWM 523
G+ YL +HR++ N+L+ + V++ADFG+A L +L + P WM
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 524 APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTP 580
A E I G K D+WS G TV E++T G P++ + + R
Sbjct: 185 ALESI-----HFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237
Query: 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
P++ + + +++C++ + RP+ EL
Sbjct: 238 Q-PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 70/296 (23%), Positives = 116/296 (39%), Gaps = 37/296 (12%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 388
PH E+P + + K+IG G G V G R G AIK
Sbjct: 27 AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK--- 83
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
+ + L E ++G H NI++ G I EY+ GS++ ++R
Sbjct: 84 ALKAGYTERQRRDFL-SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
H T + R + G+ YL +HRD+ N+LVD++ V K++DFG+++ L
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202
Query: 509 GLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559
+ ++ W APE I + A D+WS G + E+L G
Sbjct: 203 DDPDAAYTTTGGKIPIR----WTAPEAI-----AFR--TFSSASDVWSFGVVMWEVLAYG 251
Query: 560 KPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+ P+ + V R P P +L C+ ++ +RP +++
Sbjct: 252 ERPYWNMTNRDVISSVEEGYRLPA-PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 75/303 (24%), Positives = 135/303 (44%), Gaps = 53/303 (17%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q +G G +GSV + +TG A+K++ A K+ +E+++L H+
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHM 85
Query: 414 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
KHEN++ S + +Y+ + +N V+ C+ +T+ V+ IL
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQKLTDDHVQFLIYQIL 142
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW-MAPE 526
GL Y+HS + IHRD+K +NL V+ +K+ DFG+A+H E++ + W APE
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPE 199
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF 566
++ M + VDIWS+GC + E+LTG+ P +E
Sbjct: 200 IMLNWMHYNQ------TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253
Query: 567 ------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHP 615
E + + L + P + + + D L + + + +R +A + L H
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 616 FIR 618
+
Sbjct: 314 YFA 316
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-38
Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 31/303 (10%)
Query: 341 PHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD 393
P + KP +K W + K +G G FG V++ T + A+K + P
Sbjct: 168 PCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKT--MKPGS 224
Query: 394 PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CR 452
E V+ L+H+ +V+ + V + +YI E++ GS+ +++
Sbjct: 225 MSVEA----FLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGS 279
Query: 453 DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512
+ +F+ I G+A++ N IHRD++ AN+LV AS V K+ADFG+A+ + Y
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339
Query: 513 ELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGP 569
P W APE I G + D+WS G ++E++T G+ P+ P
Sbjct: 340 TAREGAKFPIKWTAPEAI-----NFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392
Query: 570 QAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQNL 625
+ + + R P PE E + ++RC+ P ERP+ + F Q
Sbjct: 393 EVIRALERGYRMPR-PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYE 451
Query: 626 SVP 628
+P
Sbjct: 452 EIP 454
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-38
Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 29/288 (10%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP 391
+ + + K W + +G+G FG V++GT T AIK + P
Sbjct: 162 TVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKP 218
Query: 392 DDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC 451
+ QE +V+ L+HE +VQ Y V ++ +YI EY+ GS+ +++
Sbjct: 219 GTMSPEAFL----QEAQVMKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGET 273
Query: 452 RD-ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
+ + + I +G+AY+ N +HRD++ AN+LV + V K+ADFG+A+ +
Sbjct: 274 GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333
Query: 511 SYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFE 567
Y P W APE + + D+WS G + E+ T G+ P+
Sbjct: 334 EYTARQGAKFPIKWTAPEAAL-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386
Query: 568 GPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+ + +V R P P D + +C+ + P ERP+ L
Sbjct: 387 NREVLDQVERGYRMPC-PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 69/321 (21%), Positives = 120/321 (37%), Gaps = 61/321 (19%)
Query: 344 MEKPSASPKK--SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
ME ++ P + +LIGRG +G+VY G+ E A+K + +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--PVAVK---VFSFANRQNF--- 52
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDD-----HLYIYLEYVHPGSINRYVREHCRDITE 456
E+ I + ++H+NI ++ + + +EY GS+ +Y+ H D
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVS 112
Query: 457 SIVRNFTRHILNGLAYLHSTNT---------IHRDIKGANLLVDASGVVKLADFGMAKHL 507
S + GLAYLH+ HRD+ N+LV G ++DFG++ L
Sbjct: 113 SC--RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 508 TGLSYEL---------SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
TG S G+ +MAPEV++ + VD+++LG E+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 559 G-------------KPPWSEFEGPQAMFKVL-------NRTPPIPEMLSSEG------KD 592
+ + G F+ + + P PE K+
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 593 FLLRCFLRNPVERPSAVELLE 613
+ C+ ++ R +A E
Sbjct: 291 TIEDCWDQDAEARLTAQXAEE 311
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 65/310 (20%), Positives = 120/310 (38%), Gaps = 65/310 (20%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ IG G +G V + AIK++ + ++ +EIK+L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYC---QRTLREIKILLRF 82
Query: 414 KHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+HENI+ + +YI + + + + ++ + ++ + F IL
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLK--TQHLSNDHICYFLYQILR 139
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----- 523
GL Y+HS N +HRD+K +NLL++ + +K+ DFG+A+ ++
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD------PDHDHTGFLTEYVA 193
Query: 524 -----APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------------- 561
APE++ ++DIWS+GC + EML+ +P
Sbjct: 194 TRWYRAPEIMLNSKGYTK------SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247
Query: 562 ---PWSEF------EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPS 607
P E + L +P + S+ D L + NP +R
Sbjct: 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 307
Query: 608 AVELLEHPFI 617
+ L HP++
Sbjct: 308 VEQALAHPYL 317
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-37
Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 29/293 (9%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAEC 399
SP +W +G G +G VY G ++ + A+K + D + E
Sbjct: 206 YGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEE- 262
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESI 458
+E V+ +KH N+VQ G + YI E++ G++ Y+RE R ++ +
Sbjct: 263 ---FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV 319
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKG 518
+ I + + YL N IHR++ N LV + +VK+ADFG+++ +TG +Y
Sbjct: 320 LLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379
Query: 519 S-PN-WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 575
P W APE + K ++ D+W+ G + E+ T G P+ + Q +
Sbjct: 380 KFPIKWTAPESLA-------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
Query: 576 LN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQN 624
R PE + + + C+ NP +RPS E+ + + ++ +
Sbjct: 433 EKDYRMER-PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 484
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 68/314 (21%), Positives = 127/314 (40%), Gaps = 66/314 (21%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q K IG G G V + + AIK++ + A K+ +E+ ++ +
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYRELVLMKCV 81
Query: 414 KHENIVQ-------YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHI 466
H+NI+ E D +YI +E + ++ + ++ ++ + +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQD-VYIVMELM-DANLCQVIQ---MELDHERMSYLLYQM 136
Query: 467 LNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-AP 525
L G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G S+ ++ + AP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAP 195
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSE 565
EVI VDIWS+GC + EM+ G P E
Sbjct: 196 EVI-------LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248
Query: 566 F-----EGPQAMFKVLNRTPPIP-----------------EMLSSEGKDFLLRCFLRNPV 603
F + + + ++ +S+ +D L + + +
Sbjct: 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 308
Query: 604 ERPSAVELLEHPFI 617
+R S E L+HP+I
Sbjct: 309 KRISVDEALQHPYI 322
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-37
Identities = 74/417 (17%), Positives = 140/417 (33%), Gaps = 108/417 (25%)
Query: 345 EKPSASPKKSQWQKGKL---IGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAEC 399
K S+ ++ + +GRGT+G VY ++ A+K+++ SA
Sbjct: 9 VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSACR 67
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDH----LYIYLEYV----------HPGSINR 445
EI +L LKH N++ +V H +++ +Y H S
Sbjct: 68 ------EIALLRELKHPNVISLQ--KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 446 YVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS----GVVKLADF 501
+ +V++ IL+G+ YLH+ +HRD+K AN+LV G VK+AD
Sbjct: 120 KKPVQ---LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 502 GMAKHLTGLSYELSLKGSPNWM---------APEVIKAVMQKDGNPKLALAVDIWSLGCT 552
G A+ + LK + APE++ G A+DIW++GC
Sbjct: 177 GFAR-----LFNSPLKPLADLDPVVVTFWYRAPELLL------GARHYTKAIDIWAIGCI 225
Query: 553 VIEMLTGKP-----------------------------------------PWSEFEGPQA 571
E+LT +P P
Sbjct: 226 FAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 285
Query: 572 MFKVLNRTPPIPEM------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA----- 620
I M S+ L + +P++R ++ + ++ P+
Sbjct: 286 RRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTS 345
Query: 621 -NYQNLSVPMRVFSRINLGDKSHDQVERATRKTESLPDSPETRVRNRKLPCNSEVCP 676
+ +P + + ++ ++ + + T + +++ P
Sbjct: 346 DVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPP 402
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 68/275 (24%), Positives = 118/275 (42%), Gaps = 26/275 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ +G G FG V++G A+K + S + E ++ L+H+ +
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVK---SLKQGSMSPD---AFLAEANLMKQLQHQRL 70
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTN 477
V+ Y V + +YI EY+ GS+ +++ +T + + + I G+A++ N
Sbjct: 71 VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKD 535
IHRD++ AN+LV + K+ADFG+A+ + Y P W APE I
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-----NY 184
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 592
G + D+WS G + E++T G+ P+ P+ + + R P+ E
Sbjct: 185 G--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-PDNCPEELYQ 241
Query: 593 FLLRCFLRNPVERPSAVELLEH--PFIRN--ANYQ 623
+ C+ P +RP+ L F YQ
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 38/297 (12%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT----NRETGASCAIKEV 387
+ P+ + K + K+IG G FG VY G + + AIK
Sbjct: 22 FQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-- 79
Query: 388 DIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYV 447
+ + + L E ++G H NI++ G + I EY+ G++++++
Sbjct: 80 -TLKAGYTEKQRVDFL-GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137
Query: 448 REHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507
RE + + + R I G+ YL + N +HRD+ N+LV+++ V K++DFG+++ L
Sbjct: 138 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 508 TGLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 558
+ ++ W APE I K A D+WS G + E++T
Sbjct: 198 EDDPEATYTTSGGKIPIR----WTAPEAI-----SYR--KFTSASDVWSFGIVMWEVMTY 246
Query: 559 GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
G+ P+ E + M + + R P P S +++C+ + RP +++
Sbjct: 247 GERPYWELSNHEVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVS 302
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 24/262 (9%)
Query: 362 IGRGTFGSVYIGT--NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FGSV G R+ AIK ++ +++ +E +++ L + IV
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQG-TEKADTEEMMREAQIMHQLDNPYIV 73
Query: 420 QYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
+ G V L + +E G +++++ +I S V + G+ YL N
Sbjct: 74 RLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKGS-P-NWMAPEVIKAVMQK 534
+HRD+ N+L+ K++DFG++K L Y G P W APE I
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI-----N 186
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGK 591
K + D+WS G T+ E L+ G+ P+ + +GP+ M + R P E
Sbjct: 187 FR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELY 243
Query: 592 DFLLRCFLRNPVERPSAVELLE 613
+ C++ +RP + + +
Sbjct: 244 ALMSDCWIYKWEDRPDFLTVEQ 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-37
Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 39/307 (12%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVD 388
V PH E P+ + + K++G G FG V G + S AIK +
Sbjct: 23 VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 389 IIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
+ + + + E ++G H NI++ G + I EY+ GS++ ++R
Sbjct: 83 VGYTEKQRRD----FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 449 EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
+H T + R I +G+ YL +HRD+ N+L++++ V K++DFG+ + L
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 509 GLSYE--------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-G 559
+ ++ W +PE I K A D+WS G + E+++ G
Sbjct: 199 DDPEAAYTTRGGKIPIR----WTSPEAI-----AYR--KFTSASDVWSYGIVLWEVMSYG 247
Query: 560 KPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HP 615
+ P+ E + V R PP P + +L C+ ++ RP +++
Sbjct: 248 ERPYWEMSNQDVIKAVDEGYRLPP-PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 616 FIRNANY 622
IRN
Sbjct: 307 LIRNPGS 313
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 71/266 (26%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+G G +VY+ + AIK + + E +K+ E+E+ L H+NI
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIF--IPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + DD Y+ +EY+ +++ Y+ H ++ NFT IL+G+ + H
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDMRI 132
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
+HRDIK N+L+D++ +K+ DFG+AK L T L+ + G+ + +PE Q G
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE------QAKG 186
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLNRTPPIP-----EMLSS 588
DI+S+G + EML G+PP F G A+ K + + P + +
Sbjct: 187 EATDE-CTDIYSIGIVLYEMLVGEPP---FNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242
Query: 589 EGKDFLLRCFLRNPVERP-SAVELLE 613
+ +LR ++ R + E+ +
Sbjct: 243 SLSNVILRATEKDKANRYKTIQEMKD 268
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 79/293 (26%), Positives = 121/293 (41%), Gaps = 49/293 (16%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIG----TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
K +K + +G G FG V + TN TG A+K + + +QEI
Sbjct: 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK----ADAGPQHRSGWKQEI 84
Query: 408 KVLGHLKHENIVQYYG--SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
+L L HE+I++Y G + L + +EYV GS+ Y+ H I + + F +
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQ 142
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS--YELSLKG-SP-N 521
I G+AYLH+ + IHRD+ N+L+D +VK+ DFG+AK + Y + G SP
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNRTP 580
W APE + K+ K A D+WS G T+ E+LT S +
Sbjct: 203 WYAPECL-----KEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-----IGI 250
Query: 581 PIPEMLSSEGKDFL--------------------LRCFLRNPVERPSAVELLE 613
+M + L C+ RP+ L+
Sbjct: 251 AQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 79/319 (24%), Positives = 127/319 (39%), Gaps = 75/319 (23%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S++ K +G G G V+ + + AIK+ I+ DP+S K +EIK++ L
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK--IVLTDPQSV---KHALREIKIIRRL 65
Query: 414 KHENIV--------------QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIV 459
H+NIV GS + +YI EY+ + + + E
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE--QGPLLEEHA 122
Query: 460 RNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKG 518
R F +L GL Y+HS N +HRD+K ANL ++ V+K+ DFG+A+ +
Sbjct: 123 RLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------PHYS 176
Query: 519 SPNWM----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP------- 561
+ +P ++ + A+D+W+ GC EMLTGK
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTK------AIDMWAAGCIFAEMLTGKTLFAGAHE 230
Query: 562 -------------PWSEF-----EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCF 598
E + P P ++L S E DFL +
Sbjct: 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL 290
Query: 599 LRNPVERPSAVELLEHPFI 617
+P++R +A E L HP++
Sbjct: 291 TFSPMDRLTAEEALSHPYM 309
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 60/264 (22%), Positives = 106/264 (40%), Gaps = 22/264 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+L+GRG G VY + A+K + ++++E + G L+ ++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMS--ETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNT 478
V + +D LY+ + ++ + +R + R I + L H+
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 479 IHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAVMQKDG 536
HRD+K N+LV A L DFG+A L+ + G+ +MAPE +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE------RFSE 209
Query: 537 NPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG--PQAMFKVLNRTPPIPEM----LSSEG 590
+ DI++L C + E LTG PP ++G M +N+ P P +
Sbjct: 210 SHATY-RADIYALTCVLYECLTGSPP---YQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265
Query: 591 KDFLLRCFLRNPVER-PSAVELLE 613
+ R +NP +R + +L
Sbjct: 266 DAVIARGMAKNPEDRYVTCGDLSA 289
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 63/272 (23%), Positives = 117/272 (43%), Gaps = 28/272 (10%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++IG+G FG VY G + + CAIK + + + ++ +E ++ L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK---SLSRITEMQQ-VEAFLREGLLMRGL 79
Query: 414 KHENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
H N++ G ++ + ++ L Y+ G + +++R R+ T + +F + G+
Sbjct: 80 NHPNVLALIG--IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAP 525
YL +HRD+ N ++D S VK+ADFG+A+ + Y + W A
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPI 582
E + + + D+WS G + E+LT G PP+ + + R P
Sbjct: 198 ESL-----QTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ- 249
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
PE + +C+ +P RP+ L+
Sbjct: 250 PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 68/316 (21%), Positives = 119/316 (37%), Gaps = 82/316 (25%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+Q + +GRG + V+ N +K + P K + +EIK+L +L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI--LKPVKKKKIK------REIKILENL 87
Query: 414 K-HENIVQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+ NI+ ++V D + E+V+ + + +T+ +R + IL
Sbjct: 88 RGGPNIITLA--DIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILK 141
Query: 469 GLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMA------KHLTGLSYELSLKGSPN 521
L Y HS +HRD+K N+++D ++L D+G+A + S
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASR----- 194
Query: 522 WM-APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP------QAMFK 574
+ PE++ D ++D+WSLGC + M+ K P+ F G + K
Sbjct: 195 YFKGPELLVDYQMYD------YSLDMWSLGCMLASMIFRKEPF--FHGHDNYDQLVRIAK 246
Query: 575 VL------------------------NRTPPIP----------EMLSSEGKDFLLRCFLR 600
VL R ++S E DFL +
Sbjct: 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306
Query: 601 NPVERPSAVELLEHPF 616
+ R +A E +EHP+
Sbjct: 307 DHQSRLTAREAMEHPY 322
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+ +G G +G+V + TGA AIK++ A K+ +E+++L H++HEN++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA---KRAYRELRLLKHMRHENVI 87
Query: 420 QYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+ Y+ + ++ + + ++ + E ++ +L GL Y+
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYI 144
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM-APEVIKAVM 532
H+ IHRD+K NL V+ +K+ DFG+A+ E++ W APEVI M
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEVILNWM 201
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKP--------------------PWSEF------ 566
+ VDIWS+GC + EM+TGK P +EF
Sbjct: 202 RYTQ------TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 567 EGPQAMFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
+ + K L +L S + L + + + +R +A E L HP+
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 68/317 (21%), Positives = 114/317 (35%), Gaps = 71/317 (22%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECI------KQLEQEI 407
S + + I G++G+V G + G AIK V D ++ + K++ +EI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 408 KVLGHLKHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
++L H H NI+ E LY+ E + + + + + I+ ++ F
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 522
HIL GL LH +HRD+ N+L+ + + + DF +A+ T +
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT----------ADAN 189
Query: 523 M----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 561
APE++ VD+WS GC + EM K
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTK------LVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 562 ---------PWSEF----EGPQA---MFKVLNRTPPIP--EML---SSEGKDFLLRCFLR 600
P E P A + L+ P ++ D + +
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303
Query: 601 NPVERPSAVELLEHPFI 617
NP R S + L HP+
Sbjct: 304 NPQRRISTEQALRHPYF 320
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 56/282 (19%), Positives = 108/282 (38%), Gaps = 39/282 (13%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKSAECIKQLE 404
+ + +G+GTF ++ G RE G +K +D +
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-----KAHRNYSESFF 60
Query: 405 QEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTR 464
+ ++ L H+++V YG V D + E+V GS++ Y++++ I +
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASG--------VVKLADFGMAKHLTGLSYELSL 516
+ + +L IH ++ N+L+ +KL+D G++ +
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--- 177
Query: 517 KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKV 575
+ W+ PE I ++ L LA D WS G T+ E+ + G P S + + +
Sbjct: 178 QERIPWVPPECI-----ENPK-NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
Query: 576 LNR----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+R P E+ + + C P RPS ++
Sbjct: 232 EDRHQLPAPKAAELA-----NLINNCMDYEPDHRPSFRAIIR 268
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 9e-36
Identities = 78/372 (20%), Positives = 137/372 (36%), Gaps = 39/372 (10%)
Query: 258 SPVSPFKRNVYSADHSPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLN 317
SP+ P + + H + SP + K+ N +
Sbjct: 2 SPIDPMGHHHHH--HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQ 59
Query: 318 -AHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR 376
A+ + + AL+P V+ ++IGRG FG VY GT
Sbjct: 60 GANTVHIDLSALNPELVQAVQHVVIGP--------SSLIVHFNEVIGRGHFGCVYHGTLL 111
Query: 377 ETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDH 430
+ CA+K + E + Q E ++ H N++ G + +
Sbjct: 112 DNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGS 165
Query: 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLV 490
+ L Y+ G + ++R + T + F + G+ +L S +HRD+ N ++
Sbjct: 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 225
Query: 491 DASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVD 545
D VK+ADFG+A+ + ++ + WMA E + + K D
Sbjct: 226 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-----QTQ--KFTTKSD 278
Query: 546 IWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNP 602
+WS G + E++T G PP+ + +L R PE + +L+C+
Sbjct: 279 VWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PEYCPDPLYEVMLKCWHPKA 337
Query: 603 VERPSAVELLEH 614
RPS EL+
Sbjct: 338 EMRPSFSELVSR 349
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-35
Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 42/298 (14%)
Query: 335 VTSAVMPHIMEKPSASPK---KSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAI 384
T + P +ME A+ +S W + + IG+G FG V +G R G A+
Sbjct: 164 CTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAV 221
Query: 385 KEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDHLYIYLEYVHPG 441
K + K+ + E V+ L+H N+VQ G V+ LYI EY+ G
Sbjct: 222 KCI-------KNDATAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKG 272
Query: 442 SINRYVREHCR-DITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
S+ Y+R R + + F+ + + YL N +HRD+ N+LV V K++D
Sbjct: 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332
Query: 501 FGMAKHLTGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
FG+ K + L +K W APE + ++ K + D+WS G + E+ +
Sbjct: 333 FGLTKEASSTQDTGKLPVK----WTAPEAL-----REK--KFSTKSDVWSFGILLWEIYS 381
Query: 559 -GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
G+ P+ + +V + P+ D + C+ + RP+ ++L E
Sbjct: 382 FGRVPYPRIPLKDVVPRVEKGYKMDA-PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 39/285 (13%)
Query: 346 KPSASPKKSQW-------QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
+S W + + IG+G FG V +G R A+K + K+
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCI-------KNDA 56
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRD-I 454
+ E V+ L+H N+VQ G V+ LYI EY+ GS+ Y+R R +
Sbjct: 57 TAQAFLAEASVMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114
Query: 455 TESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL 514
+ F+ + + YL N +HRD+ N+LV V K++DFG+ K
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SST 170
Query: 515 SLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQA 571
G P W APE + ++ K + D+WS G + E+ + G+ P+
Sbjct: 171 QDTGKLPVKWTAPEAL-----REK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223
Query: 572 MFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ +V + P+ + + C+ + RPS ++L E
Sbjct: 224 VPRVEKGYKMDA-PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-35
Identities = 71/352 (20%), Positives = 121/352 (34%), Gaps = 94/352 (26%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+++ LIG G++G V ++ AIK++ + +D K++ +EI +L L
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC---KRILREIAILNRL 109
Query: 414 KHENIVQYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
H+++V+ D LY+ LE + R +TE ++ ++L
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLV 167
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
G+ Y+HS +HRD+K AN LV+ VK+ DFG+A+ + S +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 529 KAVMQKDGN---------------PKLAL-------AVDIWSLGCTVIEM---------- 556
P+L L A+D+WS+GC E+
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 557 ------------------------------------------LTGKPP---WSEFEGPQA 571
+ G P E A
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347
Query: 572 --MFKVLNRTPPIP--EML---SSEGKDFLLRCFLRNPVERPSAVELLEHPF 616
++ + E S++ L R + NP +R + E L HPF
Sbjct: 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPF 399
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 67/270 (24%), Positives = 111/270 (41%), Gaps = 28/270 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++IGRG FG VY GT + CA+K + E + Q E ++ H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGE-VSQFLTEGIIMKDFSH 85
Query: 416 ENIVQYYGSEVV---DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
N++ G + + + L Y+ G + ++R + T + F + G+ Y
Sbjct: 86 PNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEV 527
L S +HRD+ N ++D VK+ADFG+A+ + Y + WMA E
Sbjct: 144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPE 584
+ + K D+WS G + E++T G PP+ + +L R PE
Sbjct: 204 L-----QTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-PE 255
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ +L+C+ RPS EL+
Sbjct: 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-35
Identities = 77/358 (21%), Positives = 133/358 (37%), Gaps = 31/358 (8%)
Query: 273 SPLPSPPRQSSQSNLRSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPK 332
L SS SN P +L + + N+ P
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307
Query: 333 SSVTSAVMPHIMEKPSASPKK-------SQWQKGKLIGRGTFGSVYIGTNRETGASC--A 383
+ ++V P K + +G G FGSV G R A
Sbjct: 308 MPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVA 367
Query: 384 IKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH-LYIYLEYVHPGS 442
IK + K+ +++ +E +++ L + IV+ G V L + +E G
Sbjct: 368 IKV--LKQGTEKADT--EEMMREAQIMHQLDNPYIVRLIG--VCQAEALMLVMEMAGGGP 421
Query: 443 INRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502
+++++ +I S V + G+ YL N +HR++ N+L+ K++DFG
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 503 MAKHLTGLS--YELSLKG-SP-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT 558
++K L Y G P W APE I K + D+WS G T+ E L+
Sbjct: 482 LSKALGADDSYYTARSAGKWPLKWYAPECIN-------FRKFSSRSDVWSYGVTMWEALS 534
Query: 559 -GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
G+ P+ + +GP+ M + R P E + C++ +RP + + +
Sbjct: 535 YGQKPYKKMKGPEVMAFIEQGKRMEC-PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 81/369 (21%), Positives = 132/369 (35%), Gaps = 47/369 (12%)
Query: 293 VYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSS-VTSAVMPHIMEKPSASP 351
Y H + E L L P LS ++S + + P+ S
Sbjct: 3 YYHHHHHHDYDIPTTENL-YFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSS 61
Query: 352 KKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAEC 399
+ +G G FG VY G N + A+K + P+ +
Sbjct: 62 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD- 117
Query: 400 IKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ 453
E ++ H+NIV+ G + +I LE + G + ++RE
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGL 510
+ + + R I G YL + IHRDI N L+ G V K+ DFGMA+ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 511 SYELSLKGSPN-----WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564
Y KG WM PE +G D WS G + E+ + G P+
Sbjct: 238 GYY--RKGGCAMLPVKWMPPEAF-----MEG--IFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 565 EFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNA 620
+ + V R P P+ + +C+ P +RP+ +LE ++
Sbjct: 289 SKSNQEVLEFVTSGGRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
Query: 621 NYQNLSVPM 629
+ N ++P+
Sbjct: 348 DVINTALPI 356
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-35
Identities = 72/261 (27%), Positives = 120/261 (45%), Gaps = 22/261 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+G+G FG V++GT T AIK + P + QE +V+ L+HE +
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKT--LKPGTMSPEAFL----QEAQVMKKLRHEKL 324
Query: 419 VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAYLHSTN 477
VQ Y V ++ +YI EY+ GS+ +++ + + + I +G+AY+ N
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS-P-NWMAPEVIKAVMQKD 535
+HRD++ AN+LV + V K+ADFG+A+ + Y P W APE
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL------ 437
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKD 592
+ + D+WS G + E+ T G+ P+ + + +V R P P D
Sbjct: 438 -YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPECPESLHD 495
Query: 593 FLLRCFLRNPVERPSAVELLE 613
+ +C+ + P ERP+ L
Sbjct: 496 LMCQCWRKEPEERPTFEYLQA 516
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-35
Identities = 73/333 (21%), Positives = 128/333 (38%), Gaps = 88/333 (26%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENI 418
K +G+G +G V+ +R TG A+K++ + A ++ +EI +L L HENI
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFREIMILTELSGHENI 71
Query: 419 VQYYGSEVV----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
V V+ D +Y+ +Y+ ++ +R + + ++ + YLH
Sbjct: 72 VNLL--NVLRADNDRDVYLVFDYM-ETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLH 126
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM----------- 523
S +HRD+K +N+L++A VK+ADFG+++ + +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 524 -----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP----------- 561
APE++ + +D+WSLGC + E+L GKP
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTK------GIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 562 ---------PWSEF------EGPQAMFKVLNRTPPIPEM--------------------- 585
P +E + M + L I +
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
+ E D L + NP +R SA + L+HPF+
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVS 333
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 73/322 (22%), Positives = 119/322 (36%), Gaps = 47/322 (14%)
Query: 326 GALSPPKSSVTSAVMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT---- 374
G+ P S + HI+E P +G G FG V++
Sbjct: 6 GSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65
Query: 375 -NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433
+ A+K + S + ++E ++L L+H++IV+++G L +
Sbjct: 66 LPEQDKMLVAVKALK-----EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120
Query: 434 YLEYVHPGSINRYVREHCRDITESIVRN--------------FTRHILNGLAYLHSTNTI 479
EY+ G +NR++R H D + G+ YL + +
Sbjct: 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV 180
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPN-----WMAPEVIKAVMQK 534
HRD+ N LV VVK+ DFGM++ + Y G WM PE I
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESI-----L 233
Query: 535 DGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSSEGKD 592
K D+WS G + E+ T GK PW + +A+ + P E
Sbjct: 234 YR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYA 291
Query: 593 FLLRCFLRNPVERPSAVELLEH 614
+ C+ R P +R S ++
Sbjct: 292 IMRGCWQREPQQRHSIKDVHAR 313
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 65/322 (20%), Positives = 125/322 (38%), Gaps = 82/322 (25%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++Q K IG G G V + + AIK++ + A K+ +E+ ++ +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCV 118
Query: 414 KHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
H+NI+ + +Y+ +E + ++ + ++ ++ + +L
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM---ELDHERMSYLLYQML 174
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWM---- 523
G+ +LHS IHRD+K +N++V + +K+ DFG+A+ G+ M
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA----------GTSFMMTPYV 224
Query: 524 ------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP---------------- 561
APEVI VDIWS+GC + EM+ K
Sbjct: 225 VTRYYRAPEVI-------LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277
Query: 562 ----PWSEF-----EGPQAMFKVLNRTPPIP-----------------EMLSSEGKDFLL 595
P EF + + + + ++ +S+ +D L
Sbjct: 278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337
Query: 596 RCFLRNPVERPSAVELLEHPFI 617
+ + +P +R S + L+HP+I
Sbjct: 338 KMLVIDPAKRISVDDALQHPYI 359
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 66/271 (24%), Positives = 116/271 (42%), Gaps = 29/271 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
G+++G G V++ + A+K + D + + +E + L H I
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 419 VQYY--GSEVVDDHLYIYL--EYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
V Y G Y+ EYV ++ V +T L + H
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH 133
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAPEVIKA 530
IHRD+K AN+++ A+ VK+ DFG+A+ + + ++ G+ +++PE
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE---- 189
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAM---FKVLNRTPPIP---- 583
Q G+ A D++SLGC + E+LTG+PP F G + ++ + P P
Sbjct: 190 --QARGDSVDA-RSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPSARH 243
Query: 584 EMLSSEGKDFLLRCFLRNPVERP-SAVELLE 613
E LS++ +L+ +NP R +A E+
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 75/347 (21%), Positives = 128/347 (36%), Gaps = 98/347 (28%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
LIGRG++G VY+ ++ T + AIK+V+ + +D K++ +EI +L LK + I+
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC---KRILREITILNRLKSDYII 88
Query: 420 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+ Y + D LYI LE + + + +TE ++ ++L G ++H
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH 146
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMA-------------KHLTGLSYELSLKGSPN 521
+ IHRD+K AN L++ VK+ DFG+A K
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 522 WM----------APEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSE------ 565
+ APE+I ++DIWS GC E+L
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTK------SIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 566 --FEGPQAMFKV----------------LNR------TPPIPEMLS-------------- 587
F G LN TP ++ +
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320
Query: 588 -SEGKDF-------------LLRCFLR-NPVERPSAVELLEHPFIRN 619
+ + LL L+ NP +R + + L+HP++++
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 38/295 (12%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G G FG VY G N + A+K + P+ + E ++
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQD-ELDFLMEALIISKF 90
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD------ITESIVRNFTRHIL 467
H+NIV+ G + +I +E + G + ++RE + + + R I
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASG---VVKLADFGMAKHLTGLSYELSLKGSPN--- 521
G YL + IHRDI N L+ G V K+ DFGMA+ + SY KG
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY--RKGGCAMLP 208
Query: 522 --WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-- 576
WM PE +G D WS G + E+ + G P+ + + V
Sbjct: 209 VKWMPPEAF-----MEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261
Query: 577 NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH--PFIRNANYQNLSVPM 629
R P P+ + +C+ P +RP+ +LE ++ + N ++P+
Sbjct: 262 GRMDP-PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 315
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 70/324 (21%), Positives = 127/324 (39%), Gaps = 41/324 (12%)
Query: 310 LESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGS 369
+ S++H + H L P ++ + V+ + GK++G G FGS
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDR-----------NLLILGKILGEGEFGS 49
Query: 370 VYIGT---NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYG--- 423
V G T A+K + D S I++ E + H N+++ G
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTM---KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106
Query: 424 --SEVVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTRHILNGLAYLHST 476
S + L ++ G ++ Y+ + I + F I G+ YL +
Sbjct: 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR 166
Query: 477 NTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-NWMAPEVIKAVMQ 533
N +HRD+ N ++ V +ADFG++K + Y + + P W+A E +
Sbjct: 167 NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL----- 221
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEG 590
D D+W+ G T+ E+ T G P+ + + +L+ R PE E
Sbjct: 222 ADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQ-PEDCLDEL 278
Query: 591 KDFLLRCFLRNPVERPSAVELLEH 614
+ + C+ +P++RP+ L
Sbjct: 279 YEIMYSCWRTDPLDRPTFSVLRLQ 302
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 59/275 (21%), Positives = 116/275 (42%), Gaps = 29/275 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGAS---CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
G+++G+G FGSV ++ S A+K + D ++ I++ +E + H
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML---KADIIASSDIEEFLREAACMKEFDH 84
Query: 416 ENIVQYYG------SEVVDDHLYIYLEYVHPGSINRYVREH-----CRDITESIVRNFTR 464
++ + G ++ + L ++ G ++ ++ ++ + F
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-N 521
I G+ YL S N IHRD+ N ++ V +ADFG+++ + Y S P
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RT 579
W+A E + D + D+W+ G T+ E++T G+ P++ E + ++
Sbjct: 205 WLALESL-----ADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257
Query: 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
P E D + +C+ +P +RPS L
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 30/275 (10%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G+G+FG VY G E AIK + + E + E V+
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRE-RIEFLNEASVMKEF 85
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN---------FTR 464
++V+ G + +E + G + Y+R + + V
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 465 HILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS--P-N 521
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y P
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T 579
WM+PE + KDG D+WS G + E+ T + P+ Q + V+
Sbjct: 206 WMSPESL-----KDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258
Query: 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
P+ + + C+ NP RPS +E++
Sbjct: 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 74/284 (26%), Positives = 125/284 (44%), Gaps = 45/284 (15%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G G FG V++ + A+K + D +A K ++E ++L +L
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAAR--KDFQREAELLTNL 74
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 461
+HE+IV++YG D L + EY+ G +N+++R H D +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 462 ---FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY------ 512
I +G+ YL S + +HRD+ N LV A+ +VK+ DFGM++ + Y
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 513 -ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQ 570
L ++ WM PE I K D+WS G + E+ T GK PW + +
Sbjct: 195 TMLPIR----WMPPESI-----MYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 243
Query: 571 AMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
+ + R P + E D +L C+ R P +R + E+ +
Sbjct: 244 VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 72/305 (23%), Positives = 123/305 (40%), Gaps = 49/305 (16%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP 394
P+ P +W GK +G G FG V T + + A+K ++
Sbjct: 9 PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSA 65
Query: 395 KSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
E + L E+KVL +L H NIV G+ + + EY G + ++R
Sbjct: 66 HLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 454 ITESIVRN-----------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496
S F+ + G+A+L S N IHRD+ N+L+ +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 497 KLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
K+ DFG+A+ + +Y + P WMAPE I + D+WS G +
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI-----FNC--VYTFESDVWSYGIFL 237
Query: 554 IEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 609
E+ + G P+ +K++ R PE +E D + C+ +P++RP+
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 610 ELLEH 614
++++
Sbjct: 297 QIVQL 301
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 61/282 (21%), Positives = 104/282 (36%), Gaps = 38/282 (13%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ +G FG VY G E + AIK + D + + E + L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPLREE-FRHEAMLRARL 69
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 461
+H N+V G D L + Y G ++ ++ +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 462 ---FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELSLK 517
I G+ YL S + +H+D+ N+LV VK++D G+ + + Y+L
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 518 GS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 574
P WMAPE I G K ++ DIWS G + E+ + G P+ + +
Sbjct: 190 SLLPIRWMAPEAI-----MYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 575 VLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ N P P+ + ++ C+ P RP ++
Sbjct: 243 IRNRQVLPC-PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 53/305 (17%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAE 398
+ +W GK +G G FG V T R + A+K ++ ++ +E
Sbjct: 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSE 69
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
++ L E VL + H ++++ YG+ D L + +EY GS+ ++RE + +
Sbjct: 70 -LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 459 VRN-----------------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495
F I G+ YL +HRD+ N+LV
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK 188
Query: 496 VKLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 552
+K++DFG+++ + SY +G P WMA E + D D+WS G
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL-----FDH--IYTTQSDVWSFGVL 241
Query: 553 VIEMLT-GKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 609
+ E++T G P+ + + +R P+ S E +L+C+ + P +RP
Sbjct: 242 LWEIVTLGGNPYPGIPPERLFNLLKTGHRMER-PDNCSEEMYRLMLQCWKQEPDKRPVFA 300
Query: 610 ELLEH 614
++ +
Sbjct: 301 DISKD 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 78/319 (24%), Positives = 131/319 (41%), Gaps = 51/319 (15%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDDPKS 396
P+ +W GK +G G FG V + + + A+K ++ DD
Sbjct: 25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATE 81
Query: 397 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
+ + L E++++ + KH+NI+ G+ D LY+ +EY G++ Y+R
Sbjct: 82 KD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 456 ESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
E T + G+ YL S IHRD+ N+LV + V+K+AD
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 501 FGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
FG+A+ + Y+ + G P WMAPE + D D+WS G + E+
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDR--VYTHQSDVWSFGVLMWEIF 253
Query: 558 T-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH- 614
T G P+ + + P ++E + C+ P +RP+ +L+E
Sbjct: 254 TLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313
Query: 615 ----PFIRNANYQNLSVPM 629
N Y +LS P+
Sbjct: 314 DRILTLTTNEEYLDLSQPL 332
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 53/305 (17%)
Query: 347 PSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDP 394
P+ P +W Q GK +G G FG V T + A+K ++
Sbjct: 32 PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTA 88
Query: 395 KSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD 453
+ E + L E+K++ HL +HENIV G+ + + EY G + ++R R
Sbjct: 89 HADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 454 ITESIVRNFTRHILN-------------GLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
+ + G+A+L S N IHRD+ N+L+ V K+ D
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 501 FGMAKHLTGLSY-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
FG+A+ + S L +K WMAPE I D + D+WS G +
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVK----WMAPESI-----FDC--VYTVQSDVWSYGILL 256
Query: 554 IEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 609
E+ + G P+ +K++ + P + C+ P RP+
Sbjct: 257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAFAPKNIYSIMQACWALEPTHRPTFQ 315
Query: 610 ELLEH 614
++
Sbjct: 316 QICSF 320
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 76/312 (24%), Positives = 126/312 (40%), Gaps = 51/312 (16%)
Query: 339 VMPHIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKE 386
+ H P S+W + GK +GRG FG V T + A+K
Sbjct: 8 LDEHCERLP---YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64
Query: 387 VDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYG-SEVVDDHLYIYLEYVHPGSIN 444
+ + +E + L E+K+L H+ H N+V G L + +E+ G+++
Sbjct: 65 L---KEGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 445 RYVREHCRDITESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLL 489
Y+R + V ++ + G+ +L S IHRD+ N+L
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 490 VDASGVVKLADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDI 546
+ VVK+ DFG+A+ + Y P WMAPE I D + D+
Sbjct: 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI-----FDR--VYTIQSDV 233
Query: 547 WSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNP 602
WS G + E+ + G P+ + + + L R P+ + E +L C+ P
Sbjct: 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEP 292
Query: 603 VERPSAVELLEH 614
+RP+ EL+EH
Sbjct: 293 SQRPTFSELVEH 304
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-30
Identities = 58/260 (22%), Positives = 94/260 (36%), Gaps = 32/260 (12%)
Query: 361 LIGRGTFGSVYIGT-NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
I G G +Y+ G +K AE E + L + H +IV
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLK----GLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 420 QYY-----GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
Q + D YI +EYV S+ R + + + + IL L+YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH 199
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
S ++ D+K N+++ +KL D G + L G+P + APE
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG---YLYGTPGFQAPE------IV 249
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFL 594
P +A DI+++G T+ + P G L P+ + L
Sbjct: 250 RTGP--TVATDIYTVGRTLAALTLDLPT---RNGRYV--DGLPEDDPVLK-TYDSYGRLL 301
Query: 595 LRCFLRNPVERP-SAVELLE 613
R +P +R +A E+
Sbjct: 302 RRAIDPDPRQRFTTAEEMSA 321
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 82/362 (22%), Positives = 144/362 (39%), Gaps = 50/362 (13%)
Query: 288 RSPRKVYFPLRHKSLPQNSKELLESNNHLNAHPLPLPPGALSPPKSSVTSAVMPHIMEKP 347
+ P V+ + L + ES++ +N+ PL ++ T +
Sbjct: 12 QDPPAVHKLTKRIPLRRQVTVSAESSSSMNS-NTPLVRITTRLSSTADTPMLAG---VSE 67
Query: 348 SASPKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDD 393
P+ +W GK +G G FG V + + + A+K ++ DD
Sbjct: 68 YELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDD 124
Query: 394 PKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR 452
+ + L E++++ + KH+NI+ G+ D LY+ +EY G++ Y+R
Sbjct: 125 ATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 453 DITESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVK 497
E T + G+ YL S IHRD+ N+LV + V+K
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243
Query: 498 LADFGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVI 554
+ADFG+A+ + Y+ + G P WMAPE + D D+WS G +
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL-----FDR--VYTHQSDVWSFGVLMW 296
Query: 555 EMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELL 612
E+ T G P+ + + P ++E + C+ P +RP+ +L+
Sbjct: 297 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356
Query: 613 EH 614
E
Sbjct: 357 ED 358
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 52/307 (16%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
GK++G G FG V T A+K + + S+E + L E+K++ L
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSE-REALMSELKMMTQL 105
Query: 414 -KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVR------------ 460
HENIV G+ + +Y+ EY G + Y+R +E +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 461 ----------NFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
F + G+ +L + +HRD+ N+LV VVK+ DFG+A+ +
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 511 SYELSLKGSP---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEF 566
S + + WMAPE + +G + D+WS G + E+ + G P+
Sbjct: 226 SNYVVRGNARLPVKWMAPESL-----FEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGI 278
Query: 567 EGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH-----PFIR 618
+K++ + P + E + C+ + +RPS L
Sbjct: 279 PVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337
Query: 619 NANYQNL 625
A YQN+
Sbjct: 338 EAMYQNV 344
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 70/296 (23%), Positives = 114/296 (38%), Gaps = 40/296 (13%)
Query: 359 GKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KH 415
+IG G FG V ++ G AIK + + + + E++VL L H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDD-HRDFAGELEVLCKLGHH 85
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN-------------- 461
NI+ G+ +LY+ +EY G++ ++R+ T+
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 462 -FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGS- 519
F + G+ YL IHRD+ N+LV + V K+ADFG+++ Y G
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 520 P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL- 576
P WMA E + D+WS G + E+++ G P+ + K+
Sbjct: 204 PVRWMAIESL-----NYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256
Query: 577 -NRTPPIPEMLSSEGKDFLLRCFLRNPVERPS---AVELLEHPFIRNANYQNLSVP 628
R P E D + +C+ P ERPS + L Y N ++
Sbjct: 257 GYRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 311
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 68/361 (18%), Positives = 122/361 (33%), Gaps = 124/361 (34%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK----- 414
+ +G G F +V++ + A+K I+ D E E EIK+L +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTE---AAEDEIKLLQRVNDADNT 78
Query: 415 ------HENIVQYYGS---------------EVVDDHLYIYLEYVHPGSINRYVREHCRD 453
+I++ EV+ ++L ++ +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK------YEHRG----- 127
Query: 454 ITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDAS------GVVKLADFGMAKH 506
I V+ ++ +L GL Y+H IH DIK N+L++ +K+AD G A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 507 LTG-LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTGKP 561
+ + + + +PEV+ L DIWS C + E++TG
Sbjct: 188 YDEHYTNSIQ---TREYRSPEVL-----------LGAPWGCGADIWSTACLIFELITGDF 233
Query: 562 PWSEFEG-----------------------PQAMFKVLNRT------------------P 580
FE P + + T
Sbjct: 234 L---FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 581 PIPEMLSSEGK----------DFLLRCFLRNPVERPSAVELLEHPFIRNA-NYQNLSVPM 629
P+ ++L+ + K DFL +P +R A L+ HP++++ + + VP
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 350
Query: 630 R 630
R
Sbjct: 351 R 351
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-29
Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 48/300 (16%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGT-------NRETGASCAIKEVDIIPDDPKS 396
P+ +W GK +G G FG V + A+K ++ D
Sbjct: 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATE 115
Query: 397 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDIT 455
+ + L E++++ + KH+NI+ G+ D LY+ +EY G++ Y++
Sbjct: 116 KD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 456 ESIVRN---------------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
E + G+ YL S IHRD+ N+LV V+K+AD
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 501 FGMAKHL-TGLSYELSLKGS-P-NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
FG+A+ + Y+ + G P WMAPE + D D+WS G + E+
Sbjct: 235 FGLARDIHHIDYYKKTTNGRLPVKWMAPEAL-----FDR--IYTHQSDVWSFGVLLWEIF 287
Query: 558 T-GKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
T G P+ + + +R P ++E + C+ P +RP+ +L+E
Sbjct: 288 TLGGSPYPGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 52/293 (17%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ IG G FG V+ E A+K ++ ++ + ++E ++
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADM-QADFQREAALMAEF 107
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN------------ 461
+ NIV+ G V + + EY+ G +N ++R S+ +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 462 -----------FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL 510
R + G+AYL +HRD+ N LV + VVK+ADFG+++++
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 511 SY-------ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPP 562
Y + ++ WM PE I + D+W+ G + E+ + G P
Sbjct: 228 DYYKADGNDAIPIR----WMPPESI-----FYN--RYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 563 WSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ + ++ V + PE E + + C+ + P +RPS +
Sbjct: 277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 69/334 (20%), Positives = 122/334 (36%), Gaps = 98/334 (29%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 416
K+IG+G+FG V + + A+K ++ ++ + +Q +EI++L HL+ +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK---MVRNEKRFH---RQAAEEIRILEHLRKQDKD 156
Query: 417 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 470
N++ + +H+ + E + S+N Y + + + +VR F IL L
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 471 AYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTG-LSYELSLKGSPNWMAPEV 527
LH IH D+K N+L+ +K+ DFG + + + + S + APEV
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ---SRFYRAPEV 270
Query: 528 IKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLTG---------------------KPP 562
I L +D+WSLGC + E+LTG P
Sbjct: 271 I-----------LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 563 WS----------EFEGPQAMFKVLNRTPPIPEMLSSEGK--------------------- 591
T ++ + G+
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 592 -------DFLLRCFLRNPVERPSAVELLEHPFIR 618
DFL +C +P R + + L HP++R
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLR 413
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 74/346 (21%), Positives = 109/346 (31%), Gaps = 119/346 (34%)
Query: 360 KLIGRGTFGSVYIGTNRETGA-SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-- 416
+G G FG V + + G A+K I+ + + E EI+VL HL
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVK---IVKNVDRYCE---AARSEIQVLEHLNTTDP 73
Query: 417 ----NIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNG 469
VQ H+ I E + ++ Y ++E+ +R I
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 470 LAYLHSTNTIHRDIKGAN-LLVDASGV------------------VKLADFGMA-----K 505
+ +LHS H D+K N L V + +K+ DFG A
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 506 HLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLT 558
H T +S Y APEVI LAL D+WS+GC +IE
Sbjct: 191 HSTLVSTRHYR----------APEVI-----------LALGWSQPCDVWSIGCILIEYYL 229
Query: 559 GKP----------------------------------------PWSEFEGPQAMFKVLNR 578
G W E A V
Sbjct: 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDE--HSSAGRYVSRA 287
Query: 579 TPPIPEMLSSEGK------DFLLRCFLRNPVERPSAVELLEHPFIR 618
P+ E + S+ D + + +P +R + E L+HPF
Sbjct: 288 CKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFD 333
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 73/357 (20%), Positives = 114/357 (31%), Gaps = 137/357 (38%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 416
+ +G GTFG V + + + A+K ++ + K + E +L ++++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK---VVRNIKKYTR---SAKIEADILKKIQNDDIN 94
Query: 417 --NIVQYYGS-----------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFT 463
NIV+Y+G E + LY + N Y ++ +
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR------NNYNG-----FHIEDIKLYC 143
Query: 464 RHILNGLAYLHSTNTIHRDIKGAN-LLVDASGV------------------------VKL 498
IL L YL + H D+K N LL D +KL
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 499 ADFGMA-----KHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDI 546
DFG A H + ++ Y APEVI L L + D+
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYR----------APEVI-----------LNLGWDVSSDM 242
Query: 547 WSLGCTVIEMLTGKP--------------------------------------------- 561
WS GC + E+ TG
Sbjct: 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302
Query: 562 PWSEFEGPQAMFKVLNRTPPIPEMLSSEG-KDFLLRCFLRNPVERPSAVELLEHPFI 617
W E K + + P+ +++ E DFL +P RPS ELL+H F+
Sbjct: 303 AWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 26/255 (10%), Positives = 56/255 (21%), Gaps = 45/255 (17%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
G + + A+ VD P + +++ L + + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVD--PQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 421 YYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIH 480
+ E++ GS+ + + + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVAL 152
Query: 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKL 540
+ + V G V LA
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPATMPDANPQD----------------------------- 183
Query: 541 ALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD-------F 593
DI +G ++ +L + P E + T P + +D
Sbjct: 184 ----DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 594 LLRCFLRNPVERPSA 608
R + R ++
Sbjct: 240 AARSVQGDGGIRSAS 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 70/345 (20%), Positives = 108/345 (31%), Gaps = 115/345 (33%)
Query: 360 KLIGRGTFGSVYIGTNRETG-ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE-- 416
+G GTFG V + G + A+K II + K + EI VL +K +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK---IIRNVGKYR---EAARLEINVLKKIKEKDK 78
Query: 417 ----NIVQYYGSEVVDDHLYIYLEYVHPGSINRY--VREHC-RDITESIVRNFTRHILNG 469
V H+ I E + N + ++E+ + VR+ + +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 470 LAYLHSTNTIHRDIKGAN-LLVDASGV------------------VKLADFGMA-----K 505
L +LH H D+K N L V++ +++ADFG A
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 506 HLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLAL----AVDIWSLGCTVIEMLT 558
H T ++ Y PEVI L L D+WS+GC + E
Sbjct: 196 HTTIVATRHYR----------PPEVI-----------LELGWAQPCDVWSIGCILFEYYR 234
Query: 559 GKPPW---SEFE---------G--PQAMFK------------------------VLNRTP 580
G + E G P M V
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294
Query: 581 PIPEMLSSEGK------DFLLRCFLRNPVERPSAVELLEHPFIRN 619
P+ + + D + R +P +R + E L HPF
Sbjct: 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 68/340 (20%), Positives = 112/340 (32%), Gaps = 103/340 (30%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE--- 416
LIG+G+FG V +R AIK II + Q + E+++L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK---IIKNKKAFL---NQAQIEVRLLELMNKHDTE 113
Query: 417 ---NIVQYYGSEVVDDHLYIYLEYVHPGSINRY---VREHCRDITESIVRNFTRHILNGL 470
IV + +HL + E + S N Y + R ++ ++ R F + + L
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 471 AYLHST--NTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
+L + + IH D+K N+L+ +K+ DFG + L Y S + +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRFYRSPE 228
Query: 527 VIKAVMQKDGNPKLAL----AVDIWSLGCTV---------------------IEMLTGKP 561
V+ L + A+D+WSLGC + I + G P
Sbjct: 229 VL-----------LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277
Query: 562 P---------------------WSEFEGPQ-------------AMFKVLNRTPPIPEMLS 587
P W+ + + P
Sbjct: 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337
Query: 588 SEGK---------DFLLRCFLRNPVERPSAVELLEHPFIR 618
G D +LR +P R L+H F +
Sbjct: 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 4e-23
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 45/221 (20%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
LIG G FG VY G R+ GA A+K P+S++ I++ E EI+ L +H ++V
Sbjct: 46 LIGHGVFGKVYKGVLRD-GAKVALKRRT-----PESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 421 YYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN----------- 468
G + + IY +Y+ G+ ++ H + ++
Sbjct: 100 LIGFCDERNEMILIY-KYMENGN----LKRHLYG------SDLPTMSMSWEQRLEICIGA 148
Query: 469 --GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-----LKGSPN 521
GL YLH+ IHRD+K N+L+D + V K+ DFG++K G + + +KG+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLSTVVKGTLG 206
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
++ PE +L D++S G + E+L +
Sbjct: 207 YIDPEYFI-------KGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 48/292 (16%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ G +G G FG VY G T + A+K++ D + E +Q +QEIKV+
Sbjct: 30 RPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAA-MVDITTEELKQQFDQEIKVMAK 86
Query: 413 LKHENIVQYYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRN-FTRH----- 465
+HEN+V+ G D +Y Y+ GS + + + + + R
Sbjct: 87 CQHENLVELLGFSSDGDDLCLVY-VYMPNGS----LLDRLSCLDGTPPLSWHMRCKIAQG 141
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-----LKGSP 520
NG+ +LH + IHRDIK AN+L+D + K++DFG+A+ + + + G+
Sbjct: 142 AANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQTVMTSRIVGTT 199
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF----KVL 576
+MAPE ++ G ++ DI+S G ++E++TG P E PQ + ++
Sbjct: 200 AYMAPEALR------G--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 577 NRTPPIPEMLSSEGKDFL-----------LRCFLRNPVERPS---AVELLEH 614
+ I + + + D +C +RP +LL+
Sbjct: 252 DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 35/225 (15%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ G+ IG G+FG +Y+GT+ G AIK + + QL E K+ ++
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK------LECVKTKH-PQLHIESKIYKMMQ 62
Query: 415 H-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
I +++ G+E D+ + +E + P S+ R + V +++ +
Sbjct: 63 GGVGIPTIRWCGAE--GDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 472 YLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSP 520
Y+HS N IHRD+K N L+ +V + DFG+AK +L G+
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 521 NWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ + + Q +D D+ SLG ++ G PW
Sbjct: 180 RYASINTHLGIEQSRRD---------DLESLGYVLMYFNLGSLPW 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++ G+ IG G+FG ++ GTN AIK +P+ ++ QL E + L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK------FEPRRSDA-PQLRDEYRTYKLLA 63
Query: 415 H-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
I V Y+G E H + ++ + P S+ + R + V + +L +
Sbjct: 64 GCTGIPNVYYFGQE--GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 472 YLHSTNTIHRDIKGANLLVDASG-----VVKLADFGMAK----HLTG--LSYE--LSLKG 518
+H + ++RDIK N L+ ++ + DFGM K +T + Y +L G
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 519 SPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ +M+ Q +D D+ +LG + L G PW
Sbjct: 181 TARYMSINTHLGREQSRRD---------DLEALGHVFMYFLRGSLPW 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 39/228 (17%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIK-EVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ GK IG G FG + +G N T AIK E P + QL E + L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE-------PMKSRA-PQLHLEYRFYKQL 61
Query: 414 KH-ENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
+ I V Y+G + + LE + P S+ R + V +++ +
Sbjct: 62 GSGDGIPQVYYFGPC--GKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 471 AYLHSTNTIHRDIKGANLLVDASG-----VVKLADFGMAK----HLTGLSYE----LSLK 517
Y+HS N I+RD+K N L+ G V+ + DF +AK T SL
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 518 GSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
G+ +M+ Q +D D+ +LG + L G PW
Sbjct: 179 GTARYMSINTHLGKEQSRRD---------DLEALGHMFMYFLRGSLPW 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-17
Identities = 52/300 (17%), Positives = 89/300 (29%), Gaps = 86/300 (28%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+QW GK IG G FG +Y+ A ++ + + L E+K
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH---VVKVEYQEN---GPLFSELKFYQR 89
Query: 413 LKHENIVQYYGSEVVDDHLYI-YLEY--VHPGSINRY--------------VREHCRDIT 455
+ ++ ++ + D+L I + Y +
Sbjct: 90 VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFK 149
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKH------- 506
+S V +L+ L Y+H +H DIK ANLL+ V LAD+G++
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 507 ----------LTG----------LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDI 546
G LS + D+
Sbjct: 210 KQYQENPRKGHNGTIEFTSLDAHKGVALSRRS--------------------------DV 243
Query: 547 WSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRN--PVE 604
LG ++ L GK PW + + +T + E+ +L+ E
Sbjct: 244 EILGYCMLRWLCGKLPWEQNLKDPVAVQTA-KTNLLDEL-----PQSVLKWAPSGSSCCE 297
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 361 LIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQ 420
++GRG FG VY G G A+K + + ++ Q + E++++ H N+++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLK----EERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 421 YYGSEVVDDH-LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH-----ILNGLAYLH 474
G + L +Y Y+ GS+ +RE + + R GLAYLH
Sbjct: 92 LRGFCMTPTERLLVY-PYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLH 148
Query: 475 ---STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIK 529
IHRD+K AN+L+D + DFG+AK + ++ ++G+ +APE +
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLS 208
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
G K + D++ G ++E++TG+
Sbjct: 209 T-----G--KSSEKTDVFGYGVMLLELITGQRA 234
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 4e-17
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ G+ IG G+FG +Y+GTN +T AIK ++ P QL E K+ L+
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQ 60
Query: 415 -HENI--VQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
I V+++G E D+ + ++ + P S+ R ++ V ++N +
Sbjct: 61 GGTGIPNVRWFGVE--GDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 472 YLHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSP 520
++HS + +HRDIK N L+ + V + DFG+AK S +L G+
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 521 NWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKPPW 563
+ + + Q +D D+ SLG ++ L G PW
Sbjct: 178 RYASVNTHLGIEQSRRD---------DLESLGYVLMYFLRGSLPW 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 6e-17
Identities = 43/185 (23%), Positives = 77/185 (41%), Gaps = 15/185 (8%)
Query: 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVV 496
+ +T + ++ + G+ +L S IHRD+ N+L+ VV
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232
Query: 497 KLADFGMAKHLTGLSYELSLKGSP---NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTV 553
K+ DFG+A+ + + + WMAPE I + + D+WS G +
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLL 285
Query: 554 IEMLT-GKPPWSEFEGPQAMFKVL---NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAV 609
E+ + G P+ + + + L R P+ + E +L C+ P +RP+
Sbjct: 286 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFS 344
Query: 610 ELLEH 614
EL+EH
Sbjct: 345 ELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 16/162 (9%)
Query: 359 GKLIGRGTFGSVYIGT-----NRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
GK +GRG FG V T + A+K + + +E + L E+K+L H+
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSE-HRALMSELKILIHI 82
Query: 414 -KHENIVQYYG-SEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
H N+V G L + +E+ G+++ Y+R + + G
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGA--RFRQGKD 140
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513
Y+ I D+K + +S + F K L+ + E
Sbjct: 141 YV---GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 46/242 (19%), Positives = 85/242 (35%), Gaps = 45/242 (18%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ W+ G IG+G FG +Y+ + + S ++ +P L E+K
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQR 89
Query: 413 LKHENIVQ-----------------YYGSEVVDDHLYIYL--EYVHPGSINRYVREHCRD 453
+Q G + Y ++ + + + + +
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR 148
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAK----HL 507
+ V + IL+ L Y+H +H DIK +NLL++ V L D+G+A
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 508 TGLSYEL----SLKGSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+Y G+ + + + V + D+ LG +I+ LTG
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRG---------DLEILGYCMIQWLTGHL 259
Query: 562 PW 563
PW
Sbjct: 260 PW 261
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 7e-16
Identities = 56/362 (15%), Positives = 108/362 (29%), Gaps = 109/362 (30%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK----- 414
+ +G G F +V++ + + A+K ++ E EI++L ++
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTE---TALDEIRLLKSVRNSDPN 96
Query: 415 ---HENIVQYYGSEVVD----DHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHI 466
E +VQ + H+ + E + + +++ + + + + V+ + +
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 467 LNGLAYLHST-NTIHRDIKGANLLVDASGVVKLADF-------GMAKHLTGLSYELSLKG 518
L GL YLH+ IH DIK N+L+ + S +
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 519 SPNWMAPEVIKAVMQKDGNPKLA---------------------------------LAVD 545
+ ++ + K+A D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 546 IWSLGCTVIEMLTGKPPWSEFEG------------------------------------- 568
IWS C E+ TG + G
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK 335
Query: 569 -----------PQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
P +F+VL + ++ DFLL P +R +A E L HP++
Sbjct: 336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
Query: 618 RN 619
+
Sbjct: 396 NS 397
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 2e-14
Identities = 59/334 (17%), Positives = 102/334 (30%), Gaps = 77/334 (23%)
Query: 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ-- 405
S + Q+ + IG G FG V+ T AIK + I D + K E+
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPV--AIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 406 -EIKVLGHL---------KHENIVQYYGSEVV---------------------------- 427
EI + L + E + V
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 428 --DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHST-NTIHRDIK 484
DD L+I LE+ G +R + ++ + LA ++ HRD+
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 485 GANLLVDASGVVKLADFGMAKHLT----GLSYEL--------SLKGSPNWMAPEVIKAVM 532
N+L+ + + KL K T GL + G + + + +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF-------KVLNRTPPIPEM 585
DG+ + DI+ L W E+ + K+L + +
Sbjct: 250 TGDGDYQF----DIYRLMKKENNN-----RWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300
Query: 586 LSSEGKDFL--LRCFLRNPVERPSAVELLEHPFI 617
+ K ++ F R + SA +LL +
Sbjct: 301 NTPAMKQIKRKIQEFHRTMLNFSSATDLLCQHSL 334
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 42/242 (17%), Positives = 79/242 (32%), Gaps = 45/242 (18%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETG--------ASCAIKEVDIIPDDPKSAECIKQLE 404
QW+ R G +Y T ++K + D + +
Sbjct: 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK---LDAKDGRLFNEQNFFQ 97
Query: 405 QEIKV--------LGHLKHENIVQYYGSEVV-DDHLYIYLEYVHPGSINRYVREHC--RD 453
+ K L I G V D + ++ L + S+ +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SALDVSPKHV 155
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFGMAKH----L 507
++E V +L+ L +LH +H ++ N+ VD V LA +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQ--KDGNPKLALAVDIWSLGCTVIEMLTGKP 561
++Y +G +++ ++ K + D+ SLG +++ L G
Sbjct: 216 KHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS---------DLQSLGYCMLKWLYGFL 266
Query: 562 PW 563
PW
Sbjct: 267 PW 268
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 5e-05
Identities = 53/398 (13%), Positives = 110/398 (27%), Gaps = 121/398 (30%)
Query: 331 PKSSVTSAVMPHIMEKPSASPKKSQ-----W---QKGKLIGRGTFGSV------------ 370
PKS ++ + HI+ A S W K + + + V
Sbjct: 42 PKSILSKEEIDHIIMSKDA---VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI 98
Query: 371 ---YIGTNRETGASCAIKEVDIIPDDPKS--------AECIKQLEQEIKVLGHLKHENIV 419
+ T I++ D + +D + + +L + L L+ V
Sbjct: 99 KTEQRQPSMMT--RMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---QALLELRPAKNV 153
Query: 420 QYYGSEVVDDHLYIYLEYVHPG---SINRYVREHCRDITESIVRNFTRHI--LNGLAYLH 474
G G + + C + I LN L +
Sbjct: 154 LIDGV---------------LGSGKTW--VALDVCLS--YKVQCKMDFKIFWLN-LKNCN 193
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
S T+ ++ LL + + ++K + + E+ + + K
Sbjct: 194 SPETVLEMLQ--KLLYQIDP----------NWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 535 DGNPKLALAV--DIWS--------LGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 584
+ L V ++ + L C ++ + T ++F +
Sbjct: 242 PY--ENCLLVLLNVQNAKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHI--SLDHHSM 296
Query: 585 MLS-SEGKDFLLRCFLRNPVERPSAV------------ELLEHPFIRNANYQNLSVPMRV 631
L+ E K LL+ P + P V E + N++++
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV------ 350
Query: 632 FSRINLGDKSHDQVERATRKT-ESLPDSPETRVRNRKL 668
+ D++ + L + E R +L
Sbjct: 351 ---------NCDKLTTIIESSLNVL-EPAEYRKMFDRL 378
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 83/630 (13%), Positives = 165/630 (26%), Gaps = 203/630 (32%)
Query: 108 RKSTNQTAKGSAGFLSHFHKGDSQVLNIESVKNDLR-PSVPVRSTPTSLSSSHAVSPQRS 166
K K F+ + + + L + +K + R PS+ R QR
Sbjct: 73 SKQEEMVQK----FVEEVLRINYKFL-MSPIKTEQRQPSMMTRM----------YIEQRD 117
Query: 167 NLQNPTPLHNPKSISTRRRGFSHDLNIECANYSSR-ADIIP--------KSAPTSVFSSP 217
L N + ++ +R + + L + A R A + K+ +
Sbjct: 118 RLYNDNQVFAKYNV-SRLQPY---LKLRQALLELRPAKNVLIDGVLGSGKT----WVALD 169
Query: 218 AVSPQSSKTGNVFSSFWAPKEIQDWSTAEVPDLGRFVGCTSPVSPFKR--NVYSADHSPL 275
+ F FW +L C SP + + +
Sbjct: 170 VCLSYKVQCKMDFKIFWL-------------NLKN---CNSPETVLEMLQKLLYQIDPNW 213
Query: 276 PSPPRQSSQSNLRS----PRKVYFPLRHKSLPQNSKELL-----ESNNHLNAHPLP---L 323
S SS LR L+ K N LL ++ NA L L
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRL-LKSKPYE-NC--LLVLLNVQNAKAWNAFNLSCKIL 269
Query: 324 PPGALSPPKSSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCA 383
L+ VT + S T T E +
Sbjct: 270 ----LTTRFKQVTDFLSAATTTHISLDHH-----------SMTL------TPDEVKSLLL 308
Query: 384 IKEVDIIPDD-PKSAECIKQLEQEIKVLGHLKHENIV-----QYYGSEVVDDHLYIYLEY 437
K +D P D P+ + ++ + + ++ + + + L
Sbjct: 309 -KYLDCRPQDLPREVLTTNPRR--LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNV 365
Query: 438 VHPGSI-NRYV-----REHCRDITESI--------VRNFTRHILNGLA------------ 471
+ P + I + +++ ++N L
Sbjct: 366 LEPAEYRKMFDRLSVFPPSA-HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES 424
Query: 472 --YLHSTNTIHRDIKG-----ANL---LVDA---------SGVVKLADFG-----MAKHL 507
+ S I+ ++K L +VD ++ + HL
Sbjct: 425 TISIPS---IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHL 481
Query: 508 TGLSYELSLKGSP------NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKP 561
+ + + + ++ ++ D W+ +++ L
Sbjct: 482 KNIEHPERMTLFRMVFLDFRF-----LEQKIRHDSTA--------WNASGSILNTLQQLK 528
Query: 562 PWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPF---IR 618
+ + + P E L + DFL + L+ + +R
Sbjct: 529 FYKPY---------ICDNDPKYERLVNAILDFLPKI----------EENLICSKYTDLLR 569
Query: 619 NANYQNLSVPMR-VFSRINLGDKSHDQVER 647
A L +F +++H QV+R
Sbjct: 570 IA----LMAEDEAIF------EEAHKQVQR 589
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 741 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-81 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-77 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-75 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-75 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-73 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-73 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-71 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-71 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-70 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-70 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-70 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-69 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-69 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-69 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-67 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-66 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-63 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-62 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-60 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-60 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-60 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-58 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-57 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-57 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-56 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-55 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-55 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-53 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-53 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-53 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-51 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-48 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-47 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-37 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-26 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (662), Expect = 2e-81
Identities = 93/274 (33%), Positives = 139/274 (50%), Gaps = 11/274 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
W+ +G G FG VY N+ET A K +D KS E ++ EI +L H
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVID-----TKSEEELEDYMVEIDILASCDH 68
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ + +++L+I +E+ G+++ + E R +TES ++ + L+ L YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL-SLKGSPNWMAPEVIKAVMQK 534
IHRD+K N+L G +KLADFG++ T S G+P WMAPEV+ K
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPP---IPEMLSSEGK 591
D D+WSLG T+IEM +PP E + + K+ PP P SS K
Sbjct: 189 DR--PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246
Query: 592 DFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625
DFL +C +N R + +LL+HPF+ + + +
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (634), Expect = 1e-77
Identities = 79/265 (29%), Positives = 134/265 (50%), Gaps = 11/265 (4%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ G+ +G+G FG+VY+ +++ A+K + + A QL +E+++ HL
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 63
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
+H NI++ YG +Y+ LEY G++ R ++ E + + N L+Y
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYC 122
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
HS IHRDIK NLL+ ++G +K+ADFG + H S +L G+ +++ PE+I+
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIE---- 177
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593
VD+WSLG E L GKPP+ + ++ P+ ++ +D
Sbjct: 178 ---GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234
Query: 594 LLRCFLRNPVERPSAVELLEHPFIR 618
+ R NP +RP E+LEHP+I
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 244 bits (623), Expect = 2e-75
Identities = 90/297 (30%), Positives = 146/297 (49%), Gaps = 14/297 (4%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + + IG G+FG+VY + AIK++ +S E + + +E++ L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQK 71
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L+H N +QY G + + ++ +EY GS + + H + + E + T L GLAY
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVM 532
LHS N IHRD+K N+L+ G+VKL DFG A + + S G+P WMAPEVI A+
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMD 187
Query: 533 QKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN--RTPPIPEMLSSEG 590
+ + K VD+WSLG T IE+ KPP A++ + S
Sbjct: 188 EGQYDGK----VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 591 KDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVER 647
++F+ C + P +RP++ LL+H F+ + +V M + R + D ++
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVL--RERPPTVIMDLIQRTKDAVRELDNLQY 298
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 2e-75
Identities = 71/274 (25%), Positives = 124/274 (45%), Gaps = 17/274 (6%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVL 410
P W + +G G +G V + NR T + A+K VD+ ++ +C + +++EI +
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM----KRAVDCPENIKKEICIN 57
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
L HEN+V++YG + Y++LEY G + + + E + F ++ G+
Sbjct: 58 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGV 116
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK---GSPNWMAPEV 527
YLH HRDIK NLL+D +K++DFG+A + E L G+ ++APE+
Sbjct: 117 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 528 IKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPE 584
+K A VD+WS G + ML G+ PW + + +
Sbjct: 177 LK------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
+ S L + + NP R + ++ + +
Sbjct: 231 KIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (604), Expect = 7e-73
Identities = 101/300 (33%), Positives = 152/300 (50%), Gaps = 22/300 (7%)
Query: 343 IMEK----PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAE 398
I+EK S K ++ + + IG+G G+VY + TG AI+++++ +
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQP 59
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESI 458
+ + EI V+ K+ NIV Y S +V D L++ +EY+ GS+ V E C D E
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQ 117
Query: 459 VRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LK 517
+ R L L +LHS IHRDIK N+L+ G VKL DFG +T + S +
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 518 GSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN 577
G+P WMAPEV+ VDIWSLG IEM+ G+PP+ +A++ +
Sbjct: 178 GTPYWMAPEVVT-------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
Query: 578 RTPP---IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSR 634
P PE LS+ +DFL RC + +R SA ELL+H F++ A + P+ ++
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 235 bits (601), Expect = 9e-73
Identities = 71/273 (26%), Positives = 130/273 (47%), Gaps = 11/273 (4%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQ----EIKVL 410
++ +++GRG V ++ T A+K +D+ SAE +++L + E+ +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 411 GHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+ H NI+Q + + ++ + + G + Y+ E ++E R R +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEV 122
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
+ LH N +HRD+K N+L+D +KL DFG + L + G+P+++APE+I+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----PPIPEM 585
D +P VD+WS G + +L G PP+ + + +++ P +
Sbjct: 183 C-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD 241
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
S KD + R + P +R +A E L HPF +
Sbjct: 242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 236 bits (604), Expect = 3e-72
Identities = 69/334 (20%), Positives = 133/334 (39%), Gaps = 27/334 (8%)
Query: 342 HIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIK 401
H+++ + + +G G FG V+ T R TG + A K V +
Sbjct: 23 HVLDH---------YDIHEELGTGAFGVVHRVTERATGNNFAAKFVM-----TPHESDKE 68
Query: 402 QLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRN 461
+ +EI+ + L+H +V + + D+ + + E++ G + V + ++E
Sbjct: 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLV--DASGVVKLADFGMAKHLTGLSYELSLKGS 519
+ R + GL ++H N +H D+K N++ S +KL DFG+ HL G+
Sbjct: 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
Query: 520 PNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT 579
+ APEV + + D+WS+G +L+G P+ + + V +
Sbjct: 189 AEFAAPEVAE-------GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241
Query: 580 PPIPE----MLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 635
+ + +S +GKDF+ + L +P R + + LEHP++ N +
Sbjct: 242 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYT 301
Query: 636 NLGDKSHDQVERATRKTESLPDSPETRVRNRKLP 669
+ D + + L + P
Sbjct: 302 KIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRP 335
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 5e-71
Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 22/274 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ IG G++G + G K + + + L E+ +L LKH
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWK---ELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 416 ENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRD---ITESIVRNFTRHILNGL 470
NIV+YY + + LYI +EY G + + + ++ + E V + L
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 471 AYLHSTNT-----IHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMA 524
H + +HRD+K AN+ +D VKL DFG+A+ L S+ + G+P +M+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIP 583
PE + DIWSLGC + E+ PP++ F + K+ + IP
Sbjct: 183 PEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 235
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
S E + + R RPS E+LE+P I
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 9e-71
Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 22/287 (7%)
Query: 351 PKK---SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEI 407
P+K ++ GK++G G+F +V + T AIK ++ + + +E
Sbjct: 2 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRER 59
Query: 408 KVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
V+ L H V+ Y + D+ LY L Y G + +Y+R E+ R +T I+
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIV 118
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMA 524
+ L YLH IHRD+K N+L++ +++ DFG AK L+ S + S G+ +++
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 525 PEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE 584
PE++ + D+W+LGC + +++ G PP+ K++ PE
Sbjct: 179 PELLT-------EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNL 625
+ +D + + + + +R E L HPF + ++NL
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 4e-70
Identities = 72/270 (26%), Positives = 134/270 (49%), Gaps = 23/270 (8%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
IGRG+F +VY G + ET A + D + ++ ++E ++L L+H NI
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWC---ELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 419 VQYYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
V++Y S + + E + G++ Y++ + ++R++ R IL GL +LH
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH 129
Query: 475 STNT--IHRDIKGANLLVDA-SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
+ IHRD+K N+ + +G VK+ D G+A S+ ++ G+P +MAPE+ +
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE- 187
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN---RTPPIPEMLSS 588
K +VD+++ G ++EM T + P+SE + +++ + + ++
Sbjct: 188 -------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
E K+ + C +N ER S +LL H F +
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 5e-70
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 20/272 (7%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
Q G+ IG G+FG+VY G A+K ++ + + ++ + E+ VL
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVK---MLNVTAPTPQQLQAFKNEVGVLR 59
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+H NI+ + G L I ++ S+ ++ + + R G+
Sbjct: 60 KTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVI 528
YLH+ + IHRD+K N+ + VK+ DFG+A + S L GS WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------TPPI 582
+ + + + D+++ G + E++TG+ P+S + ++ R +
Sbjct: 179 RMQDKNPYSFQ----SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
K + C + ERP ++L
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 9e-70
Identities = 82/331 (24%), Positives = 154/331 (46%), Gaps = 58/331 (17%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K ++K +G G G V+ +++ +G A K + + Q+ +E++VL
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL----EIKPAIRNQIIRELQVLH 59
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
IV +YG+ D + I +E++ GS+++ +++ R I E I+ + ++ GL
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLT 118
Query: 472 YLHSTNTI-HRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
YL + I HRD+K +N+LV++ G +KL DFG++ L S S G+ ++M+PE ++
Sbjct: 119 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQ- 176
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW--------------------------- 563
++ DIWS+G +++EM G+ P
Sbjct: 177 ------GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230
Query: 564 -----------SEFEGPQAMFKVLNRT-----PPIPE-MLSSEGKDFLLRCFLRNPVERP 606
+ P A+F++L+ P +P + S E +DF+ +C ++NP ER
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290
Query: 607 SAVELLEHPFIRNANYQNLSVPMRVFSRINL 637
+L+ H FI+ ++ + + + S I L
Sbjct: 291 DLKQLMVHAFIKRSDAEEVDFAGWLCSTIGL 321
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 1e-69
Identities = 67/313 (21%), Positives = 127/313 (40%), Gaps = 19/313 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ + +GRG FG V+ + + K V + D +++EI +L +H
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV------LVKKEISILNIARH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NI+ + S + L + E++ I + ++ E + ++ + L +LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 476 TNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
N H DI+ N++ S +K+ +FG A+ L L +P + APEV +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQ---- 176
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----LSSE 589
+ ++ A D+WSLG V +L+G P+ Q + ++N E +S E
Sbjct: 177 ---HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 590 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKSHDQVERAT 649
DF+ R ++ R +A E L+HP+++ + + +R +
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMV 293
Query: 650 RKTESLPDSPETR 662
+ R
Sbjct: 294 VSAARISCGGAIR 306
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 227 bits (579), Expect = 5e-69
Identities = 74/290 (25%), Positives = 127/290 (43%), Gaps = 19/290 (6%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + ++G G F V + ++ T AIK + + K +E EI VL
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE----GSMENEIAVLHK 63
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
+KH NIV HLY+ ++ V G + + E TE +L+ + Y
Sbjct: 64 IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKY 122
Query: 473 LHSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
LH +HRD+K NLL D + ++DFG++K S + G+P ++APEV+
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEM 585
+ AVD WS+G +L G PP+ + + ++L P +
Sbjct: 183 -------QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRI 635
+S KDF+ ++P +R + + L+HP+I + ++ V +I
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 228 bits (581), Expect = 7e-69
Identities = 64/318 (20%), Positives = 132/318 (41%), Gaps = 28/318 (8%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ + +G G FG V+ + TG K ++ ++ EI ++ L H
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFIN-----TPYPLDKYTVKNEISIMNQLHH 85
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
++ + + + + LE++ G + + ++E+ V N+ R GL ++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 476 TNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
+ +H DIK N++ + + VK+ DFG+A L + + APE++
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD---- 201
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM----LSSE 589
+ D+W++G +L+G P++ + + + V E +S E
Sbjct: 202 ---REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 590 GKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLS--VPMRVFSRINLGDKSHDQVER 647
KDF+ + P +R + + LEHP+++ ++ NL+ +P +++I Q +
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKG-DHSNLTSRIPSSRYNKI-------RQKIK 310
Query: 648 ATRKTESLPDSPETRVRN 665
P R+ N
Sbjct: 311 EKYADWPAPQPAIGRIAN 328
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-67
Identities = 73/273 (26%), Positives = 136/273 (49%), Gaps = 13/273 (4%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LK 414
+ K++G+G+FG V++ ++T AIK + D + ++ E +VL +
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H + + + ++L+ +EY++ G + +++ + S + I+ GL +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLT-GLSYELSLKGSPNWMAPEVIKAVMQ 533
S ++RD+K N+L+D G +K+ADFGM K G + + G+P+++APE++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL---- 176
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593
K +VD WS G + EML G+ P+ + + + P P L E KD
Sbjct: 177 ---GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 233
Query: 594 LLRCFLRNPVERPSAV-ELLEHPFIRNANYQNL 625
L++ F+R P +R ++ +HP R N++ L
Sbjct: 234 LVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 220 bits (562), Expect = 2e-66
Identities = 66/277 (23%), Positives = 132/277 (47%), Gaps = 17/277 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+Q + +G G+FG V++ +R G A+K + + + ++ E +L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--KEIVVRLKQVEHTNDERLMLSIV 61
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H I++ +G+ +++ ++Y+ G + + + + + + L YL
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
HS + I+RD+K N+L+D +G +K+ DFG AK++ ++Y +L G+P+++APEV+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVS---- 174
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593
++D WS G + EML G P+ + + K+LN P + + KD
Sbjct: 175 ---TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231
Query: 594 LLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
L R R+ +R ++ HP+ + ++ L
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 4e-66
Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 17/273 (6%)
Query: 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKV 409
P +SQ+Q G L+G G FGSVY G AIK V+ D ++ E+ +
Sbjct: 1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 410 LGHLK--HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHIL 467
L + +++ D + LE P + E + R+F +L
Sbjct: 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 468 NGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPE 526
+ + H+ +HRDIK N+L+D + G +KL DFG L + G+ + PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 586
I+ + + +WSLG + +M+ G P+ E +++ + +
Sbjct: 180 WIR------YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV 227
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
SSE + + C P +RP+ E+ HP++++
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-63
Identities = 67/279 (24%), Positives = 126/279 (45%), Gaps = 17/279 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIP-DDPKSAECIKQLEQEIKVLGHLK 414
+ G+ +G G F V + TG A K + + + +E+E+ +L ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H N++ + + + LE V G + ++ E +TE F + ILNG+ YLH
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH 130
Query: 475 STNTIHRDIKGANLLVDASGV----VKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
S H D+K N+++ V +K+ DFG+A + + ++ G+P ++APE++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN- 189
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPEML 586
L L D+WS+G +L+G P+ + + V
Sbjct: 190 ------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625
S+ KDF+ R +++P +R + + L+HP+I+ + Q
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 212 bits (541), Expect = 5e-63
Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 17/279 (6%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLE-QEIKVLGHLK 414
+ ++IGRG FG VY +TG A+K +D K E + E + ++
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
IV + D L L+ ++ G ++ ++ +H E+ +R + I+ GL ++H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMH 124
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
+ ++RD+K AN+L+D G V+++D G+A + + G+ +MAPEV+
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVL------ 177
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---KVLNRTPPIPEMLSSEGK 591
+ D +SLGC + ++L G P+ + + L +P+ S E +
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237
Query: 592 DFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 625
L R+ R A E+ E PF R+ ++Q +
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 2e-62
Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 22/265 (8%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
+ + + IG+G FG V +G R G A+K + K+ + E V+ L
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-------KNDATAQAFLAEASVMTQL 57
Query: 414 KHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLA 471
+H N+VQ G V + LYI EY+ GS+ Y+R R + + F+ + +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
YL N +HRD+ N+LV V K++DFG+ K + S + + K W APE ++
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGKLPVKWTAPEALR-- 173
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSE 589
K + D+WS G + E+ + G+ P+ + +V P+
Sbjct: 174 -----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228
Query: 590 GKDFLLRCFLRNPVERPSAVELLEH 614
+ + C+ + RPS ++L E
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-62
Identities = 62/265 (23%), Positives = 109/265 (41%), Gaps = 18/265 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S+ + IG G FG V++G AIK + + A + +E +V+ L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIR------EGAMSEEDFIEEAEVMMKL 57
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H +VQ YG + + + E++ G ++ Y+R + + G+AYL
Sbjct: 58 SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL--TGLSYELSLKGSPNWMAPEVIKAV 531
IHRD+ N LV + V+K++DFGM + + + K W +PEV
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS-- 175
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSE 589
+ + D+WS G + E+ + GK P+ + + + P + S+
Sbjct: 176 -----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230
Query: 590 GKDFLLRCFLRNPVERPSAVELLEH 614
+ C+ P +RP+ LL
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-62
Identities = 75/277 (27%), Positives = 130/277 (46%), Gaps = 16/277 (5%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+ KL+G+GTFG V + + TG A+K + + + + + E +VL + +
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQNTR 63
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H + + D L +EY + G + ++ TE R + I++ L YLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH 122
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS-LKGSPNWMAPEVIKAVMQ 533
S + ++RDIK NL++D G +K+ DFG+ K + G+P ++APEV++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE---- 178
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593
+ AVD W LG + EM+ G+ P+ + + +L P LS E K
Sbjct: 179 ---DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
Query: 594 LLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 625
L ++P +R A E++EH F + N+Q++
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-61
Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 23/273 (8%)
Query: 360 KLIGRGTFGSVYIGTNR--ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHEN 417
K +G G FG+V G + + + A+K I+ ++ +L E V+ L +
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVK---ILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN 477
IV+ G + + +E G +N+Y++++ + + + + G+ YL +N
Sbjct: 70 IVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESN 127
Query: 478 TIHRDIKGANLLVDASGVVKLADFGMAKHLTG----LSYELSLKGSPNWMAPEVIKAVMQ 533
+HRD+ N+L+ K++DFG++K L + K W APE I
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN---- 183
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK 591
K + D+WS G + E + G+ P+ +G + + P E
Sbjct: 184 ---YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240
Query: 592 DFLLRCFLRNPVERPSA---VELLEHPFIRNAN 621
D + C+ + RP L + + N
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (522), Expect = 5e-61
Identities = 60/272 (22%), Positives = 117/272 (43%), Gaps = 6/272 (2%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S + ++IG G FG V G + G + + + + + E ++G
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQF 84
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
H N++ G + I E++ GS++ ++R++ T + R I G+ YL
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQ 533
N +HRD+ N+LV+++ V K++DFG+++ L + + + + P A
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGK 591
K A D+WS G + E+++ G+ P+ + + + + P P S
Sbjct: 205 IQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
Query: 592 DFLLRCFLRNPVERPSAVELLEH--PFIRNAN 621
+L C+ ++ RP +++ IRN N
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-60
Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 18/265 (6%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
K +G G FG V G R AIK + + + + +E KV+ +L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIK------EGSMSEDEFIEEAKVMMNL 56
Query: 414 KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
HE +VQ YG ++I EY+ G + Y+RE + + + + YL
Sbjct: 57 SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 474 HSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVIKAV 531
S +HRD+ N LV+ GVVK++DFG+++++ Y S K W PEV+
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-- 174
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSE 589
K + DIW+ G + E+ + GK P+ F + + P + S +
Sbjct: 175 -----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 590 GKDFLLRCFLRNPVERPSAVELLEH 614
+ C+ ERP+ LL +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 202 bits (515), Expect = 2e-60
Identities = 61/279 (21%), Positives = 119/279 (42%), Gaps = 22/279 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ G+++G G V++ + A+K + D + + +E + L
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLR--ADLARDPSFYLRFRREAQNAAALN 65
Query: 415 HENIVQYYGSEVVDDH----LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
H IV Y + + YI +EYV ++ V +T L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQAL 124
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL----TGLSYELSLKGSPNWMAPE 526
+ H IHRD+K AN+++ A+ VK+ DFG+A+ + ++ ++ G+ +++PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 583
+ + D++SLGC + E+LTG+PP++ ++ + P P
Sbjct: 185 QAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 584 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
E LS++ +L+ +NP R + +R N
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-60
Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 19/270 (7%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNR---ETGASCAIKEVDIIPDDPKSAECIKQLEQEIK 408
++ + + G+ IG G FG V+ G + AIK D ++ QE
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD----SVREKFLQEAL 60
Query: 409 VLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+ H +IV+ G + ++ ++I +E G + +++ + + + + +
Sbjct: 61 TMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPE 526
LAYL S +HRDI N+LV ++ VKL DFG+++++ +Y + K WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 527 VIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPE 584
I + A D+W G + E+L G P+ + + ++ N P+P
Sbjct: 180 SIN-------FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 232
Query: 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ +C+ +P RP EL
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-60
Identities = 69/327 (21%), Positives = 127/327 (38%), Gaps = 35/327 (10%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN 417
+++G G G V N+ T A+K + + +E+++ + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPH 66
Query: 418 IVQYYG----SEVVDDHLYIYLEYVHPGSINRYVREHCRD-ITESIVRNFTRHILNGLAY 472
IV+ L I +E + G + +++ TE + I + Y
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 473 LHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIK 529
LHS N HRD+K NLL + + ++KL DFG AK T + + +P ++APEV+
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 185
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--------TPP 581
G K + D+WSLG + +L G PP+ G + R P
Sbjct: 186 ------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVPMRVFSRINLGDKS 641
+S E K + P +R + E + HP+I + + P+ + +
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ-STKVPQTPLHTSRVLKEDKER 298
Query: 642 HDQVERATRKTESLPDSPETRVRNRKL 668
+ V+ + +++ +K+
Sbjct: 299 WEDVKEEMTSALATMRVDYEQIKIKKI 325
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-60
Identities = 70/269 (26%), Positives = 115/269 (42%), Gaps = 20/269 (7%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRET---GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + +G G+FG V G S A+K + PD E + +E+ +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK--PDVLSQPEAMDDFIREVNAMHS 67
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
L H N+++ YG V+ + + E GS+ +R+H + + + G+ Y
Sbjct: 68 LDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 473 LHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL----KGSPNWMAPEVI 528
L S IHRD+ NLL+ +VK+ DFG+ + L + K W APE +
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN--RTPPIPEM 585
K + A D W G T+ EM T G+ PW G Q + K+ P PE
Sbjct: 187 K-------TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ + +++C+ P +RP+ V L +
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-59
Identities = 79/296 (26%), Positives = 128/296 (43%), Gaps = 39/296 (13%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+QK + IG GT+G VY N+ TG A+K I D ++ +EI +L L H
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNH 60
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
NIV+ ++ LY+ E++H I +++++ +L GLA+ HS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 476 TNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQK 534
+HRD+K NLL++ G +KLADFG+A+ + + + APE++
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL----- 175
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM--------- 585
G + AVDIWSLGC EM+T + + +F++ E+
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 586 --------------------LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621
L +G+ L + +P +R SA L HPF ++
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-59
Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 13/268 (4%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
K+++++K K++G G FG+VY G G I + S + K++ E V+
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
+ + ++ + G + + + + + G + YVREH +I + N+ I G+
Sbjct: 67 SVDNPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSL---KGSPNWMAPEVI 528
YL +HRD+ N+LV VK+ DFG+AK L E K WMA E I
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEML 586
+ D+WS G TV E++T G P+ + + P P +
Sbjct: 186 L-------HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 238
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ + +++C++ + RP EL+
Sbjct: 239 TIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-59
Identities = 61/267 (22%), Positives = 111/267 (41%), Gaps = 23/267 (8%)
Query: 362 IGRGTFGSVYIGTNRET--GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G FGSV G R AIK + +++ +E +++ L + IV
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK----QGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ G + L + +E G +++++ +I S V + G+ YL N +
Sbjct: 73 RLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHLTG----LSYELSLKGSPNWMAPEVIKAVMQKD 535
HRD+ N+L+ K++DFG++K L + + K W APE I
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN------ 185
Query: 536 GNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVL-NRTPPIPEMLSSEGKDF 593
K + D+WS G T+ E L+ G+ P+ + +GP+ M + + P E
Sbjct: 186 -FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244
Query: 594 LLRCFLRNPVERPSA---VELLEHPFI 617
+ C++ +RP + + +
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-59
Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 36/289 (12%)
Query: 360 KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIV 419
+G G F +VY ++ T AIK++ + + +EIK+L L H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 420 QYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTI 479
+ ++ + +++ + ++++ +T S ++ + L GL YLH +
Sbjct: 64 GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 480 HRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQKDGNP 538
HRD+K NLL+D +GV+KLADFG+AK + + + APE++
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG--- 179
Query: 539 KLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP-------------- 581
+ VD+W++GC + E+L P S+ + +F+ L
Sbjct: 180 ---VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 582 -----------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
I + D + FL NP R +A + L+ + N
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 1e-58
Identities = 64/272 (23%), Positives = 118/272 (43%), Gaps = 23/272 (8%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
+ + + +G G FG V++G A+K + + + E ++
Sbjct: 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK------QGSMSPDAFLAEANLMKQ 64
Query: 413 LKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGLA 471
L+H+ +V+ Y V + +YI EY+ GS+ +++ +T + + + I G+A
Sbjct: 65 LQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVIK 529
++ N IHRD++ AN+LV + K+ADFG+A+ + Y K W APE I
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 530 AVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLS 587
+ D+WS G + E++T G+ P+ P+ + + P+
Sbjct: 184 -------YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236
Query: 588 SEGKDFLLRCFLRNPVERPSA---VELLEHPF 616
E + C+ P +RP+ +LE F
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 9e-58
Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 37/292 (12%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVLG 411
+ + GK++G G FG V T + +V + + + + + L E+K++
Sbjct: 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95
Query: 412 HL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD----------------- 453
L HENIV G+ + +Y+ EY G + Y+R
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 454 -----ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508
+T + F + G+ +L + +HRD+ N+LV VVK+ DFG+A+ +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 509 GLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWS 564
S + + + WMAPE + + D+WS G + E+ + G P+
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLF-------EGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 565 EFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+K++ P + E + C+ + +RPS L
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-57
Identities = 76/286 (26%), Positives = 143/286 (50%), Gaps = 22/286 (7%)
Query: 355 QWQKGKLIGRGTFGSVYIG---TNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
++ K++G G +G V++ + +TG A+K + + A+ + E +VL
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-ATIVQKAKTTEHTRTERQVLE 83
Query: 412 HLKHE-NIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
H++ +V + + + L++ L+Y++ G + ++ + R TE V+ + I+ L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLAL 142
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVI 528
+LH I+RDIK N+L+D++G V L DFG++K E + G+ +MAP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----TPPIPE 584
+ AVD WSLG + E+LTG P++ + ++ R PP P+
Sbjct: 203 RGGDSGHDK-----AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 585 MLSSEGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQNL 625
+S+ KD + R +++P +R A E+ EH F + N+ +L
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 303
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 4e-57
Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 40/298 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
Q++ IG G +G V+ + + G A+K V + + + ++ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 414 KHENIVQYYGSEVV-----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
+H N+V+ + V + L + E+V + + +++ +L
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
GL +LHS +HRD+K N+LV +SG +KLADFG+A+ + S+ + + APEV+
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN----------- 577
A VD+WS+GC EM KP + + K+L+
Sbjct: 188 L-------QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 578 ----------------RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ GKD LL+C NP +R SA L HP+ ++
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 5e-57
Identities = 65/280 (23%), Positives = 128/280 (45%), Gaps = 20/280 (7%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
+++ +G G +G VY G ++ + A+K + + +++ +E V+
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK------EDTMEVEEFLKEAAVMK 68
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCR-DITESIVRNFTRHILNGL 470
+KH N+VQ G + YI E++ G++ Y+RE R +++ ++ I + +
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS--LKGSPNWMAPEVI 528
YL N IHRD+ N LV + +VK+ADFG+++ +TG +Y K W APE +
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIPEML 586
K ++ D+W+ G + E+ T ++++L + PE
Sbjct: 189 A-------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC 241
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLE--HPFIRNANYQN 624
+ + + C+ NP +RPS E+ + + ++ +
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (493), Expect = 2e-56
Identities = 78/288 (27%), Positives = 138/288 (47%), Gaps = 18/288 (6%)
Query: 344 MEKPSASPKK-SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQ 402
E PS + + Q+ + K +G G+FG V + ++E+G A+K +D + I+
Sbjct: 30 WETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--KQKVVKLKQIEH 87
Query: 403 LEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNF 462
E ++L + +V+ S + +LY+ +EYV G + ++R R +E R +
Sbjct: 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFY 146
Query: 463 TRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNW 522
I+ YLHS + I+RD+K NLL+D G +++ DFG AK + G ++ +L G+P
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEA 204
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI 582
+APE+I + AVD W+LG + EM G PP+ + Q K+++
Sbjct: 205 LAPEIIL-------SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 583 PEMLSSEGKDFLLRCFLRNPVER-----PSAVELLEHPFIRNANYQNL 625
P SS+ KD L + +R ++ H + ++ +
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-56
Identities = 78/315 (24%), Positives = 129/315 (40%), Gaps = 37/315 (11%)
Query: 337 SAVMPHIMEKPSA---SPKKSQWQKGKLIGRGTFGSVYIGT---NRETGASCAIKEVDII 390
SA+ P +++ P ++IGRG FG VY GT N CA+K ++ I
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 66
Query: 391 PDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-HLYIYLEYVHPGSINRYVRE 449
D + Q E ++ H N++ G + + + L Y+ G + ++R
Sbjct: 67 TDI----GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122
Query: 450 HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509
+ T + F + G+ +L S +HRD+ N ++D VK+ADFG+A+ +
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 510 LSYEL-----SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPW 563
++ K WMA E ++ K D+WS G + E++T G PP+
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQ-------TQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 564 SEFEGPQAMFKVL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH------PF 616
+ +L R PE + +L+C+ RPS EL+ F
Sbjct: 236 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
Query: 617 IR------NANYQNL 625
I NA Y N+
Sbjct: 296 IGEHYVHVNATYVNV 310
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-56
Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 22/275 (8%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
+ + +G+G FG V++GT T AIK + + QE +V+
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLK------PGTMSPEAFLQEAQVMK 67
Query: 412 HLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR-EHCRDITESIVRNFTRHILNGL 470
L+HE +VQ Y V ++ +YI EY+ GS+ +++ E + + + + I +G+
Sbjct: 68 KLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL--SLKGSPNWMAPEVI 528
AY+ N +HRD++ AN+LV + V K+ADFG+A+ + Y K W APE
Sbjct: 127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEML 586
+ + D+WS G + E+ T G+ P+ + + +V P P
Sbjct: 187 L-------YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 239
Query: 587 SSEGKDFLLRCFLRNPVERPSAVELLE--HPFIRN 619
D + +C+ + P ERP+ L + +
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 191 bits (486), Expect = 4e-56
Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 41/294 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
++ + IG GT+G VY N G + A+K I + + +EI +L LK
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALK---KIRLEKEDEGIPSTTIREISILKELK 58
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H NIV+ Y L + E++ + ++F +LNG+AY H
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHL-TGLSYELSLKGSPNWMAPEVIKAVMQ 533
+HRD+K NLL++ G +K+ADFG+A+ + + + AP+V+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM---- 173
Query: 534 KDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP--------- 581
G+ K + +DIWS+GC EM+ G P + SE + +F++L
Sbjct: 174 --GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 582 -----------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
+ L G D L + +P +R +A + LEH + +
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 5e-56
Identities = 65/270 (24%), Positives = 114/270 (42%), Gaps = 21/270 (7%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGAS----CAIKEVDIIPDDPKSAECIKQLEQEIKV 409
S + K+IG G FG VY G + + AIK + + + E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE----KQRVDFLGEAGI 62
Query: 410 LGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+G H NI++ G + I EY+ G++++++RE + + + R I G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL----SLKGSPNWMAP 525
+ YL + N +HRD+ N+LV+++ V K++DFG+++ L K W AP
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR--TPPIP 583
E I K A D+WS G + E++T + K +N P P
Sbjct: 183 EAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235
Query: 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
S +++C+ + RP +++
Sbjct: 236 MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 3e-55
Identities = 59/288 (20%), Positives = 105/288 (36%), Gaps = 38/288 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++ G+ IG G+FG +Y+GT+ G AIK + P QL E K+ ++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQ 60
Query: 415 HEN-IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYL 473
I D+ + +E + S+ R + V +++ + Y+
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 474 HSTNTIHRDIKGANLLV---DASGVVKLADFGMAKHLTGLSYEL--------SLKGSPNW 522
HS N IHRD+K N L+ +V + DFG+AK +L G+ +
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT--- 579
+ + + D+ SLG ++ G PW + K +
Sbjct: 180 ASINTHL-------GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 580 -----PPIPEMLSSEGKDFLLRCFLRNPVERPSA---VELLEHPFIRN 619
+ + SE +L C ++P +L + F R
Sbjct: 233 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 7e-55
Identities = 62/305 (20%), Positives = 120/305 (39%), Gaps = 51/305 (16%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
++ IG G +G V + AIK++ ++ +EIK+L
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ----TYCQRTLREIKILLRF 63
Query: 414 KHENIVQYYG---SEVVDDHLYIYL-EYVHPGSINRYVREHCRDITESIVRNFTRHILNG 469
+HENI+ + ++ +YL ++ + + ++ + ++ + F IL G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRG 121
Query: 470 LAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK----GSPNWMAP 525
L Y+HS N +HRD+K +NLL++ + +K+ DFG+A+ + + AP
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEM 585
E++ + ++DIWS+GC + EML+ +P + + +L +
Sbjct: 182 EIM------LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 586 -------------------------------LSSEGKDFLLRCFLRNPVERPSAVELLEH 614
S+ D L + NP +R + L H
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295
Query: 615 PFIRN 619
P++
Sbjct: 296 PYLEQ 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-54
Identities = 68/311 (21%), Positives = 122/311 (39%), Gaps = 55/311 (17%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL 413
S+++K IG+GTFG V+ +R+TG A+K + + + +EIK+L L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQLL 66
Query: 414 KHENIVQYYGS--------EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
KHEN+V +Y+ ++ + T S ++ +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQM 125
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL-----TGLSYELSLKGSP 520
+LNGL Y+H +HRD+K AN+L+ GV+KLADFG+A+ + + + +
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 521 NWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLN 577
+ PE++ G +D+W GC + EM T P +E + ++
Sbjct: 186 WYRPPELLL------GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239
Query: 578 RTPP-----------------------------IPEMLSSEGKDFLLRCFLRNPVERPSA 608
P + D + + + +P +R +
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299
Query: 609 VELLEHPFIRN 619
+ L H F +
Sbjct: 300 DDALNHDFFWS 310
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 1e-53
Identities = 63/303 (20%), Positives = 117/303 (38%), Gaps = 49/303 (16%)
Query: 344 MEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAE 398
+E P ++ + + IG G FG V+ E A+K + + SA+
Sbjct: 8 LEYP-----RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK----EEASAD 58
Query: 399 CIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD----- 453
++E ++ + NIV+ G V + + EY+ G +N ++R
Sbjct: 59 MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 454 ------------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGV 495
++ + R + G+AYL +HRD+ N LV + V
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV 178
Query: 496 VKLADFGMAKHLTGLSYEL---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCT 552
VK+ADFG+++++ Y + WM PE I + D+W+ G
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF-------YNRYTTESDVWAYGVV 231
Query: 553 VIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVE 610
+ E+ + G P+ + ++ V + PE E + + C+ + P +RPS
Sbjct: 232 LWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 611 LLE 613
+
Sbjct: 292 IHR 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 83/335 (24%), Positives = 133/335 (39%), Gaps = 57/335 (17%)
Query: 333 SSVTSAVMPHIMEKPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPD 392
S VT+ V + P++ + K+IG G+FG VY ++G AIK +
Sbjct: 1 SKVTTVVA--TPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQ 55
Query: 393 DPKSAECIKQLEQEIKVLGHLKHENIVQYY------GSEVVDDHLYIYLEYVHPGSINRY 446
D + +E++++ L H NIV+ G + + +L + L+YV P ++ R
Sbjct: 56 DKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRV 108
Query: 447 VREHCRD---ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFG 502
R + R + V+ + + LAY+HS HRDIK NLL+D V+KL DFG
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168
Query: 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPP 562
AK L +S S + APE+I G ++D+WS GC + E+L G+P
Sbjct: 169 SAKQLVRGEPNVSYICSRYYRAPELIF------GATDYTSSIDVWSAGCVLAELLLGQPI 222
Query: 563 WSEFEGPQAMFKVLNRTPPIPEM-----------------------------LSSEGKDF 593
+ G + +++ E
Sbjct: 223 FPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282
Query: 594 LLRCFLRNPVERPSAVELLEHPFIRNANYQNLSVP 628
R P R + +E H F N+ +P
Sbjct: 283 CSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 317
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-53
Identities = 78/330 (23%), Positives = 138/330 (41%), Gaps = 53/330 (16%)
Query: 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH 412
++ ++ + +G G +G+V + TGA AIK + +S K+ +E+++L H
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKH 73
Query: 413 LKHENIVQYYGS----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILN 468
++HEN++ E +DD YL G+ + +H + + E ++ +L
Sbjct: 74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLK 132
Query: 469 GLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVI 528
GL Y+H+ IHRD+K NL V+ +K+ DFG+A+ + + APEVI
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--GYVVTRWYRAPEVI 190
Query: 529 KAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW---SEFEGPQAMFKVLNRTPP---- 581
+ VDIWS+GC + EM+TGK + + + + KV P
Sbjct: 191 L------NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 582 ------------------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617
I S + L + + + +R +A E L HP+
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
Query: 618 RNANYQNLSVPMRVFSRINLGDKSHDQVER 647
+ + ++ + D S D V+R
Sbjct: 305 ESLHDTEDEPQVQKY------DDSFDDVDR 328
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-53
Identities = 64/281 (22%), Positives = 114/281 (40%), Gaps = 31/281 (11%)
Query: 354 SQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLG 411
+ + +IG G FG V ++ G AIK + + S + + E++VL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK----EYASKDDHRDFAGELEVLC 65
Query: 412 HL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------------IT 455
L H NI+ G+ +LY+ +EY G++ ++R+ ++
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 456 ESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELS 515
+ +F + G+ YL IHRD+ N+LV + V K+ADFG+++ +
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 185
Query: 516 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFK 574
+ WMA E + D+WS G + E+++ G P+ + K
Sbjct: 186 GRLPVRWMAIESLN-------YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 238
Query: 575 VL-NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ P E D + +C+ P ERPS ++L
Sbjct: 239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-53
Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 39/295 (13%)
Query: 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK 414
+++K + IG GT+G+V+ NRET A+K + D +EI +L LK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELK 59
Query: 415 HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
H+NIV+ + D L + E+ + +Y D+ IV++F +L GL + H
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 475 STNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQK 534
S N +HRD+K NLL++ +G +KLA+FG+A+ S + W P + +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 535 DGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNRTPP--------- 581
++D+WS GC E+ P + + +F++L
Sbjct: 179 YST-----SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 582 -----------------IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619
+ L++ G+D L NPV+R SA E L+HP+ +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 178 bits (452), Expect = 3e-51
Identities = 55/288 (19%), Positives = 105/288 (36%), Gaps = 38/288 (13%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
++ G+ IG G+FG ++ GTN AIK P A ++ + K+L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRR-SDAPQLRDEYRTYKLLAGCTG 62
Query: 416 ENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS 475
V Y+G E H + ++ + P S+ + R + V + +L + +H
Sbjct: 63 IPNVYYFGQE--GLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 476 TNTIHRDIKGANLLVDA-----SGVVKLADFGMAKHL--------TGLSYELSLKGSPNW 522
+ ++RDIK N L+ + ++ + DFGM K + +L G+ +
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 523 MAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-----LN 577
M+ + ++ + + D+ +LG + L G PW + K
Sbjct: 180 MSINTH---LGREQSRR----DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232
Query: 578 RTPPIPEM---LSSEGKDFLLRCFLRNPVERP---SAVELLEHPFIRN 619
++ P+ E+ E ++ P L R
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-51
Identities = 69/308 (22%), Positives = 123/308 (39%), Gaps = 47/308 (15%)
Query: 342 HIMEKPSASPKKSQW-------QKGKLIGRGTFGSVYIGT-----NRETGASCAIKEVDI 389
++ P+ P +W GK +G G FG V T + + A+K +
Sbjct: 4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK- 62
Query: 390 IPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVR 448
+ L E+KVL +L H NIV G+ + + EY G + ++R
Sbjct: 63 ---PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR 119
Query: 449 EHCRD-----------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD 491
+ + +F+ + G+A+L S N IHRD+ N+L+
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179
Query: 492 ASGVVKLADFGMAKHLTGLSYELS---LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWS 548
+ K+ DFG+A+ + S + + WMAPE I N D+WS
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF-------NCVYTFESDVWS 232
Query: 549 LGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVER 605
G + E+ + G P+ +K++ PE +E D + C+ +P++R
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 606 PSAVELLE 613
P+ ++++
Sbjct: 293 PTFKQIVQ 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 175 bits (443), Expect = 1e-49
Identities = 62/308 (20%), Positives = 115/308 (37%), Gaps = 60/308 (19%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK- 414
+Q + +GRG + V+ N +K + K++++EIK+L +L+
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--------PVKKKKIKREIKILENLRG 88
Query: 415 HENIVQYYGS--EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAY 472
NI+ + V + E+V+ ++ + +T+ +R + IL L Y
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDF----KQLYQTLTDYDIRFYMYEILKALDY 144
Query: 473 LHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
HS +HRD+K N+++D ++L D+G+A+ S + PE
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE----- 199
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPW----SEFEGPQAMFKVLNR--------- 578
++D+WSLGC + M+ K P+ ++ + KVL
Sbjct: 200 -LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 579 -------------------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613
++S E DFL + + R +A E +E
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
Query: 614 HPFIRNAN 621
HP+
Sbjct: 319 HPYFYTVV 326
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 28/292 (9%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVL 410
+ + + +G+G+FG VY G + V I ++ S + E V+
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 411 GHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD---------ITESIVRN 461
++V+ G + +E + G + Y+R + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 462 FTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYEL---SLKG 518
I +G+AYL++ +HRD+ N +V VK+ DFGM + + Y
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 519 SPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLN 577
WM+PE +K + D+WS G + E+ T + P+ Q + V+
Sbjct: 198 PVRWMSPESLK-------DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 578 -RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE------HPFIRNANY 622
P+ + + C+ NP RPS +E++ P R ++
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-48
Identities = 64/294 (21%), Positives = 111/294 (37%), Gaps = 50/294 (17%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI 418
+ IG+G FG V+ G + G A+K E E EI L+HENI
Sbjct: 8 QESIGKGRFGEVWRG--KWRGEEVAVKIFS------SREERSWFREAEIYQTVMLRHENI 59
Query: 419 VQYYGSEVVDD----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLH 474
+ + ++ D+ L++ +Y GS+ Y+ + +T + +GLA+LH
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH 117
Query: 475 S--------TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLK-----GSPN 521
HRD+K N+LV +G +AD G+A + + + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 522 WMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-- 579
+MAPEV+ + + + DI+++G E+ E Q + L +
Sbjct: 178 YMAPEVLDDSINM-KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 580 ---------------PPIPEMLSSEG-----KDFLLRCFLRNPVERPSAVELLE 613
P IP S + C+ N R +A+ + +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 46/299 (15%)
Query: 351 PKKSQW-------QKGKLIGRGTFGSVYIGTNRETGAS-------CAIKEVDIIPDDPKS 396
P+ +W GK +G G FG V + A+K + +
Sbjct: 3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK----SDAT 58
Query: 397 AECIKQLEQEIKVLGHL-KHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRD-- 453
+ + L E++++ + KH+NI+ G+ D LY+ +EY G++ Y++
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 454 -------------ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLAD 500
++ + + + G+ YL S IHRD+ N+LV V+K+AD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 501 FGMAKHLTGLSYELSL---KGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557
FG+A+ + + Y + WMAPE + + D+WS G + E+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALF-------DRIYTHQSDVWSFGVLLWEIF 231
Query: 558 TGKPPWSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
T + +FK+L P ++E + C+ P +RP+ +L+E
Sbjct: 232 TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-47
Identities = 64/311 (20%), Positives = 116/311 (37%), Gaps = 62/311 (19%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
Q K IG G G V + + AIK + ++ K+ +E+ ++ + H+
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 417 NIVQYYGSEVVDD------HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGL 470
NI+ +Y+ +E + + ++ + +L G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGI 132
Query: 471 AYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKA 530
+LHS IHRD+K +N++V + +K+ DFG+A+ + + APEVI
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL- 191
Query: 531 VMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLN-RTPPIPEML--- 586
VDIWS+GC + EM+ K + + KV+ P PE +
Sbjct: 192 ------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 587 --------------------------------------SSEGKDFLLRCFLRNPVERPSA 608
+S+ +D L + + +P +R S
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 609 VELLEHPFIRN 619
+ L+HP+I
Sbjct: 306 DDALQHPYINV 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-47
Identities = 67/298 (22%), Positives = 123/298 (41%), Gaps = 49/298 (16%)
Query: 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHE 416
Q +G G +GSV + +TG A+K + +S K+ +E+++L H+KHE
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 417 NIVQYYGS-----EVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLA 471
N++ + + + + ++ +N V+ C+ +T+ V+ IL GL
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLK 135
Query: 472 YLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAV 531
Y+HS + IHRD+K +NL V+ +K+ DFG+A+H + + APE++
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML-- 191
Query: 532 MQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML----- 586
VDIWS+GC + E+LTG+ + + + +L L
Sbjct: 192 ----NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 587 --------------------------SSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618
+ D L + + + +R +A + L H +
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-47
Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 31/287 (10%)
Query: 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDI-IPDDPKSAECIKQLEQEIKVL 410
+ + + GK +GRG FG V + + V + + + + + L E+K+L
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 411 GHLKHENIVQYYGSEVVDD--HLYIYLEYVHPGSINRYVREHCRD--------------- 453
H+ H V L + +E+ G+++ Y+R +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 454 ITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513
+T + ++ + G+ +L S IHRD+ N+L+ VVK+ DFG+A+ +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 514 L---SLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGP 569
+ + WMAPE I + + D+WS G + E+ + P+ +
Sbjct: 191 VRKGDARLPLKWMAPETIF-------DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 570 QAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614
+ + L P+ + E +L C+ P +RP+ EL+EH
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (356), Expect = 2e-37
Identities = 61/346 (17%), Positives = 117/346 (33%), Gaps = 86/346 (24%)
Query: 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH 415
+ + +G G F +V++ + A+K V + E EIK+L +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR------GDKVYTEAAEDEIKLLQRVND 68
Query: 416 ENIVQ-------------YYGSEVVDDHLYIYLEYVHPGSINRYV--REHCRDITESIVR 460
+ + + + + +++ + + G + + R I V+
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 461 NFTRHILNGLAYL-HSTNTIHRDIKGANLLVDASGV------VKLADFGMAKHLTGLSYE 513
++ +L GL Y+ IH DIK N+L++ +K+AD G A +
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHY 186
Query: 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEG----- 568
+ + + +PEV+ DIWS C + E++TG + EG
Sbjct: 187 TNSIQTREYRSPEVLL-------GAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
Query: 569 ---------------PQAMFK----------------------------VLNRTPPIPEM 585
P + + VL +
Sbjct: 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 299
Query: 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA-NYQNLSVPMR 630
+ E DFL +P +R A L+ HP++++ + + VP R
Sbjct: 300 EAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 345
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 105 bits (263), Expect = 1e-26
Identities = 35/210 (16%), Positives = 71/210 (33%), Gaps = 36/210 (17%)
Query: 359 GKLIGRGTFGSVYIGTNRETGASCAIKEVDI-------------IPDDPKSAECIKQLEQ 405
GKL+G G +V+ + E C +K + D S I+
Sbjct: 5 GKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 406 EIKVLGHLKHENIVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRH 465
E + L L+ + + Y + + + +E + + R E+ ++
Sbjct: 64 EFRALQKLQGLAVPKVYA---WEGN-AVLMELIDAKELYRVRVENPDEVL--------DM 111
Query: 466 ILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYELSLKGSPNWMAP 525
IL +A + +H D+ N+LV G + + DF + + + L+
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILE-----RDV 165
Query: 526 EVIKAVMQKDGNPKLALAVDIWSLGCTVIE 555
I + + DI S +++
Sbjct: 166 RNIITYFSRTYRTE----KDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 741 | |||
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.96 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.18 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.96 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.89 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=438.41 Aligned_cols=259 Identities=25% Similarity=0.423 Sum_probs=231.3
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 99907814882329769999998789947999996218999551999999999999994169987364034056356589
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++++.||+|+||+||+|+++.+|..||||++.. ......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~-----~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-----PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECC-----CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECC-----CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 6575898898407681999999889998999999845-----24316999999999998679979992999999899999
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECC--CCCEEEEECCCCHHCCCC
Q ss_conf 999522898700244201566438999999999999999999699031457776648668--994799302630101375
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA--SGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~--~g~vKLiDFGLA~~~~~~ 510 (741)
||||||+||+|.+++.+..+.+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 99985799889999976237899999999999999999999756976000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC----CCC
Q ss_conf 5333457999998769999853139999899310146678999999629999999982789999850699999----559
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EML 586 (741)
Q Consensus 511 ~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP----~~l 586 (741)
....+..||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+.+..+......++ ..+
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 252 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEG-------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHT-------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGC
T ss_pred CCCCEECCCCCCCCHHHHCC-------CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 43200068624218899758-------99872676554659999998598998997999999999847889894223589
Q ss_pred CHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCCCC
Q ss_conf 9999999999400199999999999809354245557
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 623 (741)
Q Consensus 587 s~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~~~ 623 (741)
++++++||.+||..||++|||+.|+|+||||+.....
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCCC
T ss_conf 9999999999756896679089998629132889888
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=439.02 Aligned_cols=256 Identities=21% Similarity=0.381 Sum_probs=230.5
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 99907814882329769999998789947999996218999551999999999999994169987364034056356589
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|+.|+|||||++++++.+++.+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-----CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 40359989993177829999999899979999998872-----6467999999999998679979891999999899999
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEEC--CCCCEEEEECCCCHHCCCC
Q ss_conf 99952289870024420156643899999999999999999969903145777664866--8994799302630101375
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD--ASGVVKLADFGMAKHLTGL 510 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId--~~g~vKLiDFGLA~~~~~~ 510 (741)
||||||+||+|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 99982899808888986389989999999999999999999977926513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC----CCC
Q ss_conf 5333457999998769999853139999899310146678999999629999999982789999850699999----559
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP----EML 586 (741)
Q Consensus 511 ~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP----~~l 586 (741)
....+..||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+..+.+..+......++ ..+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 255 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVD-------REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255 (352)
T ss_dssp SCEEEECSSGGGCCHHHHT-------TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred CCEEECCCCCCCCCHHHHC-------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 7201004764534899974-------799897633389899999999688998997999999999847889893002479
Q ss_pred CHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 9999999999400199999999999809354245
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 587 s~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9999999999756996689189999609734888
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=436.41 Aligned_cols=258 Identities=26% Similarity=0.487 Sum_probs=221.4
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEE
Q ss_conf 99990781488232976999999878994799999621899955199999999999999416998736403405635658
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
..++|++++.||+|+||+||+|+++.+|+.||||++.... ..+..+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~ 78 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR----AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 78 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH----CCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEE
T ss_conf 8746089989721748099999999999799999984566----412799999999999857998884696540467436
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC
Q ss_conf 99995228987002442015664389999999999999999996990314577766486689947993026301013755
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~ 511 (741)
|||||||+||+|.+++... ..+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 79 ~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 7988645898089997537-999999999999999999999997598357546899788789987983231422404688
Q ss_pred ---CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HCCCC--CCCCC
Q ss_conf ---3334579999987699998531399998993101466789999996299999999827899998-50699--99955
Q 004633 512 ---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTP--PIPEM 585 (741)
Q Consensus 512 ---~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki-~~~~~--~iP~~ 585 (741)
...+.+||+.|||||++.+ ..+++.++|||||||++|||++|+.||............ ..... .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKR------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHC------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGG
T ss_pred CCCCCCCEEECCCCCCHHHHCC------CCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 6531113255747428728618------9999971016173799999982997888898599999998638887886446
Q ss_pred CCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999999999400199999999999809354245
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 586 ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
+++++++||.+||..||++|||+.|+|+||||+..
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 99999999999767996689099999619845859
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=437.73 Aligned_cols=254 Identities=37% Similarity=0.606 Sum_probs=225.1
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 99907814882329769999998789947999996218999551999999999999994169987364034056356589
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++.+.||+|+||+||+|+++.+|+.||+|++...... . .+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--K---KELIINEILVMRENKNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--C---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH--H---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf 10538878981285829999999899989999998430172--7---999999999998679998805857798899989
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCC-C
Q ss_conf 999522898700244201566438999999999999999999699031457776648668994799302630101375-5
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~-~ 511 (741)
||||||+||+|.+++.+ ..+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+... .
T Consensus 94 ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp EEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEEEECCCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 99970379808988641--5999999999999999999999987972267768886887899686425156413213666
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC---CCCCCCCCCH
Q ss_conf 3334579999987699998531399998993101466789999996299999999827899998506---9999955999
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR---TPPIPEMLSS 588 (741)
Q Consensus 512 ~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~---~~~iP~~ls~ 588 (741)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+....+..+... ....+..+++
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~-------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 244 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTR-------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 244 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSS-------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCH
T ss_pred CCCCCCCCCCCCCHHHHCC-------CCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCH
T ss_conf 4444444777368266447-------998801203137299999804889989979999999998579998888553799
Q ss_pred HHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999999400199999999999809354245
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 589 el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
++++||.+||..||.+|||+.|+|+||||+..
T Consensus 245 ~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 99999999866996689099999649965778
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=440.15 Aligned_cols=262 Identities=29% Similarity=0.464 Sum_probs=234.3
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 99907814882329769999998789947999996218999551999999999999994169987364034056356589
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf 4742898898317684999999989998999999815654--49799999999999998679998877876403564211
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCC-CC
Q ss_conf 99952289870024420156643899999999999999999969903145777664866899479930263010137-55
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG-LS 511 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~-~~ 511 (741)
+|||||.||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCCC
T ss_conf 100035798605555325-6775999999999996521134315962246477784765899888820565200356786
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 33345799999876999985313999989931014667899999962999999998278999985069999955999999
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591 (741)
Q Consensus 512 ~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP~~ls~el~ 591 (741)
...+.+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+....+......+|..++++++
T Consensus 161 ~~~~~~GT~~Y~aPE~~~-------~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 233 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLE-------DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK 233 (337)
T ss_dssp CBCCCEECGGGCCGGGGS-------SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCCCCEECHHHHHHHHCC-------CCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHH
T ss_conf 205510088996666504-------8988833310223067889987899999969999999985289989866899999
Q ss_pred HHHHHHHHCCCCCCC-----CHHHHHCCCCCCCCCCCC
Q ss_conf 999994001999999-----999998093542455578
Q 004633 592 DFLLRCFLRNPVERP-----SAVELLEHPFIRNANYQN 624 (741)
Q Consensus 592 dLI~~mL~~DP~kRP-----Ta~EiLqHpff~~~~~~~ 624 (741)
+||.+||++||.+|+ ++.|+++||||+..++..
T Consensus 234 dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~ 271 (337)
T d1o6la_ 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf 99986663893442256523499997291503699999
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=438.21 Aligned_cols=256 Identities=30% Similarity=0.555 Sum_probs=230.1
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 99907814882329769999998789947999996218999551999999999999994169987364034056356589
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++++.||+|+||+||+|+++.+++.||+|++..... ......+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL--EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf 5376998898517785899999989994999999816885--67689999999999998568888885999999899989
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC
Q ss_conf 99952289870024420156643899999999999999999969903145777664866899479930263010137553
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~~ 512 (741)
||||||++|+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 83 ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~ 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-C
T ss_pred EEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCC-C
T ss_conf 998504798589887504-89999999999999999999999889465220234414668998711555633544888-5
Q ss_pred CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 33457999998769999853139999899310146678999999629999999982789999850699999559999999
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592 (741)
Q Consensus 513 ~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP~~ls~el~d 592 (741)
.....||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+..+......+|..+++++++
T Consensus 161 ~~~~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 233 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEG-------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 233 (263)
T ss_dssp CEETTEEGGGCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred CCCCCCCCCCCCHHHHCC-------CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHH
T ss_conf 235578876349999758-------9989314404675999998329999888999999999971899998668999999
Q ss_pred HHHHHHHCCCCCCCCHHHHHCCCCCCC
Q ss_conf 999940019999999999980935424
Q 004633 593 FLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 593 LI~~mL~~DP~kRPTa~EiLqHpff~~ 619 (741)
||.+||..||++|||+.|+|+||||+.
T Consensus 234 li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 234 LISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 999976479768909999971907078
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=439.59 Aligned_cols=263 Identities=26% Similarity=0.500 Sum_probs=233.7
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEE
Q ss_conf 99078148823297699999987899479999962189995519999999999999941699873640340563565899
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||+|+||+||+|+++.+++.||||++..... ......+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 877898898508790999999989997999999865775--577789999999999987688886179999998998899
Q ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCC---
Q ss_conf 99522898700244201566438999999999999999999699031457776648668994799302630101375---
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL--- 510 (741)
Q Consensus 434 VmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~--- 510 (741)
|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCC
T ss_conf 99704898777765315-99999999999999999997621650884767741236688853886032102422567764
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCHHH
Q ss_conf 53334579999987699998531399998993101466789999996299999999827899998506999995599999
Q 004633 511 SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEG 590 (741)
Q Consensus 511 ~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP~~ls~el 590 (741)
....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+...++......+|..+++++
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 237 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 237 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHH
T ss_pred CCCCCCCCCCCCCCCEEECC-------CCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHH
T ss_conf 33355567755258440026-------89896662304569999980388998995999999999718999985479999
Q ss_pred HHHHHHHHHCCCCCCCCHHH------HHCCCCCCCCCCCCCC
Q ss_conf 99999940019999999999------9809354245557888
Q 004633 591 KDFLLRCFLRNPVERPSAVE------LLEHPFIRNANYQNLS 626 (741)
Q Consensus 591 ~dLI~~mL~~DP~kRPTa~E------iLqHpff~~~~~~~l~ 626 (741)
++||.+||..||.+|||++| +++||||+..+|..+.
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred HHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHHHHH
T ss_conf 999999855797689197897377898769764789988961
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=435.67 Aligned_cols=260 Identities=34% Similarity=0.576 Sum_probs=228.2
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 99907814882329769999998789947999996218999551999999999999994169987364034056356589
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.+.|++++.||+|+||+||+|+++.++..||+|++..... ...+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-----GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf 0375984799307781999999999993999999872899-----99999999999998679999884988980099589
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCC-C
Q ss_conf 999522898700244201566438999999999999999999699031457776648668994799302630101375-5
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~-~ 511 (741)
||||||+||+|.+++.+..+.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCC
T ss_conf 99962799818899986289999999999999999999999988988714070031487899989971612303577864
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC---CCCCCCCH
Q ss_conf 333457999998769999853139999899310146678999999629999999982789999850699---99955999
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP---PIPEMLSS 588 (741)
Q Consensus 512 ~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~---~iP~~ls~ 588 (741)
...+..||+.|+|||++.+... ....|+.++|||||||++|||++|+.||.+.+..+.+.++..... ..+..+++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~--~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 243 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETS--KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 243 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCST--TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred CCCCCCCCCCCCCHHHHHHCCC--CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCH
T ss_conf 1001025626479999832025--78888806657878999999820889999989999999997079987776566999
Q ss_pred HHHHHHHHHHHCCCCCCCCHHHHHCCCCCCC
Q ss_conf 9999999940019999999999980935424
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 589 el~dLI~~mL~~DP~kRPTa~EiLqHpff~~ 619 (741)
++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 244 ~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 9999999976699668919999962923188
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=433.76 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=228.9
Q ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCE
Q ss_conf 79999078148823297699999987899479999962189995519999999999999941699873640340563565
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
...+.|+++++||+|+||+||+|+++.+++.||||++...... .....+.+|+.+|+.++|||||++++++.+++.
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE----GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 7766669988994065839999999999989999998157731----289999999999986799899919899998998
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEEC---CCCCEEEEECCCCHHC
Q ss_conf 8999952289870024420156643899999999999999999969903145777664866---8994799302630101
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVD---ASGVVKLADFGMAKHL 507 (741)
Q Consensus 431 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId---~~g~vKLiDFGLA~~~ 507 (741)
+|||||||+||+|.+++... +.+++.+++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+..
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 88988526898488865303-67887899999999999987524130556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCC----C
Q ss_conf 375533345799999876999985313999989931014667899999962999999998278999985069999----9
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI----P 583 (741)
Q Consensus 508 ~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~i----P 583 (741)
.......+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+....+....+......+ +
T Consensus 161 ~~~~~~~~~~GT~~y~APE~~~~-------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (307)
T d1a06a_ 161 DPGSVLSTACGTPGYVAPEVLAQ-------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233 (307)
T ss_dssp ------------CTTSCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTT
T ss_pred CCCCEEEEEEECCCCCCCHHHCC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
T ss_conf 58970440032842259188737-------99980787345159999998597999998999999998616877787666
Q ss_pred CCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 5599999999999400199999999999809354245
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 584 ~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
..+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 6789999999999760897579189998629844799
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=437.61 Aligned_cols=262 Identities=28% Similarity=0.539 Sum_probs=220.8
Q ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCE
Q ss_conf 79999078148823297699999987899479999962189995519999999999999941699873640340563565
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
...++|++.+.||+|+||+||+|+++.+|+.||+|+++.... .....++.+|+.+|+.++|||||++++++.+++.
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK----PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 78 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC----TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC----HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 875688897897127780999999989996999999875409----7899999999999986799999949999998999
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCCCCEEECCCCCEEEEECCCCHHCCC
Q ss_conf 899995228987002442015664389999999999999999996-9903145777664866899479930263010137
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASGVVKLADFGMAKHLTG 509 (741)
Q Consensus 431 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs-~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~ 509 (741)
+||||||++||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+|+.+..
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 99999767998689987424-99999999999999999999999859997144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHH----------------
Q ss_conf 5533345799999876999985313999989931014667899999962999999998278999----------------
Q 004633 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMF---------------- 573 (741)
Q Consensus 510 ~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~---------------- 573 (741)
. ...+.+||++|+|||++.+ ..|+.++||||+||++|||++|+.||.+.+......
T Consensus 158 ~-~~~~~~GT~~Y~APEvl~~-------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 158 S-MANSFVGTRSYMSPERLQG-------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp H-TC---CCSSCCCCHHHHHC-------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred C-CCCCCCCCCCCCCCHHHCC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 8-6211137714119468758-------9989488899899999999988899899887899999988751775457742
Q ss_pred --------------------------HHHCC-CCCCC-CCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf --------------------------98506-99999-559999999999940019999999999980935424555788
Q 004633 574 --------------------------KVLNR-TPPIP-EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625 (741)
Q Consensus 574 --------------------------ki~~~-~~~iP-~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~~~~l 625 (741)
.+... .+.++ ..++.++++||.+||..||.+|||+.|+|+||||+.......
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCCCCCC
T ss_conf 12333221111222354134778876650268766764448999999999986899467908999960986476982313
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=432.81 Aligned_cols=259 Identities=25% Similarity=0.497 Sum_probs=232.4
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEE
Q ss_conf 99078148823297699999987899479999962189995519999999999999941699873640340563565899
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEE
T ss_conf 470888897207680899999989997999999845775--488999999999999986369675330356852880056
Q ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCC
Q ss_conf 99522898700244201566438999999999999999999699031457776648668994799302630101375533
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~~~ 513 (741)
|||||.||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... .
T Consensus 82 vmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~ 158 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--T 158 (316)
T ss_dssp EECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--B
T ss_pred EEEECCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC--C
T ss_conf 76503786322343222-21110079999999987655412476770556810503868998898317521671245--6
Q ss_pred CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 34579999987699998531399998993101466789999996299999999827899998506999995599999999
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKDF 593 (741)
Q Consensus 514 ~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP~~ls~el~dL 593 (741)
.+.+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+..+...++......+|..++++++++
T Consensus 159 ~~~~Gt~~Y~APE~l~~-------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 231 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVST-------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL 231 (316)
T ss_dssp CCCCSCTTTCCHHHHTT-------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CCCCCCCCCCCHHHHCC-------CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
T ss_conf 43457634359999838-------99980430465333689997598999996999999999708988997789999999
Q ss_pred HHHHHHCCCCCCC-----CHHHHHCCCCCCCCCCCC
Q ss_conf 9994001999999-----999998093542455578
Q 004633 594 LLRCFLRNPVERP-----SAVELLEHPFIRNANYQN 624 (741)
Q Consensus 594 I~~mL~~DP~kRP-----Ta~EiLqHpff~~~~~~~ 624 (741)
|.+||.+||.+|+ |++++|+||||+..+++.
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~ 267 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 267 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred HHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHHH
T ss_conf 999954499766643102199998193514679899
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=431.96 Aligned_cols=259 Identities=29% Similarity=0.449 Sum_probs=232.4
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 99907814882329769999998789947999996218999551999999999999994169987364034056356589
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ......+.+.+|+.+|+.++|||||++++++.....+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCC
T ss_conf 2370898896117680899999989998999999826774--58899999999999999748772740344443222223
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC
Q ss_conf 99952289870024420156643899999999999999999969903145777664866899479930263010137553
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~~ 512 (741)
+||||+.||+|..++.+. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred CCCCCCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC--
T ss_conf 222233466226667515-89899999999999999899998599861767999936077897886101033322566--
Q ss_pred CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf 33457999998769999853139999899310146678999999629999999982789999850699999559999999
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGKD 592 (741)
Q Consensus 513 ~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP~~ls~el~d 592 (741)
..+..||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+....+.++......+|..+++++.+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~-------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 267 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILS-------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267 (350)
T ss_dssp BCCCEECGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHH
T ss_pred CCCCCCCCCCCCHHHHCC-------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHH
T ss_conf 643367635678899717-------9988533114500789999758899899599999999861798897668999999
Q ss_pred HHHHHHHCCCCCCC-----CHHHHHCCCCCCCCCCC
Q ss_conf 99994001999999-----99999809354245557
Q 004633 593 FLLRCFLRNPVERP-----SAVELLEHPFIRNANYQ 623 (741)
Q Consensus 593 LI~~mL~~DP~kRP-----Ta~EiLqHpff~~~~~~ 623 (741)
||.+||.+||.+|+ |++++++||||+..++.
T Consensus 268 li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHH
T ss_conf 999983409986065534549999719051589989
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=428.26 Aligned_cols=264 Identities=25% Similarity=0.438 Sum_probs=233.2
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCC-CHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCE
Q ss_conf 99990781488232976999999878994799999621899955-19999999999999941699873640340563565
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPK-SAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDH 430 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~-~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~ 430 (741)
..++|++++.||+|+||+||+|+++.+|+.||||++........ .....+.+.+|+.+|++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCC----CEEEEECCCCHH
Q ss_conf 8999952289870024420156643899999999999999999969903145777664866899----479930263010
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG----VVKLADFGMAKH 506 (741)
Q Consensus 431 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g----~vKLiDFGLA~~ 506 (741)
+|||||||+||+|.++|... +.+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|..
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEECCCCCCCCCHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHH
T ss_conf 99999867786431001035-64215578999999999987666254221133301279825898666469643344210
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC---
Q ss_conf 13755333457999998769999853139999899310146678999999629999999982789999850699999---
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP--- 583 (741)
Q Consensus 507 ~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP--- 583 (741)
+.......+..||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+.+..+......++
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVN-------YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHT-------TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred CCCCCCCCCCCCCCCCCCHHHHC-------CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHH
T ss_conf 57776312247777430999981-------89999766522140999999708899889999999999981688887010
Q ss_pred -CCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCCCC
Q ss_conf -5599999999999400199999999999809354245557
Q 004633 584 -EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQ 623 (741)
Q Consensus 584 -~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~~~ 623 (741)
..++.++++||.+||..||.+|||+.|+|+||||+..+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCHH
T ss_conf 47889999999999863896689199999619041888705
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=427.80 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=223.9
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCC-CCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEE
Q ss_conf 99907814882329769999998789947999996218999-55199999999999999416998736403405635658
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-PKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~-~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
.++|+++++||+|+||+||+|+++.+|+.||||++...... ............|+.+++.++|||||++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC
Q ss_conf 99995228987002442015664389999999999999999996990314577766486689947993026301013755
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~ 511 (741)
|||||||+||+|.++|.+. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCCC-
T ss_conf 9999914898389998732-55327899999999999999999779622044422167858896798220102333788-
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHCCCCCCCCCCCH
Q ss_conf 3334579999987699998531399998993101466789999996299999999827---8999985069999955999
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFKVLNRTPPIPEMLSS 588 (741)
Q Consensus 512 ~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~---~~l~ki~~~~~~iP~~ls~ 588 (741)
......||+.|+|||++.+ +..|+.++|||||||+||||++|+.||.+.... .....+......++..+++
T Consensus 161 ~~~~~~GT~~y~APE~~~~------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 234 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQK------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234 (364)
T ss_dssp CCCSCCSCGGGCCHHHHST------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred CCCCCCCCCCCCHHHHHHC------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCH
T ss_conf 6433113455421687603------8999844104677899999985999888899899999998604688878877899
Q ss_pred HHHHHHHHHHHCCCCCCCC-----HHHHHCCCCCCCCCCCC
Q ss_conf 9999999940019999999-----99998093542455578
Q 004633 589 EGKDFLLRCFLRNPVERPS-----AVELLEHPFIRNANYQN 624 (741)
Q Consensus 589 el~dLI~~mL~~DP~kRPT-----a~EiLqHpff~~~~~~~ 624 (741)
++++||.+||..||.+||| |+|+++||||++.++..
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~ 275 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHH
T ss_conf 99999999856698880887435799997491023789879
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=426.41 Aligned_cols=257 Identities=32% Similarity=0.554 Sum_probs=225.4
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEE
Q ss_conf 99078148823297699999987899479999962189995519999999999999941699873640340563565899
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
..|++.+.||+|+||+||+|+++.+++.||||++.... ....+..+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG--KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCS--SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 85676279701888099999998999399999984444--3588999999999999997789998238999998998899
Q ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCCC
Q ss_conf 99522898700244201566438999999999999999999699031457776648668994799302630101375533
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSYE 513 (741)
Q Consensus 434 VmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~~~ 513 (741)
|||||.+|+|..++... ..+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.... .
T Consensus 93 v~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~ 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---A 168 (309)
T ss_dssp EEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---B
T ss_pred EEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC---C
T ss_conf 99806999457899737-9999999999999999999999868976667884217987999789844365334677---8
Q ss_pred CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC--CCCCCCCHHHH
Q ss_conf 3457999998769999853139999899310146678999999629999999982789999850699--99955999999
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--PIPEMLSSEGK 591 (741)
Q Consensus 514 ~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~--~iP~~ls~el~ 591 (741)
....||+.|||||++.+. ....|+.++|||||||++|||++|..||.+....+.+.++..... ..+..++++++
T Consensus 169 ~~~~GT~~Y~APE~~~~~----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~ 244 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAM----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (309)
T ss_dssp CCCCSCGGGCCHHHHTTT----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHH
T ss_pred CCCCCCCCCCCHHHHHCC----CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHH
T ss_conf 731347663688998346----7888672145455899999998788999997999999999828999888788899999
Q ss_pred HHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999400199999999999809354245
Q 004633 592 DFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 592 dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
+||.+||..||.+|||+.|+|+||||...
T Consensus 245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 99999773796579189999719975378
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=426.03 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=229.6
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEE
Q ss_conf 99990781488232976999999878994799999621899955199999999999999416998736403405635658
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
.-++|++++.||+|+||+||+|+++.+++.||+|+++.. ......+.+|+.+|+.++|||||++++++.+++.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK------GTDQVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC------CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
T ss_conf 701058878983177839999999899969999997578------66599999999999857997989098999889988
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCC--CCEEEEECCCCHHCCC
Q ss_conf 99995228987002442015664389999999999999999996990314577766486689--9479930263010137
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS--GVVKLADFGMAKHLTG 509 (741)
Q Consensus 432 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~--g~vKLiDFGLA~~~~~ 509 (741)
|||||||.||+|.++|......+++.+++.|+.||+.||.|||++||+||||||+|||++.+ ..+||+|||+++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf 99995389980889987538999999999999999999999987699751355444344378851899764411100346
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCC----C
Q ss_conf 553334579999987699998531399998993101466789999996299999999827899998506999995----5
Q 004633 510 LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPE----M 585 (741)
Q Consensus 510 ~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP~----~ 585 (741)
........||+.|+|||++. +..|+.++|||||||++|+|++|+.||.+.+..+.+..+......++. .
T Consensus 157 ~~~~~~~~~t~~y~ape~~~-------~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQ-------HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHT-------TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CCCCCCCCCCCCCCCCHHCC-------CCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCCC
T ss_conf 77532122332223402104-------87778401130279999999828999999899999999983899988022367
Q ss_pred CCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999999999400199999999999809354245
Q 004633 586 LSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 586 ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
+++++++||.+||..||.+|||+.|+|+||||+..
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 89999999999866996689099999639965667
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=425.21 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=225.1
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE--CCE
Q ss_conf 999078148823297699999987899479999962189995519999999999999941699873640340563--565
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV--DDH 430 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~--~~~ 430 (741)
.++|++.+.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+.+|++++|||||++++++.+ ++.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM---TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS---CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----C
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC---CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
T ss_conf 3337996798308891999999999997999999874657---9799999999999999778999824899999178998
Q ss_pred EEEEEEECCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EECCCCCCCCEEECCCCCEEEEECC
Q ss_conf 89999522898700244201---566438999999999999999999699-----0314577766486689947993026
Q 004633 431 LYIYLEYVHPGSINRYVREH---CRDITESIVRNFTRHILNGLAYLHSTN-----TIHRDIKGANLLVDASGVVKLADFG 502 (741)
Q Consensus 431 l~LVmEy~~gGsL~~~L~~~---~~~lse~~i~~I~~QIl~gL~yLHs~g-----IVHRDIKP~NILId~~g~vKLiDFG 502 (741)
+|||||||+||+|.+++.+. ...+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECC
T ss_conf 99999568999389999851545789999999999999999999999716778878858676542574788857980010
Q ss_pred CCHHCCCCC-CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC-C
Q ss_conf 301013755-33345799999876999985313999989931014667899999962999999998278999985069-9
Q 004633 503 MAKHLTGLS-YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT-P 580 (741)
Q Consensus 503 LA~~~~~~~-~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~-~ 580 (741)
+|+.+.... ......||+.|||||++. ...|+.++|||||||++|||++|+.||.+.+..+...++.... .
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~ 232 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMN-------RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR 232 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred CEEECCCCCCCCCCCCCCCCCCCHHHHC-------CCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 0032245777556677882327999983-------999993898875278999980188998998999999999718998
Q ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCC
Q ss_conf 9995599999999999400199999999999809354
Q 004633 581 PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFI 617 (741)
Q Consensus 581 ~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff 617 (741)
.+|..+++++++||.+||..||.+|||+.|+|+|||+
T Consensus 233 ~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 8974359999999999767995579189999729819
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=417.94 Aligned_cols=265 Identities=26% Similarity=0.450 Sum_probs=234.6
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCC----HHHHHHHHHHHHHHHHCC-CCCEEEECCEEEE
Q ss_conf 99907814882329769999998789947999996218999551----999999999999994169-9873640340563
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKS----AECIKQLEQEIKVLGHLK-HENIVQYYGSEVV 427 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~----~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~ 427 (741)
.++|++.+.||+|+||+||+|+++.+|+.||||++......... ....+.+.+|+.+|+.++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf 56589999522898700244201566438999999999999999999699031457776648668994799302630101
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~ 507 (741)
++.+|||||||+||+|.++|+.. +.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEEC
T ss_conf 76059999768986689999865-99999999999999999999998759943234625489868998387124031672
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCC----
Q ss_conf 3755333457999998769999853139999899310146678999999629999999982789999850699999----
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIP---- 583 (741)
Q Consensus 508 ~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP---- 583 (741)
..........||+.|+|||++.+.... ....++.++||||+||++|||++|+.||.+.+.......+..+...++
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~-~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMND-NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCT-TSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred CCCCCEEEEECCCCCCCHHHHHCCCCC-CCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 688721345246788898886053445-6788992331856560231032288898899999999999818988898543
Q ss_pred CCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCC
Q ss_conf 559999999999940019999999999980935424
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 584 ~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~ 619 (741)
..+++++++||.+||..||.+|||+.|+|+||||+.
T Consensus 240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf 468999999999976589668919999973978797
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=417.76 Aligned_cols=252 Identities=29% Similarity=0.518 Sum_probs=215.4
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE----CC
Q ss_conf 99078148823297699999987899479999962189995519999999999999941699873640340563----56
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV----DD 429 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~----~~ 429 (741)
..|+..++||+|+||+||+|+++.++..||+|++..... .....+.+.+|+++|++++|||||++++++.. +.
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL---TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC---CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf 778851697008284999999999995999999851227---98999999999999985799985069999840334588
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCCCCEEEC-CCCCEEEEECCCCHH
Q ss_conf 589999522898700244201566438999999999999999999699--03145777664866-899479930263010
Q 004633 430 HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTN--TIHRDIKGANLLVD-ASGVVKLADFGMAKH 506 (741)
Q Consensus 430 ~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~g--IVHRDIKP~NILId-~~g~vKLiDFGLA~~ 506 (741)
.+|||||||++|+|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+.
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEEECCCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEE
T ss_conf 899999578989489997513-5546999999999999999999978997996876743511667999889800576542
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HCCCC--CCC
Q ss_conf 137553334579999987699998531399998993101466789999996299999999827899998-50699--999
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV-LNRTP--PIP 583 (741)
Q Consensus 507 ~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki-~~~~~--~iP 583 (741)
... ....+.+||+.|||||++.+ .++.++|||||||++|||++|+.||.+......+.+. ..+.. .++
T Consensus 165 ~~~-~~~~~~~GT~~Y~aPE~~~~--------~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 165 KRA-SFAKAVIGTPEFMAPEMYEE--------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235 (270)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT--------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred CCC-CCCCCCCCCCCCCCHHHHCC--------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf 368-76677553813008988478--------999867110079999999878899987655999999997389986567
Q ss_pred CCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCC
Q ss_conf 55999999999994001999999999998093542
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 584 ~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~ 618 (741)
..+++++++||.+||..||++|||+.|+|+||||+
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 55789999999997637975892999996775409
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=419.36 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=219.2
Q ss_pred EEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEE
Q ss_conf 78148823297699999987899479999962189995519999999999999941699873640340563565899995
Q 004633 357 QKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLE 436 (741)
Q Consensus 357 ~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmE 436 (741)
+.+++||+|+||+||+|+++.+|+.||||+++............+.+.+|+.+|+.++|||||++++++..++.+|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHH
T ss_conf 95638512728299999999999699999984202124567999999999999986799998689854225874022045
Q ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC-CCCC
Q ss_conf 228987002442015664389999999999999999996990314577766486689947993026301013755-3334
Q 004633 437 YVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-YELS 515 (741)
Q Consensus 437 y~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~-~~~t 515 (741)
|+.++++..++.. ...+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+.... ....
T Consensus 81 ~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 81 FMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCC
T ss_pred HHCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 5345077655412-667789999999999999998863163550357762588537784114657610005787554330
Q ss_pred CCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC---------------
Q ss_conf 57999998769999853139999899310146678999999629999999982789999850699---------------
Q 004633 516 LKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP--------------- 580 (741)
Q Consensus 516 ~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~--------------- 580 (741)
.+||+.|+|||++.+ ...|+.++|||||||++|||++|.+||.+....+.+.++.....
T Consensus 160 ~~gt~~y~aPE~~~~------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFG------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp SCCCCTTCCHHHHTT------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred EECCHHHCCHHHHCC------CCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCH
T ss_conf 204733363999726------77888056436304289999859699999999999999998518997254521000213
Q ss_pred --------C-----CCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf --------9-----9955999999999994001999999999998093542455
Q 004633 581 --------P-----IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 581 --------~-----iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~ 621 (741)
. +...+++++++||.+||..||++|||+.|+|+||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 443034789886785656899999999997638945690899996799657899
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=421.90 Aligned_cols=259 Identities=27% Similarity=0.495 Sum_probs=227.4
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHH-HCCCCCEEEECCEEEECCEEE
Q ss_conf 9907814882329769999998789947999996218999551999999999999994-169987364034056356589
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLG-HLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~-~L~HPNIVkl~g~~~~~~~l~ 432 (741)
++|+++++||+|+||+||+|+++.+++.||||++..... ......+.+..|+.++. .++|||||++++++.+++.+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH--HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEE
T ss_conf 971886589408782899999999998999999805553--384899999999999998479996878988970498316
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCC-C
Q ss_conf 999522898700244201566438999999999999999999699031457776648668994799302630101375-5
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-S 511 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~-~ 511 (741)
|||||++||+|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 ivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEECCCCCHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCCC
T ss_conf 777503798089986404-7899999999999999999999868934034765404444899630155530232356653
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCHHHH
Q ss_conf 33345799999876999985313999989931014667899999962999999998278999985069999955999999
Q 004633 512 YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEMLSSEGK 591 (741)
Q Consensus 512 ~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP~~ls~el~ 591 (741)
......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+...++....+.+|..++++++
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 231 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK 231 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCCCCCCCCCCCCHHHHCC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHH
T ss_conf 3454578777689999827-------998832320112278989873889999989999999997189989756799999
Q ss_pred HHHHHHHHCCCCCCCCHH-HHHCCCCCCCCCC
Q ss_conf 999994001999999999-9980935424555
Q 004633 592 DFLLRCFLRNPVERPSAV-ELLEHPFIRNANY 622 (741)
Q Consensus 592 dLI~~mL~~DP~kRPTa~-EiLqHpff~~~~~ 622 (741)
+||.+||.+||.+||++. ++++||||+..++
T Consensus 232 dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 232 DLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHCCHHCCCCH
T ss_conf 99999654489878388999980901315899
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=406.14 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=219.4
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEE
Q ss_conf 99078148823297699999987899479999962189995519999999999999941699873640340563565899
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC---CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
T ss_conf 997765177237680999999999997999999802225---75899999999999986799838874453322432037
Q ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCC-CC
Q ss_conf 99522898700244201566438999999999999999999699031457776648668994799302630101375-53
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGL-SY 512 (741)
Q Consensus 434 VmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~-~~ 512 (741)
||||+.++.+..........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EEEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCCC
T ss_conf 88623774455544202568888999999999999999865288992135711401134676210357861343688641
Q ss_pred CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC------------
Q ss_conf 33457999998769999853139999899310146678999999629999999982789999850699------------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------------ 580 (741)
Q Consensus 513 ~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~------------ 580 (741)
.....||+.|+|||++.. ..+++.++|||||||++|+|++|+.||.+.+....+.++.....
T Consensus 159 ~~~~~gt~~y~apE~~~~------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLG------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp TTCCBCCCTTCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CEEECCCCEEEEHHHHCC------CCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCC
T ss_conf 001036521541122136------65777422103333134279668799898899999999998328983331444222
Q ss_pred ------CC-----------CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf ------99-----------955999999999994001999999999998093542455
Q 004633 581 ------PI-----------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 581 ------~i-----------P~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~ 621 (741)
.+ ...++.++++||.+||..||.+|||+.|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 4212434543222204441667899999999997639955791899996787014699
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=409.42 Aligned_cols=255 Identities=26% Similarity=0.450 Sum_probs=217.9
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCC-CCHHHHHHHHHHHHHHHHCC--CCCEEEECCEEEEC
Q ss_conf 9999078148823297699999987899479999962189995-51999999999999994169--98736403405635
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDP-KSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVVD 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~-~~~~~ik~l~~Ei~iL~~L~--HPNIVkl~g~~~~~ 428 (741)
..++|+++++||+|+||+||+|+++.+|+.||||++....... .......++.+|+.+|++++ |||||++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEEC
T ss_conf 78837996798408783999999999997999999856884433455679999999999997435898812799998309
Q ss_pred CEEEEEEEECCC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCC-CCEEEEECCCCHH
Q ss_conf 658999952289-87002442015664389999999999999999996990314577766486689-9479930263010
Q 004633 429 DHLYIYLEYVHP-GSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS-GVVKLADFGMAKH 506 (741)
Q Consensus 429 ~~l~LVmEy~~g-GsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~-g~vKLiDFGLA~~ 506 (741)
+.+|+||||+.+ +++.+++... ..+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CEEEEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEE
T ss_conf 96899998336862289998615-89999999999999999999998779755667611147744788489775465353
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCC
Q ss_conf 13755333457999998769999853139999899310146678999999629999999982789999850699999559
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPIPEML 586 (741)
Q Consensus 507 ~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~iP~~l 586 (741)
.... ...+..||+.|+|||++.+ ..+++.++|||||||++|||++|+.||...+ .+......++..+
T Consensus 161 ~~~~-~~~~~~GT~~y~aPE~~~~------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~ 227 (273)
T d1xwsa_ 161 LKDT-VYTDFDGTRVYSPPEWIRY------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV 227 (273)
T ss_dssp CCSS-CBCCCCSCGGGSCHHHHHH------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCC
T ss_pred CCCC-CCCCCCCCCCCCCHHHHCC------CCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHHCCCCCCCCC
T ss_conf 2444-5566565877479999848------9978865332554034536756889988736------7761544778779
Q ss_pred CHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 9999999999400199999999999809354245
Q 004633 587 SSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 587 s~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
++++++||.+||..||++|||++|+|+||||++.
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9999999999760897589399998539866788
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=410.29 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=213.5
Q ss_pred CCCEEEE-EEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHH-CCCCCEEEECCEEEE---
Q ss_conf 9990781-48823297699999987899479999962189995519999999999999941-699873640340563---
Q 004633 353 KSQWQKG-KLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGH-LKHENIVQYYGSEVV--- 427 (741)
Q Consensus 353 ~~~Y~i~-k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~-L~HPNIVkl~g~~~~--- 427 (741)
.++|.+. ++||+|+||+||+|+++.+++.||||+++. . ..+.+|+.++.+ ++|||||++++++.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------C----PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------S----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC------C----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
T ss_conf 14879810796545486999999889998999999897------4----7799999999986699997829899950346
Q ss_pred -CCEEEEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECC---CCCEEEEECC
Q ss_conf -56589999522898700244201-566438999999999999999999699031457776648668---9947993026
Q 004633 428 -DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFG 502 (741)
Q Consensus 428 -~~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~---~g~vKLiDFG 502 (741)
+..+|||||||+||+|.++|.+. ...+++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 89789999977899849999986278775799999999999999999997698644410022011355556631135455
Q ss_pred CCHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----CC
Q ss_conf 30101375533345799999876999985313999989931014667899999962999999998278999985----06
Q 004633 503 MAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL----NR 578 (741)
Q Consensus 503 LA~~~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~----~~ 578 (741)
+|+............||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.........+. ..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 160 FAKETTSHNSLTTPCYTPYYVAPEVLGP-------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232 (335)
T ss_dssp TCEECCCCCCCCCCSCCCSSCCCCCCCG-------GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred EEEECCCCCCCCCCCCCCCCCCCHHHCC-------CCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCC
T ss_conf 1233368886432267756379277748-------988888888764516778865889988988778899999998538
Q ss_pred CCCCC----CCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 99999----55999999999994001999999999998093542455
Q 004633 579 TPPIP----EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 579 ~~~iP----~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~ 621 (741)
...+| ..+++++++||.+||..||.+|||+.|+|+||||....
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCCC
T ss_conf 88889854346999999999997569965790999997098761788
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=401.95 Aligned_cols=260 Identities=29% Similarity=0.479 Sum_probs=216.3
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCC-CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC---CCCCEEEECCEEEE-
Q ss_conf 99907814882329769999998789-94799999621899955199999999999999416---99873640340563-
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRET-GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL---KHENIVQYYGSEVV- 427 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~t-g~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L---~HPNIVkl~g~~~~- 427 (741)
.++|++++.||+|+||+||+|++..+ ++.||||++.......... ..+.+|+.+|+.| +|||||++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHH---HHHHHHHHHHHHHHHCCCCCCCEEEEEECCC
T ss_conf 5897988899215586999999988899899999980232451679---9999999999987425898802366322146
Q ss_pred ----CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCC
Q ss_conf ----5658999952289870024420156643899999999999999999969903145777664866899479930263
Q 004633 428 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 428 ----~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGL 503 (741)
...+|++|||+.++.+..........+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHH
T ss_conf 66667469999974058714444430378999899999999999999999758898357986278985899754210001
Q ss_pred CHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC----
Q ss_conf 0101375533345799999876999985313999989931014667899999962999999998278999985069----
Q 004633 504 AKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT---- 579 (741)
Q Consensus 504 A~~~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~---- 579 (741)
++............||+.|+|||++.+ ..|+.++||||+||++|||++|+.||.+.+..+.+.++....
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~-------~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQ-------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTT-------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred HHHHCCCCCCCCCCCCHHHCCCCHHCC-------CCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf 011002345777654851148310017-------9888111000328999999878799899898999999998407996
Q ss_pred -----------------------CCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf -----------------------9999559999999999940019999999999980935424555
Q 004633 580 -----------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 580 -----------------------~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~~ 622 (741)
..++..+++.+++||.+||..||++|||+.|+|+||||++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCHH
T ss_conf 110532111103330223456454404458999999999987489667918999966963407521
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=400.09 Aligned_cols=257 Identities=28% Similarity=0.400 Sum_probs=214.1
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC-----
Q ss_conf 990781488232976999999878994799999621899955199999999999999416998736403405635-----
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD----- 428 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~----- 428 (741)
.+|..+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|++++|+|||++++++...
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH---------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCC
T ss_conf 776751698217683999999999997999999881606---------89999999986689898738789974476577
Q ss_pred -CEEEEEEEECCCCCHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCC-CEEEEECCCC
Q ss_conf -65899995228987002442--0156643899999999999999999969903145777664866899-4799302630
Q 004633 429 -DHLYIYLEYVHPGSINRYVR--EHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMA 504 (741)
Q Consensus 429 -~~l~LVmEy~~gGsL~~~L~--~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g-~vKLiDFGLA 504 (741)
..+|||||||+++.+..+.. .....+++.+++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred CEEEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCH
T ss_conf 31899998416886078888631036899999999999999999999986687645788603787358971167336605
Q ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC------
Q ss_conf 10137553334579999987699998531399998993101466789999996299999999827899998506------
Q 004633 505 KHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR------ 578 (741)
Q Consensus 505 ~~~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~------ 578 (741)
+.+.......+..||+.|+|||++.+ ...|+.++||||+||++|||++|+.||...+..+.+.++...
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 171 KQLVRGEPNVSYICSRYYRAPELIFG------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 244 (350)
T ss_dssp EECCTTSCCCSCCSCTTSCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHC------CCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHH
T ss_conf 44047765320025555568277640------468882100024652778550287998987999999999997489817
Q ss_pred -----------CC------------CCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCCCCCC
Q ss_conf -----------99------------999559999999999940019999999999980935424555788
Q 004633 579 -----------TP------------PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANYQNL 625 (741)
Q Consensus 579 -----------~~------------~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~~~~l 625 (741)
.. .....+++++++||.+||..||++|||+.|+|+||||+.....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~ 314 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred HHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCC
T ss_conf 7654306210110355445674444315689999999999976589557929999966984524667777
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=404.09 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=217.6
Q ss_pred CCCCCCCEEEEEEEEECCCEEEEEEEECCCCC-----EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEC
Q ss_conf 99799990781488232976999999878994-----799999621899955199999999999999416-998736403
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGA-----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY 422 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~-----~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~ 422 (741)
++...++|+++++||+|+||+||+|+++.+++ .||+|.+.... .......+.+|+.+|.++ +|||||+++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA----DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC----CHHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 657789939701983078819999998578855420499999966335----8789999999999999715899686877
Q ss_pred CEEEECCEEEEEEEECCCCCHHHHHHHCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Q ss_conf 40563565899995228987002442015----------------------66438999999999999999999699031
Q 004633 423 GSEVVDDHLYIYLEYVHPGSINRYVREHC----------------------RDITESIVRNFTRHILNGLAYLHSTNTIH 480 (741)
Q Consensus 423 g~~~~~~~l~LVmEy~~gGsL~~~L~~~~----------------------~~lse~~i~~I~~QIl~gL~yLHs~gIVH 480 (741)
+++.+.+.+|+|||||++|+|.++|+... ..+++..++.|+.||+.||.|||+++|+|
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 88862995899997279995999998625777510221000012220012577899999999999999999997399050
Q ss_pred CCCCCCCEEECCCCCEEEEECCCCHHCCCCCC---CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 45777664866899479930263010137553---334579999987699998531399998993101466789999996
Q 004633 481 RDIKGANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEML 557 (741)
Q Consensus 481 RDIKP~NILId~~g~vKLiDFGLA~~~~~~~~---~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELL 557 (741)
|||||+|||++.++.+||+|||+|+....... ..+..||+.|||||++.+ ..++.++|||||||+||||+
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-------GIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHT
T ss_pred CCCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCC-------CCCCCCEECCCHHHHHHHHH
T ss_conf 52703214434598289851422220457786156234357876578388727-------99996330300039999998
Q ss_pred H-CCCCCCCCCCHHHHHHHHCC--CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 2-99999999827899998506--999995599999999999400199999999999809
Q 004633 558 T-GKPPWSEFEGPQAMFKVLNR--TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 558 t-Gk~PF~~~~~~~~l~ki~~~--~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
+ |+.||.+......+.+++.. .++.|..+++++++||.+||..||++|||+.|+++|
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 389999999898999999985699899887678999999999758896689399999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=398.07 Aligned_cols=253 Identities=25% Similarity=0.453 Sum_probs=219.4
Q ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCC---EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE
Q ss_conf 799990781488232976999999878994---79999962189995519999999999999941699873640340563
Q 004633 351 PKKSQWQKGKLIGRGTFGSVYIGTNRETGA---SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 351 ~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~---~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
...++|++.++||+|+||+||+|+++.+++ .||||.+.. .......+.+.+|+.+|++++|||||++++++..
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS----GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS----SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECC----CCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEE
T ss_conf 080042785698027882999999957997889999999784----4598999999999999985799888618999962
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf 56589999522898700244201566438999999999999999999699031457776648668994799302630101
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~ 507 (741)
++.+|+|||||++|+|.+++....+.+++.++..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCEEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 88779999722798530021045679999999999999999889885279835761504489889991998884431575
Q ss_pred CCCCCC------CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHCC-C
Q ss_conf 375533------345799999876999985313999989931014667899999962-99999999827899998506-9
Q 004633 508 TGLSYE------LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-T 579 (741)
Q Consensus 508 ~~~~~~------~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk~PF~~~~~~~~l~ki~~~-~ 579 (741)
...... ....||+.|||||++. ...++.++|||||||+||||++ |+.||.+....+.+..+..+ .
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQ-------YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251 (299)
T ss_dssp -----------------CGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCCCCCCEEEECCCCCCCCCCCCHHHHH-------CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 6777765365025666883003878883-------699786121445357899998679999999999999999973788
Q ss_pred CCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 99995599999999999400199999999999809
Q 004633 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 580 ~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
++.+..++.++.+||.+||..||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99974226999999999758797689299999999
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=393.73 Aligned_cols=256 Identities=26% Similarity=0.459 Sum_probs=217.9
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC--
Q ss_conf 999907814882329769999998789947999996218999551999999999999994169987364034056356--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-- 429 (741)
...+|++++.||+|+||+||+|+++.+|+.||||+++.. .......+.+.+|+.+|+.++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP---FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST---TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCC
T ss_conf 477189988980177819999999999989999998522---25969999999999999866898754799986357655
Q ss_pred ----EEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf ----5899995228987002442015664389999999999999999996990314577766486689947993026301
Q 004633 430 ----HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 430 ----~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~ 505 (741)
.+|+||||+ +++|..+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCCCEEEEEEECC-CCCHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEE
T ss_conf 5541599998405-5218999874--022699999999999999999873787645668511112100122113431022
Q ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC------
Q ss_conf 01375533345799999876999985313999989931014667899999962999999998278999985069------
Q 004633 506 HLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------ 579 (741)
Q Consensus 506 ~~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~------ 579 (741)
..... .....||+.|+|||++.+ ...++.++||||+||++|||++|+.||.+.+....+..+....
T Consensus 170 ~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 170 QADSE--MTGYVVTRWYRAPEVILN------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp ECCSS--CCSSCSCGGGCCTHHHHT------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCCC--CCCCCCCCCCCCHHHHCC------CCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHH
T ss_conf 06876--310245533358899817------8789965010300389999997869988897689999998503788488
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf -------------------------999955999999999994001999999999998093542455
Q 004633 580 -------------------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 580 -------------------------~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~ 621 (741)
......+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 8865300034433115786665566775568999999999997729955792999996396237587
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=400.64 Aligned_cols=253 Identities=25% Similarity=0.445 Sum_probs=215.9
Q ss_pred CCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE
Q ss_conf 99979999078148823297699999987899479999962189995519999999999999941699873640340563
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
.++...++|++++.||+|+||+||+|+++.++..||||+++... .. .+++.+|+.+|+.++|||||++++++.+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---ME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC---CH---HHHHHHHHHHHHHCCCCCEECCCCCEEE
T ss_conf 51745799398659820888089999999999699999977761---03---9999999999986799988267752745
Q ss_pred CCEEEEEEEECCCCCHHHHHHH-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf 5658999952289870024420-156643899999999999999999969903145777664866899479930263010
Q 004633 428 DDHLYIYLEYVHPGSINRYVRE-HCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~~L~~-~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~ 506 (741)
++.+|||||||++|+|.+++.. ....+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf 78547876314676067775303554157999999999999978889878930576045768998999289832445465
Q ss_pred CCCCCCC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-C-CCCCC
Q ss_conf 1375533--345799999876999985313999989931014667899999962999999998278999985-0-69999
Q 004633 507 LTGLSYE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVL-N-RTPPI 582 (741)
Q Consensus 507 ~~~~~~~--~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~-~-~~~~i 582 (741)
....... ....|+..|+|||++.+ ..|+.++|||||||++|||++|..||........+.+++ . ..+++
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~ 237 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAY-------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CCCCCCEEECCCCCCCCCCCHHHHCC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf 37887221035566546669278727-------99981043021789999998679988774259999999855888888
Q ss_pred CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHC
Q ss_conf 9559999999999940019999999999980
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 583 P~~ls~el~dLI~~mL~~DP~kRPTa~EiLq 613 (741)
|..+++++++||.+||..||++|||+.|+++
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 7433099999999975779768939999999
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=398.85 Aligned_cols=256 Identities=25% Similarity=0.443 Sum_probs=215.8
Q ss_pred CCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE
Q ss_conf 99979999078148823297699999987899479999962189995519999999999999941699873640340563
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
.|+...++|++++.||+|+||+||+|+.+ ..||||+++..... ....+.+.+|+.+|++++|||||++++++ .
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~ 74 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT---PQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC---TTHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEEE-E
T ss_conf 71315451899889830788589999999---98999999734699---89999999999999847998786456797-1
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf 56589999522898700244201566438999999999999999999699031457776648668994799302630101
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~ 507 (741)
++.++||||||++|+|.+++......+++..+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 75 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 75 APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEEC
T ss_conf 55899999658998889998523578999999999999999988875099951614789979818997887500221333
Q ss_pred CCCC---CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC-----
Q ss_conf 3755---33345799999876999985313999989931014667899999962999999998278999985069-----
Q 004633 508 TGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT----- 579 (741)
Q Consensus 508 ~~~~---~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~----- 579 (741)
.... ...+..||+.|||||++.+. ....|+.++|||||||+||||++|+.||.+......+..+....
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQ----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTC----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCC----CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf 556776312566557431799999505----6899995315163599999999788998998969999999965888986
Q ss_pred -CCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf -99995599999999999400199999999999809
Q 004633 580 -PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 580 -~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
..++..+++++.+||.+||..||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 000365554999999999758897689299999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=395.01 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=217.7
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEE
Q ss_conf 99078148823297699999987899479999962189995519999999999999941699873640340563565899
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++.++||+|+||+||+|+++ +|+.||||++...... ....+.+.+|+.+|+.++|||||++++++..++..|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED---EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG---GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEE
T ss_pred CCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCC---HHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEE
T ss_conf 99634318722778189999968-9999999998123268---5899999999999986799868766012046773158
Q ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC-
Q ss_conf 9952289870024420156643899999999999999999969903145777664866899479930263010137553-
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY- 512 (741)
Q Consensus 434 VmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~~- 512 (741)
+|||+.++.+..+.... +.+++..++.|+.||+.||+|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 78 ~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEEEHHHHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCCC
T ss_conf 99740045678998604-77514456899999999999860574882678775056868997873236643011467654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCC-------------
Q ss_conf 3345799999876999985313999989931014667899999962999999998278999985069-------------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRT------------- 579 (741)
Q Consensus 513 ~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~------------- 579 (741)
.....|++.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+.++....
T Consensus 157 ~~~~~~~~~y~~pE~~~~------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMG------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp -----CCCTTCCHHHHTT------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CCEECCCCHHHHHHHHHC------CCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 101024311013788717------88888410021117589999779799898898999999998638997110421233
Q ss_pred ----------------CCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCC
Q ss_conf ----------------9999559999999999940019999999999980935424
Q 004633 580 ----------------PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRN 619 (741)
Q Consensus 580 ----------------~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~ 619 (741)
......+++.+++||.+||..||++|||+.|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred HHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 32214333335676466651258999999999986689668909999856922074
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.00 Aligned_cols=256 Identities=24% Similarity=0.416 Sum_probs=218.5
Q ss_pred CCCCCEEEEEE-EEECCCEEEEEEEECC--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE
Q ss_conf 79999078148-8232976999999878--99479999962189995519999999999999941699873640340563
Q 004633 351 PKKSQWQKGKL-IGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 351 ~~~~~Y~i~k~-LG~GsfG~Vy~a~~k~--tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
...++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.+.+|+.+|++++|||||++++++..
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG----TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS----CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHH----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC
T ss_conf 5444718878487306080999999960897689999998820----397899999999999986799888068656036
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf 56589999522898700244201566438999999999999999999699031457776648668994799302630101
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~ 507 (741)
+.+|||||||++|+|.+++......+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf -8079999807899689975212569999999999999999878998688105767646604546885420331342115
Q ss_pred CCCCC----CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHCC-CCC
Q ss_conf 37553----3345799999876999985313999989931014667899999962-99999999827899998506-999
Q 004633 508 TGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPP 581 (741)
Q Consensus 508 ~~~~~----~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk~PF~~~~~~~~l~ki~~~-~~~ 581 (741)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+....+..+ .++
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~ 232 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINF-------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHC-------CCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 543432113562113743358688727-------9999541232201789999938999999979999999998189999
Q ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCCHHHH---HCCCCCC
Q ss_conf 995599999999999400199999999999---8093542
Q 004633 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVEL---LEHPFIR 618 (741)
Q Consensus 582 iP~~ls~el~dLI~~mL~~DP~kRPTa~Ei---LqHpff~ 618 (741)
+|..+++++.+||.+||..||++|||+.++ |++.|+.
T Consensus 233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 9976789999999997577976890999999999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.21 Aligned_cols=258 Identities=23% Similarity=0.396 Sum_probs=213.7
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC--
Q ss_conf 999907814882329769999998789947999996218999551999999999999994169987364034056356--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-- 429 (741)
...+|++++.||+|+||+||+|+++.+|+.||||++... ......+.+.+|+.+|+.|+|||||++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF----EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT----TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHH----CCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
T ss_conf 389859978994064809999999999949999998031----0958999999999999976898988588899505645
Q ss_pred --EEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf --589999522898700244201566438999999999999999999699031457776648668994799302630101
Q 004633 430 --HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 430 --~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~ 507 (741)
..+++|||+.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCCEEEEEEEECCCCHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 5414999996259865664405--89999999999999999999999789867778764378879997787545705650
Q ss_pred CCCC----CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC-----
Q ss_conf 3755----3334579999987699998531399998993101466789999996299999999827899998506-----
Q 004633 508 TGLS----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR----- 578 (741)
Q Consensus 508 ~~~~----~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~----- 578 (741)
.... .....+||+.|+|||++.. ...++.++||||+||++|||++|+.||...+...........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTT------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHC------CCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 477764101011026520003878604------78887410100467013377669799788888999998765206997
Q ss_pred ------------------C---C-----CCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf ------------------9---9-----99955999999999994001999999999998093542455
Q 004633 579 ------------------T---P-----PIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 579 ------------------~---~-----~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~ 621 (741)
. . .....++.++++||.+||..||.+|||+.|+|+||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 566423433222202446775577877783789999999999997648956790899986198655588
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=390.43 Aligned_cols=253 Identities=23% Similarity=0.385 Sum_probs=211.6
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEEEEC--
Q ss_conf 999907814882329769999998789947999996218999551999999999999994169-98736403405635--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD-- 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~-- 428 (741)
..++|+++++||+|+||+||+|+++.+|+.||||+++.. . .+++.+|+.+|+.+. ||||+++++++...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----K---KKKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----C---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-----H---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCC
T ss_conf 986718978983174819999998899979999998889-----9---99999999999851579987679999981687
Q ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCC-CEEEEECCCCHHC
Q ss_conf 658999952289870024420156643899999999999999999969903145777664866899-4799302630101
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASG-VVKLADFGMAKHL 507 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g-~vKLiDFGLA~~~ 507 (741)
..+++|||||.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 105 ~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred CCEEEEEEECCCCCHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEEC
T ss_conf 7126888631798589974----689999999999999999988764334434564412377489983664156542664
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHH---HC------
Q ss_conf 375533345799999876999985313999989931014667899999962999999998278-99998---50------
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQ-AMFKV---LN------ 577 (741)
Q Consensus 508 ~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~-~l~ki---~~------ 577 (741)
..........||+.|+|||++.+ ...++.++||||+||++|||++|+.||....... ....+ ++
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 181 HPGQEYNVRVASRYFKGPELLVD------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp CTTCCCCSCCSCGGGCCHHHHTT------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHH
T ss_conf 68874443224864247610268------888884523233545558760488999887601899999999878841555
Q ss_pred ----C------------------------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf ----6------------------------99999559999999999940019999999999980935424555
Q 004633 578 ----R------------------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNANY 622 (741)
Q Consensus 578 ----~------------------------~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~~ 622 (741)
. .......++++++|||.+||..||++|+|++|+|+||||+...+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred HHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 5542254447430000033343311211552112448999999999986699568908999964935588797
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=391.52 Aligned_cols=257 Identities=23% Similarity=0.420 Sum_probs=219.7
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC--
Q ss_conf 999907814882329769999998789947999996218999551999999999999994169987364034056356--
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD-- 429 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~-- 429 (741)
..++|++.+.||+|+||+||+|+++.+|+.||||++.... .........+.+|+.+|+.++|||||++++++..++
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL--ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHH--CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCC
T ss_conf 0620698689960899299999999999899999985566--46989999999999999856999887311435432688
Q ss_pred --EEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf --589999522898700244201566438999999999999999999699031457776648668994799302630101
Q 004633 430 --HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 430 --~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~ 507 (741)
.+|||||||+||+|.+++... +.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred CCEEEEEEECCCCCEEHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHH
T ss_conf 76699999778898710112035-89999999999999999999998579527634675566575432010034443221
Q ss_pred CCC----CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCC-
Q ss_conf 375----533345799999876999985313999989931014667899999962999999998278999985069999-
Q 004633 508 TGL----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTPPI- 582 (741)
Q Consensus 508 ~~~----~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~~i- 582 (741)
... ......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+...+++......
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~-------~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQAR-------GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp C----------------TTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHC-------CCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 23544333346425762436999983-------99999663202652899999769799899699999999984699997
Q ss_pred ---CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCC
Q ss_conf ---955999999999994001999999999998093542
Q 004633 583 ---PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIR 618 (741)
Q Consensus 583 ---P~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~ 618 (741)
...+++++.+||.+||.+||.+||+..+.|.|+|.+
T Consensus 235 ~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 100347899999999998667976777399999999999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=391.04 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=213.2
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE----
Q ss_conf 9999078148823297699999987899479999962189995519999999999999941699873640340563----
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV---- 427 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~---- 427 (741)
..++|++++.||+|+||+||+|+++.+|+.||||++...... ....+++.+|+.+|+.++|+||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT---TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC---HHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 627988999972274829999999899979999998422246---37899999999999983599966067654024654
Q ss_pred ----CCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCC
Q ss_conf ----5658999952289870024420156643899999999999999999969903145777664866899479930263
Q 004633 428 ----DDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGM 503 (741)
Q Consensus 428 ----~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGL 503 (741)
++.+|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCCCCCEEEEEEECCCCCCCCHHH-HCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 444576389998535787410122-2034433089999999999999885229988567672220366899687631350
Q ss_pred CHHCCCC-----CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC
Q ss_conf 0101375-----53334579999987699998531399998993101466789999996299999999827899998506
Q 004633 504 AKHLTGL-----SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR 578 (741)
Q Consensus 504 A~~~~~~-----~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~ 578 (741)
++.+... ....+.+||+.|+|||++.+ ...|+.++||||+||++|||++|+.||.+.........+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTT------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCCCEECCHHHHHHHHHCC------CCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf 02235544432113566024978742899707------999891787006786466174487998998999999999984
Q ss_pred CCCCC--------------------------------CCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999--------------------------------5599999999999400199999999999809354245
Q 004633 579 TPPIP--------------------------------EMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 579 ~~~iP--------------------------------~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
....+ ...++++++||.+||..||++|+|+.|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 18998255344320344433201334455503340444599899999999873896589099999749501569
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=392.83 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=215.8
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEE
Q ss_conf 99990781488232976999999878994799999621899955199999999999999416998736403405635658
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHL 431 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l 431 (741)
..++|++++.||+|+||+||+|.++ ++..||||++... ... .+.+.+|+.+++.++|||||++++++..++.+
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~---~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG---AMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS---SSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CHHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCC---CCC---HHHHHHHHHHHHHCCCCCCCCCCCEECCCCCE
T ss_conf 9699588889820888299999988-9999999998788---676---89999999999966899756535243159933
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC
Q ss_conf 99995228987002442015664389999999999999999996990314577766486689947993026301013755
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~ 511 (741)
|+||||+++|+|.+++......+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC
T ss_conf 79998369991899752013478899999999999998776531643104431532666688776865532100236887
Q ss_pred CC--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHCC-CCCCCCCCC
Q ss_conf 33--345799999876999985313999989931014667899999962-99999999827899998506-999995599
Q 004633 512 YE--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLS 587 (741)
Q Consensus 512 ~~--~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk~PF~~~~~~~~l~ki~~~-~~~iP~~ls 587 (741)
.. ....||..|+|||++.+ ..|+.++|||||||++|||++ |.+||......+.+..+..+ ....|..++
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~-------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~ 228 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSF-------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS 228 (263)
T ss_dssp ---------CTTSCCHHHHTT-------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSC
T ss_pred CEEECCEECCCCCCCHHHHCC-------CCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 335043001766678578607-------9998403321059999999878988877899999999998068889954367
Q ss_pred HHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 999999999400199999999999809
Q 004633 588 SEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 588 ~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
+++.+||.+||..||++|||+.|++++
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 999999999765797689199999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=392.28 Aligned_cols=258 Identities=24% Similarity=0.434 Sum_probs=216.6
Q ss_pred CCCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEE
Q ss_conf 99997999907814882329769999998789947999996218999551999999999999994169987364034056
Q 004633 347 PSASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (741)
Q Consensus 347 ~~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~ 426 (741)
..++...++|++++.||+|+||+||+|.++ ++..||||+++... .. .+.+.+|+.+|++++|||||++++++.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MS---PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SC---HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCEECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC---CC---HHHHHHHHHHHHHCCCCCEEEEEEEEC
T ss_conf 770038899388679810798289999999-99999999986476---88---899999999998679998857873104
Q ss_pred ECCEEEEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf 356589999522898700244201-5664389999999999999999996990314577766486689947993026301
Q 004633 427 VDDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 427 ~~~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~ 505 (741)
++.+|+||||+++|+|.+++... ...+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 79 -~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 79 -QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred -CCCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEE
T ss_conf -5976999995789828888751478988788999999999999999974895467564225156202440423410147
Q ss_pred HCCCCC--CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHCC-CCC
Q ss_conf 013755--333457999998769999853139999899310146678999999629-9999999827899998506-999
Q 004633 506 HLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGPQAMFKVLNR-TPP 581 (741)
Q Consensus 506 ~~~~~~--~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtG-k~PF~~~~~~~~l~ki~~~-~~~ 581 (741)
.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++| .+||......+.+..+..+ .+.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~-------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINY-------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ECCCCCCCCCCCCCCCCCCCCHHHHHC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 735886442035677444458289837-------9998245645257999999968988888889999999997068888
Q ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHC--CCCCCC
Q ss_conf 99559999999999940019999999999980--935424
Q 004633 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIRN 619 (741)
Q Consensus 582 iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLq--Hpff~~ 619 (741)
.|..+++++.+||.+||..||++|||+.|+++ ++||..
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 9655719999999997588976893999999986113213
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=389.23 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=215.8
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCC----EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC
Q ss_conf 9990781488232976999999878994----799999621899955199999999999999416998736403405635
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGA----SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~----~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
..+|+++++||+|+||+||+|.++.+|+ .||+|.+... ......+.+.+|+.+|++++|||||++++++.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~- 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA----TSPKANKEILDEAYVMASVDNPHVCRLLGICLT- 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC--------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-
T ss_conf 899978319820899299999995899889899999996513----497999999999999986799888158999961-
Q ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCC
Q ss_conf 65899995228987002442015664389999999999999999996990314577766486689947993026301013
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~ 508 (741)
+..+++|||+.+|+|.+++......+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred CCEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 98369998426874010111334579999999999999999999987695047621203116799875860255222335
Q ss_pred CCCC---CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHCC-CCCCC
Q ss_conf 7553---3345799999876999985313999989931014667899999962-99999999827899998506-99999
Q 004633 509 GLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIP 583 (741)
Q Consensus 509 ~~~~---~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk~PF~~~~~~~~l~ki~~~-~~~iP 583 (741)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+....+..+ .++.|
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p 235 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHC-------CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 4445322365105864467088746-------999835654407999999997799999999989999999759989998
Q ss_pred CCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCC
Q ss_conf 55999999999994001999999999998093
Q 004633 584 EMLSSEGKDFLLRCFLRNPVERPSAVELLEHP 615 (741)
Q Consensus 584 ~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHp 615 (741)
..+++++.+||.+||..||.+|||+.|+++|-
T Consensus 236 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 55689999999984789934691999999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.37 Aligned_cols=247 Identities=23% Similarity=0.409 Sum_probs=210.2
Q ss_pred EEEEECCCEEEEEEEECC--CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEE
Q ss_conf 488232976999999878--994799999621899955199999999999999416998736403405635658999952
Q 004633 360 KLIGRGTFGSVYIGTNRE--TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYIYLEY 437 (741)
Q Consensus 360 k~LG~GsfG~Vy~a~~k~--tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~LVmEy 437 (741)
++||+|+||+||+|.++. +++.||||++.... ......+.+.+|+.+|++++|||||++++++.. +..||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA---NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH---CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEEC
T ss_conf 7834587829999998169738599999988010---898999999999999986799898527777505-977999974
Q ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC----C
Q ss_conf 289870024420156643899999999999999999969903145777664866899479930263010137553----3
Q 004633 438 VHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY----E 513 (741)
Q Consensus 438 ~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~~----~ 513 (741)
|++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 89 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 89 AELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp CTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCC
T ss_conf 7889689997522-578999999999999999766874795567776113102356751234134533134323443224
Q ss_pred CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHC-CCCCCCCCCCHHHH
Q ss_conf 345799999876999985313999989931014667899999962-9999999982789999850-69999955999999
Q 004633 514 LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGK 591 (741)
Q Consensus 514 ~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk~PF~~~~~~~~l~ki~~-~~~~iP~~ls~el~ 591 (741)
....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+....+.. ..+++|..+++++.
T Consensus 168 ~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~ 240 (277)
T d1xbba_ 168 THGKWPVKWYAPECINY-------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMY 240 (277)
T ss_dssp ---CCCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred CCCCCCCEECCCHHHCC-------CCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
T ss_conf 45677842039166537-------99984344303403132896589999999899999999982899999865679999
Q ss_pred HHHHHHHHCCCCCCCCHHHHH---CCCCCC
Q ss_conf 999994001999999999998---093542
Q 004633 592 DFLLRCFLRNPVERPSAVELL---EHPFIR 618 (741)
Q Consensus 592 dLI~~mL~~DP~kRPTa~EiL---qHpff~ 618 (741)
+||.+||..||++|||+.+++ +|.|+.
T Consensus 241 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 241 DLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf 999997588976890989999985288750
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.53 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=214.6
Q ss_pred CCCCCCEEEEEEEEECCCEEEEEEEECCCC----CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEE
Q ss_conf 979999078148823297699999987899----4799999621899955199999999999999416998736403405
Q 004633 350 SPKKSQWQKGKLIGRGTFGSVYIGTNRETG----ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (741)
Q Consensus 350 ~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg----~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~ 425 (741)
+...++|++.++||+|+||+||+|.++.++ ..||||++... ........+.+|+.+|++++|||||++++++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~ 78 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG----YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 78 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 578899686159811779099999996899878799999998844----5968999999999999856898783236778
Q ss_pred EECCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf 63565899995228987002442015664389999999999999999996990314577766486689947993026301
Q 004633 426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 426 ~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~ 505 (741)
...+.+++||||+.+|++.+++......+++.++..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ECCCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHH
T ss_conf 33880389997213574022210234542089999999999985412121234257656442788899849984551030
Q ss_pred HCCCCCC----CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHCC-C
Q ss_conf 0137553----334579999987699998531399998993101466789999996299-999999827899998506-9
Q 004633 506 HLTGLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSEFEGPQAMFKVLNR-T 579 (741)
Q Consensus 506 ~~~~~~~----~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk-~PF~~~~~~~~l~ki~~~-~ 579 (741)
.+..... .....||+.|+|||++. +..++.++|||||||++|||++|. ++|......+.+..+..+ .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~ 231 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAIS-------YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231 (283)
T ss_dssp ---------------CCCGGGSCHHHHH-------SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred CCCCCCCCCEEECCCCCCCCCCCHHHHC-------CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 0357876526742677773434888870-------499997355634489899999679886556899999999863578
Q ss_pred CCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHC
Q ss_conf 9999559999999999940019999999999980
Q 004633 580 PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 580 ~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLq 613 (741)
++.+..++.++.+||.+||..||++|||+.|+++
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9985045799999999977679768939999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.37 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=213.9
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC----
Q ss_conf 9990781488232976999999878994799999621899955199999999999999416998736403405635----
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~---- 428 (741)
.++|+++++||+|+||+||+|+++.+|+.||||++.... .......++.+|+.+|++++|||||++++++...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT---SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCC
T ss_conf 377599889621758599999999999899999988233---69799999999999998648987648998970256434
Q ss_pred --CEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf --658999952289870024420156643899999999999999999969903145777664866899479930263010
Q 004633 429 --DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 429 --~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~ 506 (741)
..+|+|||||.++.+. .+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~~~~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 93 EFQDVYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp TCCEEEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCEEEEEEECCCHHHHH-HHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHC
T ss_conf 576269998414467787-650---3899999999999999999886522112456776321136544313201023211
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCC--------
Q ss_conf 137553334579999987699998531399998993101466789999996299999999827899998506--------
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNR-------- 578 (741)
Q Consensus 507 ~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~-------- 578 (741)
...........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+......+++..
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~-------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILG-------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp ------------CCTTCCHHHHTT-------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCCCCCCCCCCCCCCCCHHHHCC-------CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 466655332214655558133147-------7778774333566257898659899888977889999997205898799
Q ss_pred --------------CCCC--------------------CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf --------------9999--------------------95599999999999400199999999999809354245
Q 004633 579 --------------TPPI--------------------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 579 --------------~~~i--------------------P~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
.... ....+.++++||.+||..||++||||+|+|+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 9876566777764175435666421264333543210133379999999999876994579089999669420878
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.12 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=216.1
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC----
Q ss_conf 9990781488232976999999878994799999621899955199999999999999416998736403405635----
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD---- 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~---- 428 (741)
.++|++++.||+|+||+||+|+++.+|+.||||++... .......+++.+|+.+|+.++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT---TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCH---HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCC
T ss_conf 98718888983178839999999999979999998820---028689999999999998668987425999996346456
Q ss_pred -CEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHC
Q ss_conf -6589999522898700244201566438999999999999999999699031457776648668994799302630101
Q 004633 429 -DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHL 507 (741)
Q Consensus 429 -~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~ 507 (741)
...+++|||+.||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred CCCEEEEEEEECCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC
T ss_conf 6864999996258862320022--45309999999999999999997388765166776334554322001321000125
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCC-------
Q ss_conf 3755333457999998769999853139999899310146678999999629999999982789999850699-------
Q 004633 508 TGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKVLNRTP------- 580 (741)
Q Consensus 508 ~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki~~~~~------- 580 (741)
.. ...+..|++.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 172 ~~--~~~~~~g~~~y~apE~~~~------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 172 DD--EMTGYVATRWYRAPEIMLN------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp TG--GGSSSCHHHHTSCHHHHTT------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CC--CCCCCCCCCCCCCCHHHCC------CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 75--4444345435558355337------756785512432058999997688997889889999999973079975773
Q ss_pred ----------------CC--------CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf ----------------99--------955999999999994001999999999998093542455
Q 004633 581 ----------------PI--------PEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 581 ----------------~i--------P~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~~ 621 (741)
.. ...+++++++||.+||..||.+|||+.|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 20010244544430355787555662678999999999997758834593899985599548799
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.71 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=219.7
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 99907814882329769999998789947999996218999551999999999999994169987364034056356589
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~ 432 (741)
.++|+++++||+|+||+||+|+++ ++..||||+++.... . .+.+.+|+.+++.++|||||++++++.+++.++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---S---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---C---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC---C---HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEE
T ss_conf 699799689820788399999988-998999999874757---7---899999999999668986015889985078169
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCCC
Q ss_conf 99952289870024420156643899999999999999999969903145777664866899479930263010137553
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLSY 512 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~~ 512 (741)
+||||+.+|+|..++......+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 76 iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp EEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EEEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf 99970489938886410246776899999999999999987546843466541358876998479886144202357872
Q ss_pred C--CCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHCC-CCCCCCCCCH
Q ss_conf 3--345799999876999985313999989931014667899999962-99999999827899998506-9999955999
Q 004633 513 E--LSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPPIPEMLSS 588 (741)
Q Consensus 513 ~--~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk~PF~~~~~~~~l~ki~~~-~~~iP~~ls~ 588 (741)
. ....||..|+|||++.+ ..++.++|||||||++|||++ |+.||.+....+...++..+ ....|..+++
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~-------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 228 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMY-------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE 228 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred EEECCCCCCCCCCCCHHHCC-------CCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCH
T ss_conf 25246578877578078637-------99885210336432467397559999889999999999980797899654659
Q ss_pred HHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 99999999400199999999999809
Q 004633 589 EGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 589 el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
++.+||.+||..||++|||+.++++|
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999999766897689399999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.98 Aligned_cols=263 Identities=28% Similarity=0.494 Sum_probs=221.3
Q ss_pred CCCEEEEEEEEECCCEEEEEEEE---CCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCC-CCEEEECCEEEEC
Q ss_conf 99907814882329769999998---7899479999962189995519999999999999941699-8736403405635
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTN---RETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-ENIVQYYGSEVVD 428 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~---k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H-PNIVkl~g~~~~~ 428 (741)
.++|++++.||+|+||+||+|++ +.+|+.||||+++..... ......+.+.+|+++|++++| |||+++++++.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-EEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 10259998983287839999998765887948999998367721-01689999999999998646798399962000248
Q ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCC
Q ss_conf 65899995228987002442015664389999999999999999996990314577766486689947993026301013
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~ 508 (741)
..++++|||+.+|+|.+++... +.+.+..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCEEEEEECCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHHC
T ss_conf 7300123123411799998730-454378888889999999988514998965477320124699988874132022203
Q ss_pred C--CCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHCCCCCC
Q ss_conf 7--55333457999998769999853139999899310146678999999629999999982789----99985069999
Q 004633 509 G--LSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQA----MFKVLNRTPPI 582 (741)
Q Consensus 509 ~--~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~----l~ki~~~~~~i 582 (741)
. .....+..|++.|++||++.+ ....++.++|||||||+||||++|+.||.+...... ........+.+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~-----~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~ 255 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRG-----GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTT-----CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHC-----CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCCC
T ss_conf 444432212223333310687605-----776887132517777999999768999888877779999998335689988
Q ss_pred CCCCCHHHHHHHHHHHHCCCCCCC-----CHHHHHCCCCCCCCCC
Q ss_conf 955999999999994001999999-----9999980935424555
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERP-----SAVELLEHPFIRNANY 622 (741)
Q Consensus 583 P~~ls~el~dLI~~mL~~DP~kRP-----Ta~EiLqHpff~~~~~ 622 (741)
|..+++++.+||.+||..||.+|+ |++|+|+||||+..++
T Consensus 256 ~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCH
T ss_conf 654799999999997445898819997450999974972348998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.30 Aligned_cols=254 Identities=25% Similarity=0.438 Sum_probs=219.8
Q ss_pred CCCCCCCEEEEEEEEECCCEEEEEEEECCCC---CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEE
Q ss_conf 9979999078148823297699999987899---4799999621899955199999999999999416998736403405
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSE 425 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg---~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~ 425 (741)
++...++|++++.||+|+||.||+|++..++ ..||||.++.. ......+.+.+|+.+|++++|||||++++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC----TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT----TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf 976889969877993078829999999369964499999993656----6879999999999999868999985698899
Q ss_pred EECCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf 63565899995228987002442015664389999999999999999996990314577766486689947993026301
Q 004633 426 VVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 426 ~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~ 505 (741)
. ++.+|+||||+.+|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred E-CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHE
T ss_conf 5-374799998406980776542247899999999999999877523022674414102655320678967876503421
Q ss_pred HCCCCC--CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHCC-CCC
Q ss_conf 013755--33345799999876999985313999989931014667899999962-99999999827899998506-999
Q 004633 506 HLTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR-TPP 581 (741)
Q Consensus 506 ~~~~~~--~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk~PF~~~~~~~~l~ki~~~-~~~ 581 (741)
.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+....+...++..+ ..+
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~-------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~ 229 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINF-------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 229 (273)
T ss_dssp --------------CCGGGCCHHHHHH-------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ECCCCCCEECCCEECCCCCCHHHHHCC-------CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
T ss_conf 336776233054005831032667516-------9988745244424789999826999988899999999998189998
Q ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 995599999999999400199999999999809
Q 004633 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 582 iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
+|..+++++.+||.+||..||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 987779999999999768797689299999999
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.34 Aligned_cols=257 Identities=29% Similarity=0.458 Sum_probs=216.8
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEE
Q ss_conf 99078148823297699999987899479999962189995519999999999999941699873640340563565899
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDDHLYI 433 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~~l~L 433 (741)
++|++++.||+|+||+||+|+++.+++.||||+++.... ......++.+|+.+|+.++|||||++++++...+..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS---STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC---CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
T ss_conf 997862697128681999999999996999999803217---86899999999999985675788821354444431158
Q ss_pred EEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC-C
Q ss_conf 995228987002442015664389999999999999999996990314577766486689947993026301013755-3
Q 004633 434 YLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS-Y 512 (741)
Q Consensus 434 VmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~-~ 512 (741)
+||++.+++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... .
T Consensus 79 v~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred EEEECCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCCC
T ss_conf 86302332221121235-65403678999999999987743399860014676121133782665204601104688751
Q ss_pred CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHHC---C----------
Q ss_conf 334579999987699998531399998993101466789999996299999999-82789999850---6----------
Q 004633 513 ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVLN---R---------- 578 (741)
Q Consensus 513 ~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~-~~~~~l~ki~~---~---------- 578 (741)
.....+++.|+|||++.+ ...++.++|||||||++|||++|+.||... +..+...++.. .
T Consensus 158 ~~~~~~~~~~~~pe~~~~------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFG------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CCSCCSCGGGCCHHHHTT------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CEEECCCCCHHHHHHHCC------CCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf 001034431014667506------98888044402654188998518999988999999999998611899735513443
Q ss_pred ----------------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCCCCCCCC
Q ss_conf ----------------999995599999999999400199999999999809354245
Q 004633 579 ----------------TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEHPFIRNA 620 (741)
Q Consensus 579 ----------------~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqHpff~~~ 620 (741)
.......+++.+++||.+||..||.+||||+|+|+||||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred HCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 2221133444544310433065689999999999864996689099999649534079
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.76 Aligned_cols=259 Identities=26% Similarity=0.464 Sum_probs=216.7
Q ss_pred CCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE
Q ss_conf 99979999078148823297699999987899479999962189995519999999999999941699873640340563
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV 427 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~ 427 (741)
.++...++|++++.||+|+||+||+|+++.+ ..||||++.... ... +.+.+|+.+|++++|+|||++++++.
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~---~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~- 82 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT---MSP---EAFLQEAQVMKKLRHEKLVQLYAVVS- 82 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS---SCH---HHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CEECCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCC---CCH---HHHHHHHHHHHHCCCCCEEEEEEEEE-
T ss_conf 6074779979846993079809999999999-999999988044---888---99999999998666678868999982-
Q ss_pred CCEEEEEEEECCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf 56589999522898700244201-56643899999999999999999969903145777664866899479930263010
Q 004633 428 DDHLYIYLEYVHPGSINRYVREH-CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~~L~~~-~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~ 506 (741)
++.+|+||||+.+|+|..++... ...+++.++..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred CCCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHH
T ss_conf 39759999944799435420000355305999999999999999987541143353123079998999299844255542
Q ss_pred CCCCC--CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCHHHHHHHHCC-CCCC
Q ss_conf 13755--3334579999987699998531399998993101466789999996299-999999827899998506-9999
Q 004633 507 LTGLS--YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSEFEGPQAMFKVLNR-TPPI 582 (741)
Q Consensus 507 ~~~~~--~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk-~PF~~~~~~~~l~ki~~~-~~~i 582 (741)
+.... ......||+.|+|||++.. ..++.++|||||||++|||++|. ++|......+.+..+..+ ..++
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~ 235 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALY-------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235 (285)
T ss_dssp -------------CCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CCCCCCEEECCCCCCCCCCCHHHHHC-------CCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 56887335245455665458089837-------99891774132358999998689999988889999999982689999
Q ss_pred CCCCCHHHHHHHHHHHHCCCCCCCCHHHHHC--CCCCCCCC
Q ss_conf 9559999999999940019999999999980--93542455
Q 004633 583 PEMLSSEGKDFLLRCFLRNPVERPSAVELLE--HPFIRNAN 621 (741)
Q Consensus 583 P~~ls~el~dLI~~mL~~DP~kRPTa~EiLq--Hpff~~~~ 621 (741)
+..+++++++||.+||..||++||++.++++ ++||....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf 83237999999999756697589199999998766623899
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.08 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=218.8
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCE--EEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEECCEEEEC
Q ss_conf 999907814882329769999998789947--99999621899955199999999999999416-998736403405635
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGAS--CAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYYGSEVVD 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~--vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~g~~~~~ 428 (741)
.-++|+++++||+|+||+||+|+++.++.. ||||.+.... ..+..+.+.+|+++|..+ +|||||++++++.++
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred CHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC----CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC
T ss_conf 879968877982078828999999899969999999978233----8579999999999998622899883678888418
Q ss_pred CEEEEEEEECCCCCHHHHHHHC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCC
Q ss_conf 6589999522898700244201---------------5664389999999999999999996990314577766486689
Q 004633 429 DHLYIYLEYVHPGSINRYVREH---------------CRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~~L~~~---------------~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~ 493 (741)
+.+|+||||+++|+|.++|+.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
T ss_conf 73699998028986999986403555551231012345789999999999999999876630895455505204898688
Q ss_pred CCEEEEECCCCHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCHHHH
Q ss_conf 9479930263010137553334579999987699998531399998993101466789999996299-999999827899
Q 004633 494 GVVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK-PPWSEFEGPQAM 572 (741)
Q Consensus 494 g~vKLiDFGLA~~~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk-~PF~~~~~~~~l 572 (741)
+.+||+|||+++............||..|+|||.+.+ ..++.++|||||||++|||++|. +||.+.+..+..
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCC-------CCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 7638743443224442234553013775555387526-------999962215313889999983689999999999999
Q ss_pred HHHHCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 998506-999995599999999999400199999999999809
Q 004633 573 FKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 573 ~ki~~~-~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
..+..+ .+.++..+++++++||.+||..||++|||+.|++++
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9998268888876678999999999767896689499999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.14 Aligned_cols=255 Identities=26% Similarity=0.445 Sum_probs=211.0
Q ss_pred CCCCCCCEEEEEEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEC
Q ss_conf 99799990781488232976999999878-----994799999621899955199999999999999416-998736403
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQYY 422 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~-----tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl~ 422 (741)
++...++|++++.||+|+||.||+|.+.. +++.||||++... ......+.+.+|+.++.++ +|+|||.++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG----ATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--------CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCC----CCCHHHHHHHHHHHHHHHHCCCCEEEEEE
T ss_conf 26167997984498416783999999867775557839999998600----17178999999999988614998499741
Q ss_pred CEEEEC-CEEEEEEEECCCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCC
Q ss_conf 405635-65899995228987002442015---------------66438999999999999999999699031457776
Q 004633 423 GSEVVD-DHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGA 486 (741)
Q Consensus 423 g~~~~~-~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~ 486 (741)
+++... ..+++|||||++|+|.+++.... ..+++.++..|+.||+.||.|||+++|+||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 15404797579999845899299999853666665322202332146899999999999999999887379717867731
Q ss_pred CEEECCCCCEEEEECCCCHHCCCCC---CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHC-CCC
Q ss_conf 6486689947993026301013755---333457999998769999853139999899310146678999999629-999
Q 004633 487 NLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPP 562 (741)
Q Consensus 487 NILId~~g~vKLiDFGLA~~~~~~~---~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtG-k~P 562 (741)
|||++.++.+||+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||++| .+|
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-------~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-------RVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHC-------CCCCCCCCEEEHHHHHHHHHHCCCCC
T ss_conf 06577998289845752001135665222475166721020368646-------88996632213678999998688999
Q ss_pred CCCCCCHHHHHHHH--CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 99998278999985--06999995599999999999400199999999999809
Q 004633 563 WSEFEGPQAMFKVL--NRTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 563 F~~~~~~~~l~ki~--~~~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
|.+......+..++ +..+.+|..+++++++||.+||..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp STTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 989998999999996389888886578999999999767796679199999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=375.31 Aligned_cols=251 Identities=23% Similarity=0.412 Sum_probs=217.1
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEE
Q ss_conf 99990781488232976999999878-----9947999996218999551999999999999994169987364034056
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEV 426 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~-----tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~ 426 (741)
..++|++++.||+|+||+||+|+.+. ++..||||+++.. ...+..+++.+|+.+|++++||||+++++++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE----ASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHH----CCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 98893886798207883999999888765778829999998821----08579999999999999668997655246660
Q ss_pred ECCEEEEEEEECCCCCHHHHHHHCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCC
Q ss_conf 3565899995228987002442015-----------------------66438999999999999999999699031457
Q 004633 427 VDDHLYIYLEYVHPGSINRYVREHC-----------------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDI 483 (741)
Q Consensus 427 ~~~~l~LVmEy~~gGsL~~~L~~~~-----------------------~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDI 483 (741)
..+.++++|||+.+|+|.+++.... ..+++..+..|+.||+.||+|||+++|+||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 59803899981589929999985275542100001110012103467889899999999999999855413578685488
Q ss_pred CCCCEEECCCCCEEEEECCCCHHCCCCC---CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 7766486689947993026301013755---3334579999987699998531399998993101466789999996299
Q 004633 484 KGANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGK 560 (741)
Q Consensus 484 KP~NILId~~g~vKLiDFGLA~~~~~~~---~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk 560 (741)
||+|||++.++.+||+|||+|+.+.... ...+..|++.|+|||++.+ ..|+.++|||||||++|||++|.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-------NRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCC-------CCCCHHHHHCCCHHHHHHHHCCC
T ss_conf 40116898999289833144211367764111577776767679899726-------88980563025236299998068
Q ss_pred -CCCCCCCCHHHHHHHHCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHC
Q ss_conf -9999998278999985069-9999559999999999940019999999999980
Q 004633 561 -PPWSEFEGPQAMFKVLNRT-PPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 561 -~PF~~~~~~~~l~ki~~~~-~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLq 613 (741)
+||.+....+....+..+. +++|..+++++.+||.+||..||++|||+.|+++
T Consensus 240 ~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 240 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999998999999999739978887325299999999974889657939999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.11 Aligned_cols=257 Identities=25% Similarity=0.468 Sum_probs=219.9
Q ss_pred CCCCCCCCCCEEEEEEEEECCCEEEEEEEECCCC-------CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCC
Q ss_conf 9999979999078148823297699999987899-------4799999621899955199999999999999416-9987
Q 004633 346 KPSASPKKSQWQKGKLIGRGTFGSVYIGTNRETG-------ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHEN 417 (741)
Q Consensus 346 ~~~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg-------~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPN 417 (741)
.+.+....++|++++.||+|+||.||+|++..++ ..||||+++. + ........+.+|..++.++ +|||
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~---~-~~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---D-ATEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT---T-CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCCCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECC---C-CCHHHHHHHHHHHHHHHHHCCCCE
T ss_conf 976722589969700985167828999998578755566754999999881---1-286889999999999998139996
Q ss_pred EEEECCEEEECCEEEEEEEECCCCCHHHHHHHCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCC
Q ss_conf 3640340563565899995228987002442015---------------6643899999999999999999969903145
Q 004633 418 IVQYYGSEVVDDHLYIYLEYVHPGSINRYVREHC---------------RDITESIVRNFTRHILNGLAYLHSTNTIHRD 482 (741)
Q Consensus 418 IVkl~g~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------------~~lse~~i~~I~~QIl~gL~yLHs~gIVHRD 482 (741)
||++++++.+++.+|+||||+.+|+|.++|.... ..+++.++..|+.||+.||+|||+++|+|||
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrD 160 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 160 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEECCCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEE
T ss_conf 97346522018868999973699909999986067764322233457434679999999999999999876637978630
Q ss_pred CCCCCEEECCCCCEEEEECCCCHHCCCCC---CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-
Q ss_conf 77766486689947993026301013755---33345799999876999985313999989931014667899999962-
Q 004633 483 IKGANLLVDASGVVKLADFGMAKHLTGLS---YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT- 558 (741)
Q Consensus 483 IKP~NILId~~g~vKLiDFGLA~~~~~~~---~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt- 558 (741)
|||+|||++.++.+||+|||+++...... ......|++.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-------~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-------RIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTT
T ss_pred ECCCCEEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCC-------CCCCCHHHHHHHHHHHHHHCCC
T ss_conf 221022454789767622111011355555431466788846632667517-------9888255547758888874017
Q ss_pred CCCCCCCCCCHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHC
Q ss_conf 9999999982789999850-699999559999999999940019999999999980
Q 004633 559 GKPPWSEFEGPQAMFKVLN-RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 559 Gk~PF~~~~~~~~l~ki~~-~~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLq 613 (741)
|.+||.+.........+.. ..+..|..+++++++||.+||..||.+|||+.|+++
T Consensus 234 g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 234 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp SCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 98989999999999999728888987435299999999976679767939999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.53 Aligned_cols=255 Identities=25% Similarity=0.446 Sum_probs=216.2
Q ss_pred CCCCCCCCEEEEEEEEECCCEEEEEEEEC-----CCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEE
Q ss_conf 99979999078148823297699999987-----8994799999621899955199999999999999416-99873640
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNR-----ETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHL-KHENIVQY 421 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k-----~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L-~HPNIVkl 421 (741)
.++...++|+++++||+|+||.||+|+.+ .++..||||+++.. ........+.+|+.++..+ +|||||++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS----AHLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT----CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCCEEEE
T ss_conf 263778996985498206882999999806644778869999998742----4877999999999998762699988789
Q ss_pred CCEEEECCEEEEEEEECCCCCHHHHHHHCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCC
Q ss_conf 340563565899995228987002442015-----------------664389999999999999999996990314577
Q 004633 422 YGSEVVDDHLYIYLEYVHPGSINRYVREHC-----------------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIK 484 (741)
Q Consensus 422 ~g~~~~~~~l~LVmEy~~gGsL~~~L~~~~-----------------~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIK 484 (741)
++++...+.+|+|||||++|+|.++++... ..+++..+..|+.||+.||+|||+++|+|||||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK 172 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCC
T ss_conf 98983199789999737998799999853566544444533222334588999999999999999998875792666241
Q ss_pred CCCEEECCCCCEEEEECCCCHHCCCCCC---CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CC
Q ss_conf 7664866899479930263010137553---3345799999876999985313999989931014667899999962-99
Q 004633 485 GANLLVDASGVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GK 560 (741)
Q Consensus 485 P~NILId~~g~vKLiDFGLA~~~~~~~~---~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk 560 (741)
|+|||++.++.+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++ |.
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-------CVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCC-------CCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 0210000257521023401023367886158620135968767788617-------999974001025899999985899
Q ss_pred CCCCCCCCHHHHHHHHC--CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHC
Q ss_conf 99999982789999850--699999559999999999940019999999999980
Q 004633 561 PPWSEFEGPQAMFKVLN--RTPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 561 ~PF~~~~~~~~l~ki~~--~~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLq 613 (741)
++|........+.+++. ..+..+..++.++.+||.+||..||++|||+.|+++
T Consensus 246 p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 8877899899999998668988985436599999999975779657929999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.08 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=219.5
Q ss_pred CCCCCCCCEEEEEEEEECCCEEEEEEEECC-----CCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEC
Q ss_conf 999799990781488232976999999878-----994799999621899955199999999999999416998736403
Q 004633 348 SASPKKSQWQKGKLIGRGTFGSVYIGTNRE-----TGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYY 422 (741)
Q Consensus 348 ~~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~-----tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~ 422 (741)
.++...++|++++.||+|+||+||+|.++. ++..||||+++.. ........+.+|+.++++++|||||+++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~----~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA----ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT----SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred CEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 004268991883598207881899999878644778968999998701----2868999999999999976999884125
Q ss_pred CEEEECCEEEEEEEECCCCCHHHHHHHCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCC
Q ss_conf 40563565899995228987002442015---------664389999999999999999996990314577766486689
Q 004633 423 GSEVVDDHLYIYLEYVHPGSINRYVREHC---------RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDAS 493 (741)
Q Consensus 423 g~~~~~~~l~LVmEy~~gGsL~~~L~~~~---------~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~ 493 (741)
+++..++.+++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCC
T ss_conf 47842881067776048998899987503321134446887999999999999999998764796543286775403599
Q ss_pred CCEEEEECCCCHHCCCCCC---CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCCCCH
Q ss_conf 9479930263010137553---33457999998769999853139999899310146678999999629-9999999827
Q 004633 494 GVVKLADFGMAKHLTGLSY---ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTG-KPPWSEFEGP 569 (741)
Q Consensus 494 g~vKLiDFGLA~~~~~~~~---~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtG-k~PF~~~~~~ 569 (741)
+.+||+|||+|+.+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++| .+||.+....
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-------~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~ 242 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred CEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCC-------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 6499942454202357763031340231632378888736-------998833344437899999996899999998999
Q ss_pred HHHHHHHCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 899998506-999995599999999999400199999999999809
Q 004633 570 QAMFKVLNR-TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 570 ~~l~ki~~~-~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
+.+..+..+ .+..|..++..+.+||.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999998088888863353999999999757796589399999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.71 Aligned_cols=252 Identities=27% Similarity=0.490 Sum_probs=215.3
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECC-CCC--EEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC
Q ss_conf 99990781488232976999999878-994--799999621899955199999999999999416998736403405635
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRE-TGA--SCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVD 428 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~-tg~--~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~ 428 (741)
..++|++.+.||+|+||.||+|++.. ++. .||||++.... ....+..+.+.+|+.+|+.++|||||++++++.+
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~--~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV--LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHH--CCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-
T ss_conf 6489199789803888399999998899907999999998355--5798999999999999986899998789877740-
Q ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCC
Q ss_conf 65899995228987002442015664389999999999999999996990314577766486689947993026301013
Q 004633 429 DHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLT 508 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~ 508 (741)
..+++||||+++|+|.+++..+...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 10011465423861254442126899999999999999999987521787520566888156556543325611555303
Q ss_pred CCCC----CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHCC--CCC
Q ss_conf 7553----3345799999876999985313999989931014667899999962-99999999827899998506--999
Q 004633 509 GLSY----ELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLNR--TPP 581 (741)
Q Consensus 509 ~~~~----~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk~PF~~~~~~~~l~ki~~~--~~~ 581 (741)
.... .....|+..|+|||++.+ ..++.++||||||+++|||++ |+.||.+.+..+...++... .++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKT-------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH-------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred CCCCCCEECCCCCCCCCCCCHHHHHC-------CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 58875265476325731079999837-------99994215661489999999689999999699999999984799999
Q ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHC
Q ss_conf 99559999999999940019999999999980
Q 004633 582 IPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 582 iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLq 613 (741)
.+..++.++++||.+||..||++|||+.|+++
T Consensus 236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 85445399999999976889667929999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.79 Aligned_cols=248 Identities=27% Similarity=0.479 Sum_probs=216.0
Q ss_pred CCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE-
Q ss_conf 9979999078148823297699999987899479999962189995519999999999999941699873640340563-
Q 004633 349 ASPKKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV- 427 (741)
Q Consensus 349 ~~~~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~- 427 (741)
|+...++|++++.||+|+||.||+|.++ |..||||+++. +. ..+.+.+|++++++++|||||++++++.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~---~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN---DA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC---CC------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECC---HH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 9557899488579820798089999999--90999999885---77----799999999999867898985498788723
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf 565899995228987002442015-6643899999999999999999969903145777664866899479930263010
Q 004633 428 DDHLYIYLEYVHPGSINRYVREHC-RDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 428 ~~~l~LVmEy~~gGsL~~~L~~~~-~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~ 506 (741)
++.+|+||||+++|+|.+++.++. ..+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~ 152 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred CCCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEE
T ss_conf 89289999636999899998745788889999999999998523211337655366656760146899776324560034
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCHHHHHHHHC-CCCCCCC
Q ss_conf 1375533345799999876999985313999989931014667899999962-9999999982789999850-6999995
Q 004633 507 LTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLT-GKPPWSEFEGPQAMFKVLN-RTPPIPE 584 (741)
Q Consensus 507 ~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLt-Gk~PF~~~~~~~~l~ki~~-~~~~iP~ 584 (741)
.... .....++..|+|||++.+ ..++.++|||||||++|||++ |++||......+....+.. ..++++.
T Consensus 153 ~~~~--~~~~~~~~~y~aPE~l~~-------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~ 223 (262)
T d1byga_ 153 ASST--QDTGKLPVKWTAPEALRE-------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223 (262)
T ss_dssp -----------CCTTTSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT
T ss_pred CCCC--CCCCCCCCCCCCHHHHHC-------CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf 4787--765566646778178727-------9888588777579999999978999999999999999998089999976
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 599999999999400199999999999809
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 585 ~ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
.+++++.+||.+||..||.+|||+.+++++
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 579999999999756697689399999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.93 Aligned_cols=248 Identities=26% Similarity=0.442 Sum_probs=208.3
Q ss_pred EEEEEEEEECCCEEEEEEEECCCC---CEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE-CCEE
Q ss_conf 078148823297699999987899---479999962189995519999999999999941699873640340563-5658
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETG---ASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVV-DDHL 431 (741)
Q Consensus 356 Y~i~k~LG~GsfG~Vy~a~~k~tg---~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~-~~~l 431 (741)
+...++||+|+||+||+|++..++ ..||||+++.. ......+++.+|+++|.+++|||||++++++.. ++.+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC----CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred ECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC----CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCE
T ss_conf 52666981368809999999779987999999998843----69789999999999998678999867867898069943
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECCCCHHCCCCC
Q ss_conf 99995228987002442015664389999999999999999996990314577766486689947993026301013755
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFGMAKHLTGLS 511 (741)
Q Consensus 432 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFGLA~~~~~~~ 511 (741)
++|||||.+|+|.+++......+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEEEEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 89998740674144210134540489999999998876520033676257766875767799988991065232255665
Q ss_pred -----CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCC-CCHHHHHHHH-CCCCCCCC
Q ss_conf -----3334579999987699998531399998993101466789999996299999999-8278999985-06999995
Q 004633 512 -----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEF-EGPQAMFKVL-NRTPPIPE 584 (741)
Q Consensus 512 -----~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~-~~~~~l~ki~-~~~~~iP~ 584 (741)
......||..|+|||++.. ..++.++||||||+++|||++|..||... +..+....+. +..+..|.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~ 257 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT-------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 257 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH-------CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCT
T ss_pred CCCCEECCCCCCCCCCCCHHHHHC-------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf 553100256555645567688743-------7999745746619999999978999988899999999998089889964
Q ss_pred CCCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf 599999999999400199999999999809
Q 004633 585 MLSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 585 ~ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
.+++++.+||.+||..||++||++.|++++
T Consensus 258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 475999999999768897689399999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=351.25 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=201.3
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCE-EEECCEEEECCEE
Q ss_conf 999078148823297699999987899479999962189995519999999999999941699873-6403405635658
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENI-VQYYGSEVVDDHL 431 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNI-Vkl~g~~~~~~~l 431 (741)
.++|++++.||+|+||.||+|+++.+|+.||||++...... ..+..|+++++.++|+++ +.+++++...+..
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC-------HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEE
T ss_conf 88899968985078809999999889989999997210058-------88999999999703899601799999519877
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECC---CCCEEEEECCCCHHCC
Q ss_conf 9999522898700244201566438999999999999999999699031457776648668---9947993026301013
Q 004633 432 YIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA---SGVVKLADFGMAKHLT 508 (741)
Q Consensus 432 ~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~---~g~vKLiDFGLA~~~~ 508 (741)
++||||+. ++|.+.+....+.+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.+.
T Consensus 79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEECC-CCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf 89998738-71333244306887689999999999999999997994426678766064335777615650467513425
Q ss_pred CCC--------CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HC
Q ss_conf 755--------3334579999987699998531399998993101466789999996299999999827899998---50
Q 004633 509 GLS--------YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGPQAMFKV---LN 577 (741)
Q Consensus 509 ~~~--------~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~~~l~ki---~~ 577 (741)
... ......||+.|||||++.+ ..++.++|||||||++|||++|+.||...........+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLG-------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-------BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred CCCCCCCEECCCCCCCCCCCCCCCHHHHHC-------CCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHC
T ss_conf 544554100013577678735329999918-------9989832188617789999849876655305779999998523
Q ss_pred C-----CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHH---HHCCCCCC
Q ss_conf 6-----99999559999999999940019999999999---98093542
Q 004633 578 R-----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVE---LLEHPFIR 618 (741)
Q Consensus 578 ~-----~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~E---iLqHpff~ 618 (741)
. .......+++++.+||..||..||++||++.+ +|++.|.+
T Consensus 231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 5678983575347889999999998439955791999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=344.28 Aligned_cols=247 Identities=20% Similarity=0.266 Sum_probs=204.4
Q ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEEEECCE
Q ss_conf 999907814882329769999998789947999996218999551999999999999994169-9873640340563565
Q 004633 352 KKSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDH 430 (741)
Q Consensus 352 ~~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~ 430 (741)
..++|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+|++++..|. |+||+.+++++.....
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 75 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-------HHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
T ss_conf 898069979984178829999999889979999997502582-------9999999999996489998779999601881
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECC-----CCCEEEEECCCCH
Q ss_conf 89999522898700244201566438999999999999999999699031457776648668-----9947993026301
Q 004633 431 LYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDA-----SGVVKLADFGMAK 505 (741)
Q Consensus 431 l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~-----~g~vKLiDFGLA~ 505 (741)
.|+||||+ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+|+
T Consensus 76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred CEEEEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 17999964-88879999752031106899999999999999999779662667713152347543447956872366057
Q ss_pred HCCCC--------CCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHH
Q ss_conf 01375--------53334579999987699998531399998993101466789999996299999999827---89999
Q 004633 506 HLTGL--------SYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP---QAMFK 574 (741)
Q Consensus 506 ~~~~~--------~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~---~~l~k 574 (741)
.+... .......||+.|||||++. +..++.++||||||+++|||++|+.||.+.... ....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~-------~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHL-------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT-------TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHHC-------CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 71467665411102467627751026798964-------88888699989831999999869876788530219999999
Q ss_pred HHCC-----CCCCCCCCCHHHHHHHHHHHHCCCCCCCCHHHHHC
Q ss_conf 8506-----99999559999999999940019999999999980
Q 004633 575 VLNR-----TPPIPEMLSSEGKDFLLRCFLRNPVERPSAVELLE 613 (741)
Q Consensus 575 i~~~-----~~~iP~~ls~el~dLI~~mL~~DP~kRPTa~EiLq 613 (741)
+... ...+...+++++.+++..|+..+|++||+++.+.+
T Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 97056799958965799899999999984399300859999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.39 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=193.9
Q ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC---
Q ss_conf 99907814882329769999998789947999996218999551999999999999994169987364034056356---
Q 004633 353 KSQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKHENIVQYYGSEVVDD--- 429 (741)
Q Consensus 353 ~~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~g~~~~~~--- 429 (741)
..+|.+.+.||+|+||.||+|+. +|..||||+++.. .......+.|+..+.+++|||||++++++..++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCC------CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCC
T ss_conf 86899988982078819999999--9989999998720------046799999999996279986832688998379860
Q ss_pred -EEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCEECCCCCCCCEEECCCCCEEEEE
Q ss_conf -5899995228987002442015664389999999999999999996--------9903145777664866899479930
Q 004633 430 -HLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS--------TNTIHRDIKGANLLVDASGVVKLAD 500 (741)
Q Consensus 430 -~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs--------~gIVHRDIKP~NILId~~g~vKLiD 500 (741)
.+|+||||+.+|+|.+++++. .+++..+..++.|++.||.|||. +||+||||||+|||++.++.+||+|
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEEECCCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEE
T ss_conf 4899999646698989998658--99989999999999999999887665204689866153173135786887768876
Q ss_pred CCCCHHCCCCC-----CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC--------
Q ss_conf 26301013755-----33345799999876999985313999989931014667899999962999999998--------
Q 004633 501 FGMAKHLTGLS-----YELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFE-------- 567 (741)
Q Consensus 501 FGLA~~~~~~~-----~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~-------- 567 (741)
||+++...... ......||+.|+|||++.+..... ...++.++|||||||+||||++|..||....
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK-HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTT-CHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred CCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH
T ss_conf 3866234677762001355250354767822105654546-777675012201599999996289988766311241012
Q ss_pred ------CHHHHHHHH-C--CCCCCCCC-----CCHHHHHHHHHHHHCCCCCCCCHHHHHCC
Q ss_conf ------278999985-0--69999955-----99999999999400199999999999809
Q 004633 568 ------GPQAMFKVL-N--RTPPIPEM-----LSSEGKDFLLRCFLRNPVERPSAVELLEH 614 (741)
Q Consensus 568 ------~~~~l~ki~-~--~~~~iP~~-----ls~el~dLI~~mL~~DP~kRPTa~EiLqH 614 (741)
......... . ..+.++.. ....+.+||.+||..||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 2556430999999875024688877655776899999999999760698589599999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=345.41 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=197.6
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEEC
Q ss_conf 9907814882329769999998789947999996218999551999999999999994169-----------98736403
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----------HENIVQYY 422 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-----------HPNIVkl~ 422 (741)
.+|+++++||+|+||+||+|+++.+|+.||||+++. .....+.+.+|+.+++.+. |+|||+++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEC------CCCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEE
T ss_conf 857998997507781899999999997999999834------31336899999999998401455555422767647899
Q ss_pred CEEEEC--CEEEEEEEECCCCCHHHHH--HHCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCCCCEEECCCC---
Q ss_conf 405635--6589999522898700244--2015664389999999999999999996-9903145777664866899---
Q 004633 423 GSEVVD--DHLYIYLEYVHPGSINRYV--REHCRDITESIVRNFTRHILNGLAYLHS-TNTIHRDIKGANLLVDASG--- 494 (741)
Q Consensus 423 g~~~~~--~~l~LVmEy~~gGsL~~~L--~~~~~~lse~~i~~I~~QIl~gL~yLHs-~gIVHRDIKP~NILId~~g--- 494 (741)
+++... ...+++|+++..+...... ......+++..++.+++||+.||.|||+ .||+||||||+|||++.++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCC
T ss_conf 87631256520234320003542000001223467868999999999999988876405864656770570563057656
Q ss_pred ---CEEEEECCCCHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCH--
Q ss_conf ---479930263010137553334579999987699998531399998993101466789999996299999999827--
Q 004633 495 ---VVKLADFGMAKHLTGLSYELSLKGSPNWMAPEVIKAVMQKDGNPKLALAVDIWSLGCTVIEMLTGKPPWSEFEGP-- 569 (741)
Q Consensus 495 ---~vKLiDFGLA~~~~~~~~~~t~~GT~~Y~APEvl~~~~~~~g~~~~t~asDIWSLGiILyELLtGk~PF~~~~~~-- 569 (741)
.+||+|||.+...... .....||+.|+|||++.+ ..++.++||||+||++++|++|+.||...+..
T Consensus 167 ~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-------APWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp TEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-------CCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCCEEEEEECCCCCCCCCC--CCCCCCCCCCCCHHHCCC-------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 4430567531442123445--422366521057132146-------6777643201237899999878899898755432
Q ss_pred ----HHHHH---HHCC---------------------------------------CCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf ----89999---8506---------------------------------------9999955999999999994001999
Q 004633 570 ----QAMFK---VLNR---------------------------------------TPPIPEMLSSEGKDFLLRCFLRNPV 603 (741)
Q Consensus 570 ----~~l~k---i~~~---------------------------------------~~~iP~~ls~el~dLI~~mL~~DP~ 603 (741)
..+.. +++. ........+.++++||.+||..||.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHH
T ss_conf 10268999999983799878862453220001320122024323577644421000156743589999999998779945
Q ss_pred CCCCHHHHHCCCCCCCCC
Q ss_conf 999999998093542455
Q 004633 604 ERPSAVELLEHPFIRNAN 621 (741)
Q Consensus 604 kRPTa~EiLqHpff~~~~ 621 (741)
+|||+.|+|+||||++..
T Consensus 318 ~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 318 KRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp TCBCHHHHHTCGGGTTCT
T ss_pred HCCCHHHHHCCCCCCCCC
T ss_conf 790899996693407898
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.96 E-value=4.1e-29 Score=186.89 Aligned_cols=174 Identities=18% Similarity=0.209 Sum_probs=122.3
Q ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCC-------------CCCHHHHHHHHHHHHHHHHCCCCCEEEEC
Q ss_conf 07814882329769999998789947999996218999-------------55199999999999999416998736403
Q 004633 356 WQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDD-------------PKSAECIKQLEQEIKVLGHLKHENIVQYY 422 (741)
Q Consensus 356 Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~-------------~~~~~~ik~l~~Ei~iL~~L~HPNIVkl~ 422 (741)
+.++++||+|+||+||+|.+. +|+.||||+++..... ...........+|+..+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 022778024856599999979-9999999998604434666556563000888999999778999999981699914499
Q ss_pred CEEEECCEEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCCEEECCCCCEEEEECC
Q ss_conf 40563565899995228987002442015664389999999999999999996990314577766486689947993026
Q 004633 423 GSEVVDDHLYIYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHSTNTIHRDIKGANLLVDASGVVKLADFG 502 (741)
Q Consensus 423 g~~~~~~~l~LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs~gIVHRDIKP~NILId~~g~vKLiDFG 502 (741)
+.. ..+++|||++++.+.+ +.+..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||
T Consensus 81 ~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred EEC----CCEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEECC
T ss_conf 862----8889999504565420--------0157899999999999999826888983689036114289-89998778
Q ss_pred CCHHCCCCCCCCCCCCCCCCCCH--HHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 30101375533345799999876--99998531399998993101466789999
Q 004633 503 MAKHLTGLSYELSLKGSPNWMAP--EVIKAVMQKDGNPKLALAVDIWSLGCTVI 554 (741)
Q Consensus 503 LA~~~~~~~~~~t~~GT~~Y~AP--Evl~~~~~~~g~~~~t~asDIWSLGiILy 554 (741)
+|......... .|... +.+...+ ...|+..+|+||+.--+.
T Consensus 148 ~a~~~~~~~~~-------~~l~rd~~~~~~~f----~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 148 QSVEVGEEGWR-------EILERDVRNIITYF----SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TCEETTSTTHH-------HHHHHHHHHHHHHH----HHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCH-------HHHHHHHHHHHHHH----CCCCCCCCCHHHHHHHHH
T ss_conf 84308998709-------99987799999997----578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.02 E-value=1.4e-09 Score=71.20 Aligned_cols=140 Identities=14% Similarity=0.083 Sum_probs=89.5
Q ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEEEECCEEE
Q ss_conf 9907814882329769999998789947999996218999551999999999999994169-987364034056356589
Q 004633 354 SQWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVDDHLY 432 (741)
Q Consensus 354 ~~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~~~l~ 432 (741)
..|+..+..+-++.+.||+.. .++..+.+|......... ...+.+|..+++.+. +--+.+++.+...++..+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~-----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT-----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS-----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HCEEEEECCCCCCCCCEEEEE--ECCCEEEEEECCCCCCCC-----HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 352799767899877189999--089869999848876532-----5569999999998760699872899975089649
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q ss_conf 9995228987002442015664389999999999999999996-------------------------------------
Q 004633 433 IYLEYVHPGSINRYVREHCRDITESIVRNFTRHILNGLAYLHS------------------------------------- 475 (741)
Q Consensus 433 LVmEy~~gGsL~~~L~~~~~~lse~~i~~I~~QIl~gL~yLHs------------------------------------- 475 (741)
+|||+++|..+....... . ....+..++...+..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~---~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE---Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTTC---S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEECCCCCCCCCCCCC---C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 999860433435433440---2---6999999899999998556842143576446565557789987765555430332
Q ss_pred ----------------------CCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf ----------------------9903145777664866899479930263010
Q 004633 476 ----------------------TNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 476 ----------------------~gIVHRDIKP~NILId~~g~vKLiDFGLA~~ 506 (741)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 32005799999999844986781789860047642364996599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.74 E-value=1.7e-08 Score=64.83 Aligned_cols=83 Identities=16% Similarity=0.098 Sum_probs=52.2
Q ss_pred EEEEEEECCCEEEEEEEECCCCCEEEEEEEECC---CCCCCCHHHHHHHHHHHHHHHHCC-C--CCEEEECCEEEECCEE
Q ss_conf 814882329769999998789947999996218---999551999999999999994169-9--8736403405635658
Q 004633 358 KGKLIGRGTFGSVYIGTNRETGASCAIKEVDII---PDDPKSAECIKQLEQEIKVLGHLK-H--ENIVQYYGSEVVDDHL 431 (741)
Q Consensus 358 i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~---~~~~~~~~~ik~l~~Ei~iL~~L~-H--PNIVkl~g~~~~~~~l 431 (741)
..+.||.|..-.||++.+..++..+++|.-... ..+.. .....+...|...|+.+. + ..+.+++. .+++..
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~-~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~ 106 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESW-PLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMA 106 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCC-CCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTT
T ss_pred EEEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCC-CCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECCCCC
T ss_conf 69980798527689999579984899961771303467778-887789999999999865057988552899--859887
Q ss_pred EEEEEECCCCCH
Q ss_conf 999952289870
Q 004633 432 YIYLEYVHPGSI 443 (741)
Q Consensus 432 ~LVmEy~~gGsL 443 (741)
++|||++.+..+
T Consensus 107 ~lvmE~L~~~~~ 118 (392)
T d2pula1 107 VTVMEDLSHLKI 118 (392)
T ss_dssp EEEECCCTTSEE
T ss_pred EEEEECCCCCCC
T ss_conf 798713577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.66 E-value=1.1e-07 Score=60.12 Aligned_cols=138 Identities=13% Similarity=0.021 Sum_probs=79.3
Q ss_pred EEEEECC-CEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC--CCCEEEECCEEEECCEEEEEEE
Q ss_conf 4882329-769999998789947999996218999551999999999999994169--9873640340563565899995
Q 004633 360 KLIGRGT-FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK--HENIVQYYGSEVVDDHLYIYLE 436 (741)
Q Consensus 360 k~LG~Gs-fG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~--HPNIVkl~g~~~~~~~l~LVmE 436 (741)
+.+..|. .+.||+.... ++..+.+|...... . ..+..|...++.|. .-.+.+++.+..+.+..++|||
T Consensus 16 ~~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~ 86 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--L------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 86 (255)
T ss_dssp EECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--T------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred EECCCCCCCCEEEEEEEC-CCCEEEEEECCCCC--H------HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEE
T ss_conf 876786547758999938-98789999589667--7------68999999999998659998861322245661599987
Q ss_pred ECCCCCHHHHHH--------------H-CC-----CCCCHHH---HHHH---H----------------HHHHHHHHHHH
Q ss_conf 228987002442--------------0-15-----6643899---9999---9----------------99999999999
Q 004633 437 YVHPGSINRYVR--------------E-HC-----RDITESI---VRNF---T----------------RHILNGLAYLH 474 (741)
Q Consensus 437 y~~gGsL~~~L~--------------~-~~-----~~lse~~---i~~I---~----------------~QIl~gL~yLH 474 (741)
+++|.++..... + +. ..+.... +... . ......+..+.
T Consensus 87 ~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 166 (255)
T d1nd4a_ 87 EVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 166 (255)
T ss_dssp CCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred EEECCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 44135543221268999999999999873688544887554124688999999875411011340112137999999998
Q ss_pred HC-------CEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf 69-------903145777664866899479930263010
Q 004633 475 ST-------NTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 475 s~-------gIVHRDIKP~NILId~~g~vKLiDFGLA~~ 506 (741)
.. .++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 718765795678678887635773796589998533265
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.18 E-value=1.2e-05 Score=48.05 Aligned_cols=131 Identities=15% Similarity=0.126 Sum_probs=71.4
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCCC-----CCEEEECC--EEEECCEEEEEEEECC
Q ss_conf 7699999987899479999962189995519999999999999941699-----87364034--0563565899995228
Q 004633 367 FGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLKH-----ENIVQYYG--SEVVDDHLYIYLEYVH 439 (741)
Q Consensus 367 fG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~H-----PNIVkl~g--~~~~~~~l~LVmEy~~ 439 (741)
--.||++.. .+|..|++|+.+... .. .+++..|...+..|.. +..+..-+ .+..++..+.+++++.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~---~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER---WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT---SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred CCEEEEEEC-CCCCEEEEEEECCCC---CC---HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECC
T ss_conf 202699983-899979999847877---88---99999999999999855998787520689805665347999986527
Q ss_pred CCCHHHH-----------H---HH----C----CCC-------------------CCHH---HHHHHHHHHHHHHHHHH-
Q ss_conf 9870024-----------4---20----1----566-------------------4389---99999999999999999-
Q 004633 440 PGSINRY-----------V---RE----H----CRD-------------------ITES---IVRNFTRHILNGLAYLH- 474 (741)
Q Consensus 440 gGsL~~~-----------L---~~----~----~~~-------------------lse~---~i~~I~~QIl~gL~yLH- 474 (741)
|..+... + +. . ... ++.. .....+.+++..+.-+-
T Consensus 108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 76889999999999899999988630357865567789788766568999874769988989999999999999998454
Q ss_pred ---HCCEECCCCCCCCEEECCCCCEEEEECCCCHH
Q ss_conf ---69903145777664866899479930263010
Q 004633 475 ---STNTIHRDIKGANLLVDASGVVKLADFGMAKH 506 (741)
Q Consensus 475 ---s~gIVHRDIKP~NILId~~g~vKLiDFGLA~~ 506 (741)
..++||+|+.+.|||++. + ..++||+.+..
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCCCCEEECCCCCCCCEEEEC-C-CEEEECHHCCC
T ss_conf 568712024788804287838-9-35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.96 E-value=4e-05 Score=44.85 Aligned_cols=77 Identities=13% Similarity=0.106 Sum_probs=47.2
Q ss_pred EEEEEEEECCCEEEEEEEECCC-------CCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEEEEC
Q ss_conf 7814882329769999998789-------947999996218999551999999999999994169-98736403405635
Q 004633 357 QKGKLIGRGTFGSVYIGTNRET-------GASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-HENIVQYYGSEVVD 428 (741)
Q Consensus 357 ~i~k~LG~GsfG~Vy~a~~k~t-------g~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-HPNIVkl~g~~~~~ 428 (741)
...+.|+-|-.=.+|++..... +..|.+++.- .. ... ....+|..+++.+. +.-..++++.+.
T Consensus 45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g---~~-~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~-- 115 (395)
T d1nw1a_ 45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF---NP-ETE---SHLVAESVIFTLLSERHLGPKLYGIFS-- 115 (395)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC---SC-CCH---HHHHHHHHHHHHHHHTTSSSCEEEEET--
T ss_pred EEEEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC---CC-CHH---HHHHHHHHHHHHHHHCCCCCEEEEECC--
T ss_conf 699991785334348999688775445789817999659---96-116---589999999999975799980899818--
Q ss_pred CEEEEEEEECCCCCHH
Q ss_conf 6589999522898700
Q 004633 429 DHLYIYLEYVHPGSIN 444 (741)
Q Consensus 429 ~~l~LVmEy~~gGsL~ 444 (741)
+ .+||||++|..|.
T Consensus 116 ~--g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 116 G--GRLEEYIPSRPLS 129 (395)
T ss_dssp T--EEEECCCCEEECC
T ss_pred C--CEEEEEECCCCCC
T ss_conf 9--5699973455488
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.89 E-value=0.00018 Score=41.03 Aligned_cols=142 Identities=16% Similarity=0.125 Sum_probs=76.0
Q ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCCCCHHHHHHHHHHHHHHHHCC-----CCCEEEECC---EEE
Q ss_conf 907814882329769999998789947999996218999551999999999999994169-----987364034---056
Q 004633 355 QWQKGKLIGRGTFGSVYIGTNRETGASCAIKEVDIIPDDPKSAECIKQLEQEIKVLGHLK-----HENIVQYYG---SEV 426 (741)
Q Consensus 355 ~Y~i~k~LG~GsfG~Vy~a~~k~tg~~vAIK~i~~~~~~~~~~~~ik~l~~Ei~iL~~L~-----HPNIVkl~g---~~~ 426 (741)
+..-.+.|..|---+.|++... +..+++|++... .. ...+..|+.+|..|. .|..+...+ ...
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~-~~------~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKR-VE------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CEEEEEEECC---EEEEEEEES--SCCEEEEEECC----------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCEEEECCCCCCCCCEEEEEEC--CCCEEEEECCCC-CC------HHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEE
T ss_conf 8568523788852673899978--972899980789-99------88999999998754302555455641048976213
Q ss_pred ECCEEEEEEEECCCCCHHHHHHHCC----------------------C------------------CCCHHHHHHHHHHH
Q ss_conf 3565899995228987002442015----------------------6------------------64389999999999
Q 004633 427 VDDHLYIYLEYVHPGSINRYVREHC----------------------R------------------DITESIVRNFTRHI 466 (741)
Q Consensus 427 ~~~~l~LVmEy~~gGsL~~~L~~~~----------------------~------------------~lse~~i~~I~~QI 466 (741)
.......++.++.|........... . ..........+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred EECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHH
T ss_conf 41255024531146553332046788888998764544432024531011101200245677776531141279999999
Q ss_pred HHHHHHHH----HCCEECCCCCCCCEEECCCCCEEEEECCCCH
Q ss_conf 99999999----6990314577766486689947993026301
Q 004633 467 LNGLAYLH----STNTIHRDIKGANLLVDASGVVKLADFGMAK 505 (741)
Q Consensus 467 l~gL~yLH----s~gIVHRDIKP~NILId~~g~vKLiDFGLA~ 505 (741)
...+.-.. ..|+||+|+.++|||++.+...-|+||+.+.
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 8764204855454503337863656402045412674222123
|